Citrus Sinensis ID: 041312
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 743 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.943 | 0.895 | 0.491 | 0.0 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.978 | 0.863 | 0.421 | 1e-174 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.978 | 0.892 | 0.428 | 1e-171 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.960 | 0.870 | 0.423 | 1e-169 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.955 | 0.865 | 0.430 | 1e-167 | |
| O64782 | 805 | G-type lectin S-receptor- | no | no | 0.967 | 0.893 | 0.411 | 1e-165 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.982 | 0.879 | 0.417 | 1e-163 | |
| O64781 | 831 | G-type lectin S-receptor- | no | no | 0.959 | 0.858 | 0.407 | 1e-162 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.939 | 0.814 | 0.400 | 1e-160 | |
| O64771 | 809 | G-type lectin S-receptor- | no | no | 0.963 | 0.885 | 0.410 | 1e-160 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/739 (49%), Positives = 479/739 (64%), Gaps = 38/739 (5%)
Query: 3 SVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNP 62
+ D + +NQ +KDGD IVS G F +GFFSPG S RY+GIWY +I +QTVVWVANRD+P
Sbjct: 23 ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSP 82
Query: 63 INDTSGVLTISSLGNLVLCGRNQTVPVWHANV----SDSSESNTIAQLLDTGNLVLARNN 118
+ D SG L +S G+L L + +W ++ +S N I Q+LDTGNLV+ +
Sbjct: 83 LYDLSGTLKVSENGSLCLFNDRNHI-IWSSSSSPSSQKASLRNPIVQILDTGNLVVRNSG 141
Query: 119 TGQT-LWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQ 177
Q +WQS D+P LP MK GL+ +GLNRFLTSW++ D+P+TG+YT +M+ +G PQ
Sbjct: 142 DDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQ 201
Query: 178 LFLYKGEAKWWRVGSWTGKNFLNA-----------TYIDNEDEVSMAYSVTDPSMLTRIV 226
FL K +R G W G F Y+ E+EV Y + +PS+LTR+
Sbjct: 202 FFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQ 261
Query: 227 VNESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFE 286
+N +G QR TW + W Y + + CD Y CGS +CN + + C CL GF
Sbjct: 262 LNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCN---INESPACRCLKGFV 318
Query: 287 PKSPSEWFLREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMC 346
K+P W + GCVR+ ++ + DGF++++ +K+PD + D ++ L CK +C
Sbjct: 319 AKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVC 378
Query: 347 LRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAELDDSRRNS 406
LRNC+C AY+ +G GC+ + GD++D R Y GQDLYVR+ ++E++ +R S
Sbjct: 379 LRNCTCSAYSPFDIR---DGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRES 435
Query: 407 EY------------LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRL 454
LP DL ++ AT+ FS+ NKLG+GGFG VYKG L G+E+AVKRL
Sbjct: 436 SRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRL 495
Query: 455 SRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAK 514
SR+S QG+EEFK EI LIA+LQHRNLV ILG C++E+E+MLIYEY PNKSLD +IFD+ +
Sbjct: 496 SRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKER 555
Query: 515 RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574
R LDW KR EII GIARG+LYLH+DSRLRIIHRDLKASNVLLD+ MN KISDFG+AR
Sbjct: 556 RRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTL 615
Query: 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGS 634
GGD+ E NT RVVGTYGYM+PEY ++G FS KSDV+SFGVL+LEI+ GRRN F E+
Sbjct: 616 GGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEE-- 673
Query: 635 GSWNLVGHVWDLWKEGTAMEAVDKSLGESCC-APEILRCIHLGLLCVQEQATDRPNMSAV 693
NL+GH W + E A E +D+++ ESC E+LR IH+GLLCVQ+ DRPNMS V
Sbjct: 674 HKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVV 733
Query: 694 VSMLGSDNAPSSPKHPAFI 712
V ML S+ P+ P F
Sbjct: 734 VLMLSSEMLLLDPRQPGFF 752
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 347/824 (42%), Positives = 481/824 (58%), Gaps = 97/824 (11%)
Query: 5 DTITSNQPIKDGD--VIVSSGNIFALGFFSPGNSVRR--YVGIWYNQIPVQTVVWVANRD 60
D IT + PIKD + ++ IF GFF+P NS R YVGIWY +IP+QTVVWVAN+D
Sbjct: 31 DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANKD 90
Query: 61 NPINDTSGVLTISSLGNLVLC-GRNQTVPVWHANVSDSSESN-TIAQLLDTGNLVLARN- 117
+PINDTSGV++I GNL + GRN+ V W NVS N T QL+D+GNL+L N
Sbjct: 91 SPINDTSGVISIYQDGNLAVTDGRNRLV--WSTNVSVPVAPNATWVQLMDSGNLMLQDNR 148
Query: 118 NTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQ 177
N G+ LW+SF HP + +P M +G D R+G N LTSW S D+P+TG+YT + FP+
Sbjct: 149 NNGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPE 208
Query: 178 LFLYKGEAKWWRVGSWTGKNFLNATYID-------------NEDEVSMAYSVTDPSMLTR 224
L ++K WR G W G+ F+ +D N+ +SM+Y+ + S +
Sbjct: 209 LLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSYA--NDSFMYH 266
Query: 225 IVVNESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPG 284
++ G + WS W P CD YG CG +C+ + C C+ G
Sbjct: 267 FNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCH---AGENPPCKCVKG 323
Query: 285 FEPKSPSEWFLREGLRGCVRKPQMSTCR-----------RGDGFIRVAGVKVPDMSVARV 333
F PK+ +EW GC+RK + R + DGF+++ +KVP +S R
Sbjct: 324 FVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVP-ISAERS 382
Query: 334 DMSLGLEACKHMCLRNCSCLAYT------------------------------SAYAESE 363
+ S + C +CL NCSC AY A++E +
Sbjct: 383 EASE--QVCPKVCLDNCSCTAYAYDRGIGCMLWSGDLVDMQSFLGSGIDLFIRVAHSELK 440
Query: 364 SNGRIGCLTYH---GDMM--------DTRTYIN--------AGQDLYVRVDAAELDDSRR 404
++ + + G M+ R Y + + ++ R++A D+
Sbjct: 441 THSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESA 500
Query: 405 NSEY----LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ 460
+++ LP+F+ +A +T+ FS NKLG+GGFG VYKG L G+EIAVKRLSR SGQ
Sbjct: 501 SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQ 560
Query: 461 GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDW 520
G+EE E+ +I++LQHRNLV +LGCCIE +E+ML+YEY+P KSLD Y+FD K+ +LDW
Sbjct: 561 GLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDW 620
Query: 521 SKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
RF I+ GI RG+LYLH+DSRL+IIHRDLKASN+LLD +NPKISDFG+ARIF ++ E
Sbjct: 621 KTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDE 680
Query: 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLV 640
NT RVVGTYGYM+PEYAMEG FS KSDV+S GV+ LEII GRRN++ H E+ + NL+
Sbjct: 681 ANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEE--NNLNLL 738
Query: 641 GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700
+ W LW +G A D ++ + C EI +C+H+GLLCVQE A DRPN+S V+ ML ++
Sbjct: 739 AYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTE 798
Query: 701 N-APSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
N + + PK PAFI + ++ E S+ND+++TA R
Sbjct: 799 NMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1551), Expect = e-171, Method: Compositional matrix adjust.
Identities = 347/810 (42%), Positives = 483/810 (59%), Gaps = 83/810 (10%)
Query: 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVR---RYVGIWYNQIPVQTVVWVA 57
++ + IT + +KDGD + S +F LGFFS + R++G+WY + P VVWVA
Sbjct: 22 ALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PF-AVVWVA 79
Query: 58 NRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSE----SNTIAQLLDTGNLV 113
NR+NP+ TSG L +SSLG+L L +W ++ S + +N + ++ +GNL+
Sbjct: 80 NRNNPLYGTSGFLNLSSLGDLQLFDGEHKA-LWSSSSSSTKASKTANNPLLKISCSGNLI 138
Query: 114 LARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELD 173
+ + LWQSFD+P T+L MK+G + ++ + L+SWK+ +P+ GD+T ++
Sbjct: 139 -SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTR 197
Query: 174 GFPQLFLYK-GEAKW-WRVGSWTGKNFLNATYIDNEDEVSMAYSVTDPS----------- 220
G PQL L K G++ + +R+GSW G +F A + E+ + Y T +
Sbjct: 198 GLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSL-FDYKFTSSAQEVNYSWTPRH 256
Query: 221 -MLTRIVVNESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYEC 279
+++R+V+N +G R S Q N+WI P++ CD+Y CG+ + C + C
Sbjct: 257 RIVSRLVLNNTGKLHRFIQSKQ-NQWILANTAPEDECDYYSICGAYAVCG-INSKNTPSC 314
Query: 280 TCLPGFEPKSPSEWFLREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMS--L 337
+CL GF+PKS +W + G GCV + + C + D F++ G+K+PD S + D +
Sbjct: 315 SCLQGFKPKSGRKWNISRGAYGCVHEIP-TNCEKKDAFVKFPGLKLPDTSWSWYDAKNEM 373
Query: 338 GLEACKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAA 397
LE CK C NCSC AY A + G+ GCL + GD++D R Y + GQD+Y+R+ A
Sbjct: 374 TLEDCKIKCSSNCSCTAY--ANTDIREGGK-GCLLWFGDLVDMREYSSFGQDVYIRMGFA 430
Query: 398 ELDDSRRNSEY-------------------------------------------LPVFDL 414
+++ R LP+FD
Sbjct: 431 KIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDR 490
Query: 415 SNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ 474
I+ AT+DFS N LG GGFG VYKG L++G+EIAVKRLS +SGQG+EEFK E+ LIA+
Sbjct: 491 KTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAK 550
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534
LQHRNLV +LGCCI+ +E MLIYEY+PNKSLD +IFDE + + LDW KR II G+ARGI
Sbjct: 551 LQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGI 610
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
LYLHQDSRLRIIHRDLKA NVLLD MNPKISDFG+A+ FGGDQ E +TNRVVGTYGYM
Sbjct: 611 LYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMP 670
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM- 653
PEYA++G FS KSDV+SFGVL+LEII G+ N F NL+GHVW +W E +
Sbjct: 671 PEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFR--HADHDLNLLGHVWKMWVEDREIE 728
Query: 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIA 713
++ L E+ PE+LRCIH+ LLCVQ++ DRP M++VV M GSD++ P P F
Sbjct: 729 VPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFT 788
Query: 714 KGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
NV + + + S N+++IT Q R
Sbjct: 789 N--RNVPDISSSLSL-RSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 340/802 (42%), Positives = 462/802 (57%), Gaps = 88/802 (10%)
Query: 13 IKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTI 72
+ D + IVSS F GFFSP NS RY GIWYN IPVQTV+WVAN+D PIND+SGV++I
Sbjct: 36 LNDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSIPVQTVIWVANKDTPINDSSGVISI 95
Query: 73 SSLGNLVLCGRNQTVPVWHANVSDSSESN-TIAQLLDTGNLVLARNNTGQTLWQSFDHPS 131
S GNLV+ + V +W NVS + +N T+A+LL++GNLVL NT LW+SF +P+
Sbjct: 96 SEDGNLVVTDGQRRV-LWSTNVSTRASANSTVAELLESGNLVLKDANTDAYLWESFKYPT 154
Query: 132 ATMLPYMKIGLDKRSGL-NRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGE---AKW 187
+ LP M +G + R+G N +TSW + +P+ G YT + L +P+LF++ A
Sbjct: 155 DSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYTAALVLAPYPELFIFNNNDNNATV 214
Query: 188 WRVGSWTGKNF-----------LNATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRL 236
WR G W G F L ++++ S S + S L + ++ G R
Sbjct: 215 WRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDTNGSATMSYANDSTLRHLYLDYRGFAIRR 274
Query: 237 TWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEWFLR 296
WS W P CD Y CG + CNP + C+C+ GF P++ EW
Sbjct: 275 DWSEARRNWTLGSQVPATECDIYSRCGQYTTCNPRK---NPHCSCIKGFRPRNLIEWNNG 331
Query: 297 EGLRGCVRKPQMSTCRR-----GDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCS 351
GC+RK + R+ D F+++ +K+PD AR + E C CL++CS
Sbjct: 332 NWSGGCIRKLPLQCERQNNKGSADRFLKLQRMKMPDF--ARRSEASEPE-CFMTCLQSCS 388
Query: 352 CLAYTS------------------------------AYAESESNGR----IG-------- 369
C+A+ A++E ++ R IG
Sbjct: 389 CIAFAHGLGYGCMIWNRSLVDSQVLSASGMDLSIRLAHSEFKTQDRRPILIGTSLAGGIF 448
Query: 370 ----CLTYHGDMMDTRTYINAGQD---LYVRVDAAELDDSRRNSEYLPVFDLSNIAAATN 422
C+ ++ + G D ++ RV+A SR + LP+F+ +A AT+
Sbjct: 449 VVATCVLLARRIVMKKRAKKKGTDAEQIFKRVEALA-GGSREKLKELPLFEFQVLATATD 507
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+FS NKLG+GGFG VYKG+L G+EIAVKRLS++SGQG+EE TE+ +I++LQHRNLV
Sbjct: 508 NFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQASGQGLEELVTEVVVISKLQHRNLVK 567
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+ GCCI +E+ML+YE++P KSLD YIFD + LLDW+ RFEII GI RG+LYLH+DSR
Sbjct: 568 LFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLLDWNTRFEIINGICRGLLYLHRDSR 627
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602
LRIIHRDLKASN+LLD + PKISDFG+ARIF G++ E NT RVVGTYGYMAPEYAM GL
Sbjct: 628 LRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMGGL 687
Query: 603 FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662
FS KSDV+S GV+LLEII GRRN+ L+ HVW +W EG VD + +
Sbjct: 688 FSEKSDVFSLGVILLEIISGRRNS---------HSTLLAHVWSIWNEGEINGMVDPEIFD 738
Query: 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP-SSPKHPAFIAKGLSNVDE 721
EI +C+H+ LLCVQ+ A DRP++S V ML S+ A PK PAF+ + + E
Sbjct: 739 QLFEKEIRKCVHIALLCVQDAANDRPSVSTVCMMLSSEVADIPEPKQPAFMPRNVGLEAE 798
Query: 722 FWTGEGVTTSVNDLTITAFQPR 743
F + S+N++TIT R
Sbjct: 799 FSESIALKASINNVTITDVSGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 590 bits (1521), Expect = e-167, Method: Compositional matrix adjust.
Identities = 347/806 (43%), Positives = 469/806 (58%), Gaps = 96/806 (11%)
Query: 13 IKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTI 72
+ D + IVSS F GFFSP NS RY GIWYN + VQTV+WVAN+D PIND+SGV+++
Sbjct: 36 LNDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSVSVQTVIWVANKDKPINDSSGVISV 95
Query: 73 SSLGNLVLCGRNQTVPVWHANVSDSSESN-TIAQLLDTGNLVLARNNTGQTLWQSFDHPS 131
S GNLV+ + V +W NVS + +N T+A+LLD+GNLVL ++ LW+SF +P+
Sbjct: 96 SQDGNLVVTDGQRRV-LWSTNVSTQASANSTVAELLDSGNLVLKEASSDAYLWESFKYPT 154
Query: 132 ATMLPYMKIGLDKR-SGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGE---AKW 187
+ LP M +G + R G N +TSWKS +P+ G YT + L +P+LF+ +
Sbjct: 155 DSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYTAALVLAAYPELFIMNNNNNNSTV 214
Query: 188 WRVGSWTGKNF----------LNATYIDNED---EVSMAYSVTDPSMLTRIVVNESGNEQ 234
WR G W G+ F +I N+D V+M+Y+ + S L ++ G+
Sbjct: 215 WRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVTMSYA--NDSTLRYFYMDYRGSVI 272
Query: 235 RLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEWF 294
R WS W P CD Y CG + CNP + C+C+ GF P++ EW
Sbjct: 273 RRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRK---NPLCSCIRGFRPRNLIEWN 329
Query: 295 LREGLRGCVRKPQMSTCRR-----GDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRN 349
GC R+ + R+ DGF+R+ +K+PD AR + E C CL+
Sbjct: 330 NGNWSGGCTRRVPLQCERQNNNGSADGFLRLRRMKLPDF--ARRSEASEPE-CLRTCLQT 386
Query: 350 CSCLAYTS------------------------------AYAESESNGR----IG------ 369
CSC+A A++E ++ + IG
Sbjct: 387 CSCIAAAHGLGYGCMIWNGSLVDSQELSASGLDLYIRLAHSEIKTKDKRPILIGTILAGG 446
Query: 370 ------CLTYHGDMMDTRTYINAGQD---LYVRVDAAELDDSRRNSEYLPVFDLSNIAAA 420
C+ ++ + G+D ++ RV+A + + E LP+F+ +AAA
Sbjct: 447 IFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALAGGNKGKLKE-LPLFEFQVLAAA 505
Query: 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
TN+FS NKLG+GGFG VYKG LQ G+EIAVKRLSR+SGQG+EE E+ +I++LQHRNL
Sbjct: 506 TNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNL 565
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V +LGCCI +E+ML+YE++P KSLD Y+FD + LLDW RF II GI RG+LYLH+D
Sbjct: 566 VKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWKTRFNIINGICRGLLYLHRD 625
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
SRLRIIHRDLKASN+LLD + PKISDFG+ARIF G++ E NT RVVGTYGYMAPEYAM
Sbjct: 626 SRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEANTRRVVGTYGYMAPEYAMG 685
Query: 601 GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660
GLFS KSDV+S GV+LLEII GRRN+ L+ +VW +W EG VD +
Sbjct: 686 GLFSEKSDVFSLGVILLEIISGRRNSNS---------TLLAYVWSIWNEGEINSLVDPEI 736
Query: 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP-SSPKHPAFIAKGLSNV 719
+ EI +CIH+GLLCVQE A DRP++S V SML S+ A PK PAFI++ +NV
Sbjct: 737 FDLLFEKEIHKCIHIGLLCVQEAANDRPSVSTVCSMLSSEIADIPEPKQPAFISR--NNV 794
Query: 720 DEFWTGEG--VTTSVNDLTITAFQPR 743
E + E + S+N++TIT R
Sbjct: 795 PEAESSENSDLKDSINNVTITDVTGR 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 582 bits (1501), Expect = e-165, Method: Compositional matrix adjust.
Identities = 330/801 (41%), Positives = 454/801 (56%), Gaps = 82/801 (10%)
Query: 7 ITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDT 66
I ++ P+ + S G + LGFFSP N+ +YVGIW+ +I + VVWVANRD P+ +
Sbjct: 23 INTSSPLSIRQTLSSPGGFYELGFFSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPVTSS 82
Query: 67 SGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126
+ LTISS G+L+L Q V +W + +S + A+LLDTGN V+ + +G LWQS
Sbjct: 83 AANLTISSNGSLILLDGKQDV-IWSTGKAFTS-NKCHAELLDTGNFVVIDDVSGNKLWQS 140
Query: 127 FDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAK 186
F+H TMLP + D +G R LT+WKS +P+ G+++ + Q + +G
Sbjct: 141 FEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEFSLEITPQIPTQGLIRRGSVP 200
Query: 187 WWRVGSWTGKNF-----LNATYIDNEDEV--------SMAYSVTDPSMLTRIVVNESGNE 233
+WR G W F ++A+Y+ V S +YS L+ + + G +
Sbjct: 201 YWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFSYSTLRNYNLSYVTLTPEG-K 259
Query: 234 QRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEW 293
++ W + N W + + P+ PCD YG CG C D +C CL GF PKS EW
Sbjct: 260 MKILWDDGNN-WKLHLSLPENPCDLYGRCGPYGLC---VRSDPPKCECLKGFVPKSDEEW 315
Query: 294 FLREGLRGCVRKPQMSTCRRG---------DGFIRVAGVKVPDMSVARVDMSLGLEACKH 344
GCVR+ ++S + D F R+ VK PD+ + L E C
Sbjct: 316 GKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPDLH--QFASFLNAEQCYQ 373
Query: 345 MCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAELDDS-- 402
CL NCSC A+ AY IGCL ++G++ DT ++++G+ L++R+ ++EL S
Sbjct: 374 GCLGNCSCTAF--AYISG-----IGCLVWNGELADTVQFLSSGEFLFIRLASSELAGSSR 426
Query: 403 ----------------------------------------RRNSEYLPVFDLSNIAAATN 422
R++ + F++ I ATN
Sbjct: 427 RKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNFFEMHTIRTATN 486
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+FS NKLG+GGFG VYKG L +GKEI VKRL+ SSGQG EEF EI LI++LQHRNLV
Sbjct: 487 NFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNLVR 546
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+LG CI+ +EK+LIYE++ NKSLD++IFD + LDW KRF II GIARG+LYLH+DSR
Sbjct: 547 LLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSR 606
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602
LR+IHRDLK SN+LLD MNPKISDFG+AR+F G Q ++NT RVVGT GYM+PEYA GL
Sbjct: 607 LRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWAGL 666
Query: 603 FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662
FS KSD+YSFGVL+LEII G+R + F G S L+ + WD W E +D+ L +
Sbjct: 667 FSEKSDIYSFGVLMLEIISGKRISRFIY--GDESKGLLAYTWDSWCETGGSNLLDRDLTD 724
Query: 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNVDEF 722
+C A E+ RC+ +GLLCVQ +A DRPN V+SML S PK P F L+++
Sbjct: 725 TCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQPIFAVHTLNDMPML 784
Query: 723 WTGEGVTTSVNDLTITAFQPR 743
SVN++T + Q R
Sbjct: 785 QANSQDFLSVNEMTESMIQGR 805
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 575 bits (1483), Expect = e-163, Method: Compositional matrix adjust.
Identities = 344/823 (41%), Positives = 479/823 (58%), Gaps = 93/823 (11%)
Query: 2 ISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDN 61
++ D IT + +D + +VS+ + F GFFSP NS RY GIW+N IPVQTVVWVAN ++
Sbjct: 20 LATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNS 79
Query: 62 PINDTSGVLTISSLGNLVLC-GRNQTVPVWHANVSDSSESNTI-AQLLDTGNLVL-ARNN 118
PIND+SG+++IS GNLV+ GR Q W NV +NT A+LL+TGNLVL N
Sbjct: 80 PINDSSGMVSISKEGNLVVMDGRGQVH--WSTNVLVPVAANTFYARLLNTGNLVLLGTTN 137
Query: 119 TG-QTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQ 177
TG + LW+SF+HP LP M + D ++G + L SWKS +P+ G Y+ + FP+
Sbjct: 138 TGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPE 197
Query: 178 LFLYKGEAKWWRVGSWTGKNFL---NATY----------IDNEDEVSMAYSVTDPSMLTR 224
L ++K + WR G W G+ F+ N Y DN VSM+Y+ ++L
Sbjct: 198 LVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGN--TLLYH 255
Query: 225 IVVNESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPG 284
+++ G+ + W+ W + P CD Y CG ++C + C C+ G
Sbjct: 256 FLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCR-FNPGSTPPCMCIRG 314
Query: 285 FEPKSPSEWFLREGLRGCVRKPQMST--------CRRGDGFIRVAGVKVPDMSVARVDMS 336
F+P+S +EW +GCVRK + R+ DGF+RV +KVP
Sbjct: 315 FKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRS---G 371
Query: 337 LGLEACKHMCLRNCSCLAYTS----------------------------AYAESESNGR- 367
+ C CL+NCSC AY+ A+SE R
Sbjct: 372 ANEQDCPESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRT 431
Query: 368 -----------IGCLTYHGDMMDTRTYINAGQD-------LYVRVDAAELDD------SR 403
+G + G ++ I ++ L R++A +D ++
Sbjct: 432 NRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQ 491
Query: 404 RNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIE 463
+ LP+F+ +A ATN+FS NKLG+GGFG+VYKG LQ G +IAVKRLSR+SGQG+E
Sbjct: 492 YKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVE 551
Query: 464 EFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR 523
EF E+ +I++LQHRNLV +LG CIE +E+ML+YE++P LD Y+FD K+ LLDW R
Sbjct: 552 EFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTR 611
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
F II GI RG++YLH+DSRL+IIHRDLKASN+LLD +NPKISDFG+ARIF G++ E +T
Sbjct: 612 FNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVST 671
Query: 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643
RVVGTYGYMAPEYAM GLFS KSDV+S GV+LLEI+ GRRN++F+ + + NL +
Sbjct: 672 VRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNP--NLSAYA 729
Query: 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703
W LW G + VD + E C EI RC+H+GLLCVQ+ A DRP+++ V+ ML S+N+
Sbjct: 730 WKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSN 789
Query: 704 -SSPKHPAFIA-KGLSNVDEFWTGEG-VTTSVNDLTITAFQPR 743
PK PAFI +G S V+ +G+ S+N++++T R
Sbjct: 790 LPEPKQPAFIPRRGTSEVES--SGQSDPRASINNVSLTKITGR 830
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64781|Y1639_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61390 OS=Arabidopsis thaliana GN=At1g61390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1474), Expect = e-162, Method: Compositional matrix adjust.
Identities = 331/812 (40%), Positives = 458/812 (56%), Gaps = 99/812 (12%)
Query: 7 ITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDT 66
I ++ P+ G + S ++ LGFFSP NS ++YVGIW+ I Q VVWVANRD P+ T
Sbjct: 44 INTSSPLSIGQTLSSPDGVYELGFFSPNNSRKQYVGIWFKNIAPQVVVWVANRDKPVTKT 103
Query: 67 SGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126
+ LTISS G+L+L Q V +W + +S + A+LLDTGNLV+ + +G+TLW+S
Sbjct: 104 AANLTISSNGSLILLDGTQDV-IWSTGEAFTS-NKCHAELLDTGNLVVIDDVSGKTLWKS 161
Query: 127 FDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAK 186
F++ TMLP + D G NR LTSW+S +P+ G++T PQ + +G +
Sbjct: 162 FENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPSPGEFTLEFTPQVPPQGLIRRGSSP 221
Query: 187 WWRVGSWTGKNF-----LNATYID--------NEDEVSMAYSVTDPSMLTRIVVNESGNE 233
+WR G W F ++A+Y+ + S +YS+ L+ + + G +
Sbjct: 222 YWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKGTASFSYSMLRNYKLSYVTLTSEG-K 280
Query: 234 QRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEW 293
++ W N W +F P CD Y CG C R +C CL GF PKS EW
Sbjct: 281 MKILW-NDGKSWKLHFEAPTSSCDLYRACGPFGLCVRSR---NPKCICLKGFVPKSDDEW 336
Query: 294 FLREGLRGCVRKPQMS---------TCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKH 344
GCVR+ Q+S + D F + VK PD+ ++ L E C
Sbjct: 337 KKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTRVKTPDL--YQLAGFLNAEQCYQ 394
Query: 345 MCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRV---------- 394
CL NCSC A+ AY IGCL ++ +++DT +++ G+ L +R+
Sbjct: 395 DCLGNCSCTAF--AYISG-----IGCLVWNRELVDTVQFLSDGESLSLRLASSELAGSNR 447
Query: 395 -------------------------------------------DAAELDDSRRNSEYLPV 411
DA D ++ + +
Sbjct: 448 TKIILGTTVSLSIFVILVFAAYKSWRYRTKQNEPNPMFIHSSQDAWAKDMEPQDVSGVNL 507
Query: 412 FDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIAL 471
FD+ I ATN+FSS NKLG+GGFG VYKG L +GKEIAVKRLS SSGQG +EF EI L
Sbjct: 508 FDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKRLSSSSGQGTDEFMNEIRL 567
Query: 472 IAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIA 531
I++LQH+NLV +LGCCI+ +EK+LIYEYL NKSLDV++FD + +DW KRF II G+A
Sbjct: 568 ISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDSTLKFEIDWQKRFNIIQGVA 627
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
RG+LYLH+DSRLR+IHRDLK SN+LLD M PKISDFG+AR+ G Q ++NT RVVGT G
Sbjct: 628 RGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGTQYQDNTRRVVGTLG 687
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651
YMAPEYA G+FS KSD+YSFGVLLLEII+G + + F E+G L+ + W+ W E
Sbjct: 688 YMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFS-EEGK---TLLAYAWESWCETK 743
Query: 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAF 711
++ +D++L +S E+ RC+ +GLLCVQ Q DRPN ++SML + + SPK P F
Sbjct: 744 GVDLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMSMLTTISELPSPKQPTF 803
Query: 712 IAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
S D+ + + +T VN++T + Q R
Sbjct: 804 TVH--SRDDDSTSNDLIT--VNEITQSVIQGR 831
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 565 bits (1457), Expect = e-160, Method: Compositional matrix adjust.
Identities = 325/811 (40%), Positives = 469/811 (57%), Gaps = 113/811 (13%)
Query: 1 SISVDTITSNQP--IKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVAN 58
SI ++T++S + I +VS G+IF +GFF + R Y+G+WY ++ +T VWVAN
Sbjct: 30 SIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTNS--RWYLGMWYKKVSDRTYVWVAN 87
Query: 59 RDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSE-SNTIAQLLDTGNLVL--- 114
RDNP+++ G L IS NLVL + PVW N++ +E S +A+LL GN V+
Sbjct: 88 RDNPLSNAIGTLKISG-NNLVLLDHSNK-PVWWTNLTRGNERSPVVAELLANGNFVMRDS 145
Query: 115 ARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDG 174
+ N+ + LWQSFD+P+ T+LP MK+G + ++GLNRFLTSW+S D+P++G++++++E
Sbjct: 146 SNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQS 205
Query: 175 FPQLFLYKGEAKWWRVGSWTGKNF-----------LNATYIDNEDEVSMAYSVTDPSMLT 223
P+ +L + R G W G F + +I+N +EV+ + +T+ S +
Sbjct: 206 LPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYS 265
Query: 224 RIVVNESGNEQRLTWSNQENRWIEYFAPPKEP-CDFYGHCGSNSNCNPYRVYDEYECTCL 282
R+ + G QRLTW W +++ P +P CD Y CG + C+ V C C+
Sbjct: 266 RLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCD---VNTSPVCNCI 322
Query: 283 PGFEPKSPSEWFLREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEAC 342
GF P++ +W R GC+R+ Q+S GDGF R+ +K+P+ ++A VD S+G++ C
Sbjct: 323 QGFNPRNIQQWDQRVWAGGCIRRTQLSCS--GDGFTRMKKMKLPETTMATVDRSIGVKEC 380
Query: 343 KHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYIN---AGQDLYVRVDAAEL 399
K C+ +C+C A+ +A NG GC+ + + D R Y GQDLYVR+ AA++
Sbjct: 381 KKRCISDCNCTAFANADIR---NGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADI 437
Query: 400 DDSRRNS------------------------------------------EYLPVFDLSNI 417
R S + LP+ ++ +
Sbjct: 438 AKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEM--V 495
Query: 418 AAATNDFSSDNKLGE---------------GGFGSVYK------GVLQNGK-----EIAV 451
++ +FS + K E F S K G++ G+ EIAV
Sbjct: 496 LSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAV 555
Query: 452 KRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD 511
KRLS++S QG +EF E+ LIA+LQH NLV +LGCCIE EKMLIYEYL N SLD Y+F
Sbjct: 556 KRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFG 615
Query: 512 EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571
+ +RS L+W++RF+I G+ARG+LYLHQDSR RIIHRDLK SN+LLD M PKISDFGMA
Sbjct: 616 KTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMA 675
Query: 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLE 631
RIF D+ E NT +VVGTYGYM+PEYAM G+FS KSDV+SFGV++LEI+ G++N F+
Sbjct: 676 RIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNL 735
Query: 632 QGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCA-------PEILRCIHLGLLCVQEQA 684
+L+ +VW WKEG A+E VD + +S + E+L+CI +GLLCVQE A
Sbjct: 736 DYEN--DLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELA 793
Query: 685 TDRPNMSAVVSMLGSDNAP-SSPKHPAFIAK 714
RP MS+VV M GS+ PK P + +
Sbjct: 794 EHRPAMSSVVWMFGSEATEIPQPKPPGYCVR 824
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 565 bits (1457), Expect = e-160, Method: Compositional matrix adjust.
Identities = 335/817 (41%), Positives = 462/817 (56%), Gaps = 101/817 (12%)
Query: 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRD 60
S S IT P+ G + SS ++ LGFFS NS +YVGIW+ I + VVWVANR+
Sbjct: 20 SFSYAGITRESPLSIGKTLSSSNGVYELGFFSFNNSQNQYVGIWFKGIIPRVVVWVANRE 79
Query: 61 NPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESN-TIAQLLDTGNLVLARNNT 119
P+ D++ LTISS G+L+L N +V VW ++ ++ SN + A+L D GNLV+ NN+
Sbjct: 80 KPVTDSAANLTISSNGSLLLFNENHSV-VW--SIGETFASNGSRAELTDNGNLVVIDNNS 136
Query: 120 GQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLF 179
G+TLW+SF+H TMLP+ + + +G R LTSWKS +P+ GD+T ++ Q
Sbjct: 137 GRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGDFTVQITPQVPSQAC 196
Query: 180 LYKGEAKWWRVGSWTGKNFLNATYIDNEDEVSMAYSVTDPS-------------MLTRIV 226
+G +WR G W F +D D + +S+ + L+ I+
Sbjct: 197 TMRGSKTYWRSGPWAKTRFTGIPVMD--DTYTSPFSLQQDTNGSGSFTYFERNFKLSYIM 254
Query: 227 VNESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFE 286
+ G+ + + + W F P+ CD YG CG C + +C C GF
Sbjct: 255 ITSEGSLKIFQHNGMD--WELNFEAPENSCDIYGFCGPFGIC---VMSVPPKCKCFKGFV 309
Query: 287 PKSPSEWFLREGLRGCVRKPQM-----STCRRGDGFIRVAGVKVPDMS--VARVDMSLGL 339
PKS EW GCVR ++ + + +GF VA +K PD + VD
Sbjct: 310 PKSIEEWKRGNWTDGCVRHTELHCQGNTNGKTVNGFYHVANIKPPDFYEFASFVDA---- 365
Query: 340 EACKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAEL 399
E C +CL NCSCLA+ AY NG IGCL ++ D+MD + G+ L +R+ ++EL
Sbjct: 366 EGCYQICLHNCSCLAF--AYI----NG-IGCLMWNQDLMDAVQFSAGGEILSIRLASSEL 418
Query: 400 DDSRRNSEY------LPVF---------------------DLSNIAA------------- 419
++RN L +F +S IA+
Sbjct: 419 GGNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAWNNDLEPQDV 478
Query: 420 -------------ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFK 466
AT++FS NKLG+GGFGSVYKG LQ+GKEIAVKRLS SSGQG EEF
Sbjct: 479 SGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFM 538
Query: 467 TEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
EI LI++LQH+NLV ILGCCIE +E++L+YE+L NKSLD ++FD KR +DW KRF I
Sbjct: 539 NEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNI 598
Query: 527 ICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586
I GIARG+ YLH+DS LR+IHRDLK SN+LLD MNPKISDFG+AR++ G + ++NT RV
Sbjct: 599 IEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRV 658
Query: 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646
GT GYMAPEYA G+FS KSD+YSFGV+LLEII G + + F G L+ + W+
Sbjct: 659 AGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRF--SYGRQGKTLLAYAWES 716
Query: 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSP 706
W E ++ +DK + +SC E+ RC+ +GLLCVQ Q DRPN ++SML + + +SP
Sbjct: 717 WCESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRPNTMELLSMLTTTSDLTSP 776
Query: 707 KHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
K P F+ + DE +G+ T VN++T + R
Sbjct: 777 KQPTFV---VHTRDEESLSQGLIT-VNEMTQSVILGR 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 743 | ||||||
| 224076623 | 793 | predicted protein [Populus trichocarpa] | 0.986 | 0.924 | 0.592 | 0.0 | |
| 296086953 | 1203 | unnamed protein product [Vitis vinifera] | 0.966 | 0.596 | 0.552 | 0.0 | |
| 357476005 | 827 | Serine/threonine protein kinase [Medicag | 0.950 | 0.853 | 0.524 | 0.0 | |
| 147788840 | 763 | hypothetical protein VITISV_011747 [Viti | 0.940 | 0.916 | 0.541 | 0.0 | |
| 255578823 | 793 | S-locus-specific glycoprotein S13 precur | 0.985 | 0.923 | 0.523 | 0.0 | |
| 224116294 | 767 | predicted protein [Populus trichocarpa] | 0.944 | 0.915 | 0.541 | 0.0 | |
| 224114197 | 813 | predicted protein [Populus trichocarpa] | 0.989 | 0.904 | 0.494 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.978 | 0.927 | 0.517 | 0.0 | |
| 224114189 | 808 | predicted protein [Populus trichocarpa] | 0.983 | 0.904 | 0.503 | 0.0 | |
| 356514907 | 778 | PREDICTED: G-type lectin S-receptor-like | 0.985 | 0.940 | 0.495 | 0.0 |
| >gi|224076623|ref|XP_002304971.1| predicted protein [Populus trichocarpa] gi|222847935|gb|EEE85482.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2371), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/782 (59%), Positives = 571/782 (73%), Gaps = 49/782 (6%)
Query: 2 ISVDTITSNQPIKDGDVIVSSGN-IFALGFFSPG-NSVRRYVGIWYNQIPVQTVVWVANR 59
+S+D I NQ IKDGDV+VSSG+ + LGFFS G + RRYVGIWY ++ +TVVWVANR
Sbjct: 21 LSIDIIAPNQSIKDGDVLVSSGSQSYELGFFSSGIDYTRRYVGIWYRKVSERTVVWVANR 80
Query: 60 DNPINDTSGVLTISSLGNLVLCGRNQT-VPVWHANVSDSSESNTIAQLLDTGNLVLARNN 118
DNPIN TSGVL I+ GNLV+ N++ VPVW NV+ SS +N AQL D+GNLVL + +
Sbjct: 81 DNPINGTSGVLAINKQGNLVIYENNRSSVPVWSTNVAASSMTNCTAQLQDSGNLVLVQQD 140
Query: 119 TGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQL 178
+ + LWQSFDH + T+LP MK+GLD + GLNR L+SWKS D+P TG ++ GFPQL
Sbjct: 141 SKRVLWQSFDHATDTLLPGMKLGLDLKIGLNRSLSSWKSKDDPGTGTIVLGIDPSGFPQL 200
Query: 179 FLYKGEAKWWRVGSWTGKNF-----------LNATYIDNEDEVSMAYSVTDPSMLTRIVV 227
FLYK + + WRVG WTG + T++ + DEVS +YS+ +PS+++R+VV
Sbjct: 201 FLYKSQTRRWRVGPWTGLRWSGVPQMATTYIFGNTFVSSVDEVSYSYSINNPSLISRMVV 260
Query: 228 NESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEP 287
NESG QRLTW++ + +W + PKEPCD YG CG NSNC+PY+ + + C CLPGFEP
Sbjct: 261 NESGVVQRLTWNDPDKQWFGIWYAPKEPCDTYGQCGPNSNCDPYQT-NNFMCKCLPGFEP 319
Query: 288 KSPSEWFLREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCL 347
KSP EW+LREG RGCVRKP +STC G+GF+++A VKVPD S+A +MSL L+ C CL
Sbjct: 320 KSPQEWYLREGSRGCVRKPNVSTCHGGEGFVKLARVKVPDTSMASANMSLRLKECARECL 379
Query: 348 RNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAELD------- 400
RNCSC AY SA +GCL ++GD++DTRT+ + GQ++Y+RVD AEL+
Sbjct: 380 RNCSCTAYASADERG-----LGCLRWYGDLVDTRTFSDVGQEIYIRVDRAELEAMNWFNK 434
Query: 401 -------------------DSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKG 441
+ S LP+FDLS +AAATN+FS NKLGEGGFGSVYKG
Sbjct: 435 VLIVFCRCFGWRDLPIKEFEEGTTSSDLPLFDLSVVAAATNNFSGANKLGEGGFGSVYKG 494
Query: 442 VLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501
+L +GKEIAVKRL++ SGQGI EF+ E+ LIA+LQHRNLV ILGCCI+ +EKMLIYEYLP
Sbjct: 495 LLHDGKEIAVKRLAKYSGQGINEFRNEVELIAKLQHRNLVRILGCCIQGREKMLIYEYLP 554
Query: 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM 561
NKSLD +IF+E +RS LDWS R IICGIARGILYLH+DSRLRIIHRDLKASNVLLDA+M
Sbjct: 555 NKSLDSFIFNEPRRSQLDWSTRHNIICGIARGILYLHEDSRLRIIHRDLKASNVLLDASM 614
Query: 562 NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL 621
NPKISDFGMARIFG DQIE NTNRVVGTYGYM+PEYAM+GLFS KSDVYSFGVLLLE+I
Sbjct: 615 NPKISDFGMARIFGVDQIEANTNRVVGTYGYMSPEYAMQGLFSVKSDVYSFGVLLLEVIT 674
Query: 622 GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQ 681
GR+N F+ S S NLVG+VWDLW+EG A+E VD +G+S ++LRCI +GLLCVQ
Sbjct: 675 GRKNINFY--DKSNSSNLVGYVWDLWREGRALELVDTLMGDSYPEDQVLRCIQIGLLCVQ 732
Query: 682 EQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQ 741
E A DRP+MS VV ML +D SPK PAFI K N + T EG + S+N++TIT
Sbjct: 733 ESAMDRPSMSNVVFMLSNDTTLPSPKQPAFILKKSYNSGDPSTSEG-SHSINEVTITMLG 791
Query: 742 PR 743
PR
Sbjct: 792 PR 793
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086953|emb|CBI33186.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/767 (55%), Positives = 538/767 (70%), Gaps = 49/767 (6%)
Query: 16 GDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSL 75
GD++VS + FALGFFSP NS RY+G+WYN I QTVVWV NRD+PINDTSGVL+I++
Sbjct: 447 GDLLVSKQSRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNRDDPINDTSGVLSINTS 506
Query: 76 GNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATML 135
GNL+L N VW NVS SS + T+AQLLDTGNLVL N + +WQ FD+P+ + L
Sbjct: 507 GNLLLHRGN--THVWSTNVSISSVNPTVAQLLDTGNLVLIHNGDKRVVWQGFDYPTDSWL 564
Query: 136 PYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSWTG 195
PYMK+GL++R+G NRFLTSWKS +P TG Y+ + G PQ+FLY+G WR G+W G
Sbjct: 565 PYMKLGLNRRTGFNRFLTSWKSPTDPGTGKYSLGFNVSGSPQIFLYQGSEPLWRTGNWNG 624
Query: 196 KNF-----------LNATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRLTWSNQENR 244
+ +++N+DE+S +++ + S L R+ V+ G QR W +E++
Sbjct: 625 LRWSGLPVMKYIIQHKIIFLNNQDEISEMFTMANASFLERVTVDHDGYLQRNMWQEREDK 684
Query: 245 WIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEWFLREGLRGCVR 304
W ++ P++ CD YG CG NSNC+ + E+ECTCL GFEPKSP +WFL++G GC+R
Sbjct: 685 WFSFYTAPRDRCDRYGLCGPNSNCDDSQA--EFECTCLAGFEPKSPRDWFLKDGSAGCLR 742
Query: 305 KPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCSCLAYTSAYAESES 364
K C G+GF++V K PD SVARV+M++ +EAC+ CL+ CSC Y +A
Sbjct: 743 KEGAKVCGNGEGFVKVGRAKPPDTSVARVNMNISMEACREECLKECSCSGYAAANVSGSG 802
Query: 365 NGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAEL------------------------- 399
+G CL++HGD++DTR + GQDLYVRVDA L
Sbjct: 803 SG---CLSWHGDLVDTRVFPEGGQDLYVRVDAITLGIGRQNKMLYNSRPGATWLQDSLGA 859
Query: 400 ---DDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSR 456
D+S NSE L FDL+ I AATN+FS +N+LG GGFGSVYKG L NG+EIAVK+LS+
Sbjct: 860 KEHDESTTNSE-LQFFDLNTIVAATNNFSFENELGRGGFGSVYKGQLYNGQEIAVKKLSK 918
Query: 457 SSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRS 516
SGQG EEFK E+ LIA+LQH NLV +LGCCI+E+EKML+YEYLPNKSLD +IFDE KRS
Sbjct: 919 DSGQGKEEFKNEVTLIAKLQHVNLVRLLGCCIQEEEKMLVYEYLPNKSLDSFIFDETKRS 978
Query: 517 LLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576
LLDW KRFEII GIARGILYLH+DSRLRIIHRDLKASNVLLDA M PKISDFG+ARIFGG
Sbjct: 979 LLDWRKRFEIIVGIARGILYLHEDSRLRIIHRDLKASNVLLDAEMLPKISDFGLARIFGG 1038
Query: 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636
+Q+E NTNRVVGTYGYM+PEYAMEGLFSTKSDVYSFGVLLLEII GR+N+T + + + S
Sbjct: 1039 NQMEGNTNRVVGTYGYMSPEYAMEGLFSTKSDVYSFGVLLLEIITGRKNSTHY--RDNPS 1096
Query: 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696
NLVG+VW+LW+E A++ +D SL +S E+LRCI +GLLCVQE A DRP M ++ M
Sbjct: 1097 MNLVGNVWNLWEEDKALDIIDSSLEKSYPTDEVLRCIQIGLLCVQESAIDRPTMLTIIFM 1156
Query: 697 LGSDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
LG+++A PK P FI+K + + S N++T+T QPR
Sbjct: 1157 LGNNSALPFPKRPTFISKTTHKSQDLSSSGERLLSGNNVTLTLLQPR 1203
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357476005|ref|XP_003608288.1| Serine/threonine protein kinase [Medicago truncatula] gi|355509343|gb|AES90485.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/761 (52%), Positives = 514/761 (67%), Gaps = 55/761 (7%)
Query: 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRD 60
S S DTI+ ++ ++DG+++VS FALGFF+PG S RYVGIWYN +P+QTVVWVANRD
Sbjct: 43 SCSSDTISIDKTLRDGELLVSKSKTFALGFFTPGKSTSRYVGIWYNNLPIQTVVWVANRD 102
Query: 61 NPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVS-----DSSESNTIAQLLDTGNLVLA 115
PINDTSG+L+I+ GNL L T+P+W NVS + S IA+L D N+VL
Sbjct: 103 APINDTSGILSINQNGNLELHHNLSTIPIWSTNVSLTLSQRNITSAVIAKLTDKANIVLM 162
Query: 116 RNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGF 175
NNT +W+SFDHP+ T LPY + G D+++ + L SWK+ D+P G +T + G
Sbjct: 163 INNTKTVIWESFDHPTDTFLPYQRFGFDRKTNQSWPLQSWKTEDDPGKGAFTVKFSSIGI 222
Query: 176 PQLFLYKGEAKWWRVGSWTGKNFL------------NATYIDNEDEVSMAYSVTDPSMLT 223
PQLF+Y WWR G W G F+ NA++++ ++ V+++Y + D S++
Sbjct: 223 PQLFMYNHNLPWWRGGHWNGALFVGIPNMKRDLQTFNASFVEEDNYVALSYDMFDKSVIA 282
Query: 224 RIVVNESGNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLP 283
R+VV +SG Q TW+NQ+++W +++ P CD YG CGSNSNC+P ++ ++CTCL
Sbjct: 283 RLVVQQSGFIQIFTWNNQKSQWNRFWSEPTNQCDNYGTCGSNSNCDPLN-FENFKCTCLL 341
Query: 284 GFEPKSPSEWF-LREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEAC 342
GFEPK PS+W+ R+G GCVRK S C G+GFI+V +KVPD+S A L L+ C
Sbjct: 342 GFEPKFPSDWYESRDGSGGCVRKKGASVCGNGEGFIKVVSLKVPDISGAVTIDGLSLDEC 401
Query: 343 KHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAELDDS 402
+ CLRNCSC +Y A NG GCL +HGD+MD + + GQDLY+RVD EL +
Sbjct: 402 EKECLRNCSCTSYAVADVR---NGGSGCLAWHGDLMDIQKLSDQGQDLYLRVDKVELANY 458
Query: 403 RRNSE-------------------------------YLPVFDLSNIAAATNDFSSDNKLG 431
+ S+ LP F L I +AT S NKLG
Sbjct: 459 NKKSKGVLDKKRLAVIMQSKEDYSAEENDAQSTTHPNLPFFSLKTIMSATRYCSHQNKLG 518
Query: 432 EGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491
+GGFGSVYKG L NG+EIAVKRLS+ SGQG EFK EI L+ +LQHRNLV +LGCC E++
Sbjct: 519 KGGFGSVYKGCLVNGQEIAVKRLSKESGQGKVEFKNEITLLVKLQHRNLVRLLGCCFEKE 578
Query: 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLK 551
E+ML+YEYLPNKSLD +IFD+ +RS LDW KRFEIICGIARG+LYLHQDSRL+IIHRDLK
Sbjct: 579 ERMLVYEYLPNKSLDFFIFDQNQRSSLDWGKRFEIICGIARGVLYLHQDSRLKIIHRDLK 638
Query: 552 ASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYS 611
ASNVLLDA MNPKISDFGMARIFG D+I+ T RVVGTYGYM+PEYAMEG +STKSDV+S
Sbjct: 639 ASNVLLDAEMNPKISDFGMARIFGEDEIQARTKRVVGTYGYMSPEYAMEGRYSTKSDVFS 698
Query: 612 FGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILR 671
+GVLLLEII G+RN H E G S NL+GHVW +W E A++ VD++L +S +LR
Sbjct: 699 YGVLLLEIIAGKRNT--HCEIGRDSPNLIGHVWTVWTEERALDIVDEALNQSYPPAIVLR 756
Query: 672 CIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFI 712
CI +GLLCVQE A +RP+M VV ML +D +P+ PAF+
Sbjct: 757 CIQIGLLCVQENAMNRPSMLEVVFMLANDTPLCAPQKPAFL 797
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788840|emb|CAN67074.1| hypothetical protein VITISV_011747 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/775 (54%), Positives = 524/775 (67%), Gaps = 76/775 (9%)
Query: 3 SVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNP 62
S +TIT NQP +DGD++VS + FALGFFSP NS RY+G+WYN I QTVVWV NRD+P
Sbjct: 22 STNTITPNQPFRDGDLLVSKQSRFALGFFSPRNSTLRYIGVWYNTIREQTVVWVLNRDHP 81
Query: 63 INDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQT 122
IND+SGVL+I++ GNL+L N VW NVS SS + +AQLLDTGNLVL +N+ +
Sbjct: 82 INDSSGVLSINTSGNLLLHRGN--THVWSTNVSISSVNAXVAQLLDTGNLVLIQNDDKRV 139
Query: 123 LWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYK 182
+WQSFDHP+ TMLP+MK+GLD+R+GLNRFLTSWKS ++P TG+Y+F+++++G PQLFL
Sbjct: 140 VWQSFDHPTDTMLPHMKLGLDRRTGLNRFLTSWKSPEDPGTGEYSFKLDVNGSPQLFLSM 199
Query: 183 GEAKWWRVGSWTGKNFLNA-----TYI------DNEDEVSMAYSVTDPSMLTRIVVNESG 231
G WR G W G F+ T+I + DEVSM +++ + S + I + G
Sbjct: 200 GSKWIWRTGPWNGLGFVGVPEMLTTFIFDIRFWNTGDEVSMEFTLVNSSTFSSIKLGSDG 259
Query: 232 NEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPS 291
QR T + + + ++ ++PCD YG CG NSNC+ Y +ECTCL GFEPKS
Sbjct: 260 VYQRYTLDERNRQLVAIWSAARDPCDNYGRCGLNSNCDVY-TGAGFECTCLAGFEPKSQR 318
Query: 292 EWFLREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCS 351
+W LR+G GCVR +TCR G+GFI++AGVK PD S ARV+ SL LE C CL +C+
Sbjct: 319 DWSLRDGSGGCVRIQGTNTCRSGEGFIKIAGVKPPDASTARVNESLNLEGCXKECLNDCN 378
Query: 352 CLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVD---------------- 395
C AYTSA S G GCL+++GD+MD RT GQDL+VRVD
Sbjct: 379 CRAYTSA---DVSTGGSGCLSWYGDLMDIRTLAQGGQDLFVRVDAIILGKGRQCKTLFNM 435
Query: 396 ------------AAELDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVL 443
A E+D++ NSE L FDLS + AATN+FS NKLG GGFG VYKG+L
Sbjct: 436 SSKATRLKHYSKAKEIDENGENSE-LQFFDLSIVIAATNNFSFTNKLGRGGFGXVYKGLL 494
Query: 444 QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503
NG+EIAVKRLSR+SGQG+EEFK E+ LIA+LQH+NLV +L
Sbjct: 495 SNGQEIAVKRLSRNSGQGVEEFKNEVTLIAKLQHKNLVKLL------------------- 535
Query: 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563
DE KRS+L W KRFEII GIARGILYLHQDSRLRIIHRDLKASN+LLD M P
Sbjct: 536 -------DETKRSMLTWRKRFEIIIGIARGILYLHQDSRLRIIHRDLKASNILLDIDMIP 588
Query: 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
KISDFGMAR+FG +Q+E +TNRVVGTYGYM+PEYAMEGLFS KSDVYSFGVLLLEII GR
Sbjct: 589 KISDFGMARLFGKNQVEGSTNRVVGTYGYMSPEYAMEGLFSIKSDVYSFGVLLLEIITGR 648
Query: 624 RNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQ 683
RN+T++ S S+NLVG VW LW+EG A++ VD SL +S A E+LRCI +GLLCVQE
Sbjct: 649 RNSTYY--HDSPSFNLVGCVWSLWREGKALDIVDPSLEKSNHANEVLRCIQIGLLCVQES 706
Query: 684 ATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTIT 738
A DRP M + MLG+++ P PAF+ K N + V S+N++TIT
Sbjct: 707 AIDRPTMLTXIFMLGNNSTLPXPNQPAFVMKTCHNGAN--SXXVVVNSINEVTIT 759
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578823|ref|XP_002530266.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223530198|gb|EEF32106.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2032), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/785 (52%), Positives = 526/785 (67%), Gaps = 53/785 (6%)
Query: 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRD 60
S S DTIT NQPIKDG++++S F LGFF+PGNS RY+GIWY +IP QT+VWVANR+
Sbjct: 20 STSFDTITLNQPIKDGNLLLSEEKTFTLGFFTPGNSRYRYLGIWYYKIPKQTIVWVANRN 79
Query: 61 NPINDTSGVLTISSLGNLVL-CGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNT 119
+PIN +SG+L+++ GNL L +Q VPVW NVS S +AQLLD+GNLVL + +
Sbjct: 80 SPINGSSGILSVNRDGNLKLYSNHDQQVPVWSTNVSVEVSSTCVAQLLDSGNLVLMEDAS 139
Query: 120 GQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLF 179
+ LWQSFD+P+ TML MK+GLD+++GL RFLTSW+S D+P G+Y+ + G PQ+F
Sbjct: 140 KRVLWQSFDYPTDTMLSGMKLGLDRKTGLRRFLTSWRSADDPGIGEYSLELNPTGSPQVF 199
Query: 180 LYKGEAKWWRVGSWTGKNFL---NATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRL 236
LYKG WR W + + N T +DN+DE+S+++ + D S++ IV++ G + L
Sbjct: 200 LYKGRKTIWRTIPWRTETYADVRNYTLVDNQDEISISHFIIDDSVILIIVLDYLGIHRHL 259
Query: 237 TWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEW-FL 295
TW E +W E + PK C YGHCGS S CNP V +EC CLPGFEPK+ W L
Sbjct: 260 TWYESEGKWNEIWLAPKYQCGTYGHCGSYSKCNPALVDRVFECDCLPGFEPKNTRVWNIL 319
Query: 296 REGLRGCVRKPQMS--TCRRGDGFIRVAGVKVPDMSVAR-VDMSLGLEACKHMCLRNCSC 352
R+G GCVRK S C G+GF++V VKVPD SVA V+MS+ + C+ C R+CSC
Sbjct: 320 RDGSGGCVRKRLKSYKRCTHGEGFLKVEHVKVPDTSVATWVNMSI--KDCEQECRRDCSC 377
Query: 353 LAYTSAYAESESNGR-IGCLTYHGDMMDTRTYINAGQDLYVRVDAAELDDSRRNSEY--- 408
+AYA + G+ IGCL + GD++DT ++A DLYVRVDA EL+ +NS Y
Sbjct: 378 ----NAYANIDIVGKGIGCLMWFGDLIDTVDNLDATSDLYVRVDAVELE-HEKNSNYILF 432
Query: 409 ------------------------------LPVFDLSNIAAATNDFSSDNKLGEGGFGSV 438
L +F I AATN+FS+ NKLG+GGFGSV
Sbjct: 433 CRRTVRDKWKRRFKEINGLTANKVGDSRSHLAIFSHRTILAATNNFSAANKLGQGGFGSV 492
Query: 439 YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498
YKG L NG+EIAVKRL ++S QGIEEFK E+ LIA+LQH+NLV +LGCCIEE+E MLIYE
Sbjct: 493 YKGQLANGQEIAVKRLEKNSRQGIEEFKNEVMLIAKLQHKNLVKLLGCCIEEEEPMLIYE 552
Query: 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558
YL NKSLD+ +FDE +RS+L+W RF+II GIARGILYLHQDSRLRIIHRDLK SN+LLD
Sbjct: 553 YLSNKSLDLLLFDEMRRSILNWKNRFDIIIGIARGILYLHQDSRLRIIHRDLKTSNILLD 612
Query: 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLE 618
MNPKISDFG+ARIF G QI+E T +++GT+GYM+PEY + G FS KSDVYS+GV+LLE
Sbjct: 613 EEMNPKISDFGIARIFEGKQIQEKTKKIIGTFGYMSPEYIIRGKFSIKSDVYSYGVILLE 672
Query: 619 IILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLL 678
+I G++NN F LE S S L+ + W++W E A+E +D SL ES + E LRCI +GLL
Sbjct: 673 VIAGKKNNNFCLEDSSSS--LIEYAWEMWIEDRALEIIDSSLKESYDSHEALRCIQIGLL 730
Query: 679 CVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTIT 738
CVQ DRP MS V+ ML S+ + SPK AFI D E + SVN+ TIT
Sbjct: 731 CVQANEMDRPTMSNVLLMLSSEISLPSPKQSAFIVSKRFYND--CVREERSCSVNETTIT 788
Query: 739 AFQPR 743
R
Sbjct: 789 TVVSR 793
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116294|ref|XP_002317262.1| predicted protein [Populus trichocarpa] gi|222860327|gb|EEE97874.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/726 (54%), Positives = 513/726 (70%), Gaps = 24/726 (3%)
Query: 3 SVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNP 62
S D+I + Q I+DGDV++S GN FALGFFSPG S RY+GIWY+++P QTVVWVANR++P
Sbjct: 22 SKDSINTTQIIRDGDVLISRGNNFALGFFSPGKSSNRYLGIWYHKLPEQTVVWVANRNHP 81
Query: 63 INDTSGVLTISSLGNLVLCGR-NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQ 121
I +SGVL+ GNL L N+ V VW ANVS ++AQLLD+GN VL + +G
Sbjct: 82 IIGSSGVLSFDEYGNLSLYSDGNRNVSVWSANVSGEEADTSVAQLLDSGNFVLVQE-SGN 140
Query: 122 TLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLY 181
LWQSFD+P+ +LP MK+GLD ++GL+RFLTSW S D+P GDY++R+ G PQ+FLY
Sbjct: 141 ILWQSFDYPTHYVLPGMKLGLDLKTGLDRFLTSWISADDPGIGDYSYRVNPSGSPQIFLY 200
Query: 182 KGEAKWWRVGSWT---GKNFLNATYIDNEDEVSMAYSV-TDPSMLTRIVVNESGNEQRLT 237
KGE + WR W + N+ +++++DE+ M ++ D ++ R++V+ SG + +
Sbjct: 201 KGEKRVWRTSPWPWRPQRRSYNSQFVNDQDEIGMTTAIPADDFVMVRLLVDHSGFVKAVK 260
Query: 238 WSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEWFLRE 297
W + +W E + P+ CD YG CG S C P Y ++EC+CLPGFEP++PS+W LR
Sbjct: 261 WHESDGQWKETWRAPRSKCDSYGWCGPYSTCEPTDAY-KFECSCLPGFEPRNPSDWLLRN 319
Query: 298 GLRGCVRK--PQMSTCRRGDGFIRVAGVKVPDMSVAR-VDMSLGLEACKHMCLRNCSCLA 354
G GCVRK S CR G+GF++V V +PD S A VDM + C+ C RNCSC A
Sbjct: 320 GSTGCVRKRLESSSVCRNGEGFLKVEIVFLPDTSAAVWVDMDMSHADCERECKRNCSCSA 379
Query: 355 YTSAYAESESNGRIGCLTYHGDMMDTRTY-INAGQDLYVRVDAAEL-----DDSRRNS-- 406
Y S + G CLT++G+++D Y ++ DLYVRVDA EL ++ RR+S
Sbjct: 380 YASVDIPDKGTG---CLTWYGELIDAVRYNMSDRYDLYVRVDALELGSWVANELRRSSSG 436
Query: 407 EYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFK 466
+ LP F LS I+AATN+FS DNKLG+GGFGSVYKG L +G++IAVKRLS +S QGIEEF
Sbjct: 437 QDLPYFKLSTISAATNNFSPDNKLGQGGFGSVYKGELPDGEKIAVKRLSNNSRQGIEEFT 496
Query: 467 TEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
E+ +IA+LQHRNLV ++GCCI+ E+ML+YEY+PNKSLD ++F+E ++ LDWSKRF+I
Sbjct: 497 NEVKVIAKLQHRNLVKLVGCCIQGGEQMLVYEYMPNKSLDSFLFNETRKLFLDWSKRFDI 556
Query: 527 ICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586
I GIARGILYLHQDSRLRIIHRDLK SN+LLDA MNPKISDFG+ARIF DQI +NT RV
Sbjct: 557 IVGIARGILYLHQDSRLRIIHRDLKCSNILLDAEMNPKISDFGIARIFKSDQILDNTKRV 616
Query: 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646
VGTYGYM+PEYA+ G FS KSDV+SFGV+LLEI+ G++NN F+ + + + L+G VW L
Sbjct: 617 VGTYGYMSPEYAVFGKFSLKSDVFSFGVMLLEIVSGKKNNEFNPQNPAQT--LIGLVWGL 674
Query: 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML-GSDNAPSS 705
WKE A+E VD SL E L+CI +GLLCVQE A +RP+M AVV M S+ S
Sbjct: 675 WKEDRALEIVDSSLQVLYHPQEALKCIKIGLLCVQEDAIERPSMLAVVFMFNSSETTIPS 734
Query: 706 PKHPAF 711
PK PAF
Sbjct: 735 PKQPAF 740
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114197|ref|XP_002316693.1| predicted protein [Populus trichocarpa] gi|222859758|gb|EEE97305.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/798 (49%), Positives = 516/798 (64%), Gaps = 63/798 (7%)
Query: 3 SVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNP 62
S+D++ +NQ IK+GDV++S GN FALGFFSPG+S RY+GIWY+++P QTVVWVANR++P
Sbjct: 22 SLDSLKTNQTIKEGDVLISEGNNFALGFFSPGSSSNRYLGIWYHKVPEQTVVWVANRNDP 81
Query: 63 INDTSGVLTISSLGNLVLCGRN-QTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQ 121
I +SG L + GNLVL G + Q +PVW NVS AQLLD+GNL+L R + +
Sbjct: 82 IIGSSGFLFVDQYGNLVLYGNDDQKLPVWSTNVSVEENDTCAAQLLDSGNLILVRKRSRK 141
Query: 122 TLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLY 181
T+WQSFD+P+ +LP MK+GLD++ G +RFLTSW+S D+P GD++ R+ +G PQ FLY
Sbjct: 142 TVWQSFDYPTNILLPGMKLGLDRKLGTDRFLTSWRSADDPGIGDFSVRINPNGSPQFFLY 201
Query: 182 KGEAKWWRVGSW----TGKNFLNATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRLT 237
G R W + ++++ DE+ +V D L R++V+ SG + LT
Sbjct: 202 TGTKPISRSPPWPISISQMGLYKMVFVNDPDEIYSELTVPDGYYLVRLIVDHSGLSKVLT 261
Query: 238 WSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEWFLRE 297
W + +W EY P+ CD+YG+CG+ S C Y+ + C CLPGFEPK P EW +R
Sbjct: 262 WRESDGKWREYSKCPQLQCDYYGYCGAYSTCE-LASYNTFGCACLPGFEPKYPMEWSMRN 320
Query: 298 GLRGCVRK--PQMSTCRRGDGFIRVAGVKVPDMSVAR-VDMSLGLEACKHMCLRNCSCLA 354
G GCVRK S C G+GF++V V +PD + A VD S C+ C NCSC A
Sbjct: 321 GSGGCVRKRLQTSSVCDHGEGFVKVENVMLPDTTAAAWVDTSKSRADCELECNSNCSCSA 380
Query: 355 YTSAYAESESNGRIGCLTYHGDMMDTR-TYINAGQDLYVRVDAAELDDSRRNSE------ 407
Y + +G CL ++ +++D + + DLYVRVDA EL D++R S
Sbjct: 381 YAVIVIPGKGDG---CLNWYKELVDIKYDRRSESHDLYVRVDAYELADTKRKSNDSREKT 437
Query: 408 -----------------------------------------YLPVFDLSNIAAATNDFSS 426
L F LS I AATN+FSS
Sbjct: 438 MLAVLAPSIAFLWFLISLFASLWFKKRAKKGTELQVNSTSTELEYFKLSTITAATNNFSS 497
Query: 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
NK+G+GGFGSVYKG+L N KE+A+KRLSRSSGQG EEFK E+ +IA+LQHRNLV +LG
Sbjct: 498 ANKVGQGGFGSVYKGLLANAKEVAIKRLSRSSGQGTEEFKNEVTVIARLQHRNLVKLLGY 557
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
C+++ EKMLIYEYLPNKSLD ++FDE++R LLDW KRF+II GIARGILYLHQDSRLRII
Sbjct: 558 CLQDGEKMLIYEYLPNKSLDSFLFDESRRLLLDWRKRFDIIVGIARGILYLHQDSRLRII 617
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTK 606
HRDLK SN+LLDA MNPKISDFG+A+IF G+Q E+ T RVVGTYGYM+PEY + G FS K
Sbjct: 618 HRDLKCSNILLDAEMNPKISDFGIAKIFEGNQTEDRTRRVVGTYGYMSPEYVVFGNFSAK 677
Query: 607 SDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCA 666
SDV+SFGV+LLEI+ G++NN F+ Q L+G+VW+LW++ A+E VD SL E
Sbjct: 678 SDVFSFGVMLLEIVSGKKNNIFY--QQDPPLTLIGYVWELWRQDKALEIVDPSLKELYHP 735
Query: 667 PEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFI-AKGLSNVDEFWTG 725
E L+C+ +GLLCVQE ATDRP+M AVV ML ++ SPK PAF+ K +N D
Sbjct: 736 REALKCLQIGLLCVQEDATDRPSMLAVVFMLSNETEIPSPKQPAFLFRKSDNNPDIALDV 795
Query: 726 EGVTTSVNDLTITAFQPR 743
E S+N++TIT R
Sbjct: 796 EDGHCSLNEVTITEIACR 813
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/765 (51%), Positives = 510/765 (66%), Gaps = 38/765 (4%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
D I+ Q I DGD IVS+G F LGFFSPG+S RRY+GIWY + TVVWVANR+NPI
Sbjct: 32 DIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKKFSTGTVVWVANRENPIF 91
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQT-- 122
D SGVL ++ G L+L + V VW +N + + ++N +AQLL++GNLV+ N
Sbjct: 92 DHSGVLYFTNQGTLLLLNGTKDV-VWSSNRT-TPKNNPVAQLLESGNLVVKDGNDSNPES 149
Query: 123 -LWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLY 181
LWQSFD+P T LP MK+G + +GL+ ++SWKS D+PA G+Y+ ++ G+ QL
Sbjct: 150 FLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARGEYSLGIDPRGYQQLVYK 209
Query: 182 KGEAKWWRVGSWTGKNFLNAT-----------YIDNEDEVSMAYSVTDPSMLTRIVVNES 230
KG A +R GSW G F AT ++ N+ EV + + + S+ +R VVN S
Sbjct: 210 KGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEFVLNDKEVYFNFELLNSSVASRFVVNAS 269
Query: 231 GNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSP 290
G +RLTW +Q +RW YFA ++ CD Y CGSN+ CN + C CL GFEPKS
Sbjct: 270 GVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCN---IDKSPVCACLDGFEPKSA 326
Query: 291 SEWFLREGLRGCVRKPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNC 350
+W ++ GCVR+ + TC RG+GF++ G+K+PD S + + S+ L+ C+ +CL+ C
Sbjct: 327 RDWSFQDWSGGCVRRTTL-TCNRGEGFVKHTGMKLPDTSSSWYNTSISLKECQELCLKKC 385
Query: 351 SCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAA---------ELD- 400
SC+AY + G GCL + GD++D R ++N GQDLY+R+ A+ E+D
Sbjct: 386 SCMAYANTDVRG---GGSGCLLWFGDLIDMREFVNTGQDLYIRMAASYLGKMKNILEMDY 442
Query: 401 --DSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS 458
SR+ LP+ DLS IA AT +FSS+ KLGEGGFG VYKG L G++IAVKRLS S
Sbjct: 443 DSHSRKEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYS 501
Query: 459 GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLL 518
GQGIEEFK E+ LIA+LQHRNLV +LGCCIE E+MLIYEY+PNKSLD +IFD+++ LL
Sbjct: 502 GQGIEEFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLL 561
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
DW R II GIARG+LYLHQDSRLRIIHRDLKASNVLLD MNPKISDFGMARIFGG+Q
Sbjct: 562 DWPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQ 621
Query: 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638
E NT RVVGTYGYMAPEYA+EGLFS KSD++SFGVL+LEI+ GR+N F + N
Sbjct: 622 TEANTKRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVLEIVSGRKNRGFF--SHNHHLN 679
Query: 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698
LVGH W LW E ++E D +LG S EI+R IH+GLLCVQ+Q DRPNMS V MLG
Sbjct: 680 LVGHAWKLWMEERSLELTDNTLGASHALSEIIRYIHVGLLCVQQQPDDRPNMSTAVLMLG 739
Query: 699 SDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
+++ PK P F + E + +TS N +T+TA PR
Sbjct: 740 GESSLPQPKQPGFFLERNVPRTESSSSNYKSTSTNGITMTAQYPR 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114189|ref|XP_002316691.1| predicted protein [Populus trichocarpa] gi|222859756|gb|EEE97303.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/797 (50%), Positives = 521/797 (65%), Gaps = 66/797 (8%)
Query: 3 SVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNP 62
S D++ NQ IK+GD+++S GNIFALGFFSPG+S RY+GIWY++IP QTVVWVANR++P
Sbjct: 22 SHDSLKMNQTIKEGDLLISEGNIFALGFFSPGSSSNRYLGIWYHKIPEQTVVWVANRNDP 81
Query: 63 INDTSGVLTISSLGNLVLCGRN-QTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQ 121
I + G L I GNLVL G + Q +PVW NVS AQL+D+GNL+L + +
Sbjct: 82 IIGSLGFLFIDQYGNLVLYGNDDQKLPVWSTNVSVEENDTCEAQLMDSGNLILV---SRK 138
Query: 122 TLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLY 181
T+WQSFD+P+ +LP MK+GLD++ G++RFLTSW+S ++P GD++ R+ +G PQ F+Y
Sbjct: 139 TVWQSFDYPTNILLPGMKLGLDRKLGIDRFLTSWRSAEDPGIGDFSVRINPNGSPQFFVY 198
Query: 182 KGEAKWWRVGSWTGKN---FLNATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRLTW 238
G R W +N T++++ DE +V D S L R +++ SG+ + LT
Sbjct: 199 NGTKPIIRSRPWPWRNQMGLYKCTFVNDPDEKYCVCTVLDDSYLLRSILDHSGHVKALTR 258
Query: 239 SNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKSPSEWFLREG 298
+ +W EY+ P+ D+YGHCG+ S C + +E+ C CLPGFEPK P EW R+G
Sbjct: 259 RESDGQWKEYWKSPQFQWDYYGHCGAYSTCELANL-NEFGCACLPGFEPKYPLEWSARDG 317
Query: 299 LRGCVRK--PQMSTCRRGDGFIRVAGVKVPDMSVAR-VDMSLGLEACKHMCLRNCSCLAY 355
GCVRK S C+ G+GF++V V +P+ S A VDMS L C+ C RNCSC
Sbjct: 318 SGGCVRKRLHTSSVCQHGEGFVKVENVILPESSAAVWVDMSKSLADCEVQCKRNCSC--- 374
Query: 356 TSAYAESESNGR-IGCLTYHGDMMDTRTYINAGQDLYVRVDAAELDDSRRNSE------- 407
SAYA G+ GCLT++ +++D + + DLYVRVDA EL D++R S
Sbjct: 375 -SAYAIIAIPGKNYGCLTWYKELVDVKYDRSDSHDLYVRVDAYELADTKRKSNDSREKTM 433
Query: 408 ----------------------------------------YLPVFDLSNIAAATNDFSSD 427
L F LS I AATNDF+
Sbjct: 434 LAVLAPSIALLWFLIGLFAYLWLKKRAKKGNELQVNSTSTELEYFKLSTITAATNDFAPA 493
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
NKLG+GGFGSVYKG+L NG E+A+KRLSRSSGQG EEFK E+ +IA LQHRNLV +LG C
Sbjct: 494 NKLGQGGFGSVYKGLLPNGMEVAIKRLSRSSGQGAEEFKNEVMVIAMLQHRNLVKLLGYC 553
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
++ E+MLIYEYLPNKSLD ++FDE++R LLDW KRF+II GIARGILYLHQDSRLRIIH
Sbjct: 554 TQDGEQMLIYEYLPNKSLDSFLFDESRRLLLDWRKRFDIIVGIARGILYLHQDSRLRIIH 613
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKS 607
RDLK SN+LLDA MNPKISDFGMA+IF G++ E+ T RVVGTYGYM+PEY + G FS KS
Sbjct: 614 RDLKCSNILLDADMNPKISDFGMAKIFEGNRTEDRTTRVVGTYGYMSPEYVVFGNFSAKS 673
Query: 608 DVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAP 667
DV+SFGV+LLEI+ GR+NN F+ Q + L+G+VW+LW+E A+E VD SL E
Sbjct: 674 DVFSFGVMLLEIVSGRKNNRFY--QQNPPLTLIGYVWELWREEKALEIVDPSLTELYDPR 731
Query: 668 EILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFI-AKGLSNVDEFWTGE 726
E L+C+ +GLLCVQE ATDRP+M AVV ML ++ SPK PAF+ K +N D E
Sbjct: 732 EALKCVQIGLLCVQEDATDRPSMLAVVFMLSNETEIPSPKQPAFLFRKSDNNPDIALDVE 791
Query: 727 GVTTSVNDLTITAFQPR 743
S+N++TIT R
Sbjct: 792 DGQCSLNEVTITEIACR 808
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514907|ref|XP_003526143.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/769 (49%), Positives = 515/769 (66%), Gaps = 37/769 (4%)
Query: 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRD 60
S + DTIT +QP+ DG +VS F LGFF+PGNS YVGIW+ IP++TVVWVANRD
Sbjct: 21 SYATDTITQSQPLLDGSTLVSKEGTFELGFFTPGNSPNHYVGIWFKNIPMRTVVWVANRD 80
Query: 61 NPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLAR---- 116
NP D S +L++S GNL+L G+N+++ +W N + + SN + QLLD GNLV+
Sbjct: 81 NPAKDKSNMLSLSKDGNLILLGKNRSL-IWSTNAT-IAVSNPVVQLLDNGNLVIREEKDD 138
Query: 117 --NNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDG 174
+N +WQSFD+P T L MK+G + ++GLNR+LT+WK+W++P++GD+T ++L
Sbjct: 139 NMDNEENFVWQSFDYPCDTQLQGMKLGWNLKTGLNRYLTAWKNWEDPSSGDFTSGLKLGT 198
Query: 175 FPQLFLYKGEAKWWRVGSWTG-----------KNFLNATYIDNEDEVSMAYSVTDPSMLT 223
P+L + KG +++R G W G Y+ NEDEV + Y++ + S+++
Sbjct: 199 NPELVISKGSNEYYRSGPWNGIFSSGVFGFSPNPLFEYKYVQNEDEVYVRYTLKNSSVIS 258
Query: 224 RIVVNES-GNEQRLTWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCL 282
IV+N++ QR+TW W Y + P++ CD Y CG+ NC + C CL
Sbjct: 259 IIVLNQTLFLRQRITWIPHTRTWSVYQSLPQDSCDVYNVCGAYGNC---MINASPVCQCL 315
Query: 283 PGFEPKSPSEWFLREGLRGCVR-KPQMSTCRRGDGFIRVAGVKVPDMSVARVDMSLGLEA 341
GF+PKSP +W + +GCVR +P + DGF +AG+K+PD + + ++ S+ LE
Sbjct: 316 EGFKPKSPQDWNQMDWTKGCVRSEPWSCGVKNKDGFRLIAGMKMPDTTHSWINRSMTLED 375
Query: 342 CKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAE--- 398
CK CL+NCSC A+ + G GC + GD++D R +GQDLYVR+ +E
Sbjct: 376 CKAKCLKNCSCTAFANM---DTGGGGSGCSIWFGDLVDLRIS-ESGQDLYVRMAISENGT 431
Query: 399 ----LDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRL 454
DD + + LP FDL+ I ATN+FS DNKLGEGGFG VYKG + +G EIAVKRL
Sbjct: 432 WTEEKDDGGQENLELPFFDLATIINATNNFSIDNKLGEGGFGPVYKGTMLDGHEIAVKRL 491
Query: 455 SRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAK 514
S+SSGQG++EFK E+ L A+LQHRNLV +LGCC+E +EKML+YEY+PN+SLD +IFD A+
Sbjct: 492 SKSSGQGLKEFKNEVILCAKLQHRNLVKVLGCCVEGEEKMLLYEYMPNRSLDSFIFDPAQ 551
Query: 515 RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574
LLDW RF I+C IARG+LYLHQDSRLRIIHRDLKASN+LLD MNPKISDFG+A++
Sbjct: 552 SKLLDWPTRFNILCAIARGLLYLHQDSRLRIIHRDLKASNILLDNNMNPKISDFGLAKMC 611
Query: 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGS 634
GGDQ+E NTNR+VGTYGYMAPEYA++GLFS KSDV+SFGVLLLEII G++N T E+ S
Sbjct: 612 GGDQVEGNTNRIVGTYGYMAPEYAIDGLFSIKSDVFSFGVLLLEIISGKKNRTVTYEEHS 671
Query: 635 GSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694
NL+GH W LWKEG + +D SL +SC E++RCI +GLLC+Q DRPNM+ VV
Sbjct: 672 D--NLIGHAWRLWKEGIPEQLIDASLVDSCNISELVRCIQVGLLCLQHHPEDRPNMTTVV 729
Query: 695 SMLGSDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
ML S+N+ S PK P F+ K +S E G + S N++T++ R
Sbjct: 730 VMLSSENSLSQPKVPGFLIKNISIEGEQPCGRQESCSTNEVTVSLLNAR 778
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 743 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.436 | 0.381 | 0.576 | 7.5e-187 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.454 | 0.400 | 0.595 | 1.1e-183 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.468 | 0.410 | 0.577 | 1e-178 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.444 | 0.404 | 0.598 | 5.5e-169 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.445 | 0.389 | 0.612 | 2.8e-165 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.445 | 0.398 | 0.568 | 1.2e-162 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.442 | 0.390 | 0.578 | 1.3e-158 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.467 | 0.417 | 0.534 | 5.4e-158 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.433 | 0.398 | 0.557 | 2.1e-156 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.454 | 0.420 | 0.556 | 5.5e-156 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 7.5e-187, Sum P(2) = 7.5e-187
Identities = 196/340 (57%), Positives = 245/340 (72%)
Query: 409 LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTE 468
LP+ + +A ATN+FS+ NKLG+GGFG VYKG L +G+E+AVKRLS++S QG +EFK E
Sbjct: 511 LPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNE 570
Query: 469 IALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528
+ LIA+LQH NLV +L CC++ EKMLIYEYL N SLD ++FD+++ S L+W RF+II
Sbjct: 571 VKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIIN 630
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
GIARG+LYLHQDSR RIIHRDLKASN+LLD M PKISDFGMARIFG D+ E NT +VVG
Sbjct: 631 GIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVG 690
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648
TYGYM+PEYAM+G+FS KSDV+SFGVLLLEII +RN F+ NL+G VW WK
Sbjct: 691 TYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY--NSDRDLNLLGCVWRNWK 748
Query: 649 EGTAMEAVDKSLGESCCA---PEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP-S 704
EG +E +D + +S EILRCI +GLLCVQE+A DRP MS V+ MLGS++
Sbjct: 749 EGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIP 808
Query: 705 SPKHPAF-IAKGLSNVD---------EFWTGEGVTTSVND 734
PK P + + + L + D E WT +T SV D
Sbjct: 809 QPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLD 848
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 1.1e-183, Sum P(2) = 1.1e-183
Identities = 208/349 (59%), Positives = 252/349 (72%)
Query: 404 RNSEYL--PVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQG 461
+ SEYL P+ +L +A ATN+FS+DNKLG+GGFG VYKG L +GKEIAVKRLS+ S QG
Sbjct: 497 KKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQG 556
Query: 462 IEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWS 521
+EF E+ LIA+LQH NLV +LGCC+++ EKMLIYEYL N SLD ++FD+ + S L+W
Sbjct: 557 TDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQ 616
Query: 522 KRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581
KRF+II GIARG+LYLHQDSR RIIHRDLKASNVLLD M PKISDFGMARIFG ++ E
Sbjct: 617 KRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEA 676
Query: 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVG 641
NT RVVGTYGYM+PEYAM+G+FS KSDV+SFGVLLLEII G+RN F+ + NL+G
Sbjct: 677 NTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY--NSNRDLNLLG 734
Query: 642 HVWDLWKEGTAMEAVDK----SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
VW WKEG +E VD SL EILRCI +GLLCVQE+A DRP MS+V+ ML
Sbjct: 735 FVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML 794
Query: 698 GSDN-APSSPKHPAF-IAKGLSNVDEFW-TGEGVTTSVNDLTITAFQPR 743
GS+ A PK P F I + D T +VN +T++ R
Sbjct: 795 GSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 1.0e-178, Sum P(2) = 1.0e-178
Identities = 208/360 (57%), Positives = 258/360 (71%)
Query: 394 VDAAELDDSRRN-SEYL--PVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIA 450
V A+ S+ N ++YL P+ + +A ATN+FS+DNKLG+GGFG VYKG+L +GKEIA
Sbjct: 490 VKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIA 549
Query: 451 VKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIF 510
VKRLS+ S QG +EF E+ LIA+LQH NLV +LGCC+++ EKMLIYEYL N SLD ++F
Sbjct: 550 VKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLF 609
Query: 511 DEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570
D+ + S L+W KRF+II GIARG+LYLHQDSR RIIHRDLKASNVLLD M PKISDFGM
Sbjct: 610 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 669
Query: 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630
ARIFG ++ E NT RVVGTYGYM+PEYAM+G+FS KSDV+SFGVLLLEII G+RN F+
Sbjct: 670 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY- 728
Query: 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDK----SLGESCCAPEILRCIHLGLLCVQEQATD 686
+ NL+G VW WKEG +E VD +L EILRCI +GLLCVQE+A D
Sbjct: 729 -NSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAED 787
Query: 687 RPNMSAVVSMLGSDN-APSSPKHPAF-IAKGLSNVDEFW-TGEGVTTSVNDLTITAFQPR 743
RP MS+V+ MLGS+ A PK P F + + VD T +VN +T++ R
Sbjct: 788 RPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 5.5e-169, Sum P(2) = 5.5e-169
Identities = 201/336 (59%), Positives = 247/336 (73%)
Query: 409 LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTE 468
LP+FD I+ AT+DFS N LG GGFG VYKG L++G+EIAVKRLS +SGQG+EEFK E
Sbjct: 485 LPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNE 544
Query: 469 IALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528
+ LIA+LQHRNLV +LGCCI+ +E MLIYEY+PNKSLD +IFDE + + LDW KR II
Sbjct: 545 VKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIIN 604
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
G+ARGILYLHQDSRLRIIHRDLKA NVLLD MNPKISDFG+A+ FGGDQ E +TNRVVG
Sbjct: 605 GVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVG 664
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648
TYGYM PEYA++G FS KSDV+SFGVL+LEII G+ N F NL+GHVW +W
Sbjct: 665 TYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFR--HADHDLNLLGHVWKMWV 722
Query: 649 EGTAMEAVDKS-LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPK 707
E +E ++ L E+ PE+LRCIH+ LLCVQ++ DRP M++VV M GSD++ P
Sbjct: 723 EDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPT 782
Query: 708 HPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
P F NV + + + S N+++IT Q R
Sbjct: 783 QPGFFTN--RNVPDISSSLSLR-SQNEVSITMLQGR 815
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1059 (377.8 bits), Expect = 2.8e-165, Sum P(2) = 2.8e-165
Identities = 207/338 (61%), Positives = 259/338 (76%)
Query: 405 NSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEE 464
N+ LPVF L+ IA ATNDF +N+LG GGFG VYKGVL++G+EIAVKRLS SGQG++E
Sbjct: 510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDE 569
Query: 465 FKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF 524
FK EI LIA+LQHRNLV +LGCC E +EKML+YEY+PNKSLD ++FDE K++L+DW RF
Sbjct: 570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
II GIARG+LYLH+DSRLRIIHRDLK SNVLLDA MNPKISDFGMARIFGG+Q E NT
Sbjct: 630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644
RVVGTYGYM+PEYAMEGLFS KSDVYSFGVLLLEI+ G+RN + + GS L+G+ W
Sbjct: 690 RVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSE-HGS--LIGYAW 746
Query: 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP- 703
L+ G + E VD + +C E LRCIH+ +LCVQ+ A +RPNM++V+ ML SD A
Sbjct: 747 YLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATL 806
Query: 704 SSPKHPAFIAKGLSNVDEFW---TGEGVTTSVNDLTIT 738
++P+ P F + +++D + + + S N++T T
Sbjct: 807 AAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITST 844
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 1.2e-162, Sum P(2) = 1.2e-162
Identities = 192/338 (56%), Positives = 250/338 (73%)
Query: 409 LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTE 468
LP+F+ +A ATN+FS NKLG+GGFG+VYKG LQ G +IAVKRLSR+SGQG+EEF E
Sbjct: 497 LPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNE 556
Query: 469 IALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528
+ +I++LQHRNLV +LG CIE +E+ML+YE++P LD Y+FD K+ LLDW RF II
Sbjct: 557 VVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIID 616
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
GI RG++YLH+DSRL+IIHRDLKASN+LLD +NPKISDFG+ARIF G++ E +T RVVG
Sbjct: 617 GICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVG 676
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648
TYGYMAPEYAM GLFS KSDV+S GV+LLEI+ GRRN++F+ G NL + W LW
Sbjct: 677 TYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFY-NDGQNP-NLSAYAWKLWN 734
Query: 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP-SSPK 707
G + VD + E C EI RC+H+GLLCVQ+ A DRP+++ V+ ML S+N+ PK
Sbjct: 735 TGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPK 794
Query: 708 HPAFIAK-GLSNVDEFWTGEG-VTTSVNDLTITAFQPR 743
PAFI + G S V+ +G+ S+N++++T R
Sbjct: 795 QPAFIPRRGTSEVES--SGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.3e-158, Sum P(2) = 1.3e-158
Identities = 196/339 (57%), Positives = 250/339 (73%)
Query: 409 LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTE 468
LP+F ++A+AT DF+ +NKLG+GGFG+VYKG G+EIAVKRLS S QG+EEFK E
Sbjct: 510 LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNE 569
Query: 469 IALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528
I LIA+LQHRNLV +LGCCIE+ EKML+YEY+PNKSLD ++FDE+K+ LDW KR+E+I
Sbjct: 570 ILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIG 629
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
GIARG+LYLH+DSRL+IIHRDLKASN+LLD MNPKISDFGMARIF Q NT RVVG
Sbjct: 630 GIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVG 689
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648
TYGYMAPEYAMEG+FS KSDVYSFGVL+LEI+ GR+N +F +G+ +L+G+ W LW
Sbjct: 690 TYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSF---RGTDHGSLIGYAWHLWS 746
Query: 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA----PS 704
+G E +D + ++ E +RCIH+G+LC Q+ RPNM +V+ ML S + P
Sbjct: 747 QGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPR 806
Query: 705 SPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQPR 743
P +F+ G +++ + G V SVND+T T R
Sbjct: 807 QPTFHSFLNSG--DIELNFDGHDVA-SVNDVTFTTIVGR 842
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 5.4e-158, Sum P(2) = 5.4e-158
Identities = 193/361 (53%), Positives = 253/361 (70%)
Query: 383 YINAGQDLYVRVDAAELDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV 442
+I++ QD + + D D S N +FD+ I ATN+FSS NKLG+GGFG VYKG
Sbjct: 485 FIHSSQDAWAK-DMEPQDVSGVN-----LFDMHTIRTATNNFSSSNKLGQGGFGPVYKGK 538
Query: 443 LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502
L +GKEIAVKRLS SSGQG +EF EI LI++LQH+NLV +LGCCI+ +EK+LIYEYL N
Sbjct: 539 LVDGKEIAVKRLSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVN 598
Query: 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562
KSLDV++FD + +DW KRF II G+ARG+LYLH+DSRLR+IHRDLK SN+LLD M
Sbjct: 599 KSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMI 658
Query: 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PKISDFG+AR+ G Q ++NT RVVGT GYMAPEYA G+FS KSD+YSFGVLLLEII+G
Sbjct: 659 PKISDFGLARMSQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIG 718
Query: 623 RRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQE 682
+ + F E+G L+ + W+ W E ++ +D++L +S E+ RC+ +GLLCVQ
Sbjct: 719 EKISRFS-EEGK---TLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQH 774
Query: 683 QATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNVDEFWTGEGVTTSVNDLTITAFQP 742
Q DRPN ++SML + + SPK P F S D+ + + +T VN++T + Q
Sbjct: 775 QPADRPNTLELMSMLTTISELPSPKQPTFTVH--SRDDDSTSNDLIT--VNEITQSVIQG 830
Query: 743 R 743
R
Sbjct: 831 R 831
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 2.1e-156, Sum P(2) = 2.1e-156
Identities = 183/328 (55%), Positives = 238/328 (72%)
Query: 409 LPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTE 468
L F+++ I AT++FS NKLG+GGFGSVYKG LQ+GKEIAVKRLS SSGQG EEF E
Sbjct: 481 LKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 540
Query: 469 IALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528
I LI++LQH+NLV ILGCCIE +E++L+YE+L NKSLD ++FD KR +DW KRF II
Sbjct: 541 IVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIE 600
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
GIARG+ YLH+DS LR+IHRDLK SN+LLD MNPKISDFG+AR++ G + ++NT RV G
Sbjct: 601 GIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAG 660
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648
T GYMAPEYA G+FS KSD+YSFGV+LLEII G + + F G L+ + W+ W
Sbjct: 661 TLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRF--SYGRQGKTLLAYAWESWC 718
Query: 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKH 708
E ++ +DK + +SC E+ RC+ +GLLCVQ Q DRPN ++SML + + +SPK
Sbjct: 719 ESGGIDLLDKDVADSCHPLEVERCVQIGLLCVQHQPADRPNTMELLSMLTTTSDLTSPKQ 778
Query: 709 PAFIAKGLSNVDEFWTGEGVTTSVNDLT 736
P F+ + DE +G+ T VN++T
Sbjct: 779 PTFV---VHTRDEESLSQGLIT-VNEMT 802
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 5.5e-156, Sum P(2) = 5.5e-156
Identities = 193/347 (55%), Positives = 246/347 (70%)
Query: 391 YVRVDAAELDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIA 450
++ DA + D ++ L FD+ I ATN+FS NKLG+GGFGSVYKG LQ+GKEIA
Sbjct: 458 HISKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIA 517
Query: 451 VKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIF 510
VKRLS SSGQG EEF EI LI++LQHRNLV +LGCCIEE+EK+LIYE++ NKSLD ++F
Sbjct: 518 VKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLF 577
Query: 511 DEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570
D KR +DW KRF+II GIARG+LYLH DSRLR+IHRDLK SN+LLD MNPKISDFG+
Sbjct: 578 DSRKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGL 637
Query: 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630
AR++ G + ++NT RVVGT GYM+PEYA G+FS KSD+YSFGVL+LEII G + + F
Sbjct: 638 ARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRF-- 695
Query: 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690
G L+ + W+ W E ++ +D+ L +SC E+ RCI +GLLCVQ Q DRPN
Sbjct: 696 SYGVEGKTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNT 755
Query: 691 SAVVSMLGSDNAPSSPKHPAFIA-----KGLSNVDEFWTGEGVTTSV 732
+++ML + + SPK P F + LSN + T G+T SV
Sbjct: 756 LELLAMLTTTSDLPSPKQPTFAFHTRDDESLSN--DLITVNGMTQSV 800
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4912 | 0.9434 | 0.8952 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_IV000049 | hypothetical protein (793 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 743 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-42 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-35 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-31 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-31 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-25 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 5e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 3e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 3e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 97/284 (34%), Positives = 133/284 (46%), Gaps = 43/284 (15%)
Query: 427 DNKLGEGGFGSVYKGVLQNGK-----EIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
KLGEG FG VYKG L+ E+AVK L +S Q IEEF E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V +LG C EE+ ++ EY+ L Y+ R L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVGTYGYMAPEYAM 599
IHRDL A N L+ + KISDFG++R ++ D + ++ +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLK 176
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSW------NLVGHVWDLWKEGTAM 653
EG F++KSDV+SFGVLL EI G + ++ ++ K G +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEI----------FTLGEQPYPGMSNEEVLEYL----KNGYRL 222
Query: 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C PE+ L L C E DRP S +V +L
Sbjct: 223 PQPPN------CPPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 100/278 (35%), Positives = 136/278 (48%), Gaps = 30/278 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQNGK-----EIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
KLGEG FG VYKG L+ E+AVK L +S Q IEEF E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V +LG C EE+ M++ EY+P L Y+ + L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVGTYGYMAPEYAM 599
IHRDL A N L+ + KISDFG++R ++ D + ++ +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659
EG F++KSDV+SFGVLL EI F L + V + K+G +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSNAEVLEYLKKGYRLPKPPN- 228
Query: 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C PE+ + L L C E DRP S +V +L
Sbjct: 229 -----CPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 92/289 (31%), Positives = 136/289 (47%), Gaps = 47/289 (16%)
Query: 428 NKLGEGGFGSVYKGVLQNGK----EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVS 482
KLGEG FG VYKG L+ E+AVK L S + ++F E ++ +L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYI------FDEAKRSLLDWSKRFEIICGIARGILY 536
+LG C EE+ L+ EY+ L Y+ F ++S L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVGTYGYMAP 595
L + +HRDL A N L+ + KISDFG++R ++ D + T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEII-LGR------RNNTFHLEQGSGSWNLVGHVWDLWK 648
E +G+F++KSDV+SFGVLL EI LG N ++ ++ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----------EVLEYL----R 221
Query: 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+G + + C E+ L L C Q DRP S +V L
Sbjct: 222 KGYRLPKPE------YCPDELYE---LMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 69/194 (35%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGI-EEFKTEIALIAQLQHRNLVSILGCC 487
LGEGGFG+VY + GK++A+K + + + EE EI ++ +L H N+V + G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+E L+ EY SL + + + L + I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 548 RDLKASNVLLDAA-MNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE-YAMEGLFST 605
RDLK N+LLD+ K++DFG++++ D + +VGT YMAPE +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 606 KSDVYSFGVLLLEI 619
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (445), Expect = 7e-50
Identities = 89/286 (31%), Positives = 129/286 (45%), Gaps = 50/286 (17%)
Query: 429 KLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVS 482
KLGEG FG VYKG L ++AVK L + + EEF E +++ +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+LG C + + ++ EY+P L ++ L ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY-----MAPEY 597
+HRDL A N L+ + KISDFG++R I E+ G MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 598 AMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSWNLVGHVWDLWKEGT 651
+G F++KSDV+SFGVLL EI LG + +N V +L ++G
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--------------EVLELLEDGY 221
Query: 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ + C E+ L L C DRP S +V L
Sbjct: 222 RLPRPEN------CPDELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-48
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVSILG 485
KLGEG FG VY + GK +A+K + + + E EI ++ +L+H N+V +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
+E + L+ EY L + + + L + RF + I + YLH I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS---KGI 118
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFST 605
+HRDLK N+LLD + K++DFG+AR E VGT YMAPE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 606 KSDVYSFGVLLLEIILGR 623
D++S GV+L E++ G+
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 8e-45
Identities = 70/200 (35%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 429 KLGEGGFGSVYKGVLQN-GKEIAVKRL---SRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
KLG G FG+VYK + GK +AVK L S S + EI ++ +L H N+V ++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPNIVRLI 64
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
++ L+ EY L Y+ L + +I I RG+ YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH---SNG 118
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE-YAMEGLF 603
IIHRDLK N+LLD KI+DFG+A+ + VGT YMAPE +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 604 STKSDVYSFGVLLLEIILGR 623
K DV+S GV+L E++ G+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 428 NKLGEGGFGSVYKGVLQ-NGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
LG G FGSVY + + G+ +AVK LS S + +E + EI +++ LQH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 485 GCCIEEQEKML-IY-EYLPNKSLDVYIFDEAKRSLLDWSKRFE--IICG----IARGILY 536
G +E++ L I+ EY+ SL SLL + +I I G+ Y
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSL---------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH I+HRD+K +N+L+D+ K++DFG A+ G + E T V GT +MAPE
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRR 624
+ +D++S G ++E+ G+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 59/113 (52%), Positives = 72/113 (63%), Gaps = 4/113 (3%)
Query: 50 VQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDT 109
QTVVWVANR NP+ D+S L + S GNLVL N V VW +N S S +A L D
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRV-VWSSNTSGKG-SGCVAVLQDD 58
Query: 110 GNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPA 162
GNLVL +N+G+ LWQSFDHP+ T+LP K G G +R LTSWKS +P+
Sbjct: 59 GNLVL-YDNSGKVLWQSFDHPTDTLLPGQKDGN-VVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 429 KLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+G+GGFG VYK + GKE+A+K + S + E+ EI ++ + +H N+V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLD-WSKRF--EIICGIARGIL----YLHQD 540
+++ E ++ E+ SL + LL ++ I + + +L YLH
Sbjct: 67 LKKDELWIVMEFCSGGSL---------KDLLKSTNQTLTESQIAYVCKELLKGLEYLHS- 116
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
IIHRD+KA+N+LL + K+ DFG++ + N +VGT +MAPE
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVING 171
Query: 601 GLFSTKSDVYSFGVLLLEIILGR 623
+ K+D++S G+ +E+ G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 55/121 (45%), Positives = 72/121 (59%), Gaps = 5/121 (4%)
Query: 10 NQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGV 69
+ P+ G +VSSG++F LGFF R Y I Y +TVVWVANRDNP + +S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCT 58
Query: 70 LTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDH 129
LT+ S GNLV+ + T VW +N + N + LLD GNLVL ++ G LWQSFD+
Sbjct: 59 LTLQSDGNLVIYDGSGT-VVWSSNTT-RVNGNYVLVLLDDGNLVL-YDSDGNFLWQSFDY 115
Query: 130 P 130
P
Sbjct: 116 P 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-34
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+F+ + KLG G FG V++G+ +N +A+K L ++F+ E+ + +L+H++L+S
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+ C + +I E + SL ++ + L + ++ C +A G+ YL +
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD-QIEENTNRVVGTYGYMAPEYAMEG 601
IHRDL A N+L+ + K++DFG+AR+ D + + Y + APE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHG 179
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661
FSTKSDV+SFG+LL E+ F Q V+D G M K
Sbjct: 180 TFSTKSDVWSFGILLYEM--------FTYGQVPYPGMNNHEVYDQITAGYRMPCPAK--- 228
Query: 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699
C EI + + L C + DRP+ A+ L +
Sbjct: 229 ---CPQEIYK---IMLECWAAEPEDRPSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 76/211 (36%), Positives = 112/211 (53%), Gaps = 25/211 (11%)
Query: 430 LGEGGFGSVYKG--VLQNGKE----IAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVS 482
LGEG FG VYKG N + +A+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIF-------------DEAKRSLLDWSKRFEIICG 529
+LG C +EQ +++EYL + L ++ DE +S LD S I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVG 588
IA G+ YL S +HRDL A N L+ + KISDFG++R I+ D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M PE + G F+T+SD++SFGV+L EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 31/209 (14%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSIL 484
+ +G G FG VYKG+ L+ G +A+K++S + ++ EI L+ L+H N+V +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF----EIICG-----IARGIL 535
G +I EY N SL R ++ K+F E + + +G+
Sbjct: 66 GSIETSDSLYIILEYAENGSL---------RQII---KKFGPFPESLVAVYVYQVLQGLA 113
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
YLH+ +IHRD+KA+N+L K++DFG+A ++ + VVGT +MAP
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAP 168
Query: 596 E-YAMEGLFSTKSDVYSFGVLLLEIILGR 623
E M G ST SD++S G ++E++ G
Sbjct: 169 EVIEMSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 430 LGEGGFGSVYKGV----LQNGK-EIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSI 483
LG G FG+VYKGV + K +A+K L + + +E E ++A + H ++V +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILYLHQ 539
LG C+ Q LI + +P L Y+ + LL+W + IA+G+ YL +
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
R++HRDL A NVL+ + KI+DFG+A++ D+ E + +MA E +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 600 EGLFSTKSDVYSFGVLLLEII-LGRR 624
+++ KSDV+S+GV + E++ G +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 86/283 (30%), Positives = 127/283 (44%), Gaps = 31/283 (10%)
Query: 428 NKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLV 481
+LGEG FG V G+++AVK L+ S Q +F+ EI ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 482 SILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
G C + + LI EYLP+ SL Y+ + L F I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS--QICKGMDYLGS 127
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMAPEY 597
R IHRDL A N+L+++ KISDFG+A++ D + Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 598 AMEGLFSTKSDVYSFGVLLLEII-LGRRNN----TFHLEQG-SGSWNLVGHVWDLWKEGT 651
FS+ SDV+SFGV L E+ G + F G + +V + +L KEG
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694
+ C E+ L LC + + DRP+ + ++
Sbjct: 244 RLPRPPS------CPDEVY---DLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 70/198 (35%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
KLG G FG V+ G ++AVK L + E F E ++ +L+H LV + C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
EE+ ++ EY+ SL ++ + L + ++ IA G+ YL IHR
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SRNYIHR 127
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY--GYMAPEYAMEGLFSTK 606
DL A N+L+ + KI+DFG+AR+ D E T R + + APE A G F+ K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 607 SDVYSFGVLLLEII-LGR 623
SDV+SFG+LL EI+ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 83/282 (29%), Positives = 132/282 (46%), Gaps = 44/282 (15%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
D + +KLG G +G VY+GV + +AVK L + +EEF E A++ +++H NLV
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+LG C E +I E++ +L Y+ E R ++ + I+ + YL + +
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY----------G 591
IHRDL A N L+ K++DFG++R+ GD TY
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----------TYTAHAGAKFPIK 170
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651
+ APE FS KSDV++FGVLL EI T+ + G + V++L ++G
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIA------TYGMSPYPGI--DLSQVYELLEKGY 222
Query: 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAV 693
ME C P++ + C Q +DRP+ + +
Sbjct: 223 RME------RPEGCPPKVYELMR---ACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
F KLGEG +GSVYK + + G+ +A+K + + ++E EI+++ Q +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60
Query: 481 VSILGCCIEEQEKMLIYEY-----------LPNKSLDVYIFDEAKRSLLDWSKRFEIICG 529
V G + + ++ EY + NK+L E + + I+
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-----EEEIAA--------ILYQ 107
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+G+ YLH + IHRD+KA N+LL+ K++DFG++ + NT V+GT
Sbjct: 108 TLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+MAPE E ++ K+D++S G+ +E+ G+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSR---SSGQGIEEFKTEIALIAQLQH-RNLVSIL 484
KLGEG FG VY ++ K +A+K L++ S + +E F EI ++A L H N+V +
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
+E L+ EY+ SL+ + ++ L S+ I+ I + YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 545 IIHRDLKASNVLLDAAMN-PKISDFGMARIFGGDQ----IEENTNRVVGTYGYMAPEYAM 599
IIHRD+K N+LLD K+ DFG+A++ I + VGT GYMAPE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 600 EGLF---STKSDVYSFGVLLLEIILGRR 624
S+ SD++S G+ L E++ G
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 50/120 (41%), Positives = 69/120 (57%), Gaps = 6/120 (5%)
Query: 10 NQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGV 69
+ + G +VS ++F LGFF+ Y I Y +TVVWVANRDNP++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCT 57
Query: 70 LTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDH 129
LT+ S GNLVL + VW +N + + N + LLD GNLV+ ++ G LWQSFD+
Sbjct: 58 LTLQSDGNLVLYDGDGR-VVWSSNTT-GANGNYVLVLLDDGNLVI-YDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 49/275 (17%)
Query: 429 KLGEGGFGSVYKGVLQ-NGKEIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
LG+G G VYK + GK A+K++ + ++ E+ + + +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF-EIICG-IARGIL----YLHQD 540
+E E ++ EY+ SL LL + E + IAR IL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLA---------DLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
IIHRD+K SN+L+++ KI+DFG++++ + + N VGT YM+PE
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQG 174
Query: 601 GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK-- 658
+S +D++S G+ LLE LG+ F L G S+ ++L M+A+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK--FPF-LPPGQPSF------FEL------MQAICDGP 219
Query: 659 --SLGESCCAPE---ILRCIHLGLLCVQEQATDRP 688
SL +PE + C+Q+ RP
Sbjct: 220 PPSLPAEEFSPEFRDFISA------CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 430 LGEGGFGSVYKGVLQNGKE------IAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVS 482
LGEG FG V+ G + + +AVK L ++ + F+ E L+ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVY-----------IFDEAKRSLLDWSKRFEIICGIA 531
G C E ++++EY+ + L+ + ++ L S+ +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT-- 589
G++YL + +HRDL N L+ + KI DFGM+R D + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 590 --YGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M PE M F+T+SDV+SFGV+L EI
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 430 LGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE 489
+G+G FG V G + G+++AVK L S + F E +++ L+H NLV +LG ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRD 549
++ EY+ SL Y+ R+++ +++ + G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 550 LKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY--GYMAPEYAMEGLFSTKS 607
L A NVL+ + K+SDFG+A+ E + + G + APE E FSTKS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 608 DVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAP 667
DV+SFG+LL EI R + ++V HV ++G MEA + C P
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLK----DVVPHV----EKGYRMEAPEG------CPP 226
Query: 668 EILRCIHLGLLCVQEQATDRPNMSAVVSML 697
E+ + + C + RP + L
Sbjct: 227 EVYKVM---KDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
KLG G FG V++G+ N +AVK L + ++F E ++ +L+H L+ + C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
E+ ++ E + SL Y+ A R+L + ++ +A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPEYAMEGLFST 605
DL A NVL+ K++DFG+AR+ D E G + APE A+ FS
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183
Query: 606 KSDVYSFGVLLLEII 620
KSDV+SFG+LL EI+
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 77/198 (38%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 428 NKLGEGGFGSVYKGVLQ--NGKEI--AVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVS 482
+LG G FGSV KGV +GKE+ AVK L + G +EF E +++AQL H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
++G C E ML+ E P L Y+ KR + S E+ +A G+ YL
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK-- 114
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY--GYMAPEYAME 600
+HRDL A NVLL KISDFGM+R G + G + + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-DYYRATTAGRWPLKWYAPECINY 172
Query: 601 GLFSTKSDVYSFGVLLLE 618
G FS+KSDV+S+GV L E
Sbjct: 173 GKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 430 LGEGGFGSVYKGV--LQNGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSIL 484
LG+G FG V V GK A+K L + + +E TE +++++ H +V L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-L 58
Query: 485 GCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF--EIICGIARGILY 536
+ +EK+ L+ EY P L ++ F E + ++ + EI+ + Y
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE------ERARFYAAEIVLALE----Y 108
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH L II+RDLK N+LLDA + K++DFG+A+ + TN GT Y+APE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPEYLAPE 163
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ + D +S GVLL E++ G+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
++G G FG V+ G +++A+K + R E+F E ++ +L H LV + G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
E L++E++ + L Y+ A+R + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPEYAMEGLFST 605
DL A N L+ K+SDFGM R DQ +T GT + +PE +S+
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 606 KSDVYSFGVLLLEI 619
KSDV+SFGVL+ E+
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 49/292 (16%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKE---IAVKRL-SRSSGQGIEEFKTEIALIAQLQ 476
+ + + +G G FG V +G L+ GK+ +A+K L + SS + +F TE +++ Q
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
H N++ + G + + M+I EY+ N SLD ++ + ++ GIA G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG----- 591
L S + +HRDL A N+L+++ + K+SDFG++R E++ T G
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL------EDSEATYTTKGGKIPI 172
Query: 592 -YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649
+ APE F++ SDV+SFG+++ E++ G R WD
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP-----------------YWD-MSN 214
Query: 650 GTAMEAVDKSL----GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
++AV+ C P L L L C Q+ +RP S +VS L
Sbjct: 215 QDVIKAVEDGYRLPPPMDC--PSALY--QLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 74/209 (35%), Positives = 111/209 (53%), Gaps = 22/209 (10%)
Query: 430 LGEGGFGSVYKG----VLQNGKE---IAVKRLSR-SSGQGIEEFKTEIALIAQLQHRNLV 481
LG G FG VY+G +L G +AVK L + ++ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRS----LLDWSKRFEIICGIARGILYL 537
+LG C+ + + +I E + L Y+ D LL + +I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 538 HQDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMAR-IFGGDQIEENTNRVVGTYG 591
Q + IHRDL A N L+ DA KI DFG+AR I+ D + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
+MAPE ++G F+T+SDV+SFGVL+ EI+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 20/208 (9%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT----EIALIAQLQHR 478
+ KLGEG +G VYK + G+ +A+K++ E + EI+L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR--FEIICGIARGILY 536
N+V +L E++ L++EY + L Y+ + K ++++ G+A Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----Y 113
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H RI+HRDLK N+L++ K++DFG+AR F G + T+ VV T Y APE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 597 YAM-EGLFSTKSDVYSFGVLLLEIILGR 623
+ +ST D++S G + E+I G+
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+GEG G VYK GKE+A+K++ R Q E EI ++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 488 IEEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRF----EI--ICG-IARGILYLHQ 539
+ E ++ EY+ SL D+ + + +I +C + +G+ YLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTDI----------ITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+IHRD+K+ N+LL + K++DFG A ++ + N+ VVGT +MAPE
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIK 189
Query: 600 EGLFSTKSDVYSFGVLLLEIILG 622
+ K D++S G++ +E+ G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 64/207 (30%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKR--LSRSSGQGIEEFKTEIALIAQLQHRN 479
DF NK+G+G FG V+K V + + + A+K+ LS+ + + EE E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLD---WSKRFEIICGIARGILY 536
++ +++ + ++ EY N L + + R L + W +I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH +I+HRD+K+ N+ LDA N KI D G+A++ + NT +VGT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ ++ KSDV++ GV+L E G+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 71/195 (36%), Positives = 104/195 (53%), Gaps = 13/195 (6%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
KLG G FG V+ G ++A+K L + S E F E L+ QLQH LV L +
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVR-LYAVV 70
Query: 489 EEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
++ +I EY+ N SL D E + L +K ++ IA G+ ++ R IH
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY--GYMAPEYAMEGLFST 605
RDL+A+N+L+ + KI+DFG+AR+ + E T R + + APE G F+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 606 KSDVYSFGVLLLEII 620
KSDV+SFG+LL EI+
Sbjct: 183 KSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 17/200 (8%)
Query: 430 LGEGGFGSV----YKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
LG+G FGSV Y + N G+ +AVK+L S+ + + +F+ EI ++ LQH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 485 GCCIE--EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
G C + L+ EYLP SL Y+ + R LD K I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG---TYGYMAPEYAM 599
R +HRDL N+L+++ KI DFG+ ++ D+ E R G + Y APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184
Query: 600 EGLFSTKSDVYSFGVLLLEI 619
E FS SDV+SFGV+L E+
Sbjct: 185 ESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEF----KTEIALIAQLQHRNLVS 482
++GEG +G VYK + G+ +A+K++ + + E F EI L+ +L+H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 483 ILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICG--------IAR 532
+ + + +++EY+ + D+ LLD S + +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DL-------TGLLD-SPEVKFTESQIKCYMKQLLE 111
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
G+ YLH + I+HRD+K SN+L++ K++DFG+AR + + TNRV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 593 MAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
PE + + + D++S G +L E+ LG+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 428 NKLGEGGFGSVYKGVLQNGK------EIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
LG G FG VY+G+ + ++AVK L S Q +F E ++++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILY 536
V ++G E + ++ E + L ++ + R S L +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNP----KISDFGMAR-IFGGDQIEENTNRVVGTYG 591
L ++ IHRD+ A N LL P KI+DFGMAR I+ + R +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG-GRAMLPIK 186
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR 623
+M PE ++G+F++K+DV+SFGVLL EI LG
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 75/197 (38%), Positives = 106/197 (53%), Gaps = 16/197 (8%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
KLG G FG V+ G N ++AVK L + ++ F E L+ LQH LV +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 489 EEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+E+ +I EY+ SL D DE + LL K + IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTY--GYMAPEYAMEGLF 603
RDL+A+NVL+ ++ KI+DFG+AR+ IE+N T R + + APE G F
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARV-----IEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 604 STKSDVYSFGVLLLEII 620
+ KSDV+SFG+LL EI+
Sbjct: 182 TIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 51/236 (21%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALI-----AQL 475
+DF +GEG F +V + KE A+K L + Q I+E K + I +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 476 -QHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---E 525
H ++ L +++E + + EY PN L YI DE RF E
Sbjct: 59 NGHPGIIK-LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-------CTRFYAAE 110
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
I+ + YLH IIHRDLK N+LLD M+ KI+DFG A++ + E+
Sbjct: 111 ILLALE----YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 586 V------------------VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
VGT Y++PE E SD+++ G ++ +++ G+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKR--LSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
++G+G FG VY +GK +K LS S + E+ E+ ++ +L H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRS-------LLDWSKRFEIICGIARGILYL 537
E+ + ++ EY L I + K +LDW + + YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCLALKYL 119
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H SR +I+HRD+K N+ L + K+ DFG++++ T VVGT Y++PE
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPEL 174
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRR 624
++ KSD++S G +L E+ +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 82/289 (28%), Positives = 118/289 (40%), Gaps = 55/289 (19%)
Query: 429 KLGEGGFGSVYKGVLQN--GKEI--AVKRLSRSSGQGI-EEFKTEIALIAQLQHRNLVSI 483
KLG+G FG V +G GK I AVK L I ++F E A++ L H NL+ +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRS-----LLDWSKRFEIICGIARGILYLH 538
G + M++ E P SL + +A L D++ + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMAPE 596
R IHRDL A N+LL + KI DFG+ R D + V + + APE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPE 170
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA---M 653
FS SDV+ FGV L W + + + W + +
Sbjct: 171 SLRTRTFSHASDVWMFGVTL--------------------WEMFTYGEEPWAGLSGSQIL 210
Query: 654 EAVDKSLGE-----SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ +DK GE C +I ++ L C DRP +A+ L
Sbjct: 211 KKIDKE-GERLERPEACPQDIY---NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQHRN 479
F+ +G+G FG VYK + + + +A+K + + IE+ + EI ++Q +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKS----LDVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
+ G ++ + +I EY S L DE I I R +L
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE------------TYIAFILREVL 108
Query: 536 ----YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVG 588
YLH++ IHRD+KA+N+LL + K++DFG++ Q+ ++ VG
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVG 160
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
T +MAPE + + K+D++S G+ +E+ G
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/192 (33%), Positives = 100/192 (52%), Gaps = 6/192 (3%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGI-EEFKTEIALIAQLQHRNLVSILGCC 487
K+G+G FG VYKGVL+ E+AVK + + +F E ++ Q H N+V ++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+++Q ++ E +P SL ++ + R L K ++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKS 607
RDL A N L+ KISDFGM+R G + + APE G ++++S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 608 DVYSFGVLLLEI 619
DV+S+G+LL E
Sbjct: 177 DVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 56/293 (19%)
Query: 430 LGEGGFGSVYKGVLQN------GKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQHRNLVS 482
LG+G FG VY+G+ + +A+K ++ +S + EF E +++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYI-------FDEAKRSLLDWSKRFEIICGIARGIL 535
+LG Q +++ E + L Y+ + K ++ IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT----YG 591
YL + +HRDL A N ++ + KI DFGM R D E + R G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEII-------LGRRNNTFHLEQGSGSWNLVGHVW 644
+MAPE +G+F+TKSDV+SFGV+L E+ G N E+ V
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EE----------VL 231
Query: 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+G ++ L E+C P+ L L +C Q RP +VS L
Sbjct: 232 KFVIDGGHLD-----LPENC--PDKLL--ELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 69/208 (33%), Positives = 113/208 (54%), Gaps = 16/208 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKT-EIALIAQLQHRN 479
D++ K+GEG +G VYKG + G+ +A+K++ S +G+ EI+L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 480 LVSILGCCIEEQEKMLIYEYLP---NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+V + ++E LI+E+L K LD + + L S ++I+ +GIL+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILF 116
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H R++HRDLK N+L+D K++DFG+AR F G + T+ VV T Y APE
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPE 171
Query: 597 YAMEG-LFSTKSDVYSFGVLLLEIILGR 623
+ +ST D++S G + E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 71/212 (33%), Positives = 109/212 (51%), Gaps = 25/212 (11%)
Query: 429 KLGEGGFGSVYKGVL-----QNGKEIAVKRLSR-SSGQGIEEFKTEIALIAQLQHRNLVS 482
+LGE FG +YKG L + + +A+K L ++ Q EF+ E +L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIF--------------DEAKRSLLDWSKRFEIIC 528
+LG +EQ +++EYL L ++ D +S LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVV 587
IA G+ YL S +H+DL A N+L+ ++ KISD G++R I+ D ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M PE M G FS+ SD++SFGV+L EI
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 78/203 (38%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 430 LGEGGFGSV--YKGVLQN---GKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVSI 483
LGEG FG V Y N G+ +AVK L R GQ +K EI ++ L H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 484 LGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
GCC E+ K LI EY+P SL Y+ + L+ ++ I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGD---QIEENTNRVVGTYGYMAPEY 597
IHRDL A NVLLD KI DFG+A+ + G ++ E+ + V Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AVEC 181
Query: 598 AMEGLFSTKSDVYSFGVLLLEII 620
E FS SDV+SFGV L E++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-25
Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 14/113 (12%)
Query: 188 WRVGSWTGKNF-----------LNATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRL 236
WR G W G F + +N +EV Y +T+ S+ +R+ ++ G+ +R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 237 TWSNQENRWIEYFAPPKEPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKS 289
TW W +++ PK+ CD YG CG C+ V +C C+ GF PK+
Sbjct: 61 TWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCD---VNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 66/214 (30%), Positives = 112/214 (52%), Gaps = 32/214 (14%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG---------IEEFKTEIALIAQLQHRN 479
+G G FGSVY G+ +G+ +AVK++ S ++ EIAL+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------IICGIARG 533
+V LG ++ + EY+P S+ +LL+ FE + I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI--EENTNR--VVGT 589
+ YLH IIHRD+K +N+L+D KISDFG+++ + + + N R + G+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+MAPE + ++ K+D++S G L++E++ G+
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
NK+G G FG VY V L G+ +AVK R+ + + I+E E+ ++ L+H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 485 GCCIE-EQEKMLIY-EYLPNKSLDV-----YIFDEAKRSLLDWSKRFEIICGIARGILYL 537
G +E +EK+ I+ EY +L+ I DE + + + + G+ YL
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV------IRVYTL--QLLEGLAYL 115
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMAP 595
H I+HRD+K +N+ LD K+ DFG A + E + GT YMAP
Sbjct: 116 HSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 596 EYAMEGLFSTK---SDVYSFGVLLLEIILGRR 624
E G +D++S G ++LE+ G+R
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+ + +LG G FG V+ G + ++A+K + R ++F E ++ +L H NLV
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+ G C +++ ++ EY+ N L Y+ ++ L ++ + + YL +
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPEYAM 599
IHRDL A N L+ K+SDFG+AR DQ + GT + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFD 174
Query: 600 EGLFSTKSDVYSFGVLLLEI 619
FS+KSDV+SFGVL+ E+
Sbjct: 175 YSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSILG 485
K+GEG +G VYK G+ +A+K++ EI L+ +L H N++ +L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
+ + L++E++ D+Y + ++ L S + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE--YAMEGLF 603
+HRDLK N+L++ K++DFG+AR FG T+ VV T Y APE +G +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKG-Y 176
Query: 604 STKSDVYSFGVLLLEIILGR 623
ST D++S G + E++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 73/214 (34%), Positives = 113/214 (52%), Gaps = 21/214 (9%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
KLG G FG V+ G ++AVK L + E F E ++ +L+H LV L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQ-LYAVV 70
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
E+ ++ EY+ SL ++ D R+L ++ +A G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTY--GYMAPEYAMEGLFS 604
DL+++N+L+ + KI+DFG+AR+ IE+N T R + + APE A+ G F+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 605 TKSDVYSFGVLLLEIILGRR------NNTFHLEQ 632
KSDV+SFG+LL E++ R NN LEQ
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/213 (32%), Positives = 111/213 (52%), Gaps = 40/213 (18%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLS-----RSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG G FGSVY+G+ L +G AVK +S ++ + +++ + EIAL+++LQH N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 484 LGCCIEEQEKMLIY-EYLPNKSLDVYIFDEAKRSLLDWSKRF-----EIICGIARGIL-- 535
LG EE + + I+ E +P SL LL K++ +I R IL
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLA---------KLL---KKYGSFPEPVIRLYTRQILLG 114
Query: 536 --YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTYG 591
YLH +HRD+K +N+L+D K++DFGMA+ Q+ E G+
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPY 166
Query: 592 YMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
+MAPE +G + +D++S G +LE+ G+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 67/201 (33%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 430 LGEGGFGSVYKGVLQNGKE-----IAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSI 483
LG G FG+VYKG+ E +A+K L+ ++G + EF E ++A + H +LV +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDE----AKRSLLDWSKRFEIICGIARGILYLHQ 539
LG C+ + L+ + +P+ L Y+ + + LL+W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
R++HRDL A NVL+ + + KI+DFG+AR+ GD+ E N + +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 600 EGLFSTKSDVYSFGVLLLEII 620
F+ +SDV+S+GV + E++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 25/212 (11%)
Query: 429 KLGEGGFGSVYKGVL------QNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQHRNLV 481
+LGE FG VYKG L + + +A+K L ++ G EEFK E + ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIF-------------DEAKRSLLDWSKRFEIIC 528
+LG +EQ +I+ Y + L ++ D+ +S L+ + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVV 587
IA G+ +L S ++H+DL NVL+ +N KISD G+ R ++ D + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M+PE M G FS SD++S+GV+L E+
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS---RSSGQGIEEFKTEIALIAQLQ 476
+F + K+G+G F VYK + L +G+ +A+K++ + ++ EI L+ QL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI--FDEAKRSLLDWSKRFEIICGIARGI 534
H N++ L IE E ++ E L I F + KR L+ ++ + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSAL 119
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
++H RI+HRD+K +NV + A K+ D G+ R F ++ +VGT YM+
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEI 619
PE E ++ KSD++S G LL E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRN 479
+D+ +G G VY + L N +++A+KR+ Q ++E + E+ ++Q H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKS-LDV--YIFDEAKRSLLDWSKRFEIICGIARGIL- 535
+V + E L+ YL S LD+ + R LD + II + + +L
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY---PRGGLDEA----IIATVLKEVLK 113
Query: 536 ---YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM-ARIF-GGDQIEENTNRVVGTY 590
YLH + + IHRD+KA N+LL + KI+DFG+ A + GGD+ + VGT
Sbjct: 114 GLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 591 GYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGR 623
+MAPE ME + + K+D++SFG+ +E+ G
Sbjct: 171 CWMAPE-VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 71/203 (34%), Positives = 110/203 (54%), Gaps = 25/203 (12%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
+ KLG G FG V+ ++AVK + S +E F E ++ LQH LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVK-LHA 68
Query: 487 CIEEQEKMLIYEYLPNKSL-DVYIFDEAKR----SLLDWSKRFEIICGIARGILYLHQDS 541
+ ++ +I E++ SL D DE + L+D+S + IA G+ ++ Q +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN 122
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTY--GYMAPEY 597
IHRDL+A+N+L+ A++ KI+DFG+AR+ IE+N T R + + APE
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARV-----IEDNEYTAREGAKFPIKWTAPEA 174
Query: 598 AMEGLFSTKSDVYSFGVLLLEII 620
G F+ KSDV+SFG+LL+EI+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIE-EFKTEIALIAQLQHRNLVSILG 485
++LGEG GSV K L+N I A+K ++ ++ + E+ + + +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 486 CCIEEQEKML--IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL----YLHQ 539
++E + EY SLD I+ + K+ ++ ++ IA +L YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEK--VLGKIAESVLKGLSYLHS 123
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+IIHRD+K SN+LL K+ DFG++ G+ + GT YMAPE
Sbjct: 124 R---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPERIQ 176
Query: 600 EGLFSTKSDVYSFGVLLLEIILGR 623
+S SDV+S G+ LLE+ R
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 423 DFSSDNK---LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR 478
++ + + LG+G +G VY L IA+K + + ++ EIAL + L+HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYI------FDEAKRSLLDWSKRFEIICGIAR 532
N+V LG E + E +P SL + + +++++ ++K+ I
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILE 119
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYG 591
G+ YLH +I+HRD+K NVL++ KISDFG ++ G I T GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQ 174
Query: 592 YMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGR 623
YMAPE +G + +D++S G ++E+ G+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 25/204 (12%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQH---RNLVSIL 484
+G G +G+VY+G + G+ +A+K ++ + + + + E+AL++QL+ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE-IICGIARGIL----YLHQ 539
G ++ +I EY S+ R+L+ E I I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+IHRD+KA+N+L+ N K+ DFG+A + + + +T VGT +MAPE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVIT 174
Query: 600 EG-LFSTKSDVYSFGVLLLEIILG 622
EG + TK+D++S G+ + E+ G
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 424 FSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQG-IEEFKTEIALIAQLQHRNLV 481
F+ ++G+G FG VYKG+ KE+ A+K + + IE+ + EI +++Q +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G ++ + +I EYL S D K L+ + I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
R IHRD+KA+NVLL + K++DFG+A QI+ NT VGT +MAPE +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNT 627
+ K+D++S G+ +E+ G N+
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 39/218 (17%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRL---SRSSGQG-------IEEFKTEIALIAQLQHR 478
+G+G +G VY + + G+ +AVK++ + +G+ ++ ++EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------IICGIAR 532
N+V LG E+ + EY+P S+ S L RFE +
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIG---------SCLRTYGRFEEQLVRFFTEQVLE 119
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR----IFGGDQIEENTNRVVG 588
G+ YLH I+HRDLKA N+L+DA KISDFG+++ I+ DQ + G
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQG 172
Query: 589 TYGYMAPE--YAMEGLFSTKSDVYSFGVLLLEIILGRR 624
+ +MAPE ++ +S K D++S G ++LE+ GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 66/191 (34%), Positives = 101/191 (52%), Gaps = 13/191 (6%)
Query: 430 LGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE 489
+G+G FG V G + G ++AVK + + + F E +++ QL+H NLV +LG +E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 490 EQEKMLIY-EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
E+ + I EY+ SL Y+ RS+L + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSD 608
DL A NVL+ K+SDFG+ + Q +T ++ + APE E FSTKSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 609 VYSFGVLLLEI 619
V+SFG+LL EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQH 477
+D +LG G G V K + + GK +AVK + + K E+ ++ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--EIICGIARGIL 535
+V G + + EY+ SLD I E + R I+ IA +L
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQ-------GRIPERILGKIAVAVL 110
Query: 536 ----YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
YLH + +IIHRD+K SN+L+++ K+ DFG++ G + VGT
Sbjct: 111 KGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSS 164
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
YMAPE +S KSD++S G+ L+E+ GR
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 429 KLGEGGFGSVYKGVL------QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+LGEG FG V+ Q+ +AVK L +S ++F+ E L+ LQH+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 483 ILGCCIEEQEKMLIYEYLPNKSL---------DVYIFDEAKRSL---LDWSKRFEIICGI 530
G C E + ++++EY+ + L D I + L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVGT 589
A G++YL + L +HRDL N L+ + KI DFGM+R I+ D R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG-GRTMLP 187
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M PE + F+T+SD++SFGV+L EI
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 79/282 (28%), Positives = 138/282 (48%), Gaps = 44/282 (15%)
Query: 430 LGEGGFGSVYKGVLQ--NGKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQHRNLVSIL 484
+G G FG V++G+L+ KE+AV + G + ++F +E +++ Q H N++ +
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFD-EAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
G + + M+I EY+ N +LD Y+ D + + S + ++ GIA G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL---SDM 126
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG---TYGYMAPEYAME 600
+HRDL A N+L+++ + K+SDFG++R+ D E T G + APE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD--PEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 601 GLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659
F++ SDV+SFG+++ E++ G R WD+ + V K+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP-----------------YWDM-----SNHEVMKA 222
Query: 660 LGESCCAPEILRC----IHLGLLCVQEQATDRPNMSAVVSML 697
+ + P + C L L C Q+ RP +V++L
Sbjct: 223 INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-23
Identities = 72/214 (33%), Positives = 116/214 (54%), Gaps = 18/214 (8%)
Query: 429 KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVSILGC 486
KLGEG + +VYKG + G+ +A+K + + +G EI+L+ +L+H N+V +
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
E + ML++EY+ +K L Y+ R LD + + +GI + H++ R++
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPEYAMEG-LF 603
HRDLK N+L++ K++DFG+AR FG I NT N VV T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGSRTY 178
Query: 604 STKSDVYSFGVLLLEIILGR-----RNNTFHLEQ 632
ST D++S G ++ E+I GR NN L +
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 85/302 (28%), Positives = 139/302 (46%), Gaps = 54/302 (17%)
Query: 427 DNKLGEGGFGSVYKGVLQNGK------EIAVKRLSRSSGQG-IEEFKTEIALIAQLQHRN 479
LGEG FG V K K +AVK L ++ + + +E L+ Q+ H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEI 526
++ + G C ++ +LI EY SL ++ + K S LD +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 527 ICG--------IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGD 577
G I+RG+ YL + ++++HRDL A NVL+ KISDFG++R ++ D
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 578 Q-IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSG 635
++ + R+ +MA E + +++T+SDV+SFGVLL EI+ LG N + G
Sbjct: 182 SYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG--GNPY---PGIA 234
Query: 636 SWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695
L ++L K G ME + C+ E+ L L C +++ RP + +
Sbjct: 235 PERL----FNLLKTGYRMERPEN------CSEEMYN---LMLTCWKQEPDKRPTFADISK 281
Query: 696 ML 697
L
Sbjct: 282 EL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 25/207 (12%)
Query: 430 LGEGGFGSVY----KGVLQNGKE--IAVKRLSRSSGQGIE-EFKTEIALIAQLQHRNLVS 482
LG G FG V+ KG+ + G E + VK L ++ + ++ EF+ E+ + +L H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 483 ILGCCIEEQEKMLIYEY----------LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR 532
+LG C E + +I EY KS D ++ K L ++ + IA
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLSTKQKVALCTQIAL 128
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
G+ +L S R +HRDL A N L+ + K+S +++ + + N ++ +
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRW 184
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+APE E FSTKSDV+SFGVL+ E+
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 72/254 (28%), Positives = 117/254 (46%), Gaps = 31/254 (12%)
Query: 420 ATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRL---SRSSGQGIEEFKTEIALIAQL 475
D+ KLGEG FG VYK ++ G+ +A+K++ + G I + EI ++ +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 476 QHRNLVSILGCCIEEQEKML-----IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGI 530
+H N+V ++ +E +K +Y P D+ E L S+ + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF----------GGDQIE 580
GI YLH++ I+HRD+KA+N+L+D KI+DFG+AR + GG
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 581 ENTNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSW 637
+ TN VV T Y PE + E ++T D++ G + E+ R ++Q +
Sbjct: 182 KYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 638 NLVG----HVWDLW 647
L G W W
Sbjct: 241 KLCGTPTEETWPGW 254
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 430 LGEGGFGSVYKGVLQNGK----EIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LGEG FGSV +G L ++AVK +L + IEEF +E A + H N++ +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 484 LGCCIEEQEK------MLIYEYLPNKSLDVYIFD---EAKRSLLDWSKRFEIICGIARGI 534
+G C E M+I ++ + L ++ L + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVGTYGYM 593
YL S IHRDL A N +L M ++DFG+++ I+ GD + ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ-GRIAKMPVKWI 182
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEI 619
A E + ++++KSDV++FGV + EI
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQHRN 479
F+ ++G G FG+VY ++ + +A+K++S S Q E+++ E+ + QL+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--IC-GIARGILY 536
+ GC + E L+ EY + D I + K+ L + EI IC G +G+ Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAY 130
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH R IHRD+KA N+LL K++DFG A + N VGT +MAPE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPE 181
Query: 597 --YAM-EGLFSTKSDVYSFGVLLLEI 619
AM EG + K DV+S G+ +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKR-----LSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+G FG VY + G+E+AVK+ S + + + + EI L+ LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 484 LGCCIEEQEKMLIY-EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
GC + + E + I+ EY+P S+ + +A +L + R + I G+ YLH +
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLHSN-- 123
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR-VVGTYGYMAPEYAMEG 601
I+HRD+K +N+L D+A N K+ DFG ++ + V GT +M+PE
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 602 LFSTKSDVYSFGVLLLEII 620
+ K+DV+S G ++E++
Sbjct: 183 GYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-22
Identities = 64/195 (32%), Positives = 106/195 (54%), Gaps = 15/195 (7%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
KLG+G FG V+ G +A+K L + E F E ++ +L+H LV + +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
E+ ++ EY+ SL ++ E + L + ++ IA G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTY--GYMAPEYAMEGLFS 604
DL+A+N+L+ + K++DFG+AR+ IE+N T R + + APE A+ G F+
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 605 TKSDVYSFGVLLLEI 619
KSDV+SFG+LL E+
Sbjct: 182 IKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
+LG G FG V G + ++A+K + S +EF E ++ +L H LV + G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
+++ ++ EY+ N L Y+ + KR S+ E+ + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPEYAMEGLFST 605
DL A N L+D K+SDFG++R D+ + VG+ + PE + FS+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180
Query: 606 KSDVYSFGVLLLEII-LG-----RRNN---TFHLEQG 633
KSDV++FGVL+ E+ LG R NN + QG
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-22
Identities = 63/190 (33%), Positives = 97/190 (51%), Gaps = 7/190 (3%)
Query: 430 LGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIE-EFKTEIALIAQLQHRNLVSILGCCI 488
LG+G FG V+KG L++ +AVK Q ++ +F +E ++ Q H N+V ++G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
+ Q ++ E +P D F K+ L + + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSD 608
DL A N L+ KISDFGM+R D I ++ + APE G +S++SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 609 VYSFGVLLLE 618
V+S+G+LL E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 15/201 (7%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKT-EIALIAQLQHRNLVSILG 485
K+GEG +G VYK G+ +A+K++ + +G+ EI+L+ +L H N+V +L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWS--KRFEIICGIARGILYLHQDSRL 543
E + L++E+L + L Y+ D + + LD K + + + +GI Y H
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSY--LYQLLQGIAYCHSH--- 118
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-L 602
R++HRDLK N+L+D K++DFG+AR F G + T+ VV T Y APE +
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQ 176
Query: 603 FSTKSDVYSFGVLLLEIILGR 623
+ST D++S G + E++ R
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 11/201 (5%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG-IEEFKTEIALIAQLQHRNLV 481
F+ K+G+G FG V+KG+ + K +A+K + + IE+ + EI +++Q +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G +++ + +I EYL S D + LD ++ I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+ IHRD+KA+NVLL K++DFG+A QI+ N VGT +MAPE +
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQS 176
Query: 602 LFSTKSDVYSFGVLLLEIILG 622
+ +K+D++S G+ +E+ G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
D KLG+G FG V+ G ++A+K L + E F E ++ +L+H LV +
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
+ E+ ++ E++ SL + E L + ++ IA G+ Y+ R+ I
Sbjct: 70 -VSEEPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTY--GYMAPEYAMEGL 602
HRDL+A+N+L+ + KI+DFG+AR+ IE+N T R + + APE A+ G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 603 FSTKSDVYSFGVLLLEIILGRR 624
F+ KSDV+SFG+LL E++ R
Sbjct: 180 FTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 430 LGEGGFGSVYKGVL--QNGKEI--AVKRLSR-SSGQGIEEFKTEIALIAQLQHRNLVSIL 484
+G+G FG VY G L +G++I AVK L+R + + +E+F E ++ H N++S+L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 485 GCCI-EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
G C+ E +++ Y+ + L +I E + F + +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAPEY 597
+ +HRDL A N +LD + K++DFG+AR D ++ V G +MA E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 598 AMEGLFSTKSDVYSFGVLLLEII 620
F+TKSDV+SFGVLL E++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 429 KLGEGGFGSVYKGVLQNGKE------IAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+LGEG FG V+ N +AVK L + ++F+ E L+ LQH ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSL-------------LDWSKRFEIICG 529
G C + ++++EY+ + L+ ++ ++ L S+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG- 588
IA G++YL + +HRDL N L+ A + KI DFGM+R D + RV G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 589 ---TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630
+M PE M F+T+SDV+SFGV+L EI + F L
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 424 FSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQG-IEEFKTEIALIAQLQHRNLV 481
F+ ++G+G FG V+KG+ +++ A+K + + IE+ + EI +++Q +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G ++ + +I EYL S D + D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+ IHRD+KA+NVLL + K++DFG+A QI+ NT VGT +MAPE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNT 627
+ +K+D++S G+ +E+ G N+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-21
Identities = 33/70 (47%), Positives = 46/70 (65%), Gaps = 4/70 (5%)
Query: 311 CRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCSCLAYTSAYAESESNGRIGC 370
C GDGF+R+ +K+PD + A VD S+GL+ C+ CL NCSC AY AYA+ G GC
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAY--AYADIR--GGSGC 56
Query: 371 LTYHGDMMDT 380
L + G+++D
Sbjct: 57 LIWTGELVDM 66
|
Length = 66 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 64/225 (28%), Positives = 111/225 (49%), Gaps = 31/225 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYK----GVL--QNGKEIAVKRLSR-SSGQGIEEFKTEIALIAQ 474
N+ +G+G FG V++ G+L + +AVK L +S +F+ E AL+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSL----------------- 517
H N+V +LG C + L++EY+ L+ ++ + R+
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 518 --LDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IF 574
L +++ I +A G+ YL S + +HRDL N L+ M KI+DFG++R I+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
D + + N + +M PE ++T+SDV+++GV+L EI
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 432 EGGFGSVYKGVLQNGK-----EIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILG 485
EG FG ++ G+L + K E+ VK + + + + E L+ L H+N++ IL
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 486 CCIEEQEK-MLIYEYLPNKSLDVY-----IFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
CIE+ E ++Y Y+ +L ++ + + L + + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQ--IEENTNRVVGTYGYMAPE 596
+ +IH+D+ A N ++D + KI+D ++R +F D + +N NR V +MA E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALE 189
Query: 597 YAMEGLFSTKSDVYSFGVLLLEII 620
+ +S+ SDV+SFGVLL E++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 424 FSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFK---TEIALIAQLQHRN 479
F +++G G FG+VY + E+ AVK++S S Q E+++ E+ + QL+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+ GC ++E L+ EY + D+ E + L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+ +IHRD+KA N+LL K++DFG A N VGT +MAPE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190
Query: 600 ---EGLFSTKSDVYSFGVLLLEI 619
EG + K DV+S G+ +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKT-EIALIAQLQHRN 479
F K+GEG +G VYK G+ +A+K RL + +G+ EI+L+ +L H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPN 60
Query: 480 LVSILGCCIEEQEKMLIYEYLPN---KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+V +L E + L++E+L K +D L+ S F+++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK-SYLFQLLQGLA----F 115
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H R++HRDLK N+L++ K++DFG+AR F G + T+ VV T Y APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 170
Query: 597 YAM-EGLFSTKSDVYSFGVLLLEIILGR 623
+ +ST D++S G + E++ R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 423 DFSSDNKLGEGGFGSVYK-GVLQNGKEIAVKR--LSRSSGQGIEEFKTEIALIAQLQHRN 479
DF KLG+G +GSVYK L + + A+K L S + E+ EI ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 480 LVS-----ILGC--CIEEQEKMLIYEYLPNKSLDVYIFDEAK-RSLLDWSKRFEIICGIA 531
++S + G CI + EY P L I K R L+ + + I +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
RG+ LH+ +I+HRDLK++N+LL A KI D G++++ + +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPH 166
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
YMAPE +S KSD++S G LL E+
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 430 LGEGGFGSVYKGVLQN-GKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+GGFG V ++ GK A K+L + +G + E ++ ++ R +VS L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQDS 541
E ++ + L+ + L +I++ + + F +IICG+ +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL----EHLHQ-- 113
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
RI++RDLK NVLLD N +ISD G+A G + GT GYMAPE
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGE 169
Query: 602 LFSTKSDVYSFGVLLLEIILGR 623
++ D ++ G L E+I GR
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-21
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIE-EFKTEIALIAQLQHRNLVSILG 485
N++G G G+VYK + + G+ A+K + + + + EI ++ + H N+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 486 CCIEEQEKMLIYEYLPNKSLD-VYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E ++ E++ SL+ +I DE L D + +I+ GIA YLH R
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQF--LADVA--RQILSGIA----YLH---RRH 188
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
I+HRD+K SN+L+++A N KI+DFG++RI Q + N VGT YM+PE L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 605 TK-----SDVYSFGVLLLEIILGR 623
D++S GV +LE LGR
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 49/300 (16%)
Query: 423 DFSSDNKLGEGGFGSVYKGV---LQNGKE---IAVKRL-SRSSGQGIEEFKTEIALIAQL 475
+ LGEG FG V K L N E +AVK L ++ + + + +E+ ++ +
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 476 -QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD-----EAKRSLLDWSKRFEIIC- 528
+H+N++++LG C +E ++ EY + +L ++ E +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 529 -------GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIE 580
+ARG+ +L + IHRDL A NVL+ KI+DFG+AR I D
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 581 ENTN-RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL--GRRNNTFHLEQGSGSW 637
+ TN R+ +MAPE + +++ +SDV+SFGVLL EI G +E+
Sbjct: 190 KTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----- 242
Query: 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
++ L KEG ME C E+ HL C E + RP +V L
Sbjct: 243 -----LFKLLKEGYRMEK------PQNCTQELY---HLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQHRN 479
FS ++G G FG+VY ++N + +A+K++S S Q E+++ E+ + +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+ GC + E L+ EY + D+ E + L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+ +IHRD+KA N+LL K+ DFG A I N VGT +MAPE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVIL 184
Query: 600 ---EGLFSTKSDVYSFGVLLLEI 619
EG + K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 45/218 (20%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---------EIALIAQLQHRN 479
+G G +G V V + G+++A+K++S F EI L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-----------AKRSLLDWSKRFEIIC 528
++ +L +L + + DVYI E + + L D ++ +
Sbjct: 61 IIGLL--------DILRPPSPEDFN-DVYIVTELMETDLHKVIKSPQPLTDDHIQY-FLY 110
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRV 586
I RG+ YLH +IHRDLK SN+L+++ + KI DFG+AR D+ E+ T V
Sbjct: 111 QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 587 VGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
V T Y APE + TK+ D++S G + E++ +
Sbjct: 168 V-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 60/290 (20%)
Query: 430 LGEGGFGSVYKGVL--QNGKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQHRNLVSIL 484
+G G FG V G L +EI V + +G + +F +E +++ Q H N++ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC------GIARGILYLH 538
G + + M++ EY+ N SLD + L +F +I GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAF--------LRKHDGQFTVIQLVGMLRGIASGMKYL- 122
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------Y 592
S + +HRDL A N+L+++ + K+SDFG++R+ +E++ T G +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRW 175
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651
APE F++ SDV+S+G+++ E++ G R W++
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----------------YWEM----- 213
Query: 652 AMEAVDKSLGESCCAPEILRC---IH-LGLLCVQEQATDRPNMSAVVSML 697
+ + V K++ E P + C +H L L C Q+ +RP +VS+L
Sbjct: 214 SNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 429 KLGEGGFGSVYKGVL------QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+LGEG FG V+ Q+ +AVK L +S ++F E L+ LQH ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSL----------LDWSKRFEIICGIAR 532
G C+E ++++EY+ + L+ ++ ++ L S+ I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG---- 588
G++YL + +HRDL N L+ + KI DFGM+R D + RV G
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 184
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M PE M F+T+SDV+S GV+L EI
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 429 KLGEGGFGSVY------------KGVLQNGKE-----IAVKRLSRS-SGQGIEEFKTEIA 470
KLGEG FG V+ K +N +AVK L S E+F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 471 LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI--------FDEAKRSLLDWSK 522
++++L N+ +LG C + +I EY+ N L+ ++ L +S
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 523 RFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGD--QI 579
+ IA G+ YL L +HRDL N L+ KI+DFGM+R ++ D ++
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
+ R +MA E + G F+TKSDV++FGV L EI+ L R
Sbjct: 189 Q---GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 10/200 (5%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSIL 484
+G+G FG+V K +GK + K + + + ++ +E+ ++ +L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 485 GCCI-EEQEKMLIY-EYLPNKSLDVYIFDEAK-RSLLDWSKRFEIICGIARGILYLH--Q 539
I + + I EY L I K R ++ + I+ + + H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
D ++HRDLK +N+ LDA N K+ DFG+A+I G D T VGT YM+PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183
Query: 600 EGLFSTKSDVYSFGVLLLEI 619
+ KSD++S G L+ E+
Sbjct: 184 HMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 427 DNKLGEGGFGSVYKGV-LQNGKEIAVKRL---SRSSGQ-GIEEFKT--EIALIAQLQHRN 479
KLGEG + VYK + G+ +A+K++ R + GI F EI L+ +L+H N
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKHPN 63
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
++ +L + L++E++ L+ I D K +L + + RG+ YLH
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH- 119
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
I+HRDLK +N+L+ + K++DFG+AR F G + T++VV T Y APE
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPEL-- 173
Query: 600 EGLFSTKS-----DVYSFGVLLLEIILGR 623
LF + D++S G + E++L
Sbjct: 174 --LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQHRN 479
F+ ++G G FG+VY ++ + +A+K++S S Q E+++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+ GC + E L+ EY + D+ E + L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+ +IHRD+KA N+LL K++DFG A I N VGT +MAPE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 600 ---EGLFSTKSDVYSFGVLLLEI 619
EG + K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 429 KLGEGGFGSVY----KGVLQNGKE-----------IAVKRL-SRSSGQGIEEFKTEIALI 472
KLGEG FG V+ +G+ + E +AVK L + + +F EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 473 AQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLL---------DWSKR 523
++L++ N++ +LG C+ + +I EY+ N L+ ++ S +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGD--QIE 580
+ IA G+ YL + L +HRDL N L+ KI+DFGM+R ++ GD +I+
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
R V +MA E + G F+T SDV++FGV L E+
Sbjct: 189 ---GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS---RSSGQGIEEFKTEIALIAQLQHR 478
+F + K+G G F VY+ L + K +A+K++ + ++ EI L+ QL H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYI--FDEAKRSLLD---WSKRFEIICGIARG 533
N++ L IE+ E ++ E L I F + KR + + W K F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
H SR R++HRD+K +NV + A K+ D G+ R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEI 619
+PE E ++ KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
LG+G FG VYK + A K + S + +E+F EI ++++ +H N+V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC-GIARGILYLHQDSRLRIIH 547
E + ++ E+ +LD I E +R L + R+ +C + + +LH ++IH
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY--VCRQMLEALNFLHSH---KVIH 126
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFST-- 605
RDLKA N+LL + K++DFG++ + + +GT +MAPE F
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 606 ---KSDVYSFGVLLLEI 619
K+D++S G+ L+E+
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLS------RSSGQGIEEFKTEIALIAQLQHRNLV 481
LG+G +G+VY G+ G+ IAVK++ ++ + E+ + E+ L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF-----EIICGIARGIL- 535
LG C+++ + E++P S+ + RF + C + IL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTKQILD 113
Query: 536 ---YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR---IFGGDQIEENTNRVV-G 588
YLH + ++HRD+K +NV+L K+ DFG AR G N + + G
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
T +MAPE E + KSD++S G + E+ G+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 52/172 (30%), Positives = 91/172 (52%), Gaps = 12/172 (6%)
Query: 429 KLGEGGFGSVYK-GVLQNGKEIAVKRL-SRSSGQGI-EEFKTEIALIAQLQHRNLVSILG 485
++GEG G V+K + G+ +A+K++ R GI + EI + QH +V +L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWS-KRFEIICGIARGILYLHQDSRLR 544
+L+ EY+P+ +V + +R L + K + + + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEV--LRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NG 119
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
I+HRDLK +N+L+ A KI+DFG+AR+F ++ +++ V T Y APE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 431 GEGGFGSVYKGV--LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
G+G FG V V K A+K +++ + E ++ +L H LV+ L
Sbjct: 9 GKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN-LW 66
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+++E M L+ + L L ++ F E +F IC I + YLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-------QVKF-WICEIVLALEYLHS 118
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
IIHRD+K N+LLD + I+DF +A D T GT GYMAPE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLC 172
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRR 624
+S D +S GV E + G+R
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 430 LGEGGFGSVYK------GVLQNGKEIAVKRLSRSSGQGI-EEFKTEIALIAQLQHRNLVS 482
LG G F S Y+ G L K++ R + S + + E + EI L+A+L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+LG E+ L E++ S+ + E + RG+ YLH++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN-- 122
Query: 543 LRIIHRDLKASNVLLDA-AMNPKISDFGMA-----RIFGGDQIEENTNRVVGTYGYMAPE 596
+IIHRD+K +N+L+D+ +I+DFG A + G + + +++GT +MAPE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLLGTIAFMAPE 178
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654
+ DV+S G +++E+ + N H H+ ++K +A
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----------SNHLALIFKIASATT 228
Query: 655 AVDKSLGESCCAPEILR--CIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAF 711
A PE L + L C++ Q DRP +L KHP F
Sbjct: 229 APS--------IPEHLSPGLRDVTLRCLELQPEDRP---PSRELL---------KHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 71/203 (34%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 430 LGEGGFGSV----YKGVLQN-GKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LGEG FG V Y N G+++AVK L S G I + K EI ++ L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 484 LGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G C E+ LI E+LP+ SL Y+ + L ++ + I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--GS 127
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ----IEENTNRVVGTYGYMAPEY 597
R + +HRDL A NVL+++ KI DFG+ + D+ ++++ + V Y APE
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---APEC 183
Query: 598 AMEGLFSTKSDVYSFGVLLLEII 620
++ F SDV+SFGV L E++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 63/191 (32%), Positives = 101/191 (52%), Gaps = 13/191 (6%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
+GEG FG+V +G G+++AVK + + F E A++ +L H+NLV +LG I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
++ E + +L V R+L+ + + +A G+ YL +++HR
Sbjct: 69 LHNGLYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSD 608
DL A N+L+ K+SDFG+AR+ G +N+ V + APE FS+KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVK---WTAPEALKHKKFSSKSD 179
Query: 609 VYSFGVLLLEI 619
V+S+GVLL E+
Sbjct: 180 VWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKT-EIALIAQLQ---HRNLV 481
++GEG +G+VYK L G+ +A+K++ S +GI EIAL+ QL+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 482 SILGCC----IEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+L C + + K+ L++E++ ++ L Y+ + + L +++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH RI+HRDLK N+L+ + KI+DFG+ARI+ E VV T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPE 176
Query: 597 YAMEGLFSTKSDVYSFGVLLLEI 619
++ ++T D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
+LG G FG V+ G + ++A+K + E+F E ++ +L H LV + G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
+++ ++ E++ N L Y+ ++ L + + G+ YL ++S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAPEYAMEGL 602
DL A N L+ + K+SDFGM R D+ + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEVFNFSK 177
Query: 603 FSTKSDVYSFGVLLLEI 619
+S+KSDV+SFGVL+ E+
Sbjct: 178 YSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEI----AVKRLSR-SSGQGIEEFKTEIALIAQLQ 476
+F LG G FG+VYKG+ + G+++ A+K L +S + +E E ++A +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIAR 532
+ ++ +LG C+ + LI + +P L Y+ + LL+W + IA+
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
G+ YL + R++HRDL A NVL+ + KI+DFG+A++ G D+ E + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEII 620
MA E + +++ +SDV+S+GV + E++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
++G G +G VYK + G+ +A+K + G E + EI+++ + +H N+V+ G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--ICGIA-RGILYLHQDSRL 543
+ + ++ EY SL I+ + L +I +C +G+ YLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL----SELQIAYVCRETLKGLAYLHE---T 120
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVGTYGYMAPEYA-- 598
IHRD+K +N+LL + K++DFG++ Q+ + +GT +MAPE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA-----QLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 599 -MEGLFSTKSDVYSFGVLLLE 618
+G + K D+++ G+ +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 36/216 (16%)
Query: 429 KLGEGGFGSVYKGVLQN---GKEIAVKRL--SRSSGQGIEEFKT-EIALIAQLQHRNLVS 482
+G G +G VYK +N GKE A+K+ + GI + EIAL+ +L+H N+VS
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 483 ILGCCIEEQEKM--LIYEYLPN----------KSLDVYIFDEAKRSLLDWSKRFEIICGI 530
++ +E +K L+++Y + ++ V I +SLL ++I+ G+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-----WQILNGV 121
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFGGD-QIEENTNR 585
YLH + ++HRDLK +N+L+ KI D G+AR+F + + +
Sbjct: 122 H----YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 586 VVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEII 620
VV T Y APE + TK+ D+++ G + E++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
+LG+G FG VYK + G A K + S + +E++ EI ++A H +V +LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC-GIARGILYLHQDSRLRII 546
+ + ++ E+ P ++D + E R L + + ++IC + + YLH ++II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIML-ELDRGLTE--PQIQVICRQMLEALQYLHS---MKII 132
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM-----EG 601
HRDLKA NVLL + K++DFG++ + + + +GT +MAPE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 602 LFSTKSDVYSFGVLLLEI 619
+ K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 430 LGEGGFGSVYKGVL------QNGKEIAVKRL---SRSSGQGIEEFKTEIALIAQL-QHRN 479
LG G FG V + ++AVK L + SS + E +E+ +++ L H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHEN 100
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V++LG C ++I EY L ++ + S L +A+G+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG-----TYGYMA 594
+ IHRDL A NVLL KI DFG+AR I ++N VV +MA
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMA 211
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEI 619
PE +++ +SDV+S+G+LL EI
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 26/204 (12%)
Query: 429 KLGEGGFGSVYKGVLQNGKE-IAVKRLS-RSSGQGIEEFKT-EIALIAQLQHRNLVSILG 485
K+GEG +G VYK + E IA+K++ +G+ EI+L+ ++QH N+V +
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 486 CCIEEQEKMLIYEYLP---NKSLDVYIFDEAKRSLLDWSKRFEII----CGIARGILYLH 538
E+ L++EYL K +D S D++K +I I RGI Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMD---------SSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
S R++HRDLK N+L+D N K++DFG+AR F G + T+ VV T Y APE
Sbjct: 120 --SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEI 174
Query: 598 AMEGL-FSTKSDVYSFGVLLLEII 620
+ +ST D++S G + E++
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 429 KLGEGGFGSVYKGVLQNGK---EIAVKRLSRSSGQGI-EEFKTEIALIAQLQHRNLVSIL 484
+LG G FG V KGV + K ++A+K L + + + +E E ++ QL + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
G C E + ML+ E L+ ++ K+ + S E++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY--GYMAPEYAMEGL 602
+HRDL A NVLL KISDFG+++ G D R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 603 FSTKSDVYSFGVLLLE 618
FS++SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-19
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 11/91 (12%)
Query: 307 QMSTCRRG---DGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCSCLAYTSAYAESE 363
C DGF+++ VK+PD + A ++ LE C+ CL NCSC AY
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASA--ITAISLEECREACLSNCSCTAYAY------ 52
Query: 364 SNGRIGCLTYHGDMMDTRTYINAGQDLYVRV 394
+NG GCL ++G + + R+ + G LY+R+
Sbjct: 53 NNGSGGCLLWNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 430 LGEGGFGSVYKGVLQNG------KEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
+G G FG V+ + K+I V+++++ + E ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+E++ M++ EY P +L YI SLLD I + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 544 RIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602
I+HRDLK N+LLD M KI DFG+++I + VVGT Y++PE
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKP 177
Query: 603 FSTKSDVYSFGVLLLEIILGRR 624
++ KSD+++ G +L E+ +R
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 9e-19
Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 45/231 (19%)
Query: 429 KLGEGGFGSVYKGVLQNGKE-----------------IAVKRL-SRSSGQGIEEFKTEIA 470
KLGEG FG V+ + N ++ +AVK L ++ +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 471 LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLD----------- 519
++++L+ N++ +LG C++E +I EY+ N L+ ++ + L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 520 --------WSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571
+S + IA G+ YL S L +HRDL N L+ + KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 572 R-IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL 621
R ++ GD R V +MA E + G F+T SDV++FGV L EI++
Sbjct: 186 RNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFK---TEIALIAQLQH 477
DF ++G+GG+G V+ ++ EI A+KR+ +S + E + TE ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGI 534
LV +L +++ L EY+P D L + RF E+ +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFEAVDA-- 116
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
LH L IHRDLK N L+DA+ + K++DFG+++ I N VVG+ YMA
Sbjct: 117 --LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMA 166
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PE + D +S G +L E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 35/221 (15%)
Query: 429 KLGEGGFGSVY----KGVLQNGKE-------------IAVKRLSRSSGQGIE-EFKTEIA 470
KLGEG FG V+ +G+ + + +AVK L + + +F EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 471 LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD-EAKRSLLDWSKRF----- 524
++++L+ N++ +L CI +I EY+ N L+ ++ E + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 525 --EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGD--QI 579
+ IA G+ YL S L +HRDL N L+ KI+DFGM+R ++ GD +I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
+ R V +M+ E + G F+T SDV++FGV L EI+
Sbjct: 189 Q---GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+G+G G+VY + + G+E+A+K+++ E EI ++ + +H N+V+ L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL----YLHQDSRL 543
+ E ++ EYL SL D + +D I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEG----QIAAVCRECLQALEFLHSN--- 134
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF 603
++IHRD+K+ N+LL + K++DFG +Q + +T +VGT +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 192
Query: 604 STKSDVYSFGVLLLEIILG 622
K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 38/280 (13%)
Query: 430 LGEGGFGSVYKGVL-QNGKE---IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
+G G FG V +G L GK +A+K L S + + +F +E +++ Q H N++ +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYI-FDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
G + + M+I E++ N +LD ++ ++ + +++ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL---SEM 125
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG---TYGYMAPEYAME 600
+HRDL A N+L+++ + K+SDFG++R D + +G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 601 GLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV--D 657
F++ SDV+S+G+++ E++ G R WD+ + + A+ D
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP-----------------YWDMSNQ-DVINAIEQD 227
Query: 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
L P L L L C Q+ RP +VS L
Sbjct: 228 YRLPPPMDCPTALH--QLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 430 LGEGGFGS--VYKGVLQNG----KEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+G FG +Y+ + KE+ + RLS + EI +++ LQH N+++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+++ ++ EY +L K L + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF 603
I+HRD+K N+ L A K+ DFG+++I G + T VVGT YM+PE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 604 STKSDVYSFGVLLLEIILGRR 624
+ KSD+++ G +L E++ +R
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 429 KLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSSGQGI--EEFKTEIALIAQLQHRNLVSI 483
+LG G FG+V KG+ + + K +AVK L + +E E ++ QL + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+G C E + ML+ E L+ ++ K + E++ ++ G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL- 602
+HRDL A NVLL KISDFG+++ G D EN + + YA E +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD---ENYYKAKTHGKWPVKWYAPECMN 171
Query: 603 ---FSTKSDVYSFGVLLLE 618
FS+KSDV+SFGVL+ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS---RSSGQGIEEFKTEIALIAQLQHR 478
+F + K+G G F VY+ L +G +A+K++ + + EI L+ QL H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYI--FDEAKRSLLD---WSKRFEIICGIARG 533
N++ IE+ E ++ E L I F + KR + + W K F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
H SR R++HRD+K +NV + A K+ D G+ R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEI 619
+PE E ++ KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 65/230 (28%), Positives = 122/230 (53%), Gaps = 25/230 (10%)
Query: 429 KLGEGGFGSVYKGV-LQNG-KEIAVKRLSRSSGQGIEEFKT--EIALIAQLQ---HRNLV 481
++GEG +G V+K L+NG + +A+KR+ +G+ T E+A++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 482 SILGCCI-----EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+ C E + L++E++ ++ L Y+ D+ + +++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH R++HRDLK N+L+ ++ K++DFG+ARI+ + VV T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646
++ ++T D++S G + E+ RR F +GS + +G + D+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF--RRKPLF---RGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 429 KLGEGGFGSVY----KGVLQNGKE--IAVKRLSRSSGQGIE-EFKTEIALIAQLQHRNLV 481
+LG+G FG VY KGV+++ E +A+K ++ ++ EF E +++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIF-------DEAKRSLLDWSKRFEIICGIARGI 534
+LG + Q ++I E + L Y+ + ++ K ++ IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT----Y 590
YL+ + + +HRDL A N ++ KI DFGM R D E + R G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+M+PE +G+F+T SDV+SFGV+L EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 40/281 (14%)
Query: 430 LGEGGFGSVYKGVLQNGKEI---AVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
LGEG FGSV +G L I AVK +++ + +E+F +E + + H N++ ++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 485 GCCIEEQEK------MLIYEYLPNKSLDVYIFDEA---KRSLLDWSKRFEIICGIARGIL 535
G C++ E ++I ++ + L ++ L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTNRVVGT-YGYM 593
YL S IHRDL A N +L+ MN ++DFG++ +I+ GD + R+ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ--GRIAKMPVKWI 181
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653
A E + +++TKSDV+SFGV + EI R T + G N ++D ++G +
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI--ATRGQTPY----PGVEN--SEIYDYLRQGNRL 233
Query: 654 EAVDKSLGESCCAPEILRCIH-LGLLCVQEQATDRPNMSAV 693
+ P+ L ++ L C DRP+ +
Sbjct: 234 KQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 20/201 (9%)
Query: 430 LGEGGFGSVYKGV-LQNGKEI----AVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG G FG+VYKG+ + +G+ + A+K L +S + +E E ++A + + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILYLHQ 539
LG C+ + L+ + +P L Y+ + R LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+R++HRDL A NVL+ + + KI+DFG+AR+ D+ E + + +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 600 EGLFSTKSDVYSFGVLLLEII 620
F+ +SDV+S+GV + E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 430 LGEGGFGSVYKGV-LQNGKEI----AVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG G FG+V+KG+ + G I A+K + RS Q +E + + L H +V +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDE----AKRSLLDWSKRFEIICGIARGILYLHQ 539
LG C + L+ + P SL ++ + LL+W + IA+G+ YL +
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
R++HR+L A N+LL + +I+DFG+A + D + + +MA E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 600 EGLFSTKSDVYSFGVLLLEII 620
G ++ +SDV+S+GV + E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 430 LGEGGFGSV------YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+GGFG V G + K++ KRL + SG+ + + EI + ++ +V++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+ L+ + L +I++ +R L + + I GIL+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602
I++RD+K NVLLD N ++SD G+A + G I + GT GYMAPE E
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA----GTNGYMAPEILKEEP 170
Query: 603 FSTKSDVYSFGVLLLEIILGR 623
+S D ++ G + E++ GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 21/201 (10%)
Query: 429 KLGEGGFGSVYKGVLQNGKEI----AVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
+LG+G FG VYK QN KE A K + S + +E++ EI ++A H N+V +L
Sbjct: 12 ELGDGAFGKVYKA--QN-KETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICG-IARGILYLHQDSRL 543
E ++ E+ ++D + E +R L + + ++C + YLH++
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVML-ELERPLTE--PQIRVVCKQTLEALNYLHEN--- 122
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM---- 599
+IIHRDLKA N+L + K++DFG++ + + + +GT +MAPE M
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 600 -EGLFSTKSDVYSFGVLLLEI 619
+ + K+DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 6e-18
Identities = 55/208 (26%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 416 NIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ 474
+I ++ K+G+G G+V+ + + G+E+A+K+++ E EI ++ +
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534
L++ N+V+ L + E ++ EYL SL D + +D ++ + + +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
+LH + ++IHRD+K+ NVLL + K++DFG +Q + +T +VGT +MA
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PE + K D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 66/214 (30%), Positives = 114/214 (53%), Gaps = 28/214 (13%)
Query: 430 LGEGGFGSVYK----GVLQNGKE----IAVKRLS-RSSGQGIEEFKTEIALIAQL-QHRN 479
LGEG FG V + G+ ++ + +AVK L ++ + + + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----------FD--EAKRSLLDWSKRFEI 526
++++LG C +E +I EY +L ++ FD + L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 527 ICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNR 585
+ARG+ YL +SR R IHRDL A NVL+ KI+DFG+AR + D ++ +N
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+ +MAPE + +++ +SDV+SFG+L+ EI
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 32/219 (14%)
Query: 424 FSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQH 477
F+ LG+G FGSV + L+ + +++AVK L S IEEF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 478 RNLVSILGCCIEEQEK------MLIYEYLPNKSLDVYI---------FDEAKRSLLDWSK 522
N++ ++G + + K M+I ++ + L ++ F ++L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 523 RFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEE 581
RF I IA G+ YL S IHRDL A N +L+ M ++DFG+++ I+ GD +
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
+ ++A E + +++T SDV++FGV + EI+
Sbjct: 172 GCASKLPV-KWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 31/219 (14%)
Query: 424 FSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRL---SRSSGQGIEEFKTEIALIAQLQHRN 479
F ++GEG +G VYK ++ G+ +A+K++ + G I + EI ++ QL HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 480 LVSILGCCIEEQEKM----------LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICG 529
+V++ ++Q+ + L++EY+ + D+ E+ L+ +S+ + I
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESG--LVHFSE--DHIKS 120
Query: 530 IAR----GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
+ G+ Y H+ + L HRD+K SN+LL+ K++DFG+AR++ ++ TN+
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 586 VVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
V+ T Y PE + E + DV+S G +L E+ +
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 429 KLGEGGFGSVY-----KGVLQNG----KEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN 479
+LG+G FG+VY K V + KEI V L+ + + E L+++L H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRS--LLDWSKRFEIICGIARGILYL 537
+V +E +I EY + LD + +E K + L ++ E + G+ Y+
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKL-EELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
HQ RI+HRDLKA N+ L + KI DFG++R+ G T GT YM+PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176
Query: 598 AMEGLFSTKSDVYSFGVLLLEI 619
+ +KSD++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 430 LGEGGFGSVY-------------KGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ 476
LG G GSV K V K K++ R E+ ++ + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-----------ELQIMHECR 61
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+VS G + E + E++ SLD I+ + ++ + I + G+ Y
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGK--IAVAVVEGLTY 118
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
L+ + RI+HRD+K SN+L+++ K+ DFG++ G+ I + VGT YM+PE
Sbjct: 119 LY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPE 172
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
G ++ KSDV+S G+ ++E+ LG+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 420 ATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QH 477
T F +GEG +G VYK + G+ +A+K + EE K E ++ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 478 RNLVSILGC------CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------ 525
N+ + G + + L+ E S + D K L KR +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKG-LRKKGKRLKEEWIAY 117
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
I+ RG+ YLH++ ++IHRD+K N+LL K+ DFG++ D N
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172
Query: 586 VVGTYGYMAPE-----YAMEGLFSTKSDVYSFGVLLLE 618
+GT +MAPE + + +SDV+S G+ +E
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 57/195 (29%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 429 KLGEGGFGSVYKGVLQNGKEI-AVKRLS-RSSGQGIEEFKT-EIALIAQLQHRNLVSILG 485
K+GEG +G+V+K + EI A+KR+ +G+ EI L+ +L+H+N+V +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
+++ L++EY ++ L Y FD + +D + + +G+ + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FD-SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFS 604
+HRDLK N+L++ K++DFG+AR F G + + VV T Y P+ L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 605 TKSDVYSFGVLLLEI 619
T D++S G + E+
Sbjct: 179 TSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 430 LGEGGFGSVYKGVLQN-GKEIAVKRLSRSS--GQGIEE-FKTEIALIAQLQHRNLVSILG 485
LG GGFG V +++ + A+K + + G +E +E ++ + H +V +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
+++ ++ EY L + D +++ RF I C + YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIAC-VVLAFEYLH---NRGI 114
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFST 605
I+RDLK N+LLD+ K+ DFG A+ Q T GT Y+APE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF 171
Query: 606 KSDVYSFGVLLLEIILGR 623
D +S G+LL E++ GR
Sbjct: 172 SVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSIL 484
LG+G FG V L+ E+ AVK L + +E TE ++A +H L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ-L 61
Query: 485 GCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIARGILYLH 538
C + ++++ + EY+ L +I FDE + RF I G+ +LH
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPR-------ARFYAAE-IVLGLQFLH 113
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMAPE 596
+ II+RDLK NVLLD+ + KI+DFGM + I GG T+ GT Y+APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPE 166
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ D ++ GVLL E++ G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRL-----SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+G FG VY + G+E+A K++ S + + + + EI L+ LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 484 LGCCIEEQEKML--IYEYLPNKSLDVYIFDEAKR-SLLDWSKRFEIICGIARGILYLHQD 540
GC + EK L EY+P S+ D+ K L S + I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR-VVGTYGYMAPEYAM 599
I+HRD+K +N+L D+A N K+ DFG ++ + R V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 600 EGLFSTKSDVYSFGVLLLEII 620
+ K+DV+S G ++E++
Sbjct: 183 GEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+GGFG V ++ GK A K+L++ +G E E ++A++ R +VS L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LA 59
Query: 486 CCIEEQEKMLIYEYLPNKS---LDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQ 539
+ + + + + N +Y DE + F +II G+ +LHQ
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE----HLHQ 115
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
RII+RDLK NVLLD N +ISD G+A Q T GT G+MAPE
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQ 170
Query: 600 EGLFSTKSDVYSFGVLLLEIILGR 623
+ D ++ GV L E+I R
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNG---KEIAVKRLSRSSGQGIE-EFKTEIALIAQL-Q 476
ND + +GEG FG V K ++ + A+KR+ + + +F E+ ++ +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----------FDEAKR--SLLDWSKR 523
H N++++LG C L EY P+ +L ++ F A S L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+ARG+ YL Q + IHRDL A N+L+ KI+DFG++R G ++
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
+MA E +++T SDV+S+GVLL EI+
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 433 GGFGSVY---KGVLQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQHRNLVSILGC 486
G +G V+ K G A+K + ++ +++ TE +++Q Q +V +
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61
Query: 487 CIEEQEKMLIYEYLPN---KSL--DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
++ L+ EYLP SL +V DE D ++ I I + YLH
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVARI--YIAEIVLALEYLHS-- 111
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFG------MARIFGGDQIEENTNRVVGTYGYMAP 595
IIHRDLK N+L+D+ + K++DFG + R + E+ R+VGT Y+AP
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILG 622
E + S D +S G +L E ++G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQ---HRNLVS 482
++G G +G+VYK +G +A+K + + + T E+AL+ +L+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 483 ILGCCI-----EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
++ C E + L++E++ ++ L Y+ D+ L +++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H + I+HRDLK N+L+ + K++DFG+ARI+ + VV T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628
++ ++T D++S G + E+ RR F
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF--RRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRL-----SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+G FG VY G+E+AVK++ S + + + + EI L+ L H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 484 LGCCIEEQEKML--IYEYLPNKSLDVYIFDEAKR--SLLDWSKRFEIICGIARGILYLHQ 539
GC + E+ L E++P S I D+ K +L + R + I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTR-KYTRQILEGVSYLHS 124
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-----IFGGDQIEENTNRVVGTYGYMA 594
+ I+HRD+K +N+L D+ N K+ DFG ++ G ++ V GT +M+
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMS 177
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
PE + K+D++S G ++E++ +
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-17
Identities = 78/308 (25%), Positives = 145/308 (47%), Gaps = 34/308 (11%)
Query: 405 NSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIE 463
+S+ +++I ++ + +N + G G+ YKG ++NG + VK ++ + I
Sbjct: 676 DSKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IP 730
Query: 464 EFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR 523
+EIA + +LQH N+V ++G C E+ LI+EY+ K+L E R+ L W +R
Sbjct: 731 S--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-----SEVLRN-LSWERR 782
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+I GIA+ + +LH ++ +L +++D P + + + D
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------ 835
Query: 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR--RNNTFHLEQGSGSWNLVG 641
+ + Y+APE + KSD+Y FG++L+E++ G+ + F + W
Sbjct: 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC 895
Query: 642 ----HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
H+ D+W + D S+ ++ EI+ ++L L C T RP + V+ L
Sbjct: 896 YSDCHL-DMWID--PSIRGDVSVNQN----EIVEVMNLALHCTATDPTARPCANDVLKTL 948
Query: 698 GSDNAPSS 705
S + SS
Sbjct: 949 ESASRSSS 956
|
Length = 968 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 36/213 (16%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQG--IEEFKTEIALIAQLQHRNLVSI 483
N++ EG +G VY+ + G+ +A+K+L +G I + EI ++ +LQH N+V++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV 69
Query: 484 LGCCIEEQEKMLIYEYLPNKSLD-VYI----FDEAKRSLLDWSK-RF---EIIC---GIA 531
E + +LD +Y+ + +SL++ K F E+ C +
Sbjct: 70 -------------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
G+ +LH + I+HRDLK SN+LL+ KI DFG+AR + G ++ T VV T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLW 171
Query: 592 YMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
Y APE + +ST D++S G + E++ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSR-SSGQGIEEFKTEIALIAQL-QH 477
D ++ +GEG FG V + +++ A+K L +S +F E+ ++ +L H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSL-------------DVYIFDEAKRSLLDWSKRF 524
N++++LG C + EY P +L + + S L +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
+ +A G+ YL S + IHRDL A NVL+ + KI+DFG++R G+++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKT 176
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
+MA E +++TKSDV+SFGVLL EI+
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 430 LGEGGFGSVYKGVLQNG-------KEIAVKRLS-----RSSGQGIEEFKTEIALI-AQLQ 476
LG G FG VYK +N KEI V + R + I + +E+ +I QL+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
H N+V +E ++ + + L + + + K+ + + I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
YLH++ R I+HRDL +N++L I+DFG+A+ Q E VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG-SGSWNLVGHVWDLWKEGTAME 654
E + K+DV++FG +L ++ F+ S + +V V++ EG E
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698
V + SC P+ A RP++ V +M+
Sbjct: 241 DVTDVIT-SCLTPD---------------AEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 53/195 (27%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+G+G G+VY + + G+E+A+K+++ E EI ++ + ++ N+V+ L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+ E ++ EYL SL D + +D + + + + +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKS 607
RD+K+ N+LL + K++DFG +Q + +T +VGT +MAPE + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYSFGVLLLEIILG 622
D++S G++ +E++ G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRL-----SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG G FG VY G+E+AVK++ S+ + + + + EI L+ L+H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 484 LGCCIE-EQEKMLIY-EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
GC + E++K+ I+ EY+P S+ + +A +L + R I +G+ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR-RYTRQILQGVSYLHSN- 125
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMAR-----IFGGDQIEENTNRVVGTYGYMAPE 596
I+HRD+K +N+L D+A N K+ DFG ++ G I+ V GT +M+PE
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----VTGTPYWMSPE 179
Query: 597 YAMEGLFSTKSDVYSFGVLLLEII 620
+ K+DV+S ++E++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 429 KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIE-EFKTEIALIAQLQHRNLVSILGC 486
++G G FG V+ G L+ + +AVK + ++ +F E ++ Q H N+V ++G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
C ++Q ++ E + ++ E R L + +++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM--------APEYA 598
HRDL A N L+ KISDFGM+R E + V + G M APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--------EEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 599 MEGLFSTKSDVYSFGVLLLE 618
G +S++SDV+SFG+LL E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 28/214 (13%)
Query: 430 LGEGGFGSVY--------KGVLQNGKEIAVKRL-SRSSGQGIEEFKTEIALIAQL-QHRN 479
LGEG FG V K ++AVK L S ++ + + + +E+ ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----------FDEAKRSLLDWSKRFEIIC 528
++++LG C ++ +I EY +L Y+ ++ + S + + C
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 529 G--IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNR 585
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR I D ++ TN
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+ +MAPE + +++ +SDV+SFGVLL EI
Sbjct: 203 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 21/226 (9%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGK----EIAVKRLSRSSGQGI-EEFKTEIALIAQLQH 477
D + +GEG FG VY+GV + + +AVK + + E+F E ++ Q H
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
++V ++G E ++ E P L Y+ + + LD + ++ + YL
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYL 123
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
R +HRD+ A NVL+ + K+ DFG++R D+ ++ +MAPE
Sbjct: 124 ES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPES 179
Query: 598 AMEGLFSTKSDVYSFGVLLLEIIL-------GRRNNTF--HLEQGS 634
F++ SDV+ FGV + EI++ G +NN +E G
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 49/226 (21%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEF-------KT--EIALI 472
+ + + +GEG +G V G ++A+K+ I F +T EI ++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKIL 57
Query: 473 AQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLL-----------DWS 521
+ +H N++ IL + + +E DVYI E + L D
Sbjct: 58 RRFKHENIIGIL-----DIIRPPSFESFN----DVYIVQELMETDLYKLIKTQHLSNDHI 108
Query: 522 KRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581
+ F + I RG+ Y+H + ++HRDLK SN+LL+ + KI DFG+ARI D +
Sbjct: 109 QYF--LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161
Query: 582 NTNRV---VGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
+T + V T Y APE + TK+ D++S G +L E++ R
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 429 KLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIEEFKT----EIALIAQLQHRNLVSI 483
+GEG +G V K G+ +A+K+ S E+ K E+ ++ QL+H N+V++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+ L++EY+ L++ EA L I + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV----VGTYGYMAPEYAM 599
IIHRD+K N+L+ + K+ DFG AR + V T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPEL-- 172
Query: 600 EGLFSTKS-----DVYSFGVLLLEIILGR 623
L + DV++ G ++ E++ G
Sbjct: 173 --LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 428 NKLGEGGFGSVYKG---VLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
+KLGEG + +VYKG + N + RL G + E++L+ L+H N+V++
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E+ L++EYL +K L Y+ D + K F + + RG+ Y H R +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPEYAMEGL 602
++HRDLK N+L++ K++DFG+AR I T N VV T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 603 -FSTKSDVYSFGVLLLEIILGR 623
+ST+ D++ G + E+ GR
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 28/214 (13%)
Query: 430 LGEGGFGSVY--------KGVLQNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQL-QHRN 479
LGEG FG V K + +AVK L ++ + + + +E+ ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----------FDEAKRSLLDWSKRFEIIC 528
++++LG C ++ +I EY +L Y+ +D A+ + + + C
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 529 G--IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNR 585
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR + D ++ TN
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+ +MAPE + +++ +SDV+SFGVL+ EI
Sbjct: 200 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ K+GEG G V G+++AVK++ Q E E+ ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ + E ++ E+L +L D + ++ + + + + + +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVGTYGYMAPEYA 598
+IHRD+K+ ++LL + K+SDFG F Q+ + R +VGT +MAPE
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFG----FCA-QVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 599 MEGLFSTKSDVYSFGVLLLEIILG 622
+ T+ D++S G++++E++ G
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 39/212 (18%)
Query: 430 LGEGGFGSVYKGVLQNGKE-IAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSILGC 486
+G G +G V +A+K+LSR I +T E+ L+ + H N++ +L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 487 CIEEQEKMLIYEYLPNKSL----DVYIFDE----------AKRSLLDWSKRFEIICGIAR 532
+ P SL DVY+ + L D +F ++ I R
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILR 129
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
G+ Y+H IIHRDLK SN+ ++ KI DFG+AR ++ V T Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 181
Query: 593 MAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
APE + + ++ D++S G ++ E++ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 52/195 (26%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+G+G G+VY + + G+E+A+++++ E EI ++ + ++ N+V+ L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+ E ++ EYL SL D + +D + + + + +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKS 607
RD+K+ N+LL + K++DFG +Q + +VGT +MAPE + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 608 DVYSFGVLLLEIILG 622
D++S G++ +E+I G
Sbjct: 198 DIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 429 KLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFKT--------EIALIAQLQ-HR 478
+LG+G FGSVY + E+ A+K++ + +F + E+ + +L H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHP 58
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVY-IFDEAKRSLLDWSKRFEIICGIARGILYL 537
N+V + E E ++EY+ ++Y + + K S II I +G+ ++
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN---TNRVVGTYGYMA 594
H + HRDLK N+L+ KI+DFG+AR +I T+ V T Y A
Sbjct: 116 H---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRA 166
Query: 595 PEYAME-GLFSTKSDVYSFGVLLLEIILGR 623
PE + +S+ D+++ G ++ E+ R
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 81/297 (27%), Positives = 132/297 (44%), Gaps = 42/297 (14%)
Query: 429 KLGEGGFGSVYKGVLQN------GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLV 481
+LG+G FG VY+G ++ +AVK ++ S S + EF E +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIF-------DEAKRSLLDWSKRFEIICGIARGI 534
+LG + Q +++ E + + L Y+ + R + ++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT----Y 590
YL+ + +HRDL A N ++ KI DFGM R D E + R G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650
+MAPE +G+F+T SD++SFGV+L EI + QG + ++ V D G
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI----TSLAEQPYQGLSNEQVLKFVMD----G 237
Query: 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPK 707
++ D C R L +C Q RP +V++L D PS P+
Sbjct: 238 GYLDQPDN------CPE---RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 430 LGEGGFGSVY--------KGVLQNGKEIAVKRLSR-SSGQGIEEFKTEIALIAQL-QHRN 479
LGEG FG V K +AVK L ++ + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----------FDEAKRSLLDWSKRFEIIC 528
++++LG C ++ ++ EY +L Y+ FD K + + + C
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 529 G--IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNR 585
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR + D ++ TN
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+ +MAPE + +++ +SDV+SFGVLL EI
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 72/218 (33%), Positives = 106/218 (48%), Gaps = 41/218 (18%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFKTEIALIAQ------LQHRNLVS 482
LG+G FG V L+ E A+K L + +E+ E ++ + +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 483 ILGCCIEEQEKML-IYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIARG 533
L C + +E + + EYL L +I FDEA+ RF EIICG+
Sbjct: 61 -LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEIICGLQ-- 110
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYG 591
+LH+ II+RDLK NVLLD + KI+DFGM + + G E + GT
Sbjct: 111 --FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPD 161
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629
Y+APE ++ D +SFGVLL E+++G+ + FH
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ--SPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 30/205 (14%)
Query: 429 KLGEGGFGSVY--KGVLQNG----KEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
K+GEG FG +Y K + KEI L++ + E K E+ L+A+++H N+V+
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEID---LTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYI-------FDEAKRSLLDWSKRFEIICGIARGIL 535
E ++ EY L I F E + +L W I+ G+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSW------FVQISLGLK 115
Query: 536 YLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
++H +I+HRD+K+ N+ L M K+ DFG+AR + E VGT Y++
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLS 170
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEI 619
PE ++ K+D++S G +L E+
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 29/204 (14%)
Query: 429 KLGEGGFGSVYKGVL----QNGKEIAVKRL--SRSSGQGIEEFKTEIALIAQLQHRNLVS 482
K+GEG FG K +L ++GK+ +K + S+ S + EE + E+A+++ ++H N+V
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYI-------FDEAKRSLLDWSKRFEIICGIARGIL 535
E ++ +Y L I F E +LDW F IC L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE--DQILDW---FVQIC------L 112
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
L +I+HRD+K+ N+ L K+ DFG+AR+ + E +GT Y++P
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSP 170
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEI 619
E ++ KSD+++ G +L E+
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 72/240 (30%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 433 GGFGSVY--KGVLQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
G FGSVY K G A+K L +S + + K E A++ V+ L
Sbjct: 7 GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 488 IEEQEKM-LIYEYLPNKSLDVYIFDEAKRSL----LDWSKRFEIICGIARGILYLHQDSR 542
+ ++ + L+ EYL I ++L DW+K++ I + G+ LHQ
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602
IIHRD+K N+L+D + K++DFG++R EN + VGT Y+APE + G+
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLEN-KKFVGTPDYLAPE-TILGV 168
Query: 603 FSTK-SDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW----KEGTAMEAVD 657
K SD +S G ++ E + G FH E ++ + W KE + EAVD
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYP--PFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVD 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 422 NDFSSDNKLGEGGFGSVYK------GVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL 475
+DF ++LG G G V K G++ K I ++ Q I E + ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
+V G + E + E++ SLD + EAKR + + I + RG+
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI--AVLRGLA 117
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
YL + + +I+HRD+K SN+L+++ K+ DFG++ G I+ N VGT YM+P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILGR 623
E +S +SD++S G+ L+E+ +GR
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 428 NKLGEGGFGSVYKG---VLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
KLGEG + +V+KG + +N + RL G + E++L+ L+H N+V++
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
++ L++EYL +K L Y+ D + K F + I RG+ Y H R +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRK 124
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPEYAM-EG 601
++HRDLK N+L++ K++DFG+AR + T N VV T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 602 LFSTKSDVYSFGVLLLEIILGR 623
+ST+ D++ G + E+ GR
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 53/216 (24%)
Query: 430 LGEGGFGSV----YKGVLQNGKEIAVKRLSRS----SGQGIEEFKTEIALIAQLQHRNLV 481
LG G FG V +K +GK A+K LS++ Q +E E ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF----------EIICGIA 531
++ G ++ L+ EY+P L F S L S RF +++ +
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGEL----F-----SHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
YLH L I++RDLK N+LLD+ KI+DFG A+ ++ T + GT
Sbjct: 116 ----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGRTYTLCGTPE 163
Query: 592 YMAPEYAMEGLFSTK-----SDVYSFGVLLLEIILG 622
Y+APE + +K D ++ G+L+ E++ G
Sbjct: 164 YLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 430 LGEGGFGSVYKGVLQ-NGKE---IAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSIL 484
LG G FG + +G L+ K +A+ L S + F E + Q H N+V +
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
G M++ EY+ N +LD ++ L + ++ G+A G+ YL S +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE--NTNRVVGTYGYMAPEYAMEGL 602
+H+ L A VL+++ + KIS F + D+ E T + APE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 603 FSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL- 660
FS+ SDV+SFG+++ E++ G R WD+ + ++AV+
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP-----------------YWDMSGQ-DVIKAVEDGFR 226
Query: 661 --GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C + + L L C Q++ +RP S + S+L
Sbjct: 227 LPAPRNCPNLLHQ---LMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 430 LGEGGFGSVYKGVLQ-NGKEI--AVKRLSR-SSGQGIEEFKTEIALIAQL-QHRNLVSIL 484
+GEG FG V K ++ +G + A+KR+ +S +F E+ ++ +L H N++++L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 485 GCCIEEQEKMLIYEYLPNKSL-------------DVYIFDEAKRSLLDWSKRFEIICGIA 531
G C L EY P+ +L + + S L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
RG+ YL S+ + IHRDL A N+L+ KI+DFG++R G ++
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
+MA E +++T SDV+S+GVLL EI+
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+G FG V L+ G+ AVK L + +E E ++A ++ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 486 CCIEEQEKML-IYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQDS 541
C + +E + + E+L L +I D+ + L + F EI+CG+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCGLQ----FLHSKG 116
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMAPEYAM 599
II+RDLK NV+LD + KI+DFGM + +FG + + GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQ 169
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629
++ D +SFGVLL E+++G+ + FH
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ--SPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+G FG V+ L+ + A+K L + +E E +++ ++ L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 486 CCIEEQEKML-IYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
C + +E + + EYL L +I FD + + EIICG+ +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICGLQ----FLHS 114
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMAPEY 597
I++RDLK N+LLD + KI+DFGM + + G + T GT Y+APE
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEI 167
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629
+ ++T D +SFGVLL E+++G+ + FH
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 4e-15
Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 42/218 (19%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRL-----SRSSGQGIEEFKT--EIALIAQL-QHR 478
KLG+G +G V+K + + + +A+K++ + + Q +T EI + +L H
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHP 67
Query: 479 NLVSILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLL-DWSKRFEIICGIARGIL 535
N+V +L E +K L++EY+ L I + ++L D KR+ I+ + + +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLLKALK 121
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN-TNRV----VGTY 590
Y+H S +IHRDLK SN+LL++ K++DFG+AR ++EEN N V V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATR 176
Query: 591 GYMAPEYAMEGLFSTKS-----DVYSFGVLLLEIILGR 623
Y APE L + D++S G +L E++LG+
Sbjct: 177 WYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIA---VKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSI 483
+++G G FG V G G A VK L S+ F E+ +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--EIICGIARGILYLHQDS 541
LG CIE +L+ E+ P L Y+ K + C +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARI-FGGDQIEENTNRVVGTYGYMAPEYAME 600
IH DL N L A ++ KI D+G+A + D V ++APE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 601 -------GLFSTKSDVYSFGVLLLEI 619
+ KS+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 429 KLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKT-------EIALIAQLQHRNL 480
+GEG +G V K + G+ +A+K+ S E+ K EI ++ QL+H NL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLKQLRHENL 62
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V+++ ++ L++E++ + LD E + LD S+ + + I RGI + H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM- 599
+ IIHRD+K N+L+ + K+ DFG AR E V T Y APE +
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVG 174
Query: 600 EGLFSTKSDVYSFGVLLLEIILG 622
+ + D+++ G L+ E++ G
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 70/215 (32%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEI-AVK--RLSRS-SGQGIEEFKTEIALIAQLQHR 478
+F N++GEG +G VY+ EI A+K R+ G I + EI L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 479 NLVSILGCCIEEQ--EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR-F---EIIC---G 529
N+V + + + L+ EY D A SLLD F ++ C
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ--------DLA--SLLDNMPTPFSESQVKCLMLQ 116
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+ RG+ YLH++ IIHRDLK SN+LL KI+DFG+AR + G + T +VV T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-T 171
Query: 590 YGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
Y APE + T + D+++ G +L E++ +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 430 LGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCI 488
+G G +G VYKG ++A ++ +G EE K EI ++ + HRN+ + G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 489 E------EQEKMLIYEYLPNKSLDVYIFDEAKRSLLD-WSKRFEIIC-GIARGILYLHQD 540
+ + + L+ E+ S+ I + +L + W IC I RG+ +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW---IAYICREILRGLSHLHQH 130
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM- 599
++IHRD+K NVLL K+ DFG++ D+ N +GT +MAPE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 600 ----EGLFSTKSDVYSFGVLLLEIILG 622
+ + KSD++S G+ +E+ G
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 52/196 (26%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 429 KLGEGGFGSV-YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+GEG G V +G+++AVK + Q E E+ ++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC-GIARGILYLHQDSRLRII 546
+ +E ++ E+L +L I + + + ++ +C + + + YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGAL-TDIVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTK 606
HRD+K+ ++LL K+SDFG D + + +VGT +MAPE + T+
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTE 197
Query: 607 SDVYSFGVLLLEIILG 622
D++S G++++E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 429 KLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+GEG G V ++ GK++AVK++ Q E E+ ++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+ E ++ E+L +L D + ++ + + + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR--VVGTYGYMAPEYAMEGLFST 605
RD+K+ ++LL + K+SDFG F +E R +VGT +MAPE + T
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 606 KSDVYSFGVLLLEIILG 622
+ D++S G++++E+I G
Sbjct: 198 EVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKT---------EIA 470
TN + +G G FG V Q G+ +A+K++ ++ F T E+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 471 LIAQLQHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICG 529
L+ L+H N++S+ I E + + E L D++ ++ + + F +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYF--LYQ 116
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
I RG+ Y+H ++HRDLK SN+L++ + KI DFG+ARI Q + T V
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTR 169
Query: 590 YGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGR 623
Y Y APE + + + D++S G + E++ G+
Sbjct: 170 Y-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 39/192 (20%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRL---SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
K+G+G FG V+K + + +A+K++ + G I + EI ++ L+H N+V++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76
Query: 484 LGCCIEEQEK--------MLIYEY--------LPNKSLDVYIFDEAKRSLLDWSKRFEII 527
+ C + L++E+ L NK++ + E K+ ++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKK----------VM 125
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG---GDQIEENTN 584
+ G+ Y+H R +I+HRD+KA+N+L+ K++DFG+AR F + TN
Sbjct: 126 KMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 585 RVVGTYGYMAPE 596
RVV T Y PE
Sbjct: 183 RVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIE-EFKTEIALIAQLQHRNL 480
D LG G G+VYK L + +AVK + ++ + +E+ ++ + +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
+ G E + E++ SLDVY + +L I + +G+ YL
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY--RKIPEHVLG-----RIAVAVVKGLTYLWS- 113
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
L+I+HRD+K SN+L++ K+ DFG++ + VGT YMAPE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISG 167
Query: 601 GLFSTKSDVYSFGVLLLEIILGR 623
+ SDV+S G+ +E+ LGR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 23/223 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSIL-- 484
+G G +GSV + G +AVK+LSR I +T E+ L+ ++H N++ +L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 485 ---GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+EE + + +L L+ + + L D +F +I I RG+ Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQF-LIYQILRGLKYIHSAD 140
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
IIHRDLK SN+ ++ KI DFG+AR ++ V T Y APE +
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 602 L-FSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSWNLVG 641
+ ++ D++S G ++ E++ GR T H++Q LVG
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQHR 478
DF+ LG+G FG V + E+ A+K L + +E E ++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 479 NLVSILGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIAR 532
++ L C + +++ + EY+ L +I F E IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAEIAI 112
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTY 590
G+ +LH II+RDLK NV+LDA + KI+DFGM + IFGG T GT
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCGTP 165
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y+APE + D ++FGVLL E++ G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 66/182 (36%), Positives = 96/182 (52%), Gaps = 32/182 (17%)
Query: 525 EIIC---GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGG-DQI 579
++IC +ARG+ +L SR + IHRDL A N+LL KI DFG+AR I+ D +
Sbjct: 175 DLICYSFQVARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231
Query: 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639
+ + R+ +MAPE + +++T+SDV+SFGVLL EI F L G+ +
Sbjct: 232 RKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI--------FSL--GASPYPG 279
Query: 640 VGHVWDL---WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696
V + K+GT M A + + PEI R + L C Q +RP SA+V +
Sbjct: 280 VQINEEFCQRLKDGTRMRAPENA------TPEIYRIM---LACWQGDPKERPTFSALVEI 330
Query: 697 LG 698
LG
Sbjct: 331 LG 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 42/129 (32%), Positives = 74/129 (57%), Gaps = 15/129 (11%)
Query: 498 EYLPNKSLDVYIFDEAKR---SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASN 554
E++ SLD + +A R ++L +I + RG+ YL + + +I+HRD+K SN
Sbjct: 79 EHMDGGSLDQ-VLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSN 130
Query: 555 VLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGV 614
+L+++ K+ DFG++ G I+ N VGT YM+PE ++ +SD++S G+
Sbjct: 131 ILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186
Query: 615 LLLEIILGR 623
L+E+ +GR
Sbjct: 187 SLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 430 LGEGGFGSV------YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+GGFG V G + K++ KR+ + G+ + E ++ ++ R +VS
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVS- 64
Query: 484 LGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQ 539
L E ++ + L+ + L +I+ + + F EI CG+ LHQ
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE----DLHQ 120
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+ RI++RDLK N+LLD + +ISD G+A Q + VGT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVK 174
Query: 600 EGLFSTKSDVYSFGVLLLEIILGR 623
++ D ++ G LL E+I G+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 64/239 (26%), Positives = 116/239 (48%), Gaps = 30/239 (12%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVSILGCC 487
K+G G +G VYK ++GK+ L + G GI EIAL+ +L+H N++++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 488 IEEQEKM--LIYEYLPNKSLDVYIFDEAKRS-----LLDWSKRFEIICGIARGILYLHQD 540
+ ++ L+++Y + + F A ++ L S ++ I GI YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 541 SRLRIIHRDLKASNVLLDAAMNP-----KISDFGMARIFGGD-QIEENTNRVVGTYGYMA 594
++HRDLK +N+L+ P KI+D G AR+F + + + VV T+ Y A
Sbjct: 128 ---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 595 PEYAMEGLFSTKS-DVYSFGVLLLEIILG-----------RRNNTFHLEQGSGSWNLVG 641
PE + TK+ D+++ G + E++ + +N FH +Q ++++G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 429 KLGEGGFGSVYKGVLQ-NGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSILG 485
KLGEG + +VYKG + G+ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
I ++ + L++EYL + L Y+ + L + + RG+ Y HQ R
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYM--DDCGGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPEYAMEGL 602
++HRDLK N+L+ K++DFG+AR + T N VV T Y P+ +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 603 -FSTKSDVYSFGVLLLEIILGR 623
+ST D++ G + E+ GR
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 33/220 (15%)
Query: 424 FSSDN-----KLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH 477
F++++ ++G G FG+V K + + G +AVKR+ RS+ E+ + + L ++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRS 59
Query: 478 RNLVSIL---GCCIEEQEKMLIYEYLPNKSLD-----VYIFDEAKRSLLDWSKRFEIICG 529
+ I+ G E + + E L + SLD VY E +S++ +I
Sbjct: 60 SDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVY---EVLKSVIPEEILGKIAVA 115
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVV 587
+ + YL ++ L+IIHRD+K SN+LLD N K+ DFG I G Q+ ++ R
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISG--QLVDSIAKTRDA 168
Query: 588 GTYGYMAPE----YAMEGLFSTKSDVYSFGVLLLEIILGR 623
G YMAPE A +G + +SDV+S G+ L E+ G+
Sbjct: 169 GCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 64/239 (26%), Positives = 115/239 (48%), Gaps = 30/239 (12%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVSILGCC 487
K+G G +G VYK ++GK+ L + G GI EIAL+ +L+H N++S+
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 488 IEEQEKM--LIYEYLPNKSLDVYIFDEAKRS-----LLDWSKRFEIICGIARGILYLHQD 540
+ ++ L+++Y + + F A ++ L ++ I GI YLH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 541 SRLRIIHRDLKASNVLLDAAMNP-----KISDFGMARIFGGD-QIEENTNRVVGTYGYMA 594
++HRDLK +N+L+ P KI+D G AR+F + + + VV T+ Y A
Sbjct: 128 ---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 595 PEYAMEGLFSTKS-DVYSFGVLLLEIILG-----------RRNNTFHLEQGSGSWNLVG 641
PE + TK+ D+++ G + E++ + +N +H +Q +N++G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNL 480
+ +G G +G V + ++GK++A+K++ + +T E+ ++ +H N+
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSL--DVY-IFDEAKRSLLDWSKRFEIICG-------- 529
++I +L P + DVY + D L S II
Sbjct: 67 IAIR--------DIL----RPPGADFKDVYVVMD------LMESDLHHIIHSDQPLTEEH 108
Query: 530 -------IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582
+ RG+ Y+H + +IHRDLK SN+L++ +I DFGMAR E
Sbjct: 109 IRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 583 T--NRVVGTYGYMAPE--YAMEGLFSTKSDVYSFGVLLLEIILGRR 624
V T Y APE ++ ++T D++S G + E++ GRR
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 8e-14
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 33/208 (15%)
Query: 430 LGEGGFGSVYKGVL-QNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+G FG V L ++G+ AVK L + +E TE +++ ++ ++ L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 486 CCIEEQEKML-IYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIARGILY 536
CC + +++ + E++ L +I FDEA+ RF EI +++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-------ARFYAAEIT----SALMF 111
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMA 594
LH II+RDLK NVLLD + K++DFGM + IF G + T+ GT Y+A
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIA 164
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PE E L+ D ++ GVLL E++ G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
+D+ ++G G +G VYK L G+ AVK + G + EI ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEIIC-GIARGILYLH 538
V+ G + ++ + EY SL D+Y L + +C +G+ YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-----QIAYVCRETLQGLAYLH 123
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
++ HRD+K +N+LL + K++DFG+A + + +GT +MAPE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVA 178
Query: 599 M---EGLFSTKSDVYSFGVLLLEI 619
G ++ D+++ G+ +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 63/174 (36%), Positives = 88/174 (50%), Gaps = 29/174 (16%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGG-DQIEENTNRVV 587
+ARG+ +L SR + IHRDL A N+LL KI DFG+AR I+ D + + R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL- 646
+MAPE + +++T+SDV+SFGVLL EI F L G+ + V +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI--------FSL--GASPYPGVQIDEEFC 286
Query: 647 --WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698
KEGT M A + + PEI + L C DRP S +V +LG
Sbjct: 287 RRLKEGTRMRAPEYA------TPEIYSIM---LDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 429 KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSILG 485
KLGEG + +VYKG+ + NG+ +A+K +S + +G+ F E +L+ L+H N+V +L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV-LLH 69
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
I +E + ++EY+ + L Y+ L ++ R + + RG+ Y+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPG-GLHPYNVRL-FMFQLLRGLAYIH---GQH 123
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT-NRVVGTYGYMAPEYAMEGL- 602
I+HRDLK N+L+ K++DFG+AR I T + V T Y P+ +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 603 FSTKSDVYSFGVLLLEIILGR 623
+S+ D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 429 KLGEGGFGSVYKGVLQ-NGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSILG 485
KLGEG + +VYKG + NGK +A+K RL G + E +L+ L+H N+V +L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLH 69
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
I +E + L++EY+ + L Y+ + K F + + RG+ Y+HQ
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIHQRY--- 123
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPEYAMEGL 602
I+HRDLK N+L+ K++DFG+AR + +T N VV T Y P+ +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVV-TLWYRPPDVLLGST 179
Query: 603 -FSTKSDVYSFGVLLLEIILG 622
+ST D++ G + +E+I G
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 429 KLGEGGFGSV-YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+GEG G V V +GK +AVK++ Q E E+ ++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+ E ++ E+L +L D + ++ + + + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVGTYGYMAPEYAMEGLFS 604
RD+K+ ++LL K+SDFG Q+ + R +VGT +MAPE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA-----QVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 605 TKSDVYSFGVLLLEIILG 622
+ D++S G++++E++ G
Sbjct: 195 PEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 428 NKLGEGGFGSVYKGVLQ-NGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
+KLGEG + +V+KG + +A+K RL G + E++L+ L+H N+V++
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E+ L++EYL + L Y+ + + K F + + RG+ Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIF--MFQLLRGLSYCH---KRK 123
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPEYAMEGL 602
I+HRDLK N+L++ K++DFG+AR + T N VV T Y P+ +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 603 -FSTKSDVYSFGVLLLEIILGR 623
+ST D++ G +L E+ GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 427 DNKLGEGGFGSVYKGV-LQNGKEIAVKRL--------SRSSGQGIEE----FKT--EIAL 471
LGEG +G V K GK +A+K++ Q + F T E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 472 IAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIA 531
+ +++H N++ ++ +E L+ + + + D+ + K L + + I+ I
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMAS---DLKKVVDRKIRLTESQVKC-ILLQIL 129
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI------------ 579
G+ LH+ +HRDL +N+ +++ KI+DFG+AR +G
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 580 -EENTNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
EE T++VV T Y APE M + D++S G + E++ G+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 50/221 (22%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKE-IAVKRLSRS---SGQGIEEFKTEIALIAQLQHR 478
D +G G FG V+ + + A+K ++ + + E ++ ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGIL 535
++ + +++ ++ EY+P L Y+ + + F EI+C +
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALE---- 115
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
YLH I++RDLK N+LLD + K++DFG A+ ++ + T + GT Y+AP
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILG----RRNNTFHLEQ 632
E + D ++ G+L+ E+++G +N F + +
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+G FG V L+ E+ A+K L + ++ TE ++A ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 486 CCIEEQEKML-IYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIARGILY 536
CC + ++++ + EY+ L I FDE + RF E+ + ++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR-------SRFYAAEVTLAL----MF 111
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMA 594
LH+ +I+RDLK N+LLDA + K++DFGM + I G T GT Y+A
Sbjct: 112 LHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIA 164
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
PE E + D ++ GVL+ E++ G+
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 24/225 (10%)
Query: 413 DLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIAL 471
DLS + F +G G +G VYKG ++ G+ A+K + + + EE K EI +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINM 65
Query: 472 IAQL-QHRNLVSILGCCIE------EQEKMLIYEYLPNKSLDVYIFDEAKRSLL-DWSKR 523
+ + HRN+ + G I+ + + L+ E+ S+ + + +L DW
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--- 122
Query: 524 FEIIC-GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582
IC I RG+ +LH ++IHRD+K NVLL K+ DFG++ D+
Sbjct: 123 IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGR 177
Query: 583 TNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILG 622
N +GT +MAPE + + +SD++S G+ +E+ G
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 30/226 (13%)
Query: 400 DDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS 458
D SRRN + DF ++G G +G VYK + G+ A+K +
Sbjct: 1 DLSRRNPQ--------------EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP 46
Query: 459 GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL-DVY-IFDEAKRS 516
G+ + EI ++ +H N+V+ G + + + E+ SL D+Y + S
Sbjct: 47 GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES 106
Query: 517 LLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576
+ + R + +G+ YLH + +HRD+K +N+LL + K++DFG++
Sbjct: 107 QIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA 158
Query: 577 DQIEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEI 619
+ + +GT +MAPE A +G ++ D+++ G+ +E+
Sbjct: 159 TIAKRKS--FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 42/223 (18%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---EIALIAQLQHR 478
D D +G G FG V+ ++GK +A+K++ Q + K E+ ++ +H
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHD 59
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLD----VYIFDEAKRSLL------------DWSK 522
N++S L + L +D +Y+ E +S L D K
Sbjct: 60 NVLSAL-------------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK 106
Query: 523 RFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582
F + I RG+ YLH I+HRD+K N+L+++ KI DFG+AR+ D+ +
Sbjct: 107 VF--LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM 161
Query: 583 TNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRR 624
T VV Y Y APE M +++ D++S G + E +LGRR
Sbjct: 162 TQEVVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAE-LLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 50/228 (21%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
+D +LG G +G V K + G +AVKR+ R++ + +Q Q R L
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RAT------------VNSQEQKRLL 47
Query: 481 VSI-----LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLD--WSKRFE-------- 525
+ + C Y L + DV+I E + LD + K ++
Sbjct: 48 MDLDISMRSVDCPYTVT---FYGALFREG-DVWICMEVMDTSLDKFYKKVYDKGLTIPED 103
Query: 526 ----IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581
I I + + YLH S+L +IHRD+K SNVL++ K+ DFG++ G ++
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDS 157
Query: 582 NTNRV-VGTYGYMAPE-----YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ G YMAPE +G + KSDV+S G+ ++E+ GR
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 430 LGEGGFGSVYK-GVLQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+GGFG V V GK A KRL + +G E ++ ++ + +V+ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFD------EAKRSLLDWSKRFEIICGIARGILYLH 538
E ++ + L+ + L +I++ E +R+L + EI+CG+ LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA---EILCGLE----DLH 119
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTNRVVGTYGYMAPEY 597
+++ ++RDLK N+LLD + +ISD G+A +I G+ I VGT GYMAPE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGR 623
++ D + G L+ E+I G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 430 LGEGGFGSV----YKGVLQNGKEIAVKRLSRS---SGQGIEEFKTE--IALIA-QLQHRN 479
LG G FG V YK G+ A+K L + + +E E I A +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE---AKRSLLDWSKRFEIICGIARGILY 536
LV++ C E + EY L ++I + R+ F C + G+ Y
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------VFYAAC-VVLGLQY 116
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMA 594
LH++ +I++RDLK N+LLD KI+DFG+ + + GD+ T+ GT ++A
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPEFLA 169
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PE E ++ D + GVL+ E+++G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 422 NDFSSDNKLGEGGFGSVYK------GVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL 475
+DF ++LG G G V+K G++ K I ++ Q I E + ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
+V G + E + E++ SLD + +A R + I + +G+
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI--AVIKGLT 117
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
YL + + +I+HRD+K SN+L+++ K+ DFG++ G I+ N VGT YM+P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILGR 623
E +S +SD++S G+ L+E+ +GR
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKR-LSRSSGQGIEEFK-TEIALIAQLQHRNLVSILG 485
K+GEG +G VYK GK +A+K+ +GI EI+L+ L + L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 486 CCIEEQEKM------LIYEYLPNKSLDVYIFDEAKRSL---LDWSKRFEIICGIARGILY 536
+EK L++EYL + L ++ D R L + + +G+ +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
H + ++HRDLK N+L+D KI+D G+ R F ++ T+ +V T Y AP
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRAP 180
Query: 596 EYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTF 628
E + +ST D++S G + E+ R+ F
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSIL-- 484
+G G +GSV + +++AVK+LSR I +T E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 485 ---GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
IE ++ + L L+ + + L D +F +I + RG+ Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQF-LIYQLLRGLKYIHSAG 138
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
IIHRDLK SNV ++ +I DFG+AR Q ++ V T Y APE +
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNW 190
Query: 602 L-FSTKSDVYSFGVLLLEIILGR 623
+ ++ D++S G ++ E++ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 67/242 (27%)
Query: 430 LGEGGFGSV---YKGVLQNGKEIAVKRLSR------SSGQGIEEFKTEIALIAQLQHRNL 480
+G G G V Y V G+ +A+K+LSR + + E L+ + H+N+
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNI 77
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSL----DVYIFDEAKRSLLDWS-----------KR-- 523
+ +L + P KSL DVY+ E L+D + +R
Sbjct: 78 IGLLNV------------FTPQKSLEEFQDVYLVME----LMDANLCQVIQMDLDHERMS 121
Query: 524 ---FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
++++CGI +LH IIHRDLK SN+++ + KI DFG+AR G +
Sbjct: 122 YLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174
Query: 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSWN 638
T VV Y Y APE + + D++S G ++ E+I G T H++Q WN
Sbjct: 175 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ----WN 227
Query: 639 LV 640
+
Sbjct: 228 KI 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 430 LGEGGFGSV------YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+GGFG V G + K++ KR+ + G+ + E ++ ++ R +VS
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVS- 64
Query: 484 LGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQ 539
L E ++ + L+ + L +I++ + F E+ CG L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LED 117
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTNRVVGTYGYMAPEYA 598
R RI++RDLK N+LLD + +ISD G+A +I G+ + VGT GYMAPE
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVI 173
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGR 623
++ D + G L+ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 22/199 (11%)
Query: 430 LGEGGFGS--VYKGVLQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSILG 485
+GEG FG + + V + K A+K RL +SS +E+ + E L+A+++H N+V+
Sbjct: 8 VGEGSFGRALLVQHVNSDQK-YAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKR-----SLLDWSKRFEIICGIARGILYLHQD 540
+ ++ EY L I + + ++L W F +C G+ ++H+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHIHEK 119
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
R++HRD+K+ N+ L K+ DFG AR+ T VGT Y+ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWEN 174
Query: 601 GLFSTKSDVYSFGVLLLEI 619
++ KSD++S G +L E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 430 LGEGGFGSV------YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
LG+GGFG V G + K++ KR+ + G+ + E ++ ++ R +VS
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVS- 64
Query: 484 LGCCIEEQEKM-LIYEYLPNKSLDVYIFD------EAKRSLLDWSKRFEIICGIARGILY 536
L E ++ + L+ + L +I++ + +R++ + EI CG+
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA---EITCGLE----D 117
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTNRVVGTYGYMAP 595
LH R RI++RDLK N+LLD + +ISD G+A I G+ I VGT GYMAP
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILGR 623
E ++ D + G L+ E+I G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 6/121 (4%)
Query: 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA 559
LP+ S D+Y + + L + I I G+ YLH RIIHRD+K N+ ++
Sbjct: 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFIND 192
Query: 560 AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
I D G A+ + + GT APE +++K+D++S G++L E+
Sbjct: 193 VDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
Query: 620 I 620
+
Sbjct: 250 L 250
|
Length = 357 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 422 NDFSSDNKLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIEEFKTEIAL---IAQLQH 477
ND + ++G G G VYK + G +AVK++ R+ + EE K I + + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-RILMDLDVVLKSH 71
Query: 478 R--NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLD-WSKRF-----EIICG 529
+V G I + DV+I E + LD KR E I G
Sbjct: 72 DCPYIVKCYGYFITD--------------SDVFICMELMSTCLDKLLKRIQGPIPEDILG 117
Query: 530 -----IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
I + + YL + +IHRD+K SN+LLDA+ N K+ DFG++ G ++
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAK 171
Query: 585 -RVVGTYGYMAPEY----AMEGLFSTKSDVYSFGVLLLEIILGR 623
R G YMAPE + ++DV+S G+ L+E+ G+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 423 DFSSDNKLGEGGFGSV----YKGVLQNGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL 475
DF LG G FG V +KG G+ A+K L + + ++ E +++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--EIICGIARG 533
H +V+++ +E + E++ L ++ +A R D +K + E++
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVLAFE-- 132
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
YLH II+RDLK N+LLD + K++DFG A+ ++ + T + GT Y+
Sbjct: 133 --YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYL 182
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILG 622
APE D ++ GVLL E I G
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 39/214 (18%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSILGC 486
+G G +G V + +++A+K+++ + I+ +T EI L+ L H N+++I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEII----------C-----GIA 531
+ + DVYI E L+D + +II C +
Sbjct: 73 MPPPHRE--AFN-------DVYIVYE----LMD-TDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
RG+ Y+H + ++HRDLK SN+LL+A + KI DFG+AR ++ + T VV T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRW 173
Query: 592 YMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGRR 624
Y APE + T + DV+S G + E +LGR+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAE-LLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 429 KLGEGGFGSVYKGVLQNG---KEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSIL 484
++G G FG V G + +G ++ VK L S+ Q +F E LQH NL+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLL--DWSKRFEIICGIARGILYLHQDSR 542
G C E +L+ E+ P L Y+ K L+ D + + C IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-- 600
IH DL N LL A + KI D+G++ + +++ ++APE E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 601 -GLF----STKSDVYSFGVLLLEI 619
L + +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 430 LGEGGFGSV----YKGVLQNGKEIAVKRLS--RSSGQGIEEFKTEIALIAQLQHRNLVSI 483
+G+G +G V ++ +GK+ +K+L+ +S + + + E L++QL+H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 484 LGCCIEEQEKMLIYEYLP-NKSLDVY-IFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
E E L+Y + + D+Y E K LL ++ E IA + YLH+
Sbjct: 65 RESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
I+HRDLK NV L K+ D G+AR+ + + + ++GT YM+PE
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNK 177
Query: 602 LFSTKSDVYSFGVLLLEI 619
++ KSDV++ G + E+
Sbjct: 178 PYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 62/184 (33%), Positives = 95/184 (51%), Gaps = 34/184 (18%)
Query: 525 EIIC---GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGG-DQI 579
++IC +A+G+ +L SR + IHRDL A N+LL KI DFG+AR I+ D +
Sbjct: 180 DLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639
+ R+ +MAPE + +++ +SDV+SFGVLL EI F L G+ +
Sbjct: 237 RKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSL--GASPYPG 284
Query: 640 VGHVWDLW----KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695
V + + + KEGT M A D + PE+ + + L C + + RP S +V
Sbjct: 285 V-KIDEEFCRRLKEGTRMRAPDYT------TPEMYQTM---LDCWHGEPSQRPTFSELVE 334
Query: 696 MLGS 699
LG+
Sbjct: 335 HLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIA----LIAQLQHRNLVSIL 484
+G+G FG V +GK AVK L + + +E K +A L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 485 GCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQD 540
+ +K+ + +Y+ L ++ E RS + RF EI + YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALG----YLHS- 114
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
L II+RDLK N+LLD+ + ++DFG+ + G + + T+ GT Y+APE +
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRK 170
Query: 601 GLFSTKSDVYSFGVLLLEIILG 622
+ D + G +L E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGK--EIAVKRLSRSS---GQGIEEFKTEIALIAQLQH 477
DF+ LG G FG V +N +A+KR +S + ++ +E ++ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--EIICGIARGIL 535
V++ G +E L+ E++ + L +KRF ++ C A I+
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTF---------LRRNKRFPNDVGCFYAAQIV 141
Query: 536 YLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
+ + L I++RDLK N+LLD K++DFG A++ ++ T + GT Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIA 196
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PE + +D ++ G+ + EI++G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 430 LGEGGFGSVY----KGVLQNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLV 481
LG G +G V+ G GK A+K L +++ + E +TE ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
L + K+ LI +Y+ L +++ +R S+ I I + +LHQ
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQ- 123
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM- 599
L II+RD+K N+LLD+ + ++DFG+++ F ++ EE GT YMAPE
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRG 180
Query: 600 -EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636
G D +S GVL E++ G T EQ S S
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE---FKT----EIALIAQLQHRNL 480
K+GEG +G V+K + G+ +A+K+ S E+ K EI ++ QL+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V+++ +++ L++EY + L+ E + +II + + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK- 118
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
IHRD+K N+L+ K+ DFG ARI G ++ V T Y APE +
Sbjct: 119 --HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP--GDDYTDYVATRWYRAPELLVG 174
Query: 601 GL-FSTKSDVYSFGVLLLEIILG 622
+ DV++ G + E++ G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 430 LGEGGFGSVYKGVLQN---------GKEIAVKR-LSRSSGQGIEEFKTEIALIAQLQHRN 479
LG+G F ++YKGVL+ G+E++V + S + F +L++QL H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
LV + G C+ E +++ EY+ LDV++ E L W + ++ +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 540 DSRLRIIHRDLKASNVLL----DAAMNP---KISDFGMARIFGGDQIEENTNRVVGTYGY 592
+++H ++ N+L+ K+SD G+ EE R+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170
Query: 593 MAPEYAMEGLFSTKS--DVYSFGVLLLEI 619
+APE G S D +SFG LLEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 428 NKLGEGGFGSVYK------GVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
++LG+G +GSVYK GV KEI ++ L S I E+ ++ + +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQI---IMELDILHKAVSPYIV 62
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G E + EY+ SLD + I + +G+ +L ++
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY---- 597
IIHRD+K +NVL++ K+ DFG++ G+ + +G YMAPE
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 598 --AMEGLFSTKSDVYSFGVLLLEIILGR 623
++ +SDV+S G+ +LE+ LGR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGI--EEFKTEIALIAQLQHRNL 480
++S ++G G +GSV + + G+++A+K+LSR I + E+ L+ +QH N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 481 VSILGCCIEE---QEKMLIYEYLPNKSLDV-----YIFDEAKRSLLDWSKRFEIICGIAR 532
+ +L E Y +P D+ + E K L ++++CG+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL----VYQMLCGLK- 131
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
Y+H IIHRDLK N+ ++ KI DFG+AR D E T VV T Y
Sbjct: 132 ---YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--HADA--EMTGYVV-TRWY 180
Query: 593 MAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
APE + + ++ D++S G ++ E++ G+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 61/244 (25%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSRS----SGQGIEEFKTEIALIA 473
+DF +G G FG V+ L G+ A+K L +S Q I + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56
Query: 474 QLQHRNLVSILGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF--E 525
+V L +++E + L+ EY+P L +F E + ++ + E
Sbjct: 57 DADSPWIVK-LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFYIAE 109
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTN 584
++ + +H+ L IHRD+K N+L+DA + K++DFG+ ++ E N
Sbjct: 110 LVLALD----SVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 585 R--------------------------VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLE 618
VGT Y+APE + + D +S GV+L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 619 IILG 622
++ G
Sbjct: 223 MLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 17/224 (7%)
Query: 423 DFSSDNKLGEGGFGSVY----KGVLQNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQ 474
+F LG G +G V+ GK A+K L +++ + +E +TE ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 475 LQHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
++ + L + + K+ LI +Y+ + +++ D E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEI 114
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
IL L +L I++RD+K N+LLD+ + ++DFG+++ F ++ +E T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173
Query: 594 APEYAM-EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636
APE +G D +S G+L+ E++ G T E+ + S
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 35/226 (15%)
Query: 430 LGEGGFGSV---YKGVLQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSIL 484
+G G G V Y +L+ + +A+K+LSR + E+ L+ + H+N++ +L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 485 GC-----CIEEQEKMLIYEYLPNKSLDVYI---FDEAKRSLLDWSKRFEIICGIARGILY 536
+EE + + I L + +L I D + S L ++++CGI +
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL----LYQMLCGIK----H 141
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH IIHRDLK SN+++ + KI DFG+AR G + VV Y Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--PYVVTRY-YRAPE 195
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSWNLV 640
+ + D++S G ++ E+I G T H++Q WN V
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ----WNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 430 LGEGGFGSVYKGVL----QNGKEIAVKRLSRS----SGQGIEEFKTEIALIAQLQHRNLV 481
LG+GG+G V++ GK A+K L ++ + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLH 538
++ + LI EYL L +++ E + ++ + F EI + +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALE----HLH 117
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTYGYMAPE 596
Q II+RDLK N+LLDA + K++DFG+ + + I E T+ GT YMAPE
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPE 170
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILG 622
M D +S G L+ +++ G
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 430 LGEGGFGSVYKGVLQNGKEI----AVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSIL 484
+G G + V L+ + I VK+ + + I+ +TE + Q H LV +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
C E + EY+ L ++ + +R L + RF I+ + YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARF-YSAEISLALNYLHERG--- 116
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
II+RDLK NVLLD+ + K++D+GM + G + + T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 605 TKSDVYSFGVLLLEIILGR 623
D ++ GVL+ E++ GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI--EENTNRVV 587
+A + +LH L II+RDLK N+LLD + K++DFG+++ + I E+
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFC 159
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
GT YMAPE + +D +SFGVL+ E++ G
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 42/165 (25%)
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG-----YMAPEYAME 600
IHRD+ A NVLL KI DFG+AR I ++N VV +MAPE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFD 288
Query: 601 GLFSTKSDVYSFGVLLLEII-LGRR-------NNTFHLEQGSGSWNLVGHVWDLWKEGTA 652
+++ +SDV+S+G+LL EI LG+ N+ F + + K G
Sbjct: 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF---------------YKMVKRGYQ 333
Query: 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
M D + PEI + +C + T+RP S + ++
Sbjct: 334 MSRPDFAP------PEIYSIMK---MCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 414 LSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALI 472
L ++ T+ + +G+G +G VYK ++G AVK L S EE + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 473 AQL-QHRNLVSILGCCIEEQEKM-----LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE- 525
L H N+V G + + + L+ E S+ E + LL +R +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT-----ELVKGLLICGQRLDE 127
Query: 526 -----IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
I+ G G+ +LH + RIIHRD+K +N+LL K+ DFG++ ++
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 581 ENTNRVVGTYGYMAPEY-----AMEGLFSTKSDVYSFGVLLLEI 619
NT+ VGT +MAPE + + + DV+S G+ +E+
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQHR 478
DF+ LG+G FG V + E+ A+K L + +E E ++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 479 NLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
++ L C + +++ + EY+ L +I K + I+ G+ +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFL 117
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV-VGTYGYMAPE 596
H+ II+RDLK NV+LD+ + KI+DFGM + ++ T R GT Y+APE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE 171
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ D +++GVLL E++ G+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 430 LGEGGFGSVY--KGVL--QNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLV 481
LG G +G V+ + V +GK A+K L +++ + E +TE ++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
L + K+ LI +Y+ L ++ + K E+ +L L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRER------FKEQEVQIYSGEIVLALEHL 121
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM- 599
+L II+RD+K N+LLD+ + ++DFG+++ F D++E + GT YMAP+
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRG 180
Query: 600 -EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636
+G D +S GVL+ E++ G T E+ S +
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 29/204 (14%)
Query: 430 LGEGGFGSV---YKGVLQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSIL 484
+G G G V Y VL + +A+K+LSR + E+ L+ + H+N++S+L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 485 GC-----CIEEQEKMLIYEYLPNKSLDVYI---FDEAKRSLLDWSKRFEIICGIARGILY 536
+EE + + + L + +L I D + S L ++++CGI +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQMLCGIK----H 134
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH IIHRDLK SN+++ + KI DFG+AR G + T VV Y Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 188
Query: 597 YAMEGLFSTKSDVYSFGVLLLEII 620
+ + D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 430 LGEGGFG---SVYKGVLQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSIL 484
+G G G + + VL G +AVK+LSR + E+ L+ + H+N++S+L
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 485 GC-----CIEEQEKMLIYEYLPNKSLDVYI---FDEAKRSLLDWSKRFEIICGIARGILY 536
+EE + + + L + +L I D + S L ++++CGI +
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL----LYQMLCGIK----H 138
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH IIHRDLK SN+++ + KI DFG+AR + + T VV Y Y APE
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPE 192
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSWNLV 640
+ + D++S G ++ E++ G T H++Q WN V
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ----WNKV 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
IA G+ +LH II+RDLK NV+LD+ + KI+DFGM + D + T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y+APE + D ++FGVLL E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 430 LGEGGFGSVYKGVLQNGKEI----AVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILG 485
+G G + V L+ +I VK+ + I+ +TE + Q + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
C + ++ L+ EY+ L ++ + +R L + RF I + +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARF-YAAEICIALNFLHERG--- 116
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
II+RDLK NVLLDA + K++D+GM + G + T+ GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 605 TKSDVYSFGVLLLEIILGR 623
D ++ GVL+ E++ GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 12/99 (12%)
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
EII G+ H +R +++RDLK +N+LLD + +ISD G+A F ++ +
Sbjct: 105 EIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPH 153
Query: 585 RVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILG 622
VGT+GYMAPE +G+ + + +D +S G +L +++ G
Sbjct: 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIA---VKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSIL 484
++G G FG V + +A VK L ++ + EF + LQH N++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR-------FEIICGIARGILYL 537
G C+E +L++EY L Y+ E W +R + C IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI-FGGDQIEENTNRVVGTYGYMAPE 596
H + +H DL N L + + K+ D+G+ + D IE ++ V ++APE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171
Query: 597 YAME---GLFSTK----SDVYSFGVLLLEI 619
E GL + + S+V++ GV L E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 55/232 (23%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS-SGQGI--EEFKTEIALIAQLQHRNLVSIL 484
+G+GG G VY + +A+K++ S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLD--WSKR------------------F 524
C + +Y +P YI +SLL W K F
Sbjct: 69 SIC---SDGDPVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT- 583
IC I Y+H S+ ++HRDLK N+LL I D+G A ++ +
Sbjct: 120 HKIC---ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 584 ---------------NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
++VGT YMAPE + S +D+Y+ GV+L +++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+ARG+ +L + +HRDL A NVLL KI DFG+AR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+MAPE + L++T SDV+S+G+LL EI
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 43/224 (19%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSR--SSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
+G G +G+V + + G ++A+K+L R S + E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 487 CIEEQEKMLIYEYLPNKSLD-------VYIF---DEAKRSLLDWSKRFE-----IICGIA 531
+ P+ SLD V F D K L+ K E ++ +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGK--LMKHEKLSEDRIQFLVYQML 128
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
+G+ Y+H IIHRDLK N+ ++ KI DFG+AR Q + V T
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRW 180
Query: 592 YMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGRR--NNTFHLEQ 632
Y APE + + T++ D++S G ++ E++ G+ HL+Q
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIA----LIAQLQHRNLVSIL 484
+G+G FG V + +G AVK L + + +E +A L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61
Query: 485 GCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQD 540
+ EK+ + +Y+ L ++ + +R L+ RF E+ I YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIG----YLHS- 114
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
L II+RDLK N+LLD+ + ++DFG+ + G + EE T+ GT Y+APE +
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 601 GLFSTKSDVYSFGVLLLEIILG 622
+ D + G +L E++ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 66/251 (26%), Positives = 104/251 (41%), Gaps = 66/251 (26%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSS----GQGIEEFKTEIALIAQ 474
+DF S +G G FG V ++Q G A+K+L +S Q + + E ++A+
Sbjct: 1 DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAE 57
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSL-------DVYIFDEAKRSLLDWSKRFEII 527
+ +V + +E LI EYLP + D + +E RF I
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---------RFYI- 107
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM------------ARIFG 575
A IL + +L IHRD+K N+LLDA + K+SDFG+ RI
Sbjct: 108 ---AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 576 GDQIEENT------------------NR------VVGTYGYMAPEYAMEGLFSTKSDVYS 611
NR VGT Y+APE ++ ++ + D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 612 FGVLLLEIILG 622
GV++ E+++G
Sbjct: 225 LGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 54/226 (23%)
Query: 430 LGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
LG G G V+ V + K +AVK++ + Q ++ EI +I +L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV----- 67
Query: 489 EEQEKMLIYEYLPNKSLD-------------VYIFDEAKRSLL-----------DWSKRF 524
YE L D VYI E + L + ++ F
Sbjct: 68 --------YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIFGGD-----Q 578
+ + RG+ Y+H + ++HRDLK +NV ++ + KI DFG+ARI
Sbjct: 120 --MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
+ E T Y +P + TK+ D+++ G + E++ G+
Sbjct: 175 LSEGLV----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARG 533
H LV + C E + E++ L ++ + +R L + RF EI +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALN-- 110
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYG 591
+LH+ II+RDLK NVLLDA + K++D+GM + I GD T+ GT
Sbjct: 111 --FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPN 161
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y+APE + D ++ GVL+ E++ GR
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFKT----EIALIAQLQ 476
N F +GEG +G V K + KEI A+K+ S EE K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
N+V + + L++EY+ L+ + +E + K I + + I +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPP-EKVRSYIYQLIKAIHW 115
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H++ I+HRD+K N+L+ K+ DFG AR + N V T Y +PE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPE 171
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 12/99 (12%)
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
EII G+ H +R +++RDLK +N+LLD + +ISD G+A F ++ +
Sbjct: 105 EIILGLE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPH 153
Query: 585 RVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILG 622
VGT+GYMAPE +G + + +D +S G +L +++ G
Sbjct: 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 430 LGEGGFGSVYKGVLQNGK--------EIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
LG+G F ++KG+ + E+ +K L +S E F ++++QL H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G C+ E +++ EY+ SLD Y+ + ++L++ S + E+ +A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 542 RLRIIHRDLKASNVLL-----DAAMNP---KISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+ H ++ A NVLL NP K+SD G++ +I R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 594 APEYAMEGL-FSTKSDVYSFGVLLLEIILG 622
PE S +D +SFG L EI G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+A+G+ +L + IHRDL A N+LL KI DFG+AR I ++N VV
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 590 YG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+MAPE +++ +SDV+S+G+LL EI
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 429 KLGEGGFGSV----YKGVLQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQ-HRNLV 481
+LG+G +G V + +A+K+++ + I + E+ L+ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 482 SILGCCIEEQEK---MLIYEYLPNKSLDVYIFDEAKRSLLDW---SKRFEIICGIARGIL 535
+ I + +YE L L I + + L D S ++I+CG+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILCGLK---- 119
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN---TNRVVGTYGY 592
Y+H + ++HRDLK N+L++A KI DFG+AR F + E T V T Y
Sbjct: 120 YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVATRWY 175
Query: 593 MAPEYAMEGLFSTKS-DVYSFGVLLLEIILGRR 624
APE + TK+ DV+S G +L E +LGR+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 20/194 (10%)
Query: 444 QNGKEIAVKRLSRSSGQGIEE---FKTEIALIAQLQHRNLVSIL--GCCIEEQEKMLIYE 498
G E+A+K L + + + F+ E AL A+L H N+V++L G ++E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558
Y+P ++L + A L + ++ + + H I+HRDLK N+++
Sbjct: 60 YVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113
Query: 559 AA---MNPKISDFGMARIFGG--DQIEEN---TNRVVGTYGYMAPEYAMEGLFSTKSDVY 610
+ K+ DFG+ + G D T V+GT Y APE + SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 611 SFGVLLLEIILGRR 624
++G++ LE + G+R
Sbjct: 174 AWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 36/209 (17%)
Query: 428 NKLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQ-HRNLVSI 483
K+GEG F V K + GK A+K + + + +E+ EI + +L H N++ +
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 484 L--------GCC--IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
+ G + E M +YE + + E + K + + + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKR------VKSY--MYQLLKS 112
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR-IFGGDQIEENTNRVVGTYGY 592
+ ++H++ I HRD+K N+L+ K++DFG R I+ E + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE----YISTRWY 164
Query: 593 MAPEYAM-EGLFSTKSDVYSFGVLLLEII 620
APE + +G + K D+++ G + EI+
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIA----LIAQLQHRNLVSIL 484
+G+G FG V + +GK AVK L + +E K +A L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 485 GCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+ EK+ + +++ L ++ + +RS + RF IA + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARF-YAAEIASALGYLHS---I 115
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF 603
I++RDLK N+LLD+ + ++DFG+ + G + T GT Y+APE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 604 STKSDVYSFGVLLLEIILG 622
D + G +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-09
Identities = 20/90 (22%), Positives = 30/90 (33%), Gaps = 16/90 (17%)
Query: 309 STCRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRN---CSCLAYTSAYAESESN 365
C+ + +K+ D C + C +N SC A+ A A
Sbjct: 3 EFCKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKA----- 51
Query: 366 GRIGCLTYHGDMM-DTRTYINAGQDLYVRV 394
R CL + + M R + G DLY
Sbjct: 52 -RKQCLWFPFNSMSGVRKEFSHGFDLYENK 80
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 44/223 (19%)
Query: 430 LGEGGFGSVYKGVLQ-----------------------NGKEIAV--KRLSRSSGQGIEE 464
LG+G ++Y G L+ NG+E+ V K L S
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 465 FKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF 524
F +L++Q+ H +L + G C+ E +++ E++ + LDV + E R + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVL-----LDAAMNP--KISDFGMARIFGGD 577
+ +A + YL + ++H ++ A N+L L +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 578 QIEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEI 619
EE R+ ++APE G ST +D +SFG LLEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 30/91 (32%), Positives = 53/91 (58%)
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+L +H +IHRD+K++N+LL + K+ DFG ++++ ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
APE +S K+D++S GVLL E++ +R
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 35/90 (38%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+A G+ +L + +HRDL A NVL+ KI DFG+AR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+MAPE L++T SDV+SFG+LL EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEEFKTEIA----LIAQLQHRNLVSIL 484
+G+G FG V + ++ AVK L + + +E K ++ L+ ++H LV +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
+ + +Y+ L ++ + +R L+ RF IA + YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN--TNRVVGTYGYMAPEYAMEGL 602
I++RDLK N+LLD+ + ++DFG+ + + IE N T+ GT Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 603 FSTKSDVYSFGVLLLEIILG 622
+ D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
IA +L L + I++RDLK N+LLDA + + DFG+++ D + TN GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGT 159
Query: 590 YGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILG 622
Y+APE ++ TK D +S GVL+ E+ G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 430 LGEGGFGSVYKGVL--QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGC 486
+G+G +G V+K VL +NG + AVK L EE + E ++ L H N+V G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGM 83
Query: 487 CIEEQEK-----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE--IICGIAR----GIL 535
++ K L+ E S + D K L +R E II I G+
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGS----VTDLVK-GFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
+LH + + IHRD+K +N+LL K+ DFG++ ++ NT+ VGT +MAP
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 193
Query: 596 EY-----AMEGLFSTKSDVYSFGVLLLEI 619
E ++ + + DV+S G+ +E+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
A + L + +I+RDLK N+LLD + + DFG+ ++ D ++ TN GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGT 156
Query: 590 YGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILG 622
Y+APE + G TK+ D ++ GVLL E++ G
Sbjct: 157 PEYLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
DF + +G G FG V G A+K + +S + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 478 RNLVSILGCCIEEQEKMLIYEYLP--------NKSLDVYIFDEAKRSLLDWSKRFEIICG 529
+ + ++ L+ EY P N+ D FDE + +F +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDE---DMA----QFYL--- 108
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
A +L +H ++ +HRD+K NVL+D + K++DFG A ++ N+ VGT
Sbjct: 109 -AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGT 166
Query: 590 YGYMAPEY--AMEG----LFSTKSDVYSFGVLLLEIILGR 623
Y+APE M G + + D +S GV+ E+I GR
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 42/215 (19%)
Query: 425 SSDNKLGE----GGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQH 477
+G+ + K +AVK+++ S E+ K EI QLQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQH 58
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI---FDEAKRSLLDWSKRFEIICGIARGI 534
N++ + I + E ++ + S + + F E L I I + +
Sbjct: 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--------IAFILKDV 110
Query: 535 L----YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE-NTNRVVGT 589
L Y+H IHR +KAS++LL +S + I+ RVV
Sbjct: 111 LNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM----IKHGKRQRVVHD 163
Query: 590 YG--------YMAPEYAMEGL--FSTKSDVYSFGV 614
+ +++PE + L ++ KSD+YS G+
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 43/238 (18%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG----QGIEEFKTEIALIAQLQH 477
+DF S +G G FG V ++ I ++ R + + + + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
+V + +++ LI E+LP D+ K +L + + +F I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETVLAI 114
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE---------------- 581
+L IHRD+K N+LLDA + K+SDFG+ E
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 582 --NTNR---------------VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
N+ R VGT Y+APE M+ ++ D +S GV++ E+++G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVSILG 485
N +G G FG VY+ + + +++A+K++ + ++K E+ ++ L H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 486 C----CIEEQEKML----IYEYLP---NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534
C ++ EK + + E++P +K + Y + L +C R +
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RAL 183
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYM 593
Y+H I HRDLK N+L+D + K+ DFG A+ Q + + + Y
Sbjct: 184 AYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYR 237
Query: 594 APEYAMEGL-FSTKSDVYSFGVLLLEIILG 622
APE + ++T D++S G ++ E+ILG
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 467 TEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
TE ++ + H +++ + G + LI LP D+Y + AKR++
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI--------A 180
Query: 527 ICGIA-------RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579
IC I R I YLH++ RIIHRD+KA N+ ++ + + DFG A +
Sbjct: 181 ICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF----PV 233
Query: 580 EENTNRVVGTYGYMA---PEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ N N+ G G +A PE + D++S G++L E+
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 47/239 (19%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQ 476
DF S +G G FG V ++Q G A+K L ++ + + + E ++ +
Sbjct: 2 DFESLKVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD 59
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+V + ++ LI E+LP D+ K +L + +F I A +L
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETVLA 113
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA----------------RIFGGDQIE 580
+ +L IHRD+K N+LLD+ + K+SDFG+ D
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 581 ENTN-----------------RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
+N N VGT Y+APE M+ ++ D +S GV++ E+++G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 2/159 (1%)
Query: 466 KTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE 525
++E+ +A H +V + + +LI EY L+ I K L + +E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP--FQEYE 170
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
+ + +L L + +++HRDLK++N+ L K+ DFG ++ + + +
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
GT Y+APE +S K+D++S GV+L E++ R
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 56/224 (25%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSR-----SSGQGIEEFKTEIALIAQLQHRNLVSI 483
+G+G +G V + G+++A+K+++ S I EI L+ L+H ++V I
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIVEI 64
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDE-----------AKRSLLDWSKRFEIICGIAR 532
K ++ + D+Y+ E A L +F + + R
Sbjct: 65 ---------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-FLYQLLR 114
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR---------IFGGDQIEENT 583
+ Y+H + + HRDLK N+L +A KI DFG+AR IF D
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD------ 165
Query: 584 NRVVGTYGYMAPEYAMEGLFSTKS----DVYSFGVLLLEIILGR 623
V T Y APE G F +K D++S G + E++ G+
Sbjct: 166 --YVATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA-RIFGGDQIEENTNRVVG 588
+A +L + +L +HRD+K NVLLD + +++DFG R+ ++ N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 589 TYGYMAPEY--AME---GLFSTKSDVYSFGVLLLEIILG 622
T Y++PE AME G + + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 429 KLGEGGFGSVY----KGVLQNGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQHRNLV 481
LG+G G V+ KG GK A+K L + + K TE ++A L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYL 537
+ L + + + L+ +Y P L + + + L + RF E++ + YL
Sbjct: 65 T-LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE----YL 119
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDF---------GMARIFGGDQIE-------- 580
H L I++RDLK N+LL + + +SDF +
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 581 ----------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR------- 623
+N VGT Y+APE + D ++ G+LL E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 624 RNNTF 628
R+ TF
Sbjct: 237 RDETF 241
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
IA +L +H +L +HRD+K NVLLD + +++DFG D + ++ VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SSVAVGT 166
Query: 590 YGYMAPEY--AME---GLFSTKSDVYSFGVLLLEIILG 622
Y++PE AME G + + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 430 LGEGGFGSVYKGVL----QNGKEIAVKRLSRSSGQGIEEFK---TEIALIAQLQHRNLVS 482
LG+G FG V +L +GK A+K L + +E TE ++ +H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQ 539
+ + + EY+ L ++ E R + RF EI+ + YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALD----YLHS 113
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+I++RDLK N++LD + KI+DFG+ + D T GT Y+APE
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLE 168
Query: 600 EGLFSTKSDVYSFGVLLLEIILGR 623
+ + D + GV++ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVV 587
I + YLH +++RDLK N++LD + KI+DFG+ + I G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 156
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
GT Y+APE + + D + GV++ E++ GR
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 87/266 (32%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV--LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-- 477
DF + +G+G FG V + V GK A+K L +S E FK + QL H
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKS-----EMFKKD-----QLAHVK 49
Query: 478 --RNL---------VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
R++ VS+ + Q LI E+LP L L+ + E
Sbjct: 50 AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSED 101
Query: 527 ICG--IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA------------- 571
+ +A +L + +L IHRD+K N+L+D + K+SDFG++
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 572 RIFGGDQIEENTNRV-----------------------------------VGTYGYMAPE 596
++ G N NR+ VGT Y+APE
Sbjct: 162 KLLQGK---SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILG 622
++ + + D +S G ++ E ++G
Sbjct: 219 IFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 434 GFGSVYKGVLQNGKEIA--VKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491
G S +G + + IA VK SR++ Q + EI + +L H N++ I EE
Sbjct: 181 GVNSTNQGKPKCERLIAKRVKAGSRAAIQ----LENEILALGRLNHENILKI-----EEI 231
Query: 492 EKMLIYEYLPNKSLDV----YIFDEA---KRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
+ Y+ + D +++DEA K L R I+ + + Y+H +
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---K 287
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
+IHRD+K N+ L+ + DFG A F ++ + VGT +PE +
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW-VGTVATNSPEILAGDGYC 346
Query: 605 TKSDVYSFGVLLLEII 620
+D++S G++LL+++
Sbjct: 347 EITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 18/101 (17%)
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI---------FGGDQIEENT--- 583
YLH I+HRDLK N+L+ + + K++DFG+++I + G IE++T
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG-HIEKDTREF 171
Query: 584 --NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
+V GT Y+APE + + D ++ G++L E ++G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
I + YLH + +++RDLK N++LD + KI+DFG+ + G + GT
Sbjct: 104 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y+APE + + D + GV++ E++ GR
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
I + YLH +++RD+K N++LD + KI+DFG+ + G GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y+APE + + D + GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 25/167 (14%)
Query: 467 TEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
EI ++ + HR +I+ + K + +P D++ + + L E
Sbjct: 135 REIDILKTISHR---AIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPL-----PLEQ 186
Query: 527 ICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582
I R +L YLH IIHRD+K N+ LD N + DFG A +++ +
Sbjct: 187 AITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC-----KLDAH 238
Query: 583 TNRV-----VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
+ GT +PE + K+D++S G++L E+ +
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSS--GQGIEEFKTEIALIAQLQHRN 479
D+ +G G FG V ++ +++ A+K LS+ + F E I +
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 480 LVSILGCCIEEQEKM-LIYEYLPNKSLDVYI--FDEAKRSLLDWSKRFEIICGIARGILY 536
V L C ++ + + ++ EY+P L + +D ++ W+K + A +L
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLA 154
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE-NTNRVVGTYGYMAP 595
L + +IHRD+K N+LLD + K++DFG D+ + VGT Y++P
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISP 212
Query: 596 EY----AMEGLFSTKSDVYSFGVLLLEIILG 622
E +G + + D +S GV L E+++G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 430 LGEGGFGSVYKGVL-----------QNGKEIAV--KRLSRSSGQGIEEFKTEIALIAQLQ 476
LG G +Y G+L KEI V K L S F +++ Q+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
H+++V + G C+ + E +++ E++ LD +F K +L +F++ +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 537 LHQDSRLRIIHRDLKASNVLL-----DAAMNP--KISDFGMARIFGGDQIEENTNRVVGT 589
L +D L +H ++ N+LL D P K+SD G+ Q E R+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERI--- 172
Query: 590 YGYMAPEYAMEG-LFSTKSDVYSFGVLLLEI 619
++APE + S +D +SFG L EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY 590
A +L L + IHRD+K N+LLD + + K++DFG + + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTP 207
Query: 591 GYMAPEY----AMEGLFSTKSDVYSFGVLLLEIILG 622
Y++PE +G + + D +S GV L E+++G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 28/82 (34%), Positives = 46/82 (56%), Gaps = 7/82 (8%)
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGD-QIEENTNRVVGTYGYMAPEYAM----E 600
IHRD+K N+LLD + + K++DFG + + +T VGT Y++PE +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGD 221
Query: 601 GLFSTKSDVYSFGVLLLEIILG 622
G + + D +S GV L E+++G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSSGQGIEE---FKTEIALIAQLQHR 478
DF +G G FG V L+N ++ A+K L++ E F+ E ++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH 538
+ ++ +E L+ +Y L + R D ++ + +A ++ +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAID 116
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY- 597
+L +HRD+K N+L+D + +++DFG D + ++ VGT Y++PE
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEIL 175
Query: 598 -AME---GLFSTKSDVYSFGVLLLEIILG 622
AME G + + D +S GV + E++ G
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 60/251 (23%), Positives = 102/251 (40%), Gaps = 62/251 (24%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEE-----FKTEIALIAQLQ 476
N++ K+G G FG V+ + +E + S +G++E E+ ++ +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE------AKRSLLDWSKRF-----E 525
H+N+V I +L + +YI E R++ K F
Sbjct: 71 HKNIVR------------YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 526 IICGIARGIL----YLHQ----DSRLRIIHRDLKASNVLLDAAMN--------------- 562
I I R +L Y H + R++HRDLK N+ L +
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 563 --PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLE 618
KI DFG+++ G IE + VGT Y +PE + + KSD+++ G ++ E
Sbjct: 179 PIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 619 IILGRRNNTFH 629
+ G+ FH
Sbjct: 236 LCSGK--TPFH 244
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 34/123 (27%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL----YLHQDSRLRIIHRDLKASNV 555
LP D+Y + A+ L ++ + +AR +L Y+H + IIHRD+K NV
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENV 291
Query: 556 LLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVL 615
L++ + + DFG A G + GT APE ++ D++S G++
Sbjct: 292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 616 LLE 618
+ E
Sbjct: 352 IFE 354
|
Length = 461 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 437 SVYKGVLQNGKEIAVKRL---SRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493
S+YKG+ N KE+ ++ + I+ + EI + ++ N++ I G I+ +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 494 M----LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHR 548
+ LI EY L + E L + + ++ +G+ L++ ++ ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147
Query: 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFST--- 605
+L + + L+ KI G+ +I + N N +V Y + + + +FS
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKM-LNDIFSEYTI 201
Query: 606 KSDVYSFGVLLLEIILGR 623
K D+YS GV+L EI G+
Sbjct: 202 KDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHR 478
+F + G FG VY G +N K AVK + ++ + + + + E +A +
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 479 NLVSILGCCIEEQEKMLIYEYLPN---KSL-DVY-IFDEAKRSLLDWSKRFEIICGIARG 533
+V + L+ EYL KSL +Y FDE + + ++ I +A
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EMAVKY--ISEVALA 116
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573
+ YLH+ IIHRDLK N+L+ + K++DFG++++
Sbjct: 117 LDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 32/230 (13%)
Query: 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL 475
+I +T F + LGEG FG V + + KE ++ R+ + + K EI + ++
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-FDEAKRSLLDW-------SKRF--E 525
+ + + M I Y N++ + I + LLDW S R +
Sbjct: 183 RQADPA-------DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ 235
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKIS-----DFGMARI--FG 575
II + Y H + L ++H DLK N+L+ D ++P + D RI G
Sbjct: 236 IIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 576 G--DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
G D+ T +V T Y +PE + + +D++S G ++ E+ G+
Sbjct: 294 GCCDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 35/145 (24%), Positives = 59/145 (40%), Gaps = 51/145 (35%)
Query: 523 RF---EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF----- 574
RF E+ C I +H ++ IHRD+K N+L+D + K++DFG+ F
Sbjct: 104 RFYIAELTCAIE----SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156
Query: 575 ------GG----------DQIEENTNR--------------------VVGTYGYMAPEYA 598
G ++ E +VGT Y+APE
Sbjct: 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGR 623
+ ++ D +S GV+L E+++G+
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 29/127 (22%), Positives = 54/127 (42%), Gaps = 45/127 (35%)
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIF----------GGDQIEENT-------- 583
++ IHRD+K N+L+D + K++DFG+ F GD + +++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 584 ---------------------------NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616
+ +VGT Y+APE + ++ D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 617 LEIILGR 623
E+++G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 15/147 (10%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS--ILGC 486
L G VY + ++ +K + + E+A++ L + L +L
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
+ L+ E++ ++LD +E K + + + E++ A+ LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVS-EEEKEDIAE--QLAELL---AK----LHQLPLLVLC 111
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARI 573
H DL N+L+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 32/139 (23%), Positives = 57/139 (41%), Gaps = 45/139 (32%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF----------GGDQI 579
IA L + ++ IHRD+K N+L+D + K++DFG+ F G I
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 580 EENT-----------------------------------NRVVGTYGYMAPEYAMEGLFS 604
+++ + +VGT Y+APE + ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 605 TKSDVYSFGVLLLEIILGR 623
D +S GV+L E+++G+
Sbjct: 227 QLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.003
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 38/206 (18%)
Query: 429 KLGEGGFGSVYKGVLQNG---KEIAVKRLSRSSGQGIEEFKTEIALIAQL--QHRNLVSI 483
KL +G FG V VL++ K K + + IE + QL + N + +
Sbjct: 23 KLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPM------VHQLMKDNPNFIKL 74
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------IICGIARGILYL 537
+ +LI +Y+ + L FD LL + II + + L
Sbjct: 75 YYSVTTLKGHVLIMDYIKDGDL----FD-----LLKKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H + IIH D+K NVL D A + + D+G+ +I G + GT Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPE 176
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILG 622
+ D ++ GVL E++ G
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 26/113 (23%)
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE---EN 582
I+ G RG+ YLHQ+ IHR++KAS++L IS G+ + G + N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 583 TNRVVGTYGY----------MAPEYAMEGL--FSTKSDVYSFGVLLLEIILGR 623
+ Y + ++PE + L ++ KSD+YS G+ E+ GR
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 743 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.44 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.25 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.13 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.08 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.63 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.25 | |
| PLN02236 | 344 | choline kinase | 96.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.92 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.7 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.46 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.95 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.91 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=442.09 Aligned_cols=291 Identities=44% Similarity=0.731 Sum_probs=256.5
Q ss_pred CCCCcChhhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeE
Q 041312 408 YLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487 (743)
Q Consensus 408 ~~~~~~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~ 487 (743)
....|++.++..+|++|...+.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999988765443155699999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 488 IEEQ-EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 488 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
.+.+ +++||||||++|+|.++|+..... .++|..|++|+.++|+||+|||.....+||||||||+|||+|++.++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775544 88999999999999999999999887789999999999999999999999
Q ss_pred eeccccccCCCccccccccc-cccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 567 DFGMARIFGGDQIEENTNRV-VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
|||+|+........ .... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+ .....+..|++.
T Consensus 220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKP 295 (361)
T ss_pred CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHH
Confidence 99999765431111 1112 899999999999999999999999999999999999998886553 244558999999
Q ss_pred HhccCCcchhcccccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 646 LWKEGTAMEAVDKSLG-ESCCA-PEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.+.++.+.+++|+.+. ..+.. .++.++..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999999987 55554 7899999999999999999999999999999665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=370.61 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=206.2
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-eeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-EKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 499 (743)
+.+..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||++++.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4555689999999999999987 6889999999654 4556689999999999999999999999999998 49999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|.+|+|+.++... +.+++...-+|+.++++||.|||. .+ ||||||||+||||+..|+|||+|||.+..+-+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999998533 568999999999999999999996 65 999999999999999999999999999987655
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
.....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+...+..++...+ -.+....
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I----v~~ppP~---- 301 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI----VDEPPPR---- 301 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH----hcCCCCC----
Confidence 34458999999999999999999999999999999999999999876522111222222111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+..... ..++.+++..||+.||.+||++.++++.
T Consensus 302 -lP~~~f---S~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 -LPEGEF---SPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCcccC---CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 212122 3346677779999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=369.65 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=204.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChh-------cHHHHHHHHHHHHhcCCccEEeeeeeEecCC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ-------GIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 491 (743)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++++.... ....+.+|+++|++|+|||||++++++.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999864 7999999999865221 2334679999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC---CCeEEeee
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA---MNPKISDF 568 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~vkl~DF 568 (743)
..||||||+.||.|.+++.. .+.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999998854 445778888899999999999999999 9999999999999765 77999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCC---CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL---FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
|+|+..+.... +.+.+|||.|.|||++.++. +..|+|+||+||+||-+++|.+||...... .. ..+
T Consensus 324 GlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~s----l~e 392 (475)
T KOG0615|consen 324 GLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PS----LKE 392 (475)
T ss_pred chhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----cc----HHH
Confidence 99999874433 45689999999999998764 345889999999999999999999754321 11 112
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....++... .......-.++..+++.+||..||++|||+.|+++
T Consensus 393 QI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222222111 11123334456778888999999999999999885
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=380.06 Aligned_cols=257 Identities=32% Similarity=0.484 Sum_probs=210.1
Q ss_pred CCcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-eeEEEEEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-EKMLIYEYL 500 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~ 500 (743)
+.+.+.||.|+||+||+|.++....||||++..... ...++|.+|+.+|.+++|||||+++|++.+.. ...+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344567999999999999998666699999975432 22679999999999999999999999999988 799999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeeccccccCCCcc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGGDQI 579 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~~~~~~ 579 (743)
++|+|..++... ....+++..++.++.+|++|+.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999764 45679999999999999999999999873 99999999999999997 99999999998765432
Q ss_pred ccccccccccccccCcceec--cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 580 EENTNRVVGTYGYMAPEYAM--EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.......||+.|||||++. ...|+.|+||||||+++|||++|+.||....+ .+.+......+....+
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~Rp~~-- 267 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGLRPPI-- 267 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCC--
Confidence 2223378999999999999 66999999999999999999999999875432 1112222222222221
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
+......+..++.+||+.||+.||++.+|+..|+.+..
T Consensus 268 -------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 268 -------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11233456678889999999999999999999997755
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=382.07 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=208.2
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..|...+.||+|||+.+|.++. .+|+.||+|++.+. .....+.+.+||++.++|+|||||+++++|.+.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999998 78999999999764 4456678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
|+|+.++|..++. +++.+++.++..+++||+.||.|||+++ |||||||..|||++++.+|||+|||+|..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998884 5678999999999999999999999998 999999999999999999999999999988644
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
. +...+++|||.|+|||++....++..+||||+|||+|-||.|++||+...-. .....++..+
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---------ety~~Ik~~~------ 234 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---------ETYNKIKLNE------ 234 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---------HHHHHHHhcC------
Confidence 2 2344589999999999999999999999999999999999999999754210 1111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
-.+.. ... ....+|+..+|+.+|.+|||+++|+.
T Consensus 235 Y~~P~-~ls---~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YSMPS-HLS---AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccc-ccC---HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00101 112 23446777999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=359.85 Aligned_cols=200 Identities=31% Similarity=0.557 Sum_probs=182.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..+|...++||.|+|++||+|+++ ++..||||.+.+. .....+.+..|+++|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999986 6899999999766 5667788899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC------CCeEEeeeccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA------MNPKISDFGMA 571 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~------~~vkl~DFGla 571 (743)
|||.+|+|.+++.. ++.+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999953 447899999999999999999999998 9999999999999764 45899999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
+.+.+... ....+|++-|||||+++...|+.|+|+||+|+|||++++|+.||+..
T Consensus 163 R~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99875543 34589999999999999999999999999999999999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=346.09 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=208.8
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeee-eEecCCe-eEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILG-CCIEEQE-KMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~-~~~~~~~-~~lV 496 (743)
.+|.+.++||+|.||.||++.. .+|..+|.|.++-. ..+.......|+.+|++|+|||||++++ .+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688889999999999999995 58999999998743 4556678899999999999999999998 5666665 8999
Q ss_pred EEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccC-CCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 497 YEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDS-RLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
||++..|+|..++..- ..++.+++..+++++.|++.||..+|++- +.-|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998653 34567999999999999999999999832 224999999999999999999999999999998
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
...... ....+|||.||+||.+.+.+|+.||||||+||++|||..-+.||... ++.. ..+....++...
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHH-HHHHHHcCCCCC
Confidence 766543 33489999999999999999999999999999999999999998743 1111 122223332221
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
+.+ ......+..++..|+..||+.||+...+++.+..
T Consensus 248 ~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111 2234456677779999999999996666655544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=349.23 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=200.6
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..++|++.++||+|+||+||.++.+ +++.+|+|.+++. .....+..++|..+|.+++||.||+++..|.+..++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999975 6899999999865 23456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|+||+.||.|..+|. +...+++..+.-++..|+.||.|||+++ ||||||||+|||++.+|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999984 4456888888889999999999999999 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.. ...+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||..... ....+....+.+.
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---------~~~~~~I~~~k~~-- 243 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---------KKMYDKILKGKLP-- 243 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---------HHHHHHHhcCcCC--
Confidence 32 2234558999999999999999999999999999999999999999875432 1122222222211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRP 688 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 688 (743)
........ ...+++...|+.+|++|-
T Consensus 244 ----~~p~~ls~---~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 ----LPPGYLSE---EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CCCccCCH---HHHHHHHHHhccCHHHhc
Confidence 11111233 344667799999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=334.30 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=204.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|+.+.++|+|+||.||+++.+ +|+.||||++.... ....+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788899999999999999976 69999999996543 3344567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
||+..-|+++- .....++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 99887776653 33445788899999999999999999998 99999999999999999999999999998864
Q ss_pred cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccc--------hhhHhHhcc
Q 041312 579 IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLV--------GHVWDLWKE 649 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 649 (743)
.....+.++.|..|+|||++.+ ..|+..+||||+||++.||++|.+-|....+- ++..++ ..-...+..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHHhcc
Confidence 2334556899999999999988 68999999999999999999999877644321 111111 111111111
Q ss_pred CCcchhc-ccccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAMEAV-DKSLG-----ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~l-d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.....-+ -+... +...+....-+++++..||+.||.+|++-++++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111100 01000 0011122235789999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=358.69 Aligned_cols=256 Identities=31% Similarity=0.483 Sum_probs=207.8
Q ss_pred CCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+..+++||+|-||.|+.|.++....||+|.+... ....+.|.+|+++|++|+|++||+++++|..+..++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3455899999999999999998889999998653 445578999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccc
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 583 (743)
+|.++|.. .....+...+.+.++.|||+|++||++++ +|||||.+.||||+++..+||+|||+|+...........
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999976 34557888999999999999999999998 999999999999999999999999999966555443322
Q ss_pred ccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 584 ~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
. ..-...|.|||.+..+.++.|||||||||+|+||+| |+.|+..... ..+.+. ++..-+-
T Consensus 363 ~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---------~ev~~~---------le~GyRl 423 (468)
T KOG0197|consen 363 G-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---------EEVLEL---------LERGYRL 423 (468)
T ss_pred C-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---------HHHHHH---------HhccCcC
Confidence 1 233567999999999999999999999999999998 4445432211 112333 3333222
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
+.+......+.++|..||+.+|++|||++.+...|+.+...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 22233334456688899999999999999999999876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=340.50 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=210.1
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|+..++||.|..++||+|+. +.++.||||++... .....+.+++|+..++.++||||++++-.|..+..+|+||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 36799999999999999999995 57899999999754 33447899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
||.+||+.++++..-. ..+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||....+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999866443 34899999999999999999999999 9999999999999999999999999876543221
Q ss_pred -ccc-ccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 579 -IEE-NTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 579 -~~~-~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
... ..+..+||+.|||||++++ ..|+.|+||||||++..||.+|..||....+. .+.-+...+.+..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---------kvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---------KVLLLTLQNDPPT 251 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---------HHHHHHhcCCCCC
Confidence 111 1256799999999999755 47999999999999999999999999865441 1111112233322
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+...+..+........+.+++..||+.||.+|||+++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22222222222233346778888999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.81 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=209.3
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCe
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQE 492 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 492 (743)
.....+|.+.+.||+|+|++|++|+.. +++++|||++.+. .+...+-+..|-.+|.+| .||.|++|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345578999999999999999999965 6999999999765 334556677899999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
+|+|+||+++|.|.++|. +.+.+++.....++.+|+.||+|||+.| ||||||||+||||++++++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999984 4467899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCccc---------ccc--ccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccch
Q 041312 573 IFGGDQIE---------ENT--NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 573 ~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 641 (743)
.+...... ... ...+||..|.+||++..+..+..+|||+||||||+|+.|.+||....+ . +
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----y-l-- 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----Y-L-- 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----H-H--
Confidence 88654322 111 348999999999999999999999999999999999999999975422 1 1
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.++.+ + .++-.+.+.++ ..+.+|+.+.|..||.+|++.++|-+..
T Consensus 295 -iFqkI-----~-~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 -IFQKI-----Q-ALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -HHHHH-----H-HhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11110 0 11112222222 3455677799999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.63 Aligned_cols=237 Identities=27% Similarity=0.356 Sum_probs=197.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|+..+.||.|+||.|.+++.+ +|..+|+|++++.. -...+...+|..+|+.+.||.++++.+.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467888999999999999999987 58889999998653 23456778999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||++||.|..+++ +.+.+++..+.-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999984 4456888999999999999999999998 99999999999999999999999999998643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. +...+|||.|+|||+++.++|+.++|.|||||++|||+.|..||....+ ...++...++.+.
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------~~iY~KI~~~~v~--- 259 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------IQIYEKILEGKVK--- 259 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------HHHHHHHHhCccc---
Confidence 3 5568999999999999999999999999999999999999999985432 1122222222221
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDR 687 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 687 (743)
-+.+...+ +.+|+...|+.|-.+|
T Consensus 260 ----fP~~fs~~---~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ----FPSYFSSD---AKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----CCcccCHH---HHHHHHHHHhhhhHhh
Confidence 01122233 4456668888888887
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=350.05 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=209.8
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
..|...++||+|+.|.||.++. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4566678999999999999985 478999999998887777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999887 3345889999999999999999999999 99999999999999999999999999998876654
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
....++|||.|||||++..+.|+.|+||||||++++||+-|.+||-...+. .+..+.......++-.+
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---------rAlyLIa~ng~P~lk~~-- 492 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------RALYLIATNGTPKLKNP-- 492 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---------HHHHHHhhcCCCCcCCc--
Confidence 344589999999999999999999999999999999999999998764431 12222222222222111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..-...+.+++.+||+.|+++||++.|||+
T Consensus 493 -----~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 -----EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -----cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111234556777999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=315.67 Aligned_cols=280 Identities=23% Similarity=0.343 Sum_probs=217.2
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|...++||+|.||.||+|++ .+|+.||||++..... .......+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999996 4799999999975522 223467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
||+ .+|...+.+. ...+....+..++.++++||+|||++. |+||||||.|+||+++|.+||+|||+|+.++...
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 4787777543 457888999999999999999999998 9999999999999999999999999999987665
Q ss_pred cccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch---
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME--- 654 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 654 (743)
..... .+-|..|+|||++.+. .|+..+|+||.|||+.||+.|.+-+....+ ......+++.+-.....+
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-----idQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-----IDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-----HHHHHHHHHHcCCCCcccCcc
Confidence 43332 3779999999999885 699999999999999999998876553321 222222222222111111
Q ss_pred ---hc--------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCCCcccccc
Q 041312 655 ---AV--------DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKG 715 (743)
Q Consensus 655 ---~l--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~~ 715 (743)
+. .........+......++++..|+..||.+|.+++|.+++= -....|.|..|.-+...
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLPIP 299 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCcCC
Confidence 11 11111113334445668999999999999999999998763 44557777777766654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.77 Aligned_cols=280 Identities=23% Similarity=0.322 Sum_probs=210.3
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~l 495 (743)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.... .....-..+||.+|++|.|||||+|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35678889999999999999995 579999999997654 44556678899999999999999999999877 68999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|+|||+. +|.-++.. ..-.+++.++..+++||+.||+|+|+++ |+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 44444422 2335889999999999999999999999 9999999999999999999999999999887
Q ss_pred CCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC----
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG---- 650 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 650 (743)
.......+. .+-|..|+|||++.+. .|+.++|+||.||||.||+.|++.+....+ .+....+++++-..
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-----veQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-----VEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-----HHHHHHHHHHhCCCChhc
Confidence 666555444 5669999999999985 699999999999999999999998775432 22222222222111
Q ss_pred ----Ccc--hhc------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCCCccccc
Q 041312 651 ----TAM--EAV------DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAK 714 (743)
Q Consensus 651 ----~~~--~~l------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~ 714 (743)
.+. ..+ ...+.+. ...-....++|+..+|..||.+|.|+.++++.= -....|.|..|..+..
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se-yF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSE-YFTTEPLPCDPSSLPK 417 (560)
T ss_pred cccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCc-ccccCCCCCCcccCCC
Confidence 000 000 1111111 011122466778899999999999999887542 1234455555555554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=345.97 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=205.7
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHH--HHHHHHHHHhcC-CccEEeeeeeEecCC-ee
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEE--FKTEIALIAQLQ-HRNLVSILGCCIEEQ-EK 493 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~--~~~Ev~~l~~l~-h~niv~l~~~~~~~~-~~ 493 (743)
...++|.++++||.|.||.||+|+.. +|+.||||++++.... .++ =.+|++.|++|. |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 34578999999999999999999964 7999999999755332 233 357999999998 999999999999988 99
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||| ..+|.+++.+. +..+++..+..|+.||++||+|+|++| +.|||+||+||||.....+||+|||+|+.
T Consensus 86 ~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999999 45787777654 678999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
+..... .+.++-|..|+|||++.. +-|+.+.|+||+|||++||.+-++.|....+- ..+-.+.+.+.....
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-----Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-----DQIYKICEVLGTPDK 231 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-----HHHHHHHHHhCCCcc
Confidence 865543 445889999999998865 67999999999999999999988877643221 111111111111100
Q ss_pred -----------------chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 653 -----------------MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 653 -----------------~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.+.....+. ...+.....+++++.+|++.||.+|||+.+.+++-
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 001111111 11222456688899999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.93 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=202.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC--eeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ--EKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 498 (743)
.++...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999976 48999999987654344778999999999999999999999855544 6899999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeeccccccCC-
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGG- 576 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~~~~- 576 (743)
|+++|+|.+++..... .+++..+..+.+||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999865432 5899999999999999999999998 999999999999999 79999999999987764
Q ss_pred CccccccccccccccccCcceeccCC-CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
...........||+.|||||++..+. ...++|||||||++.||+||++||... ..................
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~P~- 243 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSLPE- 243 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCCCC-
Confidence 11122334579999999999999643 345999999999999999999998742 111112222222221111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
+... .. ....+++..|++.+|++||||+++++..-
T Consensus 244 ----ip~~-ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 244 ----IPDS-LS---DEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCcc-cC---HHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1111 12 23456777999999999999999998763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.07 Aligned_cols=261 Identities=29% Similarity=0.420 Sum_probs=202.8
Q ss_pred cCCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC-C
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE-Q 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~-~ 491 (743)
.++|++.++||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35789999999999999999974 235689999986543 33456789999999999 899999999988765 4
Q ss_pred eeEEEEEecCCCChhhhhhhccc---------------------------------------------------------
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAK--------------------------------------------------------- 514 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 514 (743)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999988854211
Q ss_pred --ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccc
Q 041312 515 --RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592 (743)
Q Consensus 515 --~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 592 (743)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778888999999999999999998 999999999999999999999999999865433222222334567889
Q ss_pred cCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHH
Q 041312 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILR 671 (743)
Q Consensus 593 ~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~ 671 (743)
+|||++.+..++.++|||||||++|||++ |..||..... ..........+..... .......
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~---------~~~~~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--------NEEFCQRLKDGTRMRA---------PENATPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc--------cHHHHHHHhcCCCCCC---------CCCCCHH
Confidence 99999999999999999999999999997 8888764221 0111122222211110 1111234
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 672 CIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 672 l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 677888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=343.30 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=215.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. .+...+.+.+|+++++.++|||||.+++.|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999976 6889999999765 45567889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+.| +|..+|. ....++++.+..|+.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9998884 4456899999999999999999999988 9999999999999999999999999999876543
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ....+.|||.|||||++.+.+|+..+|+||+|||+||+++|++||.... +.+.+..... +.+
T Consensus 155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~-d~v------ 217 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILK-DPV------ 217 (808)
T ss_pred e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhc-CCC------
Confidence 2 3345899999999999999999999999999999999999999986321 1111111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh---cCCCCCCCCCCCccc
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML---GSDNAPSSPKHPAFI 712 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L---~~~~~~~~p~~~~~~ 712 (743)
..+......+++++.-.|+.||..|-+-.+++..= ..+.....|.+|++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 12234455688899999999999999999988642 223334555555553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.19 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=203.6
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC----Ch-hcHHHHHHHHHHHHhcC-CccEEeeeeeEecCC
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS----SG-QGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQ 491 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~ 491 (743)
.....|.+.+.||+|+||+|+.|... +++.||+|++.+. .. ...+.+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44578999999999999999999865 7899999977653 22 34567778999999998 999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeecc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGM 570 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFGl 570 (743)
..++||||+.+|.|.+++.. ...+.+..+..+++||+.|++|||+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999854 456788999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCC-CC-ccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL-FS-TKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... .. ......
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~----l~~ki~ 236 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PN----LYRKIR 236 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HH----HHHHHh
Confidence 99873 1122344589999999999999977 85 789999999999999999999985221 11 111111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 694 (743)
.+.. .+..... ...+..++.+||+.+|.+|+++.+|+
T Consensus 237 ~~~~------~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 237 KGEF------KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cCCc------cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1110 0111111 34567788899999999999999999
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=337.34 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=206.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
..|+..+.||+|.||.||+|.+. +++.||+|++... ....++.+++|+.+|.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777799999999999999975 6899999999855 455678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
|.+|++.+.+. ....+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999998883 3344577778889999999999999998 99999999999999999999999999988866554
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc---
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV--- 656 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--- 656 (743)
.. ...+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+. +++-++
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIpk~ 226 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIPKS 226 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEeccCC
Confidence 43 5589999999999999999999999999999999999999998755431 111122
Q ss_pred -ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 -DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 -d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.+.+ .....+.+++..||+.||+.||++.+++.
T Consensus 227 ~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 227 APPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222333 22233667778999999999999998875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.64 Aligned_cols=264 Identities=27% Similarity=0.412 Sum_probs=201.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-----------------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-----------------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSI 483 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l 483 (743)
++|.+.++||+|+||.||++.+++ +..||+|.+.... .....++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999998532 3469999987543 3445679999999999999999999
Q ss_pred eeeEecCCeeEEEEEecCCCChhhhhhhcc----------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEe
Q 041312 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEA----------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547 (743)
Q Consensus 484 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH 547 (743)
++++.+....++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998875421 1134678889999999999999999998 999
Q ss_pred ccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcC--CC
Q 041312 548 RDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR--RN 625 (743)
Q Consensus 548 ~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~--~p 625 (743)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998664433322233455678999999999889999999999999999999754 45
Q ss_pred CCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 626 NTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
+..... ......+............. .........+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 242 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD-----EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH-----HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 442211 11111111111111100000 0011122456788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.83 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=201.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..++|.++++||+|+||.||+++.+ +|+.+|+|++.+. ....++.++.|-.+|....+|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999976 6999999999876 34567889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||++||++..+|. +...|++..+..++.+++-|+.-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999884 4567999999999999999999999999 9999999999999999999999999985331
Q ss_pred C----------------------Cccc-----c------------------ccccccccccccCcceeccCCCCccccch
Q 041312 576 G----------------------DQIE-----E------------------NTNRVVGTYGYMAPEYAMEGLFSTKSDVY 610 (743)
Q Consensus 576 ~----------------------~~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDiw 610 (743)
. .... . .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0 00124899999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-
Q 041312 611 SFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN- 689 (743)
Q Consensus 611 SlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs- 689 (743)
|||||+||||.|.+||....+. ..++.+..-+.. +.-+...+...+..+|+.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~---------~T~rkI~nwr~~------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQ---------ETYRKIVNWRET------LKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHhhh------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999999865442 122222211110 0000001111334567778888 9999965
Q ss_pred --HHHHHH
Q 041312 690 --MSAVVS 695 (743)
Q Consensus 690 --~~evl~ 695 (743)
+.||-+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 555544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=355.23 Aligned_cols=260 Identities=30% Similarity=0.478 Sum_probs=215.2
Q ss_pred CCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
+....++||+|+||+||+|+.. +...||||.++..... ...+|++|+.++..++|||||+++|.|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4455689999999999999943 3567999999876554 78899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc-----------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeE
Q 041312 496 IYEYLPNKSLDVYIFDEAK-----------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPK 564 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vk 564 (743)
|+|||..|+|.+||..... ...|+..+.+.|+.|||.|++||-++. +|||||...|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999964221 234889999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhh
Q 041312 565 ISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 643 (743)
|+|||+++..-..+.-.......-..+|||||-|..++|+.+||||||||+|||+++ |+.|+..... +.+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------~EV 714 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------QEV 714 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---------HHH
Confidence 999999987655544332222334679999999999999999999999999999997 7777664432 236
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.+.++.+.+.+-.+ -++ .++.+||+.||+.+|.+||+++||-..|+.....
T Consensus 715 Ie~i~~g~lL~~Pe------~CP---~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLLSCPE------NCP---TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCcccCCC------CCC---HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 66677776644322 133 3466799999999999999999999999876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.34 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=205.2
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
-.+++.+.+.||+|.||+||+|++. ..||||++... ..+..+.|++||.++++-+|.||+-+.|+|..... .||+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3455677899999999999999986 36999999754 45578899999999999999999999999998887 9999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
.+|+|.+|..++... ...++....++|++||++|+.|||.++ |||||||..||++.+++.|||+|||++..-..-
T Consensus 467 qwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred hhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999998643 356888999999999999999999999 999999999999999999999999999654322
Q ss_pred ccccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.-.......-|...|||||++.. .+|+..+||||||+++|||++|..|+..... +++.-+.-.|...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---------dqIifmVGrG~l~- 611 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---------DQIIFMVGRGYLM- 611 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---------hheEEEecccccC-
Confidence 22222334567788999999964 5799999999999999999999999872211 1111112222111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.|......-.+++++ +|+..||..++++||++.+|+..|+.+..
T Consensus 612 -pd~s~~~s~~pk~mk---~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 -PDLSKIRSNCPKAMK---RLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccchhhhccCHHHHH---HHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111111112334444 56669999999999999999998876654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.23 Aligned_cols=272 Identities=23% Similarity=0.329 Sum_probs=211.0
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--------------hhcHHHHHHHHHHHHhcCCccEEee
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--------------GQGIEEFKTEIALIAQLQHRNLVSI 483 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------------~~~~~~~~~Ev~~l~~l~h~niv~l 483 (743)
...++|++.+.||+|.||.|.+|+.. +++.||||++.+.. ....+..++|+.+|++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999965 79999999997531 1124688999999999999999999
Q ss_pred eeeEecC--CeeEEEEEecCCCChhhhhhhcccccc-cCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC
Q 041312 484 LGCCIEE--QEKMLIYEYLPNKSLDVYIFDEAKRSL-LDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA 560 (743)
Q Consensus 484 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 560 (743)
+++..+. +..|||+|||..|.+...- .... +++.++.+++++++.||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9999865 6789999999998886542 2233 899999999999999999999999 9999999999999999
Q ss_pred CCeEEeeeccccccCCCc---cccccccccccccccCcceeccCC----CCccccchhHHHHHHHHHhcCCCCCCCcccC
Q 041312 561 MNPKISDFGMARIFGGDQ---IEENTNRVVGTYGYMAPEYAMEGL----FSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633 (743)
Q Consensus 561 ~~vkl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDiwSlGvil~elltG~~p~~~~~~~~ 633 (743)
|++||+|||.+..+.... ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 999999999998773321 112233479999999999998733 46789999999999999999999863321
Q ss_pred CCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC--CCCCCCCcc
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA--PSSPKHPAF 711 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~--~~~p~~~~~ 711 (743)
.. .. ..++...|.-+...+.-..+.+|++++|+.||+.|-+..+|....--... .+.+.+|..
T Consensus 325 ---~~----l~--------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~ 389 (576)
T KOG0585|consen 325 ---LE----LF--------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSS 389 (576)
T ss_pred ---HH----HH--------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCccc
Confidence 11 11 12222333333333445567788999999999999999999887754433 344455544
Q ss_pred ccc
Q 041312 712 IAK 714 (743)
Q Consensus 712 ~~~ 714 (743)
...
T Consensus 390 c~~ 392 (576)
T KOG0585|consen 390 CSR 392 (576)
T ss_pred cee
Confidence 443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.02 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=202.2
Q ss_pred CCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
++|++.++||+|+||.||+++. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999973 246689999986442 34456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc-----------------------------------------------------------
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK----------------------------------------------------------- 514 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 514 (743)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999888854211
Q ss_pred -------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 515 -------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 515 -------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124778889999999999999999998 9999999999999999999999999998664332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||++.+..++.++|||||||++|||++ |..|+...... ......+..+....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~~------ 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--------SKFYKMIKEGYRML------ 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--------HHHHHHHHhCccCC------
Confidence 1222345678999999999999999999999999999998 77776532210 11122222221110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..... ...+.+++.+|++.+|++||++.+|+++|+..
T Consensus 338 ~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01111 23466788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.57 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=202.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
++|.+.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.+ +|+||+++++.+.+....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 47888999999999999998842 3457999999754 334456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc-----------------------------------------------------------
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK----------------------------------------------------------- 514 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 514 (743)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999988754211
Q ss_pred --------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccc
Q 041312 515 --------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586 (743)
Q Consensus 515 --------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 586 (743)
...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 124778889999999999999999998 999999999999999999999999999865433221112223
Q ss_pred cccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 587 ~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
.++..|+|||++.+..++.++|||||||++|||++ |+.||...... .........+.... . ....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--------~~~~~~~~~~~~~~-----~-~~~~ 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--------SKFYKMVKRGYQMS-----R-PDFA 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--------HHHHHHHHcccCcc-----C-CCCC
Confidence 45678999999999999999999999999999997 99987643211 01111111111000 0 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 341 ---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 ---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 23466788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.31 Aligned_cols=245 Identities=20% Similarity=0.302 Sum_probs=196.1
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCChhc---HHHHHHHHHHHHhcCCccEEeeeeeEec----CCeeEEEEEec
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQHRNLVSILGCCIE----EQEKMLIYEYL 500 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~ 500 (743)
..|++|+++.||+|.. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 68899999997543322 5778899999999999999999999877 35678999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999854 34688899999999999999999974 6 8899999999999999999999999998654322
Q ss_pred ccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 580 EENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... . ............
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~----~~~~~i~~~~~~---- 240 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----K----EIYDLIINKNNS---- 240 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----H----HHHHHHHhcCCC----
Confidence 12467899999999976 6899999999999999999999999864321 0 111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..+ +......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 241 ~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 LKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 001 1112234667888999999999999999999998653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.96 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=206.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.-|+.++.||.|+-|.|..|++. +|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999975 79999999997652 233456789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|.|.+++. .++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+||+..+++||+|||+|..-.+.
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999984 4567889999999999999999999988 999999999999999999999999999875444
Q ss_pred ccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. ..+.||.|.|.|||++.+.+| +.++||||+|||||.||+|+.||+... .. ....++..|. .++
T Consensus 166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir----~LLlKV~~G~-f~M- 231 (786)
T KOG0588|consen 166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IR----VLLLKVQRGV-FEM- 231 (786)
T ss_pred cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HH----HHHHHHHcCc-ccC-
Confidence 33 345799999999999999987 578999999999999999999998321 11 1111111111 111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDNAPSS 705 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~ 705 (743)
+..-..++.+|+.+|+..||++|-|++||+.. |.+...++.
T Consensus 232 --------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 232 --------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred --------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 11112345567779999999999999999985 344444333
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=348.31 Aligned_cols=259 Identities=25% Similarity=0.295 Sum_probs=213.4
Q ss_pred CCCCcCcccccCCceeEEEEEEcCC-cEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeee-eEec------CCe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNG-KEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILG-CCIE------EQE 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~-~~~~------~~~ 492 (743)
.++++.+.|.+|||+.||.|+...+ .++|+|++-...++....+++||.+|++|+ |+|||.+++ .... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3567779999999999999998765 999999998888899999999999999997 999999999 3322 135
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.+|.||||++|.|-+++....... |.+.++++|+.++++|+++||... .+|||||||-+||||..+++.||||||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 689999999999999997665555 999999999999999999999984 789999999999999999999999999986
Q ss_pred ccCCCcccc-------ccccccccccccCccee---ccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 573 IFGGDQIEE-------NTNRVVGTYGYMAPEYA---MEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 573 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
......... ..-...-|+.|+|||++ .+.++++|+|||+|||+||-|+....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 432221100 00112458999999988 57889999999999999999999999987431
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
...++.....-+..+....++..|+..||+.||++||++-+|+..+-.+...
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 2233444333344567778899999999999999999999999998766543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.88 Aligned_cols=258 Identities=32% Similarity=0.512 Sum_probs=205.7
Q ss_pred CCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 2579999986443 344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC
Q 041312 495 LIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM 561 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 561 (743)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854321 145788899999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccc
Q 041312 562 NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLV 640 (743)
Q Consensus 562 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 640 (743)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------- 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999986543332222334566889999999999999999999999999999998 9988763221
Q ss_pred hhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 641 GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 641 ~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
......+..+.... ........+.+++.+|++.+|.+||++.+|++.|+++
T Consensus 233 ~~~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 QEVIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11122222222111 1112234567788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.11 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=211.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe-eEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE-KMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 497 (743)
++|..++++|+|+||.++..+++ +++.+|+|++... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999976 6789999998744 34445578899999999999999999999999988 99999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
+|++||++.+.+.... ...+++..+..++.||+.|+.|||++. |+|||||+.||+++.+..|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986543 567899999999999999999999877 999999999999999999999999999998766
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. .....+||+.|+.||++.+.+|+.|+|||||||++|||++-+++|..... ...+.+ ++.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~k---------i~~ 220 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILK---------INR 220 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHH---------Hhh
Confidence 52 24458999999999999999999999999999999999999999874322 111111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. +-.+.+......+..++..|++.+|+.||++.+|+..
T Consensus 221 ~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 1233455556667788889999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=299.73 Aligned_cols=265 Identities=25% Similarity=0.295 Sum_probs=213.4
Q ss_pred cCCCCcCcccccCCceeEEEEE-EcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-----eeE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-----EKM 494 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~ 494 (743)
.++|++.++||+|||+-||.++ ..+++.+|+|++.-...+..+..++|++..++++||||++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4679999999999999999999 4578999999998777788899999999999999999999999876554 489
Q ss_pred EEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++++|...|+|.+.+.... +...+++.+++.|+.+|++||.+||+.. .+++||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999998886543 4458999999999999999999999875 4699999999999999999999999999876
Q ss_pred cCCC-----ccc--cccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 574 FGGD-----QIE--ENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 574 ~~~~-----~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
..-. +.. .....-.-|..|+|||++. +...++++|||||||+||+|+.|.-||+.....+ +...+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSlaL---- 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLAL---- 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEEE----
Confidence 5311 100 0011124588999999985 4467899999999999999999999988654422 11111
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.+....+.-+-.....+.+.+++.+|+|.||.+||++.+|+..++.+.
T Consensus 254 ----------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ----------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 122222332333345667888999999999999999999999998764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.17 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=204.9
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++|+||+++++.+.+....++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5788899999999999999998888899999986433 346789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999988543 2345788889999999999999999988 9999999999999999999999999998765432221
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .............
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---------~~~~~~~~~~~~~------ 224 (261)
T cd05072 161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---------DVMSALQRGYRMP------ 224 (261)
T ss_pred -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---------HHHHHHHcCCCCC------
Confidence 122345678999999998889999999999999999998 88887532210 0111111111100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
........+.+++.+|++.+|++||++++|+++|+.+
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 ---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0111123467788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.07 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=201.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 58999999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999998843 345788899999999999999999998 99999999999999999999999999986543
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ...+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---------~~~~~i~~~--~~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---------ETWENLKYW--KETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---------HHHHHHHhc--ccccc
Confidence 223467999999999999999999999999999999999999998643221 011111100 00011
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..............+.+++.+||+.+|.+||++.+|++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000001112345678889999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.91 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=197.6
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667799999999999999964 79999999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|..++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998777543 2335888999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~-------- 221 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKEDQ-------- 221 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhccc--------
Confidence 22357899999999999999999999999999999999999998753221 00001111111000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
..........+.+|+.+||+.+|.+||+ ++++++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0011112234667888999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=338.05 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=204.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~ 492 (743)
.++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457889999999999999999853 23579999997543 334567899999999996 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc----------------------------------------------------------
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK---------------------------------------------------------- 514 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 514 (743)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988754211
Q ss_pred -----------------------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC
Q 041312 515 -----------------------------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 515 -----------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 559 (743)
...+++..++.++.||++||.|||+.+ |+|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999988 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccc
Q 041312 560 AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWN 638 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 638 (743)
++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------ 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------ 346 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------
Confidence 99999999999987643332222233456788999999999999999999999999999997 88887643210
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.........+.... ........+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 347 --~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 --STFYNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 01111111111110 11112245677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.23 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=208.8
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
..+|++.+.||+|.||.|-++.. ..|+.||||.|++. .++....+++|+++|..|+||||+.++.+|...+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999985 68999999999865 456677889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||..+|.|.+++. .++.|++.++..+++||..|+.|+|+++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999994 4556999999999999999999999988 99999999999999999999999999998865
Q ss_pred CccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
..+ ...++|++-|.+||++.+.+| +..+|-|||||+||.|+.|..||+.... ..+ .+.+..+...+
T Consensus 206 ~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~l----vrQIs~GaYrE- 272 (668)
T KOG0611|consen 206 KKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRL----VRQISRGAYRE- 272 (668)
T ss_pred ccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHH----HHHhhcccccC-
Confidence 543 345899999999999999988 5789999999999999999999985321 111 11222222221
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
+ +......-|++|||-.||++|.|+.+|...-
T Consensus 273 -------P---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -------P---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------C---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1122344577899999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.10 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=202.7
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCe
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQE 492 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 492 (743)
....++|...++||+|.||+|+++..+ +++.+|||.+++. ....++..+.|.+++... +||.|+.++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999986 6889999999876 356678889999998888 49999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
+++||||+.||++..+ .+...+++..+.-++..|+.||.|||+++ ||+||||.+|||+|.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999995433 34567899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
.-... ...+.+.+|||.|||||++.+..|+..+|.|||||+|||||.|..||....++
T Consensus 517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------- 574 (694)
T KOG0694|consen 517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------- 574 (694)
T ss_pred ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------------
Confidence 65322 23567799999999999999999999999999999999999999999854321
Q ss_pred chhcccccCCC--CCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 653 MEAVDKSLGES--CCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 653 ~~~ld~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
++.|.-+..+ ++.--..+.++++.++|..+|++|.-+
T Consensus 575 -e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111111 222223456778889999999999776
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.11 Aligned_cols=256 Identities=30% Similarity=0.501 Sum_probs=209.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
..+|++.++||.|+||.||+|...+++.+|+|.+..........+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999999889999999998776656778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999986532 345789999999999999999999998 999999999999999999999999999876443222
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+..... . ........+.
T Consensus 161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~----~~~~~~~~~~-------- 221 (261)
T cd05148 161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----H----EVYDQITAGY-------- 221 (261)
T ss_pred c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----H----HHHHHHHhCC--------
Confidence 1 12345678999999998899999999999999999998 7888753321 0 1111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..+.+......+.+++.+|++.+|++|||+.+|++.|+++
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 -RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111122234567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.81 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=205.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|.+.+.||+|+||.||+|+..+ ++.||+|.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999998765443 5678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-----------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 495 LIYEYLPNKSLDVYIFDEA-----------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2345788899999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---------~ 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---------E 232 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---------H
Confidence 9999999986543322222223456788999999999999999999999999999998 99987533211 0
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..+....+..... .......+.+++.+||+.+|++||++.||++.|+.
T Consensus 233 ~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111111111 11122446778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.12 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=201.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+.++++++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999864 36689999987553 34456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 246889999999999999999999998 99999999999999999999999998765432
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... . ......++...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~----~~~~~~~~~~~-- 227 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----D----VIKAVEDGFRL-- 227 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----H----HHHHHHCCCCC--
Confidence 211 11112345678999999999999999999999999999775 99987643211 0 11111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.........+.+++..||+.+|++||++.+|.+.|+++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01111223466788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.51 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=202.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEccc--CChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-----CC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSR--SSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-----EQ 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-----~~ 491 (743)
....|...+.||+|+||.|.++... +|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666789999999999999975 799999999973 455567788999999999999999999999875 46
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..|+|+|+| +.+|...+. .++.|+...+..++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 789999999 667777763 3344888999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh--------
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH-------- 642 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------- 642 (743)
+...........+..+.|..|.|||++.. ..|+.+.||||+|||+.||++|+.-|...... .+..++..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSEE 250 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCHH
Confidence 98865422333456788999999998865 67999999999999999999999988754321 01111100
Q ss_pred hHhHhccCCcchhcccccC-CCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 643 VWDLWKEGTAMEAVDKSLG-ESCC-----APEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
....+........+...-. ...+ +..-...++|+.+||..||.+|+|++|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111111111000 0000 1112246788889999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.11 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=175.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999976 6888999998754 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ .|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999998843 335788999999999999999999853 39999999999999999999999999998654322
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2335789999999999999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.32 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=201.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||++..+++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999988889999988543 3335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999887532 235788999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .. .......+... ..+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~----~~~~i~~~~~~--~~~-- 223 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YE----VVEMISRGFRL--YRP-- 223 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HH----HHHHHHCCCCC--CCC--
Confidence 122345668999999998889999999999999999999 8888754321 11 11111111111 001
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
... ...+.+++.+|++.+|.+||++.+|+++|.
T Consensus 224 --~~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 --KLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCC---CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 235678889999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=317.08 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=204.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.++||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688899999999999999998888899999986543 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 345789999999999999999999998 999999999999999999999999999876533221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. ......+..|+|||++.+..++.++||||||+++|||++ |+.|+..... .............
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~------ 223 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---------AEVLQQVDQGYRM------ 223 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCCCC------
Confidence 1 111223457999999999999999999999999999999 8888753211 0111111111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.........+.+++.+|++.+|.+||++.+|++.|+.+
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11111234577888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=317.90 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=204.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......+.+|+.++++++|+||+++++.+.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999999752 4579999986543 34456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999988543 236889999999999999999999988 99999999999999999999999999988752
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... . ........+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~----~~~~~~~~~~~~~- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----Q----DVIKAVEDGYRLP- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----H----HHHHHHHcCCCCC-
Confidence 222222222345678999999999999999999999999999998 8888753221 0 1111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
........+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 229 --------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 --------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.77 Aligned_cols=245 Identities=21% Similarity=0.276 Sum_probs=199.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 68999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999988843 345888899999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---------~~~~~i~~~~~----- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---------GIYEKILAGKL----- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCc-----
Confidence 22357899999999999999999999999999999999999998643210 01111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 696 (743)
.+.... ...+.+++.+||+.||.+||+ ++++++.
T Consensus 216 -~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111 234567888999999999995 8887755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=321.46 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=202.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
..++|++.++||+|+||.||+|... .+..+|+|++... ......++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467999999999999999999853 3567999998643 23445678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK-------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854221 234677888999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+..... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---------~~~~ 231 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---------EQVL 231 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHH
Confidence 99999986544332222222355778999999999899999999999999999999 6777653211 0111
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
+...+...... .......+.+++.+|++.+|++||++.|++++|+.
T Consensus 232 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111111 11112346778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.78 Aligned_cols=260 Identities=30% Similarity=0.428 Sum_probs=202.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEec-CCe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIE-EQE 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~-~~~ 492 (743)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +|+||+++++++.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47899999999999999999742 35789999986543 33456788899999999 89999999998864 456
Q ss_pred eEEEEEecCCCChhhhhhhccc----------------------------------------------------------
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK---------------------------------------------------------- 514 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 514 (743)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8899999999999988753211
Q ss_pred ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccC
Q 041312 515 RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594 (743)
Q Consensus 515 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 594 (743)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136789999999999999999999988 99999999999999999999999999987643332222334566788999
Q ss_pred cceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHH
Q 041312 595 PEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCI 673 (743)
Q Consensus 595 PE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~ 673 (743)
||++.+..++.++|||||||++|||++ |..||...... .........+.... ........+.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~---------~~~~~~~~~~ 306 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRMR---------APEYATPEIY 306 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCCC---------CCccCCHHHH
Confidence 999999999999999999999999998 98887532110 01111122111111 0111224567
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 674 HLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 674 ~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
+++.+|++.+|++||++.+|+++|+.+.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.79 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=208.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999852 345689999877666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc----------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 496 IYEYLPNKSLDVYIFDEA----------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885432 2235899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+..... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---------~~~~ 232 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------NEVI 232 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH
Confidence 99999986643322222233456788999999998899999999999999999998 8888653221 0111
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.....+..... .. .....+.+++.+|++.+|.+|||+.+|++.|+.+...
T Consensus 233 ~~i~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGRVLQR-----PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCCcCCC-----CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222221111 01 1123467888899999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=323.19 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=199.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.+.||+|+||.||+++.+ +++.+|+|++... .....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999986 6889999998654 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2345888999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC------ccccchhhHhHh-ccCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG------SWNLVGHVWDLW-KEGT 651 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~------~~~~~~~~~~~~-~~~~ 651 (743)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......... ...++....... ....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 11 223357899999999999989999999999999999999999998643211000 000000000000 0000
Q ss_pred cchhcccccCCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 AMEAVDKSLGES------CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 ~~~~ld~~l~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......+..... ........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 00011234778999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.39 Aligned_cols=257 Identities=31% Similarity=0.467 Sum_probs=202.7
Q ss_pred CCCCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|++.++||+|+||.||+|.. ..++.+|+|.+... ..+....+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 24678999998743 34455788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc--------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC
Q 041312 496 IYEYLPNKSLDVYIFDEA--------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM 561 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 561 (743)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999874321 1235788889999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccc
Q 041312 562 NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLV 640 (743)
Q Consensus 562 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 640 (743)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------- 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999987644332222333455778999999998889999999999999999998 8878653211
Q ss_pred hhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 641 GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 641 ~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..+.+......... ... .....+.+++.+|++.+|++||++.+|+++|..
T Consensus 233 ~~~~~~~~~~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQLLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 01112222111111 111 112346678889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=344.93 Aligned_cols=252 Identities=18% Similarity=0.207 Sum_probs=202.8
Q ss_pred CCCcCcccccCCceeEEEEEEc-C-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-N-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.|.+.+.||+|++|.||++... + ++.||+|++..........+++|+.+++.++|||||++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999865 3 6788999876666566677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 501 PNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 501 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
++|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887543 23446888899999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~----~~~~~~~~~~~~~----- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----R----EIMQQVLYGKYDP----- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHhCCCCC-----
Confidence 2233446799999999999999999999999999999999999999853211 0 0111111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........+.+++..||+.+|++||++.+++.
T Consensus 291 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01111234677888999999999999998864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=323.11 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=209.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778899999999999999843 356689999877666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 496 IYEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 1234789999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccch
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 641 (743)
++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.|+......
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------- 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------- 232 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 99999999986544332222333556789999999999999999999999999999998 88887543210
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
...+....+...+. .......+.+++.+|++.+|++||++.+|+++|+.+..
T Consensus 233 ~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 EVIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11222222222111 11122356788889999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.93 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=199.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++.+.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357888999999999999999976 6899999998643 223456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999988853 345788888899999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ .........+...
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~~~~--- 233 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---------FRIYEKILAGRLK--- 233 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---------HHHHHHHhcCCcC---
Confidence 22 235789999999999999999999999999999999999999864321 0111112111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 696 (743)
+.. .. ...+.+++..||+.||.+||+ +.++++.
T Consensus 234 ---~p~-~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ---FPN-WF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCC-CC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001 11 124567888999999999997 5777643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.92 Aligned_cols=259 Identities=33% Similarity=0.432 Sum_probs=205.1
Q ss_pred CCCcCcccccCCceeEEEEEEcC--C--cE-EEEEEccc---CChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN--G--KE-IAVKRLSR---SSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
+....++||+|+||.||+|++.. + .. ||||.... .......+|++|++++++++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44555899999999999999753 2 23 89998874 34677889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+|||+|+||+|+++|..... .++..+++.++.+.|.||+|||+++ +|||||..+|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999965432 5889999999999999999999998 999999999999999999999999998764
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHh-ccCCc
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLW-KEGTA 652 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 652 (743)
..-.. ......-...|+|||.+..+.|+.++|||||||++||+++ |..|+...... .+.... ..+..
T Consensus 313 ~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------~v~~kI~~~~~r 381 (474)
T KOG0194|consen 313 SQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------EVKAKIVKNGYR 381 (474)
T ss_pred cceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------HHHHHHHhcCcc
Confidence 31111 1111234678999999999999999999999999999998 77776643221 111111 22222
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSP 706 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 706 (743)
.. .+......+..++.+|++.+|++||+|.++.+.|+.+.....+
T Consensus 382 ~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 MP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 21 1122233455677799999999999999999999877665444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.96 Aligned_cols=241 Identities=21% Similarity=0.260 Sum_probs=193.5
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.||+|+||.||+++.. +|+.+|+|++.+. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 6899999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccc
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 583 (743)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888743 346889999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCC
Q 041312 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGES 663 (743)
Q Consensus 584 ~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~ 663 (743)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.. .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---------~~~~~~~~~~~------~~--- 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------KLFELILMEEI------RF--- 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---------HHHHHHHcCCC------CC---
Confidence 3467999999999999999999999999999999999999998632210 01111111110 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 664 CCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 664 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111123456788899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.40 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=195.3
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
++||+|+||.||+++.. +++.+|+|.+... .......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999975 7899999987644 334557799999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 585 (743)
.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988432 345789999999999999999999998 99999999999999999999999999876543221111111
Q ss_pred ccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCC
Q 041312 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESC 664 (743)
Q Consensus 586 ~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~ 664 (743)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+...... ......... .....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---------~~~~~~~~~---------~~~~~ 217 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---------QTREAIEQG---------VRLPC 217 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---------HHHHHHHcC---------CCCCC
Confidence 223457999999999999999999999999999998 77776532210 011111111 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 665 CAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 665 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.......+.+++.+|++.+|++||++.+|+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1112345677888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=302.86 Aligned_cols=279 Identities=23% Similarity=0.301 Sum_probs=207.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChh--cHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ--GIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lV 496 (743)
++|+.+++|++|.||.||+|+++ +++.||+|+++...+. .--.-.+|+.+|.+.+|||||.+-.+..- -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56888899999999999999975 7899999999754321 22245789999999999999999988764 3679999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||||+. +|..++.. ..+.+...++..++.|+++|++|||.+. |+||||||+|+|+...|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999965 67776643 3357888999999999999999999988 99999999999999999999999999999876
Q ss_pred CccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC----
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT---- 651 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 651 (743)
... ..+..+-|..|+|||++.+. .|+...|+||+|||+.||+.+++.|..... ......+++.+.-..
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-----~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-----IDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-----HHHHHHHHHHhCCCccccC
Confidence 632 23346779999999999885 699999999999999999999988765432 222222222221100
Q ss_pred ----cchhc---------ccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCCCccccc
Q 041312 652 ----AMEAV---------DKSLGESCCAP-EILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAK 714 (743)
Q Consensus 652 ----~~~~l---------d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~ 714 (743)
....+ ...++..+... -...-.+|+...|..||.+|-|+++.++. .-..+.|.|..|.++.-
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPSMFPT 378 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChhhcCC
Confidence 00000 00111111111 11234566778999999999999987654 23355677777776653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=325.82 Aligned_cols=241 Identities=20% Similarity=0.249 Sum_probs=191.7
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||+|+||.||+++.. +++.||+|++.+. .......+..|+.++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 5889999998643 334556788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 585 (743)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 345888999999999999999999998 9999999999999999999999999997543222 12334
Q ss_pred ccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 586 ~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......... .+ +
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~-~~~~~~~~~~------~~----~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NE-MYRKILQEPL------RF----P 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HH-HHHHHHcCCC------CC----C
Confidence 6799999999999999999999999999999999999999863211 11 1111111100 01 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
......+.+++.+||+.||++||++.++.+.|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 11123456788899999999998754444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.94 Aligned_cols=255 Identities=30% Similarity=0.451 Sum_probs=203.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.+|.+.++||+|+||.||+|... .++.+|+|++... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999975 5889999998644 344578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ....+++..++.++.|+++||.|||+++ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999987543 2345788999999999999999999988 999999999999999999999999999876543221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..|+..... .............
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~------ 224 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYELLEKGYRM------ 224 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHCCCCC------
Confidence 1 112234568999999999999999999999999999998 8888653211 1112222111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.........+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 225 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111123466788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.59 Aligned_cols=268 Identities=29% Similarity=0.394 Sum_probs=201.1
Q ss_pred CCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKML 495 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~l 495 (743)
|.+.+.||+|+||+||++.. .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 357889999987543 34567788999999999999999999988754 45789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.. ..+++..+..++.|+++||.|||+++ |+|+||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhhh
Confidence 332211 112234566799999999888999999999999999999999987543211 0000000000001111112
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.++..............+.+++.+|++.+|++||++++|+++|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222211112222345777888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=344.14 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=205.2
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC--
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-- 491 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-- 491 (743)
.....++|.+.++||+|+||+||+++.. +++.||||++... .......+.+|+.++..++|+||++++..+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445578999999999999999999864 7999999998654 3455667889999999999999999988775432
Q ss_pred ------eeEEEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeE
Q 041312 492 ------EKMLIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPK 564 (743)
Q Consensus 492 ------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vk 564 (743)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3679999999999999886432 2356889999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH
Q 041312 565 ISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---------~~~~ 254 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---------EEVM 254 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---------HHHH
Confidence 9999999876544333334456899999999999999999999999999999999999999864221 0111
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.....+.... + +......+.+++..||+.+|.+||++.++++.
T Consensus 255 ~~~~~~~~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAGRYDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcCCCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111110 1 11122346678889999999999999999864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=326.22 Aligned_cols=256 Identities=25% Similarity=0.441 Sum_probs=200.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.+|++.+.||+|+||.||+|++. +++ .||+|++... .....+++.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999864 333 3899998654 344567899999999999999999999998764 5789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 335788889999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............++..|+|||++.+..++.++|||||||++|||++ |+.|+...... ........+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~~ 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------EISSILEKGERLP 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---------HHHHHHhCCCCCC
Confidence 4332222222344678999999999999999999999999999997 88887532110 0111111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
........+.+++.+|++.+|++||++.+|+..|..+.
T Consensus 232 ---------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 232 ---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111234667888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.48 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=203.3
Q ss_pred CCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
+|.+.+.||+|+||.||+|+.. ....+++|.+.... .....++.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578899886543 3445789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc---------------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCc
Q 041312 496 IYEYLPNKSLDVYIFDEA---------------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASN 554 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 554 (743)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998875321 1235788999999999999999999988 9999999999
Q ss_pred EEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccC
Q 041312 555 VLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQG 633 (743)
Q Consensus 555 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~ 633 (743)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543322112223455678999999988889999999999999999998 8888753221
Q ss_pred CCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
...+........ ..........+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 236 -------~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -------ERLFNLLKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------HHHHHHHhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112222221111 11111122457788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.34 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=201.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888999999999999999877778999988643 2345679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999885432 25889999999999999999999998 9999999999999999999999999988654332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.+..++.++|||||||++|||++ |..|+...... ........+....
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~------ 221 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---------ETVEKVSQGLRLY------ 221 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---------HHHHHHhcCCCCC------
Confidence 112345678999999998889999999999999999998 88887532210 0111111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
........+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 ---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112345678888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.39 Aligned_cols=250 Identities=33% Similarity=0.527 Sum_probs=193.6
Q ss_pred cCcccccCCceeEEEEEEc-----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 426 SDNKLGEGGFGSVYKGVLQ-----NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
..+.||.|.||.||+|++. .+..|+||.+... .....+.+.+|++.+++++||||+++++++......++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 3677999999654 344578999999999999999999999999988889999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++|+|.+++... ....+++..+..|+.||++||.|||+++ |+|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999998654 2346889999999999999999999988 99999999999999999999999999987743332
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
............|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+...+.++......
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---------~~~~~~~~~~~~~~~~-- 227 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---------EEIIEKLKQGQRLPIP-- 227 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---------HHHHHHHHTTEETTSB--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---------ccccccccccccceec--
Confidence 222333456788999999999999999999999999999999 6777643211 1122222222221111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
......+.+++.+||+.+|++||++.+|++.|
T Consensus 228 -------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 -------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11123466788899999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.80 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=192.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|+..++||+|+||.||+++.. +++.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999975 68999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 3456777889999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 580 EENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ........ ......
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~-~~~~~~-- 293 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCA-ICMSQP-- 293 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHH-HhccCC--
Confidence 1233578999999998743 23456899999999999999999998732210 00000000 000000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..........+.+++.+||+.+|++||++.||++.
T Consensus 294 -------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111222356778889999999999999999974
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.93 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=199.7
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.+|++.+.||+|+||.||++..+++..+|+|++.+.. ...+.+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578889999999999999998877889999986432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988543 236889999999999999999999998 9999999999999999999999999998654322111
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... . ..........
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~----~~~~~~~~~~-------- 219 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----E----VVESVSAGYR-------- 219 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----H----HHHHHHcCCc--------
Confidence 111223457999999999999999999999999999999 78887532211 0 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
..........+.+++.+|++.+|++||++.+|+++|.
T Consensus 220 -~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 -LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0111112335677888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.32 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=205.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-..|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999965 6788999998765 33456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
++||.+.|++...|... ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||-+....
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999998888543 3445788888999999999999999988 9999999999999999999999999987654
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
. ......+||..|.+||+..+..++.++|+|++|++.||++.|.+||..... ...+..+.
T Consensus 176 ~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------~etYkrI~------- 235 (281)
T KOG0580|consen 176 S----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------SETYKRIR------- 235 (281)
T ss_pred C----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------HHHHHHHH-------
Confidence 2 223458999999999999999999999999999999999999999874321 11112111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...+..+ ..-.....+++..|+..+|.+|.+..|++..
T Consensus 236 -k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 -KVDLKFP--STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -HccccCC--cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111111 1112235567779999999999999998863
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.70 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=200.3
Q ss_pred CCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe-----
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE----- 492 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~----- 492 (743)
|.+.+.||+|+||.||+|.... +..+|+|+++.. .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998652 467999998744 33456789999999999999999999998876554
Q ss_pred -eEEEEEecCCCChhhhhhhcc---cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 493 -KMLIYEYLPNKSLDVYIFDEA---KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 493 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
.++||||+++++|..++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346888999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... . ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~----~~~~~~ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----H----EIYDYL 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----H----HHHHHH
Confidence 99987644332222222345678999999988899999999999999999999 7777643211 0 111222
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..+..... .......+.+++.+|++.+|.+||++.+|++.|+.+
T Consensus 229 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21211111 112234577888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.60 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=196.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|.+.++||.|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999976 68899999986442 23345778999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 887776432 335788889999999999999999998 99999999999999999999999999976533221
Q ss_pred ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh--------cc-
Q 041312 580 EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW--------KE- 649 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~- 649 (743)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcc
Confidence 1223567899999998876 56899999999999999999999998643211 0000010000 00
Q ss_pred ---CCcchhcccccCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 ---GTAMEAVDKSLGESC----CAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ---~~~~~~ld~~l~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......+.+...... .......+.+++..||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000 0011234667888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.82 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=205.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 492 (743)
.++|++.+.||+|+||.||++... ....+|+|.+... ..+...++.+|+.+++++ +|+||+++++++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 356888899999999999999864 2367999998754 334556788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhc-------------ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC
Q 041312 493 KMLIYEYLPNKSLDVYIFDE-------------AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 559 (743)
.++||||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 99999999999999988532 12346889999999999999999999988 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccc
Q 041312 560 AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWN 638 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 638 (743)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------- 240 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------- 240 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-------
Confidence 99999999999987654332222222345678999999998999999999999999999998 8888653211
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
....+....+.... ........+.+++.+|++.+|.+|||+.+|++.|+.+.
T Consensus 241 --~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --EELFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01122222111111 11122345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=321.97 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=174.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||++.+. ++..+|+|++... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999976 6888999988754 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999998843 345788899999999999999999742 39999999999999999999999999997653221
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2335789999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.05 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=201.7
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChh
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLD 506 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 506 (743)
++=||.|+.|.||+|++. ++.||||+++... ..+++-|++|+|+|||++.|+|...-..+||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 377999999999999986 5789999875322 35788999999999999999999999999999999999999
Q ss_pred hhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccc
Q 041312 507 VYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586 (743)
Q Consensus 507 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 586 (743)
..|.. ...+.-.....|..+||.|+.|||.+. |||||||.-||||..+..|||+|||.++...... ....+
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence 98843 345667788899999999999999998 9999999999999999999999999998765431 22347
Q ss_pred cccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCH
Q 041312 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCA 666 (743)
Q Consensus 587 ~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~ 666 (743)
+||..|||||++.+.+.++|+|||||||||||||||.-|+....+. ..+|.. ....+.+.- ...++
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--------AIIwGV--GsNsL~Lpv----PstcP 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--------AIIWGV--GSNSLHLPV----PSTCP 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--------eeEEec--cCCcccccC----cccCc
Confidence 8999999999999999999999999999999999999997643321 001110 011111111 12233
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC--CCCCCCCccccc
Q 041312 667 PEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA--PSSPKHPAFIAK 714 (743)
Q Consensus 667 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~--~~~p~~~~~~~~ 714 (743)
+-.. -|+.+||+..|.+||++++|++.|+-..+ +.+|....|...
T Consensus 338 ~Gfk---lL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq 384 (904)
T KOG4721|consen 338 DGFK---LLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQ 384 (904)
T ss_pred hHHH---HHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHH
Confidence 4444 45669999999999999999999986544 566665555443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.95 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=201.5
Q ss_pred CCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
+|++.++||+|+||.||+|... .++.||+|++..... ...+.+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677799999999999999864 257899999975433 335678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhc-------------ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 496 IYEYLPNKSLDVYIFDE-------------AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
++||+++++|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999887422 11235788889999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccch
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 641 (743)
+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+..... .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~ 233 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------Q 233 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---------H
Confidence 99999999886643332222333456789999999998889999999999999999998 7767643211 1
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
............. ........+.+++..|++.+|++||++.+|++.|++
T Consensus 234 ~~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1122222222111 111122346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.80 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=200.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|++.+.||+|+||.||+|... +++ .+++|.+.... .....++..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46888899999999999999964 344 47888875432 334567888999999999999999999875 455789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|+||+++|+|.+++... ...+++..+..++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 345889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............++..|+|||++.+..++.++|||||||++|||++ |+.|+..... ....+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---------HEVPDLLEKGERLA 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHCCCcCC
Confidence 4333223334567789999999999999999999999999999998 8888754321 11112222222111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
. + ... ...+..++.+|++.+|++||++.||++.|..+..
T Consensus 232 ~--~----~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 Q--P----QIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C--C----CCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 1 011 1245667889999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=316.63 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=204.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC-----------------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN-----------------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVS 482 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~ 482 (743)
..+|++.++||+|+||.||++.... +..||+|++.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999988642 2468999987553 345678999999999999999999
Q ss_pred eeeeEecCCeeEEEEEecCCCChhhhhhhcc--------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCc
Q 041312 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEA--------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASN 554 (743)
Q Consensus 483 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 554 (743)
+++++......++||||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985532 1225889999999999999999999988 9999999999
Q ss_pred EEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh--cCCCCCCCccc
Q 041312 555 VLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL--GRRNNTFHLEQ 632 (743)
Q Consensus 555 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt--G~~p~~~~~~~ 632 (743)
|+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986644433333334566789999999998889999999999999999998 5555532211
Q ss_pred CCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 633 GSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..................... ........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 240 ----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ----QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ----HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111111111 111122457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=331.50 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=201.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|.+.++||+|+||.||+++.. +++.||||++.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 6899999998653 2244567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999988543 56889999999999999999999988 999999999999999999999999999866433
Q ss_pred c---------------------------cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 578 Q---------------------------IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 578 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234578999999999999999999999999999999999999987432
Q ss_pred ccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 041312 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-MSAVVSM 696 (743)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 696 (743)
.. .......... ..+.-+........+.+++..|++ +|.+||+ ++++++.
T Consensus 235 ~~---------~~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ---------ETYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH---------HHHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 0111111100 000000001012345567778997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.20 Aligned_cols=194 Identities=21% Similarity=0.296 Sum_probs=167.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
..+|++.++||+|+||.||++... +++.||+|+.. ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999975 68899999753 23567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++..+.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 85 677766633 345788999999999999999999998 99999999999999999999999999975432211
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 122336799999999999999999999999999999999999988653
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.23 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=207.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 7899999987542 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+++++|..++.... ....++...+..++.||++||.|||+++ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875422 2345788899999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.... .....|++.|+|||.+.+..++.++|+||||+++|||++|+.|+...... ... ............
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~-- 227 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFS-LCQKIEQCDYPP-- 227 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHH-HHHHHhcCCCCC--
Confidence 3221 22356888999999999888999999999999999999999997533210 011 111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
+ ........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 228 ---~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 ---L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 11122345778888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.33 Aligned_cols=201 Identities=23% Similarity=0.354 Sum_probs=172.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.|+++++||+|+||+||+|+.. +++.+|||++.+. .......+.+|+.++++++|+||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999975 6889999998653 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999988853 345788888899999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccccccccccccCcceeccCCCCccccchhHH
Q 041312 579 I---------------------------------------------EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFG 613 (743)
Q Consensus 579 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlG 613 (743)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCC
Q 041312 614 VLLLEIILGRRNNTFH 629 (743)
Q Consensus 614 vil~elltG~~p~~~~ 629 (743)
|++|||++|+.||...
T Consensus 236 ~il~elltG~~Pf~~~ 251 (381)
T cd05626 236 VILFEMLVGQPPFLAP 251 (381)
T ss_pred hHHHHHHhCCCCCcCC
Confidence 9999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.35 Aligned_cols=242 Identities=21% Similarity=0.266 Sum_probs=193.9
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 6899999998754 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccc
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 583 (743)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99887743 346889999999999999999999998 9999999999999999999999999987543221 122
Q ss_pred ccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCC
Q 041312 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGES 663 (743)
Q Consensus 584 ~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~ 663 (743)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ......... ..+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~----~~~~~~~~~------~~~p~- 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----K----LFELILMED------IKFPR- 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----H----HHHHhccCC------ccCCC-
Confidence 3467999999999999999999999999999999999999998643210 0 111111000 00111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041312 664 CCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM 696 (743)
Q Consensus 664 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 696 (743)
.....+.+++.+||+.||++|| ++.++++.
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 ---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1123456788899999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.81 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=190.8
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.. +++.+|+|++.+. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6889999998754 234456678899988877 899999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999887743 346889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+.......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--
Confidence 2346789999999999999999999999999999999999999864322111111111122222211111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
+......+.+++.+||+.||++||++
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11112346678889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.91 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=208.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC--CcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN--GKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.++|.+.++||+|+||.||+|..+. +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578999999999999999998653 368999998643 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999998853 345888999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. ........+...
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------~~~~~i~~~~~~-- 246 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---------LIYQKILEGIIY-- 246 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---------HHHHHHhcCCCC--
Confidence 32 22367999999999999988999999999999999999999998643210 111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH--hcCC-------CCCCCCCCCccccc
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM--LGSD-------NAPSSPKHPAFIAK 714 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~--L~~~-------~~~~~p~~~~~~~~ 714 (743)
+.. ... ..+.+++.+|++.+|++|+ +++++++. +.++ .....|..|.+...
T Consensus 247 ----~p~-~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 311 (340)
T PTZ00426 247 ----FPK-FLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNV 311 (340)
T ss_pred ----CCC-CCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCC
Confidence 111 112 2356788899999999995 89998875 2322 23456677766443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.32 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=169.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|.+.++||+|+||.||+|+.. +++.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999976 68999999987543 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|++ ++|.+++.. ....++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666533 2345788889999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
. ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223567899999999876 4588999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.22 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=192.2
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+.++++++||||+++++.+......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 6899999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccc
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 583 (743)
+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99887743 346889999999999999999999998 9999999999999999999999999987532221 112
Q ss_pred ccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCC
Q 041312 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGES 663 (743)
Q Consensus 584 ~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~ 663 (743)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......... .+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~----~~~~~~~~~~------~~p~~ 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----R----LFELILMEEI------RFPRT 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----H----HHHHHhcCCC------CCCCC
Confidence 3367899999999999999999999999999999999999998643210 0 1111110100 01111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 664 CCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 664 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
. ...+.+++.+||+.+|.+|| ++.++++
T Consensus 218 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 L----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1 23456778899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.02 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=203.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 356899999877666777889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 496 IYEYLPNKSLDVYIFDEAK------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998854321 135788999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~---- 232 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-----E---- 232 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-----H----
Confidence 9999999976543322222223345788999999999999999999999999999998 88886532210 0
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.......+..... .......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 233 ~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111111110 01112346678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.10 Aligned_cols=266 Identities=26% Similarity=0.410 Sum_probs=208.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE 490 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 490 (743)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888899999999999999741 2457999988654 234567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
...++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 235788889999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGS 636 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~ 636 (743)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987654333222333455678999999999899999999999999999998 6666542211
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCC
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPK 707 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~ 707 (743)
.........+..... .......+.+++.+||+.+|.+||++.+|++.|+.+.....+.
T Consensus 246 ----~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~~ 303 (304)
T cd05101 246 ----EELFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303 (304)
T ss_pred ----HHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhcC
Confidence 112222222211110 1112244667888999999999999999999999877665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.79 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=200.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|.+.+.||+|++|.||+|.+.. +..||+|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568889999999999999999753 5678999886443 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc----ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC---CeEEe
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK----RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM---NPKIS 566 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~vkl~ 566 (743)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998854321 235889999999999999999999998 99999999999998654 59999
Q ss_pred eeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHh
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... . ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~----~~~ 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----E----VME 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H----HHH
Confidence 9999987643322221222334568999999999999999999999999999997 88887643211 0 111
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
........ ..+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111100 011111245677888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=305.08 Aligned_cols=264 Identities=25% Similarity=0.329 Sum_probs=199.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCcc-EEeeeeeEecCC------
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRN-LVSILGCCIEEQ------ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~------ 491 (743)
..|..+++||+|+||+||+|+.+ +|+.||+|++..... .......+|+.+|++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666789999999999999965 789999999976543 23455689999999999999 999999998877
Q ss_pred eeEEEEEecCCCChhhhhhhcccc-cccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKR-SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 45787777553322 35666888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
|+.+.-.... ....++|..|+|||++.+. .|+...||||+|||++||++++.-|....+ ......+.+.+..
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGt 239 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGT 239 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCC
Confidence 9976533322 3346789999999999986 799999999999999999998887765432 1122222222211
Q ss_pred CCc------chhcccc--cCCCC-----C---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 GTA------MEAVDKS--LGESC-----C---APEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ~~~------~~~ld~~--l~~~~-----~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
... ..+.+-. ..... . +.-.....+++.+||+.+|.+|.|++..+++
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 100 0000100 00000 0 0001246778889999999999999999886
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.93 Aligned_cols=201 Identities=26% Similarity=0.385 Sum_probs=174.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||+||+++.. +++.+|+|++.+.. ......++.|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999875 68999999986532 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999998853 346889999999999999999999998 999999999999999999999999998765321
Q ss_pred ccc---------------------------------cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCC
Q 041312 578 QIE---------------------------------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624 (743)
Q Consensus 578 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~ 624 (743)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 041312 625 NNTF 628 (743)
Q Consensus 625 p~~~ 628 (743)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=312.28 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=197.9
Q ss_pred CCcCcccccCCceeEEEEEEcC-Cc--EEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------Ce
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQN-GK--EIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------QE 492 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~ 492 (743)
|.+.++||+|+||.||+|.... +. .+|+|.+... .....+.+..|+.++++++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999764 33 5899988653 345567889999999999999999999987532 24
Q ss_pred eEEEEEecCCCChhhhhhhcc---cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 493 KMLIYEYLPNKSLDVYIFDEA---KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
.++||||+++++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988874322 2345889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------~~~~~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---------SEIYDYLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHH
Confidence 9987644332211222345678999999999999999999999999999999 7777653211 11222222
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+..... .......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 229 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2221111 111123467888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=297.31 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=200.7
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++.|++-+.||+|.|+.||+..+. +|+.+|+|++... .....+.+.+|+++-+.|+||||+++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999998864 7999999988632 344778899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC---CCeEEeeeccccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMARI 573 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~vkl~DFGla~~ 573 (743)
+|+|.|+.|-.-+. ++..+++..+-..++||+++|.|+|.++ |||||+||+|+|+.+. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999865442 3456777888889999999999999998 9999999999999643 3499999999998
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
++.... ....+|||+|||||++...+|+..+|||+.|||||-|+.|+.||..... .. .++....+..
T Consensus 163 l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~r----lye~I~~g~y- 229 (355)
T KOG0033|consen 163 VNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HR----LYEQIKAGAY- 229 (355)
T ss_pred eCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HH----HHHHHhcccc-
Confidence 873322 3347899999999999999999999999999999999999999985321 11 1222221111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
| +..+..+.......+|+++||..||.+|-|+.|.+.
T Consensus 230 ---d--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 ---D--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---C--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1 112122222233456777999999999999987653
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.70 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=208.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+||+++++.+.+....++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 7999999988632 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+++++|..++... .....+++..++.++.+|++||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887542 22455889999999999999999999998 99999999999999999999999999886543
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.|+..... .... ..+....+......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~~~ 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYS-LCKKIEKCDYPPLP 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHH-HHhhhhcCCCCCCC
Confidence 3221 1234678899999999988899999999999999999999999753321 1110 11111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.......+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 230 --------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 --------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0122335678888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.83 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=204.4
Q ss_pred CCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|.+.+.||+|+||.||++.... +..+|+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 578888999999999999998642 4689999986543 344567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhccc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEee
Q 041312 495 LIYEYLPNKSLDVYIFDEAK-------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
+||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 99999999999998854321 234788899999999999999999988 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhH
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---------~~~~~~ 233 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---------EEVLKF 233 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---------HHHHHH
Confidence 999986654432222333456789999999988889999999999999999998 8888753221 111122
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
...+...... ......+.+++.+|++.+|++|||+.+|++.|+.
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2221111111 1113456788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=316.14 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=199.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcC---------------CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN---------------GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILG 485 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~ 485 (743)
++|++.++||+|+||.||+++... ...||+|+++.. .......+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478899999999999999987532 235899998754 3344567999999999999999999999
Q ss_pred eEecCCeeEEEEEecCCCChhhhhhhccc---------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEE
Q 041312 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAK---------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVL 556 (743)
Q Consensus 486 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 556 (743)
++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854221 124678889999999999999999998 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhc--CCCCCCCcccCC
Q 041312 557 LDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG--RRNNTFHLEQGS 634 (743)
Q Consensus 557 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG--~~p~~~~~~~~~ 634 (743)
++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|||+++ ..|+.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999865433222222334557789999999999999999999999999999984 445442211
Q ss_pred CccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 635 GSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.................... .........+.+++.+|++.+|++||++.+|++.|+
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 --EQVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 01111111111111000000 001112246778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.52 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=210.2
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCCh---hcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCee
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEK 493 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~ 493 (743)
...+.|.+.+.||.|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+......
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 344678888999999999999999874 99999999976543 34578999999999998 99999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC----CCeEEeeec
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA----MNPKISDFG 569 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~vkl~DFG 569 (743)
++|||++.||.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998655 2899999999999999999999998 9999999999999643 479999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
++..... .......+||+.|+|||++...+|+.++||||+||++|.|++|..||....... .......
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~---------~~~~i~~ 252 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE---------IFLAILR 252 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH---------HHHHHHc
Confidence 9998865 334556899999999999999999999999999999999999999998654321 0011111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.. ....+........+-+++..|+..||..|+|+.++++
T Consensus 253 ~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 253 GDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111 2223333333455667888999999999999999999
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=309.69 Aligned_cols=253 Identities=30% Similarity=0.445 Sum_probs=202.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||+|..++++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 5688899999999999999998889999999986543 34568899999999999999999998864 567899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999998875432 346788999999999999999999988 9999999999999999999999999998765332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++....++.++||||||+++|||++ |+.||..... . .....+.......
T Consensus 160 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~----~~~~~~~~~~~~~------ 223 (260)
T cd05067 160 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----P----EVIQNLERGYRMP------ 223 (260)
T ss_pred -ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----H----HHHHHHHcCCCCC------
Confidence 122345678999999998889999999999999999999 8988763221 0 0111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
........+.+++.+|++.+|++||++++|++.|+.
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111112357788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.22 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=200.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888999999999999999988888999999865432 3567999999999999999999999875 456899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999988543 2335789999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.+..++.++||||||+++|||++ |..||..... .. .......+.
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~----~~~~~~~~~--------- 220 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----RE----VLEQVERGY--------- 220 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HH----HHHHHHcCC---------
Confidence 112335668999999988889999999999999999999 7878753211 01 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..+........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011111223457788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=321.46 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=194.1
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.. +++.||+|++++. .....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999976 6889999999753 233456788999999998 799999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 999887743 346899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+........... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CCC
Confidence 33467999999999999999999999999999999999999998743221111111111222222211110 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPN------MSAVVS 695 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~ 695 (743)
. ....+.+++.+||+.||.+||+ +.++++
T Consensus 227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 1234667888999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=310.47 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=200.8
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.+|++.++||+|+||.||+|+..+...||+|++.... ...+.+.+|+.++++++|+||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4688999999999999999998777789999986532 33467899999999999999999999874 456899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999988543 2345788999999999999999999988 9999999999999999999999999998765433211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.+..++.++||||||+++|||++ |..|+...... ...........
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---------~~~~~~~~~~~-------- 221 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------EVLDQVERGYR-------- 221 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---------HHHHHHhcCCC--------
Confidence 122446678999999988899999999999999999999 77776532210 11111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..........+.+++.+|++.+|++||++.+++++|+..
T Consensus 222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011122334577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=310.18 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=189.5
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-----eeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-----EKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~lV 496 (743)
.|...+++|.|+||.||+|... +++.||||+.....+ --..|+++|++++|||||+++.+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566789999999999999976 579999999865432 2246999999999999999999987442 33579
Q ss_pred EEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeecccccc
Q 041312 497 YEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIF 574 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFGla~~~ 574 (743)
|||||. +|.+.+..- ..+..++...+.-+..||++||.|||+.+ |+||||||+|||+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 666666431 22445666777789999999999999988 9999999999999965 99999999999988
Q ss_pred CCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC--
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT-- 651 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 651 (743)
...... ....-|..|+|||.+.+ ..|+.+.||||.||++.||+.|++-|...... .....+.+.+.-..
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-----dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-----DQLVEIIKVLGTPTRE 248 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-----HHHHHHHHHhCCCCHH
Confidence 655443 23456889999999988 47999999999999999999999988754321 11111111111100
Q ss_pred -c-------chhcccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 -A-------MEAVDKSLGES-----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 -~-------~~~ld~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+ .+.-.+.+... .......+.++++.++|+++|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 01111111111 11222335667888999999999999999885
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=294.37 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=203.0
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--------hhcHHHHHHHHHHHHhc-CCccEEeeeeeEe
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--------GQGIEEFKTEIALIAQL-QHRNLVSILGCCI 488 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~ 488 (743)
.....|...+.||.|..++|.++.++ +|+++|+|++.... ....++-..|+.+|+++ -||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34466777899999999999988865 78999999986431 22345567899999998 6999999999999
Q ss_pred cCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 489 EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 489 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
.....++|+|.|+.|.|.++|. ..-.+++....+|++|+++|+.|||.++ ||||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999984 3446889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceecc------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAME------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
|++..+.+... ....+|||+|+|||.+.- ..|+..+|+|++|||+|.|+.|.+||..... + .
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------m--l 235 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------M--L 235 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------H--H
Confidence 99998865543 345899999999998853 3588899999999999999999999874321 0 0
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..++..++... ...+...+.....-+|+.+||+.||.+|-|++|.++
T Consensus 236 MLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11222222211 112222333445667888999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=346.65 Aligned_cols=262 Identities=31% Similarity=0.519 Sum_probs=208.2
Q ss_pred CCCcCcccccCCceeEEEEEEcC--Cc----EEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN--GK----EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..+..+.||+|.||.||.|+..+ |. .||||.+.+. +.+...+|.+|..+|++++|||||+++|++.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34566889999999999999653 43 4899998765 56788899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc----cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 496 IYEYLPNKSLDVYIFDEA----KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
++|||++|+|..+|.+.+ ....+.....+.++.+||+|+.||++++ +|||||...|+||++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999997652 2456888999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+.+...+.-.......-...|||||.+..+.++.|+|||||||+||||+| |..|+..... . .+...+.++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----~----~v~~~~~~g 920 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----F----EVLLDVLEG 920 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----H----HHHHHHHhC
Confidence 95544433222222233468999999999999999999999999999998 4555443221 1 122212222
Q ss_pred CcchhcccccCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCC
Q 041312 651 TAMEAVDKSLGE-SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSP 706 (743)
Q Consensus 651 ~~~~~ld~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 706 (743)
. +|.. .++++ .+.+||.+||+.+|++||++..|++.+..+.....|
T Consensus 921 g-------RL~~P~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 921 G-------RLDPPSYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred C-------ccCCCCCCCh---HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 2 2222 23333 345899999999999999999999998877654333
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.87 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=200.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-----CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-----NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~ 494 (743)
.+|++.+.||+|+||.||++..+ +++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999742 588999999987766777889999999999999999999998754 34678
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988432 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC--
Q 041312 575 GGDQIEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT-- 651 (743)
Q Consensus 575 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 651 (743)
....... ......++..|+|||++.+..++.++|||||||++|||++|..++...... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----------~~~~~~~~~~~ 228 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----------FMRMMGNDKQG 228 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----------hhhhccccccc
Confidence 4332111 111123345699999999889999999999999999999987764322110 000000000
Q ss_pred ------cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 652 ------AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 652 ------~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..+.+......+........+.+++.+|++.+|++|||+.+|+++|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011111100011111223577888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.81 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=196.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999976 6899999998643 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998853 345889999999999999999999998 999999999999999999999999998765322
Q ss_pred cccc------------------------------------ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh
Q 041312 578 QIEE------------------------------------NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL 621 (743)
Q Consensus 578 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt 621 (743)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0112469999999999999999999999999999999999
Q ss_pred cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 041312 622 GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN---MSAVVSM 696 (743)
Q Consensus 622 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 696 (743)
|+.||...... .. ............... .....+ .+.+++.+|+. +|.+|++ +.++++.
T Consensus 235 G~~Pf~~~~~~-----~~---~~~i~~~~~~~~~~~----~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ-----ET---YRKIINWKETLQFPD----EVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH-----HH---HHHHHcCCCccCCCC----CCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99998643211 00 111111000000000 001122 34456667886 8999998 8887763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.63 Aligned_cols=241 Identities=26% Similarity=0.337 Sum_probs=191.9
Q ss_pred cccccCCceeEEEEEE----cCCcEEEEEEcccC----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVL----QNGKEIAVKRLSRS----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++||+|+||.||+++. .+++.||+|.+.+. .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 35789999998643 223345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.. ...+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999888743 345778888889999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.. .
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---------~~~~~~~~~~~------~ 218 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---------KTIDKILKGKL------N 218 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCC------C
Confidence 223467999999999999989999999999999999999999998643210 01111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
+.. .....+.+++.+||+.+|++|| ++.++++
T Consensus 219 ~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111 1123456788899999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.60 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=206.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||.||+++.. +++.+|||.+... ......++.+|+.+++.++|+||+++++++.+....++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999964 7899999987643 2334568889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+++++|.+++... .....+++..++.++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887542 22456889999999999999999999998 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.... .....++..|+|||++.+..++.++||||||+++|+|++|..|+...... ... ........ .
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~-----~ 224 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYS----LCKKIEQC-----D 224 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHH----HhhhhhcC-----C
Confidence 3221 12356889999999999989999999999999999999999997532210 000 01111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.+.+.. ......+.+++.+|++.+|.+||||.+|+++|+.+.
T Consensus 225 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111111 112335667888999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.42 Aligned_cols=252 Identities=24% Similarity=0.300 Sum_probs=195.5
Q ss_pred CCCcCcccccCCceeEEEEEE----cCCcEEEEEEcccC----ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 423 DFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSRS----SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
+|++.++||+|+||.||+++. .+++.+|+|++.+. .....+.+..|+.+++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999885 35889999998643 223456788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++.. +..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999888743 345888999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+......
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~~~~~~~~--- 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-----NTQSEVSRRILK--- 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-----CCHHHHHHHHhc---
Confidence 5433221 22346799999999999875 4789999999999999999999998643211 001111111110
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM 696 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 696 (743)
.++.+.. .....+.+++.+||+.||++|| +++++++.
T Consensus 226 ---~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111111 1123456778899999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=322.74 Aligned_cols=265 Identities=20% Similarity=0.289 Sum_probs=193.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----CeeE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QEKM 494 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~ 494 (743)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 6899999998643 223445788999999999999999999988643 3479
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+. ++|..++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 678777642 345889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-ccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc--------chhh
Q 041312 575 GGDQI-EENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL--------VGHV 643 (743)
Q Consensus 575 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~ 643 (743)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..... ....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHH
Confidence 32221 112234678999999999876 67899999999999999999999998643210 00000 0000
Q ss_pred HhHhccCCcchhccc---ccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 644 WDLWKEGTAMEAVDK---SLGES---CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~---~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...+......+.+.. ..... ........+.+++.+||+.+|++||+++||++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 011111111111100 00000 000112345688889999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=328.00 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=201.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~ 493 (743)
++|.+.++||+|+||.||+|++. .++.||+|++.... ....+.+++|++++.++. ||||+++++++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45778899999999999999853 34689999997543 333457899999999997 99999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc-----------------------------------------------------------
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK----------------------------------------------------------- 514 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 514 (743)
++||||+++|+|.+++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999998854211
Q ss_pred ------------------------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 515 ------------------------------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 515 ------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 124677778899999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCcc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSW 637 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~ 637 (743)
..+.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+.....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------ 347 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------ 347 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------
Confidence 999999999999986543222111222456788999999999899999999999999999998 7888653211
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..........+... ..+......+.+++..|++.+|++||++++|++.|+.+.
T Consensus 348 --~~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 --NEQFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --hHHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01111111111110 011111235667888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.26 Aligned_cols=247 Identities=30% Similarity=0.427 Sum_probs=194.3
Q ss_pred cccccCCceeEEEEEEc---CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||+|.++ +++.+|+|++.... ....+++.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 36999999999999753 57889999986442 345678999999999999999999999875 4567899999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc-
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE- 581 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~- 581 (743)
++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999988843 345889999999999999999999998 9999999999999999999999999998764432211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||.+....++.++|||||||++|||++ |+.||..... .........+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~i~~~~~~~------ 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---------NEVTQMIESGERME------ 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHCCCCCC------
Confidence 1122334578999999988889999999999999999998 8888764321 01122222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 219 ---~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 ---CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111122346678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=314.88 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=191.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc--CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhc---CCccEEeeeeeEe-----c
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ--NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQL---QHRNLVSILGCCI-----E 489 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~-----~ 489 (743)
++|++.++||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++++ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999886432 22334566777777665 6999999999885 3
Q ss_pred CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
....++||||++ ++|..++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 58877774332 335788999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+. .......+....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~~~~~i~~~~~~ 227 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGL 227 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCC
Confidence 99865433 2233467899999999999999999999999999999999999998753221 111111111000
Q ss_pred C---Cc-------chhcccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 G---TA-------MEAVDKSLGE---SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~---~~-------~~~ld~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. .. ...+...-.. .........+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00 0000000000 000111234567888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.76 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=202.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467999999999999999999754 24579999886443 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK-------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
.++||||+++|+|.+++..... ...+.+..+..++.||+.||.|||+++ |+||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864221 234567778899999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---------~~~~ 231 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------EQVL 231 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH
Confidence 99999986543332222222345678999999999999999999999999999998 6767643211 0111
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.....+..... .......+.+++.+|++.+|++||++.++++.|....
T Consensus 232 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111110 0111245778888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=317.16 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=203.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
++|.+.+.||+|+||.||++... .+..+|+|+++... ....+.+.+|+.+++++ +|+||+++++++......
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999742 35679999987543 34456789999999999 799999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|..++.... ...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999885422 234889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ..........+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~ 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYKLIKEGYR 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHHHHHcCCc
Confidence 644322112223456788999999999999999999999999999998 8888653221 0011111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. .........+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 263 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 00111123567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.93 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=205.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC-----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-CCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN-----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-EQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~ 493 (743)
.++|.+.+.||+|+||.||+|.... +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999765 788999988654 34456778999999999999999999998776 4678
Q ss_pred EEEEEecCCCChhhhhhhcccc-----cccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKR-----SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
++++||+++++|..++...... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999988553322 46889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
|+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.|+....+ .. .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~----~~~~~ 232 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FE----MAAYL 232 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HH----HHHHH
Confidence 99986644332222223456778999999998899999999999999999999 9988764321 11 11111
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..+.... . .......+.+++.+|++.+|++|||+.+|+++|+.+.
T Consensus 233 ~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 KDGYRLA-----Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HcCCCCC-----C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111100 0 0111234678889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=312.73 Aligned_cols=246 Identities=26% Similarity=0.326 Sum_probs=193.5
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||+|+||+||++... +++.+|+|++.... ....+.+..|+.++++++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999975 68999999986432 23446778899999999999999999999999999999999999999
Q ss_pred hhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccc
Q 041312 506 DVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584 (743)
Q Consensus 506 ~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~ 584 (743)
..++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8877442 23456899999999999999999999998 99999999999999999999999999986644322 123
Q ss_pred cccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCC
Q 041312 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESC 664 (743)
Q Consensus 585 ~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~ 664 (743)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ....... .+...+ ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~-~~~~~~~--------~~~~~~--~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----E-NKELKQR--------ILNDSV--TY 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----h-HHHHHHh--------hcccCC--CC
Confidence 3578999999999999999999999999999999999999986432110 0 0000000 000000 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 665 CAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 665 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.......+.+++.+||+.+|++|| +++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 111233466788899999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=330.11 Aligned_cols=201 Identities=22% Similarity=0.349 Sum_probs=172.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.|+++++||+|+||.||+|+.. +++.+|+|++.+. .......+.+|+.++++++|+||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999975 6889999998653 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999988843 345788888999999999999999998 9999999999999999999999999975331100
Q ss_pred c---------------------------------------------ccccccccccccccCcceeccCCCCccccchhHH
Q 041312 579 I---------------------------------------------EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFG 613 (743)
Q Consensus 579 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlG 613 (743)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCC
Q 041312 614 VLLLEIILGRRNNTFH 629 (743)
Q Consensus 614 vil~elltG~~p~~~~ 629 (743)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (382)
T cd05625 236 VILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=329.54 Aligned_cols=201 Identities=26% Similarity=0.371 Sum_probs=172.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||+++.. +++.||||++.+. .....+.+++|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 7899999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999988843 345788888899999999999999998 999999999999999999999999999643211
Q ss_pred ccc---------------------------------------------cccccccccccccCcceeccCCCCccccchhH
Q 041312 578 QIE---------------------------------------------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSF 612 (743)
Q Consensus 578 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSl 612 (743)
... ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012469999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCC
Q 041312 613 GVLLLEIILGRRNNTF 628 (743)
Q Consensus 613 Gvil~elltG~~p~~~ 628 (743)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (377)
T cd05629 235 GAIMFECLIGWPPFCS 250 (377)
T ss_pred chhhhhhhcCCCCCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.04 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=198.7
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..++|++.++||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467999999999999999999976 6889999998642 22344567899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++|+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988743 34778888899999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcceeccC----CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEG----LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~ 264 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKN 264 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC
Confidence 33221 12346799999999998653 478999999999999999999999874321 011111111111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATD--RPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 696 (743)
.... +........+.+++..||+.+|.+ ||++.++++.
T Consensus 265 ~~~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLTF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111 001111234567788999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.52 Aligned_cols=264 Identities=26% Similarity=0.379 Sum_probs=200.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-----------------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-----------------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSI 483 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l 483 (743)
++|++.++||+|+||.||++... +...+|+|++... .......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 2446899998754 34456789999999999999999999
Q ss_pred eeeEecCCeeEEEEEecCCCChhhhhhhccc--------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcE
Q 041312 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAK--------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNV 555 (743)
Q Consensus 484 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 555 (743)
++++......++||||+++++|..++..... ...+++..+..++.||+.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999998855321 134677889999999999999999998 99999999999
Q ss_pred EecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh--cCCCCCCCcccC
Q 041312 556 LLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL--GRRNNTFHLEQG 633 (743)
Q Consensus 556 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt--G~~p~~~~~~~~ 633 (743)
|++.++.++|+|||+++.+.............+++.|+|||...++.++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999986543322222223345678999999888899999999999999999998 5566543221
Q ss_pred CCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..................... ........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ---EQVIENTGEFFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111110000000 011122456788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.08 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=200.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||+|+||.||+|+.. +++.+|+|++..........+.+|+.++++++|+||+++++.+......++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 57999999999999999999974 68899999987655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999988743 345788999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 581 ENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
......|++.|+|||.+. ...++.++|||||||++|||++|+.|+....+... . .. ...... ..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~----~~-~~~~~~---~~ 228 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----L----FL-MSKSNF---QP 228 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----h----ee-eecCCC---CC
Confidence 122356889999999884 34578899999999999999999999753322100 0 00 000000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
+.+.. .......+.+++.+||+.+|++||++++|++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00100 011124567888899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.10 Aligned_cols=202 Identities=22% Similarity=0.345 Sum_probs=173.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.+|++.++||+|+||.||+++.. +++.+|||++.+. .......+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 6899999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++.. ...++...+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999998843 346788888899999999999999998 999999999999999999999999998533210
Q ss_pred cc-----------------------------------------ccccccccccccccCcceeccCCCCccccchhHHHHH
Q 041312 578 QI-----------------------------------------EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616 (743)
Q Consensus 578 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil 616 (743)
.. .......+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001135799999999999999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 041312 617 LEIILGRRNNTFH 629 (743)
Q Consensus 617 ~elltG~~p~~~~ 629 (743)
|||++|+.||...
T Consensus 235 yell~G~~Pf~~~ 247 (376)
T cd05598 235 YEMLVGQPPFLAD 247 (376)
T ss_pred eehhhCCCCCCCC
Confidence 9999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.13 Aligned_cols=249 Identities=29% Similarity=0.429 Sum_probs=197.4
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChh
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLD 506 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 506 (743)
++||+|+||.||++...+++.||+|++..... .....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999999876533 35678999999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccc
Q 041312 507 VYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586 (743)
Q Consensus 507 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 586 (743)
+++... ...+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988543 235788888999999999999999988 999999999999999999999999999865432222211223
Q ss_pred cccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 587 ~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .......... .....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---------~~~~~~~~~~---------~~~~~ 217 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---------QTRERIESGY---------RMPAP 217 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---------HHHHHHhcCC---------CCCCC
Confidence 34567999999998899999999999999999999 77776532210 0111111110 00111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
......+.+++.+|++.+|.+||++.||++.|+.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1122357788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.44 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=203.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|++.++||+|+||.||++..+ ++..+|+|++.... .....++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357889999999999999999864 46789999987543 34457799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcc-------------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCc
Q 041312 494 MLIYEYLPNKSLDVYIFDEA-------------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASN 554 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 554 (743)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234778889999999999999999988 9999999999
Q ss_pred EEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccC
Q 041312 555 VLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQG 633 (743)
Q Consensus 555 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~ 633 (743)
|+++.++.+||+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543322211222344677999999998899999999999999999997 7777643211
Q ss_pred CCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.........+..... .......+.+++.+|++.+|++||++.||++.|++
T Consensus 239 -------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -------EEVIYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 011122222222110 11112456778889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=326.44 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=196.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..++|++.++||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+.+....++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3468999999999999999999976 5889999998642 22344568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998742 24788888999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcceeccCC----CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGL----FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ............
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKN 264 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCc
Confidence 3322 1123467999999999987643 78899999999999999999999864321 011111111111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATD--RPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 696 (743)
.... .. .......+.+++..|++.++.+ ||++.++++.
T Consensus 265 ~~~~-----p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNF-----PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCC-----CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111 01 1111233456667888755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=316.33 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=200.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-Cc--EEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-GK--EIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999753 33 4788888643 344556789999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 497 YEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135888999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---------~ 226 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---------E 226 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------H
Confidence 99999998643211 11111223557999999998899999999999999999997 98887533210 1
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPS 704 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 704 (743)
.......+... .........+.+++.+|++.+|.+||++++|++.|+.+....
T Consensus 227 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 227 LYEKLPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111100 011111234667888999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.09 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=202.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
++|.+.++||+|+||.||+++.. ....+|+|.+... ......++..|+.+++++ +|+||+++++++.+..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57899999999999999999853 2357999998754 234556788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999864321 135888999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCcc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSW 637 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~ 637 (743)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..|+.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 999999999999986643322222222334568999999999899999999999999999998 7777643211
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.............+. +......+.+++.+|++.+|.+||++.+|++.|+.+.
T Consensus 249 ---~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 ---EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111222222211111 1111235667888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.93 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=201.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|++.++||+|+||+||+|+.. +++ .||+|.+... .......+.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56888899999999999999854 444 4899988654 33456678999999999999999999999875 45789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
+|||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999888542 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............+++.|+|||.+.+..++.++|||||||++|||++ |..|+..... .. ....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~----~~~~~~~~~~~~ 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----RE----IPDLLEKGERLP 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HH----HHHHHHCCCcCC
Confidence 3322211222344678999999999999999999999999999998 8888753211 01 111111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPS 704 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 704 (743)
........+.+++.+|++.+|++||++.++++.|+.+...+
T Consensus 232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01112234667888999999999999999999998775554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.46 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=202.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.+.||+|++|.||+++.. +++.+++|.+... .....+.+.+|++++++++||||+++++.+.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 6899999988643 345567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988643 2346888999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....|++.|+|||++.+..++.++||||||++++||++|+.|+..... .........+...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~------ 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---------GALILKIIRGVFP------ 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHcCCCC------
Confidence 1 2235688999999999999999999999999999999999999864321 0011111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........+.+++.+|++.+|++||++.+|++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111223457788889999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.71 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=197.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999964 7889999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999996542 3677888899999999999999998 9999999999999999999999999998654321
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .............. +.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~-----~~ 219 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--MPLQLLQCIVDEDP-----PV 219 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--chHHHHHHHhccCC-----CC
Confidence 233578999999999999999999999999999999999999986532211000 00001111111110 11
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+... .....+.+++.+|++.+|++||+++++++.
T Consensus 220 ~~~~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVG---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111 112346678889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.02 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=202.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.+.||.|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57888899999999999999875 78899999975544 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999885432 236899999999999999999999998 99999999999999999999999999987632221
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
....+..|+|||++....++.++||||||+++|||++ |+.|+...... ........+.....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~~~----- 220 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------DVVPHVEKGYRMEA----- 220 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---------HHHHHHhcCCCCCC-----
Confidence 2334568999999988889999999999999999997 88887533210 11111111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.......+.+++.+|++.+|++||++++|+++|+++
T Consensus 221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111124566788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.54 Aligned_cols=250 Identities=34% Similarity=0.512 Sum_probs=202.5
Q ss_pred cccccCCceeEEEEEEcC----CcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQN----GKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||++.... +..+++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 788999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhhhhhhccc------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 503 KSLDVYIFDEAK------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 503 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
++|.+++..... ...+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367899999999999999999999988 99999999999999999999999999987765
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
...........+++.|+|||.+....++.++||||||+++|||++ |..|+..... ....+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~~~~~~~ 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------EEVLEYLRKGYRLPK 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCCCCCC
Confidence 432222334567889999999998899999999999999999999 5888764311 112222222111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.......+.+++.+|++.+|++||++.++++.|+
T Consensus 229 ---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 ---------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111345677888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.38 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=199.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|.+.++||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999975 6899999998753 2335567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988543 246889999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcceec------cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 578 QIEENTNRVVGTYGYMAPEYAM------EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~ 226 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQR 226 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 322 223357899999999986 456789999999999999999999998643221 01111111111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..... ........+.+++..|++ +|.+||++.++++.
T Consensus 227 ~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11110 011112335567778997 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.60 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=202.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CC---cEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NG---KEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.+|+..+.||+|+||.||+|+.. ++ ..+|+|++... .....+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999975 33 37999998654 344467789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|..++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999988532 346888999999999999999999998 99999999999999999999999999986643
Q ss_pred Cccccc-cccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIEEN-TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
...... ......++.|+|||++.+..++.++|||||||++|||++ |+.|+..... .............
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---------~~~~~~i~~~~~~- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---------HEVMKAINDGFRL- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---------HHHHHHHhcCCCC-
Confidence 322111 111223457999999998889999999999999999997 9999753321 0111111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+........+.+++.+|++.+|.+||++.+|++.|+++
T Consensus 230 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=320.03 Aligned_cols=242 Identities=20% Similarity=0.267 Sum_probs=192.3
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.||+|+||.||+++.. +++.+|+|++.+. .......+..|+++++.++||||+++++.+......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 6899999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 99887743 3468899999999999999999997 67 99999999999999999999999999875432211 1
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---------~~~~~i~~~~~------~~p~ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------KLFELILMEEI------RFPR 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---------HHHHHHhcCCC------CCCC
Confidence 23357999999999999999999999999999999999999998643210 01111111100 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM 696 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 696 (743)
. .. ..+.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~-~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 T-LS---PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C-CC---HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 12 2456778899999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.79 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=197.0
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChh
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLD 506 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 506 (743)
++||+|+||.||+|...+++.+|+|++.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999998889999999987654 333457889999999999999999999999999999999999999999
Q ss_pred hhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccc
Q 041312 507 VYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586 (743)
Q Consensus 507 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 586 (743)
+++... ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 887432 235788999999999999999999988 9999999999999999999999999987643322211 1123
Q ss_pred cccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 587 ~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
.++..|+|||++.+..++.++||||||+++|||++ |..||...... ........+... ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---------~~~~~~~~~~~~---------~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---------QAREQVEKGYRM---------SCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---------HHHHHHHcCCCC---------CCC
Confidence 44577999999998889999999999999999998 88887533210 011111111110 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
......+.+++.+|++.+|++||++.+|++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 122345778888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.88 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=215.0
Q ss_pred CcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 425 SSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.+.++||.|.||.|++|+++- ...||||.++.. .+.....|..|+.||.+++||||++|.|+.......+||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 567899999999999999862 356999999865 455678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
|++|+|+.||+... ..+.+.+...++++|+.|+.||-+.+ +|||||.+.||||+.+...|++|||+++.+..+.
T Consensus 712 MENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 712 MENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred hhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999997543 45888888999999999999999988 9999999999999999999999999999876554
Q ss_pred ccccccccc--cccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 EENTNRVVG--TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
....+...| ..+|.|||.+...+++.++||||||+++||.++ |.+|+..... .++...+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------------------QdVIkaI 847 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------------------QDVIKAI 847 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------------------HHHHHHH
Confidence 222222323 578999999999999999999999999999885 8999764432 2344445
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
+...+-+.+++-...|.+||++|||+|-.+||.+.+|+.+|+++..
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 5555555566666778899999999999999999999999987644
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.24 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=199.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-----hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-----GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|.+.+.||+|++|.||++... +++++|+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999965 68999999886432 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.. ...++...+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988743 345788888999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccc-cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEEN-TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--------MAAIFKIATQPTNP- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--------HHHHHHHhccCCCC-
Confidence 3221111 1235678899999999999999999999999999999999999753211 00111111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........+.+++.+|++.+|.+||++.++++.
T Consensus 227 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 --------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111122346678889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.57 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=191.1
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHH---HhcCCccEEeeeeeEecCCeeEEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALI---AQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l---~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
|++.+.||+|+||.||++... +++.||||++.+. .....+.+..|++++ ++++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999975 6899999998643 223345666776655 566899999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987763 346899999999999999999999998 99999999999999999999999999875422
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---------~~~~~i~~~~~~--- 219 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---------EVFDSIVNDEVR--- 219 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCC---
Confidence 21 1233467999999999999999999999999999999999999998643210 011111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.... ....+.+++.+||+.||.+|| ++.++++
T Consensus 220 ---~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0011 123456788899999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=305.86 Aligned_cols=254 Identities=27% Similarity=0.368 Sum_probs=191.2
Q ss_pred cccccCCceeEEEEEEcC---CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQN---GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.||+|+||.||+|...+ +..+|+|++.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 4679999886543 334457889999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc--ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 504 SLDVYIFDEAK--RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 504 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 234567778889999999999999998 9999999999999999999999999997544333222
Q ss_pred ccccccccccccCcceeccC-------CCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 582 NTNRVVGTYGYMAPEYAMEG-------LFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...... .. ......+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----~~----~~~~~~~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-----QV----LTYTVREQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-----HH----HHHHhhcccC
Confidence 22335678889999998642 35789999999999999996 99888643211 00 0111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
...++.+.. .....+.+++..|+ .+|++|||+.+|+..|+
T Consensus 229 ~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222222211 11223556777898 58999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.88 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=199.5
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|.+.++||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998877789999886433 34567899999999999999999998875 456899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999988543 2345788999999999999999999988 9999999999999999999999999998764332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....+. . .......+...
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~----~~~~~~~~~~~------- 222 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----E----VLEQVERGYRM------- 222 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H----HHHHHHcCCCC-------
Confidence 112345678999999998899999999999999999999 88887533210 0 11111111100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.........+.+++.+|++.+|++||++.+|+++|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111123456778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.36 Aligned_cols=255 Identities=30% Similarity=0.458 Sum_probs=203.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.++||+|+||.||++..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35789999999999999999998888899999986543 34577999999999999999999999999989999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.... ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999885432 245789999999999999999999998 999999999999999999999999999876543211
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .........+..
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---------~~~~~~~~~~~~------- 222 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---------REVLEQVERGYR------- 222 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCC-------
Confidence 1 112234568999999998899999999999999999998 8888753211 011111111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..........+.+++.+|++.+|++||++.+|.+.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011112356788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.64 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=201.3
Q ss_pred CCCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKM 494 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~ 494 (743)
-|.+.++||+|+||.||+++. .+++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999984 357889999987543 44557899999999999999999999998875 5689
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..+
T Consensus 85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999988432 235789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC------CCccccchhhHhHh
Q 041312 575 GGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG------SGSWNLVGHVWDLW 647 (743)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~------~~~~~~~~~~~~~~ 647 (743)
...... .......++..|+|||++.+..++.++|||||||++|||++++.|.......- ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433211 11223556778999999998889999999999999999999877643211100 00000000111111
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..+.. .+........+.+++.+|++.+|.+||++.+|++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 011111234577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.20 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=199.9
Q ss_pred CCCcCcccccCCceeEEEEEEcC-C---cEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN-G---KEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
+|++.+.||+|+||.||+|++.. + ..||||.+... ......+|..|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 57788999999999999999753 3 36999998754 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999888543 345788999999999999999999998 999999999999999999999999998766433
Q ss_pred cccccccc-cc--ccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 578 QIEENTNR-VV--GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 578 ~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
........ .. .+..|+|||++.+..++.++|||||||++|||++ |..|+...... . ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~----~~~~i~~~~~- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----D----VINAIEQDYR- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----H----HHHHHHcCCc-
Confidence 22111111 11 2457999999999999999999999999999886 99887533210 0 1111111100
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+ +........+.+++..|++.+|.+||++.+|+++|+.+
T Consensus 230 ------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------L--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00111123466788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.72 Aligned_cols=241 Identities=25% Similarity=0.300 Sum_probs=191.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCc-cEEeeeeeEecCCeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHR-NLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 497 (743)
+|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|+.++..+.|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788899999999999999976 5789999998753 234556788899999999765 6888999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888743 345788899999999999999999998 999999999999999999999999998753221
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~----~~~~i~~~~~----- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DE----LFQSIMEHNV----- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHcCCC-----
Confidence 1 122346799999999999999999999999999999999999999864321 01 1111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
.+ +......+.+++.+||+.+|.+||+.
T Consensus 219 -~~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SY----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01 11112346678889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.86 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=203.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
++|.+.++||+|+||.||+++.. ....+|+|.+... .......+..|+.+++++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888899999999999999742 2456899988754 334567789999999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+|+||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245888999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCcc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSW 637 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~ 637 (743)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------ 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987643322221222334567999999999999999999999999999999 7777643211
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.........+..... .......+.+++.+|++.+|++||++.+|++.|+.+..
T Consensus 243 ---~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 ---EELFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ---HHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 112222222211111 11112346678889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.69 Aligned_cols=242 Identities=23% Similarity=0.338 Sum_probs=191.9
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||+|+.. +++.||+|++.+. .....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 5889999998653 233456677899998876 799999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999888743 345788899999999999999999998 99999999999999999999999999875432221 1
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------~~~~~i~~~~~~------~-p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------DLFESILHDDVL------Y-P 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---------HHHHHHHcCCCC------C-C
Confidence 23467899999999999999999999999999999999999998743221 011111111100 0 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRP-------NMSAVVSM 696 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~ 696 (743)
... ...+.+++..||+.+|++|| ++.++++.
T Consensus 217 ~~~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWL---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCC---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011 23456788899999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.25 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=199.8
Q ss_pred CCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC-Ce
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE-QE 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~-~~ 492 (743)
++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999973 357889999997543 33456788999999999 789999999988654 56
Q ss_pred eEEEEEecCCCChhhhhhhccc----------------------------------------------------------
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK---------------------------------------------------------- 514 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 514 (743)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999988753210
Q ss_pred ------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccc
Q 041312 515 ------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588 (743)
Q Consensus 515 ------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 588 (743)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 124678888899999999999999998 99999999999999999999999999986533222122223445
Q ss_pred cccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHH
Q 041312 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAP 667 (743)
Q Consensus 589 t~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~ 667 (743)
++.|+|||++.+..++.++||||||+++|||++ |..|+..... .........++..... . ....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~-----~-~~~~- 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------DEEFCRRLKEGTRMRA-----P-DYTT- 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--------cHHHHHHHhccCCCCC-----C-CCCC-
Confidence 678999999999999999999999999999997 8888653211 0111111222211111 0 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 668 EILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 668 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..+.+++..|++.+|++||++.+|++.|+.+.
T Consensus 309 --~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 --PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred --HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 24677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.25 Aligned_cols=241 Identities=25% Similarity=0.320 Sum_probs=188.2
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|..++..+ +||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5888999998653 223445566677777654 899999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888743 345888899999999999999999998 9999999999999999999999999998643222 22
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .......... +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~----~~~~~i~~~~------~~~-- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----D----ELFDSILNDR------PHF-- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHcCC------CCC--
Confidence 3346799999999999999999999999999999999999999864321 0 1111111110 001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMS-AVVS 695 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 695 (743)
+......+.+++.+||+.+|++||++. ++++
T Consensus 216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 --PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111123356778899999999999975 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.17 Aligned_cols=271 Identities=27% Similarity=0.386 Sum_probs=203.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-----CCcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEec--CCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-----NGKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~ 493 (743)
++|++.+.||+|+||.||+++.. +++.+|+|.+...... ..+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777899999999999999854 3788999998755443 56789999999999999999999999887 5678
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 235889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF---LRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh---ccccccccccccHHHH
Confidence 6532211 11112344567999999988899999999999999999999998875432210 0000000000000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+.+...............+.+++.+|++.+|++||++.||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111111111224577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.18 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=198.6
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999975 68999999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998887543 2345889999999999999999999998 9999999999999999999999999998654222
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~-------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKED-------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhc--------
Confidence 1 12357899999999999999999999999999999999999998643211 0000011111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 696 (743)
...........+.+++..|++.||.+|| ++.++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0011112233466788899999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.36 Aligned_cols=241 Identities=25% Similarity=0.299 Sum_probs=191.6
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 497 (743)
+|.+.+.||+|+||.||+++.. +++.+|+|++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999976 57899999987542 23345677788888877 5899999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888743 345788999999999999999999998 999999999999999999999999999754322
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~----~~~~i~~~~~----- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DE----LFQSIMEHNV----- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HH----HHHHHHhCCC-----
Confidence 1 122346799999999999999999999999999999999999999864321 11 1111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
. .+......+.+++.+|++.+|.+|++.
T Consensus 219 ---~--~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---A--YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---C--CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 111122346678889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.12 Aligned_cols=236 Identities=25% Similarity=0.352 Sum_probs=188.4
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.+ +++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 5889999998643 233456777888888876 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999888743 345888999999999999999999998 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+... +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---------~~~~~i~~~~~~------~~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---------DLFEAILNDEVV------YPT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---------HHHHHHhcCCCC------CCC
Confidence 23467999999999999999999999999999999999999998643210 111111111110 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
. ....+.+++.+||+.||++||++
T Consensus 218 -~---~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 -W---LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -C---CCHHHHHHHHHHcccCHHHCCCC
Confidence 1 12345678889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.90 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=202.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
..+|++.+.||+|++|.||++... +++.+|+|.+........+.+.+|+.+++.+.|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 457889999999999999999964 6899999998766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999873 235788899999999999999999998 99999999999999999999999999876543321
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+. ............ .
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~------~ 235 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTP------E 235 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--------HhHHHHhcCCCC------C
Confidence 1 22346889999999999888999999999999999999999998643221 000111111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.. .......+.+++.+|++.+|++||++.+|++
T Consensus 236 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 LQN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC--ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 1112234667888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.22 Aligned_cols=243 Identities=23% Similarity=0.271 Sum_probs=192.0
Q ss_pred cccccCCceeEEEEEE----cCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 428 NKLGEGGFGSVYKGVL----QNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
+.||+|+||.||+++. .+|+.+|+|++.+.. ......+..|++++++++||||+++++.+.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999885 358899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 9999888743 345889999999999999999999998 99999999999999999999999999986543211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......... .+.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~----~~~~i~~~~~------~~p 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KE----TMTMILKAKL------GMP 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HH----HHHHHHcCCC------CCC
Confidence 22346789999999999998899999999999999999999999864321 00 1111111110 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHH--HHHHh
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSA--VVSML 697 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e--vl~~L 697 (743)
.. . ...+.+++.+||+.||++||++.+ +.+.|
T Consensus 219 ~~-~---~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~ 252 (318)
T cd05582 219 QF-L---SPEAQSLLRALFKRNPANRLGAGPDGVEEIK 252 (318)
T ss_pred CC-C---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 11 1 234567788999999999999666 44444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.11 Aligned_cols=265 Identities=27% Similarity=0.454 Sum_probs=212.2
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+...+.++||+|-||.|..++...+..||||+++..... ...+|..|+++|.+|+|||||+++++|..++.+.+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345778999999999999999988899999999876544 4589999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++..+.... +.-.....|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++-+-..+.-
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999997653332 445566789999999999999988 999999999999999999999999999976655554
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHH--hcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII--LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ell--tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
....+.+-..+|||||.+.-++++.++|||+||+++||++ +..+|+.....+ ...+..-.++..+.....+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~~~~l-- 766 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGRQVVL-- 766 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCcceec--
Confidence 4445566678999999999999999999999999999987 466777654321 1111122222222222111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.....++. .+.++++.||..+-++||++++|...|+...
T Consensus 767 -~~P~~cp~---~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 767 -SRPPACPQ---GLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -cCCCcCcH---HHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11223333 3557999999999999999999999987643
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.27 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=202.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.++||+|+||.||++....+..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578899999999999999999888888999988643 3345688999999999999999999999887 7789999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999988543 2345788889999999999999999988 999999999999999999999999999866433221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....++..|+|||++....++.++|+|||||++|++++ |+.|+..... .. .......+....
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~----~~~~~~~~~~~~----- 223 (260)
T cd05073 159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PE----VIRALERGYRMP----- 223 (260)
T ss_pred c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HH----HHHHHhCCCCCC-----
Confidence 1 122345677999999998889999999999999999999 8888753221 00 111111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
........+.+++.+|++.+|++||++.+|+++|+.
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111222457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.07 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=198.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc--EEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK--EIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+|.++ ++. .+|+|++... .......+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999975 454 4678877543 344556889999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 497 YEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999885432 1235789999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~ 231 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------E 231 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---------H
Confidence 99999998643211 11111234567999999988889999999999999999998 89887532210 0
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..+....+...+ ........+.+++.+|++.+|++||++.+++++|+.+
T Consensus 232 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 232 LYEKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111110000 0111123467788899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=314.71 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=190.3
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.. +++.+|+|++.+.. ....+.+..|+.++.++ +|+||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997542 33456788999999888 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999887743 346889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ................. . +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~-~-----~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKPI-R-----IPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCCC-C-----CCC
Confidence 234679999999999999999999999999999999999999996433211 11111122222211110 0 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
.....+.+++.+||+.||.+||++
T Consensus 225 ----~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 ----FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 111345678889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.25 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=192.9
Q ss_pred ccccCCceeEEEEEEc---CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCC
Q 041312 429 KLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999986553 334567999999999999999999999875 457899999999999
Q ss_pred hhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc-c
Q 041312 505 LDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN-T 583 (743)
Q Consensus 505 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~-~ 583 (743)
|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.+||+|||++..+........ .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988753 2346889999999999999999999998 99999999999999999999999999986543322111 1
Q ss_pred ccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 584 ~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
....++..|+|||.+....++.++|||||||++|||++ |..|+...... .+......+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------~~~~~~~~~~~~--------- 217 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---------EVMSFIEQGKRL--------- 217 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---------HHHHHHHCCCCC---------
Confidence 11233578999999988889999999999999999996 99887643210 111222211111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..+......+.+++.+|++.+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11112234456788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.63 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=201.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-C---CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-N---GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.+|++.+.||+|+||.||+|+.. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999864 2 3479999986543 34457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 245788999999999999999999998 99999999999999999999999999987653
Q ss_pred Ccccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
..... ......++..|+|||++.+..++.++||||||+++||+++ |..|+...... . ......++...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~----~~~~~~~~~~~- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----D----VIKAIEEGYRL- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----H----HHHHHhCCCcC-
Confidence 32211 1111233568999999998899999999999999999886 99987643210 0 11111111100
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+........+.+++.+|++.+|.+||++.+|+++|+.+
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 --------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01111223467888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.87 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=191.5
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||+|+||.||+++.+ +|+.+|+|++.... ......+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999975 68999999986431 22334566799999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 585 (743)
..++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 8887543 2335788889999999999999999998 99999999999999999999999999987643321 223
Q ss_pred ccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 586 ~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+....... . ............. . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~-~~~~~~~~~~~~~----~--~~~~-- 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----A-KEELKRRTLEDEV----K--FEHQ-- 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----h-HHHHHHHhhcccc----c--cccc--
Confidence 568999999999999899999999999999999999999986432110 0 0001111111110 0 0000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.....+.+++..||+.+|++||+++|+++.+
T Consensus 221 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 -NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1123456788899999999999998776444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.35 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=204.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
.+|++.+.||+|+||.||+++.. ....+|+|.+... .....+++.+|+.+++++ +|+||+++++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 1236899988644 334567899999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999885421 1235788889999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCcc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSW 637 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~ 637 (743)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999986644322222222344567999999999999999999999999999998 7777643211
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCC
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPS 704 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 704 (743)
.........+.... ........+.+++.+|++.+|++||++.+|++.|+.+....
T Consensus 243 ---~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 ---EELFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11112222111111 11112235668888999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=303.25 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=197.8
Q ss_pred cccccCCceeEEEEEEcC--C--cEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQN--G--KEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999999753 3 3689999987655 667789999999999999999999999988 889999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc-c
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE-E 581 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~-~ 581 (743)
++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998865432 46889999999999999999999998 999999999999999999999999999876542211 1
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||++.+..++.++|||||||++|||++ |+.|+...... .. ............
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~---~~~~~~~~~~~~------ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QI---LKKIDKEGERLE------ 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HH---HHHHHhcCCcCC------
Confidence 1223456789999999999899999999999999999998 99987532210 00 111111110000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
........+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01111245677888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.52 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=200.5
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.+|++.+.||+|+||.||++...++..+|+|++.... .....+.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999986442 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999887532 235788889999999999999999988 9999999999999999999999999998664332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....++..|+|||++.++.++.++||||||+++|||++ |+.|+..... .........+. ....+.
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~--~~~~~~- 224 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---------SEVVETINAGF--RLYKPR- 224 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---------HHHHHHHhCCC--CCCCCC-
Confidence 112234678999999998889999999999999999998 8888753221 01111111110 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
. ....+.+++.+||+.+|++||++.+|++.|.
T Consensus 225 ---~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ---L---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---C---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 1245778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=325.54 Aligned_cols=263 Identities=18% Similarity=0.224 Sum_probs=195.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
...|.+.++||+|+||.||++.+. .++.||||... ...+.+|+++|++++|+|||++++++......++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999986 57889999642 23457899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+. ++|..++... ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6777766432 236899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc--hh--
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM--EA-- 655 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 655 (743)
........||+.|+|||++.+..++.++|||||||++|||++|..++...... .........+.+.+...... +.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~-~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG-DERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcc-cccCCcHHHHHHHHHhhccccccCCC
Confidence 22223467999999999999999999999999999999999988765432211 01111111112221111100 00
Q ss_pred -cc------------cccCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 -VD------------KSLGESCCA-------PEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 -ld------------~~l~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. ......... .....+.+|+.+||+.||.+|||+.||++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000000 011246678889999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.66 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=197.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc---CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..+|.+.++||+|+||.||++... .++.||+|.+... ..+.+|+.++++++|+||+++++.+......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 4678999987543 24568999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
|++. ++|..++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5677766 23456899999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc-----
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA----- 652 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 652 (743)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.+.+.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS--SSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC--cHHHHHHHHHHhccCccccCCc
Confidence 33333334689999999999999999999999999999999999999986543211 00000111111000000
Q ss_pred --ch------hcccccCCCCCHH-------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 --ME------AVDKSLGESCCAP-------EILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 --~~------~ld~~l~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. ............+ ....+.+++.+||+.+|++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000001111110 12345678889999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.50 Aligned_cols=260 Identities=21% Similarity=0.312 Sum_probs=189.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--------C
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--------Q 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--------~ 491 (743)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999975 68899999885432 2345799999999999999999876432 2
Q ss_pred eeEEEEEecCCCChhhhhhh-cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeec
Q 041312 492 EKMLIYEYLPNKSLDVYIFD-EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFG 569 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFG 569 (743)
..++||||+++ +|..++.. ......+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999985 56555533 223456889999999999999999999998 99999999999998665 69999999
Q ss_pred cccccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...... .........+.
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-----~~~~~i~~~~~ 288 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-----DQLVRIIQVLG 288 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhC
Confidence 9987643321 2235789999999998764 6899999999999999999999998643211 01111111110
Q ss_pred cCCc----------c-----hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 649 EGTA----------M-----EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 649 ~~~~----------~-----~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.... . ......+...++......+.+|+.+||+.+|.+|||+.|+++.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 0 0000001000111112356788889999999999999999843
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=339.23 Aligned_cols=260 Identities=19% Similarity=0.288 Sum_probs=199.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999975 58999999987532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc--------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 498 EYLPNKSLDVYIFDEA--------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999875421 1234566778899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc----------------ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC
Q 041312 570 MARIFGGDQI----------------EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633 (743)
Q Consensus 570 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~ 633 (743)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986621110 00112357999999999999999999999999999999999999998642210
Q ss_pred CCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-NMSAVVSMLGSD 700 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 700 (743)
... . ........+ +.. .......+.+++.+|++.||++|| +++++++.|+..
T Consensus 238 ----ki~---~----~~~i~~P~~--~~p--~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 ----KIS---Y----RDVILSPIE--VAP--YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhh---h----hhhccChhh--ccc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 0 000000000 000 001123456788899999999995 667777777544
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=321.58 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=195.6
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-----eeE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-----EKM 494 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~ 494 (743)
+|++.++||+|+||.||++... +++.||||++... .....+++.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999975 7899999998643 2334567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+. ++|...+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46666653 3346889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc-
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA- 652 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 652 (743)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+. .....+.+.......
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSLE 227 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCHH
Confidence 433221 12234678999999998874 4789999999999999999999998643221 011111111000000
Q ss_pred ---------ch-hcccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 ---------ME-AVDKSLGE-------SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 ---------~~-~ld~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. +....... .........+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 00000000 0011113456788889999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.89 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=197.1
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
....++|++.+.||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.+++.++||||+++++.+.+....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 344578999999999999999999976 6889999998642 223445678999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|..++.. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999988743 34788888899999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcceeccC----CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEG----LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..........
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~ 262 (371)
T cd05622 192 MNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNH 262 (371)
T ss_pred cCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence 6433221 12346799999999998754 378999999999999999999999874321 0111111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATD--RPNMSAVVSML 697 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 697 (743)
.......+ .......+.+++..||+..+.+ ||++.+|++..
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111 1111233556777899844433 78999888853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.69 Aligned_cols=237 Identities=23% Similarity=0.291 Sum_probs=186.0
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHH-HHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIA-LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||+||+++.. +++.||+|++.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 68999999986432 223344555554 56789999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999888743 346788889999999999999999998 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...+....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~-~~~~~i~~~~~------~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------A-EMYDNILNKPL------RLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------H-HHHHHHHcCCC------CCCC
Confidence 3346799999999999999999999999999999999999999864321 0 01111111110 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMS 691 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 691 (743)
. ....+.+++.+||+.+|.+||++.
T Consensus 218 ~----~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 N----ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 123466788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.70 Aligned_cols=258 Identities=29% Similarity=0.426 Sum_probs=208.3
Q ss_pred ccccCCceeEEEEEEcC-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChhh
Q 041312 429 KLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDV 507 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 507 (743)
+||+|.||+||.|++.+ ...+|||.+.....+...-+..|+.+.++|+|.|||+++|.+.+.+..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999764 56799999987777777889999999999999999999999999999999999999999999
Q ss_pred hhhhccccccc--CHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEeeeccccccCCCccccccc
Q 041312 508 YIFDEAKRSLL--DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARIFGGDQIEENTN 584 (743)
Q Consensus 508 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~~~~~~~~~~~~ 584 (743)
+|.. +-+++ ++...--+.+||++||.|||.+. |||||||-+|+||+ -.|.+||.|||.++.+..- ...+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9853 33445 67788889999999999999988 99999999999996 5788999999999877533 34456
Q ss_pred cccccccccCcceeccC--CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 585 RVVGTYGYMAPEYAMEG--LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 585 ~~~gt~~y~aPE~~~~~--~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
...||..|||||++..+ .|+.++|||||||++.||.||++||....+. ...+++-+..+ ...
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----------qAAMFkVGmyK------vHP 798 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----------QAAMFKVGMYK------VHP 798 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----------hHhhhhhccee------cCC
Confidence 68899999999999876 4899999999999999999999998754321 11122222111 122
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhcCCCCCCCCCCC
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS--MLGSDNAPSSPKHP 709 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p~~~ 709 (743)
+.+.+-.++...++++|+..+|.+||+++++++ .|+--...+.|+.+
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 334445567788999999999999999999986 34433334444443
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.43 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=198.4
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.+++.+.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++......++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34455656679999999999999965 67889999988776677788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~~~~ 576 (743)
||+++++|.+++.........+...+..++.||+.||.|||+++ |+|+||||+||+++. .+.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999998864322212277888889999999999999988 999999999999976 67899999999876543
Q ss_pred CccccccccccccccccCcceeccCC--CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
... ......|++.|+|||++.... ++.++||||||+++|+|++|+.|+...... ... .+.. . ...
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~--~~~~---~-~~~ 228 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAA--MFKV---G-MFK 228 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhh--Hhhh---h-hhc
Confidence 221 122245789999999987643 788999999999999999999997532110 000 0000 0 000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. ...+......+.+++.+||+.+|.+||++.+|++.
T Consensus 229 -~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -IH----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -cC----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 11111122346678889999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.85 Aligned_cols=249 Identities=33% Similarity=0.442 Sum_probs=194.8
Q ss_pred cccccCCceeEEEEEEcC----CcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQN----GKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 36899999875543 35568899999999999999999999875 5568999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc-
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE- 581 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~- 581 (743)
++|.+++... ..+++..+..++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 36789999999999999999999988 9999999999999999999999999998764332211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .. ............
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~----~~~~~~~~~~~~------ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AE----VIAMLESGERLP------ 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HH----HHHHHHcCCcCC------
Confidence 1111223567999999998999999999999999999998 8988754321 11 111121111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
........+.+++.+|++.+|++||++.+|+++|+++.
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11111235667888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.69 Aligned_cols=240 Identities=25% Similarity=0.329 Sum_probs=189.1
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||+++.. +++.||+|++++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 68899999987532 23445677788888764 899999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888743 345788899999999999999999998 9999999999999999999999999987432111 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...+...... +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~----~~~~~~~~~~------~~~~~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----D----ELFESIRVDT------PHYPR 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHhCC------CCCCC
Confidence 2346799999999999999999999999999999999999999864321 0 1111111111 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMS-AVV 694 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 694 (743)
.. ...+.+++.+||+.||++||++. +++
T Consensus 218 -~~---~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -WI---TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CC---CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 23456788899999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.01 Aligned_cols=202 Identities=26% Similarity=0.394 Sum_probs=174.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||.||+++.. +++.+|+|++... .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 6899999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998843 345888999999999999999999998 999999999999999999999999998754321
Q ss_pred ccc---------------------------------cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCC
Q 041312 578 QIE---------------------------------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624 (743)
Q Consensus 578 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~ 624 (743)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 041312 625 NNTFH 629 (743)
Q Consensus 625 p~~~~ 629 (743)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=303.48 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=187.5
Q ss_pred cccccCCceeEEEEEEcC---CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQN---GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
++||+|+||.||+|.... ...+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997543 4568888876443 334567889999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc--ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 504 SLDVYIFDEAK--RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 504 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|.+++..... ....++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 233567778899999999999999998 9999999999999999999999999987543322211
Q ss_pred ccccccccccccCcceecc-------CCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 582 NTNRVVGTYGYMAPEYAME-------GLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
......+++.|+|||++.. ..++.++|||||||++|||++ |..|+....+. .. ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~---~~~~~~-~~~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QV---LKQVVR-EQDI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HH---HHHHhh-ccCc
Confidence 1223455778999998743 456889999999999999999 66676532210 00 111111 1111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.+..+.+... .. ..+.+++..|+ .+|++||++++|+++|.
T Consensus 229 ~~~~~~~~~~-~~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLK-YS---DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCccccc-CC---HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222222111 12 23445666777 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.69 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=196.5
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEe-cCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI-EEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~ 500 (743)
++|.+.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.++++++|+|++++++++. +....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999765 7789999885432 3567899999999999999999999765 456789999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999987543 2335788999999999999999999998 9999999999999999999999999987643221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
....++..|+|||++.+..++.++|||||||++|||++ |+.|+..... .. .......+....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~~~~----- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KD-VVPRVEKGYKMD----- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHhcCCCCC-----
Confidence 22344568999999998889999999999999999998 8888653211 11 111111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+ .......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 A----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 111123466788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.37 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=207.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.-|...+.||+|.|..|-++++- +|+.||||++.+.. .-...++.+|++.|+.++|||||+++++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34666789999999999999865 89999999998764 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe-cCCCCeEEeeeccccccCCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL-DAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~vkl~DFGla~~~~~~ 577 (743)
+-.+|+|.++|.++. ..+.+....+++.||+.|+.|+|+.. +|||||||+|+.+ ..-|-|||.|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996543 46889999999999999999999988 9999999999987 56788999999999877554
Q ss_pred ccccccccccccccccCcceeccCCCCc-cccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFST-KSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
+. ....+|...|-|||++.+..|+. ++||||||||||.|++|+.||....+. +.+.-++
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmIm 232 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIM 232 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhh
Confidence 42 34579999999999999999875 799999999999999999998743321 1122233
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
|-. -..+..-..++.+|+..||+.||.+|.+.++|+..
T Consensus 233 DCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 321 12344455678999999999999999999999875
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=311.52 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=189.4
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHh-cCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQ-LQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999987542 2334566778888876 4999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988743 345788899999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .......... +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~----~~~~~i~~~~------~~~~~ 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----E----ELFQSIRMDN------PCYPR 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHhCC------CCCCc
Confidence 2346789999999999999999999999999999999999999864321 0 1111111111 00111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMS-AVVS 695 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 695 (743)
.. ...+.+++.+||+.+|++||++. ++.+
T Consensus 218 -~~---~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 -WL---TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -cC---CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11 23456788899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.54 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=198.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|+..+.||+|+||.||++... ++. .+|+|.+.... .....++.+|+.++++++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46788899999999999999864 444 47889886543 33345788999999999999999999998754 5679
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999887532 335788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............++..|+|||++.+..++.++|||||||++|||++ |+.|+..... ....+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHCCCCCC
Confidence 4332222223445778999999998999999999999999999997 8888753211 11112222111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
........+..++..|+..+|++||++++|++.|+.+.
T Consensus 232 ---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 ---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111235677888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=301.29 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=200.5
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 6889999988643 3445678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ....++...+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998877432 2345788899999999999999999998 99999999999999999999999999976643221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..... .. .......+.... +
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~~~-~---- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KN-LILKVCQGSYKP-L---- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HH-HHHHHhcCCCCC-C----
Confidence 12235688999999999988899999999999999999999999863211 00 111111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+......+.+++.+||+.+|++||++.+|++.
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11112346678889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.62 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=187.3
Q ss_pred cccccCCceeEEEEEEcC-------------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 428 NKLGEGGFGSVYKGVLQN-------------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
+.||+|+||.||+|+... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358899887655555668899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC-------eEEee
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN-------PKISD 567 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-------vkl~D 567 (743)
+||||+++++|+.++.. +...+++..++.++.||++||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345889999999999999999999998 999999999999986654 89999
Q ss_pred eccccccCCCccccccccccccccccCcceec-cCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHh
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
||++...... ....++..|+|||.+. +..++.++|||||||++|||++ |+.|+...... ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------~~~~ 220 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---------EKER 220 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---------HHHH
Confidence 9998754322 2245788999999887 4678999999999999999984 66665432110 0001
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
... ... . + ..+....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ~~~-~~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYE-GQC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHh-cCc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 100 0 0 1111235677888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.18 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=201.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.++||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 468999999999999999999964 7999999999766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999873 235788899999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. .+. .....+. +.
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~----~~~----~~~~~~~------~~ 234 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALY----LIATNGT------PE 234 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch----hee----eeccCCC------CC
Confidence 1 223568899999999999889999999999999999999999986432210 000 0000000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.. .......+.+++.+|++.+|++||++++|++
T Consensus 235 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQN--PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0111233567888999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.03 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=172.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||.||++... ++..+|+|.+... ......++.+|++++++++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999975 6888999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++... ..+++..+..++.||++||.|||+ .+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998532 457889999999999999999997 46 9999999999999999999999999987653221
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2335788999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.72 Aligned_cols=251 Identities=31% Similarity=0.482 Sum_probs=196.5
Q ss_pred cccccCCceeEEEEEEcC-------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVLQN-------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2578999886543 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc----cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-----CeEEeeecc
Q 041312 500 LPNKSLDVYIFDEA----KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-----NPKISDFGM 570 (743)
Q Consensus 500 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-----~vkl~DFGl 570 (743)
+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234788999999999999999999988 99999999999999877 899999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+................++..|+|||++.+..++.++|||||||++|||++ |+.|+..... .. .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~----~~~~~~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QE----VLQHVTA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HH----HHHHHhc
Confidence 986643332222223355788999999999999999999999999999998 8888753221 11 1111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
+.... ........+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 229 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRLQ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCccC---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11110 111122456788889999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=306.40 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=196.1
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999975 68999999986542 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998875422 235888999999999999999999988 99999999999999999999999999876532221
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ........... . ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~--~----~~~ 223 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKE--V----QEE 223 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhh--h----hhh
Confidence 123478999999999999999999999999999999999999987432110 00000010000 0 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
.... ....+.+++..||+.+|++||| +.|+++
T Consensus 224 ~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEK----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCcc----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1111 1223567888999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.75 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=199.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|.+.++||+|+||.||+++.. +++.+|+|.++.........+++|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46888899999999999999975 68899999987665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999998743 346889999999999999999999998 9999999999999999999999999987654322
Q ss_pred cccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 581 ENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+.. ............
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--------~~~~~~~~~~~~---- 228 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMTKSNFQP---- 228 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--------hHHhhhccCCCC----
Confidence 1123357899999999874 4568899999999999999999999975332110 000000100000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+.+.... .....+.+++.+|++.+|++||++++|++.
T Consensus 229 ~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0010000 111346678889999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=297.87 Aligned_cols=258 Identities=21% Similarity=0.246 Sum_probs=207.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
+.|+.++.||.|.-|+||++++++ +..+|+|++.+. ..+...+.+.|-+||+.++||.|+.|+..+..+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778999999999999999874 689999999865 3556678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC-
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG- 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~- 576 (743)
|||+||+|..++..+ ..+.+++..+.-++..++-||+|||-.| ||.|||||+||||.++|++-|.||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999998887543 4557888888899999999999999998 99999999999999999999999998743210
Q ss_pred ----------------------------C-----c--------------------cccccccccccccccCcceeccCCC
Q 041312 577 ----------------------------D-----Q--------------------IEENTNRVVGTYGYMAPEYAMEGLF 603 (743)
Q Consensus 577 ----------------------------~-----~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 603 (743)
. . ........+||-.|+|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0012234689999999999999999
Q ss_pred CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccC
Q 041312 604 STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQ 683 (743)
Q Consensus 604 ~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~d 683 (743)
+.++|.|+|||++|||+.|.-||...... .....++-+.+.-+-.+.....+.+|++..|..|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~-----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch-----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999998754321 1111222222222222233455778888999999
Q ss_pred CCCCCC----HHHHHHH--hcCC
Q 041312 684 ATDRPN----MSAVVSM--LGSD 700 (743)
Q Consensus 684 P~~RPs----~~evl~~--L~~~ 700 (743)
|.+|-- +.||-+. ++++
T Consensus 376 P~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hhhhhccccchHHhhcCccccCC
Confidence 999988 8888763 4554
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.97 Aligned_cols=238 Identities=21% Similarity=0.285 Sum_probs=186.8
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHH-HHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIA-LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.. +|+.+|+|++.+. .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 6899999998643 2233345555655 56779999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988774 3346889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------~~~~~~~~~~~------~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---------EMYDNILHKPL------VLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---------HHHHHHHcCCc------cCCC
Confidence 23467999999999999999999999999999999999999998643210 11111111111 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSA 692 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 692 (743)
.....+.+++..|++.+|.+||++.+
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 12234567888999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.40 Aligned_cols=199 Identities=27% Similarity=0.371 Sum_probs=168.2
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ---- 491 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~---- 491 (743)
...++|++.++||+|+||.||+++.. +++.+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45678999999999999999999975 6899999998653 3344567889999999999999999999986543
Q ss_pred --eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 492 --EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 492 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
..++||||++++ |...+. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 579999999764 444431 23778888899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 997643221 123357899999999999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=313.62 Aligned_cols=242 Identities=25% Similarity=0.305 Sum_probs=192.5
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.. +++.+|+|++.+. .......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 5889999998753 233456678899999888 799999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999887743 335889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ .+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---------~~~~~~i~~~~~------~~~~ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---------DELFQSILEDEV------RYPR 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---------HHHHHHHHcCCC------CCCC
Confidence 2335789999999999999999999999999999999999999864321 011111111111 0001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNM-----SAVVSM 696 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 696 (743)
.....+.+++.+||+.||.+||++ .++++.
T Consensus 218 ----~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 ----WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 112346678889999999999999 877653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.85 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=198.6
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
+|++.+.||.|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 23346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998432 35788889999999999999999988 99999999999999999999999999886532
Q ss_pred Cc----cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 577 DQ----IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 577 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... . ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~ 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------A-AMFYIGAHRGL 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------H-HHHHhhhccCC
Confidence 11 111122356889999999999988999999999999999999999998642210 0 00000000000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.+ .......+.+++.+||+.+|++||++.++++
T Consensus 227 ----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 1122344677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.00 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=201.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.+.||+|+||.||+++.+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999964 3567999988654433 5678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccc------cccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 495 LIYEYLPNKSLDVYIFDEAKR------SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
+||||+++++|.+++...... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 25899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
|++......... ......++..|+|||.+.+...+.++||||||+++|+|++ |..|+..... .......
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---------~~~~~~~ 231 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---------EEVLNRL 231 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---------HHHHHHH
Confidence 998754332211 1223456778999999988889999999999999999999 6667642211 0011111
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
..+..... ........+.+++.+|++.+|++||++.+++++|+.
T Consensus 232 ~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 232 QAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111110 011122356778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.86 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=193.2
Q ss_pred cccccCCceeEEEEEEcC-Cc--EEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQN-GK--EIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+|+..+ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999753 43 4688888643 344556889999999999 899999999999999999999999999
Q ss_pred CChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 503 KSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 503 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885422 1235788999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... . .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~----~~~~~~~ 225 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A----ELYEKLP 225 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----H----HHHHHHh
Confidence 98632211 11111233567999999988889999999999999999997 9988753211 0 0111111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+...+ ........+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 226 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 226 QGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 111111 0111123467888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.93 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=201.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999976 68899999986543 44556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999988743 26889999999999999999999988 99999999999999999999999999987754321
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......+++.|+|||++.+..++.++||||||+++|+|++|+.|+....+ ..............
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---------~~~~~~~~~~~~~~----- 217 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---------MRVLFLIPKNNPPS----- 217 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---------HHHHHHhhhcCCCC-----
Confidence 22335788899999999998899999999999999999999999853221 00111111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.... ....+.+++.+|++.+|++||+++++++
T Consensus 218 ~~~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNK---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Ccccc---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11110 2234667888999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.24 Aligned_cols=196 Identities=26% Similarity=0.357 Sum_probs=170.5
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-C-----ccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-H-----RNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h-----~niv~l~~~~~~~~~~~l 495 (743)
+|.+.+.||+|.||.|.++.+. +++.||||+++ .......+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK-N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK-NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeec-cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999965 69999999995 44556677889999999997 4 389999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC--CCeEEeeeccccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA--MNPKISDFGMARI 573 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~vkl~DFGla~~ 573 (743)
|+|.+ ..+|.+++... +...++...+..++.||+.||.+||+.+ |||+||||+||||... ..|||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 66898888654 3445899999999999999999999888 9999999999999643 4699999999998
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
....-. ....+..|+|||++.+.+|+.+.||||||||++||++|.+-|...
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 654432 366788999999999999999999999999999999997766543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=312.96 Aligned_cols=199 Identities=18% Similarity=0.253 Sum_probs=165.8
Q ss_pred cCcccccC--CceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 426 SDNKLGEG--GFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 426 ~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++++||+| +|++||+++.+ +|+.||+|++... .....+.+++|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999875 7899999998654 2344567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc-
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI- 579 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~- 579 (743)
++++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+++.||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999885432 234788999999999999999999998 99999999999999999999999986544321110
Q ss_pred ----ccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 580 ----EENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 580 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011122456788999999976 4589999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.64 Aligned_cols=197 Identities=27% Similarity=0.446 Sum_probs=160.3
Q ss_pred CcccccCCceeEEEEEEc---CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEEEEEecC
Q 041312 427 DNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKMLIYEYLP 501 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 501 (743)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++.+.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999965 46789999986432 23457889999999999999999999864 456789999986
Q ss_pred CCChhhhhhhc------ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe----cCCCCeEEeeeccc
Q 041312 502 NKSLDVYIFDE------AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMA 571 (743)
Q Consensus 502 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~vkl~DFGla 571 (743)
+ +|..++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666665321 12235888999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCccc-cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 572 RIFGGDQIE-ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 572 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
+.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876533221 223346789999999998774 5899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=305.97 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=199.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999976 7899999988654 334457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|..++........+++..+..++.||+.||.|||++ + |+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988875443344789999999999999999999964 6 9999999999999999999999999997653221
Q ss_pred cccccccccccccccCcceeccC------CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEG------LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...... ..... .........
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~~~~ 227 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQ-LSAIVDGDP 227 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHH-HHHHhhcCC
Confidence 2235678899999998554 3588999999999999999999998642110 00000 000111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. .........+.+++.+|++.+|++||++.++++.
T Consensus 228 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 P---------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C---------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 1112233456678889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.84 Aligned_cols=237 Identities=22% Similarity=0.287 Sum_probs=185.5
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHH-HHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIA-LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||+++.. +++.+|+|++.+.. ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 68899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999877743 345778888899999999999999988 9999999999999999999999999987532221 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~i~~~~--------~-- 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---------SQMYDNILHKP--------L-- 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---------HHHHHHHhcCC--------C--
Confidence 3346789999999999999999999999999999999999999864321 00111111111 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMS 691 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 691 (743)
..+......+.+++.+||+.+|.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112234567788899999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.63 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=202.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEccc--CChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSR--SSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV 496 (743)
..+.|+++++||.||.+.||++...+.+.+|+|++.. ...+.+.-|.+|+.+|.+|+ |.+||+++++-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3467999999999999999999988888999998753 36677889999999999995 89999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||- ..+|..+|..... ....| .+..+..|++.++.++|.++ |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9974 6688888754322 22223 66789999999999999999 99999999999995 46899999999999888
Q ss_pred CccccccccccccccccCcceeccCC-----------CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGL-----------FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
+........-+||+.||+||.+.... .+.++||||||||||+|+.|+.||..-.. . +.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~----~a 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------Q----IA 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------H----HH
Confidence 77776666789999999999885432 56789999999999999999999863211 1 11
Q ss_pred HhccCCcchhcccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 646 LWKEGTAMEAVDKSLGESCC-APEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
++..+.++...-+++ ...-..++++|..||+.||.+||+..+|++.
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122334432211111 1111228899999999999999999999874
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.73 Aligned_cols=252 Identities=29% Similarity=0.435 Sum_probs=198.3
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHH--HHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIE--EFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
|++.+.||+|+||+||+++.. +++.+|+|++......... ....|+.++++++|+||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999987 4678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++. ....+++..+..++.||++||.+||+.+ |+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999885 4556899999999999999999999998 99999999999999999999999999986411 12
Q ss_pred cccccccccccccCcceec-cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+..... .......... . .......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~~~~~-~---~~~~~~~- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEIIEKI-L---KRPLPSS- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHHHHHH-H---HTHHHHH-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----hhhhhhhhhc-c---ccccccc-
Confidence 2334467899999999998 78899999999999999999999999774310 0000000000 0 0000000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... .......+.+++..||+.+|++||++.++++
T Consensus 223 ~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0001156778888999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.71 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=200.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+.|++.++||.|+||.||+|+.. +++.+++|.+........+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999976 58899999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|..++... ...+++..+..++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998876432 345889999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 581 ENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
......+++.|+|||++. ...++.++|||||||++|||++|+.|+....+ ....... ........
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~-~~~~~~~~ 235 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKI-AKSEPPTL 235 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHH-hcCCCccC
Confidence 122356788999999985 34578899999999999999999999753221 0001111 11111000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. .......+.+++.+||+.+|++||++.+|++.
T Consensus 236 ~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 SQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 11112346678889999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.61 Aligned_cols=249 Identities=26% Similarity=0.451 Sum_probs=197.5
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh---------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG---------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... +..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999975 688999998864322 223678899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999998843 345788889999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 573 IFGGDQIE----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 573 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~-~~ 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFK-IG 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHH-Hh
Confidence 76532111 1112346788999999999989999999999999999999999998642110 00111 00
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ...+.+ +......+.+++.+||+.+|.+||++.+|++
T Consensus 226 ~-----~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E-----NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-----cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 011111 1122345667888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=304.40 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=196.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC------C
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE------Q 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~------~ 491 (743)
+...|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +|+||+++++.+... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999975 68889999986543 4456788999999998 799999999998753 4
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 579999999999999987542 2346889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
........ ......|++.|+|||++. +..++.++|||||||++|||++|+.|+....+. . ....
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~--~~~~ 227 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------R--ALFL 227 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------H--HHHH
Confidence 86543221 223467899999999986 346888999999999999999999998532211 0 0000
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........ +.... ....+.+++.+||+.+|.+|||+.+|+.
T Consensus 228 ~~~~~~~~-----~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNPAPR-----LKSKK---WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCCCCC-----CCCCC---cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 01111111 11111 1234677888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.17 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=198.5
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
|++.++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++.+......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999976 5788899998766666778899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 999887643 2346889999999999999999999998 99999999999999999999999999876532221 1
Q ss_pred cccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 583 TNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.....+++.|+|||++. +..++.++|||||||++|||++|+.|+....+ .......... .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~-~~~~~~~ 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS-EPPTLAQ 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhc-CCCCCCC
Confidence 23356899999999984 34578899999999999999999999753221 0111111111 1111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.......+.+++.+||+.+|.+||++.++++.-
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 231 -------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 011123466788899999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=304.11 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=188.7
Q ss_pred cccccCCceeEEEEEEcC--------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVLQN--------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+.||.|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998642 335888888665556667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC--------eEEeeeccc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN--------PKISDFGMA 571 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------vkl~DFGla 571 (743)
+++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235788899999999999999999998 999999999999987665 699999988
Q ss_pred cccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCC-CCCCcccCCCccccchhhHhHhcc
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRN-NTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
...... ....+++.|+|||++.+. .++.++||||||+++|||++|..+ +....+. . ......
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~----~~~~~~- 219 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----K----KLQFYE- 219 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----H----HHHHHH-
Confidence 754322 235678899999999874 579999999999999999999644 3321110 0 000000
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.. ...+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 220 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DR----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0111122245678888999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.03 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=201.2
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||+|+||.||+++... ++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999874 88999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998743 2346889999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||++.+..++.++||||||+++|+|++|+.|+....... .. ..... .....+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------~~-~~~~~-----~~~~~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AI-FMIPN-----KPPPTL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--------hh-hhhcc-----CCCCCC
Confidence 1223557889999999999899999999999999999999999986432210 00 00000 000001
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. .......+.+++.+|++.+|.+||++.+|++
T Consensus 220 ~~--~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred Cc--hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 1111235677888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=311.95 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=194.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|.+.++||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999976 68889999987443 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++ +|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 776666432 345788889999999999999999998 99999999999999999999999999976533221
Q ss_pred ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc---------
Q 041312 580 EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE--------- 649 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 649 (743)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ............
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 1223467899999998865 46899999999999999999999998643221 000001110000
Q ss_pred --CCcchhcc-cccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 --GTAMEAVD-KSLGE----SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 --~~~~~~ld-~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+ +.... .....-...+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 00000 000011223567888999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.05 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=190.6
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 497 (743)
+|+..+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999975 6899999998753 2334566788999998885 577888999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999888743 345889999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---------~~~~~i~~~~~----- 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---------ELFQSIMEHNV----- 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCC-----
Confidence 11 223457899999999999999999999999999999999999998643210 01111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
.+ +......+.+++.+|++.+|.+|++.
T Consensus 219 -~~----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SY----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CC----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00 11112345678889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.90 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=205.6
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
|.++.+||+|+||.||++.++ +|+.+|||++.. ...+.++..|+.++++++.+++|++++.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667789999999999999987 699999999754 45678899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
|+..+.+. .++++|.++++..+++..++||+|||... -||||||..|||++.+|.+||+|||.|..+......
T Consensus 113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-- 185 (502)
T KOG0574|consen 113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-- 185 (502)
T ss_pred CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh--
Confidence 99999985 35668999999999999999999999876 899999999999999999999999999877544332
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.+.+.|||-|||||++..-.|+.++||||||++..||.-|++|+..-.+-. +. -.+.....+..+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AI-----FMIPT~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AI-----FMIPTKPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------ee-----EeccCCCCCCCCC
Confidence 345899999999999999999999999999999999999999987544310 00 0011111121211
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+..-...+-++++.||-.+|++|.|+-++++.
T Consensus 252 --PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 --PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11223457788889999999999999887763
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=312.10 Aligned_cols=240 Identities=22% Similarity=0.259 Sum_probs=185.5
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHH-HHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEI-ALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+++.. +++.+|+|++.+.. ......+..|. .+++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57889999986432 22233444444 456789999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+....+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999888743 345677888889999999999999998 9999999999999999999999999997543221 12
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~----~~~~i~~~~~------~~~~ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----E----MYDNILNKPL------QLKP 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----H----HHHHHHhCCc------CCCC
Confidence 33467999999999999999999999999999999999999998643210 0 1111111100 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 694 (743)
.....+.+++..|++.+|.+||++.+.+
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 ----NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ----CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1123456777899999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=327.84 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=163.7
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC------ccEEeeeeeEe
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH------RNLVSILGCCI 488 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h------~niv~l~~~~~ 488 (743)
++....++|++.++||+|+||+||++.+. .++.||||++... ......+..|+.++++++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999975 5788999998543 2234456677777777654 45889998887
Q ss_pred cC-CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCC-----
Q 041312 489 EE-QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAM----- 561 (743)
Q Consensus 489 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~----- 561 (743)
.. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 54 5688999987 6777777643 34688999999999999999999974 7 99999999999998665
Q ss_pred -----------CeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 562 -----------NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 562 -----------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764321 123468999999999999999999999999999999999999998743
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.89 Aligned_cols=199 Identities=27% Similarity=0.369 Sum_probs=168.5
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE----- 490 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~----- 490 (743)
...++|.+.++||+|+||.||++... .++.+|||++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34578999999999999999999975 6889999998753 234456788999999999999999999987543
Q ss_pred -CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 491 -QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 491 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 5555542 23778888899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 998654322 123357899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.18 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=201.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++|+||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999965 68899999876543 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|..++.. ...+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999888743 3458899999999999999999997 45 999999999999999999999999998654222
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCc---cccchhhHhHhccCCcchh
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS---WNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 655 (743)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ............+.
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1234578999999999988899999999999999999999999987543211100 00111111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.+.+.. ......+.+++.+|++.+|++||++.||+++.
T Consensus 230 -~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000100 11223567788899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.36 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=200.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.+|++.++||+|+||.||+|..+ +++ .+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999965 333 58999886553 3456788999999999999999999999987 78899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999988543 334889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............++..|+|||.+....++.++||||||+++|||++ |+.|+..... .........+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~~~~ 231 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---------VEIPDLLEKGERLP 231 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---------HHHHHHHhCCCCCC
Confidence 3322211112233568999999988899999999999999999998 9998764321 01111111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+......+.+++.+|+..+|.+||++.++++.|+.+
T Consensus 232 ---------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 ---------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111123466788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.06 Aligned_cols=262 Identities=27% Similarity=0.371 Sum_probs=195.5
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.++||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 68999999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
++ ++|..++........+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777754444456899999999999999999999998 99999999999999999999999999976543221
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh-------HhHhccC-
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV-------WDLWKEG- 650 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~- 650 (743)
......+++.|+|||++.+. .++.++|||||||++|||++|+.|+....... ...... ...+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID----QLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhcch
Confidence 11224568899999988764 57899999999999999999999886432110 000000 0000000
Q ss_pred ---Ccchhcc----cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 ---TAMEAVD----KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ---~~~~~ld----~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.....++ ..+.. ........+.+++.+||+.||++|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000 00001234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.71 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=187.9
Q ss_pred cccccCCceeEEEEEEcCC---cEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 428 NKLGEGGFGSVYKGVLQNG---KEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
++||+|+||.||+++..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986433 346677765443 345678999999999999999999999999999999999999999
Q ss_pred Chhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 504 SLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 504 sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
+|.+++.... ....++...+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999886532 2234666777889999999999999988 99999999999999999999999999864322211122
Q ss_pred cccccccccccCcceecc-------CCCCccccchhHHHHHHHHHhc-CCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 583 TNRVVGTYGYMAPEYAME-------GLFSTKSDVYSFGVLLLEIILG-RRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDiwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.....++..|+|||++.. ..++.++|||||||++|||+++ ..|+....+ ........ .+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~-~~~~~~ 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVI-KDQQVK 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-hhcccc
Confidence 233567889999998753 2457899999999999999975 455532211 11111111 122223
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
+.++.+...+ ...+.+++..|+ .+|++||++++|+++|.
T Consensus 229 ~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333332222 233555777898 57999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.88 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|+..+.||.|+||.||.++.. +++.+++|++... ......++.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999864 6889999987643 345567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 346789999999999999999999988 99999999999999999999999999987644332
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......+++.|+|||++.+..++.++||||||++++||++|+.|+..... ...... ...+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~-~~~~~~~~~---- 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVK-IVQGNYTPV---- 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH-HHcCCCCCC----
Confidence 22335689999999999888899999999999999999999999764221 011111 111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.......+.+++.+|++.+|.+||++.++++.+
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111223466788899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.29 Aligned_cols=267 Identities=22% Similarity=0.351 Sum_probs=209.5
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||.|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+.+....++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999986 478999999987665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|..++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999998873 235789999999999999999999998 999999999999999999999999998865433221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+. ........ ..... +
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~-~~~~~-----~ 235 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIAT-NGTPE-----L 235 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-cCCcc-----c
Confidence 22356889999999999988999999999999999999999998643221 00001100 00000 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCCCCCCCCcccc
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDNAPSSPKHPAFIA 713 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~~p~~~~~~~ 713 (743)
... ......+.+++.+||+.+|++||++.+|++. +....+...+++..+-+
T Consensus 236 ~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~ 288 (296)
T cd06655 236 QNP--EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAA 288 (296)
T ss_pred CCc--ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCCccccch
Confidence 000 0111245678889999999999999999853 44445555555444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.11 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=198.6
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666789999999999999875 57889999886443 445668899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++. ...+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999988873 245788899999999999999999988 99999999999999999999999999986643321
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||++.+..++.++|||||||++|||++|+.|+....+. . ......... .+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~----~~~~~~~~~-----~~~~ 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----R----VLFLIPKNS-----PPTL 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----h----HHhhhhcCC-----CCCC
Confidence 122346788999999999989999999999999999999999997533211 0 000111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.......+.+++.+|++.+|++||++.+|++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223456788889999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.04 Aligned_cols=198 Identities=27% Similarity=0.368 Sum_probs=168.2
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE----- 490 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~----- 490 (743)
...++|.+.+.||+|+||.||++... .++.+|||++... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999865 6889999998754 233456788999999999999999999988643
Q ss_pred -CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 491 -QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 491 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
...++||||+++ +|...+. ..++...+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999976 4544442 24778888899999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998654322 12335789999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.81 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=203.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||.|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999975 57889999998766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ...++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999887532 246889999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccccccCcceeccC---CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEG---LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..... ...... ..
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~~~-~~~~~~---~~ 223 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RALFL-ISKSNF---PP 223 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhccC---CC
Confidence 12235678899999999876 8899999999999999999999998643211 00000 110100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..+. ........+.+++.+|++.+|.+||++++|+.
T Consensus 224 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0010 11223345778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.32 Aligned_cols=201 Identities=24% Similarity=0.342 Sum_probs=172.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999975 6899999998642 2334566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2345788899999999999999999998 999999999999999999999999998765433
Q ss_pred ccccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 221 1223568999999999863 4578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=297.18 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=199.1
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-CCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-EQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 498 (743)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999975 5788999998643 33456678999999999999999999988764 446789999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++... ....+++..+..++.+++.||.+||+.+ |+|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888643 2345889999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ......+++.|+|||++.+..++.++||||||+++++|++|+.|+..... ...... ...+...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~-~~~~~~~----- 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYR-IIEGKLP----- 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH-HHhcCCC-----
Confidence 1 22335688999999999999999999999999999999999998763211 111111 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........+.+++.+|++.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112233457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.66 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=200.7
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.|+..++||.|+||.||+|... +++.+|+|.+... .......+.+|+.+++++.|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5777899999999999999975 5889999988754 3455678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.. ..++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999988742 35788888999999999999999988 99999999999999999999999999977643322
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||++.+..++.++|+|||||++|||++|..|+....+. ..........
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---------~~~~~~~~~~--------- 217 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---------RVLFLIPKNN--------- 217 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---------hHhhhhhcCC---------
Confidence 122346788999999999889999999999999999999999997643221 0000000010
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...........+.+++..||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111222334557788889999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.64 Aligned_cols=243 Identities=28% Similarity=0.412 Sum_probs=194.8
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
|.-++.||.|+||.||.+++. +.+.||||+++-. .......+..||+.|+++.|||+|.+-++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455688999999999999965 7889999999754 445567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
|- |+-.+++. ...+++-+..+..|..+.+.||+|||+.+ .||||||..|||+++.|.|||+|||.|....+.
T Consensus 108 Cl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 CL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred Hh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 95 46666652 34567888899999999999999999998 999999999999999999999999999875433
Q ss_pred ccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 EENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
+.++|||.|||||++. .+.|+-|+||||||+++.||.-.++|..... ... +.-.+..++..
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--------AMS-ALYHIAQNesP--- 243 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMS-ALYHIAQNESP--- 243 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--------HHH-HHHHHHhcCCC---
Confidence 3489999999999985 4789999999999999999999888854321 111 11111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.|. ..+-...+++++..||+.-|.+|||.++++.
T Consensus 244 --tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 --TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 121 2333455778888999999999999977653
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.38 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=200.2
Q ss_pred CCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|.+.++||+|+||.||+|...+ ...+|||...... ....+.+.+|+.++++++|+||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998643 3468999886554 4566789999999999999999999998875 557899
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++..+.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 235789999999999999999999988 99999999999999999999999999987644
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
..... .....++..|+|||.+....++.++||||||+++|||++ |..||...... .. ......+....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~----~~~~~~~~~~~- 228 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DV----IGRIENGERLP- 228 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HH----HHHHHcCCcCC-
Confidence 32211 112334568999999988889999999999999999996 99997643210 11 11111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
... .....+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus 229 ----~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ----MPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 112346678889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.73 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=190.2
Q ss_pred cccccCCceeEEEEEEc----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEe-cCCeeEEEEEecC
Q 041312 428 NKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCI-EEQEKMLIYEYLP 501 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 501 (743)
+.||+|+||.||+|... ....+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999998543 3445678899999999999999999999776 4556899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc-
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE- 580 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~- 580 (743)
+++|.+++... ...+.+..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234567778899999999999999988 999999999999999999999999999765432211
Q ss_pred -cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 -ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.......++..|+|||.+.+..++.++|||||||++|||++|..|+..... .... ......+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~----~~~~~~~~~~~----- 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDI----TVYLLQGRRLL----- 222 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHH----HHHHhcCCCCC-----
Confidence 111224557789999999888999999999999999999996554322111 1111 11111111000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. .... ...+.+++..||+.+|++||++.+|++.|+.+
T Consensus 223 ~-~~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 Q-PEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C-CCcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0111 23466888899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.67 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=186.2
Q ss_pred ccccCCceeEEEEEEcC-------------------------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEee
Q 041312 429 KLGEGGFGSVYKGVLQN-------------------------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l 483 (743)
+||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998876555556778899999999999999999
Q ss_pred eeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC--
Q 041312 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-- 561 (743)
Q Consensus 484 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-- 561 (743)
++++.+....++||||+++++|+.++... ...+++..++.++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999887532 346788999999999999999999988 99999999999997643
Q ss_pred -----CeEEeeeccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHH-hcCCCCCCCcccCC
Q 041312 562 -----NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGS 634 (743)
Q Consensus 562 -----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~ell-tG~~p~~~~~~~~~ 634 (743)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 3899999988643221 12356788999998876 56899999999999999995 688887543211
Q ss_pred CccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 635 GSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.. ........ .+.... ...+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 ---~~----~~~~~~~~-------~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 ---EK----ERFYEKKH-------RLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HH----HHHHHhcc-------CCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 01111000 011111 124677888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.79 Aligned_cols=201 Identities=23% Similarity=0.323 Sum_probs=173.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|.+.++||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999976 6888999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245788889999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
... ......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 221 1223579999999999875 4678899999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.94 Aligned_cols=193 Identities=21% Similarity=0.305 Sum_probs=164.6
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999976 5778999975432 23569999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
++. ++|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++..+.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 577776643 2346889999999999999999999998 9999999999999999999999999997543221
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNT 627 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~ 627 (743)
......||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1223578999999999999999999999999999999999766653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=296.67 Aligned_cols=238 Identities=25% Similarity=0.420 Sum_probs=187.8
Q ss_pred cccccCCceeEEEEEEcCCc-----------EEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 428 NKLGEGGFGSVYKGVLQNGK-----------EIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
+.||+|+||.||+|.+.... .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986433 5788877544333 6788999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-------CeEEeeec
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-------NPKISDFG 569 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-------~vkl~DFG 569 (743)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999885432 26888999999999999999999988 99999999999999887 79999999
Q ss_pred cccccCCCccccccccccccccccCcceeccC--CCCccccchhHHHHHHHHHhc-CCCCCCCcccCCCccccchhhHhH
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEG--LFSTKSDVYSFGVLLLEIILG-RRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDiwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... .....
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---------~~~~~ 218 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---------EKERF 218 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---------hHHHH
Confidence 9986543 1224567789999999876 789999999999999999995 5554432110 00011
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
...... + ..+....+.+++.+|++.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~-------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR-------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC-------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110000 0 0111156778889999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.78 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=199.4
Q ss_pred CCCcCcccccCCceeEEEEEEcC--CcEEEEEEcccC----------ChhcHHHHHHHHHHHHh-cCCccEEeeeeeEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN--GKEIAVKRLSRS----------SGQGIEEFKTEIALIAQ-LQHRNLVSILGCCIE 489 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~Ev~~l~~-l~h~niv~l~~~~~~ 489 (743)
+|++.+.||+|+||.||+++... ++.+|+|.+... ......++..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 788999987532 22344567789988875 799999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEee
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
....++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887442 234568889999999999999999996 55 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... . . .....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~---~-~~~~~ 225 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----L---S-LATKI 225 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----H---H-HHHHH
Confidence 99998765432 22345788999999999998899999999999999999999999753211 0 0 11111
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.+...... ... .....+.+++.+|++.||++||++.||.++|+
T Consensus 226 ~~~~~~~~-----~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPL-----PEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcC-----Ccc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111110 010 11234667888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=335.53 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=197.2
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCee
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEK 493 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~ 493 (743)
....+|.+.++||+|+||+||++... +++.+|+|.+... .......+..|+.++++++|||||++++++.+ ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999976 5778999988643 33456788999999999999999999998864 3568
Q ss_pred EEEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCC----CceEeccCCCCcEEecC---------
Q 041312 494 MLIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSR----LRIIHRDLKASNVLLDA--------- 559 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~ivH~Dikp~NIll~~--------- 559 (743)
+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999886432 23568999999999999999999998431 23999999999999964
Q ss_pred --------CCCeEEeeeccccccCCCccccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 560 --------AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 560 --------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998664332 1234579999999999864 45889999999999999999999998632
Q ss_pred cccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 630 LEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. + ......+.... .+.. ......+.+|+..||+.+|.+||++.++++
T Consensus 247 ~~-------~-~qli~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-------F-SQLISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-------H-HHHHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 1 11111111111 0100 011234677888999999999999999983
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.67 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=189.8
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhc---CCccEEeeeeeEec-----CC
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQL---QHRNLVSILGCCIE-----EQ 491 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~-----~~ 491 (743)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999976 68999999886532 22233456677776665 79999999998864 34
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++ +|..++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 777776432 2345889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC-
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG- 650 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 650 (743)
....... ......||..|+|||++.+..++.++|||||||++|||++|++||...... .............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~ 227 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIFDLIGLPP 227 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-----HHHHHHHHHhCCCC
Confidence 8764322 122356899999999999999999999999999999999999988543211 0000011100000
Q ss_pred --Ccc-------hhcccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 --TAM-------EAVDKSLG---ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 --~~~-------~~ld~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ....+... ..........+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 0001112234678888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=350.48 Aligned_cols=265 Identities=25% Similarity=0.441 Sum_probs=212.1
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
......|...+.||+|+||.||+|+. .+++.||||++...... ...|++.+++++|||||++++++.+....++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 33445677888999999999999997 47899999998644322 23568899999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|.+++. .+++..+.+++.||++||+|||.....+|+||||||+||+++.++..++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999883 27899999999999999999996544459999999999999999888875 666543321
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.....+|+.|+|||++.+..++.|+|||||||++|||++|+.|++.... .......++............+
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhhee
Confidence 1124678999999999999999999999999999999999999854322 2233444444444444455556
Q ss_pred ccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 657 DKSLGE--SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 657 d~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
++.+.. ....++..++.+++.+|++.+|++||+|+||+++|+.+..
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 665533 2345667788999999999999999999999999997755
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.51 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=197.5
Q ss_pred CCcCcccccCCceeEEEEEEc----CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC------
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------ 491 (743)
|.+.+.||+|+||.||+|... +++.+|||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999854 4688999988654 3445678899999999999999999999886542
Q ss_pred eeEEEEEecCCCChhhhhhhcc---cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEA---KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
..++++||+++++|..++.... ....++...+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988764322 2235788889999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
|+++...............+++.|++||.+.+..++.++||||||+++|||++ |+.|+..... .. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~----~~~~~ 228 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SE----IYNYL 228 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HH----HHHHH
Confidence 99987643322222223345678999999999999999999999999999999 7777653211 11 11111
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
....... ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 ~~~~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111110 0112234677889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.14 Aligned_cols=251 Identities=37% Similarity=0.547 Sum_probs=198.4
Q ss_pred CCcCcccccCCceeEEEEEEcC-----CcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQN-----GKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
|++.+.||.|+||.||+++... +..+|+|.+...... ..+.+..|+.++++++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999764 488999999655433 6778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998854322 12889999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
...... ...+++.|+|||.+.+..++.++||||||+++++|++ |+.|+..... . ..............
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~----~~~~~~~~~~~~~~- 225 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----E----EVLEYLKKGYRLPK- 225 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----H----HHHHHHhcCCCCCC-
Confidence 222111 2336789999999988889999999999999999998 6776543111 0 11111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.......+.+++.+|++.+|++|||+.++++.|
T Consensus 226 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234567788899999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.97 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=200.3
Q ss_pred hhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEe----
Q 041312 415 SNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCI---- 488 (743)
Q Consensus 415 ~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~---- 488 (743)
+.+..+.++|++.+.||+|+||.||+++.. +++.+|+|++.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 445567789999999999999999999975 58899999875432 2346788999999999 6999999999874
Q ss_pred -cCCeeEEEEEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 489 -EEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 489 -~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999887532 23346788889999999999999999988 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccch
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 641 (743)
|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+...... .
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--------~ 236 (286)
T cd06638 167 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--------R 236 (286)
T ss_pred cCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--------H
Confidence 9999986643322 1223568999999998853 45788999999999999999999997643210 0
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.... ..........++ .. ....+.+++.+|++.+|++||++.||++.+
T Consensus 237 ~~~~-~~~~~~~~~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALFK-IPRNPPPTLHQP----EL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHhh-ccccCCCcccCC----CC---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 001111111111 01 123467788899999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.21 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=203.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.+.||.|+||+||+|... ++..+|+|++... .......+.+|+.+++.++|+||+++++.+......++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999965 6889999998644 233567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++........+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356889999999999999999999988 99999999999999999999999999987654322
Q ss_pred c--cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 E--ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. .......|+..|+|||++... .++.++|+|||||+++||++|+.|+...... ....+.... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~-~----- 223 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQN-D----- 223 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcC-C-----
Confidence 2 122345789999999998877 7899999999999999999999998643221 011111111 0
Q ss_pred ccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCC-APEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...+..... ......+.+++..|++.+|++||++.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011111110 112245678888999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.47 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=200.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh---hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|++|.||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 589999999875432 35567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+.+++|.+++... ....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999987532 2356888999999999999999999988 999999999999999999999999998755322
Q ss_pred ccc---------------------------cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 578 QIE---------------------------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 578 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
... .......||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123468899999999999889999999999999999999999986432
Q ss_pred ccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 041312 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN----MSAVVS 695 (743)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~ 695 (743)
.. ...... .+....-.........+.+++.+|++.+|++||+ +.++++
T Consensus 237 ~~--------~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD--------ETFSNI---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH--------HHHHHH---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 10 001111 1111111111112345777888999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.32 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=194.4
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC----
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE---- 490 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~---- 490 (743)
....++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345678999999999999999999965 68899999986542 23445678899999999999999999987543
Q ss_pred --CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 491 --QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 491 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 4568999987 778877663 345889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH-
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL- 646 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 646 (743)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..........
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~ 232 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQLKRIMEVV 232 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHh
Confidence 999865432 223578999999999877 5689999999999999999999999864211 0000000000
Q ss_pred ----------hccCCcchhcccccCCCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 ----------WKEGTAMEAVDKSLGESCCA--------PEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 ----------~~~~~~~~~ld~~l~~~~~~--------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........+. .+.. ... .....+.+++.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQ-SLPH-MPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhh-cccc-ccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000 000 001235688889999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.72 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=171.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||+++.+ +++.+|+|++.+. .......+.+|+.++..++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999976 5788999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 235788889999999999999999998 999999999999999999999999999765432
Q ss_pred ccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 578 QIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 21 1123357999999999986 34688999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.83 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=200.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||.|+||.||++... +++.+|+|.+........+.+..|+.++++++|+||+++++.+......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888999999999999999975 68899999997766667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|..++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 999999887542 245889999999999999999999998 99999999999999999999999999876533221
Q ss_pred cccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 581 ENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
......+++.|+|||++. ...++.++||||||+++|||++|+.|+...... ... .........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~-~~~~~~~~~-- 226 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVL-LKILKSEPP-- 226 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHH-HHHhcCCCC--
Confidence 122356899999999875 345788999999999999999999997643210 001 111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+.. .......+.+++..||+.+|.+||++.+|++.
T Consensus 227 ---~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 ---TLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0100 01112245678889999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.11 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=203.5
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
|.....||+|+||.||++... +++.+|||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999975 6889999998766666677899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 99988873 234788999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... . ...... ..+...+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~----~~~~~~-----~~~~~~~~~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----Q----AMRRIR-----DNLPPRVKD 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H----HHHHHH-----hcCCCcccc
Confidence 22356889999999999889999999999999999999999997632210 0 011111 011111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH-hcCCCCCCCCCCCcc
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM-LGSDNAPSSPKHPAF 711 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~-L~~~~~~~~p~~~~~ 711 (743)
.. .....+.+++.+|++.+|.+|||+++|++. +=.....|....|.+
T Consensus 241 ~~--~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~~~~ 288 (292)
T cd06658 241 SH--KVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLM 288 (292)
T ss_pred cc--ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccccchhh
Confidence 11 112245677889999999999999999975 222233444444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=296.79 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=191.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-----hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--Cee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-----GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~ 493 (743)
.+|+..+.||+|+||.||++... +++.+|+|++.... .+....+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999975 68999999886432 23456788999999999999999999988753 567
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999988843 235788889999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQI-EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~~~~~- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIATQPT- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHhcCCC-
Confidence 543211 1112234678899999999988899999999999999999999999863211 011111111000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.+ .......+..++ .|+..+|++||+++||++
T Consensus 227 ----~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ----NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 111112233343 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.49 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=195.3
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999975 68999999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999988875432 345899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......|+..|+|||++.+..++.++|||||||++|||++|..||...... .............. ..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----~~~~~~~~~~~~~~------~~ 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----VKREEVDRRVLETE------EV 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhhccc------cc
Confidence 122357899999999999999999999999999999999999998643210 00001111111100 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
... .....+.+++..|++.+|++||+ +.+++.
T Consensus 224 ~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSA----KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCc----cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111 11223567888999999999999 556665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=297.05 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=195.7
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.+.||+|+||.||++.. .++.+|+|++.... ..+.+.+|+.++++++|+||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999874 67889999986432 346789999999999999999999998764 5799999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999985432 335788899999999999999999988 999999999999999999999999998764322
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......+..|+|||.+.+..++.++|+|||||++|||++ |+.|+...... ........+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------~~~~~~~~~~~~~------ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---------EVKECVEKGYRME------ 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---------HHHHHHhCCCCCC------
Confidence 112334568999999998899999999999999999998 88887533210 1111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111122456678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.33 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=201.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|+..+.||.|++|.||++..+ +++.+|+|++.... ....+++.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999986 68999999987653 35567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++.... ..++...+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885432 568889999999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ...... +....... +
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~-~~~~~~~~-----~ 222 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELL-QYIVNEPP-----P 222 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHH-HHHhcCCC-----C
Confidence 1 126688899999999999999999999999999999999999864321101 111111 11111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+... .....+.+++.+|++.+|++||++.+++..
T Consensus 223 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01010 022346678889999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.19 Aligned_cols=196 Identities=28% Similarity=0.447 Sum_probs=159.3
Q ss_pred cccccCCceeEEEEEEc---CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~~ 502 (743)
.+||+|+||.||+|+.. ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 68999999999999965 45789999986542 23467889999999999999999999854 4577999999875
Q ss_pred CChhhhhhhc------ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe----cCCCCeEEeeecccc
Q 041312 503 KSLDVYIFDE------AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMAR 572 (743)
Q Consensus 503 gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~vkl~DFGla~ 572 (743)
+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555554321 12235788889999999999999999998 9999999999999 466789999999998
Q ss_pred ccCCCccc-cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 573 IFGGDQIE-ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 12234578999999999876 45899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=295.57 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=194.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--Cee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~ 493 (743)
.+|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999975 5899999987532 123456788999999999999999999988764 467
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988743 234788888999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~-- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQP-- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------HHHHHHhcCC--
Confidence 5432211 1223356889999999998888999999999999999999999997532110 0011111000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.....+......+.+++..|+. +|++||++++|++.
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111122233456677778885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=295.91 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=199.0
Q ss_pred CCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCC------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSS------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.++.|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 468999999986432 2245788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeecccccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIF 574 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~ 574 (743)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 346788999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCccc--cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 575 GGDQIE--ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 575 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|..|+...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~---- 225 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIAS---- 225 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhc----
Confidence 543211 1122356889999999998888999999999999999999999997532210 01111111000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+......+.+++.+|++.+|++||++.+++.
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011122223345777888999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=295.07 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=198.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-----hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-----GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677789999999999999986 78999999886533 33567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998843 235788999999999999999999998 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCcceeccCC-CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ...............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~- 222 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKELPP- 222 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccCCC-
Confidence 32 123456889999999987766 89999999999999999999999764321 001111111011100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+......+.+++.+|++.+|.+||++.++++
T Consensus 223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111244567888999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=296.80 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=197.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC----------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS----------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~----------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 491 (743)
+|...+.||+|+||.||+|... +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999865 68999999875321 112356888999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 46888999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCC--CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+...............|+..|+|||.+.... ++.++|+||||++++||++|..|+..... .....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~ 227 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--------IAAMFKLGNK 227 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--------HHHHHHhhcc
Confidence 8654332222233456889999999987654 88999999999999999999999753211 0011111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. ....+...+ .......+.+++.+|++.+|.+||++.+|++.
T Consensus 228 ~-~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 R-SAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred c-cCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 111111111 11123456678889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.14 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=194.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|.+.++||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999976 68899999986443 33345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
++ ++|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5787776432 335788899999999999999999998 99999999999999999999999999976432221
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc--------chhhHhHh-cc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL--------VGHVWDLW-KE 649 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~ 649 (743)
......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ..... ....+... ..
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence 11224568899999988764 5788999999999999999999998643211 00000 00000000 00
Q ss_pred CCcchhcccccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAMEAVDKSLGES----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~ld~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......-.+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000000000 00011224567888999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.12 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=201.6
Q ss_pred ChhhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC
Q 041312 413 DLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE 490 (743)
Q Consensus 413 ~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 490 (743)
....+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|+|++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33455567789999999999999999999975 68899999986432 2346778899999999 899999999998754
Q ss_pred -----CeeEEEEEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeE
Q 041312 491 -----QEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPK 564 (743)
Q Consensus 491 -----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vk 564 (743)
...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999887532 23356889999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcceeccC-----CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc
Q 041312 565 ISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-----LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639 (743)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~ 639 (743)
|+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.|+....+.
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------- 239 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------- 239 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------
Confidence 9999998865432221 2235688999999988643 3688999999999999999999997643210
Q ss_pred chhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 640 VGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 640 ~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..... ..........+ .......+.+++.+|++.+|++||++.+|++.
T Consensus 240 -~~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 -KTLFK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HHHHH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00111 11111111111 11122347788899999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=294.87 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=200.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 497 (743)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+++..|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999965 6889999988643 34456678899999999999999999998764 45679999
Q ss_pred EecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhh-----ccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 498 EYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLH-----QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
||+++++|..++... .....+++..++.++.||++||.||| +.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988543 22456889999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
......... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.|+..... ....+....+.
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~ 226 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---------LQLASKIKEGK 226 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---------HHHHHHHhcCC
Confidence 876543321 2235689999999999998899999999999999999999999864321 01111112111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. .........+.+++.+|++.+|.+||++.+|++.
T Consensus 227 ~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 1112223457788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.65 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=184.4
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc---CCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL---QHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
||+|+||+||+++.. +++.||+|++.+.. ......+..|..++.++ +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 68999999986431 22334455677777665 699999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888743 345889999999999999999999998 9999999999999999999999999987543222 12
Q ss_pred cccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 583 TNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .........+.. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---------~~~~~~i~~~~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---------QQMYRNIAFGKV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---------HHHHHHHHcCCC------CCC
Confidence 3346799999999998764 489999999999999999999999864321 111111111111 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPN----MSAVVS 695 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~ 695 (743)
..... ..+.+++.+||+.+|.+||+ +.++++
T Consensus 218 ~~~~~---~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLS---DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCC---HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11112 23556788999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.14 Aligned_cols=260 Identities=25% Similarity=0.310 Sum_probs=200.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 497 (743)
++|...++||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999985 68899999987543 34567799999999999999999999998654 4689999
Q ss_pred EecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+++++|.+++... .....++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23455788899999999999999999998 99999999999999999999999999876543
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.............. .......... +
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~-~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL----SYIVNMPNPE-L 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH----HHHhcCCchh-h
Confidence 22 1234578899999999999999999999999999999999999875422101111111 1111111111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...... .......+.+++.+|++.+|++|||+.||++
T Consensus 229 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111110 0112345778999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.74 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=198.6
Q ss_pred hhhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEec--
Q 041312 414 LSNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIE-- 489 (743)
Q Consensus 414 ~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~-- 489 (743)
+..+......|++.+.||.|+||.||+|+.. +++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444456678999999999999999999975 68899999885543 3446788999999998 69999999999863
Q ss_pred ----CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 490 ----EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 490 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999998875432 345778888899999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccc
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLV 640 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 640 (743)
+|||++........ ......|++.|+|||++. +..++.++|||||||++|||++|+.||....+..
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------- 233 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------- 233 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-------
Confidence 99999876542211 123357899999999886 3468889999999999999999999986432110
Q ss_pred hhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 641 GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 641 ~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... .......+... .....+.+++.+||+.+|.+||++.||++
T Consensus 234 -~~~~~------~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 -ALFLI------PRNPPPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hhhhH------hhCCCCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 00011111111 11235677888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=293.10 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=199.8
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.++||+|+||.||+++.. +++.+|+|++... .....+++.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999965 6889999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887532 2235788899999999999999999988 99999999999999999999999999986643321
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......|++.|+|||++.+..++.++|+|||||++++|++|+.|+..... ...+..... +....
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~~~----- 220 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIR-GSYPP----- 220 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhc-CCCCC-----
Confidence 12234678899999999998999999999999999999999999763211 111111111 11100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
........+.+++.+|++.+|.+||++.+|++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111123346678889999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=301.67 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=197.8
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
|....+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334468999999999999975 6899999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++. ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..+..... .
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99988763 245788999999999999999999998 99999999999999999999999999876543321 1
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+...... . ........... ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~----~~~~~~~~~~~-----~~~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----Q----AMKRLRDSPPP-----KLKN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H----HHHHHhccCCC-----Cccc
Confidence 22357899999999999889999999999999999999999998643210 0 01111111000 0000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.......+.+++.+|++.+|.+||++++|++.
T Consensus 240 --~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 --AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00112346678889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.39 Aligned_cols=257 Identities=18% Similarity=0.249 Sum_probs=200.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999976 57899999987543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 245788889999999999999999988 999999999999999999999999998642111
Q ss_pred cc-------------ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH
Q 041312 578 QI-------------EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 578 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
.. ........++..|+|||.+.+..++.++||||||+++|||++|..||..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---------~~~~ 225 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---------EELF 225 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHH
Confidence 00 0011124678899999999988999999999999999999999999863211 0111
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.....+... .+.. ... ....+.+++.+|++.+|++||++.++.++|+.-
T Consensus 226 ~~~~~~~~~---~~~~-~~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 226 GQVISDDIE---WPEG-DEA---LPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHhcccC---CCCc-ccc---CCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111111100 0000 011 122356788899999999999988888888763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.31 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=197.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 58999999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877532 335889999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc-------chhhHhHhccC
Q 041312 579 IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL-------VGHVWDLWKEG 650 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~ 650 (743)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... +..... .......+...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcccc
Confidence 1 1223457889999999876 56789999999999999999999998643211 000000 00000000000
Q ss_pred Cc-chhcccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TA-MEAVDKSLGESCC-----APEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~-~~~ld~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. .....+....... ......+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000000000000 011245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.51 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=211.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
...+..+.++||-|-||.||.|.++. ...||||.++ .....+++|..|+.+|+.++|||+|+|+++|..+...|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 33456777999999999999999874 6679999994 455678899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
||.+|+|.++|.... +..++....+.++.||..|++||..++ +|||||...|.||.++..||++|||+++++..+.
T Consensus 344 fM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999997643 345666777899999999999999998 9999999999999999999999999999887665
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
...... ..-.+-|.|||-+....++.|+|||+|||+||||.| |.-|+.. .+ ..++++++.++..++..+
T Consensus 420 YTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-id--------lSqVY~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 420 YTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-ID--------LSQVYGLLEKGYRMDGPE 489 (1157)
T ss_pred eecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-cc--------HHHHHHHHhccccccCCC
Confidence 433221 233567999999999999999999999999999998 5555432 11 234566666555544332
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
- +++ .+.+||++||+.+|.+||++.|+-+.||..
T Consensus 490 G------CPp---kVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 490 G------CPP---KVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred C------CCH---HHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1 233 456788899999999999999999988754
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.57 Aligned_cols=265 Identities=24% Similarity=0.350 Sum_probs=197.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.++||+|+||.||++..+ +++.+|+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999986 58999999886542 2245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|..+... ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999998876532 234889999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccc-------cchhhHhHhccC
Q 041312 579 IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN-------LVGHVWDLWKEG 650 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~ 650 (743)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+...... +.... +...........
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccc
Confidence 1 1223567889999999876 45788999999999999999999887532210 00000 000000000000
Q ss_pred Ccc-hhcccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAM-EAVDKSLGES-----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~-~~ld~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ....+..... ........+.+++.+||+.+|++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 0000000000 01112345778999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.69 Aligned_cols=244 Identities=25% Similarity=0.429 Sum_probs=199.2
Q ss_pred cCcccccCCceeEEEEEEc-CCcEEEEEEcc----cCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe--eEEEEE
Q 041312 426 SDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLS----RSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE--KMLIYE 498 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~----~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~--~~lV~E 498 (743)
...+||+|+|-+||+|.+. +|.+||--.++ .......++|..|+.+|+.|+|+|||+++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3478999999999999975 57778743332 1245567899999999999999999999999998766 778999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEeeeccccccCCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~~~~~ 577 (743)
+|..|+|..++.+ .+.++...+..|++||++||.|||++. .+|||||||-+||+|+ ..|.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999854 445778899999999999999999985 7899999999999997 4689999999999987544
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
. ...+.|||.|||||+.. ..|++.+|||||||.++||+|+.-|+.. ...+.+++++.-.|.....+.
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE--------C~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE--------CTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh--------hCCHHHHHHHHHcCCCHHHhh
Confidence 3 23489999999999876 7899999999999999999999999753 233445666665555444433
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+ ...++++ +++..||.. .++|||+.|+|.
T Consensus 267 k-----V~dPevr---~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 K-----VKDPEVR---EFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred c-----cCCHHHH---HHHHHHhcC-chhccCHHHHhh
Confidence 2 2345555 466699999 899999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.06 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=198.7
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChh-----cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ-----GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
+|.+.+.||+|++|.||+|... +++.||||++...... ....+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 6899999998754322 345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+ +++|..++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899998885432 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC-----
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG----- 650 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 650 (743)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..++....+ ..............
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-----IDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-----HHHHHHHHHHcCCCchhhh
Confidence 321 1222356788999998865 4678999999999999999999776653221 00000010000000
Q ss_pred ----CcchhcccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCC
Q 041312 651 ----TAMEAVDKSLGESC-----CAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSD 700 (743)
Q Consensus 651 ----~~~~~ld~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 700 (743)
.............. .......+.+++.+|++.+|++|||+.||++. |++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00000000000001 11223567889999999999999999999985 4443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.71 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=193.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.++||+|+||.||+++.. +|+.+|+|++.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999976 68999999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++ +|..++... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 676665432 345899999999999999999999998 99999999999999999999999999986643321
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC------c
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT------A 652 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 652 (743)
......+++.|+|||++.+. .++.++|||||||++|||++|+.|+....+. ............... .
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHHhHHh
Confidence 12234678899999998764 4789999999999999999999986533221 000000000000000 0
Q ss_pred chhccc----ccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 MEAVDK----SLGE-----SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ~~~ld~----~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+..+. .... .........+.+++.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 000111235667888999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.35 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=191.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHH-HHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIAL-IAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.+.||+|+||.||+++.. +|+.||+|++.... ......+..|+.+ ++.++|+||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 69999999987542 2333455566665 666799999999999999999999999
Q ss_pred ecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 499 YLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 499 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|++ ++|..++... .....+++..+..++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6777766442 2335689999999999999999999986 6 99999999999999999999999999986543
Q ss_pred CccccccccccccccccCcceecc----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAME----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
... .....++..|+|||.+.+ ..++.++|+|||||++|||++|+.|+..... . ........ .+..
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~---~~~~~~~~-~~~~ 225 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----P---FQQLKQVV-EEPS 225 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----C---HHHHHHHH-hcCC
Confidence 221 122467889999998865 4568899999999999999999999753211 0 00111111 1111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.+.... ....+.+++..||+.+|++||++.+|++
T Consensus 226 -----~~~~~~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 -----PQLPAEK---FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----CCCCccc---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1234667888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=294.01 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=198.1
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
-|.+.++||.|+||.||+|... +++.+|+|.+... .......+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999865 6889999987643 2345567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|..++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998873 235789999999999999999999988 99999999999999999999999999876643321
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......++..|+|||.+.+..++.++|+|||||++|+|++|..|+...... ........... +.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~-----~~~ 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNNP-----PTL 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---------HHHHHHhcCCC-----CCC
Confidence 122346788999999998888999999999999999999999997532110 01111111111 011
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. ......+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 E----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 1122346678889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=298.68 Aligned_cols=266 Identities=21% Similarity=0.311 Sum_probs=199.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.++||+|+||.||++... +++.||+|++... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999976 5889999988643 33445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|++++.+..++. +...++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766542 2344788999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcc-------ccchhhHhHhc-c
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSW-------NLVGHVWDLWK-E 649 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~-------~~~~~~~~~~~-~ 649 (743)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|+.|+....... ... .+.......+. .
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccC
Confidence 21 12235678899999999888 88999999999999999999999876432100 000 00000000000 0
Q ss_pred CCcc--hhcccc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAM--EAVDKS----LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~--~~ld~~----l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.... +..+.. +...+.......+.+++.+||+.+|++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000 000011111355778899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.18 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=201.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367889999999999999999864 6889999998655555567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999988742 34788889999999999999999998 99999999999999999999999999876543322
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......+++.|+|||.+....++.++||||||+++|+|++|+.||...... ..+ ......+. +.
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~----~~~----~~~~~~~~------~~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RAL----YLIATNGT------PE 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----hhe----eehhcCCC------CC
Confidence 122346888999999998888999999999999999999999998643221 000 00000000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+. ........+.+++.+||+.+|++||++.+++..
T Consensus 235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011112346678889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.61 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=204.9
Q ss_pred CCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.|.++..||.|+||.||++..++ +-..|.|.|.......++.|+-|+.||..++||+||++++.|...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45677889999999999999775 44456788887788889999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
||-.+..+..- ...|.+.++..+++|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+...... ..
T Consensus 113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ 185 (1187)
T ss_pred CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence 99999887653 346889999999999999999999998 999999999999999999999999987643221 12
Q ss_pred ccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 582 NTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
....+.|||+|||||+.+ ..+|+.++||||||++|.||..+.+|.....+ .. +.-.+.......++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MR-VllKiaKSePPTLl 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MR-VLLKIAKSEPPTLL 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HH-HHHHHhhcCCCccc
Confidence 234578999999999885 56899999999999999999999999764322 11 22222233333333
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+ ..-...+.+++..||..||..||++++|++.
T Consensus 257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 32 2334456778889999999999999998764
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.17 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=194.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.+.||+|++|.||++..+ +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999976 689999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888776432 236788999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc-----
Q 041312 580 EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM----- 653 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 653 (743)
. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .......++.+......
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV----EDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHhcCCCChhhhhhh
Confidence 1 112346789999999876 45889999999999999999999998643210 00000011100000000
Q ss_pred -----------hhc-ccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 -----------EAV-DKSLGESC-CAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 -----------~~l-d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ...+.... .......+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00000000 0111245678888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.55 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=198.5
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 6889999998654 234567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++.... ...+++..+..++.+++++|.|||+++ |+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999985432 345788999999999999999999998 99999999999998654 58999999998765432
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ...+... .......+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~--- 221 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKI-MSGTFAPI--- 221 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHH-HhcCCCCC---
Confidence 2 2235688899999999988899999999999999999999999753221 1111111 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.......+.+++.+|++.+|++|||+.+|++.
T Consensus 222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122346678889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.37 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=204.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.+|++.+.||+|++|.||+++.. +++.+++|++..... .....+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999987 599999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++... ..++...+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568899999999999999999999 88 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ...... ..........
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~-~~~~~~~~~~----- 221 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFEL-MQAICDGPPP----- 221 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHH-HHHHhcCCCC-----
Confidence 22 1235678999999999999999999999999999999999999764321 001111 1111111111
Q ss_pred ccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAP-EILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+ ... ....+.+++.+|++.+|++||++.+|++.
T Consensus 222 ~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 111 23457778889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.97 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=199.1
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 68999999987543 33457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998875432 46889999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC-------
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT------- 651 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 651 (743)
.......++..|+|||++.+. .++.++||||+|+++|||++|.+++..... ...............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-----IEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-----HHHHHHHHHHcCCCChHHHhhc
Confidence 112335788999999998754 468999999999999999999776643221 001111111000000
Q ss_pred -----cchhcccccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 -----AMEAVDKSLG----ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 -----~~~~ld~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...+..+.-. ..........+.+++.+|++.+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00011123567788899999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.19 Aligned_cols=204 Identities=27% Similarity=0.421 Sum_probs=169.2
Q ss_pred CCCcCcccccCCceeEEEEEEc---CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKM 494 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~ 494 (743)
+|.+.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999975 47899999997633 44456788999999999999999999999988 8899
Q ss_pred EEEEecCCCChhhhhhhcc-c-ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC----CCCeEEeee
Q 041312 495 LIYEYLPNKSLDVYIFDEA-K-RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA----AMNPKISDF 568 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~----~~~vkl~DF 568 (743)
+||||+++ +|..++.... . ...++...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 5555543222 1 236888999999999999999999998 999999999999999 999999999
Q ss_pred ccccccCCCcc-ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 569 GMARIFGGDQI-EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 569 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
|++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643322 112234577899999998876 457899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.50 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=202.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999986 688999999977655567889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999998875432 46899999999999999999999988 99999999999999999999999999987654432
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... . ...............
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~-~~~~~~~~~~~~~~~---- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------K-ALFKIATNGPPGLRN---- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------H-HHHHHHhcCCCCcCc----
Confidence 23457889999999999888999999999999999999999997643210 0 001111111111110
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. ......+.+++.+|++.+|++|||+.+|++.
T Consensus 220 -~--~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 -P--EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -c--cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0012456778889999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.56 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=198.6
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC------
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~------ 491 (743)
.+++|++.+.||+|++|.||+|... +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999985 678999999865443 346799999999999 7999999999997654
Q ss_pred eeEEEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875432 2456889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
+........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.|+...... .....
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 229 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALFK 229 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHHH
Confidence 876543221 1233568899999998754 34678999999999999999999998632110 00111
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ..... +.+.. .......+.+++.+||+.||++|||+.+|++
T Consensus 230 ~-~~~~~-----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 I-PRNPP-----PTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred h-hccCC-----CCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111 11111 1112345678888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.58 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=197.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcC---CccEEeeeeeEecCCeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 497 (743)
.|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |+|++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777899999999999999974 6899999998654 3445677889999999997 999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36889999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... .....|+..|+|||.+.++ .++.++|+|||||++|+|++|+.|+...... . ........ .
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~-~~~~~~~~-----~ 218 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------R-AMMLIPKS-----K 218 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------h-hhhccccC-----C
Confidence 321 2235688999999988754 5789999999999999999999998643211 0 00000111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.+.... ....+.+++.+|++.+|++||++.+++.
T Consensus 219 ~~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111111 2234667888999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.64 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=199.1
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|.+.+.||+|+||.||++... +++.+++|.+..... ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 689999999876543 3678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998853 335788889999999999999999998 99999999999999999999999999987654332
Q ss_pred ccc--cccccccccccCcceeccCC---CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 580 EEN--TNRVVGTYGYMAPEYAMEGL---FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 580 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
... .....++..|+|||++.+.. ++.++||||||++++||++|+.||...... .. ..... ..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~---~~~~~-~~~~~~~ 226 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQ---IMFHV-GAGHKPP 226 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HH---HHHHH-hcCCCCC
Confidence 111 12356788999999998766 889999999999999999999998633210 00 00000 0010000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.. .......+.+++.+|++.+|.+||++.+++.
T Consensus 227 -----~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 -----IPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100 0111234567888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.50 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=198.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999976 6899999998643 2334577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++... ..++...+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999888433 46889999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+..... .........+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~----- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---------IQIYEKILEGKV----- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHhcCCc-----
Confidence 2335688999999999888899999999999999999999999764321 011111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.+.. .....+.+++.+||+.+|.+|| +++|+++
T Consensus 216 -~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 -RFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0111 1124566788899999999999 6666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=288.05 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=203.2
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKMLIY 497 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 497 (743)
+|...+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999987 68999999987554 25578899999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999988543 27889999999999999999999988 999999999999999999999999999877654
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
..........++..|+|||.+.+...+.++||||||+++|+|++|+.|+..... ................
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~--- 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGEPPE--- 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCCCcC---
Confidence 331112345788999999999988899999999999999999999999864321 1111111111011111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........+.+++.+|++.+|.+||++.++++
T Consensus 225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111345777888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.41 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=198.4
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999964 6889999998766555667789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|.+++.. ..++...+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999988743 35788899999999999999999998 99999999999999999999999998876543221 1
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+....+ .. .......... +.+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~----~~~~~~~~~~-----~~~~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQ----AMKRIRDNLP-----PKLKN 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HH----HHHHHHhcCC-----CCCcc
Confidence 2235688999999999988899999999999999999999999764221 00 1111111111 11111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ......+.+++.+|++.+|++||++.++++
T Consensus 238 ~--~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 L--HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1 112235778888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.46 Aligned_cols=251 Identities=28% Similarity=0.380 Sum_probs=202.0
Q ss_pred CCcCcccccCCceeEEEEEEc--CCc--EEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ--NGK--EIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.+..++||+|.||.|++|.+. +|+ .||||.+...... ....|.+|+.+|.+|+|+|+|+|+|+..+ ....+|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344589999999999999975 344 5899999766444 77899999999999999999999999988 78899999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++.|+|.+.|.+ ..+..|-......++.|||.|+.||.+++ +|||||...||||-....|||+|||+.+.++...
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999987 55667888888999999999999999998 9999999999999999999999999999887654
Q ss_pred ccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhc-CCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 579 IEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG-RRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 579 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... ......-.+.|+|||.+....++.++|||+|||++|||+++ ..||-.... -.+++.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~qIL~~i 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQILKNI 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HHHHHhc
Confidence 322 22223446789999999999999999999999999999985 445432211 1122333
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
|..-+-.......+++.+++..||..+|++|||+..|.+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 32222222333445677888999999999999999997433
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.34 Aligned_cols=202 Identities=26% Similarity=0.413 Sum_probs=168.2
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++++|.+.++||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++......++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999875 68999999986543 233346788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+. ++|..++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666655332 235677888889999999999999998 999999999999999999999999999764322
Q ss_pred ccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
.. ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 11 12224578899999998764 5788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=292.23 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=202.9
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
...+.|+..+.||+|++|.||++..+ +++.+++|.+..... ..+.+.+|+.++++++|+||+++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999987 689999999876544 5678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999985432 36899999999999999999999988 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.|+....+. ..... ..........
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~-~~~~~~~~~~- 237 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFL-ITTKGIPPLK- 237 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HHhcCCCCCc-
Confidence 21 122345788999999999888999999999999999999999997633210 00000 1111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. ......+.+++.+|++.+|.+||++.+|++.
T Consensus 238 ----~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 ----NP--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----ch--hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 0012346678889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.24 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=195.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lV 496 (743)
++|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999986 58899999986442 22334677899999999999999999998877 889999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++ +|..++... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 887776432 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh--------
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW-------- 647 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 647 (743)
... ......+++.|+|||.+.+. .++.++||||||+++|||++|..|+...... .........+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-----DQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchHHH
Confidence 321 12234578899999998764 4689999999999999999999998643211 0000000000
Q ss_pred ---------ccCCcchhcccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 648 ---------KEGTAMEAVDKSLGESCCAP-EILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 648 ---------~~~~~~~~ld~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
............+....... ....+.+++.+|++.+|++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000001111111111111 2344667888999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.09 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=197.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+|++.++||.|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999986 688999999875432 33567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++ +|..++........+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777755444456899999999999999999999998 99999999999999999999999999976543221
Q ss_pred cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH-----------hc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL-----------WK 648 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 648 (743)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ......... +.
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-----DQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhHHHHh
Confidence 11224578899999988664 5788999999999999999999998643211 010001100 00
Q ss_pred c-CCcchhccccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 E-GTAMEAVDKSL---GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~-~~~~~~ld~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ........... ...........+.+++..|++.+|.+||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000000 00001112345678888999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.63 Aligned_cols=247 Identities=25% Similarity=0.302 Sum_probs=199.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
+|.+.++||.|+||.||++... +++.+|+|.+.+.. ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 68999999987542 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|..++... ..++...+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999888432 46888999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ........... ....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~~~--- 220 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--ADVL--- 220 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--cccc---
Confidence 122356788999999999888999999999999999999999998754321 01111111110 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNM--SAVV 694 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 694 (743)
.+......+.+++.+|++.+|.+||++ +|++
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 -----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111112557788889999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=321.88 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=194.1
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec------
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE------ 489 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------ 489 (743)
.+...+|+.++.||+||||.||+++.+ ||+.+|||+|... .......+.+|+.+|.+|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678888999999999999999977 8999999999754 44556678899999999999999999876542
Q ss_pred --------------------------------------------------------------------------------
Q 041312 490 -------------------------------------------------------------------------------- 489 (743)
Q Consensus 490 -------------------------------------------------------------------------------- 489 (743)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHH
Q 041312 490 -------------------------E--------QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536 (743)
Q Consensus 490 -------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y 536 (743)
. ..+||-||||+..++.+++.++.... .....++++++|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12477899999888888875433221 356678999999999999
Q ss_pred hhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC----------------CCccccccccccccccccCcceecc
Q 041312 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG----------------GDQIEENTNRVVGTYGYMAPEYAME 600 (743)
Q Consensus 537 LH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~ 600 (743)
+|+++ ||||||||.||+++++..|||+|||+|.... ........+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998721 0011113345799999999999977
Q ss_pred C---CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHH
Q 041312 601 G---LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGL 677 (743)
Q Consensus 601 ~---~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~ 677 (743)
. .|+.|+|+||||||++||+. ||....+ . ..+...++.+.+..- ..+..++...-.++++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----R----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----R----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHH----H----HHHHHhcccCCCCCC------cccccccchHHHHHHH
Confidence 5 49999999999999999985 3432211 0 112233333333222 1223333444467888
Q ss_pred HhcccCCCCCCCHHHHHH
Q 041312 678 LCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 678 ~cl~~dP~~RPs~~evl~ 695 (743)
++++.||.+|||+.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=279.85 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=200.7
Q ss_pred cccccCCceeEEEEE-EcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
+.||+|+|+.|-.++ +.+|.++|||++.+.......++.+|++++.+.+ |+||++++++|.++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998887 6789999999999998888899999999999995 99999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEeeeccccccCCCc----
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISDFGMARIFGGDQ---- 578 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~DFGla~~~~~~~---- 578 (743)
..+|. ++..+++.++..+.++|+.||.|||.++ |.||||||+|||...... +||+||.+...+....
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 98884 4567899999999999999999999999 999999999999976554 8999999886442211
Q ss_pred -cccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcc--cCCCccccchhhHhHhccC
Q 041312 579 -IEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLE--QGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 579 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 650 (743)
........+|+..|||||+.. ...|+.++|.||||||||-||+|.+||..... .+.+.-+.... . .+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~----C-Q~ 312 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV----C-QN 312 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH----H-HH
Confidence 112233478999999999773 34689999999999999999999999986442 11111111000 0 00
Q ss_pred CcchhcccccCCCCCHHHHH----HHHHHHHHhcccCCCCCCCHHHHHH-----HhcCCCCCCCCCC
Q 041312 651 TAMEAVDKSLGESCCAPEIL----RCIHLGLLCVQEQATDRPNMSAVVS-----MLGSDNAPSSPKH 708 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~----~l~~l~~~cl~~dP~~RPs~~evl~-----~L~~~~~~~~p~~ 708 (743)
.+.+-++..- -+++..++. ..-+++...+..++.+|-++.++++ +....+++|.|..
T Consensus 313 ~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v 378 (463)
T KOG0607|consen 313 KLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQV 378 (463)
T ss_pred HHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCcc
Confidence 1111111100 012222222 2334555677799999999888876 2333355555543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=301.01 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=196.6
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE----- 490 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~----- 490 (743)
...++|++.+.||+|+||.||++... +++.||+|++.+. .......+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35578999999999999999999975 7899999998643 334456778899999999999999999988643
Q ss_pred -CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 491 -QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 491 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
...++||||+.+ +|...+.. .++...+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 67666522 2788888999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC----------CCcccc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG----------SGSWNL 639 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~----------~~~~~~ 639 (743)
+++....... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .....+
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987643322 223467889999999999999999999999999999999999986432100 000000
Q ss_pred chh---hHhHhccCC-------cchhccccc----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 640 VGH---VWDLWKEGT-------AMEAVDKSL----GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 640 ~~~---~~~~~~~~~-------~~~~ld~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
... ......... ..+.....+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000000 001111110 000111234456788999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=318.10 Aligned_cols=203 Identities=22% Similarity=0.352 Sum_probs=159.8
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEcC--CcEEEEE------------------EcccCChhcHHHHHHHHHHHHhcCCc
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQN--GKEIAVK------------------RLSRSSGQGIEEFKTEIALIAQLQHR 478 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~Ev~~l~~l~h~ 478 (743)
...++|+++++||+|+||+||++..+. +...++| ++ .........+.+|+.+|++++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987542 2222222 11 11223456788999999999999
Q ss_pred cEEeeeeeEecCCeeEEEEEecCCCChhhhhhhccc--ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEE
Q 041312 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAK--RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVL 556 (743)
Q Consensus 479 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 556 (743)
||+++++++...+..++|+|++.. +|..++..... ........+..++.||+.||.|||+++ ||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 999999999999999999999854 55555533211 122335567789999999999999998 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCC
Q 041312 557 LDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNT 627 (743)
Q Consensus 557 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~ 627 (743)
++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999999876533221 1223679999999999999999999999999999999999986543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=293.12 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=192.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|...++||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556689999999999999975 68999999987542 344567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhhh--cccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 500 LPNKSLDVYIFD--EAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 500 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
+.. ++..+... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++..+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55443211 12235688999999999999999999975 6 99999999999999999999999999976543
Q ss_pred CccccccccccccccccCcceeccC---CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEG---LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
... .....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... .......... +.
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~-~~-- 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVK-GD-- 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcC-CC--
Confidence 221 1234678999999998776 689999999999999999999999763211 1111111111 11
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+.+...........+.+++.+|++.+|++|||+.+|+..
T Consensus 228 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ---PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111223457788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=294.12 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=193.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
+.|...++||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999975 6899999988643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||++ +++.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 456555432 2345889999999999999999999988 999999999999999999999999998764322
Q ss_pred ccccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 578 QIEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+...... ...... .......
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~-~~~~~~~ 233 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHI-AQNDSPT 233 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHH-hcCCCCC
Confidence 2346788999999884 356889999999999999999999997533210 000110 0011000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+. .......+.+++.+||+.+|++||++.+|++.
T Consensus 234 -----~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -----LS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 10 11122357788889999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=287.42 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=193.1
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||.|++|.||+++.. +++.+|+|.+.+.. ....+.+.+|+.++++++|+||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999976 58999999986542 23457799999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 585 (743)
.+++.. ...++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 998843 235788999999999999999999988 9999999999999999999999999998765432 1223
Q ss_pred ccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 586 ~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..|+...... . .. .......+ ......+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~-~~~~~~~~--------~~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---P---ME-IYNDILKG--------NGKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---H---HH-HHHHHhcc--------CCCCCCC
Confidence 56889999999998888999999999999999999999998644310 0 00 01111000 0000111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 666 APEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111345778888999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=291.15 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=193.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|+..+.||.|++|.||+|+.. +++.+|||++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 68999999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5787776443 2346889999999999999999999988 99999999999999999999999999886543221
Q ss_pred ccccccccccccccCcceeccCC-CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC--------
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG-------- 650 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 650 (743)
. .....+++.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..+. ...+.....
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLF-RIFRTLGTPDEVVWPGV 228 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHH-HHHHHhCCCChhhhhhh
Confidence 1 12235688999999887654 688999999999999999999998643211 0000 000000000
Q ss_pred --------CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 --------TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 --------~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.........+.. ........+.+++.+|++.||++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 00001123567888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.24 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=201.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
...|.+.+.||+|.|++|.++++. ++..||||.+++.. ......+.+|+++|+.+.|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 356888899999999999999976 79999999998763 333455889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+.+|.+.+++.... ......+..++.|+..|++|||+++ |||||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999996543 3445777789999999999999999 999999999999999999999999999988633
Q ss_pred ccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. .....+|++.|.|||++.+..| +.++|+||+|++||-|++|..||+...- +++-
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---------------------k~Lr 264 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---------------------KELR 264 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---------------------cccc
Confidence 3 3445899999999999999876 5789999999999999999999874221 1111
Q ss_pred ccccCCCCCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCA--PEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
++.+.+.+-. --...+-++++++|-.+|.+|+++.++..-
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111111 112246678889999999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.81 Aligned_cols=201 Identities=28% Similarity=0.454 Sum_probs=176.5
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------CeeEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------QEKML 495 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~l 495 (743)
+...+.||+|+||.||+|+.+ +|+.||||.+.+. .....+....|+++|++++|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455689999999999999954 7999999999764 344567788999999999999999999886544 35689
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec--CCC--CeEEeeeccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD--AAM--NPKISDFGMA 571 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~--~vkl~DFGla 571 (743)
|||||.+|+|...|.+..+...|++.+.+.++..+..||.|||+++ |+||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888889999999999999999999999988 99999999999994 223 4799999999
Q ss_pred cccCCCccccccccccccccccCcceec-cCCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
+.+.... .....+||..|++||++. ++.|+..+|.|||||++|+++||..||.+..
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9886554 345689999999999998 5899999999999999999999999998643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=290.89 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
|++.++||.|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999975 79999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
+ ++|..++.... ...+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68888774322 235889999999999999999999988 999999999999999999999999999765432211
Q ss_pred cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc----------
Q 041312 581 ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE---------- 649 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 649 (743)
.....+++.|+|||++.+. .++.++||||||+++|+|++|+.||....+. ..+.. +.+....
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFR-IFRTLGTPDEDVWPGVT 228 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHhCCCChHHhhhhh
Confidence 1223568899999988764 5789999999999999999999998643221 00000 0000000
Q ss_pred --CCcchhcc----cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 --GTAMEAVD----KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 --~~~~~~ld----~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
......+. ..+. .........+.+++.+|++.+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 0000 0011112456788999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=285.99 Aligned_cols=249 Identities=28% Similarity=0.364 Sum_probs=201.9
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.++||+|+||.||+++.. +++.+|+|.+... .......+..|+.++++++|+||+++++.+.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 6889999998653 234456778899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999875522 2356888999999999999999999998 9999999999999999999999999998765441
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
.....+++.|+|||.+.+..++.++|+||||++++||++|+.|+..... .. ...........
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~----~~~~~~~~~~~----- 219 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QD----LRYKVQRGKYP----- 219 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHhcCCCC-----
Confidence 2224578899999999999999999999999999999999999864321 00 11111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112333557888999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.33 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=184.3
Q ss_pred ccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHH---hcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 429 KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIA---QLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~---~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..+++ ..+|+||+++++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 68999999886532 122233445544443 3479999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|..++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999888743 346899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... . ......... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~---~~~~~~~~~------~~~~~~ 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---D---KHEIDRMTL------TVNVEL 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc---C---HHHHHHHhh------cCCcCC
Confidence 223468999999998864 56899999999999999999999998643221 0 000000000 011111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM 696 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 696 (743)
+......+.+++.+||+.||++|| +++++++.
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111223566788899999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.04 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=197.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.|...+.||+|+||.||+++.. ++..+|+|++... .......+.+|+.++++++|+|++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677789999999999999965 6889999998643 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 666665332 345889999999999999999999998 999999999999999999999999998754322
Q ss_pred cccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 579 IEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
....|++.|+|||++. .+.++.++|||||||++|||++|+.|+...... . ............
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~-~~~~~~~~~~~~- 243 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------S-ALYHIAQNESPT- 243 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------H-HHHHHHhccCCC-
Confidence 2346788999999974 456889999999999999999999997532110 0 011111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSP 706 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 706 (743)
.. .......+.+++.+|++.+|.+||++.+|++.+--....+.+
T Consensus 244 ----~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 244 ----LQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred ----CC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 10 111223467788899999999999999999876554444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.20 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=195.9
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEEEEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKMLIYE 498 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 498 (743)
|++.++||.|++|.||+|+.. +++.+|+|++.... ......+.+|+.++++++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999976 58899999997653 33456788999999999999999999999988 89999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 777776432 246889999999999999999999988 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC-------
Q 041312 579 IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG------- 650 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 650 (743)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .......+.....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhccc
Confidence 21 1223456788999998765 46789999999999999999999998643211 0001111100000
Q ss_pred ----------CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 ----------TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ----------~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.........+...........+.+++.+|++.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000000111346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=286.79 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=198.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 5889999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC-eEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN-PKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999887543 2235789999999999999999999988 999999999999998764 6999999998765332
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ......|++.|+|||++.+..++.++|+||||++++||++|+.|+..... ........ .+....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~~---- 221 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKIC-QGYFAP---- 221 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHh-cccCCC----
Confidence 1 12224688999999999888899999999999999999999999753211 11111111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
........+.+++.+|++.+|++|||+.+|++.
T Consensus 222 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 -----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111122356778889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.34 Aligned_cols=259 Identities=17% Similarity=0.194 Sum_probs=181.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccCChhcH-----------HHHHHHHHHHHhcCCccEEeeeee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRSSGQGI-----------EEFKTEIALIAQLQHRNLVSILGC 486 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~Ev~~l~~l~h~niv~l~~~ 486 (743)
++|.+.++||+|+||.||+|...+ +..+|+|+......... .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 679999999999999999999764 34566665432221110 112233445666789999999987
Q ss_pred EecCC----eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 487 CIEEQ----EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 487 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||.|||+++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 66543 34677887643 44444321 223467778899999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCcc-----ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcc
Q 041312 563 PKISDFGMARIFGGDQI-----EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSW 637 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~ 637 (743)
++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~---- 240 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG---- 240 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch----
Confidence 99999999987643211 111223579999999999999999999999999999999999999987542210
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.+.... ..+....+....+.....+ ..+.+++..|++.+|++||++.+|++.|+
T Consensus 241 ~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAA----KCDFIKRLHEGKIKIKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHh----HHHHHHHhhhhhhccCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111000 0000111111111111122 44667888999999999999999999874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.29 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=192.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCe-----
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQE----- 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~----- 492 (743)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++++. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 68999999876542 223467888999999994 6999999999887665
Q ss_pred eEEEEEecCCCChhhhhhhccc--ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeec
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK--RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFG 569 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFG 569 (743)
.++||||+++ +|..++..... ...+++..+..++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777654322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred cccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+. .....+...+.
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-----QQLLHIFKLLG 229 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHhC
Confidence 99865332111 122356788999998865 45789999999999999999999988643210 00000000000
Q ss_pred cCCcc---hh------------cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 EGTAM---EA------------VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~~~~~---~~------------ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... .. ....+. .........+.+++.+||+.+|.+||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00 000000 000112234678888999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.81 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=203.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|.+.+.||.|+||.||++... +++.+|+|++.... ......+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 68999999987543 25667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++.... ....+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998885432 2367899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|+..... .. ............
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~-~~~~~~~~~~~~---- 222 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LE-LALKILKGQYPP---- 222 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HH-HHHHHhcCCCCC----
Confidence 122335788999999999988899999999999999999999999764321 01 111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+......+.+++.+|++.+|++||++.++++.
T Consensus 223 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 -----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.99 Aligned_cols=244 Identities=26% Similarity=0.328 Sum_probs=190.0
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||+|+||+||++... +|+.+|+|.+.... ......+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68999999986432 23345677899999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 585 (743)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 988854332 36889999999999999999999998 9999999999999999999999999987654321 1223
Q ss_pred ccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 586 ~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
..++..|+|||++.+..++.++||||||+++|+|++|+.||....... .. ..+....... .....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~----~~~~~~~~~~------~~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-----EK----EELKRRTLEM------AVEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-----cH----HHHHhccccc------cccCC
Confidence 467889999999988889999999999999999999999986432210 00 0000000000 00011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 666 APEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
......+.+++.+||+.+|++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11133466788899999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=287.34 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=195.8
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCCh---hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 499999999865433 4567889999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc------
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI------ 579 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~------ 579 (743)
..++... ..+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9888532 36889999999999999999999988 99999999999999999999999999876533211
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
........++..|+|||.+.....+.++||||||+++|||++|..|+...... ........+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~------ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---------EIFQNILNGKIE------ 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCcC------
Confidence 11223456788999999998888999999999999999999999998643210 111111111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
..........+.+++.+|++.+|.+|||+.++.+.|+
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 --WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000001345677888999999999999977777775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=278.86 Aligned_cols=202 Identities=26% Similarity=0.330 Sum_probs=178.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|..+++||+|.||+|-+++-+ +++.+|+|++++.. ......-..|-++|+..+||.+..+-..|...+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999865 79999999998763 34455567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||..||.|.-+|. +...+++....-+-..|+.||.|||+++ ||.||||.+|+|+|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988884 3456788887788899999999999998 9999999999999999999999999998532
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
.....+...+|||.|+|||++....|+.++|.|.+||++|||++|+.||....
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 23345667999999999999999999999999999999999999999998643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=293.95 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=200.2
Q ss_pred CCCcCcccccCCceeEEEEEEc---CCc--EEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ---NGK--EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~---~g~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.....+.||+|-||.||+|... .|+ .||||..+.. .....+.|..|..++++++|||||+++|+|.+ ...|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3445578999999999999953 233 4889988764 44567889999999999999999999999976 578999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+++-|.|..+|..+ ...++......++.||..||+|||+.. .|||||...||||.+...|||+|||+++.+..
T Consensus 469 mEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999654 345788888899999999999999988 99999999999999999999999999998765
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
...-.. ....-..-|||||-+.-..++.++|||.|||.+||+++ |.+||..... .++...
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------------------sDVI~~ 604 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------------------SDVIGH 604 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------------------cceEEE
Confidence 543222 23344677999999999999999999999999999885 8889874321 222222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
++..-+-+.++.....+..++.+||+++|.+||.+.+|...|+.
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 22222222233333345678889999999999999998877753
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.58 Aligned_cols=245 Identities=27% Similarity=0.337 Sum_probs=200.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.+.|+.-++||+||||.||-++.+ +|+.+|.|++.+. ..++.....+|-.+|.+++.+.||.+-..|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999999865 7999999988653 445667788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
+..|.||+|.-+|.+... +.++++.+.-++.+|+-||++||... ||.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999876544 57899999999999999999999998 99999999999999999999999999998876
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.+.. ...+||.+|||||++.+..|+...|.|||||+||||+.|+-||...... .+. +-+
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~----eEv 398 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKR----EEV 398 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhH----HHH
Confidence 6542 2248999999999999999999999999999999999999998743221 111 112
Q ss_pred ccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 657 DKSLG---ESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 657 d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
|.++. ..++..-...+.++.+..|+.||++|.--
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22111 11222233344456668899999998543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=283.48 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=194.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--Cee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~ 493 (743)
.+|++.+.||+|+||.||+++.. +++.+|+|.+... ..+....+++|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999975 6899999987532 234556889999999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988743 234788889999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~-- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--------MAAIFKIATQP-- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------HHHHHHHHcCC--
Confidence 5432111 112235688999999999988899999999999999999999999863211 00111111100
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.....+......+.+++.+|++ +|..||++.++++
T Consensus 226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111122222446677889999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.15 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=194.7
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChh
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLD 506 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 506 (743)
.+||+|+||.||++..+ +++.+|||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 68999999999999875 78999999987655556678999999999999999999999999999999999999999998
Q ss_pred hhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccc
Q 041312 507 VYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586 (743)
Q Consensus 507 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 586 (743)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 8763 234788899999999999999999998 99999999999999999999999999876543221 12335
Q ss_pred cccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCH
Q 041312 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCA 666 (743)
Q Consensus 587 ~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~ 666 (743)
.|++.|+|||++.+..++.++|+||+|+++|+|++|..|+..... .. ........ +...+... .
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~----~~~~~~~~-----~~~~~~~~--~ 240 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LK----AMKMIRDN-----LPPKLKNL--H 240 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHhh-----CCcccCCc--c
Confidence 688999999999888899999999999999999999999763221 00 01111111 11111000 0
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 667 PEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 667 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.....+.+++.+||+.+|.+||++.+|++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11223567788999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=297.91 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=197.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----Cee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~ 493 (743)
.++|++.++||+|+||.||+|+.. +++.||+|++... .......+..|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999965 6899999998643 233456788999999999999999999987654 357
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++|+||+.+ +|..++ ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 666555 2346889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
....... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ........+.+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPS 230 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCC
Confidence 5432211 11223578899999998755 5689999999999999999999999853211 000000111111000
Q ss_pred c---chhccc-------ccC--CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCC
Q 041312 652 A---MEAVDK-------SLG--ESC-----CAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDN 701 (743)
Q Consensus 652 ~---~~~ld~-------~l~--~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 701 (743)
. ..+... .+. ... .......+.+++.+||+.+|++||++.++++. |+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000000 000 000 01113457789999999999999999999987 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=281.54 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=200.0
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 688999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999887432 56899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.|+..... . ...+.... ... ..
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~-~~~~~~~~-~~~-----~~ 218 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------M-AALFRIVQ-DDH-----PP 218 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------H-HHHHHHhc-cCC-----CC
Confidence 1 2235678899999999888889999999999999999999999763221 0 00111110 000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+ .......+.+++.+|++.+|++||++.+++.
T Consensus 219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1111235667888999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.31 Aligned_cols=245 Identities=24% Similarity=0.269 Sum_probs=189.2
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHH-HHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIAL-IAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.||+|+||.||+|... +++.||+|.+.+.. ......+..|..+ ....+|+|++++++.+...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999975 68999999986542 2223344555544 4455899999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998843 245788999999999999999999988 99999999999999999999999999876432
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+......... .. .
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~--~~----~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---------DAVFDNILSRRIN--WP----E 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---------HHHHHHHHhcccC--CC----C
Confidence 2235678899999999888899999999999999999999999863321 0111111111110 00 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 663 SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 663 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.........+.+++.+|++.+|++||++.++.+.|..
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0011112446778889999999999998887777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=270.81 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=194.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+.+.+..||.|..|.|++++.+ +|..+|||.+.+. ..+..+++...+.++.+.+ +|.||+.+|+|......++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455678999999999999976 5899999999866 4556678888888887775 89999999999999999999998
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
| ...++.++.. ...++++..+-++...+++||.||..+. .|||||+||+|||+|+.|++||+|||++-++-...
T Consensus 173 M-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 173 M-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred H-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 8 4455555533 2345888888889999999999998765 69999999999999999999999999998765433
Q ss_pred ccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 EENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
...+..|.+.|||||.+.- ..|+..+||||||++|+||.||+.|+..... .++. .....++..
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----dFe~----ltkvln~eP---- 312 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----DFEV----LTKVLNEEP---- 312 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----cHHH----HHHHHhcCC----
Confidence 2345689999999999864 4689999999999999999999999875322 1111 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+.|.+.. .....+++++..||+.|+.+||...++++.
T Consensus 313 -P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 -PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1121111 023356778889999999999999998864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=281.61 Aligned_cols=248 Identities=20% Similarity=0.251 Sum_probs=188.4
Q ss_pred hHHHHcCCCCcCccc--ccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 416 NIAAATNDFSSDNKL--GEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 416 ~l~~~~~~y~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
++....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +|+||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334455677777776 99999999999975 688899998864322211 22222222 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeecc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGM 570 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGl 570 (743)
..++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999988433 37899999999999999999999998 99999999999999988 999999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.|+...... ....... ....
T Consensus 157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~-~~~~--- 223 (267)
T PHA03390 157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESL-LKRQ--- 223 (267)
T ss_pred ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHH-HHhh---
Confidence 87654322 246789999999999989999999999999999999999998733221 1111100 0000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-MSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 695 (743)
...+ .........+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 001122335677888999999999996 588873
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=290.89 Aligned_cols=264 Identities=19% Similarity=0.242 Sum_probs=191.5
Q ss_pred cccccC--CceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEG--GFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
..||.| +||+||++++. +++.||+|++... .....+.+++|+.+++.++||||+++++++......++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 99999999975 7999999998643 334457889999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc--
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE-- 580 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~-- 580 (743)
++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998875432 235788888999999999999999988 999999999999999999999999865433211100
Q ss_pred ---cccccccccccccCcceeccC--CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCc-------------cccchh
Q 041312 581 ---ENTNRVVGTYGYMAPEYAMEG--LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS-------------WNLVGH 642 (743)
Q Consensus 581 ---~~~~~~~gt~~y~aPE~~~~~--~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~-------------~~~~~~ 642 (743)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+.......... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC- 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch-
Confidence 001112346679999999764 47899999999999999999999986432100000 00000
Q ss_pred hHhHh----------------ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 643 VWDLW----------------KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 643 ~~~~~----------------~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
-.... .........+..+...........+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 0000001111111222222344568899999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=289.46 Aligned_cols=265 Identities=21% Similarity=0.328 Sum_probs=192.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-----
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ----- 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----- 491 (743)
..++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999976 68999999886432 223445678999999999999999999987654
Q ss_pred ---eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 492 ---EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 492 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
..++||||+.+ +|...+.. ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 66666532 2235889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccc--cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 569 GMARIFGGDQIE--ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 569 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
|++..+...... .......++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ...........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCG 241 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 999866432211 112234678899999988764 4788999999999999999999887643210 00000000000
Q ss_pred H-----hcc-------------CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 646 L-----WKE-------------GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 646 ~-----~~~-------------~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. +.. ......+...+.... ....+.+++.+||+.+|++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhccccc---CCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000 000000001111111 1234567899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.07 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=193.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~l 495 (743)
.++|++.++||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999975 68999999986432 22234567899999999999999999998765 56899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+.+ +|..++... ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677766432 246889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC----
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG---- 650 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 650 (743)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+. .....+.......
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESI 232 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhh
Confidence 3321 1122345788999999876 56889999999999999999999998643221 1111111100000
Q ss_pred -------Ccchhcc---cccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 651 -------TAMEAVD---KSLGE--SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 651 -------~~~~~ld---~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
....... ..... .........+.+++.+|++.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00000 0000012345678889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=288.60 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=192.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.++||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999976 68999999986542 2344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeeccccccCCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGD 577 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~~~~~ 577 (743)
|++ ++|..++... ....+++..+..++.||+.||+|||+++ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4676665332 2223577888899999999999999988 999999999999985 557999999999765432
Q ss_pred ccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC-----
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT----- 651 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 651 (743)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..............
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-----DELFKIFRILGTPNEETWP 229 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChhhcc
Confidence 11 1123467889999998876 45789999999999999999999998643221 00000000000000
Q ss_pred ---cchhcc---cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 ---AMEAVD---KSLGES----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 ---~~~~ld---~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...... +..... ........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 000000 00111234678888999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=285.46 Aligned_cols=259 Identities=23% Similarity=0.312 Sum_probs=196.6
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
|++.+.||.|++|.||++... +++.+++|++..... .....+..|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999975 688999999865432 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++ +|..++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 777766432 246889999999999999999999998 99999999999999999999999999987755431
Q ss_pred cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC---cchhc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT---AMEAV 656 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l 656 (743)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .........+.... .....
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCchHhcccch
Confidence 12224578899999998876 7899999999999999999999887543210 00000000000000 00000
Q ss_pred c-----------ccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 D-----------KSL--GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d-----------~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+ ... ...........+.+++..||+.+|.+||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 000 00011122346788999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=294.30 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=195.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC--Cee
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE--QEK 493 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~--~~~ 493 (743)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+..|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567899999999999999999976 6889999988543 233445677899999999 999999999988654 468
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 488777632 26788888999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccc---cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh------
Q 041312 574 FGGDQIE---ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV------ 643 (743)
Q Consensus 574 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~------ 643 (743)
....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~~ 231 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIGP 231 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCC
Confidence 6433221 12234578999999998865 56789999999999999999999998643211 000000
Q ss_pred -----HhHhccCCcchhcccccCC------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 644 -----WDLWKEGTAMEAVDKSLGE------SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 644 -----~~~~~~~~~~~~ld~~l~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+..+.......+++..... .........+.+++.+|++.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011111100000 0001123456788889999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.85 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=197.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEec----CCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIE----EQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~ 493 (743)
.++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999975 69999999987542 2345678889999999999999999998763 3568
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 578777632 345899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccc--cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh--------
Q 041312 574 FGGDQIE--ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH-------- 642 (743)
Q Consensus 574 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~-------- 642 (743)
....... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~~ 231 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGSP 231 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCCC
Confidence 5433221 11123578899999999866 46889999999999999999999998643210 00000
Q ss_pred ---hHhHhccCCcchhcccc-cCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 643 ---VWDLWKEGTAMEAVDKS-LGESCC-----APEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 643 ---~~~~~~~~~~~~~ld~~-l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..+......+.+..+.. ...... ......+.+++.+|++.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001111111111100 000011 1123557789999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=285.43 Aligned_cols=258 Identities=20% Similarity=0.263 Sum_probs=190.0
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecC--CeeEEEEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEE--QEKMLIYE 498 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 498 (743)
|++.++||+|+||.||+++.. +++.+|+|+++... .........|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999965 68999999987542 222234457888999885 99999999999987 88999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 676666432 246899999999999999999999998 999999999999999 999999999998764332
Q ss_pred cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh-----------H
Q 041312 579 IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD-----------L 646 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~ 646 (743)
. .....++..|+|||++.. +.++.++|||||||++|||++|..||...... .......+ .
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHHHh
Confidence 2 123467889999997654 56788999999999999999999998643211 01111100 0
Q ss_pred hccCCcchhcccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGE----SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...........+.... .........+.+++.+||+.+|++||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000000 0011224567888999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=283.57 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=184.5
Q ss_pred ccccCCceeEEEEEEc-CCcEEEEEEcccCCh---hcHHHHHHHHH---HHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 429 KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG---QGIEEFKTEIA---LIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ev~---~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.||+|+||.||++... +++.||+|.+.+... .....+..|.. +++...|++|+++++.+.+....++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 688999999865421 22223444443 4444579999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999888743 346899999999999999999999988 9999999999999999999999999987654322
Q ss_pred ccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........ ........ .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~~~~~ 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTL------TMAVEL 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch------HHHHHHhh------ccCCCC
Confidence 2235789999999998754 689999999999999999999999875422100 00000000 001111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.. .....+.+++.+|++.+|.+|| ++.++++
T Consensus 219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 1124566788899999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=325.12 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=200.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.+-++....+||.|.||.||.+.. .+|...|+|.+... .....+.+.+|+.++..++|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345566778999999999999995 46889999987643 345567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||||.+|+|.+.+. .....++.....+..|++.|++|||+++ ||||||||.||+++.+|.+|++|||.|..+.+
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999883 3344566666678899999999999999 99999999999999999999999999988765
Q ss_pred Cc--cccccccccccccccCcceeccC---CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 577 DQ--IEENTNRVVGTYGYMAPEYAMEG---LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 577 ~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
.. .........||+.|||||++.+. ....+.||||||||+.||+||++||..... ++.+.-+ +..+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aIMy~----V~~gh 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAIMYH----VAAGH 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHHHhH----HhccC
Confidence 42 22233457999999999999764 467789999999999999999999985432 2222211 12222
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..++.+. ... .=.+++..||+.||..|=++.||++.
T Consensus 1459 ~Pq~P~~------ls~---~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQIPER------LSS---EGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCchh------hhH---hHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2222222 122 23467779999999999777766653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=290.82 Aligned_cols=262 Identities=18% Similarity=0.197 Sum_probs=190.1
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.+.+|.|+++.|+++.. +++.+|||++... .....+.+.+|+.++++++|+||+++++++.+....+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455555555555544 6899999998754 3456678999999999999999999999999999999999999999
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc----
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI---- 579 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~---- 579 (743)
+|.+++.... ...+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999886432 235788889999999999999999998 99999999999999999999999998875532211
Q ss_pred -ccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH----hHhcc---
Q 041312 580 -EENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW----DLWKE--- 649 (743)
Q Consensus 580 -~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~--- 649 (743)
........++..|+|||++.. ..++.++|||||||+++||++|+.||...... ..+..... ..+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCch
Confidence 111233457788999999876 35889999999999999999999998743211 00000000 00000
Q ss_pred ----CCcch----hcccc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 ----GTAME----AVDKS----LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ----~~~~~----~ld~~----l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..... ..+.. ............+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 00000 0011112223457789999999999999999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.44 Aligned_cols=269 Identities=25% Similarity=0.351 Sum_probs=202.8
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHh--cCCccEEeeeeeEecCC----eeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ--LQHRNLVSILGCCIEEQ----EKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~~~----~~~lV 496 (743)
.....+.||+|.||.||||.+.+ +.||||++.. +....|++|-.+... ++|+||+++++.-.... +.+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34556899999999999999875 8999999854 445577887777665 68999999998866555 78999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc------CCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD------SRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
+||.+.|+|-++| +...++|....+|+..+++||+|||.. .+.+|+|||||.+||||..++...|+|||+
T Consensus 287 t~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999998 445789999999999999999999964 356799999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCC-CC-----ccccchhHHHHHHHHHhcCCCCCCCcccCCCcc-------
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL-FS-----TKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSW------- 637 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~------- 637 (743)
|..+........+..-+||.+|||||++.+.. +. .+.||||+|.|||||++...-++.... .+-+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v-p~Yqlpfe~evG 441 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV-PEYQLPFEAEVG 441 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC-CcccCchhHHhc
Confidence 99988766655555589999999999997643 22 368999999999999998765543111 00011
Q ss_pred --ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 638 --NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 638 --~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.-.+..+...-..+....+.... .....+.-+.+.+..||..||+.|-|+.=|.+.+..+.-.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W---~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAW---RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhh---hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11111111111111111111111 1224456688899999999999999999998888765443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.91 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=197.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----Ce
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~ 492 (743)
.++|.+.+.||+|+||+||+++.. +++.||||++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999975 6899999998653 233456778899999999999999999987654 35
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+. ++|..++. ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67777764 2346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh------
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD------ 645 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~------ 645 (743)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... ........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 229 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-----HQLKLITELLGSPS 229 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCC
Confidence 764332 11223567889999998865 46899999999999999999999998632110 00000000
Q ss_pred -----HhccCCcchhc-------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCC
Q 041312 646 -----LWKEGTAMEAV-------DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSD 700 (743)
Q Consensus 646 -----~~~~~~~~~~l-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 700 (743)
..........+ +..+.. ........+.+++.+||+.+|++|||++++++. |+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000000 000000 001123456789999999999999999999987 6544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=271.54 Aligned_cols=206 Identities=28% Similarity=0.422 Sum_probs=169.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc---C--CcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEec-CCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ---N--GKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIE-EQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~ 492 (743)
...|+...+||+|.||.||+|... + .+.+|||+++.... ..-....+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356889999999999999999643 2 34799999975522 122356789999999999999999999988 778
Q ss_pred eEEEEEecCCCChhhhhhh--cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC----CCeEEe
Q 041312 493 KMLIYEYLPNKSLDVYIFD--EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA----MNPKIS 566 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~vkl~ 566 (743)
.++++||.+.. |...+.. ..+...++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 89999999764 4444432 223357888999999999999999999988 9999999999999877 999999
Q ss_pred eeccccccCCCccc-cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 567 DFGMARIFGGDQIE-ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 567 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
|||+++.+...-.. .....++-|..|+|||++.+. .|+.+.|||+.|||+.||++-.+.|....
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999988654332 234457889999999999985 58999999999999999999888877544
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=286.74 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=194.3
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ---- 491 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~---- 491 (743)
...++|++.++||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 58899999986542 233456788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 492 ------EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 492 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 55555432 2346889999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+..... ......+.
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~ 231 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELIS 231 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence 999999876433211 1122345788999998865 4578899999999999999999998864321 01111111
Q ss_pred hHhccCCc-----------------chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 645 DLWKEGTA-----------------MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 645 ~~~~~~~~-----------------~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
........ .......+..... .....+.+++.+||+.+|.+||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000000 0000000000000 012346788889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=287.88 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=191.3
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.+.||+|++|.||++..+. ++.+|||++.... .....++..|+.++.++. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568888999999999999999874 8999999987542 234456677887777775 9999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
|+++ ++..++... ...+++..+..++.||++||.|||+ .+ |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 666655332 2368889999999999999999997 46 999999999999999999999999999766433
Q ss_pred ccccccccccccccccCcceeccCC----CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGL----FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+..... .. ........ ....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~---~~~~~~~~-~~~~ 237 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----EF---EVLTKILQ-EEPP 237 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----HH---HHHHHHhc-CCCC
Confidence 22 12235788999999987654 78899999999999999999999863211 00 00111111 1110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
. +... ......+.+++.+||+.+|.+||++.++++..
T Consensus 238 ~-----~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 S-----LPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C-----CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 1000 01223467788899999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=290.14 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=192.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------ 491 (743)
.++|++.++||+|+||.||+++.. +++.+|+|++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 68999999886432 222346788999999999999999999876543
Q ss_pred --eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 492 --EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 492 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
..++||||+.+ +|...+.. ....+++..+..++.||++||.|||+++ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 45554432 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccc---------ccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc
Q 041312 570 MARIFGGDQIEE---------NTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639 (743)
Q Consensus 570 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~ 639 (743)
++.......... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~~ 235 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----DQ 235 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 998654332111 11234678889999988664 5889999999999999999999998643221 00
Q ss_pred chhhHhHhccC-----------------CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 640 VGHVWDLWKEG-----------------TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 640 ~~~~~~~~~~~-----------------~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........... .......+.+.. ........+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100000 000000000000 00111245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=269.26 Aligned_cols=284 Identities=23% Similarity=0.255 Sum_probs=208.5
Q ss_pred HHcCCCCcC-cccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEec----CC
Q 041312 419 AATNDFSSD-NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIE----EQ 491 (743)
Q Consensus 419 ~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~----~~ 491 (743)
..+++|++. ++||-|-.|.|..+..+ +++.+|+|++... ...++||++.-.. .|||||.++++|.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 456677664 68999999999999875 7999999998543 3456788876665 69999999999864 35
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeee
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDF 568 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DF 568 (743)
.+.+|||.|+||.|...+.+.. ...+.+.++..|++||..|+.|||+.+ |.||||||+|+|... +..+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 6789999999999998886543 456899999999999999999999998 999999999999964 456999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
|+|+...+ .......+-||.|.|||++-...|+...|+||+||++|-|++|.+||.-..-. .+..-.....+
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----aispgMk~rI~ 280 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKRRIR 280 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cCChhHHhHhh
Confidence 99987543 22334578899999999999999999999999999999999999999854321 11111111111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCCCcccccccCCCCccccC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNVDEFWTG 725 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 725 (743)
.+. .++ ..+-.....+..-++++.+|..+|++|-|+.+++..=---...-+|..|-+-...+..+.+.|.+
T Consensus 281 ~gq-y~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~a~e~w~d 351 (400)
T KOG0604|consen 281 TGQ-YEF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKEAVEAWDD 351 (400)
T ss_pred ccC-ccC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcchhhhhhHH
Confidence 111 011 11111222334557888999999999999999987643333344555555444444444444544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=285.00 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=200.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV 496 (743)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+..|+.++++++ |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999976 7999999998653 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||++++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999988843 336899999999999999999999988 99999999999999999999999999987654
Q ss_pred Cccc------------------cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccc
Q 041312 577 DQIE------------------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638 (743)
Q Consensus 577 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~ 638 (743)
.... .......++..|+|||++....++.++||||||++++++++|+.|+...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----L 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----H
Confidence 3321 2223356789999999998888999999999999999999999997643210 0
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM----SAVVS 695 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~ 695 (743)
....... ............+.+++.+||+.+|.+||++ +++++
T Consensus 230 ----~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ----TFQKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011000 0001111113456788889999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-34 Score=275.44 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=195.6
Q ss_pred CcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 427 DNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-QGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+..||.|+||+|+|-.++ +|+.+|||+++.... ....++..|+....+- +.||||+++|.+..++..|+.||+| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 478999999999999976 799999999986543 5667888888876665 6899999999999999999999999 56
Q ss_pred Chhhhhhh--cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 504 SLDVYIFD--EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 504 sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
||+.+... ..+...+++...-.|..-.++||.||... ..||||||||+|||++..|.+||+|||++-.+....
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--- 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--- 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---
Confidence 77665432 23455688888888888899999999874 369999999999999999999999999997664332
Q ss_pred ccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 582 NTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
..+.-.|...|||||.+.. ..|+.+|||||||++|||+.||..|+..-.+ ..+++ .....++...++.+
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql-~~Vv~gdpp~l~~~- 293 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQL-CQVVIGDPPILLFD- 293 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHH-HHHHcCCCCeecCc-
Confidence 2334578899999999964 4599999999999999999999999764322 11111 22223333333322
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........++.++-.|+-.|..+||...++..+
T Consensus 294 ---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 ---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1123344567788889999999999999998764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.29 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=189.7
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
|...++||+|+||.||+|+.. +++.+++|++... .......+.+|+.++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 6889999998643 223446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+.+ ++.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 964 66665532 2345889999999999999999999998 99999999999999999999999999864321
Q ss_pred ccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 EENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+..... ......... .......
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~~ 241 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-NDSPTLQ 241 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHh-cCCCCCC
Confidence 22356889999999984 45688899999999999999999999754321 011111111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. ......+.+++.+||+.+|.+||++.++++.
T Consensus 242 -----~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----S---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----c---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111236678889999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.32 Aligned_cols=266 Identities=21% Similarity=0.310 Sum_probs=195.4
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC--
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-- 491 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-- 491 (743)
+....++|.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4456788999999999999999999865 7899999998643 2334567889999999999999999999987553
Q ss_pred ----eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEee
Q 041312 492 ----EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 492 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
..++||||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 458999998 778877763 345889999999999999999999988 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC------ccccc
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG------SWNLV 640 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~------~~~~~ 640 (743)
||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... .....
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865322 223467889999999876 45889999999999999999999998643210000 00000
Q ss_pred hhhHhHhccCCcchhccc--ccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 641 GHVWDLWKEGTAMEAVDK--SLGE----SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 641 ~~~~~~~~~~~~~~~ld~--~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......+........+.. .... .........+.+++.+|++.+|.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000011110000000000 0000 000111224678889999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=284.52 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=192.8
Q ss_pred CCCcCcccccCCceeEEEEEE----cCCcEEEEEEcccCC----hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 423 DFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368999999986532 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345788888899999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcceeccC--CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEG--LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
+...... ......|+..|+|||.+... .++.++||||||+++|+|++|..|+...... ..............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSE- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhccC-
Confidence 6433221 12235688999999998753 4678999999999999999999998632211 00111111110000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
+ ..+......+.+++.+|++.+|++|| ++.+++.
T Consensus 229 ------~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 01111223456788899999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=282.73 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=197.5
Q ss_pred CCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccCC----hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRSS----GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
+|++.+.||+|++|.||+++.. +++.+|||.+.+.. ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999999853 57889999886432 23446788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++.. ...+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888743 345788899999999999999999988 99999999999999999999999999886
Q ss_pred cCCCccccccccccccccccCcceeccCC--CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
+...... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..|+...... .............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~-- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKS-- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHcc--
Confidence 5433221 122346889999999987765 788999999999999999999997532211 0000001111100
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...+... ....+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 -----~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -----KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0001111 112456788899999999999999999988763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=281.94 Aligned_cols=265 Identities=22% Similarity=0.250 Sum_probs=193.7
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
|++.+.||+|++|+||+|+.. +++.++||++..... .......+|+..+++++ |+||+++++.+.+....++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999986 588899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788877764432 246789999999999999999999998 99999999999999999999999999986643221
Q ss_pred cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC--------ccccchhhHhHhccCC
Q 041312 581 ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG--------SWNLVGHVWDLWKEGT 651 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 651 (743)
.....++..|+|||++.+ ..++.++|+||||++++||++|+.|+......... ...-..+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223567889999998854 45789999999999999999999887543211000 0000000000000000
Q ss_pred cchhcccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 AMEAVDKSLG---ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
....+..... ..........+.+++.+|++.+|++||+++||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001113457789999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=280.97 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=191.6
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhc---CCccEEeeeeeEecCCe-----
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQL---QHRNLVSILGCCIEEQE----- 492 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~~~~----- 492 (743)
|++.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.+++++ .|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999987 48999999986432 22234566788777666 59999999999988776
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.+++|||+++ +|.+++.... ...+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7877764322 235889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
.+..... .....++..|+|||++.+..++.++|||||||++|||++|+.|+...... .....+.+.......
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-----DQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-----HHHHHHHHHcCCCCh
Confidence 7643321 12245788999999999999999999999999999999998887643211 001111110000000
Q ss_pred ----------chhcccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 ----------MEAVDKSLGE---SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 ----------~~~ld~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......... .....-...+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 001122345678889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=289.36 Aligned_cols=268 Identities=22% Similarity=0.292 Sum_probs=201.6
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-----eeE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-----EKM 494 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-----~~~ 494 (743)
+|.+.++||.|++|.||+++.. +++.+|||++.... ....+.+..|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999976 58999999987543 445578899999999999999999999998775 789
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++ +|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 77777632 337889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH------
Q 041312 575 GGDQI-EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL------ 646 (743)
Q Consensus 575 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 646 (743)
..... ........+++.|+|||++.+. .++.++||||||+++|+|++|+.||...... +........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~ 228 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPSE 228 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCCh
Confidence 54321 0112335678899999999887 8999999999999999999999998643211 000000000
Q ss_pred -----hccCCcchhcccc-cCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCC
Q 041312 647 -----WKEGTAMEAVDKS-LGES-----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDNA 702 (743)
Q Consensus 647 -----~~~~~~~~~ld~~-l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 702 (743)
.........+... .... ........+.+++.+||+.+|++||+++++++. |++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000001111100 0000 011123456788889999999999999999985 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=286.92 Aligned_cols=194 Identities=29% Similarity=0.475 Sum_probs=172.5
Q ss_pred cccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCC
Q 041312 428 NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
+.||.|-||+||-|+++ +|+.||||+|.+. ......++++|+.+|++++||.||.+.-.|...+..++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 78999999999999975 7999999999754 44566899999999999999999999999999999999999998777
Q ss_pred hhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC---CCeEEeeeccccccCCCcccc
Q 041312 505 LDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 505 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~vkl~DFGla~~~~~~~~~~ 581 (743)
|+..|..+ ...|++....-++.||+.||.|||.++ |+|+||||+|||+.+. -++||+|||+|+++++....
T Consensus 650 LEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 650 LEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred HHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 77666443 345788888889999999999999998 9999999999999644 46999999999999877653
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
..++|||.|+|||++..+.|...-|+||.|||+|--++|..||..+
T Consensus 724 --rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred --hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 3489999999999999999999999999999999999999998744
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=289.60 Aligned_cols=266 Identities=22% Similarity=0.342 Sum_probs=196.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------ 490 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------ 490 (743)
..++|.+.+.||+|+||.||+|+.. +++.||+|++.+. .......+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3478999999999999999999965 6899999998653 223345688999999999999999999998754
Q ss_pred CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
...++|+||+.. +|..++ ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 346899999864 555443 235788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh----
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD---- 645 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 645 (743)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~ 233 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGV 233 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCC
Confidence 8764321 223567889999999876 4688999999999999999999999874321 000000000
Q ss_pred -------HhccCCcchhccc--cc-CCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCCC
Q 041312 646 -------LWKEGTAMEAVDK--SL-GESC---CAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDNAPS 704 (743)
Q Consensus 646 -------~~~~~~~~~~ld~--~l-~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~ 704 (743)
..........+.. .. .... .......+.+++.+||+.||++||+++++++. ++.....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 0000000000000 00 0000 00112346789999999999999999999954 77665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=288.63 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=195.8
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-CCee
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-EQEK 493 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~ 493 (743)
..++++|++.+.||.|+||.||++... +++.+|+|++.+. .....+.+..|+.++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999965 7999999988643 22345678899999999999999999999875 5678
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+ +++|..++. ...++...+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 567877663 235778888899999999999999998 99999999999999999999999999875
Q ss_pred cCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC------ccccchhhHhH
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG------SWNLVGHVWDL 646 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~------~~~~~~~~~~~ 646 (743)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .......+.+.
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4322 123467889999998866 56899999999999999999999988643210000 00000001111
Q ss_pred hccCCcchhcccc-cCCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 WKEGTAMEAVDKS-LGESCCAP-----EILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 ~~~~~~~~~ld~~-l~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.......+.+... ........ ....+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111111100 00111111 12457788889999999999999998766
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=286.41 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=192.8
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.|...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666789999999999999975 6788999988642 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+. +++.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 5776665332 335788999999999999999999988 999999999999999999999999998765432
Q ss_pred cccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 579 IEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
....+++.|+|||++. ...++.++|||||||++|+|++|+.|+...... . .. .........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~---~~-~~~~~~~~~-- 232 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----S---AL-YHIAQNESP-- 232 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----H---HH-HHHhhcCCC--
Confidence 2346788999999975 356788999999999999999999997532110 0 00 011111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
... .......+.+++.+||+.+|++||++.+|++..--
T Consensus 233 ---~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 ---ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ---CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 011 11222346678889999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=291.21 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=191.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC---------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--------- 490 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--------- 490 (743)
..+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367899999999999999999975 6899999998766666677899999999999999999999776543
Q ss_pred -----CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeE
Q 041312 491 -----QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPK 564 (743)
Q Consensus 491 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vk 564 (743)
...++||||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47776663 235788999999999999999999998 999999999999974 55789
Q ss_pred EeeeccccccCCCcccc-ccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 565 ISDFGMARIFGGDQIEE-NTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 565 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
|+|||++..+....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+.. ....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~~ 230 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-----QMQL 230 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH
Confidence 99999998654322111 1122467889999998755 568889999999999999999999986432110 0000
Q ss_pred hHhHh-----------ccCCcchhcccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 643 VWDLW-----------KEGTAMEAVDKSLGESCCA-----PEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 643 ~~~~~-----------~~~~~~~~ld~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... .................+. .....+.+++.+||+.+|++|||+++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000000000000000000 11234678889999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.25 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=192.7
Q ss_pred CCCCc-CcccccCCceeEEEEEEc-CCcEEEEEEcccCChhc--------------HHHHHHHHHHHHhcCCccEEeeee
Q 041312 422 NDFSS-DNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQG--------------IEEFKTEIALIAQLQHRNLVSILG 485 (743)
Q Consensus 422 ~~y~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ev~~l~~l~h~niv~l~~ 485 (743)
++|.. .+.||.|+||.||++... +++.||||++....... ...+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 467999999999999975 68999999886432211 125778999999999999999999
Q ss_pred eEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 486 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
++......++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 578777632 345888999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCcc------------ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCccc
Q 041312 566 SDFGMARIFGGDQI------------EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQ 632 (743)
Q Consensus 566 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~ 632 (743)
+|||++........ ........+++.|+|||++.+. .++.++|||||||++|||++|+.|+....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~- 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE- 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999987652110 1111223567889999998764 468999999999999999999999864322
Q ss_pred CCCccccchhhHhHhccCCcc---h------------hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 633 GSGSWNLVGHVWDLWKEGTAM---E------------AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~---~------------~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
......+.......... . .....+.. ........+.+++..|++.+|++||++++++..
T Consensus 240 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111111100000 0 00000000 001112456788889999999999999999964
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=278.16 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=192.0
Q ss_pred CCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccC-----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRS-----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998653 444555554321 223345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 497 YEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|||+++++|..++... .....+++..++.++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 23456899999999999999999999988 999999999999975 569999999997764
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... ......|++.|+|||.+.+..++.++|+||||+++++|++|..|+..... ...... ...+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~-~~~~~---- 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLR-IVEGP---- 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHH-HHcCC----
Confidence 3321 12235678899999999888899999999999999999999999753211 111111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+ .........+.+++.+|++.+|++||++.++++
T Consensus 222 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 -TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00 111222345677888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.92 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred hhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-
Q 041312 415 SNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE- 490 (743)
Q Consensus 415 ~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~- 490 (743)
.++..+.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 355667899999999999999999999864 78999999987542 23356788899999999999999999988643
Q ss_pred -----CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 491 -----QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 491 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
...+++++++ +++|..++. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888876 778877663 235889999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-----~~~~~~~ 231 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLIL 231 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH
Confidence 999998764322 223567889999998876 56889999999999999999999998532210 0000000
Q ss_pred h-----------HhccCCcchh---cccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 645 D-----------LWKEGTAMEA---VDKSLGE---SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 645 ~-----------~~~~~~~~~~---ld~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. .+........ ++..... .........+.+++..|++.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000000000 0000000 0000112346788889999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=279.56 Aligned_cols=258 Identities=27% Similarity=0.367 Sum_probs=195.6
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
|+..+.||+|++|.||+|+.. +++.+|+|++.... ....+.+..|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556789999999999999976 59999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
+ ++|.+++.... ..+++..+..++.|+++||.|||+++ |+|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58988875432 46889999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc-----------
Q 041312 581 ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK----------- 648 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 648 (743)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.|+...... ...........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-----DQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHHHhCCCcHHHHHhhc
Confidence 1223457789999998776 8899999999999999999998887543210 00000000000
Q ss_pred -----cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 -----EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 -----~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
............. .........+.+++..||+.+|++||++++|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 000111345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=275.16 Aligned_cols=277 Identities=24% Similarity=0.372 Sum_probs=210.6
Q ss_pred CCCCCcChhhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHh--cCCccEEeee
Q 041312 407 EYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ--LQHRNLVSIL 484 (743)
Q Consensus 407 ~~~~~~~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~ 484 (743)
..+|.+-..++ .++..+.+.||+|.||.||+|.++ |+.||||++.... +..+.+|.++.+. |+|+||+.++
T Consensus 199 SGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHHhh---hheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhh
Confidence 45555544443 456778899999999999999987 7899999996443 4567777777776 5999999999
Q ss_pred eeEecC----CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhh-----ccCCCceEeccCCCCcE
Q 041312 485 GCCIEE----QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH-----QDSRLRIIHRDLKASNV 555 (743)
Q Consensus 485 ~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~~ivH~Dikp~NI 555 (743)
+.=..+ .+++||.+|.+.|||.++|. +..++....++++..+|.||++|| .+|+..|.|||||..||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 875543 46899999999999999983 457888999999999999999999 46788899999999999
Q ss_pred EecCCCCeEEeeeccccccCCC--ccccccccccccccccCcceeccCC----C-C-ccccchhHHHHHHHHHhc-----
Q 041312 556 LLDAAMNPKISDFGMARIFGGD--QIEENTNRVVGTYGYMAPEYAMEGL----F-S-TKSDVYSFGVLLLEIILG----- 622 (743)
Q Consensus 556 ll~~~~~vkl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~ksDiwSlGvil~elltG----- 622 (743)
||..++...|+|+|+|...... ......+..+||.+|||||++.... + + ..+||||||.|+||+...
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999999999876544 2334456689999999999997643 1 1 258999999999999863
Q ss_pred -----CCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 623 -----RRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG-ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 623 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+.||....+..+. .+.+++---.+.+.+.+. .....+.+..+.++|..||..||.-|-|+--|-..
T Consensus 428 i~eey~~Pyyd~Vp~DPs--------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPS--------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred EehhhcCCcccCCCCCCC--------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 2344433322111 111111112222333332 33566788889999999999999999999988888
Q ss_pred hcCCCC
Q 041312 697 LGSDNA 702 (743)
Q Consensus 697 L~~~~~ 702 (743)
|..+..
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=292.03 Aligned_cols=241 Identities=24% Similarity=0.308 Sum_probs=190.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++.|.....+|.|+|+.|..+... +++..++|++.+.. .+-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4677888889999999999998865 68899999997662 2334566555554 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe-cCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL-DAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~vkl~DFGla~~~~~ 576 (743)
|++.++-+.+.+.... .. ...+..|+.+|+.|+.|||.++ +|||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~---~~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EF-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc---hh-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877764322 22 2677789999999999999999 9999999999999 5899999999999998765
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. ....+-|..|.|||++....|++++||||||++||+||+|+.|+...... ..+...+..+...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~~s--- 532 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPKFS--- 532 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCccc---
Confidence 5 22245688999999999999999999999999999999999998754331 1111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..-.++ ..+|+.+||+.+|.+||+|.++...
T Consensus 533 ------~~vS~~---AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ------ECVSDE---AKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------cccCHH---HHHHHHHhccCChhhCcChhhhccC
Confidence 112223 3467779999999999999998753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=290.07 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=195.7
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe---
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE--- 492 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~--- 492 (743)
...++|.+.+.||+|++|.||+|+.. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999976 6889999998643 23344667889999999999999999998876554
Q ss_pred ---eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 493 ---KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 493 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5688877632 45889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh-----
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV----- 643 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~----- 643 (743)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-----~~~~~i~~~~~ 233 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-----DQLKRIMNLVG 233 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcC
Confidence 99865432 223567889999998865 36789999999999999999999998643210 000000
Q ss_pred ------HhHhccCCcchhccccc---CCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 644 ------WDLWKEGTAMEAVDKSL---GES---CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 644 ------~~~~~~~~~~~~ld~~l---~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...+........+.... ... ........+.+++.+|++.+|++|||+.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000000 000 000113467789999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=307.40 Aligned_cols=207 Identities=24% Similarity=0.322 Sum_probs=181.6
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 491 (743)
++.-..++|.+++.||+|+||.|..++++ +++.+|+|++.+. .......|+.|-.+|..-..+-|+.++..|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445578999999999999999999976 6899999999873 4455678999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
++|+|||||+||+|-.++.+ ...+++..+.-++..|+-||.-||+.| +|||||||+|||||..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999988843 336888888889999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceec----c-CCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAM----E-GLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
-.+..+.. ......+|||.|++||++. + +.|+..+|.||+||++|||+.|.-||+..
T Consensus 223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 88764433 2344579999999999995 2 57999999999999999999999999854
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=285.16 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=189.3
Q ss_pred CCCcCcccccCCceeEEEEEEc-C--CcEEEEEEcccC--ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC----Ce
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-N--GKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE----QE 492 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~----~~ 492 (743)
+|++.+.||+|+||.||+++.. . ++.+|+|++... .....+.+.+|+.+++++ +|+||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999975 3 788999998643 222356788899999999 599999999875432 45
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++++||+. ++|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899886 57877763 3346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh------
Q 041312 573 IFGGDQIE--ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV------ 643 (743)
Q Consensus 573 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~------ 643 (743)
.+...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~ 228 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-----DQLNQILQVLGT 228 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-----HHHHHHHHHhCC
Confidence 66433221 11233578999999998765 46899999999999999999999987643210 000000
Q ss_pred -----HhHhccCCcchhcc---cc--c-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 644 -----WDLWKEGTAMEAVD---KS--L-GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 644 -----~~~~~~~~~~~~ld---~~--l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...+........+. .. . ...........+.+++.+|++.+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 00 0 00000111235678888999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=293.45 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=204.3
Q ss_pred CCcCcccccCCceeEEEEEE-cCC----cEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVL-QNG----KEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~-~~g----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.+..++||+|+||+||+|.+ +.| -+||||++... ..+...++..|+-+|.+|+||||+|++++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44568999999999999995 333 46899988644 5566789999999999999999999999998766 88999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
+||+.|+|.+++.. ++..+..+..+.|..||++|+.|||.+. ++||||...||||.+-.++||.|||+++.+...
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999865 3456778889999999999999999988 999999999999999999999999999998777
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
..........-.+.|||-|.+....|+.++|||||||++|||+| |..|++.... ..+.+.++.++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dlle~geR---- 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDLLEKGER---- 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHHHhcccc----
Confidence 65554444444678999999999999999999999999999997 8888764322 112233333322
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
-+.++--...+..++.+||..|+..||+++++...+.+
T Consensus 919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11222233445667889999999999999999988753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=269.85 Aligned_cols=236 Identities=27% Similarity=0.336 Sum_probs=190.1
Q ss_pred cccCCceeEEEEEEc-CCcEEEEEEcccCCh---hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 430 LGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999976 589999999875432 3566889999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~ 585 (743)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9888433 35889999999999999999999988 9999999999999999999999999998764332 12334
Q ss_pred ccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 586 ~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
..++..|+|||.+.+...+.++|+||||+++|+|++|+.|+..... .. ........ .+ ..+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~----~~~~~~~~--------~~--~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KE----IYEKILKD--------PL--RFP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HH----HHHHHhcC--------CC--CCC
Confidence 5778899999999888889999999999999999999999853211 00 11111110 00 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSA 692 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~e 692 (743)
......+.+++.+|++.+|++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111345677888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=304.06 Aligned_cols=146 Identities=26% Similarity=0.411 Sum_probs=131.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.++||+|+||.||+|.+. +++.||||++... .......+..|+.+++.++|+||+++++.+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999976 6899999998643 233457789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
|||+.+++|..++.. ...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998843 335788889999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=271.62 Aligned_cols=201 Identities=28% Similarity=0.362 Sum_probs=171.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 495 (743)
..+|..+.+||+|+||.|.++..+ +.+.+|||++++.. ....+--+.|-++|... +-|.+++++.++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999876 57789999998762 23344556777777776 45789999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+.||+|--++.+ -..+.+..+.-++..|+-||-+||+++ ||.||||.+|||++.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999777743 344667777889999999999999999 9999999999999999999999999998532
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
.....+...+|||.|+|||++...+|+..+|.|||||+||||+.|++||+..
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 1233466789999999999999999999999999999999999999999854
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=268.61 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=200.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-C-c----cEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-H-R----NLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h-~----niv~l~~~~~~~~~~ 493 (743)
..+|.+.+.+|+|.||.|-.+.+. .+..||||++ +......+..+-|+++|+++. + | -+|++.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIi-k~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKII-KNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHH-HHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 578999999999999999998865 4788999998 455566678889999999993 2 2 378888999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC--------------
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-------------- 559 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------------- 559 (743)
++|+|.+ |-|+.+++..+ +-.+++...+..++.||++++++||+.+ ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 66888888543 3456888999999999999999999988 999999999999932
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC
Q 041312 560 ------AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633 (743)
Q Consensus 560 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~ 633 (743)
...|||+|||.|..-.+. ...++.|..|+|||++.+-.++..+||||+||||+||.+|...|......
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~- 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL- 315 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH-
Confidence 234899999999875433 34578899999999999999999999999999999999999988754311
Q ss_pred CCcc--------ccchhhHhHh------ccCCc-----------chhccc--cc--CCCCCHHHHHHHHHHHHHhcccCC
Q 041312 634 SGSW--------NLVGHVWDLW------KEGTA-----------MEAVDK--SL--GESCCAPEILRCIHLGLLCVQEQA 684 (743)
Q Consensus 634 ~~~~--------~~~~~~~~~~------~~~~~-----------~~~ld~--~l--~~~~~~~~~~~l~~l~~~cl~~dP 684 (743)
+.. .++....... ..+.+ ....+. .+ .......+..+|++|++.||..||
T Consensus 316 -EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 -EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred -HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 100 1111111111 11100 000000 00 112345667789999999999999
Q ss_pred CCCCCHHHHHH
Q 041312 685 TDRPNMSAVVS 695 (743)
Q Consensus 685 ~~RPs~~evl~ 695 (743)
.+|+|+.|+++
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999885
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.21 Aligned_cols=220 Identities=19% Similarity=0.145 Sum_probs=174.2
Q ss_pred CCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChhhhhhh
Q 041312 433 GGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD 511 (743)
Q Consensus 433 G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 511 (743)
|.+|.||+++.. +++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 68999999986543 234455666667899999999999999999999999999999888743
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccccccccc
Q 041312 512 EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591 (743)
Q Consensus 512 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 591 (743)
...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 235889999999999999999999988 9999999999999999999999999887654321 12345678
Q ss_pred ccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHH
Q 041312 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILR 671 (743)
Q Consensus 592 y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~ 671 (743)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... .. .....+... ....
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~-----~~~~~~~~~----~~~~ 204 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NT-----HTTLNIPEW----VSEE 204 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------cc-----ccccCCccc----CCHH
Confidence 999999988889999999999999999999998765321100 00 000001111 1234
Q ss_pred HHHHHHHhcccCCCCCCCHH
Q 041312 672 CIHLGLLCVQEQATDRPNMS 691 (743)
Q Consensus 672 l~~l~~~cl~~dP~~RPs~~ 691 (743)
+.+++.+|++.||++||++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 56788899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=270.16 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=197.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-------ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-C
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-------SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-Q 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-------~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-~ 491 (743)
.++|-.++.||+|||+.||++.+- ..+.||+|+-... .....+...+|.++.+.|+||.||++++++.-+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356777889999999999999954 5778888876432 223455678899999999999999999998755 5
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec---CCCCeEEeee
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD---AAMNPKISDF 568 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~vkl~DF 568 (743)
..+-|+|||+|.+|+-+|. ..+.+++.++..|+.||+.||.||... +.+|||-||||.|||+. .-|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 5677999999999999984 456789999999999999999999987 47899999999999995 4578999999
Q ss_pred ccccccCCCccc-----cccccccccccccCcceeccC----CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc
Q 041312 569 GMARIFGGDQIE-----ENTNRVVGTYGYMAPEYAMEG----LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639 (743)
Q Consensus 569 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~ 639 (743)
|+++.+...... ..+....||..|++||.+.-+ .++.|+||||+|||+|..+.|++||....++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ------- 690 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ------- 690 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-------
Confidence 999988654332 345567899999999988643 4789999999999999999999999865442
Q ss_pred chhhHhHhccCCcchhcccccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041312 640 VGHVWDLWKEGTAMEAVDKSLG-ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 640 ~~~~~~~~~~~~~~~~ld~~l~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 694 (743)
.+.+.++.+...-+-.+. .+....+ .-.++++||++--++|-...++.
T Consensus 691 ----QdILqeNTIlkAtEVqFP~KPvVsse---AkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 ----QDILQENTILKATEVQFPPKPVVSSE---AKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----HHHHhhhchhcceeccCCCCCccCHH---HHHHHHHHHHhhhhhhhhHHHHc
Confidence 233333333332222221 1122233 34577799999999997766654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=278.59 Aligned_cols=205 Identities=22% Similarity=0.348 Sum_probs=176.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..|..++.||-|+||.|.++... +...+|+|.+.+. .+.....++.|-.||..-+.+-||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45778899999999999999854 5778999998765 3456678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC--
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG-- 575 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~-- 575 (743)
+|++||++-.+|. +...+++..+.-++..+..|+++.|+.| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988874 4457888888888899999999999988 9999999999999999999999999986441
Q ss_pred -------CCc-------------------------------cccccccccccccccCcceeccCCCCccccchhHHHHHH
Q 041312 576 -------GDQ-------------------------------IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLL 617 (743)
Q Consensus 576 -------~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ 617 (743)
+.. ........+||+.|+|||++....|+..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 001122369999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCccc
Q 041312 618 EIILGRRNNTFHLEQ 632 (743)
Q Consensus 618 elltG~~p~~~~~~~ 632 (743)
||+.|+.||....+.
T Consensus 863 em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPG 877 (1034)
T ss_pred HHhhCCCCccCCCCC
Confidence 999999999876653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=283.98 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=207.3
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEec----
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIE---- 489 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~---- 489 (743)
.+..-++.|++.+.||.|.+|.||+++. ++++..|+|++... ....+++..|.++|+.+ +|||++.+++++..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3344567789999999999999999995 47888999988544 34456788899999988 69999999999874
Q ss_pred -CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 490 -EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 490 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
++.+|||||||.+||..+++..-. ...+.|..+..|++.++.||.+||... ++|||||-.|||++.++.|||.||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence 578999999999999999986654 667899999999999999999999887 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
|++..+..... ......||+.|||||++.- ..|+..+|+||||++..||--|.+|+-...+.
T Consensus 168 GvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------- 234 (953)
T KOG0587|consen 168 GVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------- 234 (953)
T ss_pred eeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----------
Confidence 99987754433 3445789999999999964 34788999999999999999999997654431
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..++. +.....+.|. .+..-.+++.+++..||..|.++||++.++++.
T Consensus 235 raLF~---IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 RALFL---IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhcc---CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 1111112221 134445678889999999999999999988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=290.18 Aligned_cols=259 Identities=20% Similarity=0.211 Sum_probs=167.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-C----CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeee------Ee
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-N----GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC------CI 488 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~------~~ 488 (743)
..++|.+.++||+|+||.||+|++. + +..||+|++...... +....| .+.+..+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 689999987543221 111111 1122222222222221 24
Q ss_pred cCCeeEEEEEecCCCChhhhhhhcccc-----------------cccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCC
Q 041312 489 EEQEKMLIYEYLPNKSLDVYIFDEAKR-----------------SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLK 551 (743)
Q Consensus 489 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 551 (743)
.....++||||+++++|.+++...... .......+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999998887532110 01122345679999999999999998 9999999
Q ss_pred CCcEEecC-CCCeEEeeeccccccCCCccccccccccccccccCcceeccC----------------------CCCcccc
Q 041312 552 ASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG----------------------LFSTKSD 608 (743)
Q Consensus 552 p~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksD 608 (743)
|+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .+..++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57899999999986543221 123346789999999966422 2345679
Q ss_pred chhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc-CC----cchhcccc----cCC--CCCHHHHHHHHHHHH
Q 041312 609 VYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE-GT----AMEAVDKS----LGE--SCCAPEILRCIHLGL 677 (743)
Q Consensus 609 iwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~ld~~----l~~--~~~~~~~~~l~~l~~ 677 (743)
||||||+||||+++..+..... ..+ ...+.. +. ....+.+. +.. +..........+|+.
T Consensus 362 VwSlGviL~el~~~~~~~~~~~------~~~----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL------IQF----NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH------HHH----HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 9999999999999776543211 000 000000 00 00001110 000 000111223457888
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 041312 678 LCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 678 ~cl~~dP~~RPs~~evl~~ 696 (743)
+||+.||++|||+.++++.
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=276.78 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=196.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCc-EEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGK-EIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.+++.+..||-||||.|=++..+... .+|+|++++. .....+.+..|-++|...+.|.||+++..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 55667788999999999888876544 4888877653 4456678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
|-|-||.|...|.+ ++.++.....-++..+++|++|||+++ ||.|||||+|.+++.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999854 455777777788899999999999999 999999999999999999999999999998755
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
. .+.+.+|||.|.|||++.++.++.++|.||||+++|||++|.+||....+- .. +... +.-+|
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--kt-------Yn~I-----LkGid 636 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--KT-------YNLI-----LKGID 636 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--HH-------HHHH-----Hhhhh
Confidence 4 467799999999999999999999999999999999999999999854331 11 1111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPN 689 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 689 (743)
.. .++....+...++++.....+|.+|.-
T Consensus 637 ~i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KI---EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hh---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 10 011222334567777888899999976
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=292.22 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=203.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc----C----CcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----N----GKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~----g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
++..+.+.||+|.||.|++|... . ...||||.+.... ....+.+..|+++++.+ +|+||+.++++|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455679999999999999843 1 4569999987553 35677899999999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcc-----c------c--cccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEA-----K------R--SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
..++|+||+..|+|..++...+ . . ..+.....+.++.||+.|++||++.. +|||||...|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997654 0 0 23888999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCcccccccccc--ccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVV--GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~ 636 (743)
++..+||+|||+|+.......-... ... -...|||||.+....|+.|+|||||||+||||++...+.....+
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----- 526 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----- 526 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----
Confidence 9999999999999865443322211 112 23459999999999999999999999999999985544332211
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
....+.+.++++...+..+ ...+ ++.++|+.||+.+|++||++.++++.|+..
T Consensus 527 --~~~~l~~~l~~G~r~~~P~------~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 --PTEELLEFLKEGNRMEQPE------HCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --cHHHHHHHHhcCCCCCCCC------CCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1112244555555443322 2333 455788999999999999999999999883
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=233.67 Aligned_cols=199 Identities=27% Similarity=0.428 Sum_probs=166.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+|...++||+|.||+||+|+.. +++.||+|++... .+.......+|+-+|+.++|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555689999999999999965 6888999988744 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
|. ..|..+. + .-++.++.+.+..++.|+++||.++|+++ +.|||+||+|+||+.+|.+|++|||+++.++-.-.
T Consensus 83 cd-qdlkkyf-d-slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYF-D-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHH-H-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 94 3444443 1 23456888888999999999999999998 99999999999999999999999999998865432
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
. ...-+-|..|.+|.++.+. -|+...|+||.|||+.||....+|.-+.
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 2 2234568999999999885 5899999999999999999877775543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=257.26 Aligned_cols=238 Identities=25% Similarity=0.320 Sum_probs=191.5
Q ss_pred CceeEEEEEEc-CCcEEEEEEcccCChhc-HHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChhhhhhh
Q 041312 434 GFGSVYKGVLQ-NGKEIAVKRLSRSSGQG-IEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD 511 (743)
Q Consensus 434 ~fg~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 511 (743)
+||.||+++.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 58999999997665444 78999999999999999999999999999999999999999999988754
Q ss_pred cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccccccccccccc
Q 041312 512 EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591 (743)
Q Consensus 512 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 591 (743)
.. .++...+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2788999999999999999999988 9999999999999999999999999998765432 2234567889
Q ss_pred ccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHH
Q 041312 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILR 671 (743)
Q Consensus 592 y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~ 671 (743)
|++||.+.+..++.++||||||+++++|++|..|+..... .....+............ .......
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-------~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--------LLELFKKIGKPKPPFPPP-------EWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHhccCCCCccc-------cccCCHH
Confidence 9999999988899999999999999999999998764211 011111111111110000 0002245
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 041312 672 CIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 672 l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 778889999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=240.53 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=169.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++...+..||+|++|.|-+-++. +|..+|+|++... ..+..++..+|+.+..+. .+|.+|.++|.+......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344555688999999999888864 8999999999755 455667788899887765 7999999999999999999999
Q ss_pred EecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|.| ..||+.+..+. .+...+++..+-+|+..+++||.|||++ +.+||||+||+||||+.+|++||||||++-.+..
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 998 56887775442 3456788888999999999999999985 4699999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceecc----CCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAME----GLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
... .+.-.|...|||||.+.. ..|+.|+||||||+++.||.+++.|++..
T Consensus 202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 322 122467889999998853 46999999999999999999999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=276.34 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=177.6
Q ss_pred HcCCCCcCcccccCCceeEEEEEE-----------------cCCcEEEEEEcccCChhcHHH--------------HHHH
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL-----------------QNGKEIAVKRLSRSSGQGIEE--------------FKTE 468 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 468 (743)
..++|.+.++||+|+||+||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235689999986543322222 3447
Q ss_pred HHHHHhcCCccE-----EeeeeeEec--------CCeeEEEEEecCCCChhhhhhhcc---------------------c
Q 041312 469 IALIAQLQHRNL-----VSILGCCIE--------EQEKMLIYEYLPNKSLDVYIFDEA---------------------K 514 (743)
Q Consensus 469 v~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~ 514 (743)
+.++.+++|.++ ++++++|.. ....++||||+++++|.+++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677777653 356899999999999998885321 1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccC
Q 041312 515 RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594 (743)
Q Consensus 515 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 594 (743)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123466778899999999999999988 99999999999999999999999999976543221 11122344789999
Q ss_pred cceeccCC--------------------C--CccccchhHHHHHHHHHhcCC-CCCCCcccCCCc--cccchhhHhHhcc
Q 041312 595 PEYAMEGL--------------------F--STKSDVYSFGVLLLEIILGRR-NNTFHLEQGSGS--WNLVGHVWDLWKE 649 (743)
Q Consensus 595 PE~~~~~~--------------------~--~~ksDiwSlGvil~elltG~~-p~~~~~~~~~~~--~~~~~~~~~~~~~ 649 (743)
||.+.... + ..+.||||+|||+|+|++|.. |+.......... .......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99885432 1 134799999999999999875 543211100000 0000011111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQA---TDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~ 695 (743)
... +- +..........+++..+|..+| .+|+|++|+++
T Consensus 459 ~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111 00 0111112345567778888765 78999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-31 Score=252.17 Aligned_cols=263 Identities=22% Similarity=0.372 Sum_probs=189.1
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--------CC
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--------EQ 491 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--------~~ 491 (743)
.|....+||+|.||.||+|+.+ +|+.||+|++--. ....-....+|+++|..|+|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555689999999999999975 5888998876432 22333456789999999999999999988863 23
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..|+|+.+|+. +|.-+|.+. ...++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999965 455555332 245788999999999999999999887 999999999999999999999999999
Q ss_pred cccCCCcc--ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh------
Q 041312 572 RIFGGDQI--EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH------ 642 (743)
Q Consensus 572 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~------ 642 (743)
+.+..... ....+..+-|..|++||.+.+ ..|+.+.|||..|||+.||.+|.+.+.....+ ....++..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCC
Confidence 87653322 222333566999999999987 46999999999999999999999887654432 11111111
Q ss_pred --hHhHhccCCcchh-------------cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 643 --VWDLWKEGTAMEA-------------VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 643 --~~~~~~~~~~~~~-------------ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+|....+-.+.+. +...+..-.-.+ ..++++.+++..||.+|+.+.+++..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~---~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDD---EALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCCh---hHHHHHHHHhccCcccCcchHhhhch
Confidence 1111111111111 111111111111 45678889999999999999988754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=246.52 Aligned_cols=289 Identities=23% Similarity=0.318 Sum_probs=212.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 495 (743)
..+|..+.+||+|+|.+|..++++ +.+.+|+|++++. ..+.++-.+.|-.+..+. +||.+|-++.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999975 6788999999765 344556677777777776 79999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|.||+++|+|--++ .++..+++..+.-+...|.-||.|||+++ ||.||||.+|+|++.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996555 45556888888888899999999999999 9999999999999999999999999998532
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.....+...+|||.|+|||++.+..|+..+|.|+|||+++||+.|+-||+....+++ ..+--++.++..
T Consensus 403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-d~ntedylfqvi-------- 471 (593)
T KOG0695|consen 403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-DMNTEDYLFQVI-------- 471 (593)
T ss_pred --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-ccchhHHHHHHH--------
Confidence 223346678999999999999999999999999999999999999999986543322 122222333322
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHH----------HHHhcCCCCCCCCCCCcccccc-cCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN------MSAV----------VSMLGSDNAPSSPKHPAFIAKG-LSN 718 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ev----------l~~L~~~~~~~~p~~~~~~~~~-~~~ 718 (743)
+++.++-+.. -..+...++..-|..||.+|.- ++++ .++|+. +++.-|=+|..-... +.+
T Consensus 472 lekqiriprs--lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~~ 548 (593)
T KOG0695|consen 472 LEKQIRIPRS--LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLDN 548 (593)
T ss_pred hhhcccccce--eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCccc
Confidence 2222221111 1123345666778888888743 2222 234433 444456666665544 444
Q ss_pred CCccccCCCce
Q 041312 719 VDEFWTGEGVT 729 (743)
Q Consensus 719 ~~~~~~~~~~~ 729 (743)
-|.-|++...+
T Consensus 549 fd~qft~e~~q 559 (593)
T KOG0695|consen 549 FDTQFTSEPVQ 559 (593)
T ss_pred cccccccCCcc
Confidence 34434444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=275.67 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=185.0
Q ss_pred CCcCcccccCCceeE-EEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecC
Q 041312 424 FSSDNKLGEGGFGSV-YKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 424 y~~~~~LG~G~fg~V-y~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
|...+.+|.|.-|+| |+|... |+.||||++-. ...+...+|+..|+.- +|||||++++.-.+.+.+||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 444467899999865 888874 78999998843 3445678999999998 6999999999999999999999999
Q ss_pred CCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---C--CCeEEeeeccccccC
Q 041312 502 NKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---A--MNPKISDFGMARIFG 575 (743)
Q Consensus 502 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~--~~vkl~DFGla~~~~ 575 (743)
..+|.+++... ...........+.++.|+++||++||+.+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56898888553 11111111334678899999999999987 999999999999975 2 569999999999887
Q ss_pred CCcccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhc-CCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 576 GDQIEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILG-RRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 576 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
..+... ......||.+|+|||++....-+.++||||+||++|+.++| .+||...... +.++ +....-.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---~~NI-------l~~~~~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---QANI-------LTGNYTL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---hhhh-------hcCccce
Confidence 665432 24457899999999999998888899999999999999987 8888754321 1111 1111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..+.+ ..+. ...+|+.+|+..+|..||++.+|+.
T Consensus 733 ~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111 1111 4557778999999999999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-30 Score=246.05 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=190.7
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----CeeEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QEKML 495 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~~l 495 (743)
.+-.+.||.|+||.||.++++ +|+.||+|++... .-...+.+.+|+++|.-++|.|++..++..... ++.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 445689999999999999975 8999999998532 223456788999999999999999998876543 35688
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|+|.|.. +|...+. ..+.++-..+.-++.||++||.|||+.+ |.||||||.|+|++++..+||+|||+|+.-.
T Consensus 135 ~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 8888854 5555552 3456777888889999999999999998 9999999999999999999999999999766
Q ss_pred CCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc------
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK------ 648 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------ 648 (743)
.++....+. -+-|..|+|||++++. .|+.+.||||.|||+.||+..+-.|....+ .+..+.+.+++.
T Consensus 208 ~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-----iqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 208 QRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-----IEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred hhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-----HHHHHHHHHHhCCCcHHH
Confidence 555544443 4568999999999985 589999999999999999987776653322 222222222221
Q ss_pred -----cCCcchhcccccCCC---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 649 -----EGTAMEAVDKSLGES---------CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 649 -----~~~~~~~ld~~l~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
++.-..++....+.+ .....-...+.+..+++..+|.+|-+..+.+.-+
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111111111110 0112222345666788999999999988887765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=232.05 Aligned_cols=197 Identities=22% Similarity=0.421 Sum_probs=167.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecC--CeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEE--QEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~--~~~~l 495 (743)
..++|++.+++|+|.|+.||.|.. .+.++++||+++.. ..+.+++|+++|+.|. |||||++++...+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999994 57889999998643 3457889999999997 99999999999876 45679
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeecccccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIF 574 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFGla~~~ 574 (743)
|+||+.+.+...+. +.+..-.+...+.++++||.|+|+.| |+|||+||.|++|+.. ..++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999988776553 34666677789999999999999999 9999999999999965 56999999999988
Q ss_pred CCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcc
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLE 631 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~ 631 (743)
.+.. ..+..+.+..|--||++.. ..|+..-|+|||||+|..|+..+.||-...+
T Consensus 184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 6554 2344567788999999876 5688899999999999999999999986654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=223.24 Aligned_cols=111 Identities=44% Similarity=0.718 Sum_probs=80.5
Q ss_pred CCeEEEeecCCCCCccC--CccEEEeecCcEEEEeCCCCceEEee-eccCCCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 50 VQTVVWVANRDNPINDT--SGVLTISSLGNLVLCGRNQTVPVWHA-NVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 50 ~~t~vW~Anr~~p~~~~--~~~l~~~~~G~L~l~~~~~~~~~ws~-~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
++||||+|||+.|+... ..+|.|+.||+|+|.+.++. .+|++ ++.+.+..+..|+|+|+|||||++ ..+.+||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~-~iWss~~t~~~~~~~~~~~L~~~GNlvl~d-~~~~~lW~S 78 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGS-VIWSSNNTSGRGNSGCYLVLQDDGNLVLYD-SSGNVLWQS 78 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTE-EEEE--S-TTSS-SSEEEEEETTSEEEEEE-TTSEEEEES
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCC-EEEEecccCCccccCeEEEEeCCCCEEEEe-ecceEEEee
Confidence 36999999999999653 47899999999999986655 49999 555443357889999999999995 688999999
Q ss_pred cCCCcccccccccccccccCCCceeEEeccCCCCCC
Q 041312 127 FDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPA 162 (743)
Q Consensus 127 Fd~PtDtllpg~kl~~~~~~g~~~~l~Sw~s~~dps 162 (743)
|||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999988888778899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=230.83 Aligned_cols=211 Identities=35% Similarity=0.591 Sum_probs=182.7
Q ss_pred cccCCceeEEEEEEcC-CcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChhh
Q 041312 430 LGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDV 507 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 507 (743)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......+++||++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998755432 45789999999999999999999999999999999999999999999
Q ss_pred hhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeeccccccCCCccccccccc
Q 041312 508 YIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRV 586 (743)
Q Consensus 508 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~ 586 (743)
++.... ..++...+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 874321 35788999999999999999999998 999999999999999 89999999999987654321 12235
Q ss_pred cccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCC
Q 041312 587 VGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCC 665 (743)
Q Consensus 587 ~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~ 665 (743)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999998877 888999999999999998
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 666 APEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 666 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467788899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=257.46 Aligned_cols=198 Identities=26% Similarity=0.404 Sum_probs=167.9
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--------hcHHHHHHHHHHHHhcC---CccEEeeeeeE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--------QGIEEFKTEIALIAQLQ---HRNLVSILGCC 487 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~---h~niv~l~~~~ 487 (743)
...+|+..+.+|+|+||.|+.++++ +..+|+||.+.+... ...-.+-.|+++|..++ |+||+|++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457899999999999999999987 467789998865421 12223457999999997 99999999999
Q ss_pred ecCCeeEEEEEecC-CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 488 IEEQEKMLIYEYLP-NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 488 ~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
.+++..||+||-.. +-+|.+++ ...+.+++.++..|++|++.|+++||+++ |||||||-+|+.++.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 99999999999753 44566666 33456889999999999999999999999 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCC
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNT 627 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~ 627 (743)
|||.|........ ...+||..|.|||++.+.+| +..-|||++|++||.++....|+.
T Consensus 713 dfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999988765543 45899999999999999887 456899999999999998888865
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=244.50 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=206.1
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEe
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~ 488 (743)
++.....+++....+-+|.||.||.|.+. +.+.|-+|.++.. +.-....+..|.-++..+.|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 33444466788889999999999999754 3455677877654 3445678889999999999999999999987
Q ss_pred cC-CeeEEEEEecCCCChhhhhh-----hcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 489 EE-QEKMLIYEYLPNKSLDVYIF-----DEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 489 ~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
+. ...++++.++.-|+|..||. +....+.++..+...++.|++.|++|||+.+ |||.||...|.+|++.-+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 65 56788999999999999997 4444566777888899999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccch
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 641 (743)
+||+|=.+++.+-+.+.......--....||+||.+.+..|+.++|+|||||++|||+| |+.|+..-.+.
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------- 505 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------- 505 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---------
Confidence 99999999987766655443333334668999999999999999999999999999997 67776543221
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
....++++|.. |..+.+. ..++..+|.-||...|++||++++++.-|..
T Consensus 506 Em~~ylkdGyR-------laQP~NC--PDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 EMEHYLKDGYR-------LAQPFNC--PDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHhccce-------ecCCCCC--cHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 12233333322 2222222 2346678889999999999999999988853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-28 Score=250.37 Aligned_cols=204 Identities=19% Similarity=0.240 Sum_probs=174.0
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC------CccEEeeeeeEecC
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ------HRNLVSILGCCIEE 490 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~------h~niv~l~~~~~~~ 490 (743)
+.....|.+.-..|+|-|++|..|.+. -|+.||||+|... +...+.=+.|+++|++|. .-|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 445678999999999999999999976 4889999999543 334455678999999996 34899999999999
Q ss_pred CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeec
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFG 569 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFG 569 (743)
++++||+|-+ ..+|.+.|..-.+.-.|...++..++.|++-||..|...+ |+|.||||.||||++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999977 5688888877777777888999999999999999999988 9999999999999865 458999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
.|...+...... +.-+.-|.|||++.+.+|+...|+||+||+||||.||+-.|....
T Consensus 583 SA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 583 SASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999877655422 334567999999999999999999999999999999998876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=239.52 Aligned_cols=131 Identities=31% Similarity=0.385 Sum_probs=110.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-----C---ccEEeeeeeEec---
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-----H---RNLVSILGCCIE--- 489 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----h---~niv~l~~~~~~--- 489 (743)
.+|.+.++||.|.|++||++-+- ..+.||+|+. +......+....|+++|+++. | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv-KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV-KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEE-ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57899999999999999999864 5678899987 556667778899999999983 3 469999999974
Q ss_pred -CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 490 -EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 490 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
+.+.+||+|++ |.+|..+|... ..+.++...+.+|++||+.||.|||.++ +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999998 55666666443 3346889999999999999999999987 79999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=257.19 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=201.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|..+.++|.|.||.|||+++. +++..|+|.++........-+++|+-+++..+|+|||.+++.+.....++++||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 57888899999999999999965 78999999998888888888999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
.+|+|.+..+ -..++++.++..+.+..++||+|||+++ -+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 95 gggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 95 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred CCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--
Confidence 9999988763 4567888899999999999999999998 8999999999999999999999999987765332
Q ss_pred cccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 581 ENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.......||+.|||||+.. .+.|..++|||++|++..|+---+.|.-...+ ..+..+.- +...+
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~LmT----kS~~q 233 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALFLMT----KSGFQ 233 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHHHhh----ccCCC
Confidence 2234478999999999874 56799999999999999998776665322211 11111111 11111
Q ss_pred c-ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 K-SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+ .+.+. ..-...+.+++..|+..+|.+||+++.+++
T Consensus 234 pp~lkDk--~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccCC--ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 11111 122344668888999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=232.56 Aligned_cols=276 Identities=24% Similarity=0.278 Sum_probs=196.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------C
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------Q 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~ 491 (743)
..+|..++.+|.|.- .|..+.+. .++.||+|++... .....++..+|..++..++|+||++++.++... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999998 66666544 6899999988654 344567788999999999999999999999754 4
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
+.|+|||+| ..+|...+. -.++...+..|+.|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 579999999 456766654 23566777899999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCccc----------CCCccccc-
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQ----------GSGSWNLV- 640 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~----------~~~~~~~~- 640 (743)
+..... ...+.++.|..|.|||++.+..+.+.+||||+||++.||++|+--|.....- +.....+.
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 875544 2344578899999999999988999999999999999999998876632210 00000000
Q ss_pred ---hhhHhHhcc--CC----cchhc-ccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh--c---CCCCC
Q 041312 641 ---GHVWDLWKE--GT----AMEAV-DKSLGE--SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML--G---SDNAP 703 (743)
Q Consensus 641 ---~~~~~~~~~--~~----~~~~l-d~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L--~---~~~~~ 703 (743)
..+....+. .. ..+++ |..... +.+......+.+++..||-.+|++|-++.++++.= + ...+.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev 322 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEV 322 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccc
Confidence 000001100 00 00111 111100 01112233456788899999999999999998863 2 23344
Q ss_pred CCCCCC
Q 041312 704 SSPKHP 709 (743)
Q Consensus 704 ~~p~~~ 709 (743)
..|+.|
T Consensus 323 ~ap~pe 328 (369)
T KOG0665|consen 323 EAPPPE 328 (369)
T ss_pred cCCCCc
Confidence 555555
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=228.04 Aligned_cols=199 Identities=32% Similarity=0.467 Sum_probs=172.3
Q ss_pred CCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
|.+.+.||.|++|.||++.... ++.+|+|.+...... ..+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 899999999766544 67889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999988753221 1788899999999999999999998 99999999999999999999999999987754421 1
Q ss_pred ccccccccccccCccee-ccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 582 NTNRVVGTYGYMAPEYA-MEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678889999998 667788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=203.55 Aligned_cols=115 Identities=47% Similarity=0.766 Sum_probs=100.4
Q ss_pred CCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCCCCceEE
Q 041312 11 QPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVW 90 (743)
Q Consensus 11 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~w 90 (743)
++|+.|++|+|++|.|++|||.+....+.|.+|||.+++ .++||.||++.|. ...+.|.|+.||+|+|.+.++ .++|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g-~~vW 78 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSG-TVVW 78 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCC-cEEE
Confidence 689999999999999999999997665589999999887 8999999999994 456789999999999997655 4699
Q ss_pred eeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCC
Q 041312 91 HANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHP 130 (743)
Q Consensus 91 s~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~P 130 (743)
++++.+ .....+|+|+|+|||||+ +..+++||||||||
T Consensus 79 ~S~~~~-~~~~~~~~L~ddGnlvl~-~~~~~~~W~Sf~~P 116 (116)
T cd00028 79 SSNTTR-VNGNYVLVLLDDGNLVLY-DSDGNFLWQSFDYP 116 (116)
T ss_pred EecccC-CCCceEEEEeCCCCEEEE-CCCCCEEEcCCCCC
Confidence 999876 345678999999999999 45689999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=230.37 Aligned_cols=205 Identities=25% Similarity=0.414 Sum_probs=169.4
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
+....+.|..+++||+|.|++||++++. ..+.||+|.+.... ...++.+|+++|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567889999999999999999964 36789999986543 446789999999999 5899999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEeeecc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGM 570 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGl 570 (743)
...+|+||++.....+++. .++...+..+++.+++||.++|.+| ||||||||+|+|.+ ..++-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999998888763 3567888899999999999999999 99999999999998 457789999999
Q ss_pred ccccCCC------------------------------------------ccccccccccccccccCcceecc-CCCCccc
Q 041312 571 ARIFGGD------------------------------------------QIEENTNRVVGTYGYMAPEYAME-GLFSTKS 607 (743)
Q Consensus 571 a~~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ks 607 (743)
|...... ..........||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 9721000 00001112479999999999987 4578899
Q ss_pred cchhHHHHHHHHHhcCCCCCCCccc
Q 041312 608 DVYSFGVLLLEIILGRRNNTFHLEQ 632 (743)
Q Consensus 608 DiwSlGvil~elltG~~p~~~~~~~ 632 (743)
||||.|||++.+++++.||-.....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred ceeeccceeehhhccccccccCccc
Confidence 9999999999999999998865543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=215.99 Aligned_cols=253 Identities=19% Similarity=0.325 Sum_probs=181.9
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeee-EecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGC-CIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~-~~~~~~~~lV 496 (743)
..+.|.+.+.||+|-||.+.+++++ +...+|+|.+.+. .....+|.+|...--.| .|.||+.-++. |...+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467999999999999999999986 6788999988654 33457888888776666 58899987765 4455677889
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec--CCCCeEEeeecccccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD--AAMNPKISDFGMARIF 574 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~vkl~DFGla~~~ 574 (743)
+||+|.|+|..-+.. ..+.+....+++.|++.|+.|+|+++ +||||||.+||||- +..++||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999876633 45677888899999999999999999 99999999999993 4458999999998765
Q ss_pred CCCccccccccccccccccCcceeccC-----CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEG-----LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+..- ....-+..|.+||..... .....+|||.||+|++.+++|..|+...... .-.-+-+..|..
T Consensus 174 g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-----d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 174 GTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-----DKPYWEWEQWLK 243 (378)
T ss_pred Ccee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-----CchHHHHHHHhc
Confidence 4321 122335679999977543 2356799999999999999999999843321 122233444444
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+....+.+. . ..-..++.++..+-+..+|++|--..++..+
T Consensus 244 rk~~~~P~~-F-----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 244 RKNPALPKK-F-----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ccCccCchh-h-----cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 433322211 1 1112233344457888898888444444333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=266.75 Aligned_cols=197 Identities=17% Similarity=0.188 Sum_probs=136.4
Q ss_pred hcCC-ccEEeeeeeE-------ecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCce
Q 041312 474 QLQH-RNLVSILGCC-------IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545 (743)
Q Consensus 474 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 545 (743)
.++| +||+++++.+ .+....++++|++ +++|.++|... ...+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5777777776 2334567788887 66999998532 345899999999999999999999998 9
Q ss_pred EeccCCCCcEEecCCC-------------------CeEEeeeccccccCCCcc--------------ccccccccccccc
Q 041312 546 IHRDLKASNVLLDAAM-------------------NPKISDFGMARIFGGDQI--------------EENTNRVVGTYGY 592 (743)
Q Consensus 546 vH~Dikp~NIll~~~~-------------------~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 592 (743)
+||||||+||||+..+ .+||+|||+++....... .......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455666666543211000 0001124688999
Q ss_pred cCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHH
Q 041312 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRC 672 (743)
Q Consensus 593 ~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l 672 (743)
||||++.+..++.++|||||||+||||++|..|+..... ....+... .+.+ .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----------~~~~~~~~----~~~~-----~~~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----------TMSSLRHR----VLPP-----QILLNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----------HHHHHHHh----hcCh-----hhhhcCHHH
Confidence 999999999999999999999999999998877432110 00001000 1111 011122334
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 041312 673 IHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 673 ~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..++.+||+.+|.+||+|.||++.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 577789999999999999999863
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=191.67 Aligned_cols=114 Identities=43% Similarity=0.736 Sum_probs=98.5
Q ss_pred CCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCCCCceE
Q 041312 10 NQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPV 89 (743)
Q Consensus 10 ~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~ 89 (743)
++.|+.|++|+|+++.|++|||.+... ..+.+|||++.+ .++||+|||+.|+... +.|.|..||+|+|.+.++ .++
T Consensus 1 ~~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g-~~v 76 (114)
T smart00108 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDG-RVV 76 (114)
T ss_pred CcccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCC-CEE
Confidence 357899999999999999999998654 678999999887 8999999999998764 789999999999997654 469
Q ss_pred EeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCC
Q 041312 90 WHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDH 129 (743)
Q Consensus 90 ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~ 129 (743)
|++++. ......+|+|+|+|||||+ +..+++|||||||
T Consensus 77 W~S~t~-~~~~~~~~~L~ddGnlvl~-~~~~~~~W~Sf~~ 114 (114)
T smart00108 77 WSSNTT-GANGNYVLVLLDDGNLVIY-DSDGNFLWQSFDY 114 (114)
T ss_pred EEeccc-CCCCceEEEEeCCCCEEEE-CCCCCEEeCCCCC
Confidence 999987 2345567999999999998 5567899999997
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=189.90 Aligned_cols=99 Identities=41% Similarity=1.034 Sum_probs=93.0
Q ss_pred EEecccCCccce-----------eeeeeecCCcEEEEEEeeCCCeEEEEEEccCCcEEEEEeecCCCceEEEecCCCCCC
Q 041312 188 WRVGSWTGKNFL-----------NATYIDNEDEVSMAYSVTDPSMLTRIVVNESGNEQRLTWSNQENRWIEYFAPPKEPC 256 (743)
Q Consensus 188 ~~~~~w~g~~~~-----------~~~~~~~~~~~~~~~~~~~~s~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 256 (743)
||+|+|+|..|. .+.|+.+++|++++|.+.+.+.++|++|+.+|+++++.|++..+.|...|.+|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999986 467899999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCccCCCCCCCCCcccccCCCCCCC
Q 041312 257 DFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKS 289 (743)
Q Consensus 257 d~~~~CG~~g~C~~~~~~~~~~C~C~~gf~~~~ 289 (743)
|+|+.||+||+|+.+.. +.|.||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~---~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNS---PKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCC---CceECCCCcCCCc
Confidence 99999999999987654 8899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=219.06 Aligned_cols=167 Identities=19% Similarity=0.206 Sum_probs=130.8
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc--CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ--NGKEIAVKRLSRS-----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE 490 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~ 490 (743)
....++|.+.++||+|+||+||+|.+. +++.+|||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999875 5777899987533 22345679999999999999999853322 2
Q ss_pred CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccC-CCCcEEecCCCCeEEeeec
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDL-KASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~vkl~DFG 569 (743)
...++||||+++++|.... .. . ...++.+++++|.|||+++ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 10 1 1367889999999999998 999999 9999999999999999999
Q ss_pred cccccCCCccccc------cccccccccccCcceecc
Q 041312 570 MARIFGGDQIEEN------TNRVVGTYGYMAPEYAME 600 (743)
Q Consensus 570 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 600 (743)
+|+.+........ -....+++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9997754431111 124678899999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=200.55 Aligned_cols=165 Identities=18% Similarity=0.158 Sum_probs=122.4
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
|+|.+++... ...+++..++.++.||++||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 5788887432 346899999999999999999999875 999999999999999 99998754321
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~ 662 (743)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .......... ....... ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~-~~~~~~~----~~ 128 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLN-GMPADDP----RD 128 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHH-HhccCCc----cc
Confidence 3688999999999999999999999999999999999999864321 1111111110 0000000 00
Q ss_pred CCCHHHH---HHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 663 SCCAPEI---LRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 663 ~~~~~~~---~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
....... ..+.+++.+|++.+|++||++.++++.+..
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 0111111 257889999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=211.76 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=191.6
Q ss_pred CCCcCcccccCCceeEEEEEEcCC--cEEEEEEcccCChhcHHHHHHHHHHHHhcCC----ccEEeeeeeE-ecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNG--KEIAVKRLSRSSGQGIEEFKTEIALIAQLQH----RNLVSILGCC-IEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h----~niv~l~~~~-~~~~~~~l 495 (743)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788887765433333378889999999873 5889999998 47778999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-----CCeEEeeecc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-----MNPKISDFGM 570 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-----~~vkl~DFGl 570 (743)
||+.+ |.+|.++..... ...++...++.|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 889988764443 567899999999999999999999999 9999999999999754 4599999999
Q ss_pred cc--ccCCCc----cc--cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 571 AR--IFGGDQ----IE--ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 571 a~--~~~~~~----~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
++ .+.... .. ......+||..|++++...+...+.+.|+||++.++.|++.|..|+....... . ...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~--~---~~~ 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD--L---KSK 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc--h---HHH
Confidence 98 332111 11 11234569999999999999999999999999999999999999975432210 0 000
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
+.. ......... .....+.+.. ++...+-..+..++|....+...|....
T Consensus 249 ~~~----~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 249 FEK----DPRKLLTDR--FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHH----Hhhhhcccc--ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111 001111110 1122333333 3444455578889999999999876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-20 Score=197.66 Aligned_cols=262 Identities=28% Similarity=0.385 Sum_probs=196.7
Q ss_pred CCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChh---cHHHHHHHHHHHHhcCCc-cEEeeeeeEecCCeeEEEEEe
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ---GIEEFKTEIALIAQLQHR-NLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~Ev~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 499 (743)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999987 78899998755332 477899999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~~~~~ 578 (743)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966532211126788889999999999999999998 99999999999999988 79999999998665443
Q ss_pred ccc----ccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 579 IEE----NTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 579 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
... ......|+..|+|||.+.+ ..+....|+||+|+++++++.|..|+...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence 221 2355789999999999988 57889999999999999999999995533210 01111122221111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. .................+.+++..++..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 000000000001223456678889999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=191.47 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=170.4
Q ss_pred CCCCcCcccccCCceeEEEEE-EcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
-.|++.++||+|.||.++.|+ +-+++.||||.-. ......++..|.+..+.| ..++|...+.+..++.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368999999999999999998 4579999999743 333456788888888888 468999999999999999999998
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-----CCCeEEeeecccccc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-----AMNPKISDFGMARIF 574 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~vkl~DFGla~~~ 574 (743)
+ |-||+++.. -....++...+..|+.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 888887753 23456899999999999999999999998 999999999999964 345999999999988
Q ss_pred CCCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 575 GGDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 575 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
...... ......-||.+||+-....+...+...|+-|||-++.+.|-|..||...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 654332 2344578999999999999999999999999999999999999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=184.21 Aligned_cols=202 Identities=22% Similarity=0.280 Sum_probs=168.3
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC-ccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-RNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 498 (743)
..+|.++++||.|+||-+|.|.. .+|++||||.-+... ...++.-|.++.+.|++ ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46799999999999999999994 689999999865433 33567789999999976 578888888999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DFGla~~~~ 575 (743)
.+ |.+|+++..- ....++...++-++-|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+.+.
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 8888887632 2345788889999999999999999999 999999999999963 4569999999999875
Q ss_pred CCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 576 GDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 576 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
..... .......||.+|.+-....+...+...|+-|+|.+|.++.-|..||....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 43221 12334789999999988888889999999999999999999999988543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=221.01 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=183.6
Q ss_pred CcCcccccCCceeEEEEEEc-CCcEEEEEEcc-----cCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 425 SSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLS-----RSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~-----~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.....+|.|++|.|+..... ..+.++.|... ... ......+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999988877744 33334444332 111 122223667888888899999998888887777666679
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++ +|..++... ..+....+..++.|++.|+.|||+.+ |.|||+||+|+++...+.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 888877432 35777888899999999999999999 999999999999999999999999999766433
Q ss_pred ccc--cccccccccccccCcceeccCCCCc-cccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 578 QIE--ENTNRVVGTYGYMAPEYAMEGLFST-KSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 578 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
... ......+|..+|+|||.+.+..|.. ..||||.|++++.|++|+.||............... ........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-----~~~~~~~~ 548 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-----SDQRNIFE 548 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----cccccccc
Confidence 322 3345578999999999999999876 589999999999999999998754332111000000 00000000
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
-. ......-..+...++..||+.+|.+|-|+++|++.
T Consensus 549 ~~-----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GP-----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred Ch-----HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00 00112223456788899999999999999999863
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=187.87 Aligned_cols=172 Identities=13% Similarity=0.163 Sum_probs=134.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhc---HHH------HHHHHHHHHhcCCccEEeeeeeEecC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQG---IEE------FKTEIALIAQLQHRNLVSILGCCIEE 490 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~------~~~Ev~~l~~l~h~niv~l~~~~~~~ 490 (743)
...+|+..+.||.|+||.||.... ++..+|||.+....... ... +.+|++.+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999655 57789999997543222 222 68999999999999999998886643
Q ss_pred --------CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 491 --------QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 491 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
...++||||++|.+|.++.. ++. ....+++.+|..||..+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 34568999999999998 99999999999999888
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL 621 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt 621 (743)
++|+|||............ .++....+..++|||+||+++..+..
T Consensus 173 i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence 9999999887653222111 13444556779999999999877653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=181.99 Aligned_cols=140 Identities=19% Similarity=0.171 Sum_probs=109.1
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChh--c------------------------HHHHHHHHHHHHhcCCccE
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ--G------------------------IEEFKTEIALIAQLQHRNL 480 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~Ev~~l~~l~h~ni 480 (743)
...||+|+||.||+|...+|+.||||+++..... . ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999889999999998654211 1 1123459999999988776
Q ss_pred EeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHh-hccCCCceEeccCCCCcEEecC
Q 041312 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL-HQDSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 481 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~Dikp~NIll~~ 559 (743)
....... ....+|||||++++++...+. ....++...+..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4333222 223489999999987765432 234678888999999999999999 6888 99999999999998
Q ss_pred CCCeEEeeeccccccC
Q 041312 560 AMNPKISDFGMARIFG 575 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~ 575 (743)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.3e-21 Score=214.82 Aligned_cols=253 Identities=17% Similarity=0.200 Sum_probs=182.0
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC-hhcHHHHHHHHHH--HHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS-GQGIEEFKTEIAL--IAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ev~~--l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++...+.||.+.|=+|.+++++.|. |+||++-+.. .-..+.|+++++- ...++|||.+++..........|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777799999999999999999888 8889886553 3334445444433 4556899999998887777888999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc--CCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF--GGD 577 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~--~~~ 577 (743)
+.+ +|.+.+ ..++.+...+.+-|+.||+.||.-+|..+ |+|||||.+||||+.-.-+.|+||..-+.. .++
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 565555 45677888888899999999999999998 999999999999999999999999876532 221
Q ss_pred c---cccccccccccccccCcceeccC----------C-CCccccchhHHHHHHHHHhc-CCCCCCCcccCCCccccchh
Q 041312 578 Q---IEENTNRVVGTYGYMAPEYAMEG----------L-FSTKSDVYSFGVLLLEIILG-RRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 578 ~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~ksDiwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~ 642 (743)
. ...-..+...-..|+|||.+... + .+++.||||+||++.||++- +++|.. .+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----------SQL 244 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----------SQL 244 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----------HHH
Confidence 1 11111222334579999988541 2 57789999999999999985 555432 111
Q ss_pred hHhHhc-cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 643 VWDLWK-EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 643 ~~~~~~-~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..-.-. .......++. +. . ..+.++++.|++.||++|-++++.++.-.++..
T Consensus 245 ~aYr~~~~~~~e~~Le~-Ie----d---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEK-IE----D---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred HhHhccCccCHHHHHHh-Cc----C---ccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 111000 1111111111 11 1 146678889999999999999999999766543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=182.69 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=186.4
Q ss_pred CcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 425 SSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
....+|.+...|..|+|+++. ..+++|++... ....-+.|..|.-.|+.+.||||+.+++.|....++.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 344689999999999999974 45666766532 334446789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
|+|...|... ..-..+..++.+++.+|++|++|||+... -|.---|....++||++..++|.- +-+++. ..
T Consensus 272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfs------fq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQ 342 (448)
T ss_pred hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceee------ee
Confidence 9999988654 33456778889999999999999999762 244446888899999998877642 112211 11
Q ss_pred cccccccccccCcceeccCCCC---ccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFS---TKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~---~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.....-.|.||+||.++.++-+ .++|+|||.+++|||.|...||....+- +--.++.-..
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-----------------ecgmkialeg 405 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-----------------ECGMKIALEG 405 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-----------------hhhhhhhhcc
Confidence 1112336789999999887643 4799999999999999999998754431 0001111122
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
|+...++-....+.+++..|+..||.+||.+..|+-+||+.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33334444556788899999999999999999999999864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=175.12 Aligned_cols=141 Identities=19% Similarity=0.213 Sum_probs=111.5
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChh--------------------------cHHHHHHHHHHHHhcCCccE
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ--------------------------GIEEFKTEIALIAQLQHRNL 480 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--------------------------~~~~~~~Ev~~l~~l~h~ni 480 (743)
...||+|++|.||+|...+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999888999999998754211 01234678999999999887
Q ss_pred EeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecC
Q 041312 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 481 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~ 559 (743)
.....+... ..+|||||++++++..... ....++......++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433332 3489999999886544322 22346778888999999999999999 88 99999999999999
Q ss_pred CCCeEEeeeccccccCC
Q 041312 560 AMNPKISDFGMARIFGG 576 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~~ 576 (743)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=169.12 Aligned_cols=186 Identities=16% Similarity=0.090 Sum_probs=139.7
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcccCChh----cHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEec
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ----GIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997665 6788888877544321 1225889999999995 5788888886 4579999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccC-CCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDL-KASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
.|.+|...+. . ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998864431 0 11357789999999999998 999999 79999999999999999999986554331
Q ss_pred c----c-------ccccccccccccCcceeccC-CCC-ccccchhHHHHHHHHHhcCCCCCCC
Q 041312 580 E----E-------NTNRVVGTYGYMAPEYAMEG-LFS-TKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 580 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
. . .......++.|++|+...-. ..+ ...+.++.|.-+|.++|++.++...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 01112457788888754332 223 4578899999999999999886643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=178.82 Aligned_cols=232 Identities=21% Similarity=0.268 Sum_probs=150.4
Q ss_pred CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCC----------ccEEeeeeeEec
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH----------RNLVSILGCCIE 489 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h----------~niv~l~~~~~~ 489 (743)
+...+.||.|+++.||.+++. +++++|+|++... .....+++++|...+..+.+ -.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345578999999999999987 5999999987633 33467788888776666432 223333332221
Q ss_pred ---------C---C-----eeEEEEEecCCCChhhhhhh---cc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEec
Q 041312 490 ---------E---Q-----EKMLIYEYLPNKSLDVYIFD---EA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548 (743)
Q Consensus 490 ---------~---~-----~~~lV~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~ 548 (743)
. . ..+++|+-+ .++|..++.- .. ....+....++.+..|+++.+++||+++ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1 1 235677776 5677666422 11 1234556666778899999999999999 9999
Q ss_pred cCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceecc--------CCCCccccchhHHHHHHHHH
Q 041312 549 DLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME--------GLFSTKSDVYSFGVLLLEII 620 (743)
Q Consensus 549 Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDiwSlGvil~ell 620 (743)
||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999988766543221 233577999997744 24788999999999999999
Q ss_pred hcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 041312 621 LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDR 687 (743)
Q Consensus 621 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 687 (743)
||+.|+....+...... .+ ..+. +-.+.+..|+..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~---------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW---------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG---------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc---------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986654322111 01 1112 334445567779999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=165.16 Aligned_cols=136 Identities=18% Similarity=0.264 Sum_probs=106.2
Q ss_pred CcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-----CCccEEeeeeeEecCC---eeE-E
Q 041312 425 SSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-----QHRNLVSILGCCIEEQ---EKM-L 495 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 495 (743)
...+.||+|+||.||. ++.....+||++........+.+.+|+.+++++ .||||+++++++.... ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 543333479988765555667899999999999 5799999999998764 333 7
Q ss_pred EEEe--cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHH-HHhhccCCCceEeccCCCCcEEecC----CCCeEEeee
Q 041312 496 IYEY--LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI-LYLHQDSRLRIIHRDLKASNVLLDA----AMNPKISDF 568 (743)
Q Consensus 496 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~ivH~Dikp~NIll~~----~~~vkl~DF 568 (743)
|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6689999998432 24444 35678888777 8999998 999999999999974 347999995
Q ss_pred ccc
Q 041312 569 GMA 571 (743)
Q Consensus 569 Gla 571 (743)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-18 Score=198.80 Aligned_cols=198 Identities=22% Similarity=0.275 Sum_probs=157.4
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC---CccEEeeeeeEecCCeeEE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~l 495 (743)
.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-. |.-=.+++.+|+ -+.|+.+...+.-.+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3446789999999999999999999889999999876543221 111122223332 2345666666777788899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-------CCCeEEeee
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-------AMNPKISDF 568 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------~~~vkl~DF 568 (743)
|+||.+.|+|.+++. ..+.+++..++.++.|+++.++.||..+ |||+||||+|.||.. .-.++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999985 5667899999999999999999999998 999999999999942 345999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCC
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRN 625 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p 625 (743)
|.+.-+.--.........++|-.+-.+|+..+.+++..+|.|.++.+++-||.|+..
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 988654322222334456788899999999999999999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-19 Score=191.07 Aligned_cols=186 Identities=27% Similarity=0.327 Sum_probs=153.7
Q ss_pred ccccCCceeEEEEE----EcCCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEecC
Q 041312 429 KLGEGGFGSVYKGV----LQNGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~----~~~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.+|+|.||.|+.++ .+.++.+|+|.+.+... ......+.|..++..++ ||.+|++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998866 34577889888765421 11125677888999997 9999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|.|...+.. ...+.+.........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+.+..-....
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9999877743 334555555667778889999999988 99999999999999999999999999987532221
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
.+||..|||||++. .+...+|.||||++.+||++|..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999988 667889999999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=181.33 Aligned_cols=219 Identities=25% Similarity=0.363 Sum_probs=161.5
Q ss_pred HHhcCCccEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCce-EeccC
Q 041312 472 IAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI-IHRDL 550 (743)
Q Consensus 472 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-vH~Di 550 (743)
|+.+.|.|+.++++.+.++...++|.+|+..|+|.+.+.. ....+++--...++++|++||.|||.-. | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578999999999999999999999999999999999965 2345778888889999999999999865 4 99999
Q ss_pred CCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCC-------CCccccchhHHHHHHHHHhcC
Q 041312 551 KASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL-------FSTKSDVYSFGVLLLEIILGR 623 (743)
Q Consensus 551 kp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDiwSlGvil~elltG~ 623 (743)
+..|.+++....+||.|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999988764311111111122345699999987631 466799999999999999999
Q ss_pred CCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 624 RNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 624 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.||+........ .++... ++. .....+.+.+...- +....+..++.+||..+|++||++..|-..++.+...
T Consensus 156 ~~~~~~~~~~~~-~eii~~----~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILR----VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCCh-HHHHHH----HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999864432111 122222 222 11111222221110 1112578888899999999999999999999876553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-18 Score=182.93 Aligned_cols=124 Identities=27% Similarity=0.446 Sum_probs=109.4
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
.+++.|++|...+|.++|.........++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666667888899999999999999 66 999999999999999999999999998
Q ss_pred cccCCCc----cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh
Q 041312 572 RIFGGDQ----IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL 621 (743)
Q Consensus 572 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt 621 (743)
....... ........+||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7665443 2234455799999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=164.02 Aligned_cols=145 Identities=17% Similarity=0.171 Sum_probs=112.2
Q ss_pred CCCCcCcccccCCceeEEEEE--EcCCcEEEEEEcccCChh------------------------cHHHHHHHHHHHHhc
Q 041312 422 NDFSSDNKLGEGGFGSVYKGV--LQNGKEIAVKRLSRSSGQ------------------------GIEEFKTEIALIAQL 475 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ev~~l~~l 475 (743)
..|.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358888999999999999998 568999999998643210 112356899999999
Q ss_pred CCc--cEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCC
Q 041312 476 QHR--NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKAS 553 (743)
Q Consensus 476 ~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~ 553 (743)
.+. .+.++++. ...++||||+++.+|...... ...+.......++.||+.+|.+||+++ .|+|+||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 763 33444432 235899999999888665422 223555667789999999999999875 4999999999
Q ss_pred cEEecCCCCeEEeeeccccccCC
Q 041312 554 NVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 554 NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+++ ++.++|+|||.+.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999886543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=158.23 Aligned_cols=134 Identities=21% Similarity=0.304 Sum_probs=112.4
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG--------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|+.++..+.|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 677899997653221 1124678899999999999988777777777889999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998887422 11 67789999999999999998 99999999999999 78899999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=154.75 Aligned_cols=144 Identities=19% Similarity=0.177 Sum_probs=111.6
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh----------------------hcHHHHHHHHHHHHh
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG----------------------QGIEEFKTEIALIAQ 474 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~Ev~~l~~ 474 (743)
+......|.+.+.||+|+||.||++...+|+.+|||++..... .....+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333344788899999999999999988899999998754320 011236778999999
Q ss_pred cCCcc--EEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCC
Q 041312 475 LQHRN--LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKA 552 (743)
Q Consensus 475 l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp 552 (743)
+.|++ +++.++ ....++||||+++++|..... ......++.+|+.++.++|+.+ |+|+||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 444433 245689999999999876531 0234568899999999999988 99999999
Q ss_pred CcEEecCCCCeEEeeeccccccCC
Q 041312 553 SNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 553 ~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.7e-16 Score=153.92 Aligned_cols=130 Identities=22% Similarity=0.346 Sum_probs=105.9
Q ss_pred ccccCCceeEEEEEEcCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG--------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.||+|++|.||+|.. ++..+++|+...... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 568899998543211 12356788999999999887665555566667789999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887632110 68999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-16 Score=180.93 Aligned_cols=218 Identities=21% Similarity=0.326 Sum_probs=144.2
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
...+|..++.|..|+||.||..+++ ..+.+|+| +.++..- +++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee-----------------
Confidence 3468999999999999999999987 46778884 4332100 011 22222333333
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC-
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD- 577 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~- 577 (743)
|+-...+. ..+.++.. ++.+++|||+.+ |+|||+||+|.+|..-|++|+.|||+.+..-..
T Consensus 136 ----gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 22222221 11233332 267899999988 999999999999999999999999998753211
Q ss_pred ------------ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 578 ------------QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 578 ------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
......+.++||+.|+|||++....|+..+|.|++|+|+||.+-|+.||..+.++ ++...+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-----elfg~vis 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVIS 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-----HHHhhhhh
Confidence 0111233469999999999999999999999999999999999999999866442 22222211
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. ..+..+. .+....|++. ++.+.|+.+|..|--...-+++
T Consensus 273 d-----~i~wpE~---dea~p~Ea~d---li~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 273 D-----DIEWPEE---DEALPPEAQD---LIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred h-----hcccccc---CcCCCHHHHH---HHHHHHHhChHhhcccchhhhh
Confidence 1 0111111 2233445544 5558899999999544444433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.5e-16 Score=176.11 Aligned_cols=139 Identities=19% Similarity=0.314 Sum_probs=111.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC-------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS-------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
...|...++||+|+||.||++.......++.+++.+.. ....+++.+|++++++++|++++....+.......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456678999999999999987654433333222211 11235688999999999999998888777777788
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988763 34578999999999999998 9999999999999 678999999999976
Q ss_pred c
Q 041312 574 F 574 (743)
Q Consensus 574 ~ 574 (743)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=153.68 Aligned_cols=197 Identities=21% Similarity=0.266 Sum_probs=131.6
Q ss_pred CCccEEeeeeeEec---------------------------CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHH
Q 041312 476 QHRNLVSILGCCIE---------------------------EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528 (743)
Q Consensus 476 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 528 (743)
+|||||+++.+|.+ ...+|+||.-. ..+|..++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence 59999999988764 23457888765 346766663 23455566677899
Q ss_pred HHHHHHHHhhccCCCceEeccCCCCcEEec--CC--CCeEEeeeccccccCC--Cccc--cccccccccccccCcceecc
Q 041312 529 GIARGILYLHQDSRLRIIHRDLKASNVLLD--AA--MNPKISDFGMARIFGG--DQIE--ENTNRVVGTYGYMAPEYAME 600 (743)
Q Consensus 529 qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~--~~vkl~DFGla~~~~~--~~~~--~~~~~~~gt~~y~aPE~~~~ 600 (743)
|+++|+.|||+++ |.|||+|.+||||. ++ -.+.|+|||.+-.-.. -+.. ...-...|....||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 33 3478999997643221 1111 11122456677899998865
Q ss_pred CC------CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHH
Q 041312 601 GL------FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIH 674 (743)
Q Consensus 601 ~~------~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~ 674 (743)
.+ --.|+|.|+.|.+.||++....||+..- +....... ..+..+.. +.+. .++ .+.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~~r~-----Yqe~qLPa-----lp~~-vpp---~~rq 488 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLDTRT-----YQESQLPA-----LPSR-VPP---VARQ 488 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheechhh-----hhhhhCCC-----Cccc-CCh---HHHH
Confidence 43 1248999999999999999999988521 11111111 11111111 1111 122 2446
Q ss_pred HHHHhcccCCCCCCCHHHHHHHh
Q 041312 675 LGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 675 l~~~cl~~dP~~RPs~~evl~~L 697 (743)
++...|+.||++||+..-...+|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 77789999999999987666665
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.6e-15 Score=144.28 Aligned_cols=137 Identities=18% Similarity=0.233 Sum_probs=98.4
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChh--cHHH----------------------HHHHHHHHHhcCCcc--E
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ--GIEE----------------------FKTEIALIAQLQHRN--L 480 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~Ev~~l~~l~h~n--i 480 (743)
.+.||+|+||.||++...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999999888999999987643211 1111 134566666664433 3
Q ss_pred EeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecC
Q 041312 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 481 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~ 559 (743)
.+.++. ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 344332 346899999999654322111110 11 5567899999999999999 77 99999999999999
Q ss_pred CCCeEEeeeccccccC
Q 041312 560 AMNPKISDFGMARIFG 575 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~ 575 (743)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-15 Score=120.51 Aligned_cols=66 Identities=47% Similarity=0.956 Sum_probs=57.7
Q ss_pred cccCCceEEEeeeccCCCcceeeccccChHHHHHhccccCCcccccccccccccCCceeeEEecccCccc
Q 041312 311 CRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDT 380 (743)
Q Consensus 311 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~g~~gC~~w~g~l~d~ 380 (743)
|+.+++|+++++|++|++....++.++++++|+..||+||||+||+|. +.. ++.+|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~---~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYS---NLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEee---ccC-CCCEEEEEcCEeecC
Confidence 456789999999999999888877789999999999999999999986 333 568999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=134.86 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=114.0
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC--ccEEeeeeeEecCCeeEEEEEecCCC
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH--RNLVSILGCCIEEQEKMLIYEYLPNK 503 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 503 (743)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.+++.++| .++++++......+..+++|||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999865 7899999865443 5678999999999977 58899998888888899999999988
Q ss_pred ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 504 SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 504 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 3455667889999999999986444599999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-15 Score=173.08 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=186.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc--CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ--NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV 496 (743)
..|...+.||+|+|+.|-..... ....+|+|.+.... ....++...|..+-+.+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35677788999999999887753 34556777765442 334455666888888887 99999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhh-ccCCCceEeccCCCCcEEecCCC-CeEEeeecccccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH-QDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIF 574 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~ 574 (743)
+||..++++...+.... ....+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988773211 112333445578999999999999 777 99999999999999999 9999999999988
Q ss_pred CC-Cccccccccccc-cccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 575 GG-DQIEENTNRVVG-TYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 575 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
.. ..........+| ++.|+|||...+. -.....|+||.|+++.-+++|..|+.............. .. .+.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~---~~---~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK---SN---KGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec---cc---ccc
Confidence 76 444444555788 9999999999884 456789999999999999999999886544211111000 00 000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... ...-.....++...++..+|+.|.+.+++..
T Consensus 250 ~~~~~--------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FTQLP--------WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCc--------cccCChhhhhcccccccCCchhccccccccc
Confidence 00000 0111112345556788889999998887653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-14 Score=143.09 Aligned_cols=135 Identities=21% Similarity=0.262 Sum_probs=104.2
Q ss_pred cccc-cCCceeEEEEEEcCCcEEEEEEcccCC-------------hhcHHHHHHHHHHHHhcCCccE--EeeeeeEecCC
Q 041312 428 NKLG-EGGFGSVYKGVLQNGKEIAVKRLSRSS-------------GQGIEEFKTEIALIAQLQHRNL--VSILGCCIEEQ 491 (743)
Q Consensus 428 ~~LG-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ev~~l~~l~h~ni--v~l~~~~~~~~ 491 (743)
..|| .||.|+||++... +..++||++.... ......+.+|+.++.+|.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999998875 6788998875321 1223567889999999998875 67776644322
Q ss_pred ----eeEEEEEecCC-CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 492 ----EKMLIYEYLPN-KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 492 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688877632 233432 4678999999999999 9999999999999998899999
Q ss_pred eecccccc
Q 041312 567 DFGMARIF 574 (743)
Q Consensus 567 DFGla~~~ 574 (743)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.6e-13 Score=146.44 Aligned_cols=146 Identities=22% Similarity=0.272 Sum_probs=103.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcH---------------------------------------
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGI--------------------------------------- 462 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~--------------------------------------- 462 (743)
..|. .+.||.|++|.||+|++++|+.||||+.+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 368999999999999999999999999865432111
Q ss_pred -HHHHHHHHHHHhcC----CccEEeeeeeE-ecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHH-HHH
Q 041312 463 -EEFKTEIALIAQLQ----HRNLVSILGCC-IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR-GIL 535 (743)
Q Consensus 463 -~~~~~Ev~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~ 535 (743)
-.|.+|+..+.++. |.+-+.+-..+ ...+..+|||||++|++|.++...... .. .+..++..+++ .+.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLN 271 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHH
Confidence 02445666666652 22223333333 234567999999999999887532111 11 23456666665 467
Q ss_pred HhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 536 yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
.+|..+ ++|+|+||.||+++.++.++++|||++..+.+
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 889888 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.8e-13 Score=133.54 Aligned_cols=205 Identities=20% Similarity=0.235 Sum_probs=142.5
Q ss_pred HHHHHhcCCccEEeeeeeEecCC-----eeEEEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCC
Q 041312 469 IALIAQLQHRNLVSILGCCIEEQ-----EKMLIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSR 542 (743)
Q Consensus 469 v~~l~~l~h~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 542 (743)
...|-++.|.|||+++.++.+.+ +..++.|||..|++..+|.+.. .+..+......+|+-||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34566678999999999987543 4689999999999999997643 3456778888899999999999999974
Q ss_pred CceEeccCCCCcEEecCCCCeEEeeeccc--cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHH
Q 041312 543 LRIIHRDLKASNVLLDAAMNPKISDFGMA--RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620 (743)
Q Consensus 543 ~~ivH~Dikp~NIll~~~~~vkl~DFGla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ell 620 (743)
.+|+|+++.-.-|++..++-+||.--... ...-............+-++|.|||.=.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 78999999999999999998887532111 1111111122233456678999999877777788999999999999998
Q ss_pred hcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 621 LGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 621 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.--.....+....+.+.. .+...+...+. ..++..|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia----------~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA----------NVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhh----------hheeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 87764333222111111110 01111111111 12345799999999999998764
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.3e-13 Score=109.13 Aligned_cols=71 Identities=23% Similarity=0.413 Sum_probs=61.7
Q ss_pred cccCCceEEEeeeccCCCcceeeccccChHHHHHhccc---cCCcccccccccccccCCceeeEEecccC-cccceeccc
Q 041312 311 CRRGDGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLR---NCSCLAYTSAYAESESNGRIGCLTYHGDM-MDTRTYINA 386 (743)
Q Consensus 311 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~g~~gC~~w~g~l-~d~r~~~~~ 386 (743)
|+..++|+++.+|++|++.. +++++|+++|++ ||||+||+|. + .+.||++|.+++ +|.+.+...
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~---~---~~~gC~~W~~~l~~d~~~~~~~ 72 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFA---K---ARKQCLWFPFNSMSGVRKEFSH 72 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeecc---C---CCCCeEEecCcchhhHHhccCC
Confidence 55668899999999998764 789999999999 9999999986 2 135899999999 999988877
Q ss_pred cccceee
Q 041312 387 GQDLYVR 393 (743)
Q Consensus 387 g~~ly~r 393 (743)
+.+||+|
T Consensus 73 g~~Ly~r 79 (80)
T cd00129 73 GFDLYEN 79 (80)
T ss_pred CceeEeE
Confidence 8899987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=138.26 Aligned_cols=147 Identities=18% Similarity=0.211 Sum_probs=97.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCChhc----------------------------------HH-
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQG----------------------------------IE- 463 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~- 463 (743)
...+|.. +.||.|++|.||+|++++ |+.||||++++...+. .+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 799999999999999987 9999999997542111 11
Q ss_pred -----HHHHHHHHHHhcC----CccEEeeeeeEec-CCeeEEEEEecCCCChhhhhhhccc---ccccCHHHHHHHHHHH
Q 041312 464 -----EFKTEIALIAQLQ----HRNLVSILGCCIE-EQEKMLIYEYLPNKSLDVYIFDEAK---RSLLDWSKRFEIICGI 530 (743)
Q Consensus 464 -----~~~~Ev~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi 530 (743)
.+.+|+..+.++. +.+.+.+-..+.+ .+..+|||||++|+.+.+...-... ...+....+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 1344555555542 3333443344433 4677899999999999764211111 1122222222333333
Q ss_pred HHHHHHhhccCCCceEeccCCCCcEEecCCC----CeEEeeeccccccCCC
Q 041312 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAM----NPKISDFGMARIFGGD 577 (743)
Q Consensus 531 ~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~vkl~DFGla~~~~~~ 577 (743)
+..+ ++|+|+||.||+++.++ .++++|||++..+...
T Consensus 277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3455 99999999999999888 9999999999877543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.8e-12 Score=137.36 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=178.7
Q ss_pred CCCcCccccc--CCceeEEEEEE--c-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeE
Q 041312 423 DFSSDNKLGE--GGFGSVYKGVL--Q-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 423 ~y~~~~~LG~--G~fg~Vy~~~~--~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 494 (743)
.|.+.+.+|. |.+|.||.+.. . ++..+|+|+-+.. .......=.+|+...+++ .|++.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566688999 99999999986 3 6888999984432 223333445677777777 4999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHH----HHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeec
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR----GILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFG 569 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFG 569 (743)
+-+|++. .+|..+... ....++....+.+..+... ||.++|+.. |+|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 666666532 3334667777888888888 999999998 9999999999999999 889999999
Q ss_pred cccccCCCcccccc---ccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 570 MARIFGGDQIEENT---NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 570 la~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
+...++........ ....|...|++||.+ ++.++.+.|||++|.++.+..++...+....-. .|..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------~W~~ 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS----------SWSQ 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC----------Cccc
Confidence 99988765532211 233677889999965 455788999999999999999998876543111 1222
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+... +..++...-..++..+..+|++.+|..|++.+.++.
T Consensus 338 ~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 22211 111112122223344777899999999988766543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.9e-11 Score=117.94 Aligned_cols=131 Identities=19% Similarity=0.123 Sum_probs=97.7
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEE-eeeeeEecCCeeEEEEEecCCCCh
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV-SILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
++.|+.|.++.||+++.. ++.+++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999865 77899998754432 223567899999998765544 444332 3346899999999888
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccC--CCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS--RLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
.... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 011245678999999999876 22359999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.4e-10 Score=108.95 Aligned_cols=137 Identities=12% Similarity=0.100 Sum_probs=99.1
Q ss_pred cccccCCceeEEEEEEcC-------CcEEEEEEcccCC----------------------hhcHHHHH----HHHHHHHh
Q 041312 428 NKLGEGGFGSVYKGVLQN-------GKEIAVKRLSRSS----------------------GQGIEEFK----TEIALIAQ 474 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~----------------------~~~~~~~~----~Ev~~l~~ 474 (743)
..||.|.-+.||.|...+ +..+|||+.+... ..-.+.+. +|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998653 4789999764210 00122333 79999999
Q ss_pred cCC--ccEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHh-hccCCCceEeccCC
Q 041312 475 LQH--RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL-HQDSRLRIIHRDLK 551 (743)
Q Consensus 475 l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~Dik 551 (743)
+.. -++.+++++ ...+|||||+.+..+..... +...++......+..+++.+|..| |+.+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 864 355566654 56789999998754422211 122344455667889999999998 8887 9999999
Q ss_pred CCcEEecCCCCeEEeeeccccccC
Q 041312 552 ASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 552 p~NIll~~~~~vkl~DFGla~~~~ 575 (743)
+.|||+. ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.1e-10 Score=123.31 Aligned_cols=243 Identities=17% Similarity=0.183 Sum_probs=153.4
Q ss_pred EcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHH
Q 041312 443 LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSK 522 (743)
Q Consensus 443 ~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 522 (743)
..++.++.|...+.......+..++-++.|+.++||||++++..+...+..|||+|-+. -|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688888887766555555667888999999999999999999999999999999873 23333322 12344
Q ss_pred HHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCC
Q 041312 523 RFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602 (743)
Q Consensus 523 ~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 602 (743)
....+.||+.||.|||..+ .++|++|....|+|+..|+-||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 4557889999999998665 599999999999999999999999998865432221 111122223466777544332
Q ss_pred CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhccc
Q 041312 603 FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQE 682 (743)
Q Consensus 603 ~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~ 682 (743)
...|.|-||++++|++.|..+-........... ....... .+++..... .... .++++..|...
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ip---k~~~~~~----~k~~~~~~~------~r~n-~~~~~~~~~~~ 245 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIP---KALIELY----CKKLGATEL------KRPN-KLRFILECRLL 245 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCcchhhhccCccc---hhHHHHH----HHHhccccc------cccc-hhhHHHHHHhc
Confidence 456999999999999999332111111100000 0000000 000000000 0001 34455566666
Q ss_pred CCCCCCCHHHHHHHhcCCCCCCCCCCCcccc
Q 041312 683 QATDRPNMSAVVSMLGSDNAPSSPKHPAFIA 713 (743)
Q Consensus 683 dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~ 713 (743)
.+--|--+-+++..|+++.-.+....-.||.
T Consensus 246 ~gff~n~fvd~~~fLeel~lks~~eK~~Ff~ 276 (690)
T KOG1243|consen 246 GGFFRNDFVDTLLFLEELRLKSVEEKQKFFS 276 (690)
T ss_pred cccccchHHHHHHHHHhcccCcHHHHHHHHH
Confidence 6667777777777777765555444444443
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.5e-11 Score=99.13 Aligned_cols=76 Identities=41% Similarity=0.870 Sum_probs=61.2
Q ss_pred cccC---CceEEEeeeccCCCcceeeccccChHHHHHhccccCCcccccccccccccCCceeeEEecccCcccceecccc
Q 041312 311 CRRG---DGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAG 387 (743)
Q Consensus 311 C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~g~~gC~~w~g~l~d~r~~~~~g 387 (743)
|... +.|+.++++++|+..+.. .++++++|++.|++||+|+||+|. .++.+|.+|.+.+.+.+.....+
T Consensus 5 C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~------~~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 5 CGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYN------NGSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred cCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeec------CCCCeEEEEeceecceEeecCCC
Confidence 6544 689999999999876554 678999999999999999999986 23568999999988876654445
Q ss_pred ccceeec
Q 041312 388 QDLYVRV 394 (743)
Q Consensus 388 ~~ly~rl 394 (743)
..+|+|+
T Consensus 77 ~~~yiKv 83 (84)
T cd01098 77 GTLYLRL 83 (84)
T ss_pred cEEEEEe
Confidence 6778775
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-09 Score=110.70 Aligned_cols=142 Identities=17% Similarity=0.273 Sum_probs=108.4
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCc--cEEeeeeeEecCC---eeEEEEEecC
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHR--NLVSILGCCIEEQ---EKMLIYEYLP 501 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~--niv~l~~~~~~~~---~~~lV~E~~~ 501 (743)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+.+++.+.+. .+.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778999998754322 2456789999999999764 4566777766542 5689999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccC----------------------------------------
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS---------------------------------------- 541 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------- 541 (743)
+.++...+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 23566666677778888888887421
Q ss_pred -------------CCceEeccCCCCcEEecC--CCCeEEeeeccccc
Q 041312 542 -------------RLRIIHRDLKASNVLLDA--AMNPKISDFGMARI 573 (743)
Q Consensus 542 -------------~~~ivH~Dikp~NIll~~--~~~vkl~DFGla~~ 573 (743)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.4e-10 Score=103.41 Aligned_cols=131 Identities=19% Similarity=0.324 Sum_probs=101.6
Q ss_pred cccccCCceeEEEEEEcCCcEEEEE-EcccCC--h-----hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVK-RLSRSS--G-----QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK-~l~~~~--~-----~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
..+.+|+-+.+|.+.+.+ ..+++| ++.+.- + -..++-.+|++++.++.--.|.-..-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 468899999999987643 335555 333321 1 1234567899999999877776666677788889999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998887433 2457777888889999998 99999999999998775 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-10 Score=127.32 Aligned_cols=250 Identities=20% Similarity=0.185 Sum_probs=175.1
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc--CCcEEEEEEcccCChhcHHHH--HHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ--NGKEIAVKRLSRSSGQGIEEF--KTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~--~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
....+|..+..||.|.|+.|++...+ ++..+++|.+.+.......++ ..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999987754 578899998865543333322 3466666665 588888888888888888
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeecccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMAR 572 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFGla~ 572 (743)
++--||+.++++...+ .....++...++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999999987766 23345667778889999999999999887 9999999999999876 788999999987
Q ss_pred ccCCCccccccccccccccc-cCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 573 IFGGDQIEENTNRVVGTYGY-MAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
.+.-.... ....+..| .+|+......+..+.|++|||..+.|.++|..-...... +.....+.
T Consensus 416 ~~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------~~~i~~~~ 479 (524)
T KOG0601|consen 416 RLAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------SLTIRSGD 479 (524)
T ss_pred ccceeccc----ccccccccccchhhccccccccccccccccccccccccCcccCccccc------------ceeeeccc
Confidence 53211111 11122333 356565667889999999999999999998764332110 00001111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. +.+.. .. ..+..+...++..++..||++.++..+.+-.
T Consensus 480 ~-----p~~~~--~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 T-----PNLPG--LK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred c-----cCCCc--hH---HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1 11111 11 2333455568889999999999887766543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.6e-09 Score=98.89 Aligned_cols=143 Identities=24% Similarity=0.334 Sum_probs=106.1
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEE-EcccCC-------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVK-RLSRSS-------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK-~l~~~~-------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
....|-+|+-+.|+++... |+..+|| ++.+.- .-...+.++|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999998875 5665555 333321 123457789999999997666665566677777888999
Q ss_pred EecCC-CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEeeeccccc
Q 041312 498 EYLPN-KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISDFGMARI 573 (743)
Q Consensus 498 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~DFGla~~ 573 (743)
||+++ .++.+++...-.....+ ......+..|-+.+.-||..+ |||+||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46777775543333222 233678889999999999988 999999999999975543 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-08 Score=108.44 Aligned_cols=169 Identities=21% Similarity=0.364 Sum_probs=129.4
Q ss_pred ceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEe----cCCeeEEEEEecCC-CChhhh
Q 041312 435 FGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI----EEQEKMLIYEYLPN-KSLDVY 508 (743)
Q Consensus 435 fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~ 508 (743)
-.+.|++... +|..+++|+++....+.......-+++++++.|.|||++.+++. .+..+.+||+|.|+ ++|-+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577999865 89999999996544444334455688999999999999999887 34567899999985 456555
Q ss_pred hhhc------------ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 509 IFDE------------AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 509 l~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
.+.. .....+++..++.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|...|+...+.+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4432 12345778899999999999999999999 88899999999999999999998888776544
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCC
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRN 625 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p 625 (743)
+... | +.+ ..+-|.=.||.+++.|.+|...
T Consensus 446 d~~~--------------~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE--------------P--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc--------------c--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4311 1 111 1245888899999999999765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=8.8e-10 Score=126.30 Aligned_cols=208 Identities=20% Similarity=0.236 Sum_probs=151.0
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
....+.+.+.+-+-.|.++.++.+.-. .|...++|..... .....+....+-.++-..+||-+++....+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345678888899999999999987743 3544444443221 112223333343444445567788777776777889
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
+||++|..+++|...|.... ..+.......+..+..+++|||... +.|+|++|.|+|+...++.++.|||....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999987774432 3444444556667888999999876 89999999999999999999999984432
Q ss_pred cCCC-------------------------ccc----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCC
Q 041312 574 FGGD-------------------------QIE----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624 (743)
Q Consensus 574 ~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~ 624 (743)
.+-. ... ......+||+.|.+||.+.+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 000 11234688999999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 041312 625 NNTFHLE 631 (743)
Q Consensus 625 p~~~~~~ 631 (743)
||....+
T Consensus 1034 p~na~tp 1040 (1205)
T KOG0606|consen 1034 PFNAETP 1040 (1205)
T ss_pred CCCCcch
Confidence 9875544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=98.72 Aligned_cols=126 Identities=26% Similarity=0.308 Sum_probs=82.9
Q ss_pred eEEEEEEcCCcEEEEEEcccCC--------------h------------hcHHHHHHHHHHHHhcCCc--cEEeeeeeEe
Q 041312 437 SVYKGVLQNGKEIAVKRLSRSS--------------G------------QGIEEFKTEIALIAQLQHR--NLVSILGCCI 488 (743)
Q Consensus 437 ~Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~Ev~~l~~l~h~--niv~l~~~~~ 488 (743)
.||.|...+|..+|||+..... . ......++|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999764210 0 0123567899999999766 45566544
Q ss_pred cCCeeEEEEEecC--CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHH-hhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 489 EEQEKMLIYEYLP--NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY-LHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 489 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
....|||||++ +..+..+. +. .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 55554432 11 11123345677778875555 57877 9999999999999988 9999
Q ss_pred eeeccccccC
Q 041312 566 SDFGMARIFG 575 (743)
Q Consensus 566 ~DFGla~~~~ 575 (743)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.8e-08 Score=99.19 Aligned_cols=135 Identities=21% Similarity=0.157 Sum_probs=96.2
Q ss_pred CceeEEEEEEcCCcEEEEEEcccCCh-hcHH----------HHHHHHHHHHhcCCccE--EeeeeeEec-----CCeeEE
Q 041312 434 GFGSVYKGVLQNGKEIAVKRLSRSSG-QGIE----------EFKTEIALIAQLQHRNL--VSILGCCIE-----EQEKML 495 (743)
Q Consensus 434 ~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~----------~~~~Ev~~l~~l~h~ni--v~l~~~~~~-----~~~~~l 495 (743)
....|++... +|+.+.||+...... ...+ .+.+|...+.++...+| ++++++... ....+|
T Consensus 34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3334666555 577899997643221 1111 47899999999854443 344555543 235789
Q ss_pred EEEecCCC-ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-------CCCeEEee
Q 041312 496 IYEYLPNK-SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-------AMNPKISD 567 (743)
Q Consensus 496 V~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------~~~vkl~D 567 (743)
|||++++. +|.+++..-. ....+......++.++++.+.-||..| |+|+|++++|||++. +..+.|+|
T Consensus 113 Vte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 99999986 7888874321 223455667789999999999999999 999999999999975 46799999
Q ss_pred eccccc
Q 041312 568 FGMARI 573 (743)
Q Consensus 568 FGla~~ 573 (743)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.1e-08 Score=109.43 Aligned_cols=187 Identities=18% Similarity=0.283 Sum_probs=115.8
Q ss_pred eeccccccceeecc---cccccccccCCCCCCCcChhhH------------HHHcCCCCcCcccccCCceeEEEEEEcCC
Q 041312 382 TYINAGQDLYVRVD---AAELDDSRRNSEYLPVFDLSNI------------AAATNDFSSDNKLGEGGFGSVYKGVLQNG 446 (743)
Q Consensus 382 ~~~~~g~~ly~rl~---~~~~~~~~~~~~~~~~~~~~~l------------~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g 446 (743)
+|++.||-+-.|-+ ..-...-.+.....|.++.+.. .....+|.. +.|+.++-|.||+|++++|
T Consensus 71 tfIK~GQ~LStR~Dl~p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG 149 (517)
T COG0661 71 TFIKLGQILSTRPDLVPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHRAVLKSG 149 (517)
T ss_pred chhhhhhHHhcCccccCHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhheeEEecCC
Confidence 35555665554433 1112222334455666666543 233345553 7899999999999999999
Q ss_pred cEEEEEEcccCChhc------------------------------HH----------HHHHHHHHHHhcC-----CccEE
Q 041312 447 KEIAVKRLSRSSGQG------------------------------IE----------EFKTEIALIAQLQ-----HRNLV 481 (743)
Q Consensus 447 ~~vavK~l~~~~~~~------------------------------~~----------~~~~Ev~~l~~l~-----h~niv 481 (743)
+.||||+.+....+. .+ .+..|...+.++. .+.|.
T Consensus 150 ~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~ 229 (517)
T COG0661 150 EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVY 229 (517)
T ss_pred CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeE
Confidence 999999987543221 01 1334555555542 23332
Q ss_pred eeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHH-HHHhhccCCCceEeccCCCCcEEecCC
Q 041312 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG-ILYLHQDSRLRIIHRDLKASNVLLDAA 560 (743)
Q Consensus 482 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~-L~yLH~~~~~~ivH~Dikp~NIll~~~ 560 (743)
-..=+..-.+...|+|||++|..+.+...-.. ...+... ++..++++ +.-+-..+ ++|.|.+|.||+++.+
T Consensus 230 VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~ 301 (517)
T COG0661 230 VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSD 301 (517)
T ss_pred eceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC---ccccCCCccceEEecC
Confidence 22223334577899999999999988853222 2334322 33333332 12222234 9999999999999999
Q ss_pred CCeEEeeeccccccCCC
Q 041312 561 MNPKISDFGMARIFGGD 577 (743)
Q Consensus 561 ~~vkl~DFGla~~~~~~ 577 (743)
+++.+.|||+...+.+.
T Consensus 302 g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 302 GRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CcEEEEcCcceecCCHH
Confidence 99999999999877544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-07 Score=94.06 Aligned_cols=136 Identities=19% Similarity=0.206 Sum_probs=96.8
Q ss_pred CCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC----------------------hhcHHHHHHHHHHHHhcCCc--c
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS----------------------GQGIEEFKTEIALIAQLQHR--N 479 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------------~~~~~~~~~Ev~~l~~l~h~--n 479 (743)
..+.++||.|.-+.||.|..+.|.++|||.-.... .-.....++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45668999999999999999999999999543110 01133467899999999765 5
Q ss_pred EEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC
Q 041312 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 480 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 559 (743)
+.+.+++ +...+|||++++-.|...-. .....-.++..|++-+.-+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6665544 55689999999977644321 12222234444444444443555 999999999999999
Q ss_pred CCCeEEeeecccccc
Q 041312 560 AMNPKISDFGMARIF 574 (743)
Q Consensus 560 ~~~vkl~DFGla~~~ 574 (743)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.6e-07 Score=94.15 Aligned_cols=192 Identities=15% Similarity=0.162 Sum_probs=125.8
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEe----eeeeE---ecCCeeEEEE
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVS----ILGCC---IEEQEKMLIY 497 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~----l~~~~---~~~~~~~lV~ 497 (743)
....||+|+-+.+|..-.- ..-+.|+.+........+. +..|.+. .||-+-. ..... .......+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999864321 1235576665433222222 2222332 4443221 11111 1122356788
Q ss_pred EecCCCChhhhhhh----cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 498 EYLPNKSLDVYIFD----EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 498 E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
+.+++.---..+.. ...-....|.-.+++++.|+.+.+.||..| .+-+|+.++|+||.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 88877632222222 122356789999999999999999999999 99999999999999999999998654332
Q ss_pred cCCCccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhc-CCCCCC
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILG-RRNNTF 628 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG-~~p~~~ 628 (743)
-.+. ......+|...|.+||.-. +..-+...|.|.||+++++|+.| ++|+..
T Consensus 167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 2111 1223468899999999654 33456789999999999999987 888774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.9e-07 Score=88.62 Aligned_cols=107 Identities=27% Similarity=0.273 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHHhcCCcc--EEeeeeeEecC----CeeEEEEEecCCC-ChhhhhhhcccccccCHHHHHHHHHHHHHHH
Q 041312 462 IEEFKTEIALIAQLQHRN--LVSILGCCIEE----QEKMLIYEYLPNK-SLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534 (743)
Q Consensus 462 ~~~~~~Ev~~l~~l~h~n--iv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L 534 (743)
.....+|...+..|...+ ..+++++.... ...++|+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 456788999888886443 45566665543 2458999999984 78888744221 45566778999999999
Q ss_pred HHhhccCCCceEeccCCCCcEEecCCC---CeEEeeecccccc
Q 041312 535 LYLHQDSRLRIIHRDLKASNVLLDAAM---NPKISDFGMARIF 574 (743)
Q Consensus 535 ~yLH~~~~~~ivH~Dikp~NIll~~~~---~vkl~DFGla~~~ 574 (743)
.-||..+ |+|+|++|.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=97.07 Aligned_cols=149 Identities=15% Similarity=0.238 Sum_probs=95.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhc-------------------------------------H
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQG-------------------------------------I 462 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~ 462 (743)
....|.. +.||.-+.|.||+|++++|+.||||+.+...+.. +
T Consensus 160 if~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 160 IFSEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred HHHhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 3344443 7899999999999999999999999987543221 0
Q ss_pred HHHHHHHHHHHhc----CCccE---EeeeeeEe-cCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHH
Q 041312 463 EEFKTEIALIAQL----QHRNL---VSILGCCI-EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534 (743)
Q Consensus 463 ~~~~~Ev~~l~~l----~h~ni---v~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L 534 (743)
-.|.+|++...++ .|-++ |++=.++. -...+.|+||||+|..+.+...-. ...++.. .++..+.++.
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~---~i~~~l~~~~ 313 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPH---DILNKLVEAY 313 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHH---HHHHHHHHHH
Confidence 1234455444433 34441 11222222 245789999999999988774321 2223333 3444444432
Q ss_pred HH-hhccCCCceEeccCCCCcEEecC----CCCeEEeeeccccccCCC
Q 041312 535 LY-LHQDSRLRIIHRDLKASNVLLDA----AMNPKISDFGMARIFGGD 577 (743)
Q Consensus 535 ~y-LH~~~~~~ivH~Dikp~NIll~~----~~~vkl~DFGla~~~~~~ 577 (743)
.. +-..| ++|+|-+|.||++.. ++.+.+.|||+...+...
T Consensus 314 ~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 LEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22 22234 999999999999983 678999999999876543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.9e-06 Score=77.13 Aligned_cols=89 Identities=27% Similarity=0.422 Sum_probs=62.1
Q ss_pred EEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCCc
Q 041312 70 LTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLN 149 (743)
Q Consensus 70 l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~~ 149 (743)
+.+..||+||+.......++|++++......+..+.|.++|||||+ +..+.++|+| +|-
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~S-----~t~--------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLY-DGDGRVVWSS-----NTT--------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEE-eCCCCEEEEe-----ccc---------------
Confidence 3445789999986543457999998754444467999999999998 4557899998 111
Q ss_pred eeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEec
Q 041312 150 RFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVG 191 (743)
Q Consensus 150 ~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 191 (743)
...|.|.+.|+.+|...++- ....+.|.+.
T Consensus 83 -----------~~~~~~~~~L~ddGnlvl~~-~~~~~~W~Sf 112 (114)
T smart00108 83 -----------GANGNYVLVLLDDGNLVIYD-SDGNFLWQSF 112 (114)
T ss_pred -----------CCCCceEEEEeCCCCEEEEC-CCCCEEeCCC
Confidence 03466889999999854432 2345778653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.2e-06 Score=81.29 Aligned_cols=139 Identities=18% Similarity=0.162 Sum_probs=101.0
Q ss_pred cccCCceeEEEEEEcCCcEEEEEEcccC------ChhcHHHHHHHHHHHHhcCCcc--EEeeeeeEec----CCeeEEEE
Q 041312 430 LGEGGFGSVYKGVLQNGKEIAVKRLSRS------SGQGIEEFKTEIALIAQLQHRN--LVSILGCCIE----EQEKMLIY 497 (743)
Q Consensus 430 LG~G~fg~Vy~~~~~~g~~vavK~l~~~------~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~~~~----~~~~~lV~ 497 (743)
-|+||-+-|+.-.+. |+.+-+|+.... .......|.+|...|.+|...+ +.+++..-.. .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 466899999987665 347889987521 1346788999999999996433 4444422211 12358999
Q ss_pred EecCC-CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC--eEEeeeccccc
Q 041312 498 EYLPN-KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN--PKISDFGMARI 573 (743)
Q Consensus 498 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--vkl~DFGla~~ 573 (743)
|-+++ .+|.+++.+.. ....+...+..++.++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 47777764321 224566677789999999999999999 999999999999986667 99999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.3e-06 Score=82.38 Aligned_cols=140 Identities=16% Similarity=0.163 Sum_probs=85.9
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeeeeEecCCeeEEEEEecCCCC-
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILGCCIEEQEKMLIYEYLPNKS- 504 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gs- 504 (743)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999983 35568888875433 3345788999999986543 4677777777777889999999973
Q ss_pred hhhhhh--------------h---cccc---cccCHHHHHH-HHHH----------HHH-HHHHhhc-cCCCceEeccCC
Q 041312 505 LDVYIF--------------D---EAKR---SLLDWSKRFE-IICG----------IAR-GILYLHQ-DSRLRIIHRDLK 551 (743)
Q Consensus 505 L~~~l~--------------~---~~~~---~~l~~~~~~~-i~~q----------i~~-~L~yLH~-~~~~~ivH~Dik 551 (743)
+...+. . ..+. .......... +..+ +.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 0000 0111111110 1000 001 1111111 112347999999
Q ss_pred CCcEEecCCCCeEEeeeccccc
Q 041312 552 ASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 552 p~NIll~~~~~vkl~DFGla~~ 573 (743)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.8e-06 Score=76.18 Aligned_cols=88 Identities=27% Similarity=0.396 Sum_probs=61.7
Q ss_pred EEee-cCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCCc
Q 041312 71 TISS-LGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLN 149 (743)
Q Consensus 71 ~~~~-~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~~ 149 (743)
.... ||+||+.......++|++|+.........+.|.++|||||. +..+.++|+|=-.
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~S~~~-------------------- 83 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIY-DGSGTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEE-cCCCcEEEEeccc--------------------
Confidence 3444 89999986543467999998764345567999999999998 4567899987210
Q ss_pred eeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEec
Q 041312 150 RFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVG 191 (743)
Q Consensus 150 ~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 191 (743)
...+.+.+.|+.+|...++-. ...+.|.+.
T Consensus 84 -----------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 113 (116)
T cd00028 84 -----------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSF 113 (116)
T ss_pred -----------CCCCceEEEEeCCCCEEEECC-CCCEEEcCC
Confidence 024668999999998443322 356678765
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.6e-07 Score=102.74 Aligned_cols=96 Identities=23% Similarity=0.464 Sum_probs=75.5
Q ss_pred HHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC-ccc------cccccccccccccCcceecc
Q 041312 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD-QIE------ENTNRVVGTYGYMAPEYAME 600 (743)
Q Consensus 528 ~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~-~~~------~~~~~~~gt~~y~aPE~~~~ 600 (743)
.+.+.|+.|+|... ++||+.|.|++|.++..+..||+.|+.+....+. ... ...........|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999754 6999999999999999999999999988755431 100 01111234567999999999
Q ss_pred CCCCccccchhHHHHHHHHHhcCCC
Q 041312 601 GLFSTKSDVYSFGVLLLEIILGRRN 625 (743)
Q Consensus 601 ~~~~~ksDiwSlGvil~elltG~~p 625 (743)
...+.++|+||+|+++|.+..|..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999966554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.2e-07 Score=101.89 Aligned_cols=197 Identities=17% Similarity=0.122 Sum_probs=142.8
Q ss_pred ChhhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc-EEeeeeeEecCC
Q 041312 413 DLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN-LVSILGCCIEEQ 491 (743)
Q Consensus 413 ~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~ 491 (743)
...+++..++.+..-+.++++++++++|.+.-..+.+..+.+... ....-++++|.+++||| .+..++-+..+.
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED 307 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence 333455566667777889999999999988544444445555332 45567899999999999 777777788888
Q ss_pred eeEEEEEecCCC-ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 492 EKMLIYEYLPNK-SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 492 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
..+++++++..+ +-..... .....+..-+...+.+.-.+++++||+.- =+|+| ||+..+ +..|..||+.
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred ccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccC
Confidence 899999999877 2211110 01112333333455566678899999753 48888 777765 6899999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNT 627 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~ 627 (743)
+..+.+.. ......+|+.++|||+...+.+..+.|+|++|+-..++--|-+|..
T Consensus 378 ~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 378 PPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 98776554 2345678999999999999999999999999987777777766543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.1e-05 Score=78.19 Aligned_cols=150 Identities=17% Similarity=0.200 Sum_probs=98.1
Q ss_pred hhHHHHcCCCCcCc---ccccCCceeEEEEEEcCCcEEEEEEcccCChh---------c----------H-----HHHHH
Q 041312 415 SNIAAATNDFSSDN---KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ---------G----------I-----EEFKT 467 (743)
Q Consensus 415 ~~l~~~~~~y~~~~---~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---------~----------~-----~~~~~ 467 (743)
..+........+.. .|..|.-+.||+|...++..+|+|+....... + . .-..+
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 34445555555444 45566777899999888999999988533111 0 1 11245
Q ss_pred HHHHHHhcC--CccEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCc
Q 041312 468 EIALIAQLQ--HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLR 544 (743)
Q Consensus 468 Ev~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ 544 (743)
|...|+++. +-.+.+.+.+. +-.|||||+....+..- ..+.-.+.......+..++++.+.-|-. .+
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP---~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--- 187 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAP---RLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--- 187 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCC---CcccCCcCchhHHHHHHHHHHHHHHHHHhcC---
Confidence 777777774 33444554443 34799999976522111 1111222333456677788888887766 44
Q ss_pred eEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 545 ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
+||+||+.=|||+. ++.+.|+||+.|....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999997654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.4e-05 Score=80.93 Aligned_cols=143 Identities=21% Similarity=0.217 Sum_probs=84.0
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCc--cEEeeeeeEec---CCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR--NLVSILGCCIE---EQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~~~~~~---~~~~~lV~E~~~~ 502 (743)
+.|+.|..+.||+....+ ..+++|..... .....+..|+.+++.+... .+.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 678999999999999887 68999986443 4567788899998888533 34566654322 2346899999999
Q ss_pred CChhh----------------hhhh--cc--cccccCHHH---------HHHH------------HHHHHH-HHHHhhc-
Q 041312 503 KSLDV----------------YIFD--EA--KRSLLDWSK---------RFEI------------ICGIAR-GILYLHQ- 539 (743)
Q Consensus 503 gsL~~----------------~l~~--~~--~~~~l~~~~---------~~~i------------~~qi~~-~L~yLH~- 539 (743)
..+.. .+.. .. ....+.... .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98877 1100 00 000000000 0000 011111 2233332
Q ss_pred ---cCCCceEeccCCCCcEEec-CCCCeEEeeeccccc
Q 041312 540 ---DSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARI 573 (743)
Q Consensus 540 ---~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~ 573 (743)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1344599999999999999 666678999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.2e-05 Score=76.08 Aligned_cols=138 Identities=17% Similarity=0.166 Sum_probs=89.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHH---------HHHHHHHHhcCCcc---EEeeeeeE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEF---------KTEIALIAQLQHRN---LVSILGCC 487 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~Ev~~l~~l~h~n---iv~l~~~~ 487 (743)
...+|.+.+.+-......|.+-.. +|+.+++|..........+.| .+++..+.++...+ +..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346777777777777777766554 468899998764432222222 23444444443222 22222222
Q ss_pred e-----cCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 488 I-----EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 488 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
. .....++||||++|..|.++. .++. .++..|.+++.-||+.| ++|+|.+|.|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 1 224456899999998886653 1221 24566778899999999 9999999999999855 4
Q ss_pred eEEeeeccccc
Q 041312 563 PKISDFGMARI 573 (743)
Q Consensus 563 vkl~DFGla~~ 573 (743)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.6e-06 Score=61.27 Aligned_cols=44 Identities=25% Similarity=0.389 Sum_probs=33.3
Q ss_pred CCCCCCCCCCcccccccCCCCccccCCC--ceeeccceeeeeeccC
Q 041312 700 DNAPSSPKHPAFIAKGLSNVDEFWTGEG--VTTSVNDLTITAFQPR 743 (743)
Q Consensus 700 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 743 (743)
...+|.|++|+|+..+...+...-+... +.+|+|+||+|.|+||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999999443322112232 7899999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.2e-05 Score=79.31 Aligned_cols=142 Identities=14% Similarity=0.174 Sum_probs=86.1
Q ss_pred cccccCCc-eeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 428 NKLGEGGF-GSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 428 ~~LG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
..|..|.. ..||+.... +..+++|+..... ...+..|+++++.+. +--+.+++.+....+..++|||+++|.++
T Consensus 4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 34566666 788988764 4788889875432 345678999988884 34456777777766678999999999887
Q ss_pred hhhhhh---------------cccc-----cccC--HHHHHHHHHH--------------------HHHHHHHhh----c
Q 041312 506 DVYIFD---------------EAKR-----SLLD--WSKRFEIICG--------------------IARGILYLH----Q 539 (743)
Q Consensus 506 ~~~l~~---------------~~~~-----~~l~--~~~~~~i~~q--------------------i~~~L~yLH----~ 539 (743)
...... ..+. ..+. .......... +...+..|- .
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 643210 0000 0000 0000000000 111111221 1
Q ss_pred cCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 540 ~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
.....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1134589999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.9e-06 Score=67.05 Aligned_cols=70 Identities=37% Similarity=0.728 Sum_probs=51.7
Q ss_pred CceEEEeeeccCCCcceeeccccChHHHHHhccc-cCCcccccccccccccCCceeeEEec-ccCcccceeccccccce
Q 041312 315 DGFIRVAGVKVPDMSVARVDMSLGLEACKHMCLR-NCSCLAYTSAYAESESNGRIGCLTYH-GDMMDTRTYINAGQDLY 391 (743)
Q Consensus 315 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~g~~gC~~w~-g~l~d~r~~~~~g~~ly 391 (743)
..|.+++++.+++..... ....++++|+..|++ +|+|.||+|.. ++.+|.+|. +.+.+.......+.++|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~------~~~~C~l~~~~~~~~~~~~~~~~~~~y 75 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN------GTKGCLLWSESSLGDARLFPSGGVDLY 75 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC------CCCEEEEeeCCccccceecccCCceeE
Confidence 569999999999665433 346799999999999 99999999861 456899999 66666553333344444
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.7e-05 Score=76.12 Aligned_cols=105 Identities=18% Similarity=0.159 Sum_probs=82.9
Q ss_pred HHHHHHHHhcCC-ccEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCc
Q 041312 466 KTEIALIAQLQH-RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544 (743)
Q Consensus 466 ~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 544 (743)
.+|..+++.+++ +++++++|+|- .++|.||...+++......-.+-...+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 69999999993 4789999987765321000011124689999999999999999999865555
Q ss_pred eEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 545 IIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 545 ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+.-.|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5e-05 Score=71.40 Aligned_cols=130 Identities=19% Similarity=0.233 Sum_probs=90.4
Q ss_pred CcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCC
Q 041312 425 SSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
...+.|++|.+|.||++.+.. ..+|+|+-..+ .....+..|+++|..++-.++-+=+..+-+ -++.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcc
Confidence 445789999999999999874 47888875443 344678999999999987776544444332 245599999988
Q ss_pred hhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCC-CCcEEecCCCCeEEeeeccccc
Q 041312 505 LDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLK-ASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 505 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik-p~NIll~~~~~vkl~DFGla~~ 573 (743)
|...-... + .+.+..+++.-.-|...| |-|+.|. |..++|..+..+.|+||..|..
T Consensus 99 L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 86553211 1 123344555544566556 9999987 6666666666999999999873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00016 Score=87.28 Aligned_cols=79 Identities=18% Similarity=0.341 Sum_probs=58.7
Q ss_pred CcccccCCceeEEEEEEcCC---cEEEEEEcccCC-hhcHHHHHHHHHHHHhcC-CccE--EeeeeeEecC---CeeEEE
Q 041312 427 DNKLGEGGFGSVYKGVLQNG---KEIAVKRLSRSS-GQGIEEFKTEIALIAQLQ-HRNL--VSILGCCIEE---QEKMLI 496 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 496 (743)
.++|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47899999999999887654 467888764322 223457889999999995 6654 7777777664 467899
Q ss_pred EEecCCCCh
Q 041312 497 YEYLPNKSL 505 (743)
Q Consensus 497 ~E~~~~gsL 505 (743)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00027 Score=69.46 Aligned_cols=128 Identities=17% Similarity=0.252 Sum_probs=90.1
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCC----------------hhcHHHHHHHHHHHHhcC------CccEEeee
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS----------------GQGIEEFKTEIALIAQLQ------HRNLVSIL 484 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ev~~l~~l~------h~niv~l~ 484 (743)
...||+|+.-.||. +++....+||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999985 5666778888886554 223566777777766666 78899999
Q ss_pred eeEecCCeeEEEEEecCCC------ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 485 GCCIEEQEKMLIYEYLPNK------SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 485 ~~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
|+........+|+|.+.+. +|.+++ ....++. ...+.+.+ -..||-... |+.+|++|+||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEEE
Confidence 9999999999999987542 455555 2333444 33333333 345565555 99999999999995
Q ss_pred CCC----CeEEee
Q 041312 559 AAM----NPKISD 567 (743)
Q Consensus 559 ~~~----~vkl~D 567 (743)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 322 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00016 Score=73.67 Aligned_cols=73 Identities=15% Similarity=0.244 Sum_probs=46.9
Q ss_pred cccccCCce-eEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCc---cEEeeeeeEecC---CeeEEEEEec
Q 041312 428 NKLGEGGFG-SVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR---NLVSILGCCIEE---QEKMLIYEYL 500 (743)
Q Consensus 428 ~~LG~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~---niv~l~~~~~~~---~~~~lV~E~~ 500 (743)
+.|+.|+.. .||+. +..+++|..+.. .....+..|++++..+... .+.+++...... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877777 48875 245777865432 2345788999999888532 234444433322 2348899999
Q ss_pred CCCChh
Q 041312 501 PNKSLD 506 (743)
Q Consensus 501 ~~gsL~ 506 (743)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00027 Score=73.06 Aligned_cols=139 Identities=17% Similarity=0.119 Sum_probs=79.0
Q ss_pred ccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEEecCCCChhh
Q 041312 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYEYLPNKSLDV 507 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~ 507 (743)
.+..|-...+|+.. .+++.+++|..........-...+|..+++.+....+ .+++... ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 45678888999887 4567888887654322211235778889988864433 2333332 2479999999877643
Q ss_pred h-------h---hh---ccc-----ccccCHHHH-HHHHHHH---------HHHHHHhhcc-----CCCceEeccCCCCc
Q 041312 508 Y-------I---FD---EAK-----RSLLDWSKR-FEIICGI---------ARGILYLHQD-----SRLRIIHRDLKASN 554 (743)
Q Consensus 508 ~-------l---~~---~~~-----~~~l~~~~~-~~i~~qi---------~~~L~yLH~~-----~~~~ivH~Dikp~N 554 (743)
. + .. ..+ ...++.... .....++ .+.+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 0 00 000 011121111 1111111 1111212111 12358999999999
Q ss_pred EEecCCCCeEEeeeccccc
Q 041312 555 VLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 555 Ill~~~~~vkl~DFGla~~ 573 (743)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 89999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00032 Score=71.38 Aligned_cols=74 Identities=18% Similarity=0.300 Sum_probs=49.5
Q ss_pred cccccCCceeEEEEEEcC--CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEEecCCCC
Q 041312 428 NKLGEGGFGSVYKGVLQN--GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
+.|..|-...+|+....+ ++.+++|+....... ......|+.+++.+...++ .+++.... ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 578888888999988764 678999976543222 1233578888888854443 34433322 248999999987
Q ss_pred hh
Q 041312 505 LD 506 (743)
Q Consensus 505 L~ 506 (743)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00061 Score=60.71 Aligned_cols=100 Identities=26% Similarity=0.387 Sum_probs=64.4
Q ss_pred CEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecC-CCCCccCCccEEEeecCcEEEEeCCCCceEEeeecc
Q 041312 17 DVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANR-DNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVS 95 (743)
Q Consensus 17 ~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr-~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~ 95 (743)
+.|.+.+|.+.|-|-..|+ |-|.- ...++||..+. ..... ..+.+.|..+|||||.|. .+.++|++..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~---~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~-~~~~lW~Sf~- 80 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYD---SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDS-SGNVLWQSFD- 80 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEE---TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEET-TSEEEEESTT-
T ss_pred cccccccccccceECCCCe-----EEEEc---CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEee-cceEEEeecC-
Confidence 5666656888888866555 55543 23677999943 33332 457899999999999985 5556999932
Q ss_pred CCCCCceEEEEcc--CCCeeEEecCCCceeeeecCCCc
Q 041312 96 DSSESNTIAQLLD--TGNLVLARNNTGQTLWQSFDHPS 131 (743)
Q Consensus 96 ~~~~~~~~~~lld--~GNlvl~~~~~~~~~WqSFd~Pt 131 (743)
. ...+.+...+ .||++ . .+...+.|.|=+.|+
T Consensus 81 ~--ptdt~L~~q~l~~~~~~-~-~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 Y--PTDTLLPGQKLGDGNVT-G-KNDSLTSWSSNTDPS 114 (114)
T ss_dssp S--SS-EEEEEET--TSEEE-E-ESTSSEEEESS----
T ss_pred C--CccEEEeccCcccCCCc-c-ccceEEeECCCCCCC
Confidence 2 2356677777 88998 5 445678999876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00069 Score=66.05 Aligned_cols=125 Identities=23% Similarity=0.375 Sum_probs=91.5
Q ss_pred CCCCcCcccccCCc-eeEEEEEEcCCcEEEEEEccc---CC--------h----------hcHHHHHHHHHHHHhcC---
Q 041312 422 NDFSSDNKLGEGGF-GSVYKGVLQNGKEIAVKRLSR---SS--------G----------QGIEEFKTEIALIAQLQ--- 476 (743)
Q Consensus 422 ~~y~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~l~~---~~--------~----------~~~~~~~~Ev~~l~~l~--- 476 (743)
.+++.++.||.|.- |.||+++.. |+.+|+|.+.. .. . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999986 56999999321 00 0 12345788999988885
Q ss_pred CccE--EeeeeeEecC------------------CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHH
Q 041312 477 HRNL--VSILGCCIEE------------------QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536 (743)
Q Consensus 477 h~ni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y 536 (743)
+.++ |+.+|+..-. ..+.||.||++... ....+-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4455 8999887422 12367888775543 1122346678888899
Q ss_pred hhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 537 LH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999985 4589999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0011 Score=70.13 Aligned_cols=78 Identities=13% Similarity=0.079 Sum_probs=57.3
Q ss_pred CcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC---ccEEeeeeeEec---CCeeEEEEE
Q 041312 425 SSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH---RNLVSILGCCIE---EQEKMLIYE 498 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h---~niv~l~~~~~~---~~~~~lV~E 498 (743)
...+.||.|..+.||.....+++ +++|..+. ......+..|...|+.|.. -.+.++++.+.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34478999999999998766664 66666422 1123578899999998853 367888887754 366899999
Q ss_pred ecCCCCh
Q 041312 499 YLPNKSL 505 (743)
Q Consensus 499 ~~~~gsL 505 (743)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0011 Score=72.06 Aligned_cols=75 Identities=15% Similarity=0.226 Sum_probs=55.0
Q ss_pred cccccCCceeEEEEEEcCC-cEEEEEEcccC-------ChhcHHHHHHHHHHHHhcC---CccEEeeeeeEecCCeeEEE
Q 041312 428 NKLGEGGFGSVYKGVLQNG-KEIAVKRLSRS-------SGQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g-~~vavK~l~~~-------~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lV 496 (743)
+.||.|.+..||++...+| +.++||.-... -....+++..|.+.|+.+. ..++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998877 58999985321 1234567888888888863 2356666666 44567899
Q ss_pred EEecCCCC
Q 041312 497 YEYLPNKS 504 (743)
Q Consensus 497 ~E~~~~gs 504 (743)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00059 Score=72.12 Aligned_cols=143 Identities=20% Similarity=0.178 Sum_probs=85.9
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeeee------EecCCeeEEEEE
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILGC------CIEEQEKMLIYE 498 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E 498 (743)
.+.|..|....+|+....+ ..+++|+... ...+.+..|+.++..+.+.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4678888888999987654 4788898754 23456777888888885433 4444432 123345689999
Q ss_pred ecCCCChhhh----hh----------hcccc--------cccCHHHHH----------HHHHHHHHHHHHhhc----cCC
Q 041312 499 YLPNKSLDVY----IF----------DEAKR--------SLLDWSKRF----------EIICGIARGILYLHQ----DSR 542 (743)
Q Consensus 499 ~~~~gsL~~~----l~----------~~~~~--------~~l~~~~~~----------~i~~qi~~~L~yLH~----~~~ 542 (743)
+++|..+... .. ..... ....|.... .....+..++.++.. .-.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876430 00 00000 001111110 011112334444443 112
Q ss_pred CceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 543 ~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0021 Score=68.67 Aligned_cols=142 Identities=19% Similarity=0.188 Sum_probs=77.6
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeeee------EecCCeeEEEEE
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILGC------CIEEQEKMLIYE 498 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E 498 (743)
.+.|+.|....+|+....+| .+++|+.... ..+.+..|+.++..|...+ +.+++.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677888889999887655 6888987522 2234445566666653222 3333321 123456789999
Q ss_pred ecCCCChhh-----h------hh---hcccc--------ccc-CHHHHHH------------HHHH-HHHHHHHhhcc--
Q 041312 499 YLPNKSLDV-----Y------IF---DEAKR--------SLL-DWSKRFE------------IICG-IARGILYLHQD-- 540 (743)
Q Consensus 499 ~~~~gsL~~-----~------l~---~~~~~--------~~l-~~~~~~~------------i~~q-i~~~L~yLH~~-- 540 (743)
|++|..+.. . +. ..... ..+ .+..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999985421 1 00 00000 001 1111111 1111 11122222211
Q ss_pred --CCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 541 --SRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 541 --~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
-...++|+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12349999999999999976556899999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00065 Score=80.32 Aligned_cols=197 Identities=17% Similarity=0.170 Sum_probs=133.0
Q ss_pred HHHHHHHHHHhcCCccEEeeeeeEecCCeeE----EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc
Q 041312 464 EFKTEIALIAQLQHRNLVSILGCCIEEQEKM----LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539 (743)
Q Consensus 464 ~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 539 (743)
...-|...+.+..|+|++.++.+..+..... +..|++..-++...+. .-..++......+..++.+||+|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3445778888999999999999987765444 3346777777766653 33456777777888999999999998
Q ss_pred cCCCceEeccCCCC---cEEecCCCCeEEe--eeccccccCCCccccccccccccccccCcceeccCCCCc--cccchhH
Q 041312 540 DSRLRIIHRDLKAS---NVLLDAAMNPKIS--DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFST--KSDVYSF 612 (743)
Q Consensus 540 ~~~~~ivH~Dikp~---NIll~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDiwSl 612 (743)
.. ..|.-+..+ +-.++.++.+.+. ||+..+.+....... ...-+..+.+||......... ..|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 75 555544444 4455666777777 998887765443221 122345678888877665544 4799999
Q ss_pred HHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041312 613 GVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSA 692 (743)
Q Consensus 613 Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 692 (743)
|..+..+..|..+...... +..+++. .... .+......|+..++++|+++.+
T Consensus 379 gll~~~~~~~~~i~~~~~~--------------------~~~~l~~-----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV--------------------PVSLLDV-----LSTS---ELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHhhhhhcCcccccccc--------------------hhhhhcc-----ccch---hhhhhhhhhcchhhhhccchhh
Confidence 9999999998876332111 1111111 0111 2344556899999999999999
Q ss_pred HHHHh
Q 041312 693 VVSML 697 (743)
Q Consensus 693 vl~~L 697 (743)
++...
T Consensus 431 ll~~~ 435 (1351)
T KOG1035|consen 431 LLTHP 435 (1351)
T ss_pred hhhch
Confidence 98765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0024 Score=67.89 Aligned_cols=143 Identities=21% Similarity=0.210 Sum_probs=82.4
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeeeeE------ecCCeeEEEEE
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILGCC------IEEQEKMLIYE 498 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~E 498 (743)
.+.++.|....+|+....++ .+++|+.+... ..+.+..|+.++..|...+ +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 46677887889998876544 67888765421 2345566777777774322 34444321 12356789999
Q ss_pred ecCCCChhhh----h----------hhcccc------c---ccCHHHHH------------HHHHHHHHHHHHhhc----
Q 041312 499 YLPNKSLDVY----I----------FDEAKR------S---LLDWSKRF------------EIICGIARGILYLHQ---- 539 (743)
Q Consensus 499 ~~~~gsL~~~----l----------~~~~~~------~---~l~~~~~~------------~i~~qi~~~L~yLH~---- 539 (743)
|++|..+... . +..... . ...|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998654211 0 000000 0 00111100 001112334444432
Q ss_pred cCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 540 ~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.-...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112459999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0015 Score=69.26 Aligned_cols=74 Identities=24% Similarity=0.399 Sum_probs=49.8
Q ss_pred cccccCCceeEEEEEEcC-------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEE-eeeeeEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVLQN-------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV-SILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~ 499 (743)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+...++. ++++++. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 566777777999988665 5789999875443 2334567888888888543333 4444443 2468999
Q ss_pred cCCCChh
Q 041312 500 LPNKSLD 506 (743)
Q Consensus 500 ~~~gsL~ 506 (743)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9988764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0053 Score=66.24 Aligned_cols=141 Identities=17% Similarity=0.250 Sum_probs=82.6
Q ss_pred cccccCCceeEEEEEEcC-----CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEE-eeeeeEecCCeeEEEEEecC
Q 041312 428 NKLGEGGFGSVYKGVLQN-----GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV-SILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~ 501 (743)
+.|-.|-...+|+....+ ++.+++|+........+.+ .+|..+++.+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 566668888999987542 3678999876654433333 7789998888654443 445554322 5899998
Q ss_pred CCChhhhhh-h---------------ccc----ccccCHHHHHHHHHHH-----------------HHHHHH----hhc-
Q 041312 502 NKSLDVYIF-D---------------EAK----RSLLDWSKRFEIICGI-----------------ARGILY----LHQ- 539 (743)
Q Consensus 502 ~gsL~~~l~-~---------------~~~----~~~l~~~~~~~i~~qi-----------------~~~L~y----LH~- 539 (743)
+.++...-. + ... .....+..+.+++.++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 877642200 0 000 0011122222222111 111111 221
Q ss_pred cCCCceEeccCCCCcEEecC-CCCeEEeeeccccc
Q 041312 540 DSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARI 573 (743)
Q Consensus 540 ~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~ 573 (743)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345899999999999986 46799999988763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0011 Score=68.12 Aligned_cols=135 Identities=17% Similarity=0.178 Sum_probs=93.0
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--C-------h-----------h--cHHHHHHHHHHHHhcCCc--
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--S-------G-----------Q--GIEEFKTEIALIAQLQHR-- 478 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~-------~-----------~--~~~~~~~Ev~~l~~l~h~-- 478 (743)
=+.+.++||-|.-+-||.+....|++.++|.-... + . . ..-...+|...|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999999999999853211 0 0 0 112345688888887532
Q ss_pred cEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 479 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
-+.+.++ .+..++|||++.+-.|...- ...+... +...+..-+.-|-..| +||+|..-=||+|.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 2344443 35668999999888775432 1222222 3333344445566677 99999999999999
Q ss_pred CCCCeEEeeeccccc
Q 041312 559 AAMNPKISDFGMARI 573 (743)
Q Consensus 559 ~~~~vkl~DFGla~~ 573 (743)
+++.++++||-....
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999986543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0087 Score=62.45 Aligned_cols=31 Identities=23% Similarity=0.497 Sum_probs=26.1
Q ss_pred CceEeccCCCCcEEecCCCC-eEEeeeccccc
Q 041312 543 LRIIHRDLKASNVLLDAAMN-PKISDFGMARI 573 (743)
Q Consensus 543 ~~ivH~Dikp~NIll~~~~~-vkl~DFGla~~ 573 (743)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.018 Score=60.66 Aligned_cols=140 Identities=15% Similarity=0.205 Sum_probs=84.0
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcc-cCChhcHHHHHHHHHHHHhcCC--ccEEeeeeeEecCC--eeEEEEEec
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQH--RNLVSILGCCIEEQ--EKMLIYEYL 500 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~--~~~lV~E~~ 500 (743)
+++++..|-.-.+|..... ++++++.+-. ...........+|..+|+.+.- --+.+.++.|.++. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3344433333344444433 7788888221 1233445667788888888753 23455666776665 669999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHH-HHHHHHHHHhh-----------------------------------------
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEII-CGIARGILYLH----------------------------------------- 538 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qi~~~L~yLH----------------------------------------- 538 (743)
+|..+...+..... . ...+ ..+++.|+-||
T Consensus 108 eGe~~~~~~~~~~~----~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPESL----G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcccc----h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 98544322211000 0 0111 13333333333
Q ss_pred ---------c-----cCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 539 ---------Q-----DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 539 ---------~-----~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
. .++..++|+|+.+.||+++.+.-+-++||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 23457999999999999999888999999998754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.03 Score=60.90 Aligned_cols=73 Identities=14% Similarity=0.108 Sum_probs=51.2
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCC-------hhcHHHHHHHHHHHHhcC---CccEEeeeeeEecCCeeEEE
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS-------GQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-------~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lV 496 (743)
.+.||.|....||+.... ++.++||+-.... .....+-..|+..|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478999999999998864 5579999765211 124455566677776663 246777777776 446788
Q ss_pred EEecCC
Q 041312 497 YEYLPN 502 (743)
Q Consensus 497 ~E~~~~ 502 (743)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.023 Score=59.76 Aligned_cols=139 Identities=22% Similarity=0.234 Sum_probs=95.2
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCC-----h----hc-------------HH----HHHHHHHHHHhcCCccEE
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS-----G----QG-------------IE----EFKTEIALIAQLQHRNLV 481 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-----~----~~-------------~~----~~~~Ev~~l~~l~h~niv 481 (743)
-.|..|.-+.||.+.-.+|..+|||+.+... + .+ .+ -...|++.|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 5688899999999999999999999875321 0 00 11 123588888888755432
Q ss_pred eeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC
Q 041312 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM 561 (743)
Q Consensus 482 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 561 (743)
-.--... ....|||+|+..... -....+...++...+...-.+++.-+.-|-+.+ ++||.||.--|+|+. +|
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CC
Confidence 2111111 234789999964332 222234445666777778888888888887766 599999999999995 46
Q ss_pred CeEEeeecccccc
Q 041312 562 NPKISDFGMARIF 574 (743)
Q Consensus 562 ~vkl~DFGla~~~ 574 (743)
.+.|+|-+.+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999998877654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.033 Score=59.53 Aligned_cols=74 Identities=18% Similarity=0.234 Sum_probs=48.9
Q ss_pred ccccCCceeEEEEEEcCC-cEEEEEEccc-------CChhcHHHHHHHHHHHHhcC--CccEEeeeeeEecCCeeEEEEE
Q 041312 429 KLGEGGFGSVYKGVLQNG-KEIAVKRLSR-------SSGQGIEEFKTEIALIAQLQ--HRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 429 ~LG~G~fg~Vy~~~~~~g-~~vavK~l~~-------~~~~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~~lV~E 498 (743)
.||.|....||++..++| +.|+||.-.. ...-..++...|...|+... -|..++-+.+ .+.....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence 589999999999998754 6899996431 12334566677888887663 3433333222 34455679999
Q ss_pred ecCCC
Q 041312 499 YLPNK 503 (743)
Q Consensus 499 ~~~~g 503 (743)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 98653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.031 Score=58.42 Aligned_cols=74 Identities=19% Similarity=0.246 Sum_probs=48.8
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC---CccEEeeeeeEecCCeeEEEEEecCC
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
..+.|+.|....+|+.. .+++.+.||.-. ......|..|..-|+.|. -..+.+++++....+..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34678989999999877 678889999865 334457888888888873 44678888888777778999999987
Q ss_pred C
Q 041312 503 K 503 (743)
Q Consensus 503 g 503 (743)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.064 Score=57.04 Aligned_cols=32 Identities=25% Similarity=0.344 Sum_probs=28.5
Q ss_pred CCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 542 ~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
+..++|+|+.++|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.041 Score=59.06 Aligned_cols=141 Identities=13% Similarity=0.185 Sum_probs=80.0
Q ss_pred cccccCCceeEEEEEEcC----CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEE-eeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQN----GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV-SILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~ 502 (743)
+.|..|-...+|+....+ +..+++|+........ -.-.+|..+++.+..-++- ++++++. . .+|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhhcC
Confidence 566667777889887543 2378899876544332 2336788888888655553 4555542 2 258999987
Q ss_pred CChhhh-------hh---h---cccc------c-ccCHHHHHHHHHHH-------------------------HHHHH-H
Q 041312 503 KSLDVY-------IF---D---EAKR------S-LLDWSKRFEIICGI-------------------------ARGIL-Y 536 (743)
Q Consensus 503 gsL~~~-------l~---~---~~~~------~-~l~~~~~~~i~~qi-------------------------~~~L~-y 536 (743)
..|... +. . ..+. . +.-+..+.++..++ +..+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 10 0 0000 0 11122222222111 11111 1
Q ss_pred hhc-cCCCceEeccCCCCcEEecC-CCCeEEeeeccccc
Q 041312 537 LHQ-DSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARI 573 (743)
Q Consensus 537 LH~-~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~ 573 (743)
+.. .....++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 11235799999999999975 57899999998753
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.0068 Score=49.21 Aligned_cols=48 Identities=21% Similarity=0.384 Sum_probs=32.9
Q ss_pred eeeccCCCcceeeccccChHHHHHhccccCCcccccccccccccCCceeeEEecc
Q 041312 321 AGVKVPDMSVARVDMSLGLEACKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHG 375 (743)
Q Consensus 321 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~g~~gC~~w~g 375 (743)
+++.++........ ..+.++|+..|+.+|+|.||+|. .+...|.....
T Consensus 10 ~~~~~~g~d~~~~~-~~s~~~Cq~~C~~~~~C~afT~~------~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTVF-ASSAEQCQAACTADPGCLAFTYN------TKSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcceee-cCCHHHHHHHcCCCCCceEEEEE------CCCCeEEcccC
Confidence 44555544433332 56899999999999999999986 22346776554
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 743 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 421 bits (1086), Expect = e-143
Identities = 105/300 (35%), Positives = 156/300 (52%), Gaps = 21/300 (7%)
Query: 409 LPVFDLSNIAAATNDFSS------DNKLGEGGFGSVYKGVLQNGKEIAVKRLS----RSS 458
F + TN+F NK+GEGGFG VYKG + N +AVK+L+ ++
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 459 GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLL 518
+ ++F EI ++A+ QH NLV +LG + + L+Y Y+PN SL + L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
W R +I G A GI +LH++ IHRD+K++N+LLD A KISDFG+AR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638
T+R+VGT YMAPE + G + KSD+YSFGV+LLEII G H E
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ----L 242
Query: 639 LVGHVWDLWKEGTAMEA-VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
L+ ++ E +E +DK + + + + + C+ E+ RP++ V +L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-143
Identities = 118/309 (38%), Positives = 167/309 (54%), Gaps = 3/309 (0%)
Query: 394 VDAAELDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKR 453
D +D + L F L + A+++FS+ N LG GGFG VYKG L +G +AVKR
Sbjct: 2 FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 61
Query: 454 LSRSSGQGIE-EFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE 512
L QG E +F+TE+ +I+ HRNL+ + G C+ E++L+Y Y+ N S+ + +
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 513 AK-RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571
+ + LDW KR I G ARG+ YLH +IIHRD+KA+N+LLD + DFG+A
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLE 631
++ T V GT G++APEY G S K+DV+ +GV+LLE+I G+R
Sbjct: 182 KLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 632 QGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMS 691
L+ V L KE VD L + E+ + I + LLC Q +RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 692 AVVSMLGSD 700
VV ML D
Sbjct: 301 EVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 371 bits (956), Expect = e-124
Identities = 108/288 (37%), Positives = 164/288 (56%), Gaps = 8/288 (2%)
Query: 412 FDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIAL 471
L ++ ATN+F +G G FG VYKGVL++G ++A+KR + S QGIEEF+TEI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 472 IAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSL-LDWSKRFEIICGI 530
++ +H +LVS++G C E E +LIY+Y+ N +L +++ ++ + W +R EI G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF-GGDQIEENTNRVVGT 589
ARG+ YLH + IIHRD+K+ N+LLD PKI+DFG+++ DQ +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649
GY+ PEY ++G + KSDVYSFGV+L E++ R L NL +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNN 262
Query: 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
G + VD +L + + + + C+ + DRP+M V+ L
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 2e-91
Identities = 65/308 (21%), Positives = 117/308 (37%), Gaps = 30/308 (9%)
Query: 412 FDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIAL 471
N+ + G FG V+K L + +AVK Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 472 IAQLQHRNLVSILGCCIE----EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEII 527
+ ++H N++ +G + + LI + SL ++ K +++ W++ I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 528 CGIARGILYLHQD-------SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
+ARG+ YLH+D + I HRD+K+ NVLL + I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 581 ENTNRVVGTYGYMAPEYAMEGL-----FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG 635
+T+ VGT YMAPE + + D+Y+ G++L E+ +++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 636 SWNLVGHVWDLWKEGTAMEAVDK-----SLGESCCAPEILRCI-HLGLLCVQEQATDRPN 689
+ E V L + + + C A R +
Sbjct: 248 --PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 690 MSAVVSML 697
V +
Sbjct: 306 AGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 2e-72
Identities = 68/322 (21%), Positives = 114/322 (35%), Gaps = 43/322 (13%)
Query: 412 FDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIAL 471
S + ++ +G G +G+VYKG L + + +AVK S ++ Q K I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 472 IAQLQHRNLVSILGCCIE-----EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
+ ++H N+ + E +L+ EY PN SL Y+ DW +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 527 ICGIARGILYLHQD------SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG---- 576
+ RG+ YLH + + I HRDL + NVL+ ISDFG++ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 577 --DQIEENTNRVVGTYGYMAPEYAMEGL-------FSTKSDVYSFGVLLLEIILGRRNNT 627
+ + VGT YMAPE + + D+Y+ G++ EI + T
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC---T 233
Query: 628 FHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK--------SLGESCCAPEILRCIHLGLL- 678
S + ++ T + E+ + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 679 -CVQEQATDRPNMSAVVSMLGS 699
C + A R +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-61
Identities = 67/284 (23%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ + +G G FG V K K++A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G C+ L+ EY SL + + ++G+ YLH
Sbjct: 65 KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 542 RLRIIHRDLKASNVLLDAAMN-PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
+IHRDLK N+LL A KI DFG A I+ + G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEG 177
Query: 601 GLFSTKSDVYSFGVLLLEIILGRR--NNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658
+S K DV+S+G++L E+I R+ + M AV
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------------------RIMWAVHN 219
Query: 659 SLGESCCAPEILRCIHLGLL-----CVQEQATDRPNMSAVVSML 697
P +++ + + C + + RP+M +V ++
Sbjct: 220 GT-----RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-60
Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 33/283 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRN 479
D + K+G G FG+V++ +G ++AVK L + + EF E+A++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V +G + ++ EYL SL + R LD +R + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
I+HR+LK+ N+L+D K+ DFG++R+ ++ GT +MAPE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLR 212
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659
+ + KSDVYSFGV+L E+ + W + V +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ---------------------QPWGNLNPAQVV-AA 250
Query: 660 LGESCCAPEILRCIHLGLL-----CVQEQATDRPNMSAVVSML 697
+G C EI R ++ + C + RP+ + ++ +L
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-59
Identities = 72/297 (24%), Positives = 113/297 (38%), Gaps = 50/297 (16%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
+D LG+G FG K + G+ + +K L R + F E+ ++ L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
+ +G +++ I EY+ +L I + WS+R IA G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR------------VVG 588
+ IIHRDL + N L+ N ++DFG+AR+ ++ + R VVG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII--------LGRRNNTFHLEQGSGSWNLV 640
+MAPE + K DV+SFG++L EII R F L
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------- 236
Query: 641 GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ C P + C RP+ + L
Sbjct: 237 -------RGFLDRYCPP------NCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWL 277
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-58
Identities = 74/292 (25%), Positives = 137/292 (46%), Gaps = 42/292 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQG-------IEEFKTEIALIA 473
N+ + ++G+GGFG V+KG L + +A+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
L H N+V + G ++ E++P L + D K + WS + ++ IA G
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAA-----MNPKISDFGMARIFGGDQIEENTNRVVG 588
I Y+ I+HRDL++ N+ L + + K++DFG+++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188
Query: 589 TYGYMAPE--YAMEGLFSTKSDVYSFGVLLLEIILGRR-NNTFHLEQGSGSWNLVGHVWD 645
+ +MAPE A E ++ K+D YSF ++L I+ G + + + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-------IKFINM 241
Query: 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ +EG + E C P LR ++ LC RP+ S +V L
Sbjct: 242 IREEGLRPT-----IPEDC--PPRLR--NVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 48/287 (16%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVKRL----SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
+G GGFG VY+ G E+AVK Q IE + E L A L+H N++++
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
G C++E L+ E+ L+ + + IARG+ YLH ++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 544 RIIHRDLKASNVLLDAAMNP--------KISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
IIHRDLK+SN+L+ + KI+DFG+AR + G Y +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655
E +FS SDV+S+GVLL E++ G ++ +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE---------------------VPFRGIDGLAV 222
Query: 656 VDKSLGESCCAPEILRCIHLGLL-----CVQEQATDRPNMSAVVSML 697
+ + A I C RP+ + ++ L
Sbjct: 223 A-YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 1e-56
Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRN 479
+ KL E G ++KG Q G +I VK L S + +F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 480 LVSILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
++ +LG C LI ++P SL + + + D S+ + +ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H L I L + +V++D M +IS + F + + ++APE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 598 AMEG----LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653
A++ +D++SF VLL E++ + + + M
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE---------------------VPFADLSNM 217
Query: 654 EAVDKSLGE-------SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
E K E +P + + + +C+ E RP +V +L
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 42/283 (14%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILG 485
++G G FG+VYKG ++AVK L+ + + Q ++ FK E+ ++ + +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
Q ++ ++ SL ++ + + K +I ARG+ YLH I
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE---YAMEGL 602
IHRDLK++N+ L KI DFG+A ++ G+ +MAPE
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 603 FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGE 662
+S +SDVY+FG++L E++ G+ + + + + +G
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQL---------------------PYSNINNRDQIIEMVGR 240
Query: 663 SCCAPEILRC--------IHLGLLCVQEQATDRPNMSAVVSML 697
+P++ + L C++++ +RP+ +++ +
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-53
Identities = 70/306 (22%), Positives = 120/306 (39%), Gaps = 57/306 (18%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVKRL--SRSSGQGIEEFKTEIALIAQLQHRNLVSILG 485
+G+G FG VY G E+A++ + R + ++ FK E+ Q +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
C+ +I ++L + D + +LD +K +I I +G+ YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVGTYGYMAPE------ 596
+H+DLK+ NV D I+DFG+ I G Q ++ G ++APE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 597 ---YAMEGLFSTKSDVYSFGVLLLEIILGR---RNNTFHLEQGSGSWNLVGHVWDLWKEG 650
+ FS SDV++ G + E+ + E
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEA------------------ 250
Query: 651 TAMEAVDK----SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML----GSDNA 702
+ + +L + EI + L C + +RP + ++ ML +
Sbjct: 251 -IIWQMGTGMKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306
Query: 703 PSSPKH 708
S P H
Sbjct: 307 LSHPGH 312
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFK--TEIALIAQLQHRNLVSILG 485
+G+G +G V++G G+ +AVK S + + + TE+ L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 486 CCIEEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ + LI Y SL Y+ + + LD I+ IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 542 RLR-----IIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMA 594
I HRDLK+ N+L+ I+D G+A + +Q++ N VGT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 595 PE------YAMEGLFSTKSDVYSFGVLLLEII 620
PE + D+++FG++L E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
++G+G +G V+ G G+++AVK + +TEI ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIAA 99
Query: 487 CIEEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
I+ LI +Y N SL Y+ K + LD ++ G+ +LH +
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 543 LR-----IIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMAP 595
I HRDLK+ N+L+ I+D G+A F ++++ N VGT YM P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 596 E------YAMEGLFSTKSDVYSFGVLLLEII 620
E +D+YSFG++L E+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 76/294 (25%), Positives = 120/294 (40%), Gaps = 47/294 (15%)
Query: 428 NKLGEGGFGSVYKGVL-----QNGKEIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLV 481
LGEG FG V G+++AVK L S G I + K EI ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 482 SILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGIL 535
G C E+ LI E+LP+ SL Y+ + L ++ I +G+
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA------VQICKGMD 140
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG---- 591
YL + +HRDL A NVL+++ KI DFG+ + IE +
Sbjct: 141 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSP 192
Query: 592 --YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGS----WNLVG-HV 643
+ APE M+ F SDV+SFGV L E++ +++ + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ KEG + C E+ + L C + Q ++R + ++
Sbjct: 253 VNTLKEGKRLPCPPN------CPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 84/309 (27%), Positives = 132/309 (42%), Gaps = 45/309 (14%)
Query: 428 NKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
++LG+G FGSV G +AVK+L S +F+ EI ++ L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 483 ILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILY 536
G + L+ EYLP+ L ++ R LL +S I +G+ Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS------SQICKGMEY 142
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG----- 591
L R +HRDL A N+L+++ + KI+DFG+A++ D+ VV G
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIF 195
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVG-----HVWD 645
+ APE + +FS +SDV+SFGV+L E+ ++ + E + +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255
Query: 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS-DNAPS 704
L +EG + A C E+ L LC DRP+ SA+ L +
Sbjct: 256 LLEEGQRLPAPPA------CPAEVH---ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
Query: 705 SPKHPAFIA 713
+ AF A
Sbjct: 307 GCETHAFTA 315
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-46
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
+G+G FG V++G G+E+AVK S + + EI L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 104
Query: 487 CIEEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-- 540
++ L+ +Y + SL FD R + ++ A G+ +LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 541 ---SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMAP 595
+ I HRDLK+ N+L+ I+D G+A D I+ N VGT YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 596 EYAMEGL-------FSTKSDVYSFGVLLLEII 620
E ++ ++D+Y+ G++ EI
Sbjct: 221 E-VLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-46
Identities = 80/289 (27%), Positives = 117/289 (40%), Gaps = 39/289 (13%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE-----IAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLV 481
LGEG FG V + +AVK L +G Q +K EI ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 482 SILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
GCC + L+ EY+P SL Y+ R + ++ I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG-----YMA 594
IHRDL A NVLLD KI DFG+A+ V G + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWN-----LVGHVWDLWK 648
PE E F SDV+SFGV L E++ + + + V + +L +
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
G + D C E+ HL C + +A+ RP ++ +L
Sbjct: 266 RGERLPRPD------KCPAEVY---HLMKNCWETEASFRPTFENLIPIL 305
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 47/294 (15%)
Query: 428 NKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+LG+G FGSV G+ +AVK+L S+ + + +F+ EI ++ LQH N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 483 ILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILY 536
G C + LI EYLP SL Y+ +R LL ++ I +G+ Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------SQICKGMEY 129
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG----- 591
L R IHRDL N+L++ KI DFG+ ++ + ++
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPI 181
Query: 592 -YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGS-----WNLVG-HV 643
+ APE E FS SDV+SFGV+L E+ ++ + E ++ H+
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+L K + D C EI + C RP+ + +
Sbjct: 242 IELLKNNGRLPRPDG------CPDEIY---MIMTECWNNNVNQRPSFRDLALRV 286
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGK-EIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRN 479
D ++G G FG V+ G L+ +AVK +F E ++ Q H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V ++G C ++Q ++ E + ++ + + L +++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY-----MA 594
IHRDL A N L+ KISDFGM+R + G A
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSRE-----EADGVYAASGGLRQVPVKWTA 283
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
PE G +S++SDV+SFG+LL E LG
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGAS 314
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 78/294 (26%), Positives = 124/294 (42%), Gaps = 47/294 (15%)
Query: 428 NKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+LG+G FGSV G+ +AVK+L S+ + + +F+ EI ++ LQH N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 483 ILGCCIEEQEK--MLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILY 536
G C + LI EYLP SL Y+ +R LL ++ I +G+ Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------SQICKGMEY 160
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG----- 591
L R IHRDL N+L++ KI DFG+ ++ + ++
Sbjct: 161 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPI 212
Query: 592 -YMAPEYAMEGLFSTKSDVYSFGVLLLEII---LGRRNNTFHLEQGSGS---WNLVG-HV 643
+ APE E FS SDV+SFGV+L E+ ++ + G+ ++ H+
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+L K + D C EI + C RP+ + +
Sbjct: 273 IELLKNNGRLPRPDG------CPDEIY---MIMTECWNNNVNQRPSFRDLALRV 317
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKE-----IAVKRL-SRSSGQGIEEFKTEIALIAQL 475
+F LG G FG+VYKG+ E +A+K L +S + +E E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIA 531
+ ++ +LG C+ LI + +P L Y+ + LL+W IA
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G ++ E + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 592 -----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
+MA E + +++ +SDV+S+GV + E++ G +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-44
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
++ + ++G G FG V+ G N ++A+K + R E+F E ++ +L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G C+E+ L+ E++ + L Y+ +R L + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT-NRVVGT---YGYMAPEY 597
+IHRDL A N L+ K+SDFGM R + ++ GT + +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRF-----VLDDQYTSSTGTKFPVKWASPEV 176
Query: 598 AMEGLFSTKSDVYSFGVLLLEII-LGRR 624
+S+KSDV+SFGVL+ E+ G+
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-43
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ +G+G FG V G G ++AVK + + + F E +++ QL+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 482 SILGCCIEEQEK-MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
+LG +EE+ ++ EY+ SL Y+ RS+L + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY--MAPEYA 598
+HRDL A NVL+ K+SDFG+ + E ++ + G APE
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 358
Query: 599 MEGLFSTKSDVYSFGVLLLEII-LGRR 624
E FSTKSDV+SFG+LL EI GR
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
D + +LG G FG V G + ++A+K + + +EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G C +++ +I EY+ N L Y+ R + E+ + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT-NRVVGT---YGYMAPEY 597
+ +HRDL A N L++ K+SDFG++R + ++ VG+ + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-----VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 598 AMEGLFSTKSDVYSFGVLLLEII-LGRR 624
M FS+KSD+++FGVL+ EI LG+
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE-----IAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNL 480
LG G FG+V+KGV E + +K + SG Q + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILY 536
V +LG C L+ +YLP SL ++ LL+W IA+G+ Y
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYY 130
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG----- 591
L ++HR+L A NVLL + +++DFG+A + D + +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
+MA E G ++ +SDV+S+GV + E++ G
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ + +LG G FG V G + ++AVK + + +EF E + +L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G C +E ++ EY+ N L Y+ + L+ S+ E+ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT-NRVVGT---YGYMAPEY 597
+ IHRDL A N L+D + K+SDFGM R + ++ VGT + APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-----VLDDQYVSSVGTKFPVKWSAPEV 176
Query: 598 AMEGLFSTKSDVYSFGVLLLEII-LGRR 624
+S+KSDV++FG+L+ E+ LG+
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ +G+G FG V G G ++AVK + + + F E +++ QL+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 482 SILGCCIEEQEK-MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
+LG +EE+ ++ EY+ SL Y+ RS+L + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY--MAPEYA 598
+HRDL A NVL+ K+SDFG+ + E ++ + G APE
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 186
Query: 599 MEGLFSTKSDVYSFGVLLLEII-LGRR 624
E FSTKSDV+SFG+LL EI GR
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 50/317 (15%)
Query: 399 LDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKE----IAVKRL 454
+D S N E + I ++ + +G G FG VY G L + AVK L
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 61
Query: 455 SR-SSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK-MLIYEYLPNKSLDVYIFDE 512
+R + + +F TE ++ H N++S+LG C+ + +++ Y+ + L +I
Sbjct: 62 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--R 119
Query: 513 AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572
+ +A+G+ YL + + +HRDL A N +LD K++DFG+AR
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 573 IFGGDQIEENTNRVVGTYG------YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR- 624
D ++ V G +MA E F+TKSDV+SFGVLL E++ G
Sbjct: 177 ----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
Query: 625 ----NNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCV 680
N + +G + + C + + L C
Sbjct: 233 YPDVNTF--------------DITVYLLQGRRLLQPE------YCPDPLY---EVMLKCW 269
Query: 681 QEQATDRPNMSAVVSML 697
+A RP+ S +VS +
Sbjct: 270 HPKAEMRPSFSELVSRI 286
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGK-EIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
D + +KLG G +G VY+GV + +AVK L + +EEF E A++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V +LG C E +I E++ +L Y+ E R + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN-----RVVGTYGYMAP 595
+ IHRDL A N L+ K++DFG++R+ GD + + + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
E FS KSDV++FGVLL EI G
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 60/299 (20%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE------IAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+LGEG FG V+ N +AVK L +S ++F+ E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVY------------IFDEAKRSLLDWSKRFEIICG 529
G C E + ++++EY+ + L+ + ++ L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+A G++YL + L +HRDL N L+ + KI DFGM+R I VG
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGG 218
Query: 590 YG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSWN 638
+M PE + F+T+SDV+SFGV+L EI G++ +N +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----TE------ 268
Query: 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
D +G +E C PE+ + C Q + R ++ V + L
Sbjct: 269 ----AIDCITQGRELERPR------ACPPEVYA---IMRGCWQREPQQRHSIKDVHARL 314
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 61/300 (20%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE------IAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+LGEG FG V+ N +AVK L + ++F+ E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVY-------------IFDEAKRSLLDWSKRFEIIC 528
G C + ++++EY+ + L+ + + L S+ I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
IA G++YL + +HRDL N L+ A + KI DFGM+R + VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192
Query: 589 TYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSW 637
+ +M PE M F+T+SDV+SFGV+L EI G++ +NT
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---------- 242
Query: 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
V + +G +E C E+ + L C Q + R N+ + +L
Sbjct: 243 ----EVIECITQGRVLERPRV------CPKEVYD---VMLGCWQREPQQRLNIKEIYKIL 289
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 56/295 (18%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE------IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
+LG+G FG VY+GV + + +A+K + +S + EF E +++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVY-------IFDEAKRSLLDWSKRFEIICGIARG 533
V +LG + Q ++I E + L Y + + + SK ++ IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY- 592
+ YL + + +HRDL A N ++ KI DFGM R I E G G
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 202
Query: 593 ----MAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSWNLVGH 642
M+PE +G+F+T SDV+SFGV+L EI L + +N EQ
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQ---------- 248
Query: 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
V EG ++ D C + L +C Q RP+ ++S +
Sbjct: 249 VLRFVMEGGLLDKPD------NCPDMLFE---LMRMCWQYNPKMRPSFLEIISSI 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+LG G FG V+ G ++AVK L + + F E L+ QLQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ +E +I EY+ N SL ++ L +K ++ IA G+ ++
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY--MAPEYAM 599
IHRDL+A+N+L+ ++ KI+DFG+AR+ + E T R + APE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAIN 183
Query: 600 EGLFSTKSDVYSFGVLLLEII-LGRR 624
G F+ KSDV+SFG+LL EI+ GR
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 80/306 (26%), Positives = 119/306 (38%), Gaps = 59/306 (19%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQ--NGKEI--AVKRL---SRSSGQGIEEFKTEIALIAQ 474
D KLG+G FG V +G +GK + AVK L S + +++F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGI 530
L HRNL+ + G + ++ E P SL + +L ++ +
Sbjct: 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA------VQV 130
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY 590
A G+ YL R IHRDL A N+LL KI DFG+ R + +N + V
Sbjct: 131 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA-----LPQNDDHYVMQE 182
Query: 591 G------YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGHV 643
+ APE FS SD + FGV L E+ G+
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE------------------P 224
Query: 644 WDLWKEGTAMEAVDKSLGESCCAPEILRC---IH-LGLLCVQEQATDRPNMSAVVSMLGS 699
W + +DK GE PE C I+ + + C + DRP A+ L
Sbjct: 225 WIGLNGSQILHKIDKE-GERLPRPED--CPQDIYNVMVQCWAHKPEDRPTFVALRDFL-L 280
Query: 700 DNAPSS 705
+ P+
Sbjct: 281 EAQPTD 286
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKE-----IAVKRL-SRSSGQGIEEFKTEIALIAQL 475
+F LG G FG+VYKG+ E +A+K L +S + +E E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIA 531
+ ++ +LG C+ LI + +P L Y+ + LL+W IA
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G ++ E + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 592 -----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
+MA E + +++ +SDV+S+GV + E++ G +
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQ--NGKEI--AVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ +G G G V G L+ +++ A+K L + + + +F +E +++ Q H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G + M++ EY+ N SLD ++ + + ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---S 168
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAP 595
L +HRDL A NVL+D+ + K+SDFG++R+ +E++ + T G + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAYTTTGGKIPIRWTAP 223
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
E FS+ SDV+SFGV++ E++ G R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ KLG G FG V+ ++AVK + + +E F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ +E +I E++ SL ++ + + S K + IA G+ ++
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY--MAPEYAM 599
+ IHRDL+A+N+L+ A++ KI+DFG+AR+ + E T R + APE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAIN 358
Query: 600 EGLFSTKSDVYSFGVLLLEII-LGRR 624
G F+ KSDV+SFG+LL+EI+ GR
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 429 KLGEGGFGSVYKGVLQNGKE-----IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+G G FG VYKG+L+ +A+K L + + + +F E ++ Q H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
+ G + + M+I EY+ N +LD ++ K + ++ GIA G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPEYAM 599
+ +HRDL A N+L+++ + K+SDFG++R+ D E T G + APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSGGKIPIRWTAPEAIS 223
Query: 600 EGLFSTKSDVYSFGVLLLEII-LGRR 624
F++ SDV+SFG+++ E++ G R
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-42
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 28/279 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
D + +KLG G +G VY+GV + +AVK L + +EEF E A++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V +LG C E +I E++ +L Y+ + R + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
+ IHR+L A N L+ K++DFG++R+ GD + + APE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 601 GLFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGH-VWDLWKEGTAMEAVDK 658
FS KSDV++FGVLL EI G + V++L ++ ME +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPY----------PGIDLSQVYELLEKDYRMERPEG 443
Query: 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C ++ L C Q +DRP+ + +
Sbjct: 444 ------CPEKVYE---LMRACWQWNPSDRPSFAEIHQAF 473
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 80/301 (26%), Positives = 126/301 (41%), Gaps = 62/301 (20%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE------IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
+LGE FG VYKG L +A+K L ++ G EEF+ E L A+LQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVY-------------IFDEAKRSLLDWSKRFEII 527
V +LG ++Q +I+ Y + L + D +S L+ ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVV 587
IA G+ YL S ++H+DL NVL+ +N KISD G+ R ++ +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKL 186
Query: 588 GTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGS 636
+MAPE M G FS SD++S+GV+L E+ G + +N +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QD---- 238
Query: 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696
V ++ + + D C + L + C E + RP + S
Sbjct: 239 ------VVEMIRNRQVLPCPD------DCPAWVYA---LMIECWNEFPSRRPRFKDIHSR 283
Query: 697 L 697
L
Sbjct: 284 L 284
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE---IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVS 482
D +LG G FGSV +GV + K+ +A+K L + EE E ++ QL + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
++G C E ML+ E L ++ KR + S E++ ++ G+ YL
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAPE 596
+HRDL A NVLL KISDFG+++ + + + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKA-----LGADDSYYTARSAGKWPLKWYAPE 183
Query: 597 YAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
FS++SDV+S+GV + E + G++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 79/295 (26%), Positives = 117/295 (39%), Gaps = 56/295 (18%)
Query: 428 NKLGEGGFGSVYKGVLQNGK------EIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
LG G FG VY+G + ++AVK L S Q +F E +I++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYI----FDEAKRSLLDWSKRFEIICGIARGILY 536
V +G ++ + ++ E + L ++ ++ S L + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 537 LHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMARIFGGDQIEENTNRVVGTYGY- 592
L IHRD+ A N LL KI DFGMAR I + G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAML 207
Query: 593 ----MAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSWNLVGH 642
M PE MEG+F++K+D +SFGVLL EI LG +N
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------E 253
Query: 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
V + G M+ C + + C Q Q DRPN + ++ +
Sbjct: 254 VLEFVTSGGRMDPPK------NCPGPVY---RIMTQCWQHQPEDRPNFAIILERI 299
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 427 DNKLGEGGFGSVYKGVLQNGK---EIAVKRL--SRSSGQGIEEFKTEIALIAQLQHRNLV 481
D +LG G FG+V KG Q K +AVK L + +E E ++ QL + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
++G C E ML+ E L+ Y+ + + E++ ++ G+ YL
Sbjct: 82 RMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAP 595
+HRDL A NVLL KISDFG+++ D+ + AP
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAP 189
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
E FS+KSDV+SFGVL+ E G++
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE----IAVKRLSR--SSGQGIEEFKTEIALIAQLQHRNLV 481
LGEG FGSV +G L+ +AVK + SS + IEEF +E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 482 SILGCCIEEQ-----EKMLIYEYLPNKSLDVYI---FDEAKRSLLDWSKRFEIICGIARG 533
+LG CIE + M+I ++ L Y+ E + + + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG-- 591
+ YL S +HRDL A N +L M ++DFG+++ +I G
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKM 211
Query: 592 ---YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR-----RNNTFHLEQGSGSWNLVGH 642
++A E + ++++KSDV++FGV + EI G N
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------------E 257
Query: 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
++D G ++ + C E+ + C + DRP S + L
Sbjct: 258 MYDYLLHGHRLKQPE------DCLDELYE---IMYSCWRTDPLDRPTFSVLRLQL 303
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 405 NSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKE----IAVKRLSR-SSG 459
+S L I SD +G+G FG VY G + + A+K LSR +
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 460 QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE-KMLIYEYLPNKSLDVYIFDEAKRSLL 518
Q +E F E L+ L H N+++++G + + ++ Y+ + L +I + +
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNP 121
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
+ARG+ YL + + +HRDL A N +LD + K++DFG+AR D
Sbjct: 122 TVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DI 174
Query: 579 IEENTNRVVGTYG------YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
++ V + A E F+TKSDV+SFGVLL E++ G
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 70/253 (27%), Positives = 118/253 (46%), Gaps = 22/253 (8%)
Query: 385 NAGQDLYVRVDAAELDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQ 444
+ + + +D S N E + I ++ + +G G FG VY G L
Sbjct: 52 GSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 445 --NGKEI--AVKRLSR-SSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK-MLIYE 498
+GK+I AVK L+R + + +F TE ++ H N++S+LG C+ + +++
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171
Query: 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558
Y+ + L +I + +A+G+ +L + + +HRDL A N +LD
Sbjct: 172 YMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLD 226
Query: 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAPEYAMEGLFSTKSDVYSF 612
K++DFG+AR D ++ + V G +MA E F+TKSDV+SF
Sbjct: 227 EKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282
Query: 613 GVLLLEII-LGRR 624
GVLL E++ G
Sbjct: 283 GVLLWELMTRGAP 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE----IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLV 481
D +G G FG V G L+ + +A+K L + + +F E +++ Q H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G + + M++ EY+ N SLD ++ + + ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAP 595
+ +HRDL A N+L+++ + K+SDFG+ R+ +E++ T G + +P
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRV-----LEDDPEAAYTTRGGKIPIRWTSP 219
Query: 596 EYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
E F++ SDV+S+G++L E++ G R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-41
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 28/278 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ KLG+G FG V+ G +A+K L + E F E ++ +L+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ EE ++ EY+ SL ++ E L + ++ IA G+ Y+
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
R+ +HRDL+A+N+L+ + K++DFG+AR+ ++ + APE A+ G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 602 LFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGH-VWDLWKEGTAMEAVDKS 659
F+ KSDV+SFG+LL E+ GR +V V D + G M +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPY----------PGMVNREVLDQVERGYRMPCPPE- 405
Query: 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C + L C +++ +RP + + L
Sbjct: 406 -----CPESLHD---LMCQCWRKEPEERPTFEYLQAFL 435
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 79/295 (26%), Positives = 116/295 (39%), Gaps = 56/295 (18%)
Query: 428 NKLGEGGFGSVYKGVLQNGK------EIAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNL 480
LG G FG VY+G + ++AVK L S Q +F E +I++ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYI----FDEAKRSLLDWSKRFEIICGIARGILY 536
V +G ++ + ++ E + L ++ ++ S L + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 537 LHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMARIFGGDQIEENTNRVVGTYGY- 592
L IHRD+ A N LL KI DFGMAR I G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAML 248
Query: 593 ----MAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSWNLVGH 642
M PE MEG+F++K+D +SFGVLL EI LG +N
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------E 294
Query: 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
V + G M+ C + + C Q Q DRPN + ++ +
Sbjct: 295 VLEFVTSGGRMDPPK------NCPGPVY---RIMTQCWQHQPEDRPNFAIILERI 340
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE---IAVKRL-SRSSGQGIEEFKTEIALIAQL-QHRNLV 481
+ +GEG FG V K ++ A+KR+ +S +F E+ ++ +L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVY-------------IFDEAKRSLLDWSKRFEIIC 528
++LG C L EY P+ +L + + S L +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
+ARG+ YL S+ + IHRDL A N+L+ KI+DFG++R V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKK 198
Query: 589 TYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
T G +MA E +++T SDV+S+GVLL EI+ LG
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 49/292 (16%)
Query: 428 NKLGEGGFGSVYKGVLQNGKE----IAVKRL--SRSSGQGIEEFKTEIALIAQLQHRNLV 481
LG+G FGSV + L+ +AVK L + IEEF E A + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 482 SILGCCIEEQEK------MLIYEYLPNKSLDVYIFD---EAKRSLLDWSKRFEIICGIAR 532
++G + + K M+I ++ + L ++ L + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG- 591
G+ YL S IHRDL A N +L M ++DFG++R +I G
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASK 200
Query: 592 ----YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLE--QGSGSWNLVGHVWD 645
++A E + L++ SDV++FGV + EI+ T G + + ++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIM------TRGQTPYAGIENAEIYNYL-- 252
Query: 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
G ++ C E+ L C RP+ + + L
Sbjct: 253 --IGGNRLKQPP------ECMEEVYD---LMYQCWSADPKQRPSFTCLRMEL 293
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-41
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 28/278 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ KLG+G FG V+ G +A+K L + E F E ++ +L+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ EE ++ EY+ SL ++ E L + ++ IA G+ Y+
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
R+ +HRDL+A+N+L+ + K++DFG+AR+ ++ + APE A+ G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 602 LFSTKSDVYSFGVLLLEII-LGRRNNTFHLEQGSGSWNLVGH-VWDLWKEGTAMEAVDKS 659
F+ KSDV+SFG+LL E+ GR +V V D + G M +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPY----------PGMVNREVLDQVERGYRMPCPPE- 488
Query: 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C + L C +++ +RP + + L
Sbjct: 489 -----CPESLHD---LMCQCWRKEPEERPTFEYLQAFL 518
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE--------IAVKRL-SRSSGQGIEEFKTEIALIAQL-Q 476
LGEG FG V + +AVK L ++ + + + +E+ ++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSL-------------DVYIFDEAKRSLLDWSKR 523
H+N++++LG C ++ +I EY +L Y + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR I
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-----INNID 257
Query: 584 NRVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR-----RNNTFHLEQ 632
T G +MAPE + +++ +SDV+SFGVL+ EI LG
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 312
Query: 633 GSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSA 692
++ L KEG M+ C E+ + C + RP
Sbjct: 313 ---------ELFKLLKEGHRMDKPA------NCTNELYM---MMRDCWHAVPSQRPTFKQ 354
Query: 693 VVSML 697
+V L
Sbjct: 355 LVEDL 359
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 49/226 (21%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGK--------EIAVKRLSRSSGQGIEEFKTEIALIA 473
D + LG+G F ++KGV + E+ +K L ++ E F ++++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
+L H++LV G C+ E +L+ E++ SLD Y+ + ++ ++ + E+ +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNP--------KISDFGMARIFGGDQIEENTNR 585
+ +L +IH ++ A N+LL + K+SD G++
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 586 VVGTYGY-----MAPEYAMEG-LFSTKSDVYSFGVLLLEII-LGRR 624
+ PE + +D +SFG L EI G +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 427 DNKLGEGGFGSVYKGVL--------QNGKEIAVKRL-SRSSGQGIEEFKTEIALIAQL-Q 476
LGEG FG V + +AVK L ++ + + + +E+ ++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSL-------------DVYIFDEAKRSLLDWSKR 523
H+N++++LG C ++ +I EY +L Y + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR I
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 211
Query: 584 NRVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR-----RNNTFHLEQ 632
T G +MAPE + +++ +SDV+SFGVL+ EI LG
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 266
Query: 633 GSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSA 692
++ L KEG M+ C E+ + C + RP
Sbjct: 267 ---------ELFKLLKEGHRMDKPAN------CTNELYM---MMRDCWHAVPSQRPTFKQ 308
Query: 693 VVSML 697
+V L
Sbjct: 309 LVEDL 313
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 75/303 (24%), Positives = 115/303 (37%), Gaps = 62/303 (20%)
Query: 427 DNKLGEGGFGSVYKGVL------QNGKEIAVKRL-SRSSGQGIEEFKTEIALIAQL-QHR 478
LG G FG V + ++AVK L S + E +E+ +++ L QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSL-----------DVYIFDEAKRSLLDWSKRFEII 527
N+V++LG C ++I EY L + S
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVV 587
+A+G+ +L + IHRD+ A NVLL KI DFG+AR I ++N +V
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 222
Query: 588 GTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR------RNNTFHLEQGSG 635
+MAPE + +++ +SDV+S+G+LL EI LG N+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-------- 274
Query: 636 SWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695
+ L K+G M I + C + T RP + S
Sbjct: 275 ------KFYKLVKDGYQMAQPA------FAPKNIYS---IMQACWALEPTHRPTFQQICS 319
Query: 696 MLG 698
L
Sbjct: 320 FLQ 322
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 42/231 (18%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE------IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRN 479
LGEG FG V K + K +AVK L +S + + +E ++ Q+ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSL---------------------DVYIFDEAKRSLL 518
++ + G C ++ +LI EY SL + D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
I++G+ YL + ++++HRDL A N+L+ KISDFG++R
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----D 199
Query: 579 IEENTNRVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR 623
+ E + V + G +MA E + +++T+SDV+SFGVLL EI+ LG
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 75/343 (21%)
Query: 399 LDDSRRNSEYLPVFDLSNIAAATNDFSSDN-----KLGEGGFGSVYKGVLQNGKE----- 448
LD N Y + L N + ++ +N +GEG FG V++
Sbjct: 19 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 78
Query: 449 -IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLD 506
+AVK L +S +F+ E AL+A+ + N+V +LG C + L++EY+ L+
Sbjct: 79 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 507 VY---------------------IFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
+ L +++ I +A G+ YL S +
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKF 195
Query: 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY-----MAPEYAME 600
+HRDL N L+ M KI+DFG++R I M PE
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSR-----NIYSADYYKADGNDAIPIRWMPPESIFY 250
Query: 601 GLFSTKSDVYSFGVLLLEII-LGRR-----NNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654
++T+SDV+++GV+L EI G + + E+ V ++G +
Sbjct: 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----EE----------VIYYVRDGNILA 296
Query: 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ C E+ L LC + DRP+ ++ +L
Sbjct: 297 CPE------NCPLELYN---LMRLCWSKLPADRPSFCSIHRIL 330
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-40
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 429 KLGEGGFGSVYKGVLQNGKE----IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
+GEG FG V++G+ + + +A+K + +S E+F E + Q H ++V +
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+G E +I E L ++ + ++ LD + ++ + YL
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESK 135
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG------YMAPEY 597
R +HRD+ A NVL+ + K+ DFG++R +E++T +MAPE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDST--YYKASKGKLPIKWMAPES 188
Query: 598 AMEGLFSTKSDVYSFGVLLLEII-LGRR 624
F++ SDV+ FGV + EI+ G +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 9e-40
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 429 KLGEGGFGSVYKGVLQNGKE----IAVKRLSR-SSGQGIEEFKTEIALIAQLQHRNLVSI 483
LGEG FG VY+GV N K +AVK + + E+F +E ++ L H ++V +
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR----SLLDWSKRFEIICGIARGILYLHQ 539
+G EE +I E P L Y+ +L+ +S I + + YL
Sbjct: 79 IGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL-- 129
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPE 596
+ +HRD+ N+L+ + K+ DFG++R +E+ + T +M+PE
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKASVTRLPIKWMSPE 184
Query: 597 YAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
F+T SDV+ F V + EI+ G++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-39
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE---IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLVS 482
D +LG G FGSV +GV + K+ +A+K L + EE E ++ QL + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
++G C E ML+ E L ++ KR + S E++ ++ G+ YL
Sbjct: 401 LIGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT---YGYMAPEYAM 599
+HR+L A NVLL KISDFG+++ G D + APE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECIN 512
Query: 600 EGLFSTKSDVYSFGVLLLEII-LGRR 624
FS++SDV+S+GV + E + G++
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
DF +G GGFG V+K +GK +KR+ ++ E+ + E+ +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 481 VSILGCCIEEQEKM----------------LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF 524
V GC + E+ +L+ +I ++ + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
E+ I +G+ Y+H ++I+RDLK SN+ L KI DFG+ D
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
R GT YM+PE + + D+Y+ G++L E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE------IAVKRL-SRSSGQGIEEFKTEIALIAQL-QHR 478
LG G FG V + + +AVK L ++ +E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 479 NLVSILGCC-IEEQEKMLIYEYLPNKSL-------------DVYIFDEAKRSLLDWSKRF 524
N+V++LG C M+I E+ +L ++ + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
+A+G+ +L + + IHRDL A N+LL KI DFG+AR I ++ +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPD 203
Query: 585 RVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR 623
V +MAPE + +++ +SDV+SFGVLL EI LG
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN 479
+DF LG+G FG V K + + A+K++ + + + +E+ L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 480 LVSILGCCIEE----------QEKMLIY---EYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
+V +E ++K ++ EY N +L I ++ + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 527 ICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI------- 579
I + Y+H IIHRDLK N+ +D + N KI DFG+A+
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 580 -----EENTNRVVGTYGYMAPE-YAMEGLFSTKSDVYSFGVLLLE 618
+N +GT Y+A E G ++ K D+YS G++ E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 37/226 (16%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE------IAVKRL-SRSSGQGIEEFKTEIALIAQL-QHR 478
LG G FG V + + +AVK L + E +E+ +++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSL---------------DVYIFDEAKRSLLDWSKR 523
N+V++LG C ++I EY L E LD
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+A+G+ +L + IHRDL A N+LL KI DFG+AR I+ ++
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDS 199
Query: 584 NRVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR 623
N VV +MAPE +++ +SDV+S+G+ L E+ LG
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 427 DNKLGEGGFGSVYKGVLQNGK--------EIAVKRL-SRSSGQGIEEFKTEIALIAQL-Q 476
LGEG FG V ++AVK L S ++ + + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSL-------------DVYIFDEAKRSLLDWSKR 523
H+N++++LG C ++ +I EY +L Y L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+ARG+ YL + + IHRDL A NVL+ KI+DFG+AR I
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-----IHHID 245
Query: 584 NRVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR 623
T G +MAPE + +++ +SDV+SFGVLL EI LG
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 27/223 (12%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRN 479
DF LG GGFG V++ + A+KR+ E+ E+ +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 480 LVSILGCCIEE---------QEKMLIY---EYLPNKSLDVYIFDEAKRSLLDWSKRFEII 527
+V +E+ K+ +Y + ++L ++ + S I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV- 586
IA + +LH ++HRDLK SN+ K+ DFG+ D+ E+
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 587 ---------VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEII 620
VGT YM+PE +S K D++S G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHR 478
+ K+GEG FG ++G++ +K +SR S + EE + E+A++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH 538
N+V E ++ +Y L I + K L + + I + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
+I+HRD+K+ N+ L ++ DFG+AR+ +GT Y++PE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
++ KSD+++ G +L E+ +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE------IAVKRL-SRSSGQGIEEFKTEIALIAQL-QHR 478
LG G FG V + +AVK L ++ E +E+ ++ QL H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSL-----------DVYIFDEAKRSLLDWSKRFEII 527
N+V++LG C LI+EY L + + L+ + ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 528 CG---------IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
+A+G+ +L +HRDL A NVL+ KI DFG+AR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----D 221
Query: 579 IEENTNRVVGTYG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR 623
I ++N VV +MAPE EG+++ KSDV+S+G+LL EI LG
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 427 DNKLGEGGFGSVYKGVLQNGKE----IAVKRL-SRSSGQGIEEFKTEIALIAQLQHRNLV 481
+GEG FG V++G+ + + +A+K + +S E+F E + Q H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
++G E +I E L ++ + ++ LD + ++ + YL
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG-----YMAPE 596
R +HRD+ A NVL+ + K+ DFG++R E++ + G +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 562
Query: 597 YAMEGLFSTKSDVYSFGVLLLEII-LGRR 624
F++ SDV+ FGV + EI+ G +
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
LG+G +G VY G L N IA+K + + + EIAL L+H+N+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 489 EEQEKMLIY-EYLPNKSLDVYIFDEAKRSLLDWS-KRFE----IICGIARGIL----YLH 538
E + I+ E +P SL +LL + I + IL YLH
Sbjct: 90 EN-GFIKIFMEQVPGGSL---------SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 539 QDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE- 596
+ +I+HRD+K NVL++ KISDFG ++ G T GT YMAPE
Sbjct: 140 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEI 194
Query: 597 --YAMEGLFSTKSDVYSFGVLLLEIILGRR 624
G + +D++S G ++E+ G+
Sbjct: 195 IDKGPRG-YGKAADIWSLGCTIIEMATGKP 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 427 DNKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRNLVSI 483
D ++G G F +VYKG+ + E+A + + + + FK E ++ LQH N+V
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 484 LGCCIEEQEKM----LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--EIICGIARGIL-- 535
+ L+ E + + +L ++ L K +++ R IL
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTL---------KTYLKRFKVMKIKVLRSWCRQILKG 141
Query: 536 --YLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
+LH + IIHRDLK N+ + + KI D G+A + V+GT +
Sbjct: 142 LQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEF 196
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
MAPE E + DVY+FG+ +LE+
Sbjct: 197 MAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRL---SRSSGQGIEEFKTEIALIAQLQH 477
+F + K+G G F VY+ L +G +A+K++ + + EI L+ QL H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI---------FDEAKRSLLDWSKRFEIIC 528
N++ IE+ E ++ E L I E + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT--VWKY------FV 143
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
+ + ++H R++HRD+K +NV + A K+ D G+ R F ++ +VG
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 198
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGS 634
T YM+PE E ++ KSD++S G LL E+ + F+ ++ +
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMN 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRN 479
+S ++G GG V++ + + + A+K ++ Q ++ ++ EIA + +LQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 480 L--VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
+ + I +Q ++ E N L+ ++ K+ +D +R + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE- 596
HQ I+H DLK +N L+ K+ DFG+A D + VGT YM PE
Sbjct: 144 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 597 ----------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ S KSDV+S G +L + G+
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRN 479
+S ++G GG V++ + + + A+K ++ Q ++ ++ EIA + +LQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 480 L--VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
+ + I +Q ++ E N L+ ++ K+ +D +R + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE- 596
HQ I+H DLK +N L+ K+ DFG+A D + VGT YM PE
Sbjct: 125 HQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 597 ----------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ S KSDV+S G +L + G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 53/219 (24%), Positives = 84/219 (38%), Gaps = 35/219 (15%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
KLGEGGF V L +G A+KR+ Q EE + E + H N++ ++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 488 IEEQEKM----LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------IICGIARGILYL 537
+ E+ L+ + +L I L D ++ GI RG+ +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD-------QIEENTNRVVGTY 590
H HRDLK +N+LL P + D G ++ T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 591 GYMAPE------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y APE + + ++DV+S G +L ++ G
Sbjct: 208 SYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE 243
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 10/211 (4%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHR 478
D+ +G G +G K +GK + K + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 479 NLVSILGCCIEEQEKML--IYEYLPNKSLDVYIFDEAK-RSLLDWSKRFEIICGIARGIL 535
N+V I+ L + EY L I K R LD ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 536 YLHQ--DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
H+ D ++HRDLK +NV LD N K+ DFG+ARI D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
+PE ++ KSD++S G LL E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRN 479
+S ++G GG V++ + + + A+K ++ Q ++ ++ EIA + +LQ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 480 L--VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
+ + I +Q ++ E N L+ ++ K+ +D +R + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE- 596
HQ I+H DLK +N L+ K+ DFG+A D + VG YM PE
Sbjct: 172 HQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 597 ----------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ S KSDV+S G +L + G+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 62/272 (22%), Positives = 102/272 (37%), Gaps = 31/272 (11%)
Query: 365 NGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAELDDSRRNSEYLPVFDLSNIAAATNDF 424
+G + H +T+ + L E ++ +E L D +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEY-REEVHWM 60
Query: 425 SSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVS 482
+ ++G G FG V++ Q G + AVK++ +E F+ E+ A L +V
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVP 114
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE--IICGIARGIL----Y 536
+ G E + E L SL L+ L Y
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNR---VVGTYGY 592
LH RI+H D+KA NVLL + + + DFG A D + ++ + GT +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
MAPE M K D++S ++L ++ G
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 47/219 (21%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRN 479
+ + + LG+G +V++G + G A+K + S + ++ E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 480 LVSILGCCIEEQEKMLIY---EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+V + EE E+ P SL + + + L S+ ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 537 LHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
L + I+HR++K N++ D K++DFG AR D E + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEY 181
Query: 593 MAPE--------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ P+ + + D++S GV G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN 479
++ K+G+G G+VY + + G+E+A+++++ E EI ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSL-DVY---IFDEAKRSLLDWSKRFEIIC-GIARGI 534
+V+ L + E ++ EYL SL DV DE + + +C + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA---------AVCRECLQAL 129
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
+LH + ++IHRD+K+ N+LL + K++DFG +Q + +T +VGT +MA
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILG 622
PE + K D++S G++ +E+I G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 25/213 (11%)
Query: 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLV 481
F + LG G G++ + + +++AVKR+ E+ L+ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 482 SILGCCIEEQEKMLIY---EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH 538
E+++ Y E +L Y+ E K + ++ G+ +LH
Sbjct: 82 RYFCT---EKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 539 QDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMARIFGGDQIE-ENTNRVVGTYGY 592
L I+HRDLK N+L+ + ISDFG+ + + + V GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 593 MAPEY---AMEGLFSTKSDVYSFGVLLLEIILG 622
+APE + + D++S G + +I
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 60/240 (25%), Positives = 111/240 (46%), Gaps = 24/240 (10%)
Query: 393 RVDAAELDD-SRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIA 450
+++ ELD+ R+ E +DF ++LG G G V+K +G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 451 VKRLSRSSGQG-IEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI 509
K + + E+ ++ + +V G + E + E++ SLD
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--- 119
Query: 510 FDEAKRSLLDWSKRF--EIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNP 563
+L + R +I+ ++ ++ YL + +I+HRD+K SN+L+++
Sbjct: 120 ------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEI 171
Query: 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
K+ DFG++ G I+ N VGT YM+PE +S +SD++S G+ L+E+ +GR
Sbjct: 172 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 47/219 (21%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRN 479
+ + + LG+G +V++G + G A+K + S + ++ E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 480 LVSILGCCIEEQEKMLIY---EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+V + EE E+ P SL + + + L S+ ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 537 LHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
L + I+HR++K N++ D K++DFG AR D E + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEY 181
Query: 593 MAPE--------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ P+ + + D++S GV G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQHRNLVSILG 485
LG+GGF ++ + A K + +S E+ EI++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E+ + + ++ E +SL + +++L + R+ + I G YLH R R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLH---RNR 135
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
+IHRDLK N+ L+ + KI DFG+A D + + GT Y+APE + S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 605 TKSDVYSFGVLLLEIILGR 623
+ DV+S G ++ +++G+
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
S K+GEG G V +G+++AVK + Q E E+ ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 483 ILGCCIEEQEKMLIYEYLPNKSL-DVY---IFDEAKRSLLDWSKRFEIIC-GIARGILYL 537
+ + +E ++ E+L +L D+ +E + + +C + + + YL
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA---------TVCEAVLQALAYL 157
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H +IHRD+K+ ++LL K+SDFG D + + +VGT +MAPE
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEV 212
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILG 622
L++T+ D++S G++++E++ G
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 16/206 (7%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHR 478
F ++LG G +G V+K ++G+ AVKR + E+ ++ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 479 NLVSILGCCIEEQEKMLIY-EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
V + EE + + E SL + EA + L ++ + + + +L
Sbjct: 118 CCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H ++H D+K +N+ L K+ DFG+ G G YMAPE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPE- 226
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGR 623
++G + T +DV+S G+ +LE+
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQHRNLVSILG 485
LG+GGF ++ + A K + +S E+ EI++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E+ + + ++ E +SL + +++L + R+ + I G YLH+ R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHR---NR 161
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
+IHRDLK N+ L+ + KI DFG+A D + + GT Y+APE + S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 219
Query: 605 TKSDVYSFGVLLLEIILGR 623
+ DV+S G ++ +++G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLS---RSSGQGIEEFKTEIALIAQLQHRNLVSIL 484
KLG GG +VY ++A+K + R + ++ F+ E+ +QL H+N+VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E+ L+ EY+ +L YI L I GI + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
I+HRD+K N+L+D+ KI DFG+A+ + + TN V+GT Y +PE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATD 190
Query: 605 TKSDVYSFGVLLLEIILGRR 624
+D+YS G++L E+++G
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG-IEEFKTEIALIAQLQHRNL 480
F+ K+G+G FG V+KG+ + K +A+K + + IE+ + EI +++Q +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSL-DVY---IFDEAKRSLLDWSKRFEIICGIARGIL- 535
G +++ + +I EYL S D+ DE I I R IL
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE------------TQIATILREILK 130
Query: 536 ---YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
YLH + + IHRD+KA+NVLL K++DFG+A QI+ NT VGT +
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFW 185
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILG 622
MAPE + + +K+D++S G+ +E+ G
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSG-QGIEEFKTEIA-LIAQLQHR 478
+D +LG G +G V K + +G+ +AVKR+ + Q + ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--EIICGIARGIL- 535
V+ G E + + E + Y + ++D + +I+ IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFY------KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 536 ---YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
+LH S+L +IHRD+K SNVL++A K+ DFG++ D + ++ + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKPY 175
Query: 593 MAPE----YAMEGLFSTKSDVYSFGVLLLEIILGR 623
MAPE + +S KSD++S G+ ++E+ + R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 27/219 (12%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGC 486
L EGGF VY+ + +G+E A+KRL + + E+ + +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 487 CIEEQEKM-------LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+E+ L+ L L ++ R L +I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF----------GGDQIEENTNRVVGT 589
+ IIHRDLK N+LL K+ DFG A + E T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 590 YGYMAPEYAMEGLFS-----TKSDVYSFGVLLLEIILGR 623
Y PE + L+S K D+++ G +L + +
Sbjct: 214 PMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 23/235 (9%)
Query: 402 SRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSG- 459
S +S L + + D ++G G +GSV K V +G+ +AVKR+ +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 460 QGIEEFKTEIA-LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLL 518
+ ++ ++ ++ +V G E + + E + Y K
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY-----KYVYS 116
Query: 519 DWSKRF--EIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572
EI+ I + +L L+IIHRD+K SN+LLD + N K+ DFG++
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 573 IFGGDQIEENTNRVVGTYGYMAPE----YAMEGLFSTKSDVYSFGVLLLEIILGR 623
D I + + G YMAPE A + +SDV+S G+ L E+ GR
Sbjct: 175 QL-VDSIAKTRD--AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+ +LG+G FG VYK + G A K + S + +E++ EI ++A H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 483 ILGCCIEEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEI--IC-GIARGILYLH 538
+LG + + ++ E+ P ++ + E R L +I +C + + +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGL----TEPQIQVVCRQMLEALNFLH 134
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE-- 596
RIIHRDLKA NVL+ + +++DFG++ + ++ +GT +MAPE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVV 189
Query: 597 ---YAMEGLFSTKSDVYSFGVLLLEIILG 622
+ + K+D++S G+ L+E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 57/268 (21%), Positives = 95/268 (35%), Gaps = 72/268 (26%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQHRN 479
DF +G GGFG V++ + A+KR+ + E+ E+ +A+L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 480 LVSILGCCIEE-------------------------------------------QEKMLI 496
+V +E + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 497 YEYLPNKSLDVYIFDE--AKRSLLDWSKR------------FEIICGIARGILYLHQDSR 542
+ + +YI + K +L DW R I IA + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN----------RVVGTYGY 592
++HRDLK SN+ K+ DFG+ D+ E+ VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEII 620
M+PE +S K D++S G++L E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-32
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 427 DNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVSIL 484
+LG GGFG V + + G+++A+K+ + E + EI ++ +L H N+VS
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 485 GCCIEEQEKM-------LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
+ +K+ L EY L Y+ L ++ I+ + YL
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNP---KISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
H+ RIIHRDLK N++L KI D G A+ E VGT Y+A
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLA 191
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
PE + ++ D +SFG L E I G R
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 12/201 (5%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
F KLGEG +GSVYK + + G+ +A+K++ ++E EI+++ Q ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 483 ILGCCIEEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G + + ++ EY S+ D+ + L + I+ +G+ YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
R IHRD+KA N+LL+ + K++DFG+A + NT V+GT +MAPE E
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEI 200
Query: 602 LFSTKSDVYSFGVLLLEIILG 622
++ +D++S G+ +E+ G
Sbjct: 201 GYNCVADIWSLGITAIEMAEG 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSS--GQGIEE-FKTEIALIAQLQHRNLVSILG 485
LG+G F VY+ + G E+A+K + + + G+ + + E+ + QL+H +++ +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
E+ + L+ E N ++ Y+ + K + R + I G+LYLH
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARH-FMHQIITGMLYLH---SHG 132
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVGTYGYMAPEYAMEG 601
I+HRDL SN+LL MN KI+DFG+A Q++ + + GT Y++PE A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 602 LFSTKSDVYSFGVLLLEIILGR 623
+SDV+S G + +++GR
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKTEIALIAQLQHRN 479
+D+ +G G V +++A+KR++ ++E EI ++Q H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSL-DVYIFDEAKRSLLDWSKRFEIICGIARGIL--- 535
+VS + + E L+ + L S+ D+ AK I I R +L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 536 -YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM-ARIFGGDQIEENTNR--VVGTYG 591
YLH++ IHRD+KA N+LL + +I+DFG+ A + G I N R VGT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 592 YMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGR 623
+MAPE + + K+D++SFG+ +E+ G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG----IEEFKTEIALIAQLQHRNLVSI 483
LG GG V+ L++ +++AVK L R+ F+ E A L H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 484 LGCCIEEQEKMLIY----EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
E + EY+ +L + E + + E+I + + + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE-NTNRVVGTYGYMAPEYA 598
+ IIHRD+K +N+++ A K+ DFG+AR T V+GT Y++PE A
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
+SDVYS G +L E++ G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS---RSSGQGIEEFKTEIALIAQLQHRN 479
FS ++G G FG+VY ++N + +A+K++S + S + ++ E+ + +L+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVY-----IFDEAKRSLLDWSKRFEIIC-GIARG 533
+ GC + E L+ EY + D+ E + + + G +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA---------AVTHGALQG 166
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+ YLH +IHRD+KA N+LL K+ DFG A N+ VGT +M
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWM 217
Query: 594 APE---YAMEGLFSTKSDVYSFGVLLLEIILG 622
APE EG + K DV+S G+ +E+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQHRNLVSI- 483
+G GG G VY+ + +A+K +S + + E +LQ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 484 -LGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
G E ++ + + L + + L + I+ I + H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
HRD+K N+L+ A + DFG+A +++ + VGT YMAPE E
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSES 210
Query: 602 LFSTKSDVYSFGVLLLEIILGRR 624
+ ++D+Y+ +L E + G
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 35/242 (14%)
Query: 399 LDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS 457
S + + YL + A ND + ++G G G V+K + G IAVK++ RS
Sbjct: 3 SGSSGKQTGYLTI-GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 458 SG-QGIEEFKTEIA-LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----F 510
+ + ++ ++ +V G I + + E + + +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 511 DEAKRSLLDWSKRFEIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566
E I+ + I+ YL + +IHRD+K SN+LLD K+
Sbjct: 122 PE------------RILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLC 167
Query: 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPE-----YAMEGLFSTKSDVYSFGVLLLEIIL 621
DFG++ D ++ + G YMAPE + + ++DV+S G+ L+E+
Sbjct: 168 DFGISGRL-VDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224
Query: 622 GR 623
G+
Sbjct: 225 GQ 226
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 24/249 (9%), Positives = 56/249 (22%), Gaps = 43/249 (17%)
Query: 410 PVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEF 465
S ++ L G V+ ++ ++ A+K + S +E
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 466 KTEIALIAQLQHRNLVSILGCC--------IEEQEKMLIYEYLPNKS----LDVYIFDEA 513
A+L + + Q + + P + + + A
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 514 -----------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVL 556
R + + R L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 557 LDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM--EGLFSTKSDVYSFGV 614
+ + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 615 LLLEIILGR 623
+ +
Sbjct: 282 SIYRVWCLF 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 42/231 (18%), Positives = 82/231 (35%), Gaps = 32/231 (13%)
Query: 413 DLSNIAAATNDFSSDNKLGEG--GFGSVYKGV-LQNGKEIAVKR--LSRSSGQGIEEFKT 467
+S+ + +G+G +V G+ + V+R L S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 468 EIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--- 524
E+ + H N+V I + E ++ ++ S + L+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA---------KDLICTHFMDGMN 126
Query: 525 -EIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579
I I +G+L Y+H +HR +KAS++L+ +S
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 580 EENT-----NRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGR 623
+ V +++PE + L + KSD+YS G+ E+ G
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKR--LSRSSGQGIEEFKTEIALIAQL-Q 476
T +F K+G G FGSV+K V +G A+KR + + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 477 HRNLVSILGCCIEEQEKMLIY-EYLPNKSLDVYIFDEAKR-SLLDWSKRFEIICGIARGI 534
H ++V E + MLI EY SL I + + S ++ +++ + RG+
Sbjct: 70 HSHVVRYFSA-WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 535 LYLHQDSRLRIIHRDLKASNVLLD-------------------AAMNPKISDFGMARIFG 575
Y+H ++H D+K SN+ + + KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 576 GDQIEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGR 623
+ G ++A E E K+D+++ + ++
Sbjct: 186 ------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 36/273 (13%), Positives = 73/273 (26%), Gaps = 26/273 (9%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV------LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ 474
+ + LGEG F VY+ +N ++ +K ++ + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI--FDEAKRSLLDWSKRFEIICGIAR 532
+ + + +L+ E +L I + ++ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNP-----------KISDFGMARIFGGDQIEE 581
I +H IIH D+K N +L + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVG 641
T G+ E ++ + D + + ++ G ++ G G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT---YMKVKNEGGECKPEG 297
Query: 642 HVWDLWKEGTAMEAVDKSLG-ESCCAPEILRCI 673
L E L C L +
Sbjct: 298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 26/205 (12%)
Query: 429 KLGEGGFGSVYKGV--LQNGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSIL 484
+ GG G +Y + NG+ + +K L SG + E +A++ H ++V I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 485 --GCCIEEQEKMLIY---EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+ + Y EY+ +SL +K L ++ + I + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH- 199
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+ +++ DLK N++L K+ D G + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVR 250
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRR 624
G + +D+Y+ G L + L
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
DF LG+G FG+VY Q+ +A+K L ++ + + E+ + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------IICGIA 531
N++ + G + LI EY P ++ + E ++ +F+ I +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKL-----SKFDEQRTATYITELA 119
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR---VVG 588
+ Y H R+IHRD+K N+LL +A KI+DFG + + ++R + G
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCG 169
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
T Y+ PE + K D++S GVL E ++G+
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 58/226 (25%), Positives = 90/226 (39%), Gaps = 42/226 (18%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNL 480
N S+ LG G G+V G+ +AVKR+ + EI L+ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 481 VSILGCCIEEQEKM--LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF------EIICGIAR 532
+ C E ++ + E N +L + E+K + K ++ IA
Sbjct: 72 IRYY--CSETTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNP-------------KISDFGMARIFGGDQ- 578
G+ +LH L+IIHRDLK N+L+ + ISDFG+ + Q
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 579 -IEENTNRVVGTYGYMAPEYAMEGLF-------STKSDVYSFGVLL 616
N N GT G+ APE E + D++S G +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQH 477
+ + KLG G +G V E A+K + ++ S + E+A++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILY 536
N++ + +++ L+ E L FDE R + II + G+ Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 537 LHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
LH+ I+HRDLK N+LL + KI DFG++ +F + +GT Y+
Sbjct: 152 LHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYI 205
Query: 594 APEYAMEGLFSTKSDVYSFGVLL 616
APE + + K DV+S GV+L
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVIL 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 43/232 (18%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS-----------------SGQGIEE 464
ND+ L +G F + ++ K A+K+ +S ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 465 FKTEIALIAQLQHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLL 518
FK E+ +I +++ ++ G I +++ +IYEY+ N S+ + D+ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
II + Y+H + I HRD+K SN+L+D K+SDFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 579 IEENTNRVVGTYGYMAPEYAMEGLFSTK-------SDVYSFGVLLLEIILGR 623
I+ GTY +M PE FS + D++S G+ L +
Sbjct: 207 IK--G--SRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 31/206 (15%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVK-----RLSRSSGQGIEEFKTEIALIAQLQHRNLVS 482
+G+G F V + + + G++ AVK + + S G E+ K E ++ L+H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 483 ILGCCIEEQEKMLIYEYLP---------NKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
+L + +++E++ ++ +++ EA S + I
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS--------HYMRQILEA 142
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNP---KISDFGMARIFGGDQIEENTNRVVGTY 590
+ Y H IIHRD+K VLL + N K+ FG+A G VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTP 197
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLL 616
+MAPE + DV+ GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 24/236 (10%)
Query: 402 SRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQ 460
S + L DLS + F +G G +G VYKG ++ G+ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGD 62
Query: 461 GIEEFKTEIALIAQL-QHRNLVSILGC------CIEEQEKMLIYEYLPNKSL-DVYIFDE 512
EE K EI ++ + HRN+ + G + + L+ E+ S+ D+ +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 513 AKRSLLDWSKRFEIIC-GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571
+W IC I RG+ +LHQ ++IHRD+K NVLL K+ DFG++
Sbjct: 123 GNTLKEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 572 RIFGGDQIEENTNRVVGTYGYMAPE-----YAMEGLFSTKSDVYSFGVLLLEIILG 622
NT +GT +MAPE + + KSD++S G+ +E+ G
Sbjct: 177 AQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQH 477
++ LG+G FG V K +E AVK ++++ + E+ L+ +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILY 536
N++ + + ++ E L FDE KR II + GI Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 537 LHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+H+ I+HRDLK N+LL + + KI DFG++ F + +GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI 190
Query: 594 APEYAMEGLFSTKSDVYSFGVLL 616
APE + G + K DV+S GV+L
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVIL 212
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 31/215 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFK-----T---EIALIA 473
+ K+GEG +G VYK G+ +A+KR+ ++ T EI+L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
+L H N+VS++ E+ L++E++ K L + + ++ L S+ + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRG 131
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+ + HQ RI+HRDLK N+L+++ K++DFG+AR F G + T+ VV T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186
Query: 594 APEYAMEGLF-----STKSDVYSFGVLLLEIILGR 623
AP+ L ST D++S G + E+I G+
Sbjct: 187 APDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-28
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQ 476
++ + LG+G FG V G+E AVK +S+ E E+ L+ QL
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGIL 535
H N++ + ++ L+ E L FDE R II + GI
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 536 YLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
Y+H+ +I+HRDLK N+LL N +I DFG++ F + +GT Y
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYY 194
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLL 616
+APE + G + K DV+S GV+L
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS-GQGIEEFKT---EIALIAQLQ 476
+ K+GEG +G V+K G+ +A+K+ S I+ K EI ++ QL+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIALREIRMLKQLK 60
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
H NLV++L ++ L++EY V + + + I + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H+ IHRD+K N+L+ K+ DFG AR+ + + V T Y +PE
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRSPE 172
Query: 597 -------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y DV++ G + E++ G
Sbjct: 173 LLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 20/250 (8%)
Query: 377 MMDTRTYINAGQDLYVRVDAAELDDSRRN-SEYLPVFDLSNIAAATNDFSS----DNKLG 431
M + + + G + + D +++D + + + + +LG
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 432 EGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE 490
G FG V++ V G+ K ++ K EI+++ QL H L+++ ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 491 QEKMLIYEYLPNKSLDVYIFDE--AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHR 548
E +LI E+L L FD A+ + ++ + G+ ++H+ I+H
Sbjct: 121 YEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 173
Query: 549 DLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTK 606
D+K N++ + KI DFG+A D E T + APE
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 607 SDVYSFGVLL 616
+D+++ GVL
Sbjct: 231 TDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
S LG G FG V+K G ++A K + + EE K EI+++ QL H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSLDVYIFDE--AKRSLLDWSKRFEIICGIARGILYLH 538
+ E + + L+ EY+ L FD + L + I GI ++H
Sbjct: 150 QLYD-AFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
Q + I+H DLK N+L KI DFG+AR + E GT ++APE
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPE 258
Query: 597 YAMEGLFSTKSDVYSFGVLL 616
S +D++S GV+
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 419 AATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---EIALIAQ 474
++++ F KLG G + +VYKG+ G +A+K + S +G T EI+L+ +
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKE 59
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICG---IA 531
L+H N+V + E + L++E++ L Y+ + + + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
+G+ + H++ +I+HRDLK N+L++ K+ DFG+AR F G + ++ VV T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLW 173
Query: 592 YMAPE-------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y AP+ Y ST D++S G +L E+I G+
Sbjct: 174 YRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+G FG V K +E AVK ++++ + E+ L+ +L H N++ +
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
+ ++ E L FDE KR II + GI Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 545 IIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
I+HRDLK N+LL + + KI DFG++ F + +GT Y+APE + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRG 197
Query: 602 LFSTKSDVYSFGVLL 616
+ K DV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFK-----T---EIALI 472
+ K+GEG +G+V+K + + +A+KR+ +++ + EI L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 473 AQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR 532
+L+H+N+V + +++ L++E+ + L Y + K F + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSF--LFQLLK 112
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
G+ + H ++HRDLK N+L++ K+++FG+AR F G + + VV T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 593 MAPEYAMEGLF-----STKSDVYSFGVLLLEIILGRR 624
P+ LF ST D++S G + E+ R
Sbjct: 168 RPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS-GQGIEEFKT---EIALIAQLQ 476
+ + +GEG +G V K G+ +A+K+ S + ++ K EI L+ QL+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK--KIAMREIKLLKQLR 82
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
H NLV++L C +++ L++E++ + E + LD+ + + I GI +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H IIHRD+K N+L+ + K+ DFG AR E + V T Y APE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPE 194
Query: 597 -------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y DV++ G L+ E+ +G
Sbjct: 195 LLVGDVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS-------------SGQGIEEFK 466
+ KLG G +G V E A+K + +S + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 467 TEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFE 525
EI+L+ L H N++ + +++ L+ E+ L F++ R D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAAN 150
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEEN 582
I+ I GI YLH+ I+HRD+K N+LL ++ +N KI DFG++ F D
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--- 204
Query: 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616
+GT Y+APE ++ ++ K DV+S GV++
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 31/215 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFK-----T---EIALIA 473
+ K+GEG +G VYK G+ A+K++ +E+ T EI+++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533
+L+H N+V + ++ +L++E+L + L + +K F + + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
I Y H R++HRDLK N+L++ KI+DFG+AR F G + + T+ +V T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167
Query: 594 APEYAMEGLF-----STKSDVYSFGVLLLEIILGR 623
AP+ L ST D++S G + E++ G
Sbjct: 168 APDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 16/193 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
+G G +G V V A K++ + + ++ FK EI ++ L H N++ +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
+ + L+ E L F+ + + S I+ + + Y H+ L +
Sbjct: 76 EDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVA 128
Query: 547 HRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF 603
HRDLK N L K+ DFG+A F ++ VGT Y++P+ +EGL+
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQ-VLEGLY 184
Query: 604 STKSDVYSFGVLL 616
+ D +S GV++
Sbjct: 185 GPECDEWSAGVMM 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 45/226 (19%), Positives = 91/226 (40%), Gaps = 19/226 (8%)
Query: 400 DDSRRNSEYLPVFDLSNIAAATNDFSS----DNKLGEGGFGSVYKGV-LQNGKEIAVKRL 454
+ + + + + +LG G FG V++ G A K +
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 190
Query: 455 SRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-- 512
E + EI ++ L+H LV++ ++ E ++IYE++ L F++
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVA 246
Query: 513 AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP--KISDFGM 570
+ + + + E + + +G+ ++H+ +H DLK N++ + K+ DFG+
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616
++ GT + APE A +D++S GVL
Sbjct: 304 TAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG-IEEFKTEIALIAQLQHRNLVSILGC 486
KLG G FG V+ +G E +K +++ Q +E+ + EI ++ L H N++ I
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF------EIICGIARGILYLHQD 540
+ ++ E L I R K E++ + + Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARG-----KALSEGYVAELMKQMMNALAYFHS- 142
Query: 541 SRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
++H+DLK N+L KI DFG+A +F D+ + GT YMAPE
Sbjct: 143 --QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE- 196
Query: 598 AMEGLFSTKSDVYSFGVLL 616
+ + K D++S GV++
Sbjct: 197 VFKRDVTFKCDIWSAGVVM 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKG-VLQNGKEIAVKRLSRSSGQGIEEFKT---EIALIAQLQH 477
+ +KLGEG + +VYKG +A+K + +G T E++L+ L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
N+V++ E+ L++EYL +K L Y+ + ++++ + + RG+ Y
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H+ +++HRDLK N+L++ K++DFG+AR + N VV T Y P+
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDI 171
Query: 598 AMEGLF-----STKSDVYSFGVLLLEIILGR 623
L ST+ D++ G + E+ GR
Sbjct: 172 ----LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 27/233 (11%), Positives = 67/233 (28%), Gaps = 43/233 (18%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLS---RSSGQGIEEFKTEIALIAQLQ--------- 476
LG+ + + + G+ V R I++ K E+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 477 -------------HRNLVSILGCCIEEQEKMLIYEYLPNKSLDV-------YIFDEAKRS 516
++ ++E++ ++ + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 517 -LLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575
L R ++ + R + LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 576 GDQIEENTNRVVGTYGYMAPE-----YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ R A L + D ++ G+ + I
Sbjct: 263 ASAVSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFK-----T---EIALI 472
+ + KLGEG +G VYK + + +A+KR+ +E + T E++L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 473 AQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICG 529
+LQHRN++ + LI+EY D+ + +D + I
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA---ENDL-------KKYMDKNPDVSMRVIKSF 137
Query: 530 ---IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP-----KISDFGMARIFGGDQIEE 581
+ G+ + H R +HRDLK N+LL + KI DFG+AR F G I +
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 582 NTNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
T+ ++ T Y PE + +ST D++S + E+++
Sbjct: 194 FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
+DF LG+G FG+VY QN +A+K L +S + + EI + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 478 RNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE------IICGI 530
N++ + +++++ L+ E+ P L + E ++ RF+ + +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKH-----GRFDEQRSATFMEEL 123
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTY 590
A + Y H ++IHRD+K N+L+ KI+DFG + + + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTL 176
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y+ PE K D++ GVL E ++G
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKT----EIALIAQL 475
+ + LGEG F +VYK + +A+K++ ++ EI L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
H N++ +L + L+++++ L+V I D + K + + +G+
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLE 126
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
YLHQ I+HRDLK +N+LLD K++DFG+A+ F G T++VV T Y AP
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAP 181
Query: 596 EYAMEGLF-----STKSDVYSFGVLLLEIILGR 623
E LF D+++ G +L E++L
Sbjct: 182 EL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 38/213 (17%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVSILGCC 487
+G G FG V++ L E+A+K++ + + FK E+ ++ ++H N+V +
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 488 IEEQEKM------LIYEYLPNKSLDVY----IFDEAKRSL-LDWSKRFEIICGIARGILY 536
+K L+ EY+P VY + + K+++ + K + + + R + Y
Sbjct: 102 YSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLY--MYQLLRSLAY 156
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
+H + I HRD+K N+LLD K+ DFG A+I E N + + Y Y AP
Sbjct: 157 IHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAP 210
Query: 596 EYAMEGLF-----STKSDVYSFGVLLLEIILGR 623
E +F +T D++S G ++ E++ G+
Sbjct: 211 EL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 421 TNDFSSD----NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIA 473
+ FS + +LG+G F V + V G E A K ++ S + ++ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIAR 532
+LQH N+V + EE L+++ + L F++ R + I I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNP---KISDFGMARIFGGDQIEENTNRVVGT 589
I Y H I+HR+LK N+LL + K++DFG+A + + GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLL 616
GY++PE + +S D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 64/196 (32%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVSILGCC 487
LGEG +G V V + +AVK + E K EI + L H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 488 IEEQEKM-LIYEYLPNKSLDVYIFD---EAKRSLLDWSKRF--EIICGIARGILYLHQDS 541
E L EY L FD ++RF +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+ I HRD+K N+LLD N KISDFG+A +F + E N++ GT Y+APE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 602 LFS-TKSDVYSFGVLL 616
F DV+S G++L
Sbjct: 183 EFHAEPVDVWSCGIVL 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 17/195 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILG 485
+LG+G F V + V G E A K ++ S + ++ + E + +LQH N+V +
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
EE L+++ + L F++ R + I I I Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCHS---NG 148
Query: 545 IIHRDLKASNVLLDAAMNP---KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
I+HR+LK N+LL + K++DFG+A + + GT GY++PE +
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKD 205
Query: 602 LFSTKSDVYSFGVLL 616
+S D+++ GV+L
Sbjct: 206 PYSKPVDIWACGVIL 220
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 16/193 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
LG G FG V++ V + K K + G K EI+++ +HRN++ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDE--AKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545
+E ++I+E++ + F+ L+ + + + + +LH I
Sbjct: 71 ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 546 IHRDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF 603
H D++ N++ + KI +FG AR +N + Y APE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 604 STKSDVYSFGVLL 616
ST +D++S G L+
Sbjct: 181 STATDMWSLGTLV 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 20/199 (10%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS------SGQGIEEFKTEIALIAQLQHRNLV 481
+LG G F V K G E A K + + G EE + E++++ Q+ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
++ + +LI E + L ++ + S + + + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHT-- 133
Query: 542 RLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
+I H DLK N++L P K+ DFG+A + GT ++APE
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 598 AMEGLFSTKSDVYSFGVLL 616
++D++S GV+
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 22/200 (11%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVK------RLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+LG G F V K G E A K + G EE + E++++ Q+ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQD 540
++ + +LI E + L FD A++ L + I I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 541 SRLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
+I H DLK N++L P K+ DFG+A + GT ++APE
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188
Query: 597 YAMEGLFSTKSDVYSFGVLL 616
++D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 36/203 (17%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
LG G F V+ GK A+K + +S + EIA++ +++H N+V++
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFD---------EAKRSLLDWSKRFEIICGIARGILYLH 538
L+ + + L FD E S +I + + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS--------LVIQQVLSAVKYLH 123
Query: 539 QDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+ I+HRDLK N+L ++ + I+DFG++++ + GT GY+
Sbjct: 124 E---NGIVHRDLKPENLLYLTPEENSKI--MITDFGLSKMEQNGIMST----ACGTPGYV 174
Query: 594 APEYAMEGLFSTKSDVYSFGVLL 616
APE + +S D +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 28/239 (11%), Positives = 68/239 (28%), Gaps = 54/239 (22%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQ--------- 476
LG+ + + + G+ V + I++ K E+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 477 ----------------HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-----AKR 515
+ ++ + + + Y +S + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 516 SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575
L R ++ + R + LH ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 576 GDQIEENTNRVVGTYGYMAPEY-----------AMEGLFSTKSDVYSFGVLLLEIILGR 623
+ G+ PE L + D ++ G+++ I
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 50/246 (20%), Positives = 87/246 (35%), Gaps = 54/246 (21%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVK-----RLSRSSGQGIEEFKTEIALIAQ 474
+ +G+G +G V + Q A+K ++ + + + +E KTE+ L+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 475 LQHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF--------- 524
L H N+ + E+++ + L+ E L + S +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 525 ----------------------------EIICGIARGILYLHQDSRLRIIHRDLKASNVL 556
I+ I + YLH I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 557 L--DAAMNPKISDFGMARIFGGDQIEENT--NRVVGTYGYMAPE--YAMEGLFSTKSDVY 610
+ + K+ DFG+++ F E GT ++APE + K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 611 SFGVLL 616
S GVLL
Sbjct: 261 SAGVLL 266
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 41/221 (18%)
Query: 429 KLGEGGFGSVYKGV---LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILG 485
K+G G +G VYK ++ K+ A+K++ +G + + EIAL+ +L+H N++S+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 486 CCIEEQEK--MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICG--------IARGIL 535
+ ++ L+++Y D++ + R+ K ++ G I GI
Sbjct: 86 VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFG--GDQIEENTNRVVGT 589
YLH + ++HRDLK +N+L+ KI+D G AR+F + + VV T
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 198
Query: 590 YGYMAPE-------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ Y APE Y + D+++ G + E++
Sbjct: 199 FWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLVSIL 484
LGEG +G V + + + AVK L + G K EI L+ +L+H+N++ ++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 485 GCCIEEQEKM--LIYEYLPNKSLDVYIFDE-AKRSLLDWSKRF---EIICGIARGILYLH 538
E+++ ++ EY ++ D ++ ++I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEM--LDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
I+H+D+K N+LL KIS G+A ++ G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 599 M-EGLFS-TKSDVYSFGVLLLEIILGR 623
FS K D++S GV L I G
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS------SGQGIEEFKTEIALIAQLQHRNLV 481
+LG G F V K GKE A K + + G EE + E+ ++ +++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
++ + + +LI E + L ++ ++ + + ++ + I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHS-- 126
Query: 542 RLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
RI H DLK N++L P K+ DFG+A + GT ++APE
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 182
Query: 598 AMEGLFSTKSDVYSFGVLL 616
++D++S GV+
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 30/204 (14%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRL------SRSSGQGIEEFKTEIALIAQLQHRNLV 481
+LG G F V K G + A K + S G E+ + E++++ ++QH N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 482 SILGCCIEEQEKMLIYEY-----LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
++ + + +LI E L + + E + + E + I G+ Y
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--------EFLKQILNGVYY 129
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFGGDQIEENTNRVVGTYGY 592
LH L+I H DLK N++L P KI DFG+A + GT +
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLL 616
+APE ++D++S GV+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 41/205 (20%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGC 486
+G+G F V + G+E+A+K + ++ + +++ E+ ++ L H N+V +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 487 CIEEQEKM-LIYEYLPNKSLDVYIF-------DEAKRSLLDWSKRF-EIICGIARGILYL 537
IE ++ + LI EY + Y+ EA+ +F +I+ + Y
Sbjct: 83 -IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-------KFRQIVSAVQ----YC 130
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H + RI+HRDLKA N+LLDA MN KI+DFG + F + G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPE- 183
Query: 598 AMEGLFS------TKSDVYSFGVLL 616
LF + DV+S GV+L
Sbjct: 184 ----LFQGKKYDGPEVDVWSLGVIL 204
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 64/196 (32%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVSILGCC 487
LGEG +G V V + +AVK + E K EI + L H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 488 IEEQEKM-LIYEYLPNKSLDVYIFD---EAKRSLLDWSKRF--EIICGIARGILYLHQDS 541
E L EY L FD ++RF +++ G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+ I HRD+K N+LLD N KISDFG+A +F + E N++ GT Y+APE
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 602 LFS-TKSDVYSFGVLL 616
F DV+S G++L
Sbjct: 183 EFHAEPVDVWSCGIVL 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCC 487
LGEG V + L +E AVK + + G E+ ++ Q Q HRN++ ++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 488 IEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIARGILYLHQDSR 542
EE L++E + S+ +I F+E + S ++ +A + +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------VVVQDVASALDFLHN--- 129
Query: 543 LRIIHRDLKASNVLL---DAAMNPKISDFGMARIF--GGDQIEENTNR---VVGTYGYMA 594
I HRDLK N+L + KI DF + GD +T G+ YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 595 PE-----YAMEGLFSTKSDVYSFGVLL 616
PE ++ + D++S GV+L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 53/232 (22%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS--------------------------SGQGI 462
+G+G +G V + A+K LS+ I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 463 EEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY---EYLPNKSLDVYIFDEAKRSLL- 518
E+ EIA++ +L H N+V L +++ + +Y E + + + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 519 -DWSKRF--EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF- 574
D ++ + ++I GI YLH +IIHRD+K SN+L+ + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 575 GGDQIEENTNRVVGTYGYMAPE--YAMEGLFS-TKSDVYSFGVLLLEIILGR 623
G D + NT VGT +MAPE +FS DV++ GV L + G+
Sbjct: 189 GSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGI---------EEFKTEIALIAQL-QH 477
LG G V + + KE AVK + + G E E+ ++ ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIAR 532
N++ + L+++ + L Y+ E + +I+ +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--------KIMRALLE 135
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
I LH+ L I+HRDLK N+LLD MN K++DFG + + V GT Y
Sbjct: 136 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSY 189
Query: 593 MAPE------YAMEGLFSTKSDVYSFGVLL 616
+APE + + D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 422 NDFSSDNKLGEGGFGSVY----KGVLQNGKEIAVKRLSRSS---GQGIEEFKTEIALIAQ 474
DF LGEG F +V +E A+K L + + E ++++
Sbjct: 30 EDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EI 526
L H V + ++++ Y N L YI FDE + RF EI
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CT------RFYTAEI 139
Query: 527 ICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586
+ + YLH IIHRDLK N+LL+ M+ +I+DFG A++ + + N
Sbjct: 140 VSALE----YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
VGT Y++PE E SD+++ G ++ +++ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--------SGQGIEEFKTEIALIAQLQHRN 479
LG G G V + K++A++ +S+ +TEI ++ +L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLH 538
++ I + ++ ++ E + L FD+ L + + + YLH
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNP---KISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
+ IIHRDLK NVLL + KI+DFG ++I G + + GT Y+AP
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAP 310
Query: 596 E---YAMEGLFSTKSDVYSFGVLL 616
E ++ D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 41/215 (19%)
Query: 429 KLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKT-EIALIAQLQHRNLVSILGC 486
+G G FG VY+ L +G+ +A+K++ + + FK E+ ++ +L H N+V +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 487 CIEEQEKM------LIYEYLPNKSLDVY----IFDEAKRSLLDWSKRFEIICGIARGILY 536
EK L+ +Y+P VY + AK++L + + + R + Y
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 171
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
+H I HRD+K N+LLD K+ DFG A+ + E N + + Y Y AP
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAP 225
Query: 596 E-------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
E Y ++ DV+S G +L E++LG+
Sbjct: 226 ELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 47/214 (21%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE--------FKTEIALIAQLQHRN 479
LG G G V + K++A+K +S+ +TEI ++ +L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD-----------EAKRSLLDWSKRFEIIC 528
++ I + ++ ++ E + L FD K
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL----------YFY 121
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMARIFGGDQIEENTNR 585
+ + YLH IIHRDLK NVLL + KI+DFG ++I G +
Sbjct: 122 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRT 175
Query: 586 VVGTYGYMAPE---YAMEGLFSTKSDVYSFGVLL 616
+ GT Y+APE ++ D +S GV+L
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/218 (27%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 420 ATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLS-RSSGQGIEEFKT----EIALIA 473
AT+ + ++G G +G+VYK +G +A+K + + G G E+AL+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 474 QLQ---HRNLVSILGCCIEEQEK-----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFE 525
+L+ H N+V ++ C + L++E++ ++ L Y+ D+A L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
++ RG+ +LH + I+HRDLK N+L+ + K++DFG+ARI+ T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPV 179
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
VV T Y APE ++ ++T D++S G + E+ +
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 19/235 (8%)
Query: 397 AELDDSRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLS 455
A+ DS + +L L N F LG+GGFG V ++ ++ A K+L
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 456 RS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFD 511
+ +G E ++ ++ R +VS L E ++ + L+ + L +I+
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYH 277
Query: 512 EAKRSLLDWSKRF---EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568
+ + F EI CG+ LH R RI++RDLK N+LLD + +ISD
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLE----DLH---RERIVYRDLKPENILLDDHGHIRISDL 330
Query: 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
G+A + VGT GYMAPE ++ D ++ G LL E+I G+
Sbjct: 331 GLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHR-NLVSIL 484
+LG G F V + + G+E A K + R E EIA++ + ++++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF------EIICGIARGILYLH 538
E +LI EY + F L + ++ +I I G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FS---LCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 539 QDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
Q I+H DLK N+LL + KI DFGM+R G ++GT Y+AP
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAP 202
Query: 596 EYAMEGLFSTKSDVYSFGVLL 616
E +T +D+++ G++
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 421 TNDFSSD----NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIA 473
F+ + +LG+G F V + V + G+E A ++ S + ++ + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIAR 532
L+H N+V + EE LI++ + L F++ R + I I
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 121
Query: 533 GILYLHQDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMARIFGGDQIEENTNRVV 587
+L+ HQ + ++HR+LK N+LL AA+ K++DFG+A G+Q +
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAV--KLADFGLAIEVEGEQ--QAWFGFA 174
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616
GT GY++PE + + D+++ GV+L
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG--------IEEFKTEIALIAQL-QHR 478
+G G V + V G E AVK + ++ + E + E ++ Q+ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD-----------EAKRSLLDWSKRFEII 527
++++++ L+++ + L FD E + I+
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRS----------IM 206
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVV 587
+ + +LH I+HRDLK N+LLD M ++SDFG + + +
Sbjct: 207 RSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELC 260
Query: 588 GTYGYMAPE------YAMEGLFSTKSDVYSFGVLL 616
GT GY+APE + + D+++ GV+L
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 32/211 (15%)
Query: 421 TNDFSSD----NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL 475
+ F+ +G G + + + E AVK + +S + EI ++ +
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRY 72
Query: 476 -QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICG 529
QH N++++ + + ++ E + L I F E + S ++
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--------AVLFT 124
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMARIFGGDQIEENTNR 585
I + + YLH ++HRDLK SN+L + +I DFG A+ + T
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-- 179
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616
T ++APE + D++S GVLL
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 60/236 (25%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFK-----T---EIALI 472
+ + K+G+G FG V+K + G+++A+K++ +E K T EI ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 473 AQLQHRNLVSILGCCIEEQEKM--------LIYEYL----------PNKSLDVYIFDEAK 514
L+H N+V+++ C + L++++ + E K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL---SEIK 127
Query: 515 ---RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571
+ LL G+ Y+H++ +I+HRD+KA+NVL+ K++DFG+A
Sbjct: 128 RVMQMLL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
Query: 572 RIFGGDQIEEN---TNRVVGTYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR 623
R F + + TNRVV T Y PE + E + D++ G ++ E+
Sbjct: 172 RAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS--------SGQGIEEFKTEIALIAQLQHRNL 480
LG G FG V+ V + KE+ VK + + + + EIA++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 481 VSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLL-DWSKRF--EIICGIARGILY 536
+ +L E Q L+ E + LD++ F + L + +++ + Y
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
L IIHRD+K N+++ K+ DFG A ++ GT Y APE
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPE 199
Query: 597 YAMEGLFSTKS------DVYSFGVLLLEIILGR 623
+ +++S GV L ++
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 8e-24
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE---IALIAQ 474
NDFS +G GGFG VY + ++ A+K L + QG E ++L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 475 LQHRNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---E 525
+V + +K+ I + + L ++ F EA RF E
Sbjct: 249 GDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-------MRFYAAE 300
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
II G+ ++H +++RDLK +N+LLD + +ISD G+A F + +
Sbjct: 301 IILGLE----HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 586 VVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
VGT+GYMAPE +G+ S D +S G +L +++ G
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 54/221 (24%), Positives = 111/221 (50%), Gaps = 34/221 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKG--VLQNGKEIAVKRLSRSSGQGIEEFK-----T---EIAL 471
+ ++GEG +G V+K + G+ +A+KR+ ++ + + E+A+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 472 IAQLQ---HRNLVSILGCCIEEQEK-----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKR 523
+ L+ H N+V + C + L++E++ ++ L Y+ D+ +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN- 582
+++ + RG+ +LH R++HRDLK N+L+ ++ K++DFG+ARI+ +
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMAL 176
Query: 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
T+ VV T Y APE ++ ++T D++S G + E+ +
Sbjct: 177 TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
+ F LG GGFG V+ ++ ++ A K+L++ +G + E ++A++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 478 RNLVSILGCCIEEQEKM-LIYEY---------LPNKSLDVYIFDEAKRSLLDWSKRF--- 524
R +VS L E + + L+ + N D F E R+ F
Sbjct: 245 RFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRA------IFYTA 296
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
+I+ G+ +LHQ II+RDLK NVLLD N +ISD G+A + T
Sbjct: 297 QIVSGLE----HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG--QTKTK 347
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
GT G+MAPE + + D ++ GV L E+I R
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 43/227 (18%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKT----EIALIAQL 475
+ F + G+G FG+V G G +A+K++ + F+ + +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVL 76
Query: 476 QHRNLVSILGCCIEEQEK-------MLIYEYLPNKSLDVY----IFDEAKRSLLDWSKRF 524
H N+V + E+ ++ EY+P ++ + + + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENT 583
+ + R I LH S + + HRD+K NVL++ A K+ DFG A+ E N
Sbjct: 134 -FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNV 189
Query: 584 NRVVGTYGYMAPE-------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ Y Y APE Y +T D++S G + E++LG
Sbjct: 190 AYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 40/206 (19%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGC 486
LG G G V + + G++ A+K L S + + E+ Q ++V IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89
Query: 487 CIEEQEKMLIYEYLPNKSLDVYI----------FDE-AKRSLLDWSKRF--EIICGIARG 533
+YE + + + I F +R +++R EI+ I
Sbjct: 90 ---------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 534 ILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGGDQIEENTNRVVGTY 590
I +LH I HRD+K N+L + K++DFG A+ + ++ T
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTP 193
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLL 616
Y+APE + D++S GV++
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 425 SSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVS 482
D LGEG F K V ++ + AVK +S+ + EI + + H N+V
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 483 ILGCCIEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRFEIICGIARGILYL 537
+ ++ L+ E L L I F E + S I+ + + ++
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSHM 122
Query: 538 HQDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
H + ++HRDLK N+L + + KI DFG AR+ D T T Y
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEI--KIIDFGFARLKPPDNQPLKT--PCFTLHY 175
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLL 616
APE + + D++S GV+L
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVIL 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILG 485
KLG G + V++ + + N +++ VK L + + K EI ++ L+ N++++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLAD 98
Query: 486 CCIEEQEKM--LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+ + L++E++ N ++L D+ RF + I + + Y H S
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKALDYCH--SM- 149
Query: 544 RIIHRDLKASNVLLDAA-MNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL 602
I+HRD+K NV++D ++ D+G+A +E RV Y + PE ++
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELLVDYQ 206
Query: 603 FSTKS-DVYSFGVLLLEIILGRR 624
S D++S G +L +I +
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKE 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS------SGQGIEEFKTEIALIAQLQHR--NL 480
LG GGFGSVY G+ + + +A+K + + E+ L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 481 VSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLL-DWSKRF--EIICGIARGILY 536
+ +L E + LI E P D++ F + +L + ++ F +++ + +
Sbjct: 111 IRLLDW-FERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 164
Query: 537 LHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP 595
H ++HRD+K N+L+D K+ DFG + + GT Y P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPP 217
Query: 596 EYAMEGLFS-TKSDVYSFGVLLLEIILGR 623
E+ + + V+S G+LL +++ G
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
+LG G VY+ K A+K L ++ + +TEI ++ +L H N++ +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFD---------EAKRSLLDWSKRFEIICGIARGILYLH 538
E L+ E + L FD E + + + I + YLH
Sbjct: 118 ETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA--------DAVKQILEAVAYLH 165
Query: 539 QDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+ I+HRDLK N+L DA + KI+DFG+++I + V GT GY
Sbjct: 166 E---NGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVL---MKTVCGTPGYC 217
Query: 594 APEYAMEGLFSTKSDVYSFGVLL 616
APE + + D++S G++
Sbjct: 218 APEILRGCAYGPEVDMWSVGIIT 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG G FG V G G ++AVK L+R S + + K EI + +H +++ +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF-EIICGIARGILYLHQDSRL 543
I ++ EY+ L YI + ++ + F +I+ + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130
Query: 544 RIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF 603
++HRDLK NVLLDA MN KI+DFG++ + + + G+ Y APE L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLY 187
Query: 604 S-TKSDVYSFGVLLLEIILGR 623
+ + D++S GV+L ++ G
Sbjct: 188 AGPEVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS------SGQGIEEFKTEIALIAQL----QHR 478
LG+GGFG+V+ G L + ++A+K + R+ E+AL+ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 479 NLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLL-DWSKRF--EIICGIARGI 534
++ +L E QE L+ E P + D++ + K L S+ F +++ I
Sbjct: 99 GVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ--- 153
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNP-KISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+ H ++HRD+K N+L+D K+ DFG + + + GT Y
Sbjct: 154 -HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVYS 205
Query: 594 APEYAMEGLFS-TKSDVYSFGVLLLEIILGR 623
PE+ + + V+S G+LL +++ G
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 43/208 (20%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGC 486
LG G G V + + ++ A+K L + + E+ L + ++V I+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122
Query: 487 CIEEQEKMLIYEYLPNKSLDVYI----------FDE-AKRSLLDWSKR--FEIICGIARG 533
+YE L + I F R +++R EI+ I
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 534 ILYLHQDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
I YLH + I HRD+K N+L +A + K++DFG A+
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNS---LTTPCY 225
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLL 616
T Y+APE + D++S GV++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 42/206 (20%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG G FG V G G ++AVK L+R S + + + EI + +H +++ +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 486 CCIEEQEKM-LIYEYLPNKSLDVYIF-------DEAKRSLLDWSKRF-EIICGIARGILY 536
I + ++ EY+ L YI E++R F +I+ G+ Y
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR-------LFQQILSGVD----Y 131
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
H R ++HRDLK NVLLDA MN KI+DFG++ + + + G+ Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE 185
Query: 597 ------YAMEGLFSTKSDVYSFGVLL 616
YA + D++S GV+L
Sbjct: 186 VISGRLYA-----GPEVDIWSSGVIL 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 43/182 (23%)
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+A+G+ +L + + IHRDL A N+LL KI DFG+AR I ++ + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 590 YG-----YMAPEYAMEGLFSTKSDVYSFGVLLLEII-LGR------RNNTFHLEQGSGSW 637
+MAPE + +++ +SDV+SFGVLL EI LG + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------- 303
Query: 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
KEGT M A D PE+ + L C + + RP S +V L
Sbjct: 304 ----EFCRRLKEGTRMRAPD------YTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHL 350
Query: 698 GS 699
G+
Sbjct: 351 GN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 33/155 (21%), Positives = 59/155 (38%), Gaps = 19/155 (12%)
Query: 427 DNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSSGQG-IEEFKTEIALIAQL-QHR 478
LG G FG V + + +AVK L + +E+ ++ + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 479 NLVSILGCCIEEQEK-MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
N+V++LG C + M+I E+ +L Y+ SKR E + +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572
+ I DLK + ++ + S F +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 53/218 (24%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LGEG FG V + +++A+K +SR + EI+ + L+H +++ +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYI---------FD---EAKRSLLDWSKRF--EIICGIA 531
Y+ + + D+ + FD E KR D +RF +IIC I
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
Y H R +I+HRDLK N+LLD +N KI+DFG++ I + + G+
Sbjct: 123 ----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPN 172
Query: 592 YMAPE------YAMEGLFSTKSDVYSFGVLLLEIILGR 623
Y APE YA + DV+S G++L +++GR
Sbjct: 173 YAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGR 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 36/202 (17%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHRNLVSILGCC 487
+G G FG + +AVK + R G I+E + EI L+H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFD---EAKRSLLDWSKRF--EIICGIARGILYLHQDSR 542
+ +I EY L ++ A R D ++ F +++ G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 543 LRIIHRDLKASNVLLDA--AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
++I HRDLK N LLD A KI DFG ++ ++T VGT Y+APE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPE---- 187
Query: 601 GLFSTK------SDVYSFGVLL 616
+ + +DV+S GV L
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTL 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
+ F +G+G FG V + K++ A+K +++ + E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 478 RNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF----------EI 526
LV+ L +++E M ++ + L L R L + F E+
Sbjct: 75 PFLVN-LWYSFQDEEDMFMVVDLLLGGDL---------RYHLQQNVHFKEETVKLFICEL 124
Query: 527 ICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV 586
+ + YL RIIHRD+K N+LLD + I+DF +A + + +
Sbjct: 125 VMALD----YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTM 174
Query: 587 VGTYGYMAPE--YAMEGLFSTKS-DVYSFGVLLLEIILGRR 624
GT YMAPE + +G + + D +S GV E++ GRR
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 38/227 (16%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---------EIA 470
+ + LG GG G V+ V K +A+K++ EI
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 471 LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE----------AKRSLLDW 520
+I +L H N+V + ++ + VYI E + LL+
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 521 SKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIFGGDQI 579
R + + RG+ Y+H + ++HRDLK +N+ ++ + KI DFG+ARI
Sbjct: 121 HARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 580 EEN--TNRVVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
+ + +V T Y +P + TK+ D+++ G + E++ G+
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 52/245 (21%), Positives = 99/245 (40%), Gaps = 69/245 (28%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---EIALIAQLQHRNLVSIL 484
LG G FG V + +++GK A+K++ +++ + E+ ++ L H N++ ++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 485 GCCIEEQEKM--------------------------------------LIYEYLPNKSLD 506
++ +I EY+P
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DT 123
Query: 507 VY----IFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562
++ F + RS+ I + R + ++H L I HRD+K N+L+++ N
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDN 179
Query: 563 P-KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY---AMEGLFSTKSDVYSFGVLLLE 618
K+ DFG A+ E + + + Y APE A E ++ D++S G + E
Sbjct: 180 TLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVFGE 234
Query: 619 IILGR 623
+ILG+
Sbjct: 235 LILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQH 477
+ + +G G G V + +A+K+LSR + E+ L+ + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSL----DVYIFDE---------AKRSLLDWSKRF 524
+N++ +L + P KSL DVYI E + L +
Sbjct: 84 KNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 131
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
++ + GI +LH IIHRDLK SN+++ + KI DFG+AR G + T
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTP 185
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
VV T Y APE + + D++S G ++ E+I G
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 25/217 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
+DF +G G F V ++ ++ A+K +++ + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 478 RNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRF---EIICGIARG 533
R + L +++ + L+ EY L + +R + + RF EI+ I
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMAID-- 176
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
+H+ L +HRD+K N+LLD + +++DFG D + VGT Y+
Sbjct: 177 --SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYL 230
Query: 594 APEYAMEGLFSTKSDVY-------SFGVLLLEIILGR 623
+PE + Y + GV E+ G+
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 40/224 (17%)
Query: 424 FSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEE--FKT---------EIALI 472
++ + G +G+V GV G +A+KR+ + G EI L+
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 473 AQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE------------AKRSLLDW 520
H N++ + + + +Y+ E + +
Sbjct: 84 NHFHHPNILGLRD---------IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ 134
Query: 521 SKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
++ + I G+ LH+ ++HRDL N+LL + I DF +AR D
Sbjct: 135 HIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD--A 188
Query: 581 ENTNRVVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
T+ V Y APE M+ TK D++S G ++ E+ +
Sbjct: 189 NKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 7e-19
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQH 477
+ + +G G G V + +A+K+LSR + E+ L+ + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSL----DVYIFDE---------AKRSLLDWSKRF 524
+N++S+L + P K+L DVY+ E + L +
Sbjct: 121 KNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 168
Query: 525 EIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN 584
++ + GI +LH IIHRDLK SN+++ + KI DFG+AR G + T
Sbjct: 169 -LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTP 222
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
VV T Y APE + + D++S G ++ E++ +
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 48/216 (22%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQH 477
+ S +G G +GSV + ++G+++A+K+LSR I + E+ L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE---------AKRSLLDWSKRFEIIC 528
N++ +L + D Y+ + ++ ++
Sbjct: 83 ENVIGLL--------DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-LVY 133
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
+ +G+ Y+H ++HRDLK N+ ++ KI DFG+AR + V
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-----VV 185
Query: 589 TYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
T Y APE + + ++ D++S G ++ E++ G+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
DF +G G FG V L+N ++ A+K L++ F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 478 RNLVSILGCCIEEQEKM-LIYEYLP--------NKSLDVYIFDEAKRSLLDWSKRF---E 525
+ + + L ++ + L+ +Y +K D E + + RF E
Sbjct: 134 KWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED--RLPE------EMA-RFYLAE 183
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
++ I +HQ L +HRD+K N+L+D + +++DFG D ++
Sbjct: 184 MVIAID----SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSV 235
Query: 586 VVGTYGYMAPE-----YAMEGLFSTKSDVYSFGVLLLEIILGR 623
VGT Y++PE +G + + D +S GV + E++ G
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 50/217 (23%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQH 477
+ +G G +G+V V + G ++A+K+L R + + E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE----------AKRSLLDWSKRFEII 527
N++ +L + + + D Y+ L + +F ++
Sbjct: 84 ENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-LV 134
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVV 587
+ +G+ Y+H IIHRDLK N+ ++ KI DFG+AR + V
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----V 186
Query: 588 GTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
T Y APE + + T++ D++S G ++ E+I G+
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 15/180 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSILG 485
+G G +G V + + +A+K++ R I+ + EIA++ +L H ++V +L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 486 CCIEEQEKM-----LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
I + + ++ E D L + + ++ + G+ Y+H
Sbjct: 120 IVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH-- 173
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
S I+HRDLK +N L++ + K+ DFG+AR + + + M
Sbjct: 174 SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---------EIA 470
+++ + +GEG +G V N +A+K++S F+ EI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 471 LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE----------AKRSLLDW 520
++ + +H N++ I +I + DVYI + + L +
Sbjct: 78 ILLRFRHENIIGIND---------IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND 128
Query: 521 SKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
+ + I RG+ Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D
Sbjct: 129 HICY-FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 581 EN--TNRVVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
T V T Y APE + TKS D++S G +L E++ R
Sbjct: 185 TGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 20/200 (10%), Positives = 54/200 (27%), Gaps = 41/200 (20%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSG---QGIEEFKTEIALIAQLQHRNLVSIL 484
G ++ + +++A+ + ++E + ++++ + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
+++ E++ SL + + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS 604
+ S V +S G V+ M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 605 TKSDVYSFGVLLLEIILGRR 624
+ D+ G L +++ R
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 430 LGEGGFGSVY---KGVLQNGKEI-AVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLV 481
LG+GG+G V+ K N +I A+K L ++ + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EIICGIAR 532
L + K+ LI EYL L IF E + F EI +
Sbjct: 85 D-LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME-DTA------CFYLAEISMALG- 135
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTY 590
+LHQ II+RDLK N++L+ + K++DFG+ + I G T+ GT
Sbjct: 136 ---HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185
Query: 591 GYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
YMAPE M + D +S G L+ +++ G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
N+F LG+G FG V + A+K L + + + TE ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 478 RNLVSILGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIIC 528
L + L + +++ + EY L ++ F E R+ RF EI+
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE-DRA------RFYGAEIVS 259
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRV 586
+ YLH S +++RDLK N++LD + KI+DFG+ + I G
Sbjct: 260 ALD----YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTF 309
Query: 587 VGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
GT Y+APE + + D + GV++ E++ GR
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 430 LGEGGFGSVY---KGVLQNGKEI-AVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSI 483
LG+G FG V+ K + +++ A+K L +++ + K E ++ ++ H +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK- 90
Query: 484 LGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EIICGIARGI 534
L + + K+ LI ++L L +F E + +F E+ +
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDV------KFYLAELALALD--- 140
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGY 592
+LH L II+RDLK N+LLD + K++DFG+++ I + GT Y
Sbjct: 141 -HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYSFCGTVEY 192
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
MAPE + +D +SFGVL+ E++ G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 56/255 (21%), Positives = 106/255 (41%), Gaps = 37/255 (14%)
Query: 390 LYVRVDAAELDDSRRNSEYL-----PVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQ 444
L +D L ++ +L + + ++ D+ +G G FG V +
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK 91
Query: 445 NGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM-LIYEY 499
+ +++ A+K LS+ F E ++A +V L ++ + ++ EY
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ-LFYAFQDDRYLYMVMEY 150
Query: 500 LPN----KSLDVYIFDEAKRSLLDWSKRF---EIICGIARGILYLHQDSRLRIIHRDLKA 552
+P + Y E W+ RF E++ + +H + IHRD+K
Sbjct: 151 MPGGDLVNLMSNYDVPE------KWA-RFYTAEVVLALD----AIHS---MGFIHRDVKP 196
Query: 553 SNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE----YAMEGLFSTKSD 608
N+LLD + + K++DFG + + VGT Y++PE +G + + D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 609 VYSFGVLLLEIILGR 623
+S GV L E+++G
Sbjct: 256 WWSVGVFLYEMLVGD 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 39/221 (17%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQH 477
+ + + +G G +GSV + G +AVK+LSR I +T E+ L+ ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSL----DVYIFDE----------AKRSLLDWSKR 523
N++ +L + P +SL DVY+ + L D +
Sbjct: 88 ENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
F +I I RG+ Y+H IIHRDLK SN+ ++ KI DFG+AR +
Sbjct: 136 F-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-- 189
Query: 584 NRVVGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
V T Y APE + + ++ D++S G ++ E++ GR
Sbjct: 190 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILG 485
LG+G FG V + A+K L + + + TE ++ +H L + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA-LK 71
Query: 486 CCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EIICGIARGILY 536
+ +++ + EY L +F E +R+ RF EI+ + Y
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-ERA------RFYGAEIVSALE----Y 120
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYMA 594
LH +++RD+K N++LD + KI+DFG+ + I G GT Y+A
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----MKTFCGTPEYLA 173
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
PE + + D + GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT---------EIA 470
++DF + LGEG +G V G+ +A+K+ IE F EI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 471 LIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDE----------AKRSLLDW 520
++ +H N+++I + +VYI E + + L D
Sbjct: 62 ILKHFKHENIITIFN---------IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD 112
Query: 521 SKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580
++ I R + LH + +IHRDLK SN+L+++ + K+ DFG+ARI +
Sbjct: 113 HIQY-FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 581 ENTNRV--------VGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
+ V T Y APE + +++ DV+S G +L E+ L R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 33/215 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRSS----GQGIEEFKTEIALIAQLQ 476
+ F LG G FG V + A+K L + Q IE E ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIIC 528
LV + + ++ EY+ + ++ F E RF +I+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-------ARFYAAQIVL 152
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG 588
YLH L +I+RDLK N+L+D +++DFG A+ +++ T + G
Sbjct: 153 TFE----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 200
Query: 589 TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
T +APE + ++ D ++ GVL+ E+ G
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 422 NDFSSDNKLGEGGFGSVY----KGVLQNGKEIAVKRLSRSS----GQGIEEFKTEIALIA 473
DF LG G FG V+ + NG+ A+K L + Q +E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLS 61
Query: 474 QLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---E 525
+ H ++ + G + Q+ +I +Y+ L + F + +F E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VA------KFYAAE 114
Query: 526 IICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR 585
+ + YLH II+RDLK N+LLD + KI+DFG A+ + + T
Sbjct: 115 VCLALE----YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYT 162
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ GT Y+APE ++ D +SFG+L+ E++ G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE--IALIAQLQHRNLVSI 483
LG+G FG V + E+ AVK L + +E E + L + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQ- 85
Query: 484 LGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EIICGIARGI 534
L C + +++ + EY+ L V F E + F EI G+
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE-PHA------VFYAAEIAIGLF--- 135
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGY 592
+L II+RDLK NV+LD+ + KI+DFGM + I+ G T GT Y
Sbjct: 136 -FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDY 187
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+APE + D ++FGVLL E++ G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE--IALIAQLQHRNLVSI 483
+G G + V L+ I A+K + + + I+ +TE + H LV
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVG- 74
Query: 484 LGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIARGI 534
L C + + ++ + EY+ L ++ E + + RF EI +
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-EHA------RFYSAEISLALN--- 124
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGY 592
YLH+ II+RDLK NVLLD+ + K++D+GM + + GD T+ GT Y
Sbjct: 125 -YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNY 176
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+APE + D ++ GVL+ E++ GR
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQHRNLVSILG 485
+G G +G VY K +A+K+++R I+ + EI ++ +L+ ++ +
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 486 CCIEEQEKMLIYEYLPNKSLDVYIFDE-----------AKRSLLDWSKRFEIICGIARGI 534
LI K ++YI E L + + I+ + G
Sbjct: 93 ---------LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT-ILYNLLLGE 142
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV-------- 586
++H IIHRDLK +N LL+ + K+ DFG+AR ++ N +
Sbjct: 143 NFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 587 ------------VGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGRRNNT 627
V T Y APE + TKS D++S G + E++ +++
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 430 LGEGGFGSVY---KGVLQNGKEI-AVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLV 481
LG G +G V+ K + ++ A+K L +++ + E +TE ++ ++ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIAR 532
L + + K+ LI +Y+ L ++ F E + EI+ +
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE-HEV------QIYVGEIVLALE- 173
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
+LH+ L II+RD+K N+LLD+ + ++DFG+++ F D+ E GT Y
Sbjct: 174 ---HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 226
Query: 593 MAPEYAMEGLFS-TKS-DVYSFGVLLLEIILGR 623
MAP+ G K+ D +S GVL+ E++ G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 67/211 (31%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE--IALIAQLQHRNLVSI 483
LG+G FG V ++ ++ AVK L + +E TE I L H L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI-LSLARNHPFLTQ- 88
Query: 484 LGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EIICGIARGI 534
L CC + +++ + E++ L FDE R+ RF EII +
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE-ARA------RFYAAEIISALM--- 138
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA--RIFGGDQIEENTNRVVGTYGY 592
+LH II+RDLK NVLLD + K++DFGM I G T GT Y
Sbjct: 139 -FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDY 190
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+APE E L+ D ++ GVLL E++ G
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE--IALIAQLQHRNLVSI 483
+G G + V L+ I A++ + + + I+ +TE + H LV
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVG- 117
Query: 484 LGCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIARGI 534
L C + + ++ + EY+ L ++ E + + RF EI +
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-EHA------RFYSAEISLALN--- 167
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGY 592
YLH+ II+RDLK NVLLD+ + K++D+GM + + GD T+ GT Y
Sbjct: 168 -YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNY 219
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+APE + D ++ GVL+ E++ GR
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 4e-15
Identities = 63/218 (28%), Positives = 92/218 (42%), Gaps = 35/218 (16%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE-IALIAQLQ 476
DF+ LG+G FG V + E+ AVK L + +E E L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 477 HRNLVSILGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EII 527
L L C + +++ + EY+ L V F E F EI
Sbjct: 401 PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-------AVFYAAEIA 452
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNR 585
G+ +L II+RDLK NV+LD+ + KI+DFGM + I+ G T
Sbjct: 453 IGLF----FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKT 501
Query: 586 VVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
GT Y+APE + D ++FGVLL E++ G+
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE--IALIAQLQHRNLVSI 483
+G+G FG V + + AVK L + + + +E + L+ ++H LV
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG- 103
Query: 484 LGCCIEEQEKM-LIYEYLPNKSL-----DVYIFDEAKRSLLDWSKRF---EIICGIARGI 534
L + +K+ + +Y+ L F E R+ RF EI +
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRA------RFYAAEIASALG--- 153
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGY 592
YLH L I++RDLK N+LLD+ + ++DFG+ + I T+ GT Y
Sbjct: 154 -YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST----TSTFCGTPEY 205
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+APE + + D + G +L E++ G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 35/210 (16%)
Query: 430 LGEGGFGSVYKGVLQNGKEI-AVKRLSRS---SGQGIEEFKTE-IALIAQLQHRNLVSIL 484
LG+G FG V+ + + A+K L + +E E L +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH-M 83
Query: 485 GCCIEEQEKM-LIYEYLPNKSLDVYI-----FDEAKRSLLDWSKRF---EIICGIARGIL 535
C + +E + + EYL L +I FD R+ F EII G+
Sbjct: 84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL-SRA------TFYAAEIILGLQ---- 132
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR--IFGGDQIEENTNRVVGTYGYM 593
+LH I++RDLK N+LLD + KI+DFGM + + G + TN GT Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNTFCGTPDYI 185
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
APE + ++ D +SFGVLL E+++G+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 40/163 (24%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGC 486
LG G G V + + ++ A+K L + + E+ L + Q ++V I+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78
Query: 487 CIEEQEKMLIYEYLPNKSLDVYI----------FDE-AKRSLLDWSKRF--EIICGIARG 533
+YE L + I F R +++R EI+ I
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 534 ILYLHQDSRLRIIHRDLKASNVLL-----DAAMNPKISDFGMA 571
I YLH + I HRD+K N+L +A + K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAIL--KLTDFGFA 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 50/230 (21%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKT--EIALIAQLQ-HRNLVSI 483
KLG+G +G V+K + + G+ +AVK++ + + +T EI ++ +L H N+V++
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 484 LGCCIEEQEKMLIYEYLPNKSLDVYIFDE----------AKRSLLDWSKRFEIICGIARG 533
L + DVY+ + L K++ ++ + +
Sbjct: 75 LNV------------LRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-VVYQLIKV 121
Query: 534 ILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRV------- 586
I YLH S ++HRD+K SN+LL+A + K++DFG++R F + N +
Sbjct: 122 IKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 587 ------------VGTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
V T Y APE + TK D++S G +L EI+ G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILG-- 485
KLG G F +V+ + N +A+K + R E + EI L+ ++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 486 --CCIEEQEKMLIYEYLPNKSLD--VYIFDEAKRSLLDWSKRF-------EIICGIARGI 534
+ K+L + + V +F+ +LL K++ + I++ +
Sbjct: 85 ANHIL----KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 535 L----YLHQDSRLRIIHRDLKASNVLLDAAMNP------KISDFGMARIFGGDQIEENTN 584
L Y+H R IIH D+K NVL++ +P KI+D G A +E+
Sbjct: 141 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WYDEHYT 193
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ T Y +PE + + +D++S L+ E+I G
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 1e-13
Identities = 37/264 (14%), Positives = 73/264 (27%), Gaps = 59/264 (22%)
Query: 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS--------GQGIEEFKTEIAL 471
T K+GEG FG V++ + + +A+K ++ + EE EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 472 IAQLQ---------HRNLVSILGCCI-------------------EEQEKMLIYEYLPNK 503
+L + + + + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 504 SLDVYIFDEAKRSLLDWSKRFE-------IICGIARGILYLHQDSRLRIIHRDLKASNVL 556
V F+ L + I+ + + LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 557 LDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAP--EYAMEGLFSTKSDVYSFGV 614
L K+ + + + G +Y + L V+
Sbjct: 195 LKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 615 LLLEIILGRRNNTFHLEQGSGSWN 638
+ ++ G + F + + N
Sbjct: 244 MDEDLFTGDGDYQFDIYRLMKKEN 267
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-12
Identities = 22/128 (17%), Positives = 46/128 (35%), Gaps = 18/128 (14%)
Query: 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPI 63
V++++S + G + + + L N V G W +N
Sbjct: 1 VNSLSSPNSLFTGHSLEVGPS-YRLIMQGDCNFVLYDSGKPV---------WASNTGGLG 50
Query: 64 NDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTL 123
+ L + GNLV+ ++ +W ++ E + + L N+V+ G +
Sbjct: 51 SGCRLTLHNN--GNLVIYDQSNR-VIWQTK-TNGKEDHYVLVLQQDRNVVI----YGPVV 102
Query: 124 WQSFDHPS 131
W + P+
Sbjct: 103 WATGSGPA 110
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-11
Identities = 21/122 (17%), Positives = 44/122 (36%), Gaps = 17/122 (13%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
D + S + G + + + N V VW + + +
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCNLVLYDNN---------RAVWASGTNGKAS 50
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
VL + + GNLV+ + + +W +N + + N L N+V+ +N+ +W
Sbjct: 51 GC--VLKMQNDGNLVI--YSGSRAIWASNTNRQN-GNYYLILQRDRNVVI-YDNSNNAIW 104
Query: 125 QS 126
+
Sbjct: 105 AT 106
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-RNLVSILGC 486
K+G G FG +Y G + G+E+A+K + E + +Q + +I C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--ICGIARGIL----YLHQD 540
E +++ E L SL+ +F+ R +F + + +A ++ Y+H
Sbjct: 74 GAEGDYNVMVMELL-GPSLE-DLFNFCSR-------KFSLKTVLLLADQMISRIEYIHSK 124
Query: 541 SRLRIIHRDLKASNVLLDAAMNPK---ISDFGMARIF----GGDQIEENTNR-VVGTYGY 592
+ IHRD+K N L+ I DFG+A+ + I N+ + GT Y
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 593 MAPEYAMEGLF-STKSDVYSFGVLLLEIILGR 623
A G+ S + D+ S G +L+ LG
Sbjct: 182 -ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 19/125 (15%), Positives = 39/125 (31%), Gaps = 18/125 (14%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ +T+ + + G + + N V W +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLVLYDHSTSV---------WASNTGILGK 50
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
+ S GN V+ +W ++ S N + L + GN+V+ G +W
Sbjct: 51 KGC-KAVLQSDGNFVVYDAEGR-SLWASH-SVRGNGNYVLVLQEDGNVVI----YGSDIW 103
Query: 125 QSFDH 129
+ +
Sbjct: 104 STGTY 108
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV-SILGC 486
K+G G FG +Y G +Q +E+A+K + + + E + LQ + ++
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--ICGIARGIL----YLHQD 540
+E +L+ + L SL+ +F+ R + + + +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLE-DLFNFCSR-------KLSLKTVLMLADQMINRVEFVHSK 122
Query: 541 SRLRIIHRDLKASNVLLDAAMNPK---ISDFGMARIF----GGDQIEENTNR-VVGTYGY 592
S +HRD+K N L+ I DFG+A+ + I N+ + GT Y
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 593 MAPEYAMEGLF-STKSDVYSFGVLLLEIILGR 623
A G+ S + D+ S G +L+ + G
Sbjct: 180 -ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 42/190 (22%), Positives = 71/190 (37%), Gaps = 32/190 (16%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-RN 479
+F K+G G FG + G L + +A+K S E QL
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--ICGIARGIL-- 535
+ + + ++ E L SL+ +FD R F + + IA ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDR-------TFSLKTVLMIAIQLISR 117
Query: 536 --YLHQDSRLRIIHRDLKASNVLLDAAMNPK-----ISDFGMARIF----GGDQIEENTN 584
Y+H + +I+RD+K N L+ N I DF +A+ + I +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 585 R-VVGTYGYM 593
+ + GT YM
Sbjct: 175 KSLTGTARYM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 44/214 (20%), Positives = 85/214 (39%), Gaps = 34/214 (15%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-RNLVSILGC 486
++GEG FG +++G L N +++A+K R S E L + ++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--ICGIARGIL----YLHQD 540
E +L+ + L SL+ + D R +F + + A+ +L +H+
Sbjct: 75 GQEGLHNVLVIDLLG-PSLE-DLLDLCGR-------KFSVKTVAMAAKQMLARVQSIHEK 125
Query: 541 SRLRIIHRDLKASNVLLDAAMNPK-----ISDFGMARIF----GGDQIEENTNR-VVGTY 590
S +++RD+K N L+ + + DFGM + + I + + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 591 GYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGR 623
Y G S + D+ + G + + + G
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 9e-10
Identities = 25/122 (20%), Positives = 40/122 (32%), Gaps = 19/122 (15%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ + S Q + + + + L + N V+ G +W +N D
Sbjct: 3 NVLLSGQTLHADHSLQA--GAYTLTIQNKCNLVKYQNG---------RQIWASNTDR--R 49
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
+ LT+ S GNLV+ N VW + L G V+ G LW
Sbjct: 50 GSGCRLTLLSDGNLVIYDHNNN-DVWGSA-CWGDNGKYALVLQKDGRFVI----YGPVLW 103
Query: 125 QS 126
Sbjct: 104 SL 105
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 59/232 (25%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR------NLVS 482
+G+G FG V K + + +A+K + R+ + + EI ++ L+ + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 483 ILGC-------CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--ICGIARG 533
+L C+ +E L S+++Y + + + F + + A
Sbjct: 164 MLENFTFRNHICM-------TFELL---SMNLYELIKKNKF-----QGFSLPLVRKFAHS 208
Query: 534 IL----YLHQDSRLRIIHRDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVV 587
IL LH + RIIH DLK N+LL K+ DFG + ++ V
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---------EHQRV 256
Query: 588 GTY----GYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR-----RNNTFHL 630
TY Y APE + + D++S G +L E++ G + L
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 38/197 (19%), Positives = 73/197 (37%), Gaps = 45/197 (22%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIA---VKRLSRSSGQGIEEFKTEIAL-----IAQLQHRN 479
K+G GGFG +Y ++ A VK + +G E K + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 480 LVSILG----------CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI--I 527
+ LG + ++ E L L + + F+ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ---------KISGQNGTFKKSTV 153
Query: 528 CGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKI--SDFGMARIF----GGD 577
+ +L Y+H++ +H D+KA+N+LL ++ +D+G++ +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 578 QIEENTNRV-VGTYGYM 593
Q +EN + GT +
Sbjct: 211 QYQENPRKGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 36/199 (18%), Positives = 70/199 (35%), Gaps = 46/199 (23%)
Query: 429 KLGEGGFGSVYKGVLQNGKEI------AVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV- 481
+G+GGFG +Y + + + + VK +G E K Q + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 482 ----------SILGCCIEEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI- 526
G + ++ +I + L I++ + RF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAK-------RFSRK 152
Query: 527 -ICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKI--SDFGMARIF----G 575
+ ++ IL Y+H+ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 576 GDQIEENTNRV-VGTYGYM 593
+ R GT +
Sbjct: 210 HKAYAADPKRCHDGTIEFT 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 51/231 (22%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVK---RLSRSSGQGIEEFKTEIALIAQLQHR----- 478
+ +G+G FG V K + +A+K Q + E+ L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 479 -NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF-------EIICGI 530
+V + + L++E L S ++Y D + +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML---SYNLY----------DLLRNTNFRGVSLNLTRKF 162
Query: 531 ARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTN 584
A+ + +L L IIH DLK N+LL KI DFG + G +
Sbjct: 163 AQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-----QRIY 216
Query: 585 RVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR-----RNNTFHL 630
+ + + Y +PE + + D++S G +L+E+ G N +
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 27/200 (13%), Positives = 69/200 (34%), Gaps = 46/200 (23%)
Query: 428 NKLGEGGFGSVYKGV---------LQNGKEIAVKRLSRSSGQGIEEFKT--------EIA 470
+ G +Y+ ++ ++K L G+ E ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 471 LIAQLQHRNLV---SILGCCIEEQE-KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEI 526
+L L+ + +G + + + + L+ L +SL D + +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPK------HVLSE 158
Query: 527 --ICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNPKI--SDFGMARIF--GG 576
+ +A +L +LH++ +H ++ A N+ +D ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 577 DQIE--ENTNRV-VGTYGYM 593
+ E + G ++
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 50/266 (18%), Positives = 91/266 (34%), Gaps = 88/266 (33%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ--------HRN 479
KLG G F +V+ +Q K +A+K + +S+ E EI L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 480 LVSILGCCIEEQEKMLIYEYL-PNKSLDVYIFDEAKRSLLDWSKRF-----------EII 527
+V +L ++ N + +F+ LL W + +II
Sbjct: 103 VVQLLDD----------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLL------------------------------ 557
+ +G+ YLH ++ RIIH D+K N+LL
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 558 -------------------DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
+ KI+D G A ++ + T Y + E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV-----HKHFTEDIQTRQYRSLEVL 265
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
+ ++T +D++S + E+ G
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDY 291
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (132), Expect = 2e-08
Identities = 28/208 (13%), Positives = 47/208 (22%), Gaps = 14/208 (6%)
Query: 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSV--RRYVGIWYNQIPVQTVVWVAN 58
+ + + Q + G ++S F L GN V +W +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPL 70
Query: 59 RDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNN 118
R+ L L ++ N + +S L +
Sbjct: 71 RNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLV 125
Query: 119 TGQTLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQL 178
LW + L S L + + G + DG
Sbjct: 126 DSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVY-------GAGASKLVFQGDGNLVA 178
Query: 179 FLYKGEAKWWRVGSWTGKNFLNATYIDN 206
+ G A W G N
Sbjct: 179 YGPNGAATWNAGTQGKGAVRAVFQGDGN 206
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 23/122 (18%), Positives = 41/122 (33%), Gaps = 19/122 (15%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ + S + + G+ + + + N V V W N
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCNLVLYDVDKPI---------WATNTGG--L 48
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
D L++ S GNLV+ P+W +N + N + L N+V+ G W
Sbjct: 49 DRRCHLSMQSDGNLVVYSPRNN-PIWASN-TGGENGNYVCVLQKDRNVVI----YGTARW 102
Query: 125 QS 126
+
Sbjct: 103 AT 104
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 61/260 (23%), Positives = 92/260 (35%), Gaps = 91/260 (35%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEF----KTEIALIAQLQHR----- 478
K+G+G FG V + N K AVK + R+ I+++ K E ++ ++Q+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNN 96
Query: 479 NLVSILGC-------CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF------- 524
N+V G C+ IF+ SL + R
Sbjct: 97 NIVKYHGKFMYYDHMCL--------------------IFEPLGPSLYEIITRNNYNGFHI 136
Query: 525 EIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNP----------------- 563
E I IL YL ++ + H DLK N+LLD
Sbjct: 137 EDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 564 --------KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVL 615
K+ DFG A F D ++ T Y APE + + SD++SFG +
Sbjct: 194 YRTKSTGIKLIDFGCA-TFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248
Query: 616 LLEIILGR-----RNNTFHL 630
L E+ G + HL
Sbjct: 249 LAELYTGSLLFRTHEHMEHL 268
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-06
Identities = 19/108 (17%), Positives = 32/108 (29%), Gaps = 17/108 (15%)
Query: 19 IVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNL 78
I+ +++ + N V +W N N VL G L
Sbjct: 25 ILFGTHVYRFIMQTDCNLVLYDNN---------NPIWATNTGGLGNGCRAVLQPD--GVL 73
Query: 79 VLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126
V+ VW + + + L N+V+ G LW +
Sbjct: 74 VVITNENV-TVWQSP-VAGKAGHYVLVLQPDRNVVI----YGDALWAT 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 5e-06
Identities = 75/609 (12%), Positives = 157/609 (25%), Gaps = 212/609 (34%)
Query: 205 DNEDEVSMAYSVTDPSMLTRIVVNESGNEQ---RLTW---SNQEN--------------R 244
D +D S + ++ RL W S QE +
Sbjct: 37 DVQDMPKSILSKEE----IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK 92
Query: 245 WI--EYFAPPKEPC---DFYGHCGSNSNCNPYRVYDEYECTCLPGFEPK----------S 289
++ ++P Y + N +V+ +Y + +P
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQ-RDRLYNDNQVFAKYN---VSRLQPYLKLRQALLELR 148
Query: 290 PSEWFLREGLRGC--------VRKPQMSTCRRGDG-F-IRVAGVKVPDMSVARVDMSLGL 339
P++ L +G+ G V C+ F + + P+ ++M L
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE---TVLEMLQKL 205
Query: 340 EACKHMCLRNCSCLAYTSAYAESESNGRIGCLTYHGDMMDTRTYINAGQDLYVRVDAAEL 399
+ S ++S + + ++ ++ Y N L V L
Sbjct: 206 --LYQIDPNWTSRSDHSSNIKLRIHSIQ----AELRRLLKSKPYENC---LLV------L 250
Query: 400 DDSRRNSEYLPVFDLS-NIAAATNDFSSDNKLGEGGFGSVYKGVLQNG--KEIAVKRLSR 456
+ + N++ F+LS I T + L + + L +
Sbjct: 251 LNVQ-NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 457 SSGQGIEEFKTE--------IALIA--------------QLQHRNLVSILGCCIE----- 489
++ E +++IA + L +I+ +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 490 -------------------------------EQEKMLIYEYLPNKSLDVYIFDEAKRSLL 518
+ + M++ L SL ++
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL-------VEK--- 419
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
K I + I+ +LK + + A++ I
Sbjct: 420 -QPKESTI---------SIPS------IYLELKV-KLENEYALHRSI------------- 449
Query: 579 IEENTNRVVGTYGYMAPE-YAMEGLFSTKSDVYSFGVL---LLEIILGRRNNTFH----- 629
++ Y P+ + + L D Y + + L I R F
Sbjct: 450 VDH----------YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 630 ---LEQ----GSGSWNLVGHVWDLW-----------KEGTAMEAVDKSLGE--SCCAPEI 669
LEQ S +WN G + + E + ++ + +
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL 559
Query: 670 LRCIHLGLL 678
+ + LL
Sbjct: 560 ICSKYTDLL 568
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 47/256 (18%), Positives = 89/256 (34%), Gaps = 87/256 (33%)
Query: 429 KLGEGGFGSVYKGV--LQNGKEIAVKRLSRSSGQGIEEF----KTEIALIAQLQHR---- 478
LGEG FG V + + + ++A+K + R+ + ++ + EI ++ +++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKEKDKEN 80
Query: 479 --NLVSILGC-------CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF----- 524
V + CI F+ ++ ++ K
Sbjct: 81 KFLCVLMSDWFNFHGHMCI--------------------AFELLGKNTFEFLKENNFQPY 120
Query: 525 --EIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNP--------------- 563
+ +A + +LH ++ H DLK N+L +
Sbjct: 121 PLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 564 ----KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
+++DFG A F + +V T Y PE +E ++ DV+S G +L E
Sbjct: 178 NTSIRVADFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 620 ILGR-----RNNTFHL 630
G N HL
Sbjct: 233 YRGFTLFQTHENREHL 248
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 56/256 (21%), Positives = 94/256 (36%), Gaps = 87/256 (33%)
Query: 429 KLGEGGFGSVYKGV--LQNGKEIAVKRLSRSSGQGIEEF----KTEIALIAQLQHR---- 478
LGEG FG V + + G+ +AVK + ++ ++ + ++EI ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 479 --NLVSILGC-------CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRF----- 524
V +L CI +F+ S D+ K
Sbjct: 76 TFRCVQMLEWFEHHGHICI--------------------VFELLGLSTYDFIKENGFLPF 115
Query: 525 --EIICGIARGIL----YLHQDSRLRIIHRDLKASNVLLDAAMNP--------------- 563
+ I +A I +LH ++ H DLK N+L +
Sbjct: 116 RLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 564 ----KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619
K+ DFG A + +E+ + +V T Y APE + +S DV+S G +L+E
Sbjct: 173 NPDIKVVDFGSA-TY----DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
Query: 620 ILGR-----RNNTFHL 630
LG ++ HL
Sbjct: 228 YLGFTVFPTHDSKEHL 243
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 18/110 (16%), Positives = 34/110 (30%), Gaps = 16/110 (14%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ + S Q + + + L N V W +N N
Sbjct: 7 NLLFSGQVLYGDGRLTAKN--HQLVMQGDCNLVLYG----------GKYGWQSNTHG--N 52
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVL 114
L ++ G L++ + +W + S S + + L D G V+
Sbjct: 53 GEHCFLRLNHKGELIIKDDDFK-TIWSSR-SSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-05
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 22/125 (17%)
Query: 2 ISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDN 61
+ + + S Q + + + F L N V Y G W +
Sbjct: 1 LGTNYLLSGQTLDTEGHLKNGD--FDLVMQDDCNLVL-YNGNWQSNTANN---------- 47
Query: 62 PINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQ 121
LT++ G LV+ + + VW + + S + N A + G LV+ G
Sbjct: 48 ---GRDCKLTLTDYGELVIKNGDGS-TVWKSG-AQSVKGNYAAVVHPDGRLVV----FGP 98
Query: 122 TLWQS 126
++++
Sbjct: 99 SVFKI 103
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 29/182 (15%), Positives = 51/182 (28%), Gaps = 38/182 (20%)
Query: 43 IWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNT 102
I + + + + +S T+ S NLVL + V VW +N + + +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVL--FDSDVRVWASNTAGA--TGC 58
Query: 103 IAQLLDTGNLVLARNNTGQTLWQS-------------------------------FDHPS 131
A L G LV+ W S + S
Sbjct: 59 RAVLQSDGLLVILTAQN-TIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGS 117
Query: 132 ATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVG 191
+ L G + + + + Y ME D L L+ + + W
Sbjct: 118 VVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTN 175
Query: 192 SW 193
+
Sbjct: 176 TA 177
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 743 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.84 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.82 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.81 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.79 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.74 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.67 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.64 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.58 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.58 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.53 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.52 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.5 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.22 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.2 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.0 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.95 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.74 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.76 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.75 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.38 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=437.70 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=214.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|.+.++||+|+||+||+|++. ++..||||+++....+..++|.+|+++|++++|||||++++++.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 478899999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc----------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 496 IYEYLPNKSLDVYIFDEA----------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
|||||++|+|.++|.... ....+++..++.|+.||++||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2346899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||+|+...............||+.|||||++.+..|+.|+|||||||++|||+| |+.||..... ..+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---------~~~~ 240 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------NEVI 240 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHH
Confidence 99999987655444333445679999999999999999999999999999999998 8999864321 1122
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.....+...... . ..+ ..+.+|+.+||+.||++|||+++|++.|+++.
T Consensus 241 ~~i~~~~~~~~p-----~-~~~---~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 241 ECITQGRVLQRP-----R-TCP---QEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHTCCCCCC-----T-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCC-----c-cch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 233333222111 1 122 34667888999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=441.68 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=206.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+....+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 478899999988777788899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 496 IYEYLPNKSLDVYIFDEA------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
|||||++|+|.+++.... ....+++..++.|+.||++||.|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999986532 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||..... . .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~----~ 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----T----E 268 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----H----H
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----H----H
Confidence 9999999997755544444455789999999999999999999999999999999999 8999864321 1 1
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
+...+..+...+. .. ..+ ..+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 269 ~~~~i~~g~~~~~-----p~-~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 AIDCITQGRELER-----PR-ACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHTCCCCC-----CT-TCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC-----cc-ccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2222222221111 11 122 346678889999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=435.02 Aligned_cols=260 Identities=29% Similarity=0.412 Sum_probs=212.2
Q ss_pred CCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++++.++||+|+||+||+|++. +++.||||+++.. .....++|++|+.++++++|||||++++++.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999862 4788999999754 33456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 496 IYEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
|||||++|+|.++|.... ....+++..++.|+.||++||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999986432 2346899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccch
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 641 (743)
+||+|||+++.+............+||+.|||||++.++.|+.++|||||||+||||+| |+.||..... .
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---------~ 254 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------Q 254 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---------H
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---------H
Confidence 99999999987755444444455789999999999999999999999999999999998 8889864321 1
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.+......+..... +......+.+|+.+||+.||++||||+||++.|+....+
T Consensus 255 ~~~~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 255 DVVEMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred HHHHHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 12233333322221 111223466788899999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=427.88 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=202.8
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
+++.+.++||+|+||+||+|+++. .||||+++.. ..+..++|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567888999999999999998753 5999998643 45567889999999999999999999998865 568999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
|++|+|.++|... ...+++..++.|+.||++||+|||+++ ||||||||+||||++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999998543 346899999999999999999999998 99999999999999999999999999987654443
Q ss_pred ccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 EENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.......+||+.|||||++.+ ++|+.++|||||||+||||++|+.||..... ...+......+.....+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFMVGRGYASPDL 259 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHTTCCCCCS
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCCCc
Confidence 334455789999999999964 4689999999999999999999999864321 11112222222111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKH 708 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~ 708 (743)
. .+ .......+.+|+.+||+.||++||||.||++.|+.+. .+.|+.
T Consensus 260 ~-~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~-~~lpk~ 305 (307)
T 3omv_A 260 S-KL----YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ-HSLPKI 305 (307)
T ss_dssp T-TS----CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH-TTCCC-
T ss_pred c-cc----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh-ccCCCC
Confidence 0 01 1111234667888999999999999999999998653 334443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=424.91 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=206.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999986 69999999997665556677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998843 45899999999999999999999998 99999999999999999999999999987754322
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .. .......+.. +.+
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~----~~~~i~~~~~-----~~~ 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LK----AMKMIRDNLP-----PRL 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HH----HHHHHHHSSC-----CCC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HH----HHHHHHcCCC-----CCC
Confidence 23457999999999999999999999999999999999999999864321 11 1122221111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SC--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 0111234667888999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=427.62 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=200.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|+++++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 6999999999754 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
||++|+|.+++... +...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998543 3345788999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ...... ...+....
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~-i~~~~~~~---- 244 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLK-IISGSFPP---- 244 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH-HHHTCCCC----
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHH-HHcCCCCC----
Confidence 123347899999999999999999999999999999999999999974321 111111 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 245 -~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 -VSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 234667888999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=417.99 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=207.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6999999999753 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999853 456899999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .. .......+..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~----~~~~i~~~~~----- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GL----IFAKIIKLEY----- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHTCC-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHcCCC-----
Confidence 444445568999999999999999999999999999999999999999964321 11 1111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 694 (743)
.+.... . ..+.+|+.+||+.||++|||++|++
T Consensus 252 -~~p~~~-s---~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -DFPEKF-F---PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCTTC-C---HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCccc-C---HHHHHHHHHHccCCHhHCcChHHHc
Confidence 111111 2 2456788899999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=419.64 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=200.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+.|.+.++||+|+||.||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 46778889999999999999975 699999999975432 246999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeeccccccCCCcc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGGDQI 579 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~~~~~~ 579 (743)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999853 346999999999999999999999998 99999999999999887 699999999998754332
Q ss_pred c---cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 E---ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+. ............
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~---~~i~~~~~~~~~- 277 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-----GPLC---LKIASEPPPIRE- 277 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-----SCCH---HHHHHSCCGGGG-
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHH---HHHHcCCCCchh-
Confidence 1 123346899999999999999999999999999999999999999974322 1111 111111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
+.... . ..+.+++.+||+.||.+|||+.||++.|..
T Consensus 278 ---~~~~~-s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 ---IPPSC-A---PLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp ---SCTTS-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCccC-C---HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11111 2 345677889999999999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=426.75 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=207.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56899999999999999999986 69999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 9999999884 335899999999999999999999998 99999999999999999999999999987754322
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .. +......+.. +.+
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~----~~~~i~~~~~-----~~~ 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LK----AMKMIRDNLP-----PRL 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HH----HHHHHHHSCC-----CCC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HH----HHHHHHcCCC-----CCC
Confidence 23457999999999999999999999999999999999999999864321 11 1122221111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ......+.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~~--~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNL--HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCT--TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 111234567888999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=404.83 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=196.4
Q ss_pred CcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec----CCeeEEEE
Q 041312 425 SSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE----EQEKMLIY 497 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 497 (743)
++.++||+|+||+||+|++. ++..||+|++... .....+.|.+|+.++++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999976 6899999998643 34456789999999999999999999999865 34579999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~~~~ 576 (743)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999853 456899999999999999999999875 35999999999999984 78999999999986533
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||..... ...+......+.....+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--------~~~~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--------AAQIYRRVTSGVKPASF 251 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--------HHHHHHHHTTTCCCGGG
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--------HHHHHHHHHcCCCCCCC
Confidence 2 2345789999999998865 699999999999999999999999863221 11122222222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+. ...+ .+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~-----~~~~---~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 DK-----VAIP---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG-----CCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-----cCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1122 3567888999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=423.37 Aligned_cols=263 Identities=28% Similarity=0.394 Sum_probs=213.0
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCC-ccEEeeeeeEecC
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQH-RNLVSILGCCIEE 490 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~ 490 (743)
...++|++.++||+|+||+||+|++.. ++.||||++.... ....++|.+|+.+|.++.| ||||+++++|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 344689999999999999999999642 4689999997653 3456789999999999965 8999999999764
Q ss_pred -CeeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEE
Q 041312 491 -QEKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVL 556 (743)
Q Consensus 491 -~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 556 (743)
...+||||||++|+|.++|..... ...+++..++.++.||++||.|||+++ ||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 568999999999999999965332 345899999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCC
Q 041312 557 LDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSG 635 (743)
Q Consensus 557 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~ 635 (743)
+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---- 293 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 293 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999997765544344455789999999999999999999999999999999998 8999864321
Q ss_pred ccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 636 SWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
...+...+.++...... +..+ ..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 294 ----~~~~~~~i~~g~~~~~p------~~~~---~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 294 ----DEEFCRRLKEGTRMRAP------DYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ----SHHHHHHHHHTCCCCCC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHcCCCCCCC------ccCC---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11223333333222111 1122 34667888999999999999999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=413.26 Aligned_cols=270 Identities=22% Similarity=0.293 Sum_probs=200.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----eeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ----EKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 497 (743)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567789999999999999997 5899999999654322 223345677778899999999999998754 579999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccC-----CCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS-----RLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
|||++|+|.+++.. ..+++..+++++.|+++||+|||++. ..+||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999843 45899999999999999999999871 2249999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCcceeccC------CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc-----
Q 041312 573 IFGGDQIE--ENTNRVVGTYGYMAPEYAMEG------LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL----- 639 (743)
Q Consensus 573 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~----- 639 (743)
........ ......+||+.|||||++.+. .++.|+|||||||+||||++|+.|+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543322 223346899999999999764 46789999999999999999988775433211000000
Q ss_pred -chhhHhHhccCCcchhcccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 640 -VGHVWDLWKEGTAMEAVDKSLGES-CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 640 -~~~~~~~~~~~~~~~~ld~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.......... +.+++.+... ...+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 237 ~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0111111111 1112222111 12345567889999999999999999999999998653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=399.64 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=188.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999975 7999999999754 234467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 6788888743 456999999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..... . ........+...
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~----~~~~~i~~~~~~-- 230 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----P----VLFKNISNGVYT-- 230 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHTCCC--
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----H----HHHHHHHcCCCC--
Confidence 32 2334789999999999998876 5799999999999999999999864221 1 111222222110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+... .. ..+.+++.+||+.||++|||++|+++
T Consensus 231 ----~p~~-~s---~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ----LPKF-LS---PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCTT-SC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCC-CC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 12 24567888999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=403.35 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=190.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------- 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------- 491 (743)
.++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 346889999999999999999975 79999999997543 345578999999999999999999999987654
Q ss_pred -----eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 492 -----EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 492 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
..|+||||+++|+|.+++.........++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999976544455667778899999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCccc----------cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCc
Q 041312 567 DFGMARIFGGDQIE----------ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636 (743)
Q Consensus 567 DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~ 636 (743)
|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----- 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence 99999877543221 11234689999999999999999999999999999999996 5542110
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ............. .......+.+++.+||+.||++|||+.||++
T Consensus 233 --~~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 --RVR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --HHH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 1111111111111 1112233567888999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=406.84 Aligned_cols=242 Identities=22% Similarity=0.267 Sum_probs=190.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|++.++||+|+||+||+|+.. +++.||||++++.. .....++.+|+.+|++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 47889999997542 2234468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999853 456899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .. .......+..
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~----~~~~i~~~~~--- 243 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KE----TMTMILKAKL--- 243 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHCCC---
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HH----HHHHHHcCCC---
Confidence 3322 23347899999999999999999999999999999999999999874321 11 1111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
.+.. ... ..+.+|+.+||+.||++|||+
T Consensus 244 ---~~p~-~~s---~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GMPQ-FLS---PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCT-TSC---HHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCC-cCC---HHHHHHHHHHcccCHHHCCCC
Confidence 0111 112 245678889999999999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=382.90 Aligned_cols=284 Identities=37% Similarity=0.615 Sum_probs=242.7
Q ss_pred hhhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 414 LSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 414 ~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
..++..++++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445677899999999999999999999888999999999877777788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc-ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK-RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999854322 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+. .......+.......+..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhccccccH
Confidence 765433333334467899999999999999999999999999999999999998765432 233344445555556666
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
...+++.+...........+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 77777777777778888899999999999999999999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=390.63 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=199.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec------CCe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE------EQE 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------~~~ 492 (743)
++|+++++||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 7999999999754 33456778899999999999999999998763 367
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.|||||||+ |+|.+++. ....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67888874 3457999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 573 IFGGDQI--EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 573 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
.+..... .......+||+.|||||++.+. .++.++||||+|||+|||++|+.||..... ......+......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-----~~~l~~I~~~~g~ 281 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-----VHQLQLIMMVLGT 281 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----HHHHHHHHHHHCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhcCC
Confidence 7643321 2233457999999999998875 569999999999999999999999974321 1111111111100
Q ss_pred C-----------Ccchhccccc-CCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 G-----------TAMEAVDKSL-GESCCAP-----EILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~-----------~~~~~ld~~l-~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. .....+...- ....... ....+.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000000000 0000111 1234667888999999999999999887
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=383.12 Aligned_cols=294 Identities=39% Similarity=0.643 Sum_probs=248.8
Q ss_pred CCCCcChhhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh-hcHHHHHHHHHHHHhcCCccEEeeeee
Q 041312 408 YLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG-QGIEEFKTEIALIAQLQHRNLVSILGC 486 (743)
Q Consensus 408 ~~~~~~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ev~~l~~l~h~niv~l~~~ 486 (743)
.+..++..++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456888899999999999999999999999999988899999999975432 233478999999999999999999999
Q ss_pred EecCCeeEEEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 487 CIEEQEKMLIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 487 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
+......++||||+++++|.+++.... ....+++..+..++.||+.||.|||++...+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999986543 3345899999999999999999999981112999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............+...
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999876543322 2334569999999999999999999999999999999999999997543333344555566666
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..........++..+...........+.+++.+||+.+|.+|||+.+|+++|++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 666777778888888888889999999999999999999999999999999987533
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=371.57 Aligned_cols=228 Identities=20% Similarity=0.249 Sum_probs=180.5
Q ss_pred CccccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccC----CccEEEeecC
Q 041312 1 SISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDT----SGVLTISSLG 76 (743)
Q Consensus 1 ~~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~----~~~l~~~~~G 76 (743)
+++.|||++||+|++|++|+|++|.|+||||.++ ++|| |+ |.+ |||+|||++|+.++ +++|+|+.||
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 4678999999999999999999999999999443 6787 77 777 99999999999885 7899999999
Q ss_pred cEEE--EeCCCCceEEeeeccCCC----CCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCCce
Q 041312 77 NLVL--CGRNQTVPVWHANVSDSS----ESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGLNR 150 (743)
Q Consensus 77 ~L~l--~~~~~~~~~ws~~~~~~~----~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~~~ 150 (743)
+|+| .|..+ .+||+|+++... .++++|+|+|+|||||++ +.+|||| |||||||||||||.+.++|..
T Consensus 82 ~Lvl~~~~~~~-~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~- 154 (276)
T 3m7h_A 82 QYGAFLDDYSR-RRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE- 154 (276)
T ss_dssp SSSEEEEEGGG-TEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE-
T ss_pred cEEEEEeCCCC-CEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc-
Confidence 9999 65444 469999986521 345789999999999995 6899999 999999999999999998865
Q ss_pred eEEeccCCCCCCCCCceEEeeeCCCceEEEEcC-CeeEEEecccCCccce-------eeeeeecCCcEEEEEEeeCCCeE
Q 041312 151 FLTSWKSWDNPATGDYTFRMELDGFPQLFLYKG-EAKWWRVGSWTGKNFL-------NATYIDNEDEVSMAYSVTDPSML 222 (743)
Q Consensus 151 ~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~-~~~~~~~~~w~g~~~~-------~~~~~~~~~~~~~~~~~~~~s~~ 222 (743)
| ++.+||++|.|+++|+++|. +++++. ..+||++|.|++.... ++.+.++++ ..+-++.......
T Consensus 155 -L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~-~~vWsS~t~~~~~ 227 (276)
T 3m7h_A 155 -L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGN-AVLWHSHTGGHAS 227 (276)
T ss_dssp -E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTS-CEEEECSCTTCTT
T ss_pred -c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCC-cEEEEecCCCCCC
Confidence 6 67899999999999999995 555654 6899999999765321 122222222 1222222223335
Q ss_pred EEEEEccCCcEEEEEeecCCCceEEEecCCCC
Q 041312 223 TRIVVNESGNEQRLTWSNQENRWIEYFAPPKE 254 (743)
Q Consensus 223 ~r~~l~~~G~l~~~~w~~~~~~W~~~~~~p~~ 254 (743)
.|++|+.||++++|.| ...|..++.+|+.
T Consensus 228 ~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 228 AVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp CEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred EEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 7999999999999999 3568777766654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=383.89 Aligned_cols=200 Identities=27% Similarity=0.388 Sum_probs=171.8
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
...++|++.++||+|+||+||+|+.+ +++.||||++.+.. ...++.+|+++|+++ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999864 46889999986543 345788999999998 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeecccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMAR 572 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFGla~ 572 (743)
++||||+++++|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999998872 3889999999999999999999999 9999999999999876 799999999998
Q ss_pred ccCCCccc--------------------------cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCC
Q 041312 573 IFGGDQIE--------------------------ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRN 625 (743)
Q Consensus 573 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p 625 (743)
........ ......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432211 112335899999999999876 489999999999999999999999
Q ss_pred CCCC
Q 041312 626 NTFH 629 (743)
Q Consensus 626 ~~~~ 629 (743)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=402.86 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=207.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999986 6999999999877777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC--CCeEEeeeccccccCCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA--MNPKISDFGMARIFGGD 577 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~vkl~DFGla~~~~~~ 577 (743)
|++|+|.+++.. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999988853 2346889999999999999999999998 9999999999999854 89999999999987544
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .. ........... +.
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~----~~~~i~~~~~~--~~ 376 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DE----TLRNVKSCDWN--MD 376 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HH----HHHHHHTTCCC--CC
T ss_pred Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HH----HHHHHHhCCCC--CC
Confidence 32 3346899999999999999999999999999999999999999874322 11 11111111110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....... ...+.+|+.+||+.||.+|||+.|+++
T Consensus 377 ~~~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111 234567888999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=398.29 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=197.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHH---HHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEF---KTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~---~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+ +.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999986 69999999996431 1222333 4456777788999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
||||||++||+|..+|.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999853 456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
+.... ....+||+.|||||++.+ ..|+.++||||||||+|||++|+.||...... ... ...........
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~----~i~~~i~~~~~ 411 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKH----EIDRMTLTMAV 411 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHH----HHHHHHHHCCC
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH----HHHHhhcCCCC
Confidence 75432 334799999999999975 57999999999999999999999999743221 000 11111111110
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
.+... .. ..+.+|+..||+.||.+|++ ++||++
T Consensus 412 ------~~p~~-~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ------ELPDS-FS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCTT-SC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCcc-CC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01111 12 34567888999999999998 677764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=356.77 Aligned_cols=284 Identities=37% Similarity=0.571 Sum_probs=231.4
Q ss_pred CCCCcChhhHHHHcCCCCcC------cccccCCceeEEEEEEcCCcEEEEEEcccC----ChhcHHHHHHHHHHHHhcCC
Q 041312 408 YLPVFDLSNIAAATNDFSSD------NKLGEGGFGSVYKGVLQNGKEIAVKRLSRS----SGQGIEEFKTEIALIAQLQH 477 (743)
Q Consensus 408 ~~~~~~~~~l~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l~h 477 (743)
..+.|.+.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678889999999998877 8999999999999986 5889999998643 23456789999999999999
Q ss_pred ccEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 478 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999876555567999999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSW 637 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~ 637 (743)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----- 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----- 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-----
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-----
Confidence 9999999999999987654433333444679999999998765 5789999999999999999999998754321
Q ss_pred ccchhhHhHhc--cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 638 NLVGHVWDLWK--EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 638 ~~~~~~~~~~~--~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
........... ...+...+++.+ ..........+.+++.+||+.+|.+|||+.+|++.|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111222111 122233444433 23456667788899999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=356.41 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=211.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|.+.++||+|+||.||++++. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999986 68999999997777778889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999998542 346899999999999999999999998 999999999999999999999999999876443221
Q ss_pred c------------ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 581 E------------NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 581 ~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
. ......||+.|+|||++.+..++.++||||||+++|||++|..|+............. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---~~---- 237 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---VR---- 237 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---HH----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---hh----
Confidence 1 1114679999999999999999999999999999999999999876543321111100 01
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..++....... + ..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 238 -----~~~~~~~~~~~-~---~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 238 -----GFLDRYCPPNC-P---PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -----HHHHHTCCTTC-C---TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccccccCCCCC-C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111 1 236678889999999999999999999987743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=363.32 Aligned_cols=267 Identities=27% Similarity=0.432 Sum_probs=202.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..+|++.++||+|+||+||+|+. .++.||||++.... ....+++.+|+.++++++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788999999999999999987 58899999987543 4456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999866544456899999999999999999999874 249999999999999999999999999998654332
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ............
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~---~~~~~~~~~~~~---- 259 (309)
T 3p86_A 194 L--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QV---VAAVGFKCKRLE---- 259 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HH---HHHHHHSCCCCC----
T ss_pred c--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---HHHHHhcCCCCC----
Confidence 1 223467999999999999999999999999999999999999998643221 00 111100111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCC
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKH 708 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~ 708 (743)
+ +......+.+++.+||+.+|.+|||+.+|++.|+.+.....|+.
T Consensus 260 -~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 260 -I----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred -C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 1 11112346678889999999999999999999998866544443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.10 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=211.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE 490 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 490 (743)
.++|.+.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367889999999999999999863 3567999999755 344567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999865321 235789999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGS 636 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~ 636 (743)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~----- 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 9999999999999987765443333444677889999999999999999999999999999999 8888764321
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.........+.... .+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 312 ----~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 ----EELFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ----GGHHHHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122222221111 11112234677888999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=355.22 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=206.1
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.++||+|+||+||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999996 47899999999766656677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999998843 35889999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~------ 235 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTPE------ 235 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSCC------
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC------
Confidence 233468999999999999999999999999999999999999998643210 1111111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+ .........+.+++.+||+.||++|||++|+++
T Consensus 236 ~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp C--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 001111234667888999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.84 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=206.9
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----eeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ----EKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 497 (743)
++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.+.. ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 57888999999999999999876 7899999986543 33445667999999999999999999998754 369999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc----------CCCceEeccCCCCcEEecCCCCeEEee
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD----------SRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
||+++|+|.+++.. ..+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999843 3489999999999999999999988 7 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccc----
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN---- 638 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~---- 638 (743)
||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987765544333445689999999999987 35667899999999999999999998754332110000
Q ss_pred ---cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 639 ---LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 639 ---~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.................+.... ........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000111111111111111111 11234556888999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=351.66 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=210.8
Q ss_pred CcChhhHHHHcCC----------CCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc
Q 041312 411 VFDLSNIAAATND----------FSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN 479 (743)
Q Consensus 411 ~~~~~~l~~~~~~----------y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n 479 (743)
.++.+++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666665543 566679999999999999987 79999999998776677788999999999999999
Q ss_pred EEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC
Q 041312 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 480 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 559 (743)
|+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999874 235899999999999999999999998 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc
Q 041312 560 AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~ 639 (743)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~-- 247 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----V-- 247 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H--
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H--
Confidence 99999999999987654322 12346899999999999999999999999999999999999999864321 0
Q ss_pred chhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 640 VGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 640 ~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
............ .+.. .......+.+++.+||+.||++|||+.+|++
T Consensus 248 --~~~~~~~~~~~~-----~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 --QAMKRLRDSPPP-----KLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --HHHHHHHHSSCC-----CCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHhcCCCC-----CcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111 1100 0111234667888999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.37 Aligned_cols=272 Identities=24% Similarity=0.422 Sum_probs=208.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|++.++||+|+||.||+|++. +++ +||+|.+... .....+++.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999964 344 3688887543 3456678999999999999999999999998754 789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999988543 346889999999999999999999998 9999999999999999999999999998876
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... . .......+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~----~~~~~~~~~~-- 237 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----E----ISSILEKGER-- 237 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----G----HHHHHHTTCC--
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----H----HHHHHHcCCC--
Confidence 5544433444567889999999999999999999999999999999 99998643211 1 1111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC---------------CCCCCCCCcccccccC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN---------------APSSPKHPAFIAKGLS 717 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~---------------~~~~p~~~~~~~~~~~ 717 (743)
..........+.+++.+||+.+|++||++.+|++.|+.+. ..+.|..+.|+.....
T Consensus 238 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 308 (327)
T 3poz_A 238 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMD 308 (327)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHHBCCTTGGGCCCCCTTTCHHHHHHHC
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhhhhhcCCCccCCCCCCchHHHHhccc
Confidence 1111222345778888999999999999999999986542 3456667777766533
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=358.84 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=206.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.++||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999975 3456999999765 445567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 9999999999998532 346899999999999999999999998 99999999999999999999999999987754
Q ss_pred Cccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ........+..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---------~~~~~~~~~~~-- 272 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---------DVISSVEEGYR-- 272 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---------HHHHHHHTTCC--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---------HHHHHHHcCCC--
Confidence 3221 12223456788999999999999999999999999999999 99998643211 11111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
..........+.+++..||+.||++|||+.+|+++|+.+...
T Consensus 273 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 -------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 111112223567788899999999999999999999887543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.62 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=209.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.++||+|+||.||+++.+++..||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35788999999999999999999988899999996543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998543 345899999999999999999999998 999999999999999999999999999876544332
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~~~~~~~~~~~~--~--- 225 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---------EVVLKVSQGHRL--Y--- 225 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---------HHHHHHHTTCCC--C---
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---------HHHHHHHcCCCC--C---
Confidence 2 223456778999999999899999999999999999999 99897643211 011111111100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
...... ..+.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus 226 -~~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 -RPHLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCTTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCCcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011112 3466788899999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=351.92 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=204.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
..++|++.+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999998 47999999998654 345567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998854 345889999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCCC-ccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFS-TKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.. .....+||+.|+|||++.+..+. .++|||||||++|||++|+.||..... . ........+...
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~-~~~~~i~~~~~~-- 232 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------K-ELRERVLRGKYR-- 232 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------H-HHHHHHHHCCCC--
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------H-HHHHHHHhCCCC--
Confidence 32 23446899999999999988765 799999999999999999999864321 0 111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+ +......+.+++.+||+.||.+|||++|+++.
T Consensus 233 ----~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ----I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 11112346678889999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=347.54 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=208.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||+++..+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5688899999999999999999889999999996543 335679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++.. ....+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999854 2346899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ........+...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---------~~~~~~~~~~~~------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---------EVVEDISTGFRL------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------HHHHHHHTTCCC-------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---------HHHHHHhcCccC-------
Confidence 2223566788999999999999999999999999999999 88887643210 111111111100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..+......+.+++..||+.+|++||++.++++.|+.+.
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 227 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 001111234667888999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.25 Aligned_cols=254 Identities=27% Similarity=0.351 Sum_probs=202.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 78999999986443 3334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999884 3345899999999999999999999998 9999999999999999999999999998764433
Q ss_pred cccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .. ....+...... ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~-----~~~~~~~~~~~--~~ 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQ-----EYSDWKEKKTY--LN 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SH-----HHHHHHTTCTT--ST
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HH-----HHHHHhccccc--CC
Confidence 3333445789999999999988775 78999999999999999999998743221 00 11111111100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
........+.+++.+||+.||++|||+.||++.
T Consensus 230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001112345678889999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=365.85 Aligned_cols=274 Identities=27% Similarity=0.393 Sum_probs=217.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE 490 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 490 (743)
.++|.+.++||+|+||.||+|+.. .+..||||++... ......++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467889999999999999999863 2357999999754 345567899999999999 999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999865431 245899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGS 636 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~ 636 (743)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999987765443334445677899999999999999999999999999999999 8888763321
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCCCCcccccc
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKG 715 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~~ 715 (743)
......+..+..... .......+.+++.+||+.+|++|||+.+|++.|+.+..........++...
T Consensus 300 ----~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~ 365 (382)
T 3tt0_A 300 ----EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH 365 (382)
T ss_dssp ----HHHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-------
T ss_pred ----HHHHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCcc
Confidence 112222222211111 111123466788899999999999999999999998876666666665543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=367.64 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=207.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|.+.++||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++.+....++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 357888899999999999999986 78999999987543 3445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998543 345889999999999999999999998 9999999999999999999999999998755433
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..|+..... .........+.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~~~-- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFVEKGGRLPC-- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHHHHHHTTCCCCC--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCCCC--
Confidence 2222223346788999999999999999999999999999998 8888764321 111222222211110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
....+ ..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 337 ----~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 337 ----PELCP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11112 3466788899999999999999999999865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=345.75 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=209.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999975 6899999998543 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. ..
T Consensus 164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~-~~- 232 (294)
T 4eqm_A 164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDSVP-NV- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSCCC-CH-
T ss_pred cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhccCC-Cc-
Confidence 3322 23346799999999999999999999999999999999999999864321 1111111111111 10
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCCCCCCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRP-NMSAVVSMLGSDNAPSSPKHP 709 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~p~~~ 709 (743)
...+... ....+.+++.+|++.||++|| +++++.+.|+.+......+..
T Consensus 233 ~~~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 233 TTDVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HHHSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred chhcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 0111111 123466788899999999998 999999999987665444443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=362.16 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=197.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 495 (743)
.++|++.++||+|+||.||+++.+ +++.||+|++.+. .....+.+..|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999976 5889999999754 233345688999999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988853 346899999999999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........................
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-- 280 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-- 280 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--
Confidence 221 2244578999999999999999999999999999999999999999743221111111111122222111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
+ +......+.+++..||+.||.+||++
T Consensus 281 ----~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 ----I----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----C----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----C----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 11112346678889999999999996
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=354.94 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=211.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
..++|.+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3467899999999999999999862 4578999999754 34556789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc---------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCC
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK---------------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLK 551 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 551 (743)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999865332 235889999999999999999999998 9999999
Q ss_pred CCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCc
Q 041312 552 ASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHL 630 (743)
Q Consensus 552 p~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~ 630 (743)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755443333444567889999999999999999999999999999999 999886432
Q ss_pred ccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.. ........+.... ........+.+++.+||+.||++||++.+|++.|+.+
T Consensus 258 ~~---------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PE---------RLFNLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG---------GHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------HHHHHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 1122222221111 1111223466788899999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=364.88 Aligned_cols=269 Identities=28% Similarity=0.401 Sum_probs=212.3
Q ss_pred cChhhHHHHcCCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEee
Q 041312 412 FDLSNIAAATNDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSI 483 (743)
Q Consensus 412 ~~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l 483 (743)
++........++|++.++||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33444445567899999999999999999984 24688999999764 344557899999999999 89999999
Q ss_pred eeeEecCCe-eEEEEEecCCCChhhhhhhccc------------------------------------------------
Q 041312 484 LGCCIEEQE-KMLIYEYLPNKSLDVYIFDEAK------------------------------------------------ 514 (743)
Q Consensus 484 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 514 (743)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999865432
Q ss_pred ---------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 515 ---------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 515 ---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..........+.....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--- 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------DEEFCRRLKEGTRMRA--- 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------SHHHHHHHHHTCCCCC---
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch--------hHHHHHHHHcCCCCCC---
Confidence 333445678999999999999999999999999999999998 9999864321 1112222222211111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.......+.+++..||+.+|++|||+.+|++.|+.+
T Consensus 318 ------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 ------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111123466788899999999999999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=363.76 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=196.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999975 5778999999754 345567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999998542 346889999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .........+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---------~~~~~~i~~~---- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------QDVIKAVDEG---- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---------HHHHHHHHTT----
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcC----
Confidence 32211 1222345778999999999999999999999999999998 9999864321 0111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
............+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 267 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 -----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 111111222345778888999999999999999999998663
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.55 Aligned_cols=267 Identities=28% Similarity=0.409 Sum_probs=204.9
Q ss_pred cCCCCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--Cee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~ 493 (743)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788999999999999999984 36889999999877777788999999999999999999999998653 568
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 335889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCccc-----CCC--ccccchhhHh
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQ-----GSG--SWNLVGHVWD 645 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~-----~~~--~~~~~~~~~~ 645 (743)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 1222345778899999999999999999999999999999999987643210 000 0000001111
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
....+. ...........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 244 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 244 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111111 11111122245677888999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.81 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=212.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
..++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999975 3478999999765 34456789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc---------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCC
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK---------------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLK 551 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 551 (743)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999865321 256899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCc
Q 041312 552 ASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHL 630 (743)
Q Consensus 552 p~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~ 630 (743)
|+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654433233344678899999999999999999999999999999999 998886432
Q ss_pred ccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
. .........+..... +......+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 282 ~---------~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 H---------EEVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp H---------HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h---------HHHHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 1 111222222222111 11112346678889999999999999999999998765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.12 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=207.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888999999999999999943 4678999999654 4555668899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc----cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC---CeEEee
Q 041312 495 LIYEYLPNKSLDVYIFDEA----KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM---NPKISD 567 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~vkl~D 567 (743)
+||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999986532 2245889999999999999999999998 99999999999999555 599999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhH
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---------~~~~~~ 298 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------QEVLEF 298 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------HHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHH
Confidence 999986533322223344678999999999999999999999999999999998 8888764321 111122
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
...+.... ........+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 299 i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 22111111 111112346678889999999999999999999976643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.28 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=203.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999976 6999999999654 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988843 346889999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...........
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~----~~~~~i~~~~~---- 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E----RLFELILMEEI---- 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCCC----
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----H----HHHHHHHcCCC----
Confidence 22 123447899999999999999999999999999999999999999864321 0 11111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 696 (743)
.+.. ... ..+.+++.+||+.||++|| ++++|++.
T Consensus 223 --~~p~-~~s---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 --RFPR-TLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCT-TSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCC-CCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0111 112 3456788899999999999 89998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=345.23 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=204.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.++||+|+||.||++...++..||+|++.... ...+++.+|++++++++|+||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45788899999999999999999988899999996543 33577999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999998542 345899999999999999999999998 999999999999999999999999999876543222
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ........+.. ..
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---------~~~~~~~~~~~-----~~ 241 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---------ETAEHIAQGLR-----LY 241 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---------HHHHHHHTTCC-----CC
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---------HHHHHHhcccC-----CC
Confidence 1223456788999999999999999999999999999998 99998643211 11111111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. .... ...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 242 ~-~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 242 R-PHLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp C-CTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-CCcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 1111 23466788899999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=352.51 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=200.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC------
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------ 491 (743)
..++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467899999999999999999986 79999999997543 345678999999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEEecCCCChhhhhhhcccccccCH
Q 041312 492 ---------------------------------------------------EKMLIYEYLPNKSLDVYIFDEAKRSLLDW 520 (743)
Q Consensus 492 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~ 520 (743)
..++||||+++++|.+++..........+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 27999999999999999977655566777
Q ss_pred HHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc----------cccccccccc
Q 041312 521 SKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE----------ENTNRVVGTY 590 (743)
Q Consensus 521 ~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~----------~~~~~~~gt~ 590 (743)
..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 788999999999999999998 999999999999999999999999999877544211 1223357999
Q ss_pred cccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHH
Q 041312 591 GYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEIL 670 (743)
Q Consensus 591 ~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~ 670 (743)
.|+|||++.+..++.++|||||||++|||++|..|+.... .............. ......
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----------~~~~~~~~~~~~~~---------~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----------RIITDVRNLKFPLL---------FTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----------HHHHHHHTTCCCHH---------HHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----------HHHHHhhccCCCcc---------cccCCh
Confidence 9999999999999999999999999999999876632100 01111111111110 112223
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 671 RCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 671 ~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 4678889999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=341.91 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=194.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC----hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||++++. ++.+|||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357889999999999999999975 8899999986542 23467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC--------CCCeEEeee
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA--------AMNPKISDF 568 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--------~~~vkl~DF 568 (743)
|||+++++|.+++. ...+++..+..++.||++||.|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998873 346889999999999999999999987556899999999999986 678999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
|++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~ 228 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYGVAM 228 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHT
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHhhhc
Confidence 9998664332 22357899999999999999999999999999999999999998643210 00111111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.... ..........+.+++.+|++.+|.+|||+.+|++.|+.+
T Consensus 229 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKLA---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCC---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1110 111111223466788899999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.92 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=203.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
..+.|.+.+.||+|+||.||+++.. +|+.||+|++.+... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999986 689999999975432 235789999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC----CeEEeee
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM----NPKISDF 568 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~vkl~DF 568 (743)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 346899999999999999999999998 99999999999998776 7999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
|++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... . ......
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~----~~~~i~ 231 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----E----TLANIT 231 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----H----HHHHHH
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----H----HHHHHH
Confidence 9998765432 233467999999999999999999999999999999999999998643210 0 111111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... .++.... .....+.+++..||+.||++|||+.|+++
T Consensus 232 ~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11100 0000000 11234667888999999999999999885
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=345.43 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=199.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHh--cCCccEEeeeeeEecC----CeeE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ--LQHRNLVSILGCCIEE----QEKM 494 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~~----~~~~ 494 (743)
.++|++.++||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 6899999998643 34556667777766 7999999999987543 4579
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhh--------ccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH--------QDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
+||||+++++|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346899999999999999999999 777 9999999999999999999999
Q ss_pred eeccccccCCCccc--cccccccccccccCcceeccC------CCCccccchhHHHHHHHHHhc----------CCCCCC
Q 041312 567 DFGMARIFGGDQIE--ENTNRVVGTYGYMAPEYAMEG------LFSTKSDVYSFGVLLLEIILG----------RRNNTF 628 (743)
Q Consensus 567 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDiwSlGvil~elltG----------~~p~~~ 628 (743)
|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999866443322 112335899999999999876 456799999999999999999 666653
Q ss_pred CcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 629 HLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...... .................+.. ..........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 236 ~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP----SFEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC----CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc----chhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322111 01111111111111111110 011234556788899999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=356.44 Aligned_cols=262 Identities=28% Similarity=0.412 Sum_probs=207.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 492 (743)
.++|.+.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 367889999999999999999962 4568999999754 334457899999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc--------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCC
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK--------------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKA 552 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp 552 (743)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999865322 134789999999999999999999998 99999999
Q ss_pred CcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcc
Q 041312 553 SNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLE 631 (743)
Q Consensus 553 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~ 631 (743)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654433333344677889999999999999999999999999999998 9999864321
Q ss_pred cCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 632 QGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
. .........+... ..+......+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 281 ~--------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 D--------ANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp S--------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred H--------HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 1112222211111 1111112346678889999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.27 Aligned_cols=269 Identities=19% Similarity=0.243 Sum_probs=211.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC--eeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ--EKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 497 (743)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999986 58999999987543 345678889999999999999999999998765 779999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe----cCCCCeEEeeeccccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMARI 573 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~vkl~DFGla~~ 573 (743)
||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555899999999999999999999998 9999999999999 7788899999999987
Q ss_pred cCCCccccccccccccccccCcceec--------cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAM--------EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...... .........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~ 238 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMYK 238 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHHH
Confidence 654332 23367999999999986 577899999999999999999999998643221 111111111
Q ss_pred HhccC---Ccchhc-----------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 646 LWKEG---TAMEAV-----------DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 646 ~~~~~---~~~~~l-----------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..... ...... +..............+.+++.+||+.||++|||++|+++..+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11110 000000 00111233455566788899999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=351.88 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=193.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC-C---cEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee-
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN-G---KEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK- 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~- 493 (743)
.++|++.+.||+|+||.||+|+... + ..||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4679999999999999999999654 3 27999998754 345578899999999999999999999999877665
Q ss_pred -----EEEEEecCCCChhhhhhhccc---ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 494 -----MLIYEYLPNKSLDVYIFDEAK---RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 494 -----~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 999999999999999865332 225899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .. ..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~----~~ 249 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AE----IY 249 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG----HH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HH----HH
Confidence 99999987654443333334567889999999999999999999999999999999 8888764321 11 11
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.....+.... ........+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 250 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 250 NYLIGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111 111122356778889999999999999999999987644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=367.97 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=208.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|.+.++||+|+||.||+|+++++..||||++.... ...+.|.+|+.++++++||||+++++++. ....++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35678889999999999999999888999999997543 45788999999999999999999999986 66789999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 265 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999985432 235788899999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....+|+.|+|||++....++.++|||||||++|||++ |+.||..... . .+...+..+...
T Consensus 341 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----~----~~~~~i~~~~~~------ 404 (454)
T 1qcf_A 341 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----P----EVIRALERGYRM------ 404 (454)
T ss_dssp T-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H----HHHHHHHHTCCC------
T ss_pred c-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----H----HHHHHHHcCCCC------
Confidence 1 222456788999999999999999999999999999999 9999863221 1 111122111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
+.+......+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus 405 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11111123466788899999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.84 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=200.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..++|++.++||+|+||+||+++..+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357899999999999999999999889999999986542 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++ +|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 67666643 2345889999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh-
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA- 655 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 655 (743)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..................
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-----DQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-----THHHHHHHHHCCCCTTTSG
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHCCCChHHhh
Confidence 22 2233578999999999876 56899999999999999999999998754321 111111111111100000
Q ss_pred --------cccc--cCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 --------VDKS--LGESCC-----APEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 --------ld~~--l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.. ...... ......+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 000000 011234678888999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.41 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=210.3
Q ss_pred cCCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 492 (743)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788999999999999999985 246789999997553 34567899999999999 99999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhccc---------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK---------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999865432 224899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGS 636 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~ 636 (743)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 9999999999999987765543333344567889999999999999999999999999999999 88887643210
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
............ ..........+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 255 ----~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 ----SKFYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ----HHHHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hHHHHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111121111111 0011111234667888999999999999999999998653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=369.10 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=209.4
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||+|+||.||+|++.. +..||||++.... ...++|.+|+.++++++||||+++++++.+....++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 467888999999999999999874 8899999996543 34678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 299 ~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 299 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred CCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999999998643 2345889999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....+++.|+|||++.+..++.++|||||||++|||++ |+.|+..... ..+...+..+...
T Consensus 375 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~------ 438 (495)
T 1opk_A 375 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYELLEKDYRM------ 438 (495)
T ss_dssp C-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------GGHHHHHHTTCCC------
T ss_pred e-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCC------
Confidence 1 223456789999999999999999999999999999999 8888764221 1122222211111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..+......+.+++.+||+.+|++|||+.+|+++|+.+..
T Consensus 439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111122346678889999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.79 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=202.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356889999999999999999975 6899999998532 1224678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEeeecc
Q 041312 495 LIYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISDFGM 570 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~DFGl 570 (743)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 2345889999999999999999999998 999999999999986654 99999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........+
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~i~~~ 247 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------RLFEGIIKG 247 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----------HHHHHHHHT
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----------HHHHHHHcC
Confidence 987754332 12346799999999999999999999999999999999999999864211 111111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ..+.... .....+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYK--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 0000000 01234667888999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.64 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=194.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--------------------------hcHHHHHHHHHHHH
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--------------------------QGIEEFKTEIALIA 473 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~Ev~~l~ 473 (743)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999975 688999999865421 12357899999999
Q ss_pred hcCCccEEeeeeeEec--CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCC
Q 041312 474 QLQHRNLVSILGCCIE--EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLK 551 (743)
Q Consensus 474 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 551 (743)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||++||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56889999999999998865 3346899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCC---CCccccchhHHHHHHHHHhcCCCCCC
Q 041312 552 ASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL---FSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 552 p~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123467999999999998765 47889999999999999999999863
Q ss_pred CcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 629 HLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... . ............ . +........+.+++.+||+.||++|||+.||++
T Consensus 243 ~~~-----~----~~~~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI-----M----CLHSKIKSQALE-F-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH-----H----HHHHHHHHCCCC-C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH-----H----HHHHHHhcccCC-C-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 0 011111111110 0 000111234667888999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.67 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=203.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|.+.++||+|+||.||+++.. +++.+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999976 6889999998644 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC--CCCeEEeeeccccccCCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA--AMNPKISDFGMARIFGGD 577 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~vkl~DFGla~~~~~~ 577 (743)
+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999998 999999999999987 789999999999877543
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ........+... .+
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~----~~~~~i~~~~~~--~~ 223 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----Q----QIIENIMNAEYT--FD 223 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----H----HHHHHHHHTCCC--CC
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----H----HHHHHHHcCCCC--CC
Confidence 22 2346789999999999998899999999999999999999999864321 0 111111111110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 224 ~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000 112346678889999999999999999983
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.38 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=199.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+++.+ +++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999986 6889999999754 344567788999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999988853 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........................
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 123446899999999999999999999999999999999999999964321110011111112222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 690 (743)
.+. ......+.+++.+||+.||.+||++
T Consensus 237 --~~p----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 --RIP----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCC----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCC----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011 1112346678889999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=352.80 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=195.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCC--ccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQH--RNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||++...+++.||||++... ..+..+.+.+|+.++++++| +||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568999999999999999999988999999998644 44556789999999999976 9999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899998853 346889999999999999999999998 99999999999997 57899999999987755
Q ss_pred CccccccccccccccccCcceecc-----------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAME-----------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~ 232 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHA 232 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHHH
Confidence 443333445689999999999865 6789999999999999999999999863221 1111111
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.++.......+......+.+++..||+.||.+|||+.++++.
T Consensus 233 ---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111111111112346678889999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=350.49 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=212.8
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEe
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~ 488 (743)
+.....++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999864 3788999999754 3345567899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCChhhhhhhccc-------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC
Q 041312 489 EEQEKMLIYEYLPNKSLDVYIFDEAK-------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM 561 (743)
Q Consensus 489 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 561 (743)
+....++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999865322 145688999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccc
Q 041312 562 NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLV 640 (743)
Q Consensus 562 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 640 (743)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------- 246 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------- 246 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---------
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---------
Confidence 999999999987654433333344567889999999999999999999999999999999 7888753321
Q ss_pred hhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 641 GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 641 ~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.........+..... .......+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 247 ~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 EQVLRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111122222211111 11112346678889999999999999999999988755
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.07 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=210.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc--------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE 490 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~ 490 (743)
.++|.+.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367899999999999999999863 4678999999755 345567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999865331 234889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGS 636 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~ 636 (743)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 9999999999999987765443333444567889999999999999999999999999999999 9888764321
Q ss_pred cccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 637 WNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.........+.... + .......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 266 ----~~~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 ----EELFKLLKEGHRMD-----K----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ----HHHHHHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCCCC-----C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11112222111111 1 11112346678889999999999999999999987754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.37 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=203.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.+.|.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356889999999999999999986 689999999875432 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC----CeEEeeec
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM----NPKISDFG 569 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~vkl~DFG 569 (743)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 346889999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... . .......
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~----~~~~~~~ 231 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----E----TLANVSA 231 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----H----HHHHHHH
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----H----HHHHHHh
Confidence 998765332 123467999999999999999999999999999999999999998643210 0 1111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
... . ....... .....+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~-~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 VNY-E-FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TCC-C-CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCC-C-cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0 0000000 112346678889999999999999999873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.21 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=203.6
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
...++|++.++||+|+||.||++... +|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34568999999999999999999975 78999999987543 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec---CCCCeEEeeecccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD---AAMNPKISDFGMAR 572 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~vkl~DFGla~ 572 (743)
||||+++|+|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999888853 346899999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . ........+..
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~----~~~~~i~~~~~ 230 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----H----RLYQQIKAGAY 230 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H----HHHHHHHHTCC
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----H----HHHHHHHhCCC
Confidence 7654332 12346899999999999999999999999999999999999999864321 1 11122211111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. .. .+........+.+++..||+.||.+|||+.|+++.
T Consensus 231 ~-~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 D-FP-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C-CC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-CC-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 00 00001112346678889999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.88 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=202.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||+|+++.+..||||++.... ...++|.+|+.++++++||||+++++++.+ ...++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 4677889999999999999999888889999997543 345789999999999999999999999876 67899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999998542 2345889999999999999999999998 9999999999999999999999999998765432211
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.|+..... ..+......+...
T Consensus 338 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---------~~~~~~i~~~~~~------- 400 (452)
T 1fmk_A 338 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVERGYRM------- 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCCC-------
T ss_pred -ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCC-------
Confidence 223456789999999999999999999999999999999 8888763321 0112222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
+.+......+.+++.+||+.+|++|||+++|++.|+.+...
T Consensus 401 --~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11111223566788899999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=351.60 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=201.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcE----EEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKE----IAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|++.++||+|+||.||+|++. +++. ||+|.+... .......+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999975 4443 788887543 2344456788999999999999999999886 567899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999988543 346888999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............||+.|+|||++.+..++.++|||||||++|||++ |+.||..... . ........+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~----~~~~~~~~~~~~~ 237 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----A----EVPDLLEKGERLA 237 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----T----HHHHHHHTTCBCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----H----HHHHHHHcCCCCC
Confidence 5544444455678889999999999999999999999999999999 9999874321 1 1112222211111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.. ......+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 238 ~~---------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 QP---------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CC---------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CC---------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 10 001113566888999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=337.80 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=198.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|++.++||+|+||+||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999986 6899999998754 33445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|++++.+..+. . ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864444333 2 2356899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcceeccCC-CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc----
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM---- 653 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 653 (743)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+..... .......+..........
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~----~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTT
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCChhhhhh
Confidence 2 223467899999999998765 89999999999999999999988643321 111111111111100000
Q ss_pred --hhcc---------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 --EAVD---------KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 --~~ld---------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...+ ..............+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00000011112234667888999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.41 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=198.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 494 (743)
..++|++.++||+|+||.||+++.. +++.||||++.+. .....+.+..|..+++++ +||||+++++++.+....+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999976 6899999998754 234567788999999998 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999988853 346899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+...
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~----~~~~~i~~~~~~- 242 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----D----DLFEAILNDEVV- 242 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCCCC-
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----H----HHHHHHHcCCCC-
Confidence 3222 223446899999999999999999999999999999999999999864321 1 111111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM------SAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 695 (743)
+ +......+.+++..||+.||++||++ .+|++
T Consensus 243 -----~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 -----Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 11112345678889999999999998 66665
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.07 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=195.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcC--CccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQ--HRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.++++++ |+||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999888999999998654 3456678999999999996 599999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 678899998854 336788889999999999999999998 99999999999995 578999999999877544
Q ss_pred ccccccccccccccccCcceecc-----------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME-----------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~~ 280 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAI 280 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHH
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHHH
Confidence 33333345689999999999865 4689999999999999999999999864221 01111111
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
++.......+......+.+++.+||+.||.+||++.||++.
T Consensus 281 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 ---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111111112346678889999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.02 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=196.2
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.+.||+|+||.||+++.. ++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56888899999999999999875 788999998643 345789999999999999999999998874 4799999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC-eEEeeeccccccCCCccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN-PKISDFGMARIFGGDQIE 580 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-vkl~DFGla~~~~~~~~~ 580 (743)
+++|.+++........++...++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999876544456788999999999999999999932223999999999999998887 799999999765422
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+. ...+.... +
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~-----~ 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWA-VHNGTRPP-----L 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHH-HHTTCCCC-----C
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHH-HhcCCCCC-----c
Confidence 22356899999999999999999999999999999999999998643210 0001111 11111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.... ...+.+++.+||+.+|++|||+.+|+++|+.+..
T Consensus 226 ~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 IKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp BTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111 2346678889999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.81 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=203.6
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
..++|.+.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999976 6899999999754 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC---CeEEeeeccccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM---NPKISDFGMARI 573 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~vkl~DFGla~~ 573 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999888743 346899999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. .......+...
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~----~~~~i~~~~~~ 248 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HR----LYAQIKAGAYD 248 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHTCCC
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HH----HHHHHHhCCCC
Confidence 653322 2346899999999999999999999999999999999999999864321 11 11111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...+ ........+.+++.+||+.||++||++.++++.
T Consensus 249 -~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -YPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CCTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCcc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 001112346678889999999999999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=352.04 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=210.6
Q ss_pred CCCCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEe--cCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI--EEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~~~ 494 (743)
++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 368899999998877777788999999999999999999999887 456689
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999998543 235899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC------CCccccchhhHhHh
Q 041312 575 GGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG------SGSWNLVGHVWDLW 647 (743)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~------~~~~~~~~~~~~~~ 647 (743)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.|+....... ............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 255 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE-- 255 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH--
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH--
Confidence 543321 22333568888999999999999999999999999999999999976432110 000000011111
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.+...............+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 256 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 256 -------LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred -------HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111111112222234567788899999999999999999999887553
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=361.18 Aligned_cols=250 Identities=29% Similarity=0.412 Sum_probs=202.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC-eeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ-EKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~ 500 (743)
++|++.++||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 56888899999999999999876 7899999997543 4578999999999999999999999987765 789999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999998643 2334788999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... . +......+....
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~----~~~~i~~~~~~~----- 406 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D----VVPRVEKGYKMD----- 406 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----T----HHHHHHTTCCCC-----
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H----HHHHHHcCCCCC-----
Confidence 122367889999999999999999999999999999998 99998643211 1 122222221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 407 ----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 407 ----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111234667888999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.09 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=203.5
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-C-------cEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-G-------KEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
++|.+.++||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578889999999999999999653 3 47999999777777788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC--------eEE
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN--------PKI 565 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------vkl 565 (743)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999998543 334889999999999999999999998 999999999999998887 999
Q ss_pred eeeccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+...... . ...
T Consensus 163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~-~~~ 228 (289)
T 4fvq_A 163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------Q-RKL 228 (289)
T ss_dssp CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------H-HHH
T ss_pred ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------H-HHH
Confidence 999999765322 23568899999999987 77999999999999999999976654432210 0 011
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSS 705 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 705 (743)
....... .+.... ...+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 229 ~~~~~~~-------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 229 QFYEDRH-------QLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHHTTC-------CCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HHhhccC-------CCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1111100 000001 1235678889999999999999999999998876433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=343.36 Aligned_cols=260 Identities=17% Similarity=0.186 Sum_probs=204.9
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +|+||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35789999999999999999997 4789999999865432 24688999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC-----eEEeeeccccc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN-----PKISDFGMARI 573 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----vkl~DFGla~~ 573 (743)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999988543 346899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 574 FGGDQIEE-----NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 574 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~-~~~~i~ 233 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKE-RYQKIG 233 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHH-HHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHH-HHHHHH
Confidence 64432211 124578999999999999999999999999999999999999998753211 1110 111110
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...... ....+.. ..+ .+.+++..|++.+|.+||++.+|++.|+.+
T Consensus 234 ~~~~~~-~~~~~~~-~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 234 DTKRAT-PIEVLCE-NFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHS-CHHHHTT-TCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hhhccC-CHHHHhc-cCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000000 0000001 111 577788899999999999999999999644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=351.89 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=206.2
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..++|.+.++||+|+||.||+|+.. +++.+|+|++..........+.+|+.++++++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3468999999999999999999986 689999999987766667789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC--CCCeEEeeeccccccCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA--AMNPKISDFGMARIFGG 576 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~vkl~DFGla~~~~~ 576 (743)
|+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.....
T Consensus 129 ~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999888532 335899999999999999999999998 999999999999974 57799999999987754
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ..........
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~----~~~i~~~~~~--- 268 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LET----LQNVKRCDWE--- 268 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHH----HHHHHHCCCC---
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHH----HHHHHhCCCC---
Confidence 332 2335799999999999999999999999999999999999999864321 111 1111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
............+.+++.+||+.||++|||+.++++.
T Consensus 269 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 ---FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011111112346678889999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.33 Aligned_cols=257 Identities=29% Similarity=0.427 Sum_probs=209.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..++|++.++||+|+||.||+|++. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567889999999999999999987 4889999998654 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 3346899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..|+...... ...........
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---------~~~~~~~~~~~----- 230 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------QVYELLEKDYR----- 230 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------GHHHHHHTTCC-----
T ss_pred cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHhccCC-----
Confidence 22 2233567889999999999999999999999999999999 88887643210 11111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
..........+.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 231 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111111123566788899999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.50 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=207.2
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5688889999999999999999888999999997543 334789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+++|.+++... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence 99999998542 346889999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .........+...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~i~~~~~~------- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------SEVVEDISTGFRL------- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHHHHHHTTCCC-------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---------HHHHHHHhcCCcC-------
Confidence 1223567789999999998999999999999999999999 8888764321 0111111111100
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..+......+.+++.+|++.+|++||+++++++.|+.+.
T Consensus 225 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 --YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001111234667888999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.13 Aligned_cols=260 Identities=26% Similarity=0.444 Sum_probs=194.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||+++.. ..+|+|++... .....+.+.+|+.++++++|+||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999864 35999998644 345567899999999999999999999965 5567899999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999888532 346889999999999999999999998 9999999999999999999999999998665433
Q ss_pred cccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 579 IEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.........||+.|+|||++. +..++.++||||||+++|||++|+.||..... ..........+.....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGSLSPD 246 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--------HHHHHHHHHHTSCCCC
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--------HHHHHHHhcccccCcc
Confidence 333344567999999999986 56788999999999999999999999864321 1112222222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
+.. + .......+.+++.+||+.+|.+|||+.+|+++|+.+.
T Consensus 247 ~~~-~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 LSK-V----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTS-S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhh-c----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111 1 1111245677888999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.61 Aligned_cols=269 Identities=28% Similarity=0.365 Sum_probs=206.6
Q ss_pred CCcCcccccCCceeEEEEEEc-----CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEE
Q 041312 424 FSSDNKLGEGGFGSVYKGVLQ-----NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKML 495 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~l 495 (743)
|++.++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998742 68899999997653 45567899999999999999999999999874 67899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34889999999999999999999998 9999999999999999999999999998775
Q ss_pred CCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
..... .......+|+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..................+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK---FLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh---hhhhhcccccchhHHHHHH
Confidence 44321 2233456788999999999999999999999999999999999997643210 0000000000000011111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.+...............+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 222222222222233457788889999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.94 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=204.8
Q ss_pred CCCCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--Cee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~ 493 (743)
+.|++.++||+|+||.||++++ .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 36899999999744 344567899999999999999999999999876 668
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998543 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCccc------CCCccccchhhHhH
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQ------GSGSWNLVGHVWDL 646 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~------~~~~~~~~~~~~~~ 646 (743)
....... .......||..|+|||++.+..++.++||||||+++|||++|+.|+...... ..............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7544321 2233457888999999999999999999999999999999999885432110 00000000001111
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...+ .....+......+.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 256 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111 11111222234567888899999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=338.53 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=197.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||.||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++ +|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 985 887777432 346888999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc------
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA------ 652 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 652 (743)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ................
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhh
Confidence 12235789999999999764 589999999999999999999999864321 1111111111100000
Q ss_pred --chhcccccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 --MEAVDKSLG-------ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 --~~~ld~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....++.+. ..........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 0000111234667888999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.72 Aligned_cols=245 Identities=23% Similarity=0.305 Sum_probs=202.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999986 69999999986542 23567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999853 345889999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~-~~~~i~~~~~---- 220 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MK-TYEKILNAEL---- 220 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HH-HHHHHHHCCC----
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HH-HHHHHHhCCC----
Confidence 2 2346899999999999999999999999999999999999999864321 01 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.+.. .. ...+.+++.+||+.||++|| ++++|++
T Consensus 221 --~~p~-~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 --RFPP-FF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCT-TS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCC-CC---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111 11 23456788899999999999 8899884
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.67 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=192.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578889999999999999999743 457999998754 3445678999999999999999999999984 567899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998532 335889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... . .......+....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~----~~~~i~~~~~~~ 237 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----D----VIGRIENGERLP 237 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----G----HHHHHHTTCCCC
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----H----HHHHHHcCCCCC
Confidence 43221 1223456789999999999999999999999999999996 88888643211 1 111111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+ .......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 238 -----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 238 -----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111123466788899999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.71 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=205.8
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEe----cCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI----EEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~----~~~~~~lV 496 (743)
++|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 5788999999999999999997 479999999997777777888999999999999999999999987 34578999
Q ss_pred EEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 497 YEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|||+++++|.+++.... ....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999886532 2456899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCccc-------cccccccccccccCcceeccCC---CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 576 GDQIE-------ENTNRVVGTYGYMAPEYAMEGL---FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 576 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
..... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ . ...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~----~~~ 258 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---S----VAL 258 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---C----HHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---h----hhH
Confidence 22110 0112346799999999987654 68899999999999999999999853221100 0 011
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.... ....+........+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 1111 000011111223567788899999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.67 Aligned_cols=267 Identities=27% Similarity=0.384 Sum_probs=211.0
Q ss_pred hhHHHHcCCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeee
Q 041312 415 SNIAAATNDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGC 486 (743)
Q Consensus 415 ~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~ 486 (743)
.......++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444557899999999999999999984 246889999997643 34556899999999999 79999999999
Q ss_pred EecCC-eeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCC
Q 041312 487 CIEEQ-EKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKA 552 (743)
Q Consensus 487 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp 552 (743)
+...+ ..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88754 58999999999999999865332 123789999999999999999999998 99999999
Q ss_pred CcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcc
Q 041312 553 SNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLE 631 (743)
Q Consensus 553 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~ 631 (743)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987654433333444678899999999999999999999999999999998 9988764321
Q ss_pred cCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 632 QGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
..........+.... . .......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 257 --------~~~~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 257 --------DEEFCRRLKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp --------SHHHHHHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------hHHHHHHhccCccCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111222222221111 1 1111234667888999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.74 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=199.6
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 478999999986431 22345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6888887743 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .+.. ......
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~----~i~~~~---- 224 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NLFK----KVNSCV---- 224 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TCBC----CCCSSC----
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HHHH----HHHcCC----
Confidence 332 234679999999999988876 78999999999999999999998743221 0000 000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..+. .... ..+.+++.+||+.||.+|||++||++.
T Consensus 225 --~~~p-~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 --YVMP-DFLS---PGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCC-TTSC---HHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCc-ccCC---HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011 1112 345678889999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.70 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=208.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
..++|.+.+.||+|+||.||+|.... .+.||+|++... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34678999999999999999999742 247999998755 334567899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhccc-----------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAK-----------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA 560 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 560 (743)
..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999865321 345789999999999999999999998 9999999999999999
Q ss_pred CCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCcccc
Q 041312 561 MNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNL 639 (743)
Q Consensus 561 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~ 639 (743)
+.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 273 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------- 273 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-------
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-------
Confidence 9999999999987644333223334567889999999999999999999999999999998 88887643210
Q ss_pred chhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 640 VGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 640 ~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.........+... ..+......+.+++..||+.+|.+|||+.+|++.|+.+
T Consensus 274 -~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 274 -SKFYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111222111110 01111123466788899999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=335.41 Aligned_cols=255 Identities=26% Similarity=0.468 Sum_probs=200.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChh-------cHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ-------GIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-------~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
.++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367899999999999999999985 7899999998654321 1267899999999999999999999987655
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC-----eEEee
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN-----PKISD 567 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----vkl~D 567 (743)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998887543 346899999999999999999999875 34999999999999988776 99999
Q ss_pred eccccccCCCccccccccccccccccCcceec--cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAM--EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...... . .. ...
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~---~~-~~~ 240 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG---K---IK-FIN 240 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC---H---HH-HHH
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc---H---HH-HHH
Confidence 9999854332 33467899999999984 456789999999999999999999998643211 0 00 011
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
......... .+ .......+.+++.+||+.||++|||+++|++.|+.+
T Consensus 241 ~~~~~~~~~----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIREEGLRP----TI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHSCCCC----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhccCCCC----CC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 11 111223567788899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=350.22 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=201.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999976 5889999998643 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999998843 346899999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... . .............
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~-~~~~~~~~~~~~~- 237 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----S-SKEIVHTFETTVV- 237 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----C-HHHHHHHHHHCCC-
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----c-HHHHHHHHhhccc-
Confidence 32 2344789999999999874 45899999999999999999999998743221 0 0111111111100
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-MSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 695 (743)
..+......+.+++.+||+.||.+||+ +++|++
T Consensus 238 ---------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011111234677888999999999999 677664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.14 Aligned_cols=258 Identities=24% Similarity=0.432 Sum_probs=198.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcE----EEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKE----IAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357999999999999999999964 4443 577877543 4456788999999999999999999999998754 88
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+|+||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988543 345889999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... . .......+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~----~~~~~~~~~~~ 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----E----ISSILEKGERL 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----G----HHHHHHTTCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----H----HHHHHHcCCCC
Confidence 55443333344567889999999999999999999999999999999 99998643221 1 11111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.........+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 239 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 ---------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111122346778889999999999999999999987754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.46 Aligned_cols=205 Identities=18% Similarity=0.259 Sum_probs=177.7
Q ss_pred cCCCCcCcccccC--CceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEG--GFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.++|++.++||+| +||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3579999999999 99999999986 6999999998754 34556788899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999985432 245899999999999999999999998 9999999999999999999999999986542
Q ss_pred CCc-----cccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 576 GDQ-----IEENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 576 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 211 1112233578999999999987 67999999999999999999999998643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=349.30 Aligned_cols=268 Identities=16% Similarity=0.195 Sum_probs=203.9
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcC------CcEEEEEEcccCChhcH-----------HHHHHHHHHHHhcCCccEEe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSSGQGI-----------EEFKTEIALIAQLQHRNLVS 482 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~Ev~~l~~l~h~niv~ 482 (743)
..++|++.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999999764 47899999876542211 12345666777888999999
Q ss_pred eeeeEecC----CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 483 ILGCCIEE----QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 483 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4589999999 9999999854 2356899999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeeeccccccCCCcccc-----ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcc
Q 041312 559 --AAMNPKISDFGMARIFGGDQIEE-----NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLE 631 (743)
Q Consensus 559 --~~~~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~ 631 (743)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332211 11335699999999999999999999999999999999999999874321
Q ss_pred cCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 632 QGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
............ ...+.+++++.+.....++ .+.+++..|++.+|++||++.+|+++|+.+.
T Consensus 267 ----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 ----DPKYVRDSKIRY-RENIASLMDKCFPAANAPG---EIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp ----CHHHHHHHHHHH-HHCHHHHHHHHSCTTCCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHh-hhhHHHHHHHhcccccCHH---HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 111111111111 1223344444333222333 4556777999999999999999999997653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=345.79 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=201.9
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCe
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQE 492 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~ 492 (743)
....++|.+.+.||+|+||.||+++.+ +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999986 68999999997542 34566788999999987 99999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999998853 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~----~~~~~i~~~~~ 235 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----E----ELFHSIRMDNP 235 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCCC
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----H----HHHHHHHhCCC
Confidence 643222 123457899999999999999999999999999999999999999864321 1 11111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMS-AVV 694 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 694 (743)
.+... . ...+.+++.+||+.||++||++. +|+
T Consensus 236 ------~~p~~-~---s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ------FYPRW-L---EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CCCTT-S---CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CCCcc-c---CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01111 1 23456788899999999999997 665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.96 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=197.5
Q ss_pred cCCCCcC-cccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSD-NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.+.|.+. +.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999965 7999999999877666778899999999995 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEeeecccccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISDFGMARIF 574 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~DFGla~~~ 574 (743)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999854 346889999999999999999999998 999999999999988776 999999999765
Q ss_pred CCCcc-----ccccccccccccccCcceecc-----CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC--cccc---
Q 041312 575 GGDQI-----EENTNRVVGTYGYMAPEYAME-----GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG--SWNL--- 639 (743)
Q Consensus 575 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~--~~~~--- 639 (743)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223569999999999875 56889999999999999999999998754321100 0000
Q ss_pred -chhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 640 -VGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 640 -~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..........+... ...... . .....+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-FPDKDW-A----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCC-CCHHHH-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcc-cCchhc-c----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00011111111100 000000 0 01234678888999999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=336.47 Aligned_cols=256 Identities=30% Similarity=0.439 Sum_probs=205.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 35788899999999999999999888899999986543 34678999999999999999999999986 45689999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998542 2235889999999999999999999998 999999999999999999999999999877544322
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... . ........+...
T Consensus 166 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~----~~~~~~~~~~~~------ 229 (279)
T 1qpc_A 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----P----EVIQNLERGYRM------ 229 (279)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H----HHHHHHHTTCCC------
T ss_pred c-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----H----HHHHHHhcccCC------
Confidence 2 223456889999999998899999999999999999999 8888763221 0 111111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.........+.+++.+|++.+|++|||+.+|+++|+.+.
T Consensus 230 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 230 ---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 011111235667888999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.62 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=188.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999975 68999999987543 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcc---cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEA---KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875432 1245889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc-----
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE----- 649 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 649 (743)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.+....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCTTT
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCChhH
Confidence 3321 1233578999999999976 46899999999999999999999998743221 111111111000
Q ss_pred -------------------CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 -------------------GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 -------------------~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....+.+.+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00001111111111 1235678888999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.01 Aligned_cols=244 Identities=21% Similarity=0.252 Sum_probs=192.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||+||+|+.. +++.||||++... ......++..|+..+.++ +|+||+++++++.+....++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 7999999998653 233444556666666665 9999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67888877543 346899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|..++.... .+..+..+.....+.
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------------~~~~~~~~~~~~~~~ 274 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------------GWQQLRQGYLPPEFT 274 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------------HHHHHTTTCCCHHHH
T ss_pred CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------------HHHHHhccCCCcccc
Confidence 22 234579999999998876 78999999999999999999987754321 112222222111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. .....+.+++.+||+.||++|||++||++
T Consensus 275 ~--------~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 A--------GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp T--------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c--------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 11234677888999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.62 Aligned_cols=245 Identities=21% Similarity=0.247 Sum_probs=203.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367899999999999999999986 6999999998653 224567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999854 345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+...
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~~~~~~i~~~~~~--- 256 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------IQIYEKIVSGKVR--- 256 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHCCCC---
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---------HHHHHHHHcCCCC---
Confidence 3 2346899999999999999999999999999999999999999864321 1111222222110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
+... ....+.+++.+||+.||.+||+ +++|++
T Consensus 257 ---~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 ---FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111 1234667888999999999998 888875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.96 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=191.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|.+.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999986 78999999996543 2336788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC--eEEeeeccccccCCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN--PKISDFGMARIFGGD 577 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--vkl~DFGla~~~~~~ 577 (743)
+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999988843 345899999999999999999999998 999999999999987765 999999999754322
Q ss_pred ccccccccccccccccCcceeccCCCCcc-ccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTK-SDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. ......||+.|+|||++.+..+..+ +|||||||++|+|++|+.||...... ..+......... .
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~-~------ 237 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILS-V------ 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHT-T------
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhc-C------
Confidence 1 2234679999999999988887665 89999999999999999998743221 111111111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
....+........+.+++.+||+.||++|||+.|+++.
T Consensus 238 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 --KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000000112346678889999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.41 Aligned_cols=254 Identities=27% Similarity=0.353 Sum_probs=203.9
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467899999999999999999986 6899999998643 3345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999884 3346889999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
..........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .. ....+...... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~-----~~~~~~~~~~~--~ 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQ-----EYSDWKEKKTY--L 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SH-----HHHHHHTTCTT--S
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HH-----HHHHhhhcccc--c
Confidence 32223345678999999999988765 78999999999999999999998753221 00 11111111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ........+.+++.+||+.||++|||+.+|++
T Consensus 229 ~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 N------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 00111234667888999999999999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.93 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=202.8
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
+....++|++.++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999986 58899999986421 1233458899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999998743 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCC----CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGL----FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
........ .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .... .....
T Consensus 217 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~---~~i~~ 287 (410)
T 3v8s_A 217 KMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY---SKIMN 287 (410)
T ss_dssp ECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH---HHHHT
T ss_pred eeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHH---HHHHh
Confidence 76544321 233478999999999998765 78999999999999999999999874321 1111 11111
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATD--RPNMSAVVSM 696 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 696 (743)
........+ ..... ..+.+++.+||+.+|.+ ||+++||++.
T Consensus 288 ~~~~~~~p~----~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNSLTFPD----DNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHCCCCT----TCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccccCCC----ccccc---HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000000000 00112 34556778999999988 9999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.84 Aligned_cols=273 Identities=23% Similarity=0.340 Sum_probs=201.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe---
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE--- 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~--- 492 (743)
..++|++.++||+|+||.||++++ .+++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346899999999999999999997 47899999999754 33445678999999999999999999999876543
Q ss_pred -eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 493 -KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 493 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 3999999999999999853 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 572 RIFGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 572 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
..+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCC
Confidence 876543221 223346789999999999999999999999999999999999999864322 11111212211
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHhcCCCCCCCCCCCcccc
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSA-VVSMLGSDNAPSSPKHPAFIA 713 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-vl~~L~~~~~~~~p~~~~~~~ 713 (743)
...... ... .. ...+.+++.+||+.||++||++.+ +...|........|..|....
T Consensus 236 ~~~~~~---~~~-~~---~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~ 292 (311)
T 3ork_A 236 PIPPSA---RHE-GL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT 292 (311)
T ss_dssp CCCHHH---HST-TC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCCC
T ss_pred CCCccc---ccC-CC---CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcccc
Confidence 111000 000 01 234667888999999999996555 555665554444455554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.00 Aligned_cols=262 Identities=15% Similarity=0.189 Sum_probs=206.5
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45799999999999999999997 478999999986543 234678899999999 89999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC-----eEEeeeccccc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN-----PKISDFGMARI 573 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----vkl~DFGla~~ 573 (743)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 335899999999999999999999998 999999999999987766 99999999987
Q ss_pred cCCCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 574 FGGDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 574 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQ 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHHHHHhhcc
Confidence 6543321 1234467999999999999999999999999999999999999998753221 01111111111100
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.....+ +.... ...+.+++.+|++.+|++||++++|++.|+.+.
T Consensus 239 ~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 239 STPLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HSCHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CccHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 011111 11111 234667888999999999999999999998763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=341.23 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=195.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe-
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE- 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~- 492 (743)
..++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3467889999999999999999864 3458999998754 34556789999999999999999999999987653
Q ss_pred ----eEEEEEecCCCChhhhhhhc---ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 493 ----KMLIYEYLPNKSLDVYIFDE---AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 493 ----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
.++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 49999999999999988542 23456899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhH
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... .. ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~----~~ 259 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HE----MY 259 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG----HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HH----HH
Confidence 99999987654433233334567889999999999999999999999999999999 7888754321 11 11
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.....+..... .......+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 260 ~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 DYLLHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHHTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111111 111123467788899999999999999999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=333.23 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=202.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC--CeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE--QEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~--~~~~lV 496 (743)
.++|.+.++||+|+||.||+|+.. ++.+|||++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357889999999999999999985 889999998754 345567899999999999999999999999887 788999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ....+++..++.++.||+.||.|||+++ ..|+||||||+|||++.++.++|.|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998543 2235899999999999999999999864 3499999999999999999999999998764322
Q ss_pred CccccccccccccccccCcceeccCCCCc---cccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFST---KSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
....||+.|+|||++.+..++. ++||||||+++|||++|+.||..... ..........+...
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALEGLRP 230 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHSCCCC
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhcCCCC
Confidence 2357899999999998765544 89999999999999999999864321 01111111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.+ +......+.+++..||+.||++|||+++|++.|+.+.
T Consensus 231 -----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 -----TI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 1111234667888999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.72 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=199.0
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc--CCccEEeeeeeEecC----C
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL--QHRNLVSILGCCIEE----Q 491 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l--~h~niv~l~~~~~~~----~ 491 (743)
....++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++.+. .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999876 899999998543 234455566665554 899999999999887 7
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc--------CCCceEeccCCCCcEEecCCCCe
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD--------SRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~~~~ivH~Dikp~NIll~~~~~v 563 (743)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 88999999999999999843 3588999999999999999999988 6 9999999999999999999
Q ss_pred EEeeeccccccCCCcccc--ccccccccccccCcceeccCCCCcc------ccchhHHHHHHHHHhcCCC----------
Q 041312 564 KISDFGMARIFGGDQIEE--NTNRVVGTYGYMAPEYAMEGLFSTK------SDVYSFGVLLLEIILGRRN---------- 625 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDiwSlGvil~elltG~~p---------- 625 (743)
||+|||++..+....... ......||+.|+|||++.+.....+ +|||||||++|||++|..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999998764433221 1224579999999999988766665 9999999999999999544
Q ss_pred CCCCcccCCCccccchhhHhHhccCCcchhcccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 626 NTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESC-CAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
+....... ............... .+.+.... .......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 262 ~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 262 YHDLVPSD----PSYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTTTSCSS----CCHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhcCCC----CchhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 33221110 000111111111111 11111111 12445668889999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=367.74 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=208.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.++|++.++||+|+||.||+|++..+..||||++.... ...++|.+|+.+|++++|+||+++++++.+ ...++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688889999999999999999888889999997543 345789999999999999999999999876 6789999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++... ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999998543 2345889999999999999999999998 999999999999999999999999999876533211
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...+..+....
T Consensus 420 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---------~~~~~~i~~~~~~~----- 484 (535)
T 2h8h_A 420 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVERGYRMP----- 484 (535)
T ss_dssp -TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---------HHHHHHHHTTCCCC-----
T ss_pred -cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCCC-----
Confidence 1223456789999999999999999999999999999999 8888764321 11122222221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
........+.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus 485 ----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1111223466788899999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=345.98 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=187.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..++|++.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999986 58899999987543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DFGla~~~~ 575 (743)
|+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999988843 345889999999999999999999998 999999999999975 8899999999998764
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............. .
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~i~~~~~~-~ 270 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------QFMFRRILNCEYY-F 270 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------HHHHHHHHTTCCC-C
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------HHHHHHHHhCCCc-c
Confidence 332 123467899999999999999999999999999999999999998643210 0111111111110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. .+........+.+++.+||+.||++|||+.++++
T Consensus 271 ~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 I-----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C-----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111112235667888999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.29 Aligned_cols=268 Identities=24% Similarity=0.341 Sum_probs=195.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHH--HHhcCCccEEeeeeeEec-----CCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIAL--IAQLQHRNLVSILGCCIE-----EQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~--l~~l~h~niv~l~~~~~~-----~~~~ 493 (743)
.++|++.++||+|+||.||+|+. +++.||||++.... ...+..|..+ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46789999999999999999976 68999999986433 2344444444 555899999999975532 2356
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc---------CCCceEeccCCCCcEEecCCCCeE
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD---------SRLRIIHRDLKASNVLLDAAMNPK 564 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~~~~ivH~Dikp~NIll~~~~~vk 564 (743)
++||||+++++|.+++.. ...++..+..++.||++||.|||++ + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999843 2357888999999999999999998 7 99999999999999999999
Q ss_pred EeeeccccccCCCcc------ccccccccccccccCcceecc-------CCCCccccchhHHHHHHHHHhcCCCCCCCcc
Q 041312 565 ISDFGMARIFGGDQI------EENTNRVVGTYGYMAPEYAME-------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLE 631 (743)
Q Consensus 565 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDiwSlGvil~elltG~~p~~~~~~ 631 (743)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 112224579999999999987 4567789999999999999999888765433
Q ss_pred cCCCccccc---------hhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 632 QGSGSWNLV---------GHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 632 ~~~~~~~~~---------~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.......+. ...............+..... ........+.+++.+||+.||++|||++||++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 211111000 000000111111111111110 12234556888999999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.37 Aligned_cols=262 Identities=20% Similarity=0.238 Sum_probs=201.0
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-----SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE 489 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 489 (743)
++....++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667788999999999999999999975 6889999998643 34456789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhhhc-------------------------------------ccccccCHHHHHHHHHHHHH
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDE-------------------------------------AKRSLLDWSKRFEIICGIAR 532 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~qi~~ 532 (743)
....++||||+++++|.+++... .....+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999887421 01223467778899999999
Q ss_pred HHHHhhccCCCceEeccCCCCcEEecCCC--CeEEeeeccccccCCCcc--ccccccccccccccCcceecc--CCCCcc
Q 041312 533 GILYLHQDSRLRIIHRDLKASNVLLDAAM--NPKISDFGMARIFGGDQI--EENTNRVVGTYGYMAPEYAME--GLFSTK 606 (743)
Q Consensus 533 ~L~yLH~~~~~~ivH~Dikp~NIll~~~~--~vkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~k 606 (743)
||.|||+++ |+||||||+|||++.++ .+||+|||++..+..... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998766 899999999986543211 112334679999999999975 678999
Q ss_pred ccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 041312 607 SDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATD 686 (743)
Q Consensus 607 sDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~ 686 (743)
+|||||||++|||++|+.||..... ................ + ........+.+++.+||+.+|.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCFEN--P-----NYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCTTS--G-----GGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcccccCC--c-----ccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999864321 1111111111111100 0 00011234667888999999999
Q ss_pred CCCHHHHHH
Q 041312 687 RPNMSAVVS 695 (743)
Q Consensus 687 RPs~~evl~ 695 (743)
||++.++++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=335.33 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=204.2
Q ss_pred CCCCcCc-ccccCCceeEEEEEEc---CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDN-KLGEGGFGSVYKGVLQ---NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|.+.+ .||+|+||.||+|+.. ++..||||++... .....+.+.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999853 5788999999764 345677899999999999999999999999 55678999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999998853 3346899999999999999999999998 99999999999999999999999999987754
Q ss_pred Cccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... . ........+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~----~~~~~i~~~~~~~ 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P----EVMAFIEQGKRME 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----H----HHHHHHHTTCCCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----H----HHHHHHhcCCcCC
Confidence 3321 12233456889999999998899999999999999999998 9999864321 1 1111222111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+......+.+++..||+.+|++||++.+|++.|+.+
T Consensus 234 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 234 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111223566788899999999999999999999765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.37 Aligned_cols=254 Identities=14% Similarity=0.119 Sum_probs=203.1
Q ss_pred HcCCCCcCcccccCCceeEEEEE------EcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC---CccEEeeeeeEecC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGV------LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEE 490 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~ 490 (743)
..++|.+.++||+|+||.||+|+ ..+++.||||++.... ..++..|+.++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678999999999999999994 4468999999997553 446777888888876 99999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhhcc--cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---------
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEA--KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA--------- 559 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--------- 559 (743)
+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999986432 3456999999999999999999999998 999999999999998
Q ss_pred --CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcc
Q 041312 560 --AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSW 637 (743)
Q Consensus 560 --~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~ 637 (743)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~ 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---EC 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---EE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---ce
Confidence 8999999999997654332233344578999999999999999999999999999999999999997543211 00
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhcCCCC
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDR-PNMSAVVSMLGSDNA 702 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~~ 702 (743)
.+...+......+ .+.+++..|++.+|.+| |++.++.+.|+....
T Consensus 294 -----------------~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 -----------------KPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -----------------EECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----------------eechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0111111111233 34456778999999998 788888888876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.73 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=203.2
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..++|++.++||+|+||.||+|+.. ++..+|+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567899999999999999999976 578899999987666677899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~~~ 575 (743)
|+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999888743 345889999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... .....||+.|+|||++.+. ++.++||||||+++|||++|+.||...... ........+....
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~- 226 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---------EVMLKIREGTFTF- 226 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCCC-
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHhCCCCC-
Confidence 4332 2345789999999988654 899999999999999999999998643210 1111111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... . .....+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~-~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDW-L----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHH-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cchhh-h----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0 01234667888999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.44 Aligned_cols=248 Identities=24% Similarity=0.298 Sum_probs=191.2
Q ss_pred cCCCCcCcccccCCceeEEEEEE----cCCcEEEEEEcccCC----hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
.++|++.++||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35789999999999999999997 478999999997542 2345668899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999988843 345888999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~----~~~~i~~~~~ 238 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KK----TIDKILKCKL 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHHTCC
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HH----HHHHHHhCCC
Confidence 6432221 23346799999999999999999999999999999999999999864321 01 1111111110
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.+. ......+.+++.+||+.||++|| ++.++++
T Consensus 239 ------~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011 11123466788899999999999 6777765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.66 Aligned_cols=246 Identities=25% Similarity=0.274 Sum_probs=195.0
Q ss_pred CcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 427 DNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999975 6899999999877667778899999999999999999999999999999999999999999
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe--cCCCCeEEeeeccccccCCCcccccc
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL--DAAMNPKISDFGMARIFGGDQIEENT 583 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll--~~~~~vkl~DFGla~~~~~~~~~~~~ 583 (743)
.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+..... .
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 8887543 345889999999999999999999998 9999999999999 5678899999999987754332 2
Q ss_pred ccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCC
Q 041312 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGES 663 (743)
Q Consensus 584 ~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~ 663 (743)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ........ ... .... ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~---~~~~i~~~-~~~-~~~~-~~~- 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AE---TLNNILAC-RWD-LEDE-EFQ- 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HH---HHHHHHHT-CCC-SCSG-GGT-
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HH---HHHHHHhc-cCC-CChh-hhc-
Confidence 335799999999999999999999999999999999999999864321 11 11111111 000 0000 000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 664 CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 664 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.....+.+++.+||+.||.+|||+.|+++
T Consensus 314 ---~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 ---DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11234667888999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.70 Aligned_cols=266 Identities=17% Similarity=0.209 Sum_probs=198.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccCChh-----------cHHHHHHHHHHHHhcCCccEEeeeee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRSSGQ-----------GIEEFKTEIALIAQLQHRNLVSILGC 486 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ev~~l~~l~h~niv~l~~~ 486 (743)
++|.+.++||+|+||.||+|+.. ++..+|||++...... ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57899999999999999999975 5788999998765322 12346678899999999999999999
Q ss_pred Eec----CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-
Q 041312 487 CIE----EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM- 561 (743)
Q Consensus 487 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~- 561 (743)
+.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 987 67889999999 99999998533 37899999999999999999999998 99999999999998877
Q ss_pred -CeEEeeeccccccCCCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC
Q 041312 562 -NPKISDFGMARIFGGDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG 635 (743)
Q Consensus 562 -~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~ 635 (743)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--- 266 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--- 266 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC---
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc---
Confidence 9999999999876432211 1123468999999999999999999999999999999999999998632110
Q ss_pred ccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 636 SWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.............. ....+......... ...+.+++..||+.+|++||++.+|++.|+.+..
T Consensus 267 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 -PVAVQTAKTNLLDE-LPQSVLKWAPSGSS---CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHHHHHT-TTHHHHHHSCTTSC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cHHHHHHHHhhccc-ccHHHHhhcccccc---HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 01111111111111 11111111111011 2346678889999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.31 Aligned_cols=270 Identities=19% Similarity=0.255 Sum_probs=212.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC--eeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ--EKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 497 (743)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56889999999999999999986 58999999987542 345678889999999999999999999998765 779999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe----cCCCCeEEeeeccccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL----DAAMNPKISDFGMARI 573 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~vkl~DFGla~~ 573 (743)
||+++++|.+++........+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999876555555899999999999999999999998 9999999999999 7778899999999987
Q ss_pred cCCCccccccccccccccccCcceecc--------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAME--------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . .......
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-~---~~~~~~~ 238 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-R---NKEVMYK 238 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-T---CHHHHHH
T ss_pred ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-c---hHHHHHH
Confidence 654322 234679999999999865 567889999999999999999999987432211 1 1111111
Q ss_pred HhccCCcchhc---------------ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 646 LWKEGTAMEAV---------------DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 646 ~~~~~~~~~~l---------------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
... +.....+ +..............+.+++..||+.||++||++.++++.|+.+..
T Consensus 239 ~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IIT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred Hhc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111 1111000 0001122335556678899999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=358.12 Aligned_cols=261 Identities=18% Similarity=0.216 Sum_probs=203.3
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 491 (743)
++....++|++.++||+|+||+||++++. +++.||+|++.+.. ......+.+|+.++.+++||||+++++++.+..
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33445678999999999999999999987 58899999986431 122334889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999998542 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
+........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+...
T Consensus 223 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~ 296 (437)
T 4aw2_A 223 LKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNH 296 (437)
T ss_dssp EECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTH
T ss_pred hhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----hHHHHhhhhc
Confidence 876543322 233468999999999997 56789999999999999999999999874321 1111111110
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATD--RPNMSAVVSM 696 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 696 (743)
...-.... ... ... ..+.+++.+||+.+|++ ||+++||++.
T Consensus 297 ~~~~~~p~-----~~~-~~s---~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQFPT-----QVT-DVS---ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCCCCS-----SCC-CSC---HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCc-----ccc-cCC---HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000000 000 012 23556777899888887 9999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.49 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=203.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
..++|++.++||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999976 6899999998643 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEeeeccccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISDFGMARI 573 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~DFGla~~ 573 (743)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888743 346899999999999999999999998 999999999999986655 99999999987
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .. .......+...
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~----~~~~~~~~~~~ 225 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HR----LYAQIKAGAYD 225 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHTCCC
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hH----HHHHHHhcccc
Confidence 654322 2336789999999999999999999999999999999999999864321 11 11111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~-~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 Y-PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C-CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-Cch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 000 00111234667888999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=333.99 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=200.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.++|.+.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678899999999999999998653 346999998765 34556789999999999999999999999865 45789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999998542 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... . .......+....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~----~~~~~~~~~~~~ 234 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----D----VIGVLEKGDRLP 234 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----G----HHHHHHHTCCCC
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----H----HHHHHhcCCCCC
Confidence 43321 1233567889999999998999999999999999999998 99998643221 1 111111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
........+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 235 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 235 ---------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0111123466788899999999999999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.64 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=199.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|.+.+.||+|+||.||+|+... +..||||++... .......+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999998653 245999999754 34455678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998542 346889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 576 GDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 576 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .........+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------HEVMKAINDGFRL 269 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHHHHHHTTCCC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---------HHHHHHHHCCCcC
Confidence 43221 11223456788999999999999999999999999999999 9999863321 0111222211110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.........+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 270 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 ---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111112234667888999999999999999999998664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.08 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=201.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 494 (743)
..++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999986 4889999998754 234567788999999988 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999998853 345889999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ...........
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~----~~~~i~~~~~~- 239 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DE----LFQSIMEHNVA- 239 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHCCCC-
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HH----HHHHHHhCCCC-
Confidence 3222 123457899999999999999999999999999999999999999864321 11 11111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
+ +......+.+++.+||+.||.+||+ +++|++
T Consensus 240 -----~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 -----Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 1111234667888999999999996 466664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.76 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=204.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec---------
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--------- 489 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--------- 489 (743)
...+|++.+.||+|+||.||+++.. +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467899999999999999999986 79999999997554 356789999999999999999998864
Q ss_pred -------CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC
Q 041312 490 -------EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 490 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44579999999999999998543 2346889999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... .
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----------~ 226 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----------K 226 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----------H
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----------H
Confidence 99999999987654322 233578999999999999999999999999999999999998753210 1
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPK 707 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~ 707 (743)
.......+.. ... .. ..+.+++.+||+.||++|||+.++++.|+.+...+..+
T Consensus 227 ~~~~~~~~~~--------~~~-~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 227 FFTDLRDGII--------SDI-FD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHHTTCC--------CTT-SC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHHHhhcccc--------ccc-CC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 1111111111 111 12 23567888999999999999999999998876654443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=341.80 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=203.5
Q ss_pred cCCCCcCcccccCCceeEEEEEE------cCCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35799999999999999999983 35788999999744 445667899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc----ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEe
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK----RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKIS 566 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~ 566 (743)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ...+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999865432 245889999999999999999999998 999999999999984 4469999
Q ss_pred eeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHh
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------~~~~~ 256 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------QEVLE 256 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------HHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---------HHHHH
Confidence 9999986544333333344678899999999999999999999999999999998 8888764321 01112
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
....+.... . .......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 257 ~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 222111111 1 11112346678889999999999999999999986643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.90 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=202.1
Q ss_pred CCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee-EEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK-MLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~-~lV 496 (743)
.|...++||+|+||.||+|+..+ +..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35556899999999999998642 237999998754 345567899999999999999999999999876665 999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+.+++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 2346788999999999999999999998 99999999999999999999999999986644
Q ss_pred Ccc--ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQI--EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~----~~~~~~~~~~~~ 248 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFD----LTHFLAQGRRLP 248 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGG----HHHHHHTTCCCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHH----HHHHhhcCCCCC
Confidence 321 1223345778999999999999999999999999999999997776543221 111 111111111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
........+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus 249 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 249 ---------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111234667888999999999999999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.62 Aligned_cols=263 Identities=23% Similarity=0.356 Sum_probs=199.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999974 7899999998753 345567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 497 YEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999885432 3456889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .... .............
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYS-LCKKIEQCDYPPL 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHH-HHHHHHTTCSCCC
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHH-HHHHhhcccCCCC
Confidence 3322 12235789999999999999999999999999999999999999863211 1111 1111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
..... ...+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus 259 -----~~~~~---~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 259 -----PSDHY---SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -----CTTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----ccccc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 23466788899999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.28 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=200.6
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--------hcHHHHHHHHHHHHhcCCccEEeeeeeEec
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--------QGIEEFKTEIALIAQLQHRNLVSILGCCIE 489 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 489 (743)
...++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34568999999999999999999975 689999999875421 133467789999999999999999999999
Q ss_pred CCeeEEEEEecCCC-ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 490 EQEKMLIYEYLPNK-SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 490 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
.+..++||||+.+| +|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 88888743 345899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 99987654332 234679999999999988876 88999999999999999999998642110
Q ss_pred ccCCcchhcccccCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 648 KEGTAMEAVDKSLGE-SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+...+.. .... ..+.+++..||+.||++|||+.+|++.
T Consensus 237 --------~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --------VEAAIHPPYLVS---KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------TTTCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------HhhccCCCcccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0112 246678889999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.66 Aligned_cols=251 Identities=23% Similarity=0.265 Sum_probs=178.8
Q ss_pred CcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEecCCCC
Q 041312 427 DNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
.++||+|+||.||+++.. +++.||||++.+. ....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999986 6899999998643 4567889999999997 9999999999999999999999999999
Q ss_pred hhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC---CeEEeeeccccccCCCcccc
Q 041312 505 LDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM---NPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 505 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~vkl~DFGla~~~~~~~~~~ 581 (743)
|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9998853 356899999999999999999999998 99999999999997765 799999999986643322
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............+... +.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~i~~~~~~------~~ 236 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL--TCTSAVEIMKKIKKGDFS------FE 236 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCCHHHHHHHHTTTCCC------CC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc--ccccHHHHHHHHHcCCCC------CC
Confidence 2234678999999999999999999999999999999999999987533210 001111122222222110 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..........+.+++..||+.||.+|||+++|++.
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00000112356778889999999999999998743
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.17 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=199.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
+.++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467999999999999999999976 5778999998643 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999988843 345889999999999999999999998 9999999999999999999999999986544
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~---- 223 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------ETYKRISRVE---- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHHTC----
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---------HHHHHHHhCC----
Confidence 322 23367899999999999999999999999999999999999998643210 0111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..+ +......+.+++.+||+.+|++|||+.||++.
T Consensus 224 --~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 --FTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001 11112345678889999999999999999974
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.05 Aligned_cols=251 Identities=21% Similarity=0.277 Sum_probs=203.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457899999999999999999986 689999999875432 1467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC----CeEEeeec
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM----NPKISDFG 569 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~vkl~DFG 569 (743)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999853 346889999999999999999999998 99999999999999887 79999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... . .......
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~----~~~~i~~ 232 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----E----TLANITS 232 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----H----HHHHHHT
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----H----HHHHHHh
Confidence 9987654321 23467899999999999999999999999999999999999998643210 0 1111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ..++.+... ....+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSY--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCC--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccc--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 100 000000011 1234667888999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.71 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=203.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999986 79999999986432 23456889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999843 446899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . ........+...
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~----~~~~~i~~~~~~-- 234 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----P----TLFKKICDGIFY-- 234 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----H----HHHHHHHTTCCC--
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----H----HHHHHHhcCCcC--
Confidence 322 234689999999999988765 7899999999999999999999864321 1 111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ..... ..+.+++.+||+.||++|||+.+|++
T Consensus 235 ----~-p~~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ----T-PQYLN---PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----C-CTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----C-CccCC---HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 01112 24567888999999999999999997
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.77 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=198.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555569999999999999975 68899999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeeccccccCCCcc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFGla~~~~~~~~ 579 (743)
++++|.+++........+++..+..++.||+.||.|||+++ |+|+||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999865544456678889999999999999999998 999999999999987 89999999999987653321
Q ss_pred ccccccccccccccCcceeccCC--CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .. ........ ...
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~--~~~~~~~~-----~~~ 244 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----QA--AMFKVGMF-----KVH 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----HH--HHHHHHHH-----CCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----hH--HHHhhccc-----ccc
Confidence 123467899999999997754 889999999999999999999998632110 00 00000000 001
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.+ .......+.+++.+||+.||++||++.++++
T Consensus 245 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111234667888999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.43 Aligned_cols=259 Identities=28% Similarity=0.421 Sum_probs=200.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEe-cCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCI-EEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~-~~~~~~l 495 (743)
..|++.++||+|+||.||+|+..+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999999642 335899998754 3455678999999999999999999999865 4567899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999854 2345788999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc--cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 576 GDQIE--ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 576 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ... ......+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~~----~~~~~~~~~~ 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDI----TVYLLQGRRL 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----TTH----HHHHHTTCCC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----HHH----HHHHhcCCCC
Confidence 43321 1223356788999999999999999999999999999999965554322211 111 1111111110
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
......+ ..+.+++.+||+.+|++|||+.+|+++|+.+..
T Consensus 252 ------~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 ------LQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ------CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0011112 346678889999999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=346.44 Aligned_cols=208 Identities=28% Similarity=0.325 Sum_probs=179.8
Q ss_pred CcChhhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-----CccEEeee
Q 041312 411 VFDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-----HRNLVSIL 484 (743)
Q Consensus 411 ~~~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----h~niv~l~ 484 (743)
.+.+.......++|.+.++||+|+||.||+|+.. +++.||||++.. .......+..|+.++++++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3444444456688999999999999999999985 689999999854 3445567888999999997 99999999
Q ss_pred eeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-----
Q 041312 485 GCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA----- 559 (743)
Q Consensus 485 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~----- 559 (743)
+++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 999999885432 235889999999999999999999998 999999999999975
Q ss_pred --------------------CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHH
Q 041312 560 --------------------AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEI 619 (743)
Q Consensus 560 --------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~el 619 (743)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 788999999999865432 2346789999999999999999999999999999999
Q ss_pred HhcCCCCCCC
Q 041312 620 ILGRRNNTFH 629 (743)
Q Consensus 620 ltG~~p~~~~ 629 (743)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999998743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=344.27 Aligned_cols=203 Identities=27% Similarity=0.477 Sum_probs=164.2
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCC--e
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQ--E 492 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~--~ 492 (743)
...++|++.++||+|+||.||+|.+. +++.||||++... .......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35678999999999999999999975 6899999998643 3455677889999999997 999999999997544 6
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||++ ++|..++.. ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 578777742 46888999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc-------------------cccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 573 IFGGDQ-------------------IEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 573 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
.+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 754311 0112234689999999999987 67899999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.35 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=181.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4467999999999999999999974 79999999986432 2345788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999988532 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . .......
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~----~~~~~~~----- 227 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----T----LNKVVLA----- 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCSS-----
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----H----HHHHhhc-----
Confidence 3321 1223578999999999999999999999999999999999999986432210 0 0000000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+..+.. .. ...+.+++.+||+.||++|||+++|++
T Consensus 228 -~~~~~~-~~---~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYEMPS-FL---SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCCCT-TS---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCCcc-cc---CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000111 11 234567888999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.51 Aligned_cols=258 Identities=23% Similarity=0.271 Sum_probs=189.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEe--------cCC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCI--------EEQ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~--------~~~ 491 (743)
.+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47888999999999999999975 78999999997777777788999999999996 999999999984 334
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+. |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5799999996 788888866445567999999999999999999999864 34999999999999999999999999999
Q ss_pred cccCCCccc----------cccccccccccccCccee---ccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccc
Q 041312 572 RIFGGDQIE----------ENTNRVVGTYGYMAPEYA---MEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638 (743)
Q Consensus 572 ~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~ 638 (743)
......... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~ 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----R 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----H
Confidence 876543221 111235689999999998 5677899999999999999999999998643211 0
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
. +...............+.+++.+||+.||++||++.||++.|+.+..
T Consensus 261 ~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 I----------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h----------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00000000000111225678889999999999999999999987644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.79 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=205.8
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHh--cCCccEEeeeeeEecCC---
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQ--LQHRNLVSILGCCIEEQ--- 491 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~--l~h~niv~l~~~~~~~~--- 491 (743)
.....++|.+.+.||+|+||.||+++. +++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345567899999999999999999998 5899999998543 34677889998888 78999999999998876
Q ss_pred -eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhh--------ccCCCceEeccCCCCcEEecCCCC
Q 041312 492 -EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH--------QDSRLRIIHRDLKASNVLLDAAMN 562 (743)
Q Consensus 492 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~Dikp~NIll~~~~~ 562 (743)
..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999843 35889999999999999999999 777 999999999999999999
Q ss_pred eEEeeeccccccCCCcccc--ccccccccccccCcceeccC------CCCccccchhHHHHHHHHHhc----------CC
Q 041312 563 PKISDFGMARIFGGDQIEE--NTNRVVGTYGYMAPEYAMEG------LFSTKSDVYSFGVLLLEIILG----------RR 624 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDiwSlGvil~elltG----------~~ 624 (743)
+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765433211 23346799999999999876 334789999999999999999 55
Q ss_pred CCCCCcccCCCccccchhhHhHhccCCcchhcccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 625 NNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGES-CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 625 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
||........ .............. .+.+... ........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 266 p~~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 266 PYYDLVPSDP----SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTTSCSSC----CHHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCcCcc----cHHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 5543221100 01111111111111 1111111 12355567889999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.41 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=195.7
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-----hhcHHHHHHHHHHHHhcC---CccEEeeeeeEecC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-----GQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEE 490 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~ 490 (743)
..++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999974 78999999986322 122345667777777664 99999999999876
Q ss_pred C-----eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 491 Q-----EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 491 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 59988875432 234899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----HHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Confidence 9999998764332 23346889999999999999999999999999999999999999864322 111111111
Q ss_pred HhccCCcch------hcccccC--CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 646 LWKEGTAME------AVDKSLG--ESC-----CAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 646 ~~~~~~~~~------~ld~~l~--~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......... .....+. ... .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111000000 0000000 000 0111235677888999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.16 Aligned_cols=266 Identities=28% Similarity=0.407 Sum_probs=207.0
Q ss_pred cCCCCcCcccccCCceeEEEEEE-----cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC--ee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-----QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ--EK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~--~~ 493 (743)
.++|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 368899999998777777789999999999999999999999987654 78
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 245889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCccc-----C-CCc-cccchhhHh
Q 041312 574 FGGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQ-----G-SGS-WNLVGHVWD 645 (743)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~-----~-~~~-~~~~~~~~~ 645 (743)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... . ... .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7544321 1122346778899999999989999999999999999999999886532110 0 000 000000111
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
....+. ...........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1111112224567788899999999999999999999865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.17 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=192.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 6899999998743 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988843 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...........
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~----~~~~~i~~~~~--- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E----KLFELILMEEI--- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCCC---
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----H----HHHHHHHhCCC---
Confidence 322 123347899999999999999999999999999999999999999864321 0 11111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.+... ....+.+++..||+.||.+|| +++|+++
T Consensus 367 ---~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ---RFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01111 123466788899999999999 9999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=332.95 Aligned_cols=264 Identities=18% Similarity=0.210 Sum_probs=198.4
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
...++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999976 68899999987542 334578899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 99999999999999853 346889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc-c
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA-M 653 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 653 (743)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........... .
T Consensus 185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~ 254 (309)
T 2h34_A 185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---------VMGAHINQAIPRP 254 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---------HHHHHHHSCCCCG
T ss_pred cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---------HHHHHhccCCCCc
Confidence 543222 123457899999999999999999999999999999999999998643210 11111111110 1
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCCCCCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-NMSAVVSMLGSDNAPSSP 706 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~p 706 (743)
... ... .+ ..+.+++.+||+.||++|| +++++++.|+.......+
T Consensus 255 ~~~----~~~-~~---~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 255 STV----RPG-IP---VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp GGT----STT-CC---THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ccc----CCC-CC---HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 111 111 11 2456788899999999999 999999999987665443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.58 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=198.6
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 495 (743)
..++|++.++||+|+||.||+++.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567899999999999999999986 7999999998754 334567788999999999 99999999999999999999
Q ss_pred EEEecCCCChhhhhhhccc-ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC--------------
Q 041312 496 IYEYLPNKSLDVYIFDEAK-RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-------------- 560 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-------------- 560 (743)
||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999865322 256899999999999999999999998 9999999999999844
Q ss_pred -----CCeEEeeeccccccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCC
Q 041312 561 -----MNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGS 634 (743)
Q Consensus 561 -----~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~ 634 (743)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|||++|..++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998765432 24589999999999876 66789999999999999999987754221
Q ss_pred CccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 635 GSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+.... +... .. ..+.+++.+||+.||++|||+.++++
T Consensus 236 --------~~~~~~~~~~~~-----~~~~-~~---~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --------QWHEIRQGRLPR-----IPQV-LS---QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHHHHTTCCCC-----CSSC-CC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHcCCCCC-----CCcc-cC---HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111222222111 1111 12 34667888999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=351.23 Aligned_cols=259 Identities=23% Similarity=0.256 Sum_probs=193.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------C
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------Q 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~ 491 (743)
.++|++.++||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999975 6899999999754 445567889999999999999999999999654 4
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 444432 23888999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC-
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG- 650 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 650 (743)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.+.+...
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-----~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-----IDQWNKVIEQLGTPC 283 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCSCC
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCC
Confidence 8765332 23346899999999999999999999999999999999999999864321 11111111100000
Q ss_pred ------------------------CcchhcccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 651 ------------------------TAMEAVDKSLGESC---CAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 651 ------------------------~~~~~ld~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.........+.... .......+.+|+.+||+.||++|||++|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000111000000 01113457889999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=334.33 Aligned_cols=254 Identities=30% Similarity=0.419 Sum_probs=200.8
Q ss_pred CCCCcCc-ccccCCceeEEEEEEc---CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDN-KLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|.+.+ .||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4677777 9999999999999653 47889999987543 33467899999999999999999999999 5677899
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999854 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 576 GDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 576 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .........+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGERM 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCCCC
Confidence 44321 11223456788999999998889999999999999999999 9999864321 1112222222111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. .+......+.+++.+||+.||.+||++.+|++.|+.+
T Consensus 240 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 240 G---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111223466788899999999999999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.60 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=198.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..++|++.+.||+|+||.||+++.. +++.||||++.+.... ..+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999986 6899999999765432 35688888888 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC----CCeEEeeeccccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA----MNPKISDFGMARI 573 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~vkl~DFGla~~ 573 (743)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999988853 346899999999999999999999998 9999999999998543 3499999999987
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........+...
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD------TPEEILARIGSGKFS 241 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS------CHHHHHHHHHHCCCC
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC------CHHHHHHHHccCCcc
Confidence 654322 223468899999999999888999999999999999999999998743211 111122222222111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+...........+.+++.+||+.||++||++.++++
T Consensus 242 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111112234667888999999999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.31 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=190.9
Q ss_pred CCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-CCeeEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-EQEKMLI 496 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lV 496 (743)
.|.+.++||+|+||.||+|+..+ +..+|+|.+... .....+++.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999999642 236899998654 34556789999999999999999999998754 4678999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999998532 345788899999999999999999998 99999999999999999999999999986643
Q ss_pred Cccc--cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 577 DQIE--ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 577 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |..|+..... ... ......+...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~----~~~~~~~~~~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDI----TVYLLQGRRL 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCH----HHHHHTTCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHH----HHHHHcCCCC
Confidence 3221 11233567889999999999999999999999999999999 5555543211 111 1111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
. .....+ ..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 316 ~------~p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 L------QPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp C------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C------CCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 011122 346678889999999999999999999987644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.38 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=196.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367899999999999999999986 58999999886543 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988764 2345889999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh---------
Q 041312 578 QIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW--------- 647 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 647 (743)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..........
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-----DQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHH
T ss_pred cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhccccccccc
Confidence 22 1234578999999999976 67899999999999999999999998653321 0110011100
Q ss_pred --ccCCcchhcccccCCCCC------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 648 --KEGTAMEAVDKSLGESCC------APEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 648 --~~~~~~~~ld~~l~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
............-..... ......+.+++.+||+.||++|||++||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000000 111234678888999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=329.43 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=197.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4467899999999999999999975 68999999987543 345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeeccccc
Q 041312 498 EYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARI 573 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~ 573 (743)
||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999998886532 3456899999999999999999999998 9999999999999 4567899999999987
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
+..... .....||+.|+|||++. ..++.++||||||+++|||++|+.||...... ............
T Consensus 177 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~ 243 (285)
T 3is5_A 177 FKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---------EVQQKATYKEPN 243 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHCCCC
T ss_pred cCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---------HHHhhhccCCcc
Confidence 644322 23467899999999875 56899999999999999999999998643210 011111101000
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. ...... ...+.+++.+||+.||++|||+.||++
T Consensus 244 ~~----~~~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YA----VECRPL---TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC----C--CCC---CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc----cccCcC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000011 234567888999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=348.45 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=190.6
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--------hhcHHHHHHHHHHHHhcCCccEEeeeeeEec
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--------GQGIEEFKTEIALIAQLQHRNLVSILGCCIE 489 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~ 489 (743)
...++|.+.++||+|+||.||+|... +++.||||++.+.. ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999976 68999999986431 122335889999999999999999999975
Q ss_pred CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC---CeEEe
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM---NPKIS 566 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~vkl~ 566 (743)
....++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999988874 3456899999999999999999999998 99999999999997544 59999
Q ss_pred eeccccccCCCccccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .. .
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~----~ 353 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VS----L 353 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CC----H
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HH----H
Confidence 999998765432 2334689999999999864 67889999999999999999999998643221 11 1
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......+.... ... ... .....+.+++.+||+.||++|||+.++++
T Consensus 354 ~~~i~~~~~~~-~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 KDQITSGKYNF-IPE-VWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHTTCCCC-CHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCCCC-Cch-hhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111111100 000 000 11234677888999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.97 Aligned_cols=259 Identities=18% Similarity=0.221 Sum_probs=201.9
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE 492 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~ 492 (743)
+....++|++.++||+|+||.||+++.+ +++.||||++.+.. ....+.+++|+.++.+++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3345678999999999999999999986 69999999986532 2234568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++|+|..++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999998542 236889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceec-------cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAM-------EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..... .
T Consensus 211 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~---~ 281 (412)
T 2vd5_A 211 KLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----AETYG---K 281 (412)
T ss_dssp ECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH---H
T ss_pred eccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----HHHHH---H
Confidence 76543321 223468999999999997 35789999999999999999999999864321 11111 1
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDR---PNMSAVVSM 696 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~ 696 (743)
....... ..-+.+.. ... ..+.+++.+||+ +|++| |+++||++.
T Consensus 282 i~~~~~~--~~~p~~~~-~~s---~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEH--LSLPLVDE-GVP---EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHH--CCCC-----CCC---HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccC--cCCCcccc-CCC---HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1100000 00000101 112 345677789999 99998 689998763
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.57 Aligned_cols=246 Identities=27% Similarity=0.433 Sum_probs=197.3
Q ss_pred CCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
+.|...++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999997 478999999987542 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+. |+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 577666643 2346899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 578 QIEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~~--- 270 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES--- 270 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC---
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcCC---
Confidence 2367999999999985 56789999999999999999999999864321 111111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
+.+...... ..+.+++.+||+.+|++|||+++|++.
T Consensus 271 ---~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ---PALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCCCCC---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111122 335678889999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.88 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=201.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEE--EEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEI--AVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~v--avK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+++.. ++..+ |+|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999975 56644 99988653 334556789999999999 999999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 497 YEYLPNKSLDVYIFDEA-------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------~~ 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------AE 249 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---------HH
Confidence 99999999743221 11223466889999999998899999999999999999998 9999864321 01
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
.......+... .........+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 250 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 250 LYEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHHHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11222211110 1111112346778889999999999999999999986544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.61 Aligned_cols=251 Identities=29% Similarity=0.398 Sum_probs=195.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-CeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-QEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~ 499 (743)
.++|++.+.||+|+||.||+++.. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357889999999999999999875 8899999986543 457899999999999999999999997654 478999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998543 2234788999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .........+...
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---------~~~~~~~~~~~~~----- 233 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKM----- 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---------GGHHHHHTTTCCC-----
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHhcCCCC-----
Confidence 22467889999999999999999999999999999998 9988764321 0111112111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.........+.+++..||+.||++||++.+|++.|+.+.
T Consensus 234 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 111111234667888999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.70 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=204.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.+.|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999975 68999999987543 4456889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999874 346889999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ........... +
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~-----~ 237 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---------KVLFLIPKNNP-----P 237 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------HHHHHHHHSCC-----C
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---------HHHHHhhcCCC-----C
Confidence 2 223467899999999999999999999999999999999999998643210 01111111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+.... ...+.+++..||+.+|++|||+.+|++.
T Consensus 238 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 2346678889999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=330.96 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=203.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457889999999999999999986 7999999999866555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeeccccccCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~~~~ 576 (743)
+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988743 345889999999999999999999998 9999999999999 7889999999999976543
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........+...
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~i~~~~~~--- 225 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---------SKLFEKIKEGYYE--- 225 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHHHCCCC---
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------HHHHHHHHcCCCC---
Confidence 2 12335789999999999999999999999999999999999999864321 0111112111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhcCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS--MLGSDNA 702 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~ 702 (743)
............+.+++.+||+.||++||++.++++ .+++...
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 226 ---FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 000111112234667888999999999999999987 3444433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.13 Aligned_cols=197 Identities=23% Similarity=0.398 Sum_probs=155.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----Ce
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~ 492 (743)
.++|++.++||+|+||.||+|++. +++.||||++... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999976 6899999998653 344567899999999999999999999998543 57
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+ +++|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 568877773 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------cccccccccccccCccee-ccCCCCccccchhHHHHHHHHHhcCC
Q 041312 573 IFGGDQIE-------------------------ENTNRVVGTYGYMAPEYA-MEGLFSTKSDVYSFGVLLLEIILGRR 624 (743)
Q Consensus 573 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDiwSlGvil~elltG~~ 624 (743)
........ ......+||+.|+|||++ .+..++.++||||||||+|||++|..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 76432110 122346889999999986 45679999999999999999999543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.82 Aligned_cols=254 Identities=11% Similarity=0.077 Sum_probs=180.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhc--CCccEEeee-------eeE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQL--QHRNLVSIL-------GCC 487 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l--~h~niv~l~-------~~~ 487 (743)
..+|.+.++||+|+||.||+|++. +++.||||++.... ....+.+++|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999976 78999999998653 24456778886555555 699988755 333
Q ss_pred ecC-----------------CeeEEEEEecCCCChhhhhhhcccccccCHHHH------HHHHHHHHHHHHHhhccCCCc
Q 041312 488 IEE-----------------QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR------FEIICGIARGILYLHQDSRLR 544 (743)
Q Consensus 488 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~~ 544 (743)
... ...++||||++ ++|.+++.... ..++...+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 322 33799999999 89999986532 23455555 678899999999999998
Q ss_pred eEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhc
Q 041312 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILG 622 (743)
Q Consensus 545 ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG 622 (743)
|+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998764322 13566799999999987 6799999999999999999999
Q ss_pred CCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 623 RRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 623 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.||....+....... ...........+..+........+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCC----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchh----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998765332111100 00000000111111111112235667888999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.52 Aligned_cols=245 Identities=22% Similarity=0.256 Sum_probs=189.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHH-HHhcCCccEEeeeeeEecCCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIAL-IAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~-l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
.++|++.+.||+|+||.||+++.+ +++.||||++.+.. ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999986 58899999997542 2344566777776 577899999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999988853 345888999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...........
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~----~~~~~i~~~~~--- 256 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----A----EMYDNILNKPL--- 256 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----H----HHHHHHHHSCC---
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----H----HHHHHHHhccc---
Confidence 222 123457899999999999999999999999999999999999999864321 1 11111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSA 692 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 692 (743)
.+... . ...+.+++..||+.||.+||++.+
T Consensus 257 ---~~~~~-~---~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 ---QLKPN-I---TNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---CCCSS-S---CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---CCCCC-C---CHHHHHHHHHHcccCHHhCCCCCC
Confidence 01111 1 234567888999999999999853
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=363.84 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=198.3
Q ss_pred CCcCc-ccccCCceeEEEEEEc---CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 424 FSSDN-KLGEGGFGSVYKGVLQ---NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 424 y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
+.+.+ +||+|+||.||+|.+. ++..||||+++.. .....+++.+|+.++++++|||||++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999875 4667999999765 33467889999999999999999999999976 56899999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 416 ~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 416 MAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp CCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred eCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 99999999998542 446899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccc-ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 579 IEE-NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 579 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... . .+...+..+....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~----~~~~~i~~~~~~~-- 559 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P----EVMAFIEQGKRME-- 559 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----H----HHHHHHHTTCCCC--
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----H----HHHHHHHcCCCCC--
Confidence 211 1122345689999999999999999999999999999998 9999864321 1 1222222222111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+......+.+++..||+.+|++||++.+|++.|+.+
T Consensus 560 -------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111223566788899999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=357.94 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=204.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +|+.||+|++.+. .......+.+|+.+|++++||||+++++++.+....++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999986 7999999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|..++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999998885432 334899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~-----~~~~~i~~~i~~~~----- 405 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEVP----- 405 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC-----CCHHHHHHHHHHCC-----
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc-----hhHHHHHHHhhccc-----
Confidence 322 23358999999999999999999999999999999999999998753221 01111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
..+ .......+.+++.+||+.||.+|| +++||++
T Consensus 406 -~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 -EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 001 111123466788899999999999 7788875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.42 Aligned_cols=198 Identities=26% Similarity=0.386 Sum_probs=175.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57899999999999999999986 6899999999765 344567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
+++++|.+++.. ...+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999853 34588999999999999999999986 7 999999999999999999999999999765322
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223467899999999999999999999999999999999999998743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.64 Aligned_cols=253 Identities=21% Similarity=0.229 Sum_probs=189.7
Q ss_pred cCCCCcC-cccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHh-cCCccEEeeeeeEec----CCee
Q 041312 421 TNDFSSD-NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQ-LQHRNLVSILGCCIE----EQEK 493 (743)
Q Consensus 421 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~-l~h~niv~l~~~~~~----~~~~ 493 (743)
.++|.+. +.||+|+||+||++++. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 68999999999999976 6899999998532 456788888754 589999999999875 5678
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeeecc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDFGM 570 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DFGl 570 (743)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998543 2345899999999999999999999998 999999999999987 78899999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............+
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIRMG 282 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC-----SSCCSHHHHHHHT
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc-----cccHHHHHHHHcC
Confidence 98754322 223468899999999999999999999999999999999999998754321 1111111111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
... +...........+.+++..||+.||++|||+.+|++.
T Consensus 283 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 0000001112346678889999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=336.81 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=203.9
Q ss_pred hHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--------hcHHHHHHHHHHHHhc-CCccEEeeee
Q 041312 416 NIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--------QGIEEFKTEIALIAQL-QHRNLVSILG 485 (743)
Q Consensus 416 ~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l-~h~niv~l~~ 485 (743)
......++|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999986 799999999865431 2245788999999999 7999999999
Q ss_pred eEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 486 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999998853 346899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcceecc------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc
Q 041312 566 SDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639 (743)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~ 639 (743)
+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~- 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----IL- 312 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HH-
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----HH-
Confidence 99999987654322 234689999999999863 3588999999999999999999999864221 00
Q ss_pred chhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 640 VGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 640 ~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+.... ..+.. . .....+.+++.+||+.||++|||+.++++
T Consensus 313 ---~~~~i~~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 ---MLRMIMEGQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHHTCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHhCCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111100 00000 0 01234677888999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.03 Aligned_cols=201 Identities=23% Similarity=0.395 Sum_probs=168.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----Ce
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~ 492 (743)
.++|.+.++||+|+||.||+|+.. +++.||||++... .....+++.+|+.+|++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 6889999999754 344567899999999999999999999999876 57
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+. ++|..++. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 58888874 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------cccccccccccccCccee-ccCCCCccccchhHHHHHHHHHhcCCCCCC
Q 041312 573 IFGGDQIE--------------------ENTNRVVGTYGYMAPEYA-MEGLFSTKSDVYSFGVLLLEIILGRRNNTF 628 (743)
Q Consensus 573 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDiwSlGvil~elltG~~p~~~ 628 (743)
........ ......+||+.|+|||++ ....++.++||||||||+|||++|..|+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 76543211 123457899999999986 556799999999999999999987666553
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.06 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=199.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.++||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999986 689999999875421 24678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC----CeEEeeecc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM----NPKISDFGM 570 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~vkl~DFGl 570 (743)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999843 346899999999999999999999998 99999999999998877 799999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~ 226 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---------ETLTNISAV 226 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHTT
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---------HHHHHhHhc
Confidence 987643321 23357899999999999999999999999999999999999998643210 011111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... ....... .....+.+++.+||+.||++||++.++++
T Consensus 227 ~~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NYD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 0000000 11234677888999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.92 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=203.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999986 5889999998644 334567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988743 346889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ..........
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~-~~~~~~~~~~---- 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KE-TYLRIKKNEY---- 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HH-HHHHHHHTCC----
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HH-HHHHHhcCCC----
Confidence 321 22346789999999999999999999999999999999999999864321 00 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.... . ..+.+++.+||+.||++||++.+|++
T Consensus 259 --~~~~~~-~---~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 --SIPKHI-N---PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCCTTS-C---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCCccC-C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111 1 24567888999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.54 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=203.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKML 495 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~l 495 (743)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999986 6899999998754 34456789999999999999999999998753 578899
Q ss_pred EEEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccC--CCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 496 IYEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDS--RLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ..+|+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986533 2345899999999999999999999875 1239999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .........+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~i~~~~~ 233 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------KELAGKIREGKF 233 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHTCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---------HHHHHHHhhccc
Confidence 7653321 12235789999999999999999999999999999999999999864321 111122222221
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.. +.. .....+.+++.+||+.+|++||++.+|++.+..
T Consensus 234 ~~-----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 RR-----IPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC-----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cc-----CCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 111 112346678889999999999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=325.53 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=199.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeE-ecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC-IEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 497 (743)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 4789999998654322 23578899999999988776666655 6677889999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeecccccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIF 574 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~~ 574 (743)
||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999988532 345899999999999999999999998 9999999999999 78899999999999876
Q ss_pred CCCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 575 GGDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 575 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEKKMS 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SSSSHHHHHHHHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh--hhhhhhhhhhccccc
Confidence 544321 1223468999999999999999999999999999999999999998754321 111111111111000
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.. ... +.... ...+.+++.+||+.+|++||++++|++.|+.+.
T Consensus 237 ~~-~~~----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 237 TP-IEV----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SC-HHH----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ch-hhh----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00 000 00111 134677888999999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.45 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=190.8
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
...++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999975 78999999997543 2335677899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-----CCCCeEEeeecc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-----AAMNPKISDFGM 570 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-----~~~~vkl~DFGl 570 (743)
||||+++ +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999984 88888743 345889999999999999999999998 99999999999994 455699999999
Q ss_pred ccccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+..+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .............
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-----IDQLFKIFEVLGL 256 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCC
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-----HHHHHHHHHHhCC
Confidence 987653322 22335789999999999875 489999999999999999999999864321 1111111111000
Q ss_pred CCc------------chhcccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTA------------MEAVDKSLGESC-----CAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~------------~~~ld~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... .... +...... .......+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSF-PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTC-CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cchhhhhhhhhhhhhhhhh-hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000 0000000 0001234678888999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=326.28 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=203.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999986 5888999998654 344567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988743 346889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... . ..........
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~-~~~~~~~~~~---- 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------E-TYLRIKKNEY---- 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------H-HHHHHHTTCC----
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------H-HHHHHhhccC----
Confidence 221 223467899999999999999999999999999999999999998643210 0 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+.... ...+.+++.+||+.||++|||+.++++.
T Consensus 233 --~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SIPKHI----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCcccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011111 1346678889999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.82 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=195.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc--CCc--EEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ--NGK--EIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.++||+|+||.||+|++. +++ .||||++... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57889999999999999999864 333 6899998754 3345678999999999999999999999998765 89
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999988543 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 575 GGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 243 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGER 243 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHccCCC
Confidence 543321 12234567889999999998889999999999999999999 9999864321 0111111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
.. ........+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 244 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 LP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CC---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00 1111224567788899999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.00 Aligned_cols=255 Identities=25% Similarity=0.310 Sum_probs=204.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +|+.||+|++.+.. ......+.+|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999986 69999999996532 23457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 497 YEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999886533 2446899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..............
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~-~~~~~~~~i~~~~~--- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----V-ENKELKQRVLEQAV--- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----C-CHHHHHHHHHHCCC---
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----h-hHHHHHHHHhhccc---
Confidence 4332 223468999999999999999999999999999999999999998753211 0 00111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM-----SAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 695 (743)
. .+......+.+++..||+.||++||++ .+|++
T Consensus 411 -----~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -----T--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----C--CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----C--CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 111112345678889999999999975 56653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.23 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=202.2
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeE-ecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC-IEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~-~~~~~~~lV~E 498 (743)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 5799999999865432 24688999999999988766656555 56778899999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~~~ 575 (743)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999988532 346899999999999999999999998 9999999999999 488899999999998765
Q ss_pred CCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 576 GDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 576 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch--hhhhhhhhhcccccCC
Confidence 44321 1123468999999999999999999999999999999999999998753321 1111111111100000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.. . .+.... ...+.+++.+||+.||++||++++|++.|+.+
T Consensus 238 ~~-~----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 238 PI-E----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp CH-H----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ch-H----HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00 0 011111 13467788899999999999999999999865
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=332.53 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=184.7
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..++|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999964 68999999986542 344577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-----ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 498 EYLPNKSLDVYIFDE-----AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988542 12346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc---ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 573 IFGGDQI---EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 573 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... . .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~---~~~~~~~ 241 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----K---VLMLTLQ 241 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----G---HHHHHHT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----h---HHHHHhc
Confidence 6643221 112234578999999999876 56899999999999999999999998753221 0 0111111
Q ss_pred cCCcch----hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 EGTAME----AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~~~~~~----~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... ..+..+.... ...+.+++.+||+.||.+||++.+|++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 -NDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -SSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -cCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11110 1111111111 234667888999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=336.90 Aligned_cols=264 Identities=21% Similarity=0.320 Sum_probs=196.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------ 491 (743)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999975 6999999998653 3445678899999999999999999999998653
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899888743 45889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+..... ....++|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTP 245 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCC
Confidence 875432 234678999999999987 6799999999999999999999999874321 11111111100000
Q ss_pred -----------Ccchh---c----ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhcCCCCC
Q 041312 651 -----------TAMEA---V----DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS--MLGSDNAP 703 (743)
Q Consensus 651 -----------~~~~~---l----d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~ 703 (743)
..... + ...+. .........+.+++.+||+.||.+|||+.++++ .++.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 00000 0 00000 011111234677888999999999999999998 35555443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=334.43 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=202.2
Q ss_pred hhHHHHcCCCCcC-cccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEec
Q 041312 415 SNIAAATNDFSSD-NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIE 489 (743)
Q Consensus 415 ~~l~~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~ 489 (743)
.......+.|.+. ++||+|+||.||+++.. +++.||+|++... .......+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344556677777 88999999999999976 6899999998754 334567899999999999 56999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEe
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKIS 566 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~ 566 (743)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999987543 2356899999999999999999999998 999999999999987 7899999
Q ss_pred eeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....
T Consensus 177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~----~~~~ 244 (327)
T 3lm5_A 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-----E----TYLN 244 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H----HHHH
T ss_pred eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----H----HHHH
Confidence 9999987653322 23467999999999999999999999999999999999999998643210 0 0111
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...... .............+.+++.+||+.||++|||++++++.
T Consensus 245 i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 110000 00011111122346678889999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=363.72 Aligned_cols=248 Identities=30% Similarity=0.417 Sum_probs=195.7
Q ss_pred cccccCCceeEEEEEEc---CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||.||+|.+. .++.||||+++.. .....+++.+|+.++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4678999999754 23456889999999999999999999999864 568899999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc-c
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE-E 581 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~-~ 581 (743)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999843 346889999999999999999999998 999999999999999999999999999877543321 1
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...+..+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---------~~~~~~i~~~~~~~------ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGERMG------ 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCCCC------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcCCCCC------
Confidence 2223456789999999999999999999999999999998 9999864321 11222222222111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.+......+.+++..||+.||++||++.+|++.|+.+
T Consensus 593 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111224566788899999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.50 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=196.8
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec----CCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE----EQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~ 494 (743)
+.|.+.++||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34677789999999999999975 6888999998643 34556789999999999999999999998875 35689
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEeeeccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARI 573 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~ 573 (743)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ .+|+|+||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999843 346889999999999999999999874 3499999999999997 789999999999976
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
..... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||..... ..........+...
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--------AAQIYRRVTSGVKP 248 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--------HHHHHHHHTTTCCC
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--------HHHHHHHHhccCCc
Confidence 54332 23357899999999876 4589999999999999999999999864321 11112222222111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...+. ... ..+.+++..||+.||.+|||+.+|++
T Consensus 249 ~~~~~-----~~~---~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ASFDK-----VAI---PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGG-----CCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCC-----CCC---HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111 111 34667888999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=336.77 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=197.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357899999999999999999986 58999999986543 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988763 2345899999999999999999999998 999999999999999999999999999866433
Q ss_pred ccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH-----------h
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW-----------D 645 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~ 645 (743)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....... .
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-----DQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHH
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhhh
Confidence 22 22335789999999999875 7899999999999999999999998754321 0000000 0
Q ss_pred HhccCCc-chhcccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 646 LWKEGTA-MEAVDKSLGESCCA-----PEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 646 ~~~~~~~-~~~ld~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+..... .....+.+...... .....+.+++.+||+.||++|||+.||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 00000111111111 11345778888999999999999999886
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=323.24 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=201.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357899999999999999999986 5788999998643 223456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999988543 45889999999999999999999998 99999999999999999999999999976543
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...... . ..........
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~-~~~~~~~~~~---- 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------E-THRRIVNVDL---- 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------H-HHHHHHTTCC----
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------H-HHHHHhcccc----
Confidence 22 23467899999999999999999999999999999999999998643210 0 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.. .....+.+++.+||+.+|.+||++.+|++
T Consensus 230 --~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 --KFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0111 11234567888999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.75 Aligned_cols=261 Identities=13% Similarity=0.164 Sum_probs=200.8
Q ss_pred CCCCcCcccccCCceeEEEEEEcC---------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEe----------
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN---------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVS---------- 482 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~---------- 482 (743)
++|.+.+.||+|+||.||+|+... ++.||||++... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999763 789999998654 46789999999999999988
Q ss_pred -----eeeeEec-CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEE
Q 041312 483 -----ILGCCIE-EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVL 556 (743)
Q Consensus 483 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 556 (743)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 5666665 67889999999 99999998643 2356899999999999999999999998 999999999999
Q ss_pred ecCCC--CeEEeeeccccccCCCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 557 LDAAM--NPKISDFGMARIFGGDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 557 l~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876533211 1123358999999999999999999999999999999999999998754
Q ss_pred cccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 630 LEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
... ...+.. ...... .....+.+......... ..+.+++.+||+.||++||++++|+++|+.+
T Consensus 272 ~~~---~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 272 LPN---TEDIMK-QKQKFV-DKPGPFVGPCGHWIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TTC---HHHHHH-HHHHHH-HSCCCEECTTSCEECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CcC---HHHHHH-HHHhcc-CChhhhhhhccccCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 211 011111 111111 11111111111000112 3466788899999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.24 Aligned_cols=242 Identities=14% Similarity=0.159 Sum_probs=187.6
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccC---ChhcHHHHHHHH---HHHHhcCCccEEeee-------ee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS---SGQGIEEFKTEI---ALIAQLQHRNLVSIL-------GC 486 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ev---~~l~~l~h~niv~l~-------~~ 486 (743)
.++|.+.++||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788899999999999999996 46999999999743 344567899999 555566899999998 55
Q ss_pred EecCC-----------------eeEEEEEecCCCChhhhhhhccc----ccccCHHHHHHHHHHHHHHHHHhhccCCCce
Q 041312 487 CIEEQ-----------------EKMLIYEYLPNKSLDVYIFDEAK----RSLLDWSKRFEIICGIARGILYLHQDSRLRI 545 (743)
Q Consensus 487 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 545 (743)
+.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 6899999864321 123445888899999999999999998 9
Q ss_pred EeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccC-----------CCCccccchhHHH
Q 041312 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-----------LFSTKSDVYSFGV 614 (743)
Q Consensus 546 vH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDiwSlGv 614 (743)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041312 615 LLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 615 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 694 (743)
++|||++|+.||...... .... .+.. .. .. .+ ..+.+++.+||+.||++|||+.+++
T Consensus 302 il~elltg~~Pf~~~~~~-----~~~~------------~~~~-~~-~~-~~---~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL-----GGSE------------WIFR-SC-KN-IP---QPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHHSSCCC-----------CCSG------------GGGS-SC-CC-CC---HHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHHCCCCCcccccc-----cchh------------hhhh-hc-cC-CC---HHHHHHHHHHcCCCchhCCCHHHHh
Confidence 999999999998643221 0000 0000 00 11 12 3466788899999999999999998
Q ss_pred H
Q 041312 695 S 695 (743)
Q Consensus 695 ~ 695 (743)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=349.45 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=201.3
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
...++|.+.++||+|+||+||+++.. +++.||||++.+. .......+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34567999999999999999999986 7899999998643 23356789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec---CCCCeEEeeecccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD---AAMNPKISDFGMAR 572 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~vkl~DFGla~ 572 (743)
||||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999888743 346899999999999999999999998 99999999999995 45679999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .. .......+..
T Consensus 173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~----~~~~i~~~~~ 239 (486)
T 3mwu_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YD----ILKRVETGKY 239 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHTCC
T ss_pred ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHhCCC
Confidence 765432 2234679999999999875 589999999999999999999999864321 11 1111111111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
..... ........+.+++.+||+.+|.+|||+.++++.
T Consensus 240 ~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 AFDLP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSCSG------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCc------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10000 001112346678889999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.80 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=195.2
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChh-----cHHHHHHHHHHHHhcCCccEEeeeeeEecCC
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ-----GIEEFKTEIALIAQLQHRNLVSILGCCIEEQ 491 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~ 491 (743)
....++|.+.+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999975 6899999998643221 1246789999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++ +|..++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999986 77777643 2345788889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|..|+..... ......+.......
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-----~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTP 232 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence 87643322 22346789999999999764 589999999999999999999988764321 11111111111100
Q ss_pred Ccch---------hcccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 041312 651 TAME---------AVDKSLGESCC-----APEILRCIHLGLLCVQEQATDRPNMSAVVSML 697 (743)
Q Consensus 651 ~~~~---------~ld~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 697 (743)
.... .+...-..... ......+.+++.+||+.||++|||+.|+++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000 00000000001 11124577888899999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.33 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=194.6
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcC--CccEEeeeeeEecCCeeE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQ--HRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~~~~ 494 (743)
...++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++++++ |+||+++++++.+....+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345679999999999999999999988999999998643 3456678999999999997 599999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||++..+
T Consensus 105 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 678899998853 346888999999999999999999998 999999999999965 88999999999876
Q ss_pred CCCccccccccccccccccCcceecc-----------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAME-----------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~ 249 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKL 249 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHHH
Confidence 54433323334678999999999875 46888999999999999999999998643210 0111
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.... +..............+.+++.+||+.||.+||++.+|++
T Consensus 250 ~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 HAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111 111111111111234667888999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=339.12 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=200.2
Q ss_pred cCCCCcCcccccCCceeEEEEEE----cCCcEEEEEEcccCC----hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSRSS----GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
.++|++.++||+|+||.||+++. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999997 378999999986432 23345677899999999 6999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999854 345889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
+.+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... . ...........
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~-~~~~~~~~~~~ 280 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----N-SQAEISRRILK 280 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----C-CHHHHHHHHHH
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----c-hHHHHHHHHhc
Confidence 876433222 2334679999999999986 35789999999999999999999998743221 0 01111111110
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVSML 697 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 697 (743)
.. + ..+......+.+++.+||+.||.+|| ++.++++..
T Consensus 281 ~~------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 SE------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CC------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cC------C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00 0 11111123466788899999999999 999998765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.42 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=197.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEec--------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIE-------- 489 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-------- 489 (743)
.++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367999999999999999999984 78999999986442 2335678899999999999999999999987
Q ss_pred CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
.+..++||||+++ +|...+.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999985 66555533 2245899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc--ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 570 MARIFGGDQI--EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 570 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHH
Confidence 9987653221 122334678999999999876 46899999999999999999999998753221 111111110
Q ss_pred hc-----------cCCcchhcccccCCCCCH-HH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 647 WK-----------EGTAMEAVDKSLGESCCA-PE------ILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 647 ~~-----------~~~~~~~ld~~l~~~~~~-~~------~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. .....+.+.......... .. ...+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 000000000000000111 11 123678899999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.47 Aligned_cols=264 Identities=21% Similarity=0.246 Sum_probs=200.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC--------CccEEeeeeeEe---
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ--------HRNLVSILGCCI--- 488 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~--------h~niv~l~~~~~--- 488 (743)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999999999999975 6889999998643 445678899999999996 788999999987
Q ss_pred -cCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCC-----
Q 041312 489 -EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAM----- 561 (743)
Q Consensus 489 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~----- 561 (743)
.....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 566889999999 55555555332 224589999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------CeEEeeeccccccCCCccccccccccccccccCcce
Q 041312 562 --------------------------------------------NPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597 (743)
Q Consensus 562 --------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 597 (743)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 233578999999999
Q ss_pred eccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCC-ccccchhhHhHhcc--------CC-cchhcccc-----c--
Q 041312 598 AMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSG-SWNLVGHVWDLWKE--------GT-AMEAVDKS-----L-- 660 (743)
Q Consensus 598 ~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~--------~~-~~~~ld~~-----l-- 660 (743)
+.+..++.++|||||||++|||++|+.||......... .............. +. ..+..... +
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999754321100 00001111111000 00 00000000 0
Q ss_pred ------------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 661 ------------GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 661 ------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...........+.+|+.+||+.||++|||++||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234556677889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.93 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=184.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-h-hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-G-QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~-~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++|++.++||+|+||.||+++.. +++.||+|++.... . ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999974 78999999997542 2 23334555666688899999999999999999999999
Q ss_pred EecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 498 EYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 498 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||++ ++|.+++... .....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 4877776442 2345789999999999999999999998 8 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCccee----ccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYA----MEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||..... .............
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~ 231 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQVVEEPS 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHHHHSCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHHhccCC
Confidence 4322 2234789999999996 556789999999999999999999999863211 0011111111111
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. .... .....+.+++.+||+.||++|||+.++++
T Consensus 232 -~~-----~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -PQ-----LPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CC-----CCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CC-----cccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 1111 11234667888999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=322.53 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=197.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC----hhcHHHHHHHHHHHHhcCCccEEeeeeeEe--cCCe
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS----GQGIEEFKTEIALIAQLQHRNLVSILGCCI--EEQE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~--~~~~ 492 (743)
..++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999975 68899999986432 345678999999999999999999999984 4567
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999887 55555432 3456889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCC--CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGL--FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
...............||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~i~~~ 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---------YKLFENIGKG 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHHHC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---------HHHHHHHhcC
Confidence 765433333334467899999999987644 47899999999999999999999864321 0111111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. .+... ....+.+++.+||+.||.+|||+.++++.
T Consensus 229 ~~------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SY------AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC------CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC------CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 01111 12345678889999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.14 Aligned_cols=255 Identities=17% Similarity=0.283 Sum_probs=197.1
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEec--CCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIE--EQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 497 (743)
++|++.++||+|+||.||+|+.. +++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 67899999999999999999974 7899999998643 3467899999999997 9999999999987 66789999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~~~ 576 (743)
||+++++|..++. .++...+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999988862 3788899999999999999999998 99999999999999776 899999999987654
Q ss_pred CccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc---
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA--- 652 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 652 (743)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ................
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~----~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH----HHHHHHHHHHHCHHHHHHH
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch----HHHHHHHHHhcCCchhhhH
Confidence 322 234578999999999987 67899999999999999999999998543221 0000000000000000
Q ss_pred --------------------chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 653 --------------------MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 653 --------------------~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+...........+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000111111112345678888999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.75 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=194.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367899999999999999999986 79999999986432 23466889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 45889999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... .........+..
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~~--- 228 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---------PTLFKKIRGGVF--- 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHCCC---
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---------HHHHHHhhcCcc---
Confidence 322 223578999999999988765 6899999999999999999999864211 111111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.+.. .. ...+.+++.+||+.||.+|||+.+|++.
T Consensus 229 ---~~~~-~~---~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ---YIPE-YL---NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCCT-TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---cCch-hc---CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111 11 2346678889999999999999999983
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.03 Aligned_cols=252 Identities=22% Similarity=0.366 Sum_probs=196.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.+.||+|+||.||+|+.. +++.+|+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999986 5899999999877667788999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++++|..++... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999887542 345889999999999999999999998 9999999999999999999999999876432111
Q ss_pred ccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 580 EENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.......||+.|+|||++. +..++.++||||||+++|+|++|+.|+..... .......... ....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~ 241 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS-DPPT 241 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS-CCCC
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhcc-CCcc
Confidence 1122357899999999984 66789999999999999999999999864321 0111111111 1111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... .......+.+++.+||+.||++|||+.+|++
T Consensus 242 ~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 100 0111234667888999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=334.84 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=191.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChh-cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ-GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|.+.++||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999986 7899999998654322 122455799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
++ ++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 5887777532 346889999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC---cchh
Q 041312 580 EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT---AMEA 655 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 655 (743)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+........ ....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHhchhh
Confidence 2233578999999999877 5689999999999999999999999865321 111111111111000 0000
Q ss_pred cc---------cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VD---------KSLGES----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld---------~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. +..... ........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 000000 00011234668888999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=348.61 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=195.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++|.+.++||+|+||+||+++.. ++..+|+|++.+.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456899999999999999999986 68899999987542 334578899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC---CCeEEeeecccccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMARIF 574 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~vkl~DFGla~~~ 574 (743)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++..+
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888743 345889999999999999999999998 9999999999999764 45999999999876
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... ........+....
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~ 256 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---------EILRKVEKGKYTF 256 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHTCCCC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCCC
Confidence 5432 233467999999999876 56899999999999999999999998643221 1112121111110
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..+.. ......+.+++.+||+.+|.+|||+.++++
T Consensus 257 -~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 -DSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -Cchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 011234667888999999999999999885
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=361.22 Aligned_cols=249 Identities=24% Similarity=0.282 Sum_probs=202.2
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~ 494 (743)
..++|++.++||+|+||.||+++.. +++.||||++.+. .....+.+..|..++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999976 6889999998743 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999988543 46899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...........
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~----~~~~~i~~~~~-- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----D----ELFQSIMEHNV-- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHSSCC--
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----H----HHHHHHHhCCC--
Confidence 3222 224457899999999999999999999999999999999999999874321 1 11111111111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM-----SAVVS 695 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 695 (743)
. ++......+.+|+..||+.||++||++ +||++
T Consensus 560 ------~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------A--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------C--CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------C--CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 111112346678889999999999998 67764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=350.42 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=202.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999986 79999999986542 34577899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeeccccc
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARI 573 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~ 573 (743)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999888743 346889999999999999999999998 9999999999999 5678899999999987
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .. .......+...
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~----~~~~i~~~~~~ 245 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YD----ILKKVEKGKYT 245 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHCCCC
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HH----HHHHHHcCCCC
Confidence 654322 234579999999999876 689999999999999999999999864321 11 11112111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
-.. +........+.+++.+||+.+|.+|||+.++++
T Consensus 246 ~~~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FEL------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCS------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 000111234667888999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=347.78 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=198.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-------------hcHHHHHHHHHHHHhcCCccEEeeee
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-------------QGIEEFKTEIALIAQLQHRNLVSILG 485 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~Ev~~l~~l~h~niv~l~~ 485 (743)
..++|.+.++||+|+||+||+|+.. +++.+|||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999976 588999999875421 34578899999999999999999999
Q ss_pred eEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC---C
Q 041312 486 CCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM---N 562 (743)
Q Consensus 486 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~ 562 (743)
++.+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999888843 346899999999999999999999998 99999999999998775 6
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 563 PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 563 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
+||+|||++..+.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~ 254 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---------D 254 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------H
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---------H
Confidence 9999999998765432 223467999999999876 46899999999999999999999998743211 1
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+....... ... .....+.+++.+||+.||.+|||++|+++
T Consensus 255 ~~~~i~~~~~~~~~~--~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVEKGKYYFDFN--DWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHCCCCCCHH--HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCCCcc--ccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 112222111100000 000 01134667888999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.65 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=195.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe------eE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE------KM 494 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~------~~ 494 (743)
..+|++.++||+|+||.||+|+...+..+|+|++...... ..+|+.++++++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3468899999999999999999987777999988654322 2369999999999999999999865433 78
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEeeeccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARI 573 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~ 573 (743)
+||||++++.+............+++..+..++.||++||.|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988665544433334567899999999999999999999998 99999999999999 789999999999987
Q ss_pred cCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.........
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-----IDQLVEIIKVLGTPSR 263 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCH
Confidence 643332 2346789999999998765 589999999999999999999999874321 1111111111000000
Q ss_pred c-------hhcc---cccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCC
Q 041312 653 M-------EAVD---KSLGE-----SCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSD 700 (743)
Q Consensus 653 ~-------~~ld---~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 700 (743)
. .... +.+.. .........+.+++.+||+.||.+|||+.|+++. ++.+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0 0000 00000 0011122357788889999999999999999974 4444
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.06 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=197.5
Q ss_pred cChhhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEec
Q 041312 412 FDLSNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIE 489 (743)
Q Consensus 412 ~~~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~ 489 (743)
+++..+....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444445556788999999999999999999975 78999999986543 3446889999999999 89999999999987
Q ss_pred ------CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 490 ------EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 490 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999998643 2356889999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccc
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~ 638 (743)
||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||......
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 240 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------ 240 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------
Confidence 9999999987643221 123357899999999987 567899999999999999999999998643210
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........ .... .+...... ..+.+++.+||+.||.+||++.+|++
T Consensus 241 --~~~~~~~~-~~~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 --RALFLIPR-NPAP-----RLKSKKWS---KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HHHHHHHH-SCCC-----CCSCSCSC---HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHhhc-Cccc-----cCCccccC---HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01111111 1111 11111112 34667888999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.95 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=197.9
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..++|++.+.||+|+||.||+|+.. +|+.||+|++.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999986 58999999987543 34678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998852 2456899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ...... ...........
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~~~~~- 247 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFM-IPTNPPPTFRK- 247 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHH-HHHSCCCCCSS-
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH-HhcCCCcccCC-
Confidence 2 22345789999999999999999999999999999999999999864321 001111 11111100000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......+.+++.+||+.||.+|||+.+|++
T Consensus 248 ------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111234667888999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=334.11 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=202.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChh-----------------cHHHHHHHHHHHHhcCCccEEee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQ-----------------GIEEFKTEIALIAQLQHRNLVSI 483 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-----------------~~~~~~~Ev~~l~~l~h~niv~l 483 (743)
.++|.+.+.||+|+||.||+++. +++.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998643211 12789999999999999999999
Q ss_pred eeeEecCCeeEEEEEecCCCChhhh------hhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEE
Q 041312 484 LGCCIEEQEKMLIYEYLPNKSLDVY------IFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVL 556 (743)
Q Consensus 484 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIl 556 (743)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ ++ |+|+||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 124678999999999999999999998 88 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccC-CCCc-cccchhHHHHHHHHHhcCCCCCCCcccCC
Q 041312 557 LDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFST-KSDVYSFGVLLLEIILGRRNNTFHLEQGS 634 (743)
Q Consensus 557 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDiwSlGvil~elltG~~p~~~~~~~~~ 634 (743)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876443 23346789999999999887 6666 999999999999999999998743220
Q ss_pred CccccchhhHhHhccCCcchh------cccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 635 GSWNLVGHVWDLWKEGTAMEA------VDKSLG---ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~------ld~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.........+...-. ..+... ..........+.+++.+||+.||.+|||+.++++
T Consensus 259 ------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111111000 000000 0000111234667888999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.55 Aligned_cols=269 Identities=20% Similarity=0.291 Sum_probs=196.8
Q ss_pred hhhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC-----------hhcHHHHHHHHHHHHhcCCccEEe
Q 041312 414 LSNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS-----------GQGIEEFKTEIALIAQLQHRNLVS 482 (743)
Q Consensus 414 ~~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~-----------~~~~~~~~~Ev~~l~~l~h~niv~ 482 (743)
..++....++|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 446677889999999999999999999998889999999986432 122478999999999999999999
Q ss_pred eeeeEec-----CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe
Q 041312 483 ILGCCIE-----EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL 557 (743)
Q Consensus 483 l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 557 (743)
+++++.. ....++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 9999854 346799999998 577776643 3346899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCc
Q 041312 558 DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS 636 (743)
Q Consensus 558 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~ 636 (743)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----- 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF----- 239 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-----
Confidence 999999999999997543322 2234678999999999887 6789999999999999999999999874321
Q ss_pred cccchhhHhHhccCCcc-----------hhcccccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 637 WNLVGHVWDLWKEGTAM-----------EAVDKSLGES-------CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 637 ~~~~~~~~~~~~~~~~~-----------~~ld~~l~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
................. ..+...+... ........+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111111111111000 0000000000 001112346788889999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.20 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=194.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEE 490 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~ 490 (743)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4467999999999999999999976 58899999986432 12234588999999999999999999998765
Q ss_pred CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEee
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISD 567 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~D 567 (743)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999888743 346889999999999999999999998 999999999999987654 99999
Q ss_pred eccccccCCCccccccccccccccccCcceec---cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW 644 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 644 (743)
||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ..+ .
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~----~ 229 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSL----K 229 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCH----H
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHH----H
Confidence 999987654321 23357899999999974 467899999999999999999999998643221 111 1
Q ss_pred hHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 645 DLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 645 ~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.....+.... . +.+.. .....+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~-~-~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 DQITSGKYNF-I-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHTCCCC-C-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhCcccc-C-chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111111100 0 00000 11235678888999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=323.21 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=202.2
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---------hhcHHHHHHHHHHHHhcC-CccEEeeeeeE
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---------GQGIEEFKTEIALIAQLQ-HRNLVSILGCC 487 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~ 487 (743)
...++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44578999999999999999999986 68999999986542 123467889999999995 99999999999
Q ss_pred ecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEee
Q 041312 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 488 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999853 346889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceec------cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccch
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAM------EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVG 641 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~ 641 (743)
||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.|+..... .
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~---- 235 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----M---- 235 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----H----
Confidence 999987654322 23467899999999885 45688999999999999999999999864321 0
Q ss_pred hhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 642 ~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........+... ...+........+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 LMLRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 011111111110 000011122345678888999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=332.72 Aligned_cols=259 Identities=22% Similarity=0.261 Sum_probs=190.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------ 491 (743)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999975 6889999998753 3445677899999999999999999999997664
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6766652 24788999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH-----
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL----- 646 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~----- 646 (743)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-----DQWNKVIEQLGTPC 246 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHC-CCCCC
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCC
Confidence 8764332 123467899999999999999999999999999999999999998643210 000000000
Q ss_pred --------------hccC------CcchhcccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 --------------WKEG------TAMEAVDKSLGESC---CAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 --------------~~~~------~~~~~ld~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.... .........+.... .......+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 00000000000000 11124567889999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.01 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=193.1
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-------
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE------- 489 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------- 489 (743)
....++|++.++||+|+||.||+|+.. +|+.||||++...... ..+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999974 7999999998654322 2479999999999999999999844
Q ss_pred -------------------------------CCeeEEEEEecCCCChhhhhhhc-ccccccCHHHHHHHHHHHHHHHHHh
Q 041312 490 -------------------------------EQEKMLIYEYLPNKSLDVYIFDE-AKRSLLDWSKRFEIICGIARGILYL 537 (743)
Q Consensus 490 -------------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yL 537 (743)
....++||||++ ++|.+.+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999998 5777766542 2345789999999999999999999
Q ss_pred hccCCCceEeccCCCCcEEec-CCCCeEEeeeccccccCCCccccccccccccccccCcceeccC-CCCccccchhHHHH
Q 041312 538 HQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVL 615 (743)
Q Consensus 538 H~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvi 615 (743)
|+++ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999997 688999999999987644332 2335789999999998875 48999999999999
Q ss_pred HHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc----------h-----hcccccCCCCCHHHHHHHHHHHHHhc
Q 041312 616 LLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM----------E-----AVDKSLGESCCAPEILRCIHLGLLCV 680 (743)
Q Consensus 616 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~-----~ld~~l~~~~~~~~~~~l~~l~~~cl 680 (743)
+|||++|+.||..... ................. + .....+...........+.+++.+||
T Consensus 232 l~ell~g~~pf~~~~~-----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 232 FGELILGKPLFSGETS-----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 9999999999875322 11111111111100000 0 00000000011112234678888999
Q ss_pred ccCCCCCCCHHHHHH
Q 041312 681 QEQATDRPNMSAVVS 695 (743)
Q Consensus 681 ~~dP~~RPs~~evl~ 695 (743)
+.||++|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.26 Aligned_cols=259 Identities=23% Similarity=0.305 Sum_probs=183.0
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------ 490 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------ 490 (743)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3468999999999999999999965 6899999998653 344567888999999999999999999998754
Q ss_pred CeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 491 QEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
...++|||++ +++|..++.. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 7889888732 46899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.+....
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~ 248 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGT 248 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCS
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCC
Confidence 9865432 234678999999999987 6789999999999999999999999864321 1111111111100
Q ss_pred C-----------Ccchhccccc-CCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 G-----------TAMEAVDKSL-GESCCAP-----EILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ~-----------~~~~~ld~~l-~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. .....+.... ....... ....+.+|+.+||+.||.+|||+.++++.
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000000000 0000111 12346788889999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.81 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=198.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
..++|++.+.||+|+||.||+|+... .+|+|++... .....+.+.+|+.++++++|+||+++++++.+....++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999998764 5999998643 2334456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999998542 345888999999999999999999998 99999999999998 679999999998765322
Q ss_pred cc---ccccccccccccccCcceecc---------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh
Q 041312 578 QI---EENTNRVVGTYGYMAPEYAME---------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD 645 (743)
Q Consensus 578 ~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 645 (743)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~ 253 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---------AIIW 253 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---------HHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHH
Confidence 11 122233568999999999874 45788999999999999999999998643211 1111
Q ss_pred HhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 041312 646 LWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAP 703 (743)
Q Consensus 646 ~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 703 (743)
....+........ ... ..+.+++..||+.+|++|||+.+|+++|+.+...
T Consensus 254 ~~~~~~~~~~~~~-----~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 254 QMGTGMKPNLSQI-----GMG---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHTTCCCCCCCS-----SCC---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HhccCCCCCCCcC-----CCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111111 111 2366788899999999999999999999988663
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=341.14 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=202.4
Q ss_pred cCCCCcCcccccCCceeEEEEEE-cCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC-ccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-RNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||.||+|+. .+++.||||++..... ..++..|+++++.++| +++..+..++.+....+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999997 4699999998764432 2357899999999987 566666677778888999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---cCCCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL---DAAMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~vkl~DFGla~~~~ 575 (743)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999988532 346899999999999999999999998 9999999999999 688999999999998775
Q ss_pred CCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 576 GDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 576 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~----~~~i~~~ 231 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQK----YEKISEK 231 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SHHHH----HHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--hHHHH----HHHHhhc
Confidence 44321 1123568999999999999999999999999999999999999998753221 11111 1111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
.....++. +...+ ...+.+++..||+.+|++||++.+|+++|+.+
T Consensus 232 ~~~~~~~~-l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 232 KVATSIEA-LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHSCHHH-HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccccHHH-HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111110 00111 23567788899999999999999999998765
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=331.67 Aligned_cols=270 Identities=18% Similarity=0.213 Sum_probs=190.4
Q ss_pred hhHHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe-
Q 041312 415 SNIAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE- 492 (743)
Q Consensus 415 ~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~- 492 (743)
.......++|.+.++||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999985 68999999986542 333466788889999999999999999975433
Q ss_pred ------eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhh--ccCCCceEeccCCCCcEEecC-CCCe
Q 041312 493 ------KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH--QDSRLRIIHRDLKASNVLLDA-AMNP 563 (743)
Q Consensus 493 ------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~ivH~Dikp~NIll~~-~~~v 563 (743)
.++||||++++.+..+.........+++..+..++.||+.||.||| +++ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987544333222234556888999999999999999999 887 999999999999996 8999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~~ 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQLHE 243 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-----HHHHHH
Confidence 9999999987654332 2345789999999998765 489999999999999999999999875322 111111
Q ss_pred hHhHhccC-----------C-cchhcc------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 643 VWDLWKEG-----------T-AMEAVD------KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 643 ~~~~~~~~-----------~-~~~~ld------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
........ . .....+ ..+...........+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111000 0 000000 000011112234567789999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=339.09 Aligned_cols=198 Identities=22% Similarity=0.272 Sum_probs=171.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc------CCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL------QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l------~h~niv~l~~~~~~~~~~ 493 (743)
..+|++.++||+|+||.||+|... +++.||||++... .....++.+|+.+++.+ .|+||+++++.+......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999976 5899999999643 34456778888888887 567999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC--eEEeeeccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN--PKISDFGMA 571 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--vkl~DFGla 571 (743)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 58888775432 234889999999999999999999998 999999999999999887 999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765432 22367899999999999999999999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.06 Aligned_cols=263 Identities=20% Similarity=0.290 Sum_probs=199.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----Cee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~~ 493 (743)
.++|++.++||+|+||.||+++.. +++.||||++... .......+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999976 6889999999754 344457889999999999999999999998755 468
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+. ++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58887773 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-ccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 574 FGGDQIEE-NTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 574 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPS 252 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSCC
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 65332211 1234689999999998765 4589999999999999999999999864322 111111111111000
Q ss_pred cc-----------hhccccc-CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 652 AM-----------EAVDKSL-GESCC-----APEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 652 ~~-----------~~ld~~l-~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. ....... ..... ......+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000 00000 0112346788889999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=323.15 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=191.8
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec---------
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--------- 489 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--------- 489 (743)
..++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3457899999999999999999975 789999999854 34456789999999999999999999998865
Q ss_pred ----CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEE
Q 041312 490 ----EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKI 565 (743)
Q Consensus 490 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl 565 (743)
....++||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+|+||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 35679999999999999998542 345778889999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCcc------------ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCccc
Q 041312 566 SDFGMARIFGGDQI------------EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQ 632 (743)
Q Consensus 566 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~ 632 (743)
+|||++........ ........||+.|+|||++.+. .++.++|||||||++|||++ |+.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~- 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME- 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence 99999987643210 1122345789999999999864 68999999999999999998 4331110
Q ss_pred CCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 633 GSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. .......... ...+...........+.+++.+||+.||.+|||+.++++
T Consensus 234 ------~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 ------R-VNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ------H-HHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------H-HHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 0011111111 111112222333345678888999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.61 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=154.2
Q ss_pred CCCc-CcccccCCceeEEEEEEc---CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEEE
Q 041312 423 DFSS-DNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKMLI 496 (743)
Q Consensus 423 ~y~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lV 496 (743)
.|.+ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 468999999999999975 57899999986543 23468899999999999999999999954 6789999
Q ss_pred EEecCCCChhhhhhhcc------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe----cCCCCeEEe
Q 041312 497 YEYLPNKSLDVYIFDEA------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL----DAAMNPKIS 566 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~vkl~ 566 (743)
|||+.+ +|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||| +..+.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 6666654321 1224899999999999999999999998 9999999999999 677899999
Q ss_pred eeccccccCCCcc-ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCc
Q 041312 567 DFGMARIFGGDQI-EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHL 630 (743)
Q Consensus 567 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~ 630 (743)
|||+++.+..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987654321 1223346899999999999874 58999999999999999999999997543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.85 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=200.8
Q ss_pred cCCCCcCcccccCCceeEEEEEE-c-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc------EEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVL-Q-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN------LVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~-~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n------iv~l~~~~~~~~~ 492 (743)
.++|++.++||+|+||.||++.. . +++.||||++... ....+.+.+|+.++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999997 3 6889999998543 445678899999999997765 9999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-------------
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA------------- 559 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~------------- 559 (743)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889988875432 235889999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC
Q 041312 560 ------AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633 (743)
Q Consensus 560 ------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~ 633 (743)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK- 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence 668999999999865432 23467899999999999999999999999999999999999998753221
Q ss_pred CCccccchhhHhHhccCCcchh------------------------------ccccc-CCCCCHHHHHHHHHHHHHhccc
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEA------------------------------VDKSL-GESCCAPEILRCIHLGLLCVQE 682 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~------------------------------ld~~l-~~~~~~~~~~~l~~l~~~cl~~ 682 (743)
........... ...... ..+.. ...........+.+++.+||+.
T Consensus 241 ----~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 ----EHLAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp ----HHHHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ----HHHHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 00000000000 000000 00000 0011234456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 041312 683 QATDRPNMSAVVS 695 (743)
Q Consensus 683 dP~~RPs~~evl~ 695 (743)
||.+|||+.||++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=339.90 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=189.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------CeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------QEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~ 494 (743)
.+|++.++||+|+||.||+|++. +++.||||++..... .+.+|++++++++|+||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888899999999999999986 699999999865432 234799999999999999999998542 2367
Q ss_pred EEEEecCCCChhhhhhh-cccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-CCeEEeeecccc
Q 041312 495 LIYEYLPNKSLDVYIFD-EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMAR 572 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~vkl~DFGla~ 572 (743)
+||||+++ +|...+.. ......+++..+..++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 45444432 233457899999999999999999999998 9999999999999965 568999999998
Q ss_pred ccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC-
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG- 650 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 650 (743)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...+...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-----~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-----VDQLVEIIKVLGTPT 277 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCSCC
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCC
Confidence 7643322 2336789999999999765 799999999999999999999999874321 11111111111000
Q ss_pred ---------CcchhcccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 ---------TAMEAVDKSLGES-----CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ---------~~~~~ld~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...+..-+.+... +.......+.+|+.+||+.||.+||++.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000000001000 01111245678888999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.85 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=192.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEe-----------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI----------- 488 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~----------- 488 (743)
.++|.+.++||+|+||.||+|+.. +++.||+|++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367899999999999999999987 58999999998777777889999999999999999999998874
Q ss_pred ---cCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeE
Q 041312 489 ---EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPK 564 (743)
Q Consensus 489 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vk 564 (743)
+....++||||++ ++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 68988873 345889999999999999999999998 99999999999997 567899
Q ss_pred EeeeccccccCCCcc-ccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 565 ISDFGMARIFGGDQI-EENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 565 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
|+|||+++....... ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~ 236 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-----EQMQL 236 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 999999987643321 112233567999999998876 67899999999999999999999998743221 11111
Q ss_pred hHhHhcc----------CCcchhcccccCCC-CC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 643 VWDLWKE----------GTAMEAVDKSLGES-CC-----APEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 643 ~~~~~~~----------~~~~~~ld~~l~~~-~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....... ......+....... .. ......+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1100000 00000000000000 00 011235678888999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.38 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=176.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHH-HHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIA-LIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++|++.+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888999999999999999985 78999999997653 334455666666 777789999999999999999999999
Q ss_pred EecCCCChhhhhhhc--ccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 498 EYLPNKSLDVYIFDE--AKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 498 E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
||+++ +|.+++... .....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 776666431 1245788999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCccee----ccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYA----MEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .... ...+
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~-~~~~ 245 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQ-VVKG 245 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CC-CCCS
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HHHH-HhcC
Confidence 43321 2234789999999998 456789999999999999999999999864321100 0000 0001
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... .+...........+.+++.+||+.||++||++.+|++
T Consensus 246 ~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111 1111111112234667888999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.08 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=196.7
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-----Ce
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-----QE 492 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-----~~ 492 (743)
..++|.+.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3468999999999999999999976 6899999999654 334556788999999999999999999988754 67
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 588877743 46889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc--------ccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 573 IFGGDQIEE--------NTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 573 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~ 235 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-----HQLLLI 235 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHH
Confidence 765332111 1223578999999998765 67899999999999999999999998743210 000000
Q ss_pred HhHhccCC------------cchhccccc-CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 644 WDLWKEGT------------AMEAVDKSL-GESC-----CAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 644 ~~~~~~~~------------~~~~ld~~l-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........ ..+.+.... .... .......+.+++.+||+.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 000000000 0000 0011234667888999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.76 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=200.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-----------CccEEeeeeeEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-----------HRNLVSILGCCI 488 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----------h~niv~l~~~~~ 488 (743)
.++|.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++++. |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999999999999974 7899999998643 344567889999999886 889999999988
Q ss_pred cCC----eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEec-----
Q 041312 489 EEQ----EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLD----- 558 (743)
Q Consensus 489 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~----- 558 (743)
... ..++|||++ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 899998885432 34588999999999999999999998 8 99999999999994
Q ss_pred -CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCC-Cc
Q 041312 559 -AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGS-GS 636 (743)
Q Consensus 559 -~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~-~~ 636 (743)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999876432 2335789999999999999999999999999999999999999875432100 00
Q ss_pred cccchhhHhHhcc------------------CCcchhccc--------cc--CCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 041312 637 WNLVGHVWDLWKE------------------GTAMEAVDK--------SL--GESCCAPEILRCIHLGLLCVQEQATDRP 688 (743)
Q Consensus 637 ~~~~~~~~~~~~~------------------~~~~~~ld~--------~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RP 688 (743)
............. ......+.. .+ ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0001111110000 000000000 00 1123455567788999999999999999
Q ss_pred CHHHHHH--HhcCC
Q 041312 689 NMSAVVS--MLGSD 700 (743)
Q Consensus 689 s~~evl~--~L~~~ 700 (743)
|++||++ .+.+.
T Consensus 327 t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 327 DAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHTCGGGTTC
T ss_pred CHHHHhhChhhhcc
Confidence 9999998 34443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.61 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=194.3
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee---
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK--- 493 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~--- 493 (743)
..++|.+.++||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468899999999999999999976 6899999999754 334467889999999999999999999999877655
Q ss_pred ---EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecc
Q 041312 494 ---MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGM 570 (743)
Q Consensus 494 ---~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGl 570 (743)
++||||+. ++|..++ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 5776665 234889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~ 260 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGV 260 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCC
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCC
Confidence 9865432 233678999999999987 6899999999999999999999999874321 1111111110000
Q ss_pred C-----------CcchhcccccCC-CC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 G-----------TAMEAVDKSLGE-SC-----CAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ~-----------~~~~~ld~~l~~-~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. .....+...... .. .......+.+|+.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000000 00 01112456788889999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=355.79 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=200.7
Q ss_pred HcCCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
..++|.+.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678889999999999999999742 567999998754 3445578999999999999999999999985 45689
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998532 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... . ........+...
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~----~~~~~i~~~~~~ 611 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----N----DVIGRIENGERL 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H----HHHHHHHHTCCC
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----H----HHHHHHHcCCCC
Confidence 543321 1223566789999999999999999999999999999997 8888764321 0 111111111111
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. + +......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 612 ~-----~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 P-----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----C----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 1 111123466788899999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.90 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=201.3
Q ss_pred HHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 418 AAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 418 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
....++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999999986 6899999998643 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC---CCeEEeeeccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA---MNPKISDFGMA 571 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~vkl~DFGla 571 (743)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999888753 345889999999999999999999998 9999999999999754 46999999999
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... . ........+.
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~----~~~~~~~~~~ 238 (287)
T 2wei_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y----DILKRVETGK 238 (287)
T ss_dssp GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCC
T ss_pred eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHcCC
Confidence 87654321 223468999999998875 489999999999999999999999864321 0 1112222221
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....... . . .....+.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~~-~-~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFDLPQ-W-R----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCSGG-G-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCchh-h-h----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1100000 0 0 11234667888999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.87 Aligned_cols=200 Identities=22% Similarity=0.306 Sum_probs=170.9
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-Cc-----cEEeeeeeEecCC
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HR-----NLVSILGCCIEEQ 491 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~-----niv~l~~~~~~~~ 491 (743)
...++|++.++||+|+||+||+|+.. +++.||||++... .....++..|+.+++.+. |+ +|+++++++....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999976 6889999999643 344567888999998885 44 4999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc--cCCCceEeccCCCCcEEec--CCCCeEEee
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ--DSRLRIIHRDLKASNVLLD--AAMNPKISD 567 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--~~~~~ivH~Dikp~NIll~--~~~~vkl~D 567 (743)
..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++ .++.+||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999996 48888875432 2358899999999999999999995 45 99999999999994 577899999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876433 23467899999999999999999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.81 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=196.5
Q ss_pred HcCCCCcCcccccCCceeEEEEEE--cCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhc---CCccEEeeeeeEe----
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVL--QNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQL---QHRNLVSILGCCI---- 488 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~---- 488 (743)
+.++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 368899999986432 22223566777777666 8999999999987
Q ss_pred -cCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEee
Q 041312 489 -EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 489 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
.....++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 58988875432 334889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVI 235 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHc
Confidence 99998664322 23346789999999999999999999999999999999999999874321 11111111110
Q ss_pred ccCCc----------chhcccc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 648 KEGTA----------MEAVDKS---LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 648 ~~~~~----------~~~ld~~---l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..... ....... ............+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000000 000011112234667888999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.87 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=171.6
Q ss_pred HcCCCCcCc-ccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEec----CCee
Q 041312 420 ATNDFSSDN-KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIE----EQEK 493 (743)
Q Consensus 420 ~~~~y~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~ 493 (743)
..++|.+.+ .||+|+||.||+++.. +++.||||++.... ....+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456788855 5999999999999987 69999999986532 222233344667799999999999876 4558
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeeecc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDFGM 570 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DFGl 570 (743)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986432 246899999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
+....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ............
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~ 248 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-----ISPGMKRRIRLG 248 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh-----hhhhHHHhhhcc
Confidence 98664332 234678999999999988899999999999999999999999986543210 000000000000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ..+...........+.+++..||+.||.+|||+.++++
T Consensus 249 ~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 Q------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000011112234667888999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.48 Aligned_cols=257 Identities=20% Similarity=0.316 Sum_probs=193.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe-----
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE----- 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~----- 492 (743)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999999999999975 6899999998654 33446788999999999999999999999987654
Q ss_pred -eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 493 -KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 493 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
.++||||+. ++|..++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 57877662 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc-
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE- 649 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 649 (743)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVP 243 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHHHHHHHHCBC
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 865432 233578999999999887 6789999999999999999999999874321 0111111110000
Q ss_pred ----------CCcchh---cccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 650 ----------GTAMEA---VDKSLG---ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 650 ----------~~~~~~---ld~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
...... +..... ..........+.+++.+||+.||++|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 000000 00111223456778889999999999999999863
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.79 Aligned_cols=207 Identities=16% Similarity=0.157 Sum_probs=159.4
Q ss_pred ccccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEE
Q 041312 2 ISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLC 81 (743)
Q Consensus 2 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~ 81 (743)
++.|||++||+|++|++| ++|.|+|||+.+++ +.+|+ . +|+||+|||+.| ..+.|+|+.||+|||.
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~-~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD-S---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE-S---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEE-C---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 467999999999999999 49999999987665 33443 2 799999999998 4678999999999999
Q ss_pred eCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccc-cccccccccc-cCCC-----ceeEEe
Q 041312 82 GRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATM-LPYMKIGLDK-RSGL-----NRFLTS 154 (743)
Q Consensus 82 ~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtl-lpg~kl~~~~-~~g~-----~~~l~S 154 (743)
|.++. +||+|++.... ....|+|+|+|||||++ .++||||||||||+ ||+| |.+. .+|+ ++.|+|
T Consensus 72 d~~~~-~vW~s~~~~~~-~~~~~~l~d~Gnlvl~~----~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s 143 (236)
T 1dlp_A 72 TAQNT-IRWSSGTKGSI-GNYVLVLQPDRTVTIYG----PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA 143 (236)
T ss_dssp CTTTC-CSCCCCCCCCS-SCCEEEECSSSCEEEEC----SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS
T ss_pred cCCCc-EEEeCCccccC-CcEEEEEeCCCCEEEec----CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc
Confidence 86555 59999986432 34579999999999983 28999999999887 6665 5554 5554 567874
Q ss_pred ccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecccCCccce---------e-eeeeecCCcEEEEEEeeCCCeEEE
Q 041312 155 WKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSWTGKNFL---------N-ATYIDNEDEVSMAYSVTDPSMLTR 224 (743)
Q Consensus 155 w~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~w~g~~~~---------~-~~~~~~~~~~~~~~~~~~~s~~~r 224 (743)
.+||++|.|+|+++++| +++++++..+||++++|++. +. + ..|..++++++.+|...+. ...|
T Consensus 144 ---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~~r 216 (236)
T 1dlp_A 144 ---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRYV 216 (236)
T ss_dssp ---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCCE
T ss_pred ---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CCEE
Confidence 78999999999999999 57888888899999999653 22 1 1222233344444443333 3589
Q ss_pred EEEccCCcEEEEE
Q 041312 225 IVVNESGNEQRLT 237 (743)
Q Consensus 225 ~~l~~~G~l~~~~ 237 (743)
++|+.||++++|.
T Consensus 217 l~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 217 FVLQPDRNLAIYG 229 (236)
T ss_dssp EEECSSSCEEEEC
T ss_pred EEEcCCCcEEEeC
Confidence 9999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=318.68 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=189.7
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhc----CCccEEeeee
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQL----QHRNLVSILG 485 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l----~h~niv~l~~ 485 (743)
.....++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455678999999999999999999874 688999999965432 1233456799999999 8999999999
Q ss_pred eEecCCeeEEEEEe-cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCe
Q 041312 486 CCIEEQEKMLIYEY-LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNP 563 (743)
Q Consensus 486 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~v 563 (743)
++...+..++|||+ +.+++|.+++.. ...+++..++.++.||++||.|||+++ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999854 345899999999999999999999998 99999999999999 88999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCC-ccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFS-TKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGH 642 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 642 (743)
||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 999999998765432 2346789999999999877664 589999999999999999999863211
Q ss_pred hHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 643 VWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
... ... .+.. .....+.+++.+||+.+|++|||+.+|++.
T Consensus 245 ---~~~-~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ---ILE-AEL------HFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HHH-TCC------CCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---Hhh-hcc------CCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000 0111 112346678889999999999999999983
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=331.08 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=184.5
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEecC
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556889999999998777778999999998643 345678999999986 89999999999999999999999995
Q ss_pred CCChhhhhhhccccc----ccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC-------------CCeE
Q 041312 502 NKSLDVYIFDEAKRS----LLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-------------MNPK 564 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-------------~~vk 564 (743)
++|.+++....... ...+..++.++.||+.||.|||+++ |+||||||+|||++.+ ..+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999886432211 1133345789999999999999998 9999999999999754 4799
Q ss_pred EeeeccccccCCCccc--cccccccccccccCcceecc-------CCCCccccchhHHHHHHHHHh-cCCCCCCCcccCC
Q 041312 565 ISDFGMARIFGGDQIE--ENTNRVVGTYGYMAPEYAME-------GLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGS 634 (743)
Q Consensus 565 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~ 634 (743)
|+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-- 246 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-- 246 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence 9999999887544321 12234689999999999976 668999999999999999999 89888633210
Q ss_pred CccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 635 GSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
............ .+...........+.+++.+||+.||.+|||+.+|++
T Consensus 247 --------~~~i~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 --------ESNIIRGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --------HHHHHHTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHHhcCCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 001111000000 0111112334456788999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.74 Aligned_cols=258 Identities=18% Similarity=0.249 Sum_probs=197.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CC-cEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc------EEeeeeeEecCCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NG-KEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN------LVSILGCCIEEQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n------iv~l~~~~~~~~~ 492 (743)
.++|++.++||+|+||.||+++.. ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999975 34 68999998643 445677889999999998766 8999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEe---------------
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLL--------------- 557 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll--------------- 557 (743)
.++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55665555432 2245889999999999999999999998 9999999999999
Q ss_pred ----cCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC
Q 041312 558 ----DAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633 (743)
Q Consensus 558 ----~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~ 633 (743)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR- 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 56789999999999865432 23467899999999999999999999999999999999999998743211
Q ss_pred CCccccchhhHhHhccCCcchh------------------------------ccc-ccCCCCCHHHHHHHHHHHHHhccc
Q 041312 634 SGSWNLVGHVWDLWKEGTAMEA------------------------------VDK-SLGESCCAPEILRCIHLGLLCVQE 682 (743)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~------------------------------ld~-~l~~~~~~~~~~~l~~l~~~cl~~ 682 (743)
........... ...... ..+ .........+...+.+++.+||+.
T Consensus 246 ----~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 246 ----EHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ----HHHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ----HHHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 01111111000 000000 000 000011223445688899999999
Q ss_pred CCCCCCCHHHHHH
Q 041312 683 QATDRPNMSAVVS 695 (743)
Q Consensus 683 dP~~RPs~~evl~ 695 (743)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.31 Aligned_cols=242 Identities=22% Similarity=0.392 Sum_probs=196.9
Q ss_pred HHcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhcC--CccEEeeeeeEec
Q 041312 419 AATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQLQ--HRNLVSILGCCIE 489 (743)
Q Consensus 419 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~ 489 (743)
...++|.+.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++++. |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34578999999999999999999975 689999999865421 12245678999999996 5999999999999
Q ss_pred CCeeEEEEEecCC-CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEee
Q 041312 490 EQEKMLIYEYLPN-KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISD 567 (743)
Q Consensus 490 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~D 567 (743)
.+..++|||++.+ ++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999976 899988853 346889999999999999999999998 99999999999999 788999999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------~ 255 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------I 255 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------------h
Confidence 99998765432 233578999999999987765 7889999999999999999999863211 0
Q ss_pred hccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 647 WKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 647 ~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. ... .+.... . ..+.+++.+||+.||++|||+++|++
T Consensus 256 ~~-~~~------~~~~~~-~---~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IR-GQV------FFRQRV-S---SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HH-CCC------CCSSCC-C---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hc-ccc------cccccC-C---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 011111 1 34667888999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.54 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=184.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
.+|.+.++||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +|||||++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 358888999999999977666678999999998654322 356899999999 7999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-----CCCeEEeeeccccccC
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-----AMNPKISDFGMARIFG 575 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~vkl~DFGla~~~~ 575 (743)
. ++|.+++.... ..+....+..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++.+.
T Consensus 101 ~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 6 58988875432 22344456789999999999999998 999999999999953 3458899999998765
Q ss_pred CCccc-cccccccccccccCcceec---cCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 576 GDQIE-ENTNRVVGTYGYMAPEYAM---EGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 576 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----------~~~~~~~~ 244 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----------QANILLGA 244 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----------HHHHHTTC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----------HHHHHhcc
Confidence 43211 2233467999999999997 4567889999999999999999 88887532110 01111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
....... ........+.+++.+||+.||.+|||+.+|++
T Consensus 245 ~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111 11223344678889999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.17 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=176.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG--QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999986 789999999975532 22334555566788889999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
||+ ++.+..+... ....+++..+..++.||++||.|||++ + |+|+||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455444322 235688999999999999999999985 8 99999999999999999999999999976643
Q ss_pred CccccccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
... .....||+.|+|||++. ...++.++||||||+++|||++|+.||..... . ......... +.
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~---~~~~~~~~~-~~ 246 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----D---FEVLTKVLQ-EE 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----H---HHHHHHHHH-SC
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----c---HHHHHHHhc-cC
Confidence 321 23357899999999984 45688999999999999999999999864221 0 011111111 11
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... +.... .....+.+++.+||+.||.+||++.+|++
T Consensus 247 ~~~-----~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPL-----LPGHM--GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCC-----CCSSS--CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCC-----CCccC--CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 11000 11234667888999999999999999876
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=341.18 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=198.1
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec------CC
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE------EQ 491 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------~~ 491 (743)
..++|++.++||+|+||.||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999975 6899999998754 44556789999999999999999999998765 67
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCC---eEEeee
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMN---PKISDF 568 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---vkl~DF 568 (743)
..++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 78999999999999999876554456888999999999999999999998 999999999999997765 999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHh-Hh
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWD-LW 647 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~ 647 (743)
|++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........-.......... ..
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 99987654332 234689999999999999999999999999999999999999986432100000000000000 00
Q ss_pred ccCCcchh--ccccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041312 648 KEGTAMEA--VDKSL--GESCCAPEILRCIHLGLLCVQEQATDRPNMSA 692 (743)
Q Consensus 648 ~~~~~~~~--ld~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 692 (743)
........ ....+ ...........+.+++..||+.||++|||+.+
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000000 00000 11233344567888999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=340.22 Aligned_cols=238 Identities=20% Similarity=0.303 Sum_probs=191.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc--CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCe-----
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ--NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQE----- 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~----- 492 (743)
.++|++.++||+|+||.||++.+. +++.||||++... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999986 5899999998644 34556788999999999999999999999987665
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 6899999999999999999999998 9999999999999885 89999999998
Q ss_pred ccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+....... .
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------L 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------C
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------c
Confidence 76433 3467999999999987664 889999999999999999988765321100 0
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhcC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-MSAVVSMLGS 699 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~ 699 (743)
.. ..........+.+++.+||+.||++||+ ++++...|.+
T Consensus 285 ~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 PE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 0000111235678888999999999995 6666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.98 Aligned_cols=232 Identities=10% Similarity=0.056 Sum_probs=181.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999986 58999999997553 34457899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. . .....+..++.||+.||.|||+++ |+||||||+|||++.++.+||+++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~-------- 173 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP-------- 173 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC--------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec--------
Confidence 999999999999832 2 244567889999999999999998 999999999999999999999743
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
+|++| ++.++|||||||++|||++|+.||....... ............ ...
T Consensus 174 --------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~-~~~-- 224 (286)
T 3uqc_A 174 --------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRS-----GLAPAERDTAGQ-PIE-- 224 (286)
T ss_dssp --------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCC-----CSEECCBCTTSC-BCC--
T ss_pred --------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcch-----hhHHHHHHhccC-CCC--
Confidence 33443 6889999999999999999999987543211 000000000000 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
...+.... ...+.+++.+||+.||++| |+.++++.|+.+..
T Consensus 225 ~~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 225 PADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00011111 1346678889999999999 99999999987544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.59 Aligned_cols=241 Identities=16% Similarity=0.174 Sum_probs=176.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCC-ccE---------------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQH-RNL--------------- 480 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h-~ni--------------- 480 (743)
...|...+.||+|+||.||+|++. +|+.||||++.... ....+.+++|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777789999999999999965 79999999987332 2346789999999999987 211
Q ss_pred Eee------eeeEec-----CCeeEEEEEecCCCChhhhhhh----cccccccCHHHHHHHHHHHHHHHHHhhccCCCce
Q 041312 481 VSI------LGCCIE-----EQEKMLIYEYLPNKSLDVYIFD----EAKRSLLDWSKRFEIICGIARGILYLHQDSRLRI 545 (743)
Q Consensus 481 v~l------~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 545 (743)
+.+ +.++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111 111111 12346666654 6889888742 122456788899999999999999999998 9
Q ss_pred EeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccccccccCccee----------ccCCCCccccchhHHHH
Q 041312 546 IHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA----------MEGLFSTKSDVYSFGVL 615 (743)
Q Consensus 546 vH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDiwSlGvi 615 (743)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865432 334577 999999999 55568889999999999
Q ss_pred HHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 041312 616 LLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 616 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 694 (743)
+|||++|+.||....... .. ...+... ... + ..+.+++..||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~-----~~------------~~~~~~~--~~~-~---~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG-----GS------------EWIFRSC--KNI-P---QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS-----CS------------GGGGSSC--CCC-C---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh-----hH------------HHHHhhc--ccC-C---HHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999986433210 00 0011100 011 1 3466788899999999999976654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.42 Aligned_cols=228 Identities=21% Similarity=0.247 Sum_probs=176.1
Q ss_pred HcCCCCcC-cccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHH-HhcCCccEEeeeeeEec----CCe
Q 041312 420 ATNDFSSD-NKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALI-AQLQHRNLVSILGCCIE----EQE 492 (743)
Q Consensus 420 ~~~~y~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l-~~l~h~niv~l~~~~~~----~~~ 492 (743)
..++|.+. +.||+|+||.||++... +++.||+|++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34567776 77999999999999975 6899999998542 4567888888 55699999999999876 677
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeeec
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDFG 569 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DFG 569 (743)
.++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 89999999999999998653 2346899999999999999999999998 999999999999998 7889999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
++.... +..++.++|||||||++|||++|+.||....... .. .
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~--------~ 208 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----IS--------P 208 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------C
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----hh--------H
Confidence 986532 2346788999999999999999999986432210 00 0
Q ss_pred CCcchhcccccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCA----PEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
........... .... .....+.+++.+||+.||++|||+.|+++
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 GMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000000 0010 11234677888999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.09 Aligned_cols=242 Identities=15% Similarity=0.136 Sum_probs=180.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC--------hhcHHHHHHHHHHHHhcC---------CccEEee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS--------GQGIEEFKTEIALIAQLQ---------HRNLVSI 483 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~Ev~~l~~l~---------h~niv~l 483 (743)
.++|++.++||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999998 68999999997542 234578899999999886 6666555
Q ss_pred eee-----------------Eec-------------CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHH
Q 041312 484 LGC-----------------CIE-------------EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARG 533 (743)
Q Consensus 484 ~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~ 533 (743)
.+. +.+ ....++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 333 6789999999999977666532 457899999999999999
Q ss_pred HHHhh-ccCCCceEeccCCCCcEEecCCC--------------------CeEEeeeccccccCCCccccccccccccccc
Q 041312 534 ILYLH-QDSRLRIIHRDLKASNVLLDAAM--------------------NPKISDFGMARIFGGDQIEENTNRVVGTYGY 592 (743)
Q Consensus 534 L~yLH-~~~~~~ivH~Dikp~NIll~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y 592 (743)
|.||| +++ |+||||||+||||+.++ .+||+|||+|+..... ..+||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 898 99999999999999887 8999999999876432 35899999
Q ss_pred cCcceeccCCCCccccchhHHHH-HHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHH
Q 041312 593 MAPEYAMEGLFSTKSDVYSFGVL-LLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILR 671 (743)
Q Consensus 593 ~aPE~~~~~~~~~ksDiwSlGvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~ 671 (743)
+|||++.+.. +.++||||++++ .+++++|..|+.... ......+........ ...............
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHYLTDKMLKQMTF---KTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHHHHHHHHHTCCC---SSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhhHHHHhhhhhhcc---CcccchhhhhhcCHH
Confidence 9999998776 899999998777 778888988863210 000000111000000 000000111233456
Q ss_pred HHHHHHHhcccCCCCCCCHHHHH
Q 041312 672 CIHLGLLCVQEQATDRPNMSAVV 694 (743)
Q Consensus 672 l~~l~~~cl~~dP~~RPs~~evl 694 (743)
+.+|+.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 888999999966 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-29 Score=288.09 Aligned_cols=186 Identities=19% Similarity=0.164 Sum_probs=132.0
Q ss_pred cccccCCceeEEEEEE-cCCcEEEEEEcccCC----------hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEE
Q 041312 428 NKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSS----------GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~-~~g~~vavK~l~~~~----------~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~l 495 (743)
..++.|++|.+..++. --|+.+++|.+.+.. ....++|.+|+++|+++ +|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3567777777766553 368999999986541 23456799999999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||++|++|.++|.. ...++.. +|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999954 3445543 58899999999999999 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCC
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRN 625 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p 625 (743)
.... .....+||+.|+|||++.+. +..++|+||+|+++++|.++..+
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 4332 23347899999999998764 56789999999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=253.32 Aligned_cols=185 Identities=18% Similarity=0.203 Sum_probs=146.1
Q ss_pred CcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 425 SSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG--------QGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
...++||+|+||.||++. ..++.+++|+...... ...+++.+|++++++++||||+++..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 345789999999999994 4578889887643211 1245689999999999999999777777777888999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998843 4579999999999999998 999999999999999 999999999998754
Q ss_pred Ccccc-----ccccccccccccCcceecc--CCCCccccchhHHHHHHHHHhcCCCC
Q 041312 577 DQIEE-----NTNRVVGTYGYMAPEYAME--GLFSTKSDVYSFGVLLLEIILGRRNN 626 (743)
Q Consensus 577 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDiwSlGvil~elltG~~p~ 626 (743)
..... ......||+.|+|||++.. ..|+.++|+|+..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1235789999999999987 67888999999999998888777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=210.18 Aligned_cols=151 Identities=18% Similarity=0.126 Sum_probs=121.4
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh------------------hcHHHHHHHHHHHHhcCCc
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG------------------QGIEEFKTEIALIAQLQHR 478 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ev~~l~~l~h~ 478 (743)
+.....-|.+.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444456777799999999999999997799999999864321 13567899999999999
Q ss_pred cEEeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 479 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
| +++.+++. .+..++||||+++++|.+ +. ......++.||+.||.|||+++ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 5 66666554 356799999999999987 31 1223469999999999999998 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceecc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 600 (743)
++.+||+|||+++. +..++|||++..
T Consensus 228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999864 235688998753
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-20 Score=167.01 Aligned_cols=108 Identities=15% Similarity=0.306 Sum_probs=91.6
Q ss_pred ccccccCCCCCcCCCCEEE--eCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEE
Q 041312 2 ISVDTITSNQPIKDGDVIV--SSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLV 79 (743)
Q Consensus 2 ~~~~~~~~~~~l~~~~~l~--S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~ 79 (743)
++.|||++||+|.+|++|+ |++|.|+|+|+.+++ + +||++ .++||+||++.| +.++.|+|..|||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 4679999999999999999 999999999998776 2 58875 799999999977 335789999999999
Q ss_pred EEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 80 LCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 80 l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
|.|.++. ++|++++.... ....++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~-~lW~S~~~~~~-g~~~l~l~~~Gnlvl~~----~~~W~S 115 (119)
T 1b2p_A 75 VITNENV-TVWQSPVAGKA-GHYVLVLQPDRNVVIYG----DALWAT 115 (119)
T ss_dssp EECTTCC-EEEECSCCCCS-SCEEEEECTTSCEEEEE----SEEEEC
T ss_pred EEeCCCc-EEEcCCCCCCC-CCEEEEEECCCcEEEEC----ccEeCC
Confidence 9976554 69999976543 35679999999999984 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.8e-20 Score=162.45 Aligned_cols=110 Identities=20% Similarity=0.390 Sum_probs=92.0
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
+|||.+||.|.+|++|+ ++|.|+|+|+..|+ | |||+ ..++||.||++.|. ..+.++|..||||||.+.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 48999999999999999 99999999987776 3 6776 37999999998773 346899999999999976
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCc
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPS 131 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~Pt 131 (743)
++ .++|++++.... ....++|+|+|||||++ . ++||||+||.
T Consensus 69 ~~-~~~W~S~t~~~~-g~~~l~l~~dGnlvl~~-~---~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SN-RVIWQTKTNGKE-DHYVLVLQQDRNVVIYG-P---VVWATGSGPA 110 (110)
T ss_dssp TC-CEEEECCCCCSS-SCCEEEECTTSCEEEEC-S---EEEECSCCC-
T ss_pred CC-cEEEecCCCCCC-CCEEEEEeCCccEEEEC-C---CEecCCCcCC
Confidence 54 469999977543 34579999999999984 2 7999999983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=157.11 Aligned_cols=105 Identities=18% Similarity=0.358 Sum_probs=88.2
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
.|+|.+||.|.+||.|+| |.|.|.|-..++ |.++.. .++||+|||+.|... .+.|+|+.||+|||.|.
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~----~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH----STSTWASNTEIGGKS-GCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCCCTTCC-SCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC----CEEEEEecCCCCCCc-cEEEEEeCCccEEEECC
Confidence 389999999999999998 889999976666 777653 589999999999765 46899999999999976
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
.+. +||+|+++... ...+|+|+|+|||||++ ..||||
T Consensus 69 ~~~-~vWss~t~~~~-~~~~l~L~ddGNlVly~----~~~W~S 105 (105)
T 4h3o_A 69 SGR-SLWASHSTRGS-GNYILILQDDGNVIIYG----SDIWST 105 (105)
T ss_dssp TCC-EEEECCCCCCS-SCEEEEECTTSCEEEEE----SEEEEC
T ss_pred CcE-EEEEecCCCCC-CCEEEEEeCCCeEEEEC----CcEecC
Confidence 555 69999987543 35679999999999983 369998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=159.29 Aligned_cols=110 Identities=21% Similarity=0.304 Sum_probs=90.8
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
.|||.+||+|.+|++|+ +|.|+|+|+.+++ +- +|+ ..++||+||++.|. .++.|+|..+|||||.|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 69999999999999999 8999999987765 32 364 37999999999884 357899999999999975
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcc
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSA 132 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtD 132 (743)
++ .++|++++.... ....|+|+|+|||||++ . ++||||.+++.
T Consensus 69 ~~-~~vW~S~~~~~~-g~~~l~l~~dGnlvl~~-~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NN-NDVWGSACWGDN-GKYALVLQKDGRFVIYG-P---VLWSLGPNGCR 111 (115)
T ss_dssp TC-CEEEECCCCCSS-SCCEEEECTTSCEEEEC-S---EEECSSTTCBC
T ss_pred Cc-eEEEEcCCCCCC-CCEEEEEeCCCeEEEEC-C---CEEECCCCCCc
Confidence 44 469999876432 34579999999999983 2 89999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.4e-19 Score=156.54 Aligned_cols=110 Identities=19% Similarity=0.428 Sum_probs=90.8
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
+|||.+||+|.+|++| ++|.|+|+|+.+++ | +||++ .++||+||++.+ +.++.|+|..+|||||.+
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 5999999999999999 48999999998877 3 35764 689999999864 345789999999999997
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCC
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHP 130 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~P 130 (743)
. +.++|++.+.... ....++|+++|||||++ ..+.++||||+|.
T Consensus 67 ~-~~~~W~S~~~~~~-g~~~l~l~~dGnlvl~~-~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 G-SRAIWASNTNRQN-GNYYLILQRDRNVVIYD-NSNNAIWATHTNV 110 (112)
T ss_dssp T-TEEEEECCCCCSC-CCCEEEECTTSCEEEEC-TTSCEEEECCCCC
T ss_pred C-CEEEEECCccCCC-CCEEEEEeCCCcEEEEC-CCCceEEECCCcc
Confidence 4 4579999876533 34579999999999984 4568999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=178.93 Aligned_cols=136 Identities=15% Similarity=0.162 Sum_probs=105.2
Q ss_pred CCcCcccccCCceeEEEEEE-cCCcE--EEEEEcccCChh------------------------cHHHHHHHHHHHHhcC
Q 041312 424 FSSDNKLGEGGFGSVYKGVL-QNGKE--IAVKRLSRSSGQ------------------------GIEEFKTEIALIAQLQ 476 (743)
Q Consensus 424 y~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ev~~l~~l~ 476 (743)
|.+.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 68999 999987543111 1236789999999998
Q ss_pred CccE--EeeeeeEecCCeeEEEEEecCC-C----ChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhh-ccCCCceEec
Q 041312 477 HRNL--VSILGCCIEEQEKMLIYEYLPN-K----SLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH-QDSRLRIIHR 548 (743)
Q Consensus 477 h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH~ 548 (743)
|+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 333332 356899999942 4 55444321 123456789999999999999 888 9999
Q ss_pred cCCCCcEEecCCCCeEEeeecccccc
Q 041312 549 DLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 549 Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.2e-18 Score=148.30 Aligned_cols=105 Identities=20% Similarity=0.397 Sum_probs=85.8
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
.+||.|||.|.+|++|+ +|.|+|+|...++ |-+ |.. .++||+||++.+ +..+.|.|..||||||.+.
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 47999999999999997 7999999987776 433 654 589999999876 3457899999999999976
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeec
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSF 127 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSF 127 (743)
.+ .++|++++.... ....|+|+|+|||||++ .++|||=
T Consensus 68 ~~-~~~W~S~t~~~~-~~~~~~L~ddGNlvly~----~~~W~s~ 105 (109)
T 3dzw_A 68 RN-NPIWASNTGGEN-GNYVCVLQKDRNVVIYG----TARWATG 105 (109)
T ss_dssp TS-CEEEECCCCCSS-SCEEEEECTTSCEEEEE----SCCCCCC
T ss_pred CC-CEEEECCCCCCC-CCEEEEEeCCCEEEEEC----CCEEeCC
Confidence 54 469999986543 34679999999999984 2799983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=140.09 Aligned_cols=105 Identities=15% Similarity=0.266 Sum_probs=82.8
Q ss_pred ccccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEE
Q 041312 2 ISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLC 81 (743)
Q Consensus 2 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~ 81 (743)
++.|||.|||.|..|++|+| |.|.|-|-..++ |.+ |.. ++||.+|++.. +..+.|.|..||||||.
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 57899999999999999997 458886643343 555 654 48999999863 33468999999999999
Q ss_pred eCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 82 GRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 82 ~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
+..+ .++|++++.... ....|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~-~~iW~S~t~~~~-~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 70 DDDF-KTIWSSRSSSKQ-GEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp CTTC-CEEEECCCCCSS-SCCEEEECTTSCEEEEC----SEEEES
T ss_pred eCCC-CEEEEcCCcCCC-CCEEEEEcCCccEEEec----CCEecC
Confidence 7655 469999986432 34679999999999984 489987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-15 Score=134.57 Aligned_cols=108 Identities=14% Similarity=0.211 Sum_probs=87.2
Q ss_pred ccccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEE
Q 041312 2 ISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLC 81 (743)
Q Consensus 2 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~ 81 (743)
.+.|||.+||.|.+|+.|. +|.|.|-|-..|+ |.++..+ ..++||.+|+..+- ..+.|.|..||||||.
T Consensus 4 ~~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGRG--QHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTSC--SSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEECCCCEeE--cCCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccCC--cCEEEEEeCCCcEEEE
Confidence 4689999999999999998 4889999866655 7775431 47899999998763 3578999999999999
Q ss_pred eCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 82 GRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 82 ~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
+..+. ++|++++.... ....|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~-~iW~S~t~~~~-~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 73 DDRLN-TVFVSNTVGQE-GDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp CTTSC-EEEECSCCCSS-SCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCCC-EEEECCCcCCC-CCEEEEEcCCceEEEec----CCEecC
Confidence 76554 69999986533 34679999999999983 589997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=134.79 Aligned_cols=97 Identities=22% Similarity=0.454 Sum_probs=78.2
Q ss_pred CCccCCccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCccccccccccc
Q 041312 62 PINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIG 141 (743)
Q Consensus 62 p~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~ 141 (743)
|+.+....|.|..||+|+|.+. +.+||++++.... .+..|+|+++|||||++ .+.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~--~~~vW~sn~~~~~-~~~~l~l~~~GNLvl~d--~~~~~W~S~~------------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN--NRAVWASGTNGKA-SGCVLKMQNDGNLVIYS--GSRAIWASNT------------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET--TEEEEECCCTTSC-SSEEEEECTTSCEEEEE--TTEEEEECCC-------------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC--CEEEEeCCCcCCC-CCEEEEEeCCCCEEEEc--CCEEEEECCc-------------
Confidence 3434456899999999999875 4579999986532 45689999999999995 6789999993
Q ss_pred ccccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEc-CCeeEEEecccCCc
Q 041312 142 LDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYK-GEAKWWRVGSWTGK 196 (743)
Q Consensus 142 ~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~~~~~~~w~g~ 196 (743)
||++|.|++.|+++|. ++++. ...+||++++|+|.
T Consensus 77 ------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g~ 112 (112)
T 1xd5_A 77 ------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp ------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCCC
T ss_pred ------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccCC
Confidence 4567899999999998 56665 46899999999873
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-16 Score=170.28 Aligned_cols=138 Identities=14% Similarity=0.157 Sum_probs=99.2
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh--------------hcHHH--------HHHHHHHHHhcCCccE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG--------------QGIEE--------FKTEIALIAQLQHRNL 480 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~Ev~~l~~l~h~ni 480 (743)
=|++.++||.|++|.||+|...+|+.||||+++.... ..... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999999999999998753210 01111 2345666666644433
Q ss_pred EeeeeeEecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCC
Q 041312 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA 560 (743)
Q Consensus 481 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 560 (743)
.-.. .+. ....+|||||+++..|..+.. ......++.||+.+|.|||+.+ ||||||||.|||++++
T Consensus 176 ~vp~-p~~-~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPE-PIA-QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCC-EEE-EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCe-eee-ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 2111 111 123379999999988865431 1233568899999999999998 9999999999999877
Q ss_pred C----------CeEEeeecccccc
Q 041312 561 M----------NPKISDFGMARIF 574 (743)
Q Consensus 561 ~----------~vkl~DFGla~~~ 574 (743)
+ .+.|+||+.+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999988654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.5e-15 Score=130.52 Aligned_cols=88 Identities=27% Similarity=0.452 Sum_probs=72.2
Q ss_pred CccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccC
Q 041312 67 SGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRS 146 (743)
Q Consensus 67 ~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~ 146 (743)
...|.|..||+|||.+ . +.+||++++.... .+..|+|+|+|||||+ +..+.++||||
T Consensus 21 ~~~l~~~~dGnlvl~~-~-~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~-~~~~~~~W~S~------------------- 77 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYD-S-GKPVWASNTGGLG-SGCRLTLHNNGNLVIY-DQSNRVIWQTK------------------- 77 (110)
T ss_dssp TEEEEECTTSCEEEEE-T-TEEEEECCCTTSC-SSCEEEECTTSCEEEE-CTTCCEEEECC-------------------
T ss_pred CEEEEEcCCCcEEEEE-C-CEEEEECCCCCCC-CcEEEEEeCCCCEEEE-CCCCcEEEecC-------------------
Confidence 4689999999999997 3 4679999986543 3467999999999998 45678999999
Q ss_pred CCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEeccc
Q 041312 147 GLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSW 193 (743)
Q Consensus 147 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~w 193 (743)
++|++|.|++.++++|. ++++++ .||+++.+
T Consensus 78 ------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 34577999999999998 667765 79998864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.58 E-value=6e-15 Score=129.34 Aligned_cols=109 Identities=20% Similarity=0.333 Sum_probs=85.4
Q ss_pred ccccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEE
Q 041312 2 ISVDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLC 81 (743)
Q Consensus 2 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~ 81 (743)
.+.|||.|||.|..|+.| .+|.|.|.|...++ |-+ |.. +|.+|+..+ +..+.|+|..||+|||.
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 478999999999999999 47999999966665 333 432 699998865 23578999999999999
Q ss_pred eCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCccccccc
Q 041312 82 GRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPY 137 (743)
Q Consensus 82 ~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg 137 (743)
|..+ .++|++++... .....|+|+|+|||||++ ..+|+| .|.+||
T Consensus 65 d~~~-~~vWss~t~~~-~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 65 NGDG-STVWKSGAQSV-KGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp CTTS-CEEEECCCCCS-SSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred eCCC-CEEEcCCCcCC-CcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 7654 46999997643 234579999999999983 689998 555543
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.53 E-value=2.4e-14 Score=125.91 Aligned_cols=105 Identities=17% Similarity=0.249 Sum_probs=83.2
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
.|||.+||.|.+|+.|. +|.|.|-|-..++ |.+ |.. .. ||.+|+..+. ..+.|.|..||||||.+.
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~~--~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGRG--VDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTSC--SSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccCC--cCEEEEEcCCCcEEEEeC
Confidence 68999999999999994 7899999966555 544 543 23 9999998762 346899999999999987
Q ss_pred CCCceEEeeeccC-CCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 84 NQTVPVWHANVSD-SSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 84 ~~~~~~ws~~~~~-~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
.+..++|++++.. .......|+|+++|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 6655699999743 22345679999999999983 689998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.52 E-value=4.8e-14 Score=125.56 Aligned_cols=86 Identities=26% Similarity=0.419 Sum_probs=70.5
Q ss_pred ccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCC
Q 041312 68 GVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSG 147 (743)
Q Consensus 68 ~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g 147 (743)
..|.|..||+|+|.+. +.+||++++.... .+..|+|+|+|||||+ +..+.++||||
T Consensus 32 ~~L~~~~dgnlvly~~--~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~-d~~~~~lW~S~-------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN--NNPIWATNTGGLG-NGCRAVLQPDGVLVVI-TNENVTVWQSP-------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET--TEEEEECCCTTSC-SSCEEEECTTSCEEEE-CTTCCEEEECS--------------------
T ss_pred EEEEEecCCCEEEEEC--CEEEEeCCCccCC-CceEEEEccCCEEEEE-eCCCcEEEcCC--------------------
Confidence 4688899999999875 5679999986543 3467999999999999 45678999999
Q ss_pred CceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecc
Q 041312 148 LNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGS 192 (743)
Q Consensus 148 ~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 192 (743)
+||++|.|+++++++|. +++++ .+||++|+
T Consensus 88 -----------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -----------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -----------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -----------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 56666 38999885
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=8e-14 Score=123.71 Aligned_cols=91 Identities=26% Similarity=0.445 Sum_probs=74.1
Q ss_pred CccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccC
Q 041312 67 SGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRS 146 (743)
Q Consensus 67 ~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~ 146 (743)
...|.|..||+|+|.+ ...+||++++.... .+..++|+++|||||++ ..+.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~--~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~d-~~~~~vW~S~~~----------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ--NGRQIWASNTDRRG-SGCRLTLLSDGNLVIYD-HNNNDVWGSACW----------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE--TTEEEEECSCTTSC-SSCEEEECTTSCEEEEC-TTCCEEEECCCC-----------------
T ss_pred CEEEEEcCCCcEEEEe--CCEEEEeCCCCCCC-CceEEEECCCCcEEEEC-CCceEEEEcCCC-----------------
Confidence 3478889999999986 35579999986543 34679999999999984 567899999998
Q ss_pred CCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecccCCc
Q 041312 147 GLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSWTGK 196 (743)
Q Consensus 147 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~w~g~ 196 (743)
|++|.|++.++++|. +++++. +||++++|...
T Consensus 80 --------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 --------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp --------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred --------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356889999999998 667754 89999999754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=8.2e-12 Score=128.16 Aligned_cols=147 Identities=16% Similarity=0.082 Sum_probs=114.3
Q ss_pred HHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEE
Q 041312 417 IAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 417 l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~l 495 (743)
+......|++...++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. +..+.+++++..+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455678888888999999999998754 6889999986422222346889999999985 6678899999988889999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-----------------------------------
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD----------------------------------- 540 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------------------------------- 540 (743)
|||+++|.+|...+. +......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999876531 1122346788999999999981
Q ss_pred ---------------------CCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 541 ---------------------SRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 541 ---------------------~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01349999999999999876667799998875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-11 Score=124.14 Aligned_cols=115 Identities=15% Similarity=0.326 Sum_probs=87.2
Q ss_pred cccccCCCCC----cCCCCEEEeCCCeEEEeeeCCC--CCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecC
Q 041312 3 SVDTITSNQP----IKDGDVIVSSGNIFALGFFSPG--NSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLG 76 (743)
Q Consensus 3 ~~~~~~~~~~----l~~~~~l~S~~g~F~lgF~~~~--~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G 76 (743)
.+|||.|||. |..|+.|+|+ ..++.|+|... ...+.+ +| .+ ..+++|.+++..+- . ..|.+..+|
T Consensus 135 ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--Ly-~~--~~~~yW~Sgt~~~~--~-~~l~l~~dG 205 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--AY-GP--NGAATWNAGTQGKG--A-VRAVFQGDG 205 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--EE-CT--TSSEEEECCCTTTT--C-CEEEECTTS
T ss_pred cccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--EE-eC--CCeEEEECCCCCCc--c-EEEEEcCCC
Confidence 5799999999 8999999664 57777777542 222333 43 32 26899999998773 2 689999999
Q ss_pred cEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCC-Ccc
Q 041312 77 NLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDH-PSA 132 (743)
Q Consensus 77 ~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~-PtD 132 (743)
+|++.++.+ .++|++++... ....|+|+++|||||+.. .++|||||| |+.
T Consensus 206 nLvl~d~~~-~~vWsS~t~~~--~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 206 NLVVYGAGN-AVLWHSHTGGH--ASAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp CEEEECTTS-CEEEECSCTTC--TTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred eEEEEeCCC-cEEEEecCCCC--CCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 999997655 46999997643 246899999999999843 689999997 443
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.20 E-value=6.8e-11 Score=104.23 Aligned_cols=96 Identities=21% Similarity=0.359 Sum_probs=70.9
Q ss_pred CCCCccCCccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCccccccccc
Q 041312 60 DNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMK 139 (743)
Q Consensus 60 ~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~k 139 (743)
+.|+.+....|.+..||||||.+.+...++|++++.... .+..|+|+++|||||+ +..+.++|||-.+ -
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~-~~~~l~l~~dGNLVl~-d~~~~~iW~S~t~-----~---- 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRG-QHCFMRLGHSGELDIT-DDRLNTVFVSNTV-----G---- 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSC-SSCEEEECTTSCEEEE-CTTSCEEEECSCC-----C----
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCC-cCEEEEEeCCCcEEEE-CCCCCEEEECCCc-----C----
Confidence 445555567899999999999975445679999987543 3467999999999998 4566899998221 0
Q ss_pred ccccccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecc
Q 041312 140 IGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGS 192 (743)
Q Consensus 140 l~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 192 (743)
..|.|.+.++.+|. ++++. .+.|.+++
T Consensus 87 ----------------------~~~~~~~~L~~dGn--lvly~--~~~W~s~~ 113 (113)
T 3mez_B 87 ----------------------QEGDYVLILQINGQ--AVVYG--PAVWSTAA 113 (113)
T ss_dssp ----------------------SSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred ----------------------CCCCEEEEEcCCce--EEEec--CCEecCCC
Confidence 12568999999998 45555 57898764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-10 Score=102.06 Aligned_cols=93 Identities=18% Similarity=0.329 Sum_probs=67.1
Q ss_pred CccCCccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccc
Q 041312 63 INDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGL 142 (743)
Q Consensus 63 ~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~ 142 (743)
+......|.+..||||||.+.++ +|++++.... .+..|+|+++|||||++.....++|||.-+
T Consensus 17 L~~g~~~L~~q~dGnLvl~~~~~---vW~snt~~~~-~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------- 79 (111)
T 3mez_A 17 LSYESAAFVMQGDCNLVLYNEAG---GFQSNTHGRG-VDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------- 79 (111)
T ss_dssp EEETTEEEEECTTSCEEEECSSC---CEECCCTTSC-SSCEEEECTTSCEEEECSSCSSCSEEESSS-------------
T ss_pred EecCCEEEEEccCCeEEEECCCC---EEECCcccCC-cCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------
Confidence 33345689999999999986543 8999987542 346799999999999943333469999621
Q ss_pred cccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecc
Q 041312 143 DKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGS 192 (743)
Q Consensus 143 ~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 192 (743)
.....|.|.+.++.+|. ++++. ..+|.++.
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGN--lvly~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQH--VTIYG--PAIWSTPA 109 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSC--EEEEC--SEEEECCC
T ss_pred ----------------cCCCCcCEEEEECCCCe--EEEec--cCEEccCC
Confidence 00134789999999998 45554 67898763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=119.14 Aligned_cols=138 Identities=17% Similarity=0.176 Sum_probs=101.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~ 499 (743)
.++.+....+.|..+.||+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445543333456669999998777888999987543 2245788999999986544 55688888877889999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccC--------------------------------------
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS-------------------------------------- 541 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------- 541 (743)
++|.+|. ... .. ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999884 210 11 1246677777888887642
Q ss_pred -----------------CCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 542 -----------------RLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 542 -----------------~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.3e-09 Score=95.41 Aligned_cols=84 Identities=24% Similarity=0.466 Sum_probs=63.3
Q ss_pred ccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCC
Q 041312 68 GVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSG 147 (743)
Q Consensus 68 ~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g 147 (743)
..|.+..||+|+|.+. . ++|++++.... .+..++|+++|||||+ +..+.++|||-.+-
T Consensus 26 ~~L~~q~dGnLvl~~~--~-~vW~snt~~~~-~~~~l~l~~dGNLvl~-d~~~~~iW~S~t~~----------------- 83 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG--K-YGWQSNTHGNG-EHCFLRLNHKGELIIK-DDDFKTIWSSRSSS----------------- 83 (110)
T ss_dssp CEEEECTTSCEEEECS--S-SCEECCCTTSS-SSCEEEECTTSCEEEE-CTTCCEEEECCCCC-----------------
T ss_pred EEEEEcCCCeEEEECC--e-EEEECCCcCCC-cCEEEEEeCCCcEEEE-eCCCCEEEEcCCcC-----------------
Confidence 5789999999999854 3 69999987533 3457999999999998 45678999984210
Q ss_pred CceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEec
Q 041312 148 LNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVG 191 (743)
Q Consensus 148 ~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 191 (743)
..|.|.+.++.+|. ++++. ...|.+|
T Consensus 84 --------------~~~~~~~~L~~dGN--lvly~--~~~W~t~ 109 (110)
T 3r0e_B 84 --------------KQGEYVLILQDDGF--GVIYG--PAIFETS 109 (110)
T ss_dssp --------------SSSCCEEEECTTSC--EEEEC--SEEEESC
T ss_pred --------------CCCCEEEEEcCCcc--EEEec--CCEecCC
Confidence 12458899999998 45555 3678765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=2.3e-09 Score=93.79 Aligned_cols=86 Identities=23% Similarity=0.432 Sum_probs=63.7
Q ss_pred CccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccC
Q 041312 67 SGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRS 146 (743)
Q Consensus 67 ~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~ 146 (743)
...|.|..||+|+|.+. ..++|++++.... .+..++|+++|||||+ +..+.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~--~~~vW~snt~~~~-~~~~l~l~~dGNLvl~-~~~~~~~W~S~t~~---------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV--DKPIWATNTGGLD-RRCHLSMQSDGNLVVY-SPRNNPIWASNTGG---------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET--TEEEEECCCTTSS-SSCEEEECTTSCEEEE-CTTSCEEEECCCCC----------------
T ss_pred CEEEEEcCCCcEEEEeC--CEEEEECCcccCC-CCEEEEEeCCCCEEEE-CCCCCEEEECCCCC----------------
Confidence 34789999999999865 4579999987542 3457999999999998 44668999984321
Q ss_pred CCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEec
Q 041312 147 GLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVG 191 (743)
Q Consensus 147 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 191 (743)
..+.|.+.++.+|. ++++.. ..|.++
T Consensus 80 ---------------~~~~~~~~L~ddGN--lvly~~--~~W~s~ 105 (109)
T 3dzw_A 80 ---------------ENGNYVCVLQKDRN--VVIYGT--ARWATG 105 (109)
T ss_dssp ---------------SSSCEEEEECTTSC--EEEEES--CCCCCC
T ss_pred ---------------CCCCEEEEEeCCCE--EEEECC--CEEeCC
Confidence 12467899999998 445543 567665
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.8e-09 Score=92.28 Aligned_cols=92 Identities=24% Similarity=0.481 Sum_probs=67.8
Q ss_pred CCCccCCccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccc
Q 041312 61 NPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKI 140 (743)
Q Consensus 61 ~p~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl 140 (743)
.|+......|.+..||||||.+. +|++++.... .+..++|+++|||||++ ..+.++|+|- |-
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~-----~Wssnt~~~~-~~~~l~l~~dGnLvl~d-~~~~~vWss~-----t~------ 77 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG-----NWQSNTANNG-RDCKLTLTDYGELVIKN-GDGSTVWKSG-----AQ------ 77 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT-----TEECCCTTSC-SSCEEEECTTSCEEEEC-TTSCEEEECC-----CC------
T ss_pred CEeECCCEEEEEecCCeEEEEeC-----eEEcCCCCCC-CcEEEEEcCCCeEEEEe-CCCCEEEcCC-----Cc------
Confidence 34444456899999999999852 7999987643 34679999999999984 4668999762 10
Q ss_pred cccccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecccC
Q 041312 141 GLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSWT 194 (743)
Q Consensus 141 ~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~w~ 194 (743)
...+.|.+.++++|. ++++. .+.|.++.|-
T Consensus 78 --------------------~~~~~~~~~L~~dGN--lvly~--~~~W~s~t~~ 107 (109)
T 3r0e_A 78 --------------------SVKGNYAAVVHPDGR--LVVFG--PSVFKIDPWV 107 (109)
T ss_dssp --------------------CSSSCCEEEEETTTE--EEEEC--SEEEEECTTS
T ss_pred --------------------CCCcCEEEEEcCCCe--EEEEe--cCEECCCCcc
Confidence 023568999999998 44554 6789998873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=3.1e-09 Score=114.21 Aligned_cols=142 Identities=15% Similarity=0.226 Sum_probs=106.0
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcc--cCC-hhcHHHHHHHHHHHHhcC--CccEEeeeeeEecC---CeeEEEE
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLS--RSS-GQGIEEFKTEIALIAQLQ--HRNLVSILGCCIEE---QEKMLIY 497 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 497 (743)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35789999999999988654 678888875 221 123457888999999997 45578888888766 4589999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccC------------------------------------
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS------------------------------------ 541 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 541 (743)
||++|..+.+.. ...++...+..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998885422 123567777889999999999999731
Q ss_pred -------------------CCceEeccCCCCcEEecCCCC--eEEeeeccccc
Q 041312 542 -------------------RLRIIHRDLKASNVLLDAAMN--PKISDFGMARI 573 (743)
Q Consensus 542 -------------------~~~ivH~Dikp~NIll~~~~~--vkl~DFGla~~ 573 (743)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=3.3e-09 Score=111.25 Aligned_cols=187 Identities=17% Similarity=0.176 Sum_probs=119.9
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-Ccc--EEeeeeeEecCC---eeEEEEEec
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRN--LVSILGCCIEEQ---EKMLIYEYL 500 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~ 500 (743)
.+.++.|....||+.. ..+++|+... ......+.+|+.+++.+. +.. +.+++....... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3678999999999863 5688998532 244578899999998883 332 344444433332 348899999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc----------------------------------------
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD---------------------------------------- 540 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------------------------------------- 540 (743)
+|..|..... ..++...+..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865332 2355566667777788777777751
Q ss_pred ---------------CCCceEeccCCCCcEEecC--CCCeEEeeeccccccCCCccccccc------------ccccccc
Q 041312 541 ---------------SRLRIIHRDLKASNVLLDA--AMNPKISDFGMARIFGGDQIEENTN------------RVVGTYG 591 (743)
Q Consensus 541 ---------------~~~~ivH~Dikp~NIll~~--~~~vkl~DFGla~~~~~~~~~~~~~------------~~~gt~~ 591 (743)
....++|+|++|.||+++. ...+.|+||+.+..-.......... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 5568899999987542211000000 0000011
Q ss_pred ccC-cceeccCCCCccccchhHHHHHHHHHhcCCCC
Q 041312 592 YMA-PEYAMEGLFSTKSDVYSFGVLLLEIILGRRNN 626 (743)
Q Consensus 592 y~a-PE~~~~~~~~~ksDiwSlGvil~elltG~~p~ 626 (743)
... |+..... ....+.|+++.+++++.+|..++
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 112 2221111 12258999999999999998763
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.74 E-value=5.5e-08 Score=84.15 Aligned_cols=83 Identities=27% Similarity=0.537 Sum_probs=62.1
Q ss_pred cEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCC
Q 041312 69 VLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGL 148 (743)
Q Consensus 69 ~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~ 148 (743)
+|.+..||||||.+. ..+||++++......+..++|.++|||||+ +..++++|.|- |
T Consensus 22 ~l~~q~DgNLvly~~--~~~vW~ant~~~~~~~~~L~l~~dGnLvL~-d~~~~~vWss~-----t--------------- 78 (105)
T 4h3o_A 22 HFIMQDDCNLVLYDH--STSTWASNTEIGGKSGCSAVLQSDGNFVVY-DSSGRSLWASH-----S--------------- 78 (105)
T ss_dssp EEEECTTSCEEEEET--TEEEEECCCCCTTCCSCEEEECTTSCEEEE-CTTCCEEEECC-----C---------------
T ss_pred EEEECCCCeEEEEEC--CEEEEEecCCCCCCccEEEEEeCCccEEEE-CCCcEEEEEec-----C---------------
Confidence 688999999999863 356999998765555667999999999998 56778999871 1
Q ss_pred ceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEE
Q 041312 149 NRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWR 189 (743)
Q Consensus 149 ~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~ 189 (743)
....+.|.+.|+.+|.. ++++. ..|.
T Consensus 79 -----------~~~~~~~~l~L~ddGNl--Vly~~--~~W~ 104 (105)
T 4h3o_A 79 -----------TRGSGNYILILQDDGNV--IIYGS--DIWS 104 (105)
T ss_dssp -----------CCCSSCEEEEECTTSCE--EEEES--EEEE
T ss_pred -----------CCCCCCEEEEEeCCCeE--EEECC--cEec
Confidence 01346788999999984 44432 3554
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.61 E-value=1.4e-07 Score=94.66 Aligned_cols=86 Identities=27% Similarity=0.429 Sum_probs=63.5
Q ss_pred cEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCC
Q 041312 69 VLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGL 148 (743)
Q Consensus 69 ~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~ 148 (743)
.|.|..+|+|+|.+. ..+||.+|+... .+..++|.++|||||+ +..+.+||+|+.+.
T Consensus 29 ~l~f~~~gnl~ly~~--~~~vW~an~~~~--~~~~l~l~~dGnLvl~-d~~~~~vW~s~~~~------------------ 85 (236)
T 1dlp_A 29 RFTMQSDCNLVLFDS--DVRVWASNTAGA--TGCRAVLQSDGLLVIL-TAQNTIRWSSGTKG------------------ 85 (236)
T ss_dssp EEEECTTSCEEEEES--SSEEECCCCCSC--SCCBCCBCSSSCBCCB-CTTTCCSCCCCCCC------------------
T ss_pred EEEECCCCcEEEEEC--CEEEEECCCCCC--CCeEEEEcCCCcEEEE-cCCCcEEEeCCccc------------------
Confidence 566777899999864 457999998654 3456999999999998 46778999998651
Q ss_pred ceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecccC
Q 041312 149 NRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSWT 194 (743)
Q Consensus 149 ~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~w~ 194 (743)
+.|.|.+.|+.+|. ++++.. .+|.+..+.
T Consensus 86 -------------~~~~~~~~l~d~Gn--lvl~~~--~~W~S~~~p 114 (236)
T 1dlp_A 86 -------------SIGNYVLVLQPDRT--VTIYGP--GLWDSGTSN 114 (236)
T ss_dssp -------------CSSCCEEEECSSSC--EEEECS--EEEECSCCC
T ss_pred -------------cCCcEEEEEeCCCC--EEEecC--CEEECCCCC
Confidence 23567788888887 344432 788877654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.1e-06 Score=86.66 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=95.9
Q ss_pred cccccCCce-eEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCeeEEEEEecCCCC
Q 041312 428 NKLGEGGFG-SVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 428 ~~LG~G~fg-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
+.+..|..+ .||+.... ++..+++|+-.. .....+..|...|+.+. +--+.+++.++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 455666665 58987765 466789997542 23456888999998884 3346788888888899999999999988
Q ss_pred hhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc--------------------------------------------
Q 041312 505 LDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-------------------------------------------- 540 (743)
Q Consensus 505 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-------------------------------------------- 540 (743)
+.+..... ......+..++++.|..||..
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 76553211 112234555566666666621
Q ss_pred -----------CCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 541 -----------SRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 541 -----------~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
....++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 122489999999999999877778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.2e-06 Score=87.52 Aligned_cols=136 Identities=22% Similarity=0.186 Sum_probs=91.5
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCc---cEEeeeeeEe-cCCeeEEEEEecCC
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR---NLVSILGCCI-EEQEKMLIYEYLPN 502 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~ 502 (743)
.+.++.|....||+. +..+++|+- ........+..|+.+|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 357888988899987 577888884 2234457889999999999752 3556666664 44567899999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc------------------------------------------
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD------------------------------------------ 540 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------------------------------------------ 540 (743)
..+...... .++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 122233333344444444433321
Q ss_pred ---------------CCCceEeccCCCCcEEecC---CCC-eEEeeeccccc
Q 041312 541 ---------------SRLRIIHRDLKASNVLLDA---AMN-PKISDFGMARI 573 (743)
Q Consensus 541 ---------------~~~~ivH~Dikp~NIll~~---~~~-vkl~DFGla~~ 573 (743)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=3.6e-06 Score=89.93 Aligned_cols=80 Identities=4% Similarity=-0.022 Sum_probs=56.4
Q ss_pred ccc-ccCCceeEEEEEEc-------CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCC---ccEEeeeeeEecC---
Q 041312 428 NKL-GEGGFGSVYKGVLQ-------NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQH---RNLVSILGCCIEE--- 490 (743)
Q Consensus 428 ~~L-G~G~fg~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h---~niv~l~~~~~~~--- 490 (743)
+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+.. ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999988765 26788999764322 0012457788888888843 3467777777655
Q ss_pred CeeEEEEEecCCCChhh
Q 041312 491 QEKMLIYEYLPNKSLDV 507 (743)
Q Consensus 491 ~~~~lV~E~~~~gsL~~ 507 (743)
...++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=3.2e-05 Score=81.80 Aligned_cols=141 Identities=17% Similarity=0.220 Sum_probs=80.4
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCc--cEEeeee------eEecCCeeEEEEEe
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR--NLVSILG------CCIEEQEKMLIYEY 499 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~--niv~l~~------~~~~~~~~~lV~E~ 499 (743)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.|... .+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887655 4899988652 23444566666655321 2334443 12345678999999
Q ss_pred cCCCChhh-----------hh---hhccc----c-------cccCHHHH-------------------------------
Q 041312 500 LPNKSLDV-----------YI---FDEAK----R-------SLLDWSKR------------------------------- 523 (743)
Q Consensus 500 ~~~gsL~~-----------~l---~~~~~----~-------~~l~~~~~------------------------------- 523 (743)
++|..+.. .+ +.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 01 10000 0 00112110
Q ss_pred HHHHHHHHHHHHHhhc----------cCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 524 FEIICGIARGILYLHQ----------DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 524 ~~i~~qi~~~L~yLH~----------~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
..+..++.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 1234599999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.9e-05 Score=84.26 Aligned_cols=75 Identities=12% Similarity=0.193 Sum_probs=50.1
Q ss_pred CcccccCCceeEEEEEEc-CCcEEEEEEcccCCh-------hcHHHHHHHHHHHHhcCC--c-cEEeeeeeEecCCeeEE
Q 041312 427 DNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG-------QGIEEFKTEIALIAQLQH--R-NLVSILGCCIEEQEKML 495 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ev~~l~~l~h--~-niv~l~~~~~~~~~~~l 495 (743)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.. + .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 468899997643211 123467789999888742 3 34455543 3455689
Q ss_pred EEEecCCC
Q 041312 496 IYEYLPNK 503 (743)
Q Consensus 496 V~E~~~~g 503 (743)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00013 Score=75.38 Aligned_cols=79 Identities=16% Similarity=0.230 Sum_probs=58.4
Q ss_pred CCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCc---cEEeeeeeEecCCeeEEEEEe
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHR---NLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~---niv~l~~~~~~~~~~~lV~E~ 499 (743)
+...++.+|.|..+.||+.++.+|+.+++|+-..........|..|+..|+.|... .+.+++.. +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 44556789999999999999999999999987544444445688899999888421 23444443 234789999
Q ss_pred cCCCCh
Q 041312 500 LPNKSL 505 (743)
Q Consensus 500 ~~~gsL 505 (743)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00023 Score=74.18 Aligned_cols=76 Identities=21% Similarity=0.180 Sum_probs=60.9
Q ss_pred cCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC---CccEEeeeeeEecCCeeEEEEEecCC
Q 041312 426 SDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ---HRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 426 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.+....+..++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346899999999999876 4678889986532 3567889999988884 35688888888878889999999999
Q ss_pred CCh
Q 041312 503 KSL 505 (743)
Q Consensus 503 gsL 505 (743)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00034 Score=76.37 Aligned_cols=77 Identities=13% Similarity=0.036 Sum_probs=47.3
Q ss_pred CceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccccccccc--cccccCcceeccCC---CCccccchhHHHHHH
Q 041312 543 LRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVG--TYGYMAPEYAMEGL---FSTKSDVYSFGVLLL 617 (743)
Q Consensus 543 ~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~ksDiwSlGvil~ 617 (743)
..++|+|++|.|||++.++ ++|+||+.+..-.....- ..... ...|++|+...... -....++..+...++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999998776 999999988753211100 00010 23466666543111 112345567788888
Q ss_pred HHHhcC
Q 041312 618 EIILGR 623 (743)
Q Consensus 618 elltG~ 623 (743)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00042 Score=72.51 Aligned_cols=157 Identities=15% Similarity=0.131 Sum_probs=85.4
Q ss_pred ChhhHHHHcCCCCc-----CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeee
Q 041312 413 DLSNIAAATNDFSS-----DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILG 485 (743)
Q Consensus 413 ~~~~l~~~~~~y~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~ 485 (743)
+.+.+......|.. .+.|+.|....+|+....+| .+++|+..... ..+.+..|+.+++.+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 34577788899999887665 68899876521 1234567788877774322 333432
Q ss_pred e------EecCCeeEEEEEecCCCChhhh--------------hhhccc----c-----cccCHHHHHH-----------
Q 041312 486 C------CIEEQEKMLIYEYLPNKSLDVY--------------IFDEAK----R-----SLLDWSKRFE----------- 525 (743)
Q Consensus 486 ~------~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~~----------- 525 (743)
. ....+..+++|++++|..+... +..... . ....|...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223567899999998765320 000000 0 0001211100
Q ss_pred -HHHHHHHHHHHhhcc----CCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 526 -IICGIARGILYLHQD----SRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 526 -i~~qi~~~L~yLH~~----~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
+...+.+.+..++.. ....++|+|+++.|||++.+..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133344444421 13359999999999999987666899999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00071 Score=73.97 Aligned_cols=73 Identities=15% Similarity=0.251 Sum_probs=50.6
Q ss_pred CcccccCCceeEEEEEEcC--------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEE
Q 041312 427 DNKLGEGGFGSVYKGVLQN--------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIY 497 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 497 (743)
.+.|+.|....+|+....+ ++.+++|+.... ...+.+..|+.+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3678889999999998753 578899987432 112455679999988854343 456665432 3899
Q ss_pred EecCCCCh
Q 041312 498 EYLPNKSL 505 (743)
Q Consensus 498 E~~~~gsL 505 (743)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987555
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00073 Score=70.05 Aligned_cols=72 Identities=7% Similarity=0.143 Sum_probs=45.9
Q ss_pred CcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEEec-CCCC
Q 041312 427 DNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYEYL-PNKS 504 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 504 (743)
.+.|+.|....+|+. +.+++|+........ .....|+.+++.+...++ .++++. +.+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 568888875432111 123568877777743333 344443 344467899999 6666
Q ss_pred hh
Q 041312 505 LD 506 (743)
Q Consensus 505 L~ 506 (743)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0014 Score=70.03 Aligned_cols=141 Identities=17% Similarity=0.223 Sum_probs=82.3
Q ss_pred cccccCCceeEEEEEEc--------CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc-EEeeeeeEecCCeeEEEEE
Q 041312 428 NKLGEGGFGSVYKGVLQ--------NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN-LVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 498 (743)
+.|..|-...+|+.... +++.+++|+... .......+.+|.++++.|...+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 67888888999998865 247899998633 2234566778999998885322 2456655543 39999
Q ss_pred ecCCCChhhhh-hh--------------ccc----ccccC--HHHHHHHHHHHHH-------------------HHHHh-
Q 041312 499 YLPNKSLDVYI-FD--------------EAK----RSLLD--WSKRFEIICGIAR-------------------GILYL- 537 (743)
Q Consensus 499 ~~~~gsL~~~l-~~--------------~~~----~~~l~--~~~~~~i~~qi~~-------------------~L~yL- 537 (743)
|++|..|..-- .+ +.. ..... +..+.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99987764211 00 000 01111 2334444433321 12222
Q ss_pred ---hc-cCCCceEeccCCCCcEEecCC----CCeEEeeeccccc
Q 041312 538 ---HQ-DSRLRIIHRDLKASNVLLDAA----MNPKISDFGMARI 573 (743)
Q Consensus 538 ---H~-~~~~~ivH~Dikp~NIll~~~----~~vkl~DFGla~~ 573 (743)
.. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 123469999999999999876 7899999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0038 Score=65.50 Aligned_cols=142 Identities=15% Similarity=0.121 Sum_probs=72.0
Q ss_pred cccccCCcee-EEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC--ccEEeeeeeEecCCeeEEEEEecCCCC
Q 041312 428 NKLGEGGFGS-VYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH--RNLVSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 428 ~~LG~G~fg~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
+.|+.|.... +|+....+++.+++|....... +.+..|+.+++.+.. -.+.+++.+..+. .++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665554 6676654477788876543221 234556777766642 2345566553332 378999997766
Q ss_pred hhhhhhhccc-----------------------ccccCHHHHH-------HH-------------HHHHHHHHHHhh---
Q 041312 505 LDVYIFDEAK-----------------------RSLLDWSKRF-------EI-------------ICGIARGILYLH--- 538 (743)
Q Consensus 505 L~~~l~~~~~-----------------------~~~l~~~~~~-------~i-------------~~qi~~~L~yLH--- 538 (743)
+...+..... ...++..... .+ ...+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6433321000 0011111000 00 001111222221
Q ss_pred ccCCCceEeccCCCCcEEecCC----CCeEEeeecccccc
Q 041312 539 QDSRLRIIHRDLKASNVLLDAA----MNPKISDFGMARIF 574 (743)
Q Consensus 539 ~~~~~~ivH~Dikp~NIll~~~----~~vkl~DFGla~~~ 574 (743)
......++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123459999999999999874 67999999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0055 Score=64.02 Aligned_cols=142 Identities=13% Similarity=0.157 Sum_probs=82.7
Q ss_pred cccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc--EEeeeee-----EecCCeeEEEEEec
Q 041312 428 NKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN--LVSILGC-----CIEEQEKMLIYEYL 500 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~E~~ 500 (743)
..|+ |....||+....+|+.+++|+.... ......+..|+.+++.+.... +++++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 8888999888777878999998532 123456777888888875322 4444443 12245568899999
Q ss_pred CCCChhh----hh----------hhcc------cccccCHHHH----------------------HHHHHHHHHHHHHhh
Q 041312 501 PNKSLDV----YI----------FDEA------KRSLLDWSKR----------------------FEIICGIARGILYLH 538 (743)
Q Consensus 501 ~~gsL~~----~l----------~~~~------~~~~l~~~~~----------------------~~i~~qi~~~L~yLH 538 (743)
+|..+.. .+ +... .....++... ...+..++..+.-+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9865431 00 0000 0011121111 011112222222211
Q ss_pred c-cCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 539 Q-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 539 ~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1233589999999999999 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0032 Score=69.22 Aligned_cols=75 Identities=13% Similarity=0.065 Sum_probs=49.0
Q ss_pred CcccccCCceeEEEEEEcC-CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEEecCCCC
Q 041312 427 DNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYEYLPNKS 504 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 504 (743)
.+.|+.|-...+|+....+ +..+++|+......... .-..|..+++.|...++ .++++.+. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3678889999999998765 57888887643322211 12578999998865444 46666652 2 35999999866
Q ss_pred hh
Q 041312 505 LD 506 (743)
Q Consensus 505 L~ 506 (743)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0019 Score=68.93 Aligned_cols=73 Identities=11% Similarity=0.154 Sum_probs=44.5
Q ss_pred cccccCCceeEEEEEEcC---------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCcc-EEeeeeeEecCCeeEEEE
Q 041312 428 NKLGEGGFGSVYKGVLQN---------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN-LVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 497 (743)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++.. ..++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 578888888999988654 267888876543221 122467888888875333 33555443 137899
Q ss_pred EecCCCCh
Q 041312 498 EYLPNKSL 505 (743)
Q Consensus 498 E~~~~gsL 505 (743)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0094 Score=62.81 Aligned_cols=68 Identities=10% Similarity=0.151 Sum_probs=43.8
Q ss_pred ccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC---ccEEeeeee------EecCCeeEEEEEecC
Q 041312 431 GEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH---RNLVSILGC------CIEEQEKMLIYEYLP 501 (743)
Q Consensus 431 G~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h---~niv~l~~~------~~~~~~~~lV~E~~~ 501 (743)
|.|....||+....+| .+++|+...... ..|+.+++.|.. +.+++++.. ....+..++||||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344689999987777 899998754431 345666665532 224454432 233467799999999
Q ss_pred CCCh
Q 041312 502 NKSL 505 (743)
Q Consensus 502 ~gsL 505 (743)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.75 E-value=0.04 Score=53.23 Aligned_cols=102 Identities=9% Similarity=0.022 Sum_probs=64.4
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccccc
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN 582 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 582 (743)
-+|.+.|. ....++++.+++.++.|.+++|.-+-.+. . -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 36777764 34568999999999999999887762111 0 11333457899999999988764 1110
Q ss_pred cccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCC
Q 041312 583 TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624 (743)
Q Consensus 583 ~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~ 624 (743)
.....+.|||... ...+.+.=|||||+++|..+-=..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123467888753 345678889999999999885333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.085 Score=57.09 Aligned_cols=73 Identities=16% Similarity=0.227 Sum_probs=48.1
Q ss_pred cccccCCceeEEEEEEcC--------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEE
Q 041312 428 NKLGEGGFGSVYKGVLQN--------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 498 (743)
+.|..|-...+|+....+ ++.+++++....... .-...+|..+++.+...++ .++++.+. .++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 678888888999998763 578999986443222 1223578888888753233 44444332 378999
Q ss_pred ecCCCCh
Q 041312 499 YLPNKSL 505 (743)
Q Consensus 499 ~~~~gsL 505 (743)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.38 E-value=0.16 Score=54.52 Aligned_cols=30 Identities=23% Similarity=0.360 Sum_probs=25.3
Q ss_pred ceEeccCCCCcEEe------cCCCCeEEeeeccccc
Q 041312 544 RIIHRDLKASNVLL------DAAMNPKISDFGMARI 573 (743)
Q Consensus 544 ~ivH~Dikp~NIll------~~~~~vkl~DFGla~~ 573 (743)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999998853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 743 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 5e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-16 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 2e-71
Identities = 64/279 (22%), Positives = 130/279 (46%), Gaps = 22/279 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ ++G G FG+VYKG + + ++ + Q ++ FK E+ ++ + +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+G + ++ ++ SL ++ + + K +I A+G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM-- 599
IIHRDLK++N+ L + KI DFG+A + ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 600 -EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658
+ +S +SDVY+FG++L E++ G+ + + N + + G + K
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YS------NINNRDQIIFMVGRGYLSPDLSK 233
Query: 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
S C + R + C++++ +RP +++ +
Sbjct: 234 V--RSNCPKAMKRLM---AECLKKKRDERPLFPQILASI 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-66
Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 26/289 (8%)
Query: 429 KLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCI 488
+G+G FG V++G G+E+AVK S + + EI L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 489 EEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD---- 540
++ L+ +Y + SL Y+ R + ++ A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 541 -SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF--GGDQIEENTNRVVGTYGYMAPEY 597
+ I HRDLK+ N+L+ I+D G+A D I+ N VGT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 598 AMEGL------FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL--WKE 649
+ + ++D+Y+ G++ EI H + ++LV + ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 650 GTAMEAVDKSLGESCCAPEILRCIH-LGLLCVQEQATDRPNMSAVVSML 697
+ + ++ + E LR + + C R + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 7e-66
Identities = 80/276 (28%), Positives = 125/276 (45%), Gaps = 24/276 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+LG G FG V+ G ++AVK L + S + F E L+ QLQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ +E +I EY+ N SL ++ + L +K ++ IA G+ ++ + +
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
IHRDL+A+N+L+ ++ KI+DFG+AR+ ++ + APE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661
F+ KSDV+SFG+LL EI+ R + V + G M D
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMVRPDN--- 234
Query: 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C E L LC +E+ DRP + S+L
Sbjct: 235 ---CPEE---LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 9e-65
Identities = 66/276 (23%), Positives = 116/276 (42%), Gaps = 24/276 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
D + +LG G FG V G + ++A+K + S +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G C +++ +I EY+ N L Y+ + R + E+ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+ +HRDL A N L++ K+SDFG++R D+ + + PE M
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661
FS+KSD+++FGVL+ EI + ++ + E + + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTNSETAEHIAQGLR 219
Query: 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ + C E+A +RP ++S +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-64
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 24/276 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
++ + ++G G FG V+ G N ++A+K + + E+F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ G C+E+ L++E++ + L Y+ +R L + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+IHRDL A N L+ K+SDFGM R DQ ++ + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661
+S+KSDV+SFGVL+ E+ + ++ +E +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK-----------------IPYENRSNSEVVEDISTGFR 220
Query: 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ C +E+ DRP S ++ L
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-64
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 420 ATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGI-EEFKTEIALIAQLQH 477
+DF ++LG G G V+K +G +A K + I + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
+V G + E + E++ SLD + K + ++ + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
+ +I+HRD+K SN+L+++ K+ DFG++ N VGT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRR 624
+S +SD++S G+ L+E+ +GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 5e-63
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 39/307 (12%)
Query: 408 YLPVFDLSNIAAATNDFSS---------DNKLGEGGFGSVYKGVL----QNGKEIAVKRL 454
++ F + A +F+ + +G G FG V G L + +A+K L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 455 SRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEA 513
+ + +F +E +++ Q H N++ + G + M+I E++ N SLD ++
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122
Query: 514 KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573
+ + ++ GIA G+ YL + +HRDL A N+L+++ + K+SDFG++R
Sbjct: 123 GQF--TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 574 FGGDQIEENTNRVVG---TYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHL 630
D + +G + APE F++ SDV+S+G+++ E++
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------ 231
Query: 631 EQGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNM 690
+ + A+++ L L C Q+ RP
Sbjct: 232 -----------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 691 SAVVSML 697
+V+ L
Sbjct: 281 GQIVNTL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-62
Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 30/277 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ +G+G FG V G G ++AVK + + + F E +++ QL+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 482 SILGCCIEEQEKM-LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
+LG +EE+ + ++ EY+ SL Y+ RS+L + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
+HRDL A NVL+ K+SDFG+ + + + + APE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 601 GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660
FSTKSDV+SFG+LL EI R + + V ++G M+A D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDAPDG-- 224
Query: 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C P + C A RP+ + L
Sbjct: 225 ----CPPA---VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (531), Expect = 1e-62
Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 24/277 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQN-GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
D + +KLG G +G VY+GV + +AVK L + + +EEF E A++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V +LG C E +I E++ +L Y+ E R + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
+ IHRDL A N L+ K++DFG++R+ GD + + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 601 GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660
FS KSDV++FGVLL EI + + E ++K
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 233
Query: 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ L C Q +DRP+ + +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 8e-62
Identities = 67/287 (23%), Positives = 124/287 (43%), Gaps = 24/287 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
+ KLG+G FG V+ G +A+K L + E F E ++ +L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+ E+ ++ EY+ SL ++ E + L + ++ IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEG 601
+ +HRDL+A+N+L+ + K++DFG+AR+ ++ + APE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 602 LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661
F+ KSDV+SFG+LL E+ R + ++ V++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQVERGYR 232
Query: 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKH 708
C L C +++ +RP + + L + P++
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 2e-61
Identities = 67/304 (22%), Positives = 126/304 (41%), Gaps = 48/304 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSSGQGIE-EFKTEIALIAQ 474
N+ +GEG FG V++ + +AVK L + ++ +F+ E AL+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSL----------------- 517
+ N+V +LG C + L++EY+ L+ ++ + ++
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 518 ----LDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573
L +++ I +A G+ YL + + +HRDL N L+ M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633
+ +M PE ++T+SDV+++GV+L EI + +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248
Query: 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAV 693
V ++G + + C E +L LC + DRP+ ++
Sbjct: 249 -------EEVIYYVRDGNILACPEN------CPLE---LYNLMRLCWSKLPADRPSFCSI 292
Query: 694 VSML 697
+L
Sbjct: 293 HRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 29/284 (10%)
Query: 420 ATNDFS-SDNKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRSSGQG-IEEFKTEIALIAQ 474
++ +D +LG G FGSV +GV + ++A+K L + + + EE E ++ Q
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534
L + +V ++G C + + ML+ E L ++ KR + S E++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEEN-TNRVVGTYGYM 593
YL + +HRDL A NVLL KISDFG+++ G D + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653
APE FS++SDV+S+GV + E + + ++ V ++G M
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM 231
Query: 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
E + C PE+ L C + DRP+ V +
Sbjct: 232 ECPPE------CPPEL---YALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 7e-60
Identities = 75/277 (27%), Positives = 113/277 (40%), Gaps = 30/277 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQN---GKEIAVKRLSRSSGQG--IEEFKTEIALIAQLQHRNLV 481
D +LG G FG+V KG Q K +AVK L + +E E ++ QL + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
++G C E + ML+ E L+ Y+ + + E++ ++ G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTN-RVVGTYGYMAPEYAME 600
+HRDL A NVLL KISDFG+++ D+ + APE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 601 GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660
FS+KSDV+SFGVL+ E + + K ++K
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGSEVTAMLEKGE 227
Query: 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C A L LC +RP +AV L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 9e-60
Identities = 68/283 (24%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKE-----IAVKRLSRSSGQG-IEEFKTEIALIAQL 475
+ + +G G FG VYKG+L+ +A+K L + +F E ++ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 476 QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
H N++ + G + + M+I EY+ N +LD ++ + K + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 536 YLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT-NRVVGTYGYMA 594
YL + +HRDL A N+L+++ + K+SDFG++R+ D T + + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654
PE F++ SDV+SFG+++ E++ + M+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE-----------------RPYWELSNHEVMK 224
Query: 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
A++ L + C Q++ RP + +VS+L
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 30/279 (10%)
Query: 427 DNKLGEGGFGSVYKGVLQNGK----EIAVKRLSRSSGQG-IEEFKTEIALIAQLQHRNLV 481
+ +G G FG VY G L + AVK L+R + G + +F TE ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 482 SILGCCIE-EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
S+LG C+ E +++ Y+ + L +I +E + F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 541 SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR--VVGTYGYMAPEYA 598
+ + +HRDL A N +LD K++DFG+AR + + N+ +MA E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658
F+TKSDV+SFGVLL E++ N L + +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTFDITVYLLQG-------RR 252
Query: 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
L C + L C +A RP+ S +VS +
Sbjct: 253 LLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-59
Identities = 73/306 (23%), Positives = 116/306 (37%), Gaps = 47/306 (15%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRSSGQG-IEEFKTEIALIAQ 474
+ LG G FG V ++AVK L + E +E+ ++ Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 475 L-QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKR------------------ 515
L H N+V++LG C LI+EY L Y+ + ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 516 --SLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573
++L + +A+G+ +L +HRDL A NVL+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG 633
D +MAPE EG+++ KSDV+S+G+LL EI N +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYP---- 268
Query: 634 SGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAV 693
+ + + L + G M+ E + C + RP+ +
Sbjct: 269 --GIPVDANFYKLIQNGFKMDQPFY------ATEE---IYIIMQSCWAFDSRKRPSFPNL 317
Query: 694 VSMLGS 699
S LG
Sbjct: 318 TSFLGC 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 8e-59
Identities = 70/307 (22%), Positives = 112/307 (36%), Gaps = 42/307 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL------QNGKEIAVKRLSRSSGQG-IEEFKTEIALIAQ 474
N S LG G FG V + +AVK L S+ E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 475 L-QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFD---------------EAKRSLL 518
L H N+V++LG C ++I EY L ++ E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
D +A+G+ +L IHRDL A N+LL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638
+MAPE +++ +SDV+S+G+ L E+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MP 252
Query: 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698
+ + + KEG M + + E + C RP +V ++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEH------APAE---MYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 699 SDNAPSS 705
+ S+
Sbjct: 304 KQISEST 310
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 9e-59
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 36/279 (12%)
Query: 424 FSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQHRN 479
FS ++G G FG+VY ++N + +A+K++S S Q ++ E+ + +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+ GC + E L+ EY + D+ + L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+IHRD+KA N+LL K+ DFG A I N VGT +MAPE +
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 600 ---EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656
EG + K DV+S G+ +E+ + + + + H+ +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK-----PPLFNMNAMSALYHI---------AQNE 230
Query: 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695
+L + + C+Q+ DRP ++
Sbjct: 231 SPALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-57
Identities = 64/281 (22%), Positives = 121/281 (43%), Gaps = 29/281 (10%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKE----IAVKRLSRS-SGQGIEEFKTEIALIAQLQ 476
+F LG G FG+VYKG+ + G++ +A+K L + S + +E E ++A +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
+ ++ +LG C+ LI + +P L Y+ + + + IA+G+ Y
Sbjct: 70 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
L R++HRDL A NVL+ + KI+DFG+A++ G ++ E + +MA E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656
+ +++ +SDV+S+GV + E++ +D +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPASEISSIL 226
Query: 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+K + + + C A RP ++
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 61/277 (22%), Positives = 116/277 (41%), Gaps = 33/277 (11%)
Query: 427 DNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSI 483
D ++G G F +VYKG+ + E+A L + + FK E ++ LQH N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 484 LGCCIEEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+ +L+ E + + +L Y+ + ++ I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 540 DSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
+ IIHRDLK N+ + + KI D G+A + V+GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658
E + DVY+FG+ +LE+ ++ + +++ V
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP-----------YSECQNAAQIYRR--VTSGVKP 231
Query: 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695
+ + PE+ I C+++ +R ++ +++
Sbjct: 232 ASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-57
Identities = 68/280 (24%), Positives = 111/280 (39%), Gaps = 28/280 (10%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRN 479
D+ +G G +G K +GK + K L S + +E+ L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 480 LVSILGCCIEEQEKML--IYEYLPNKSLDVYIFDEAK-RSLLDWSKRFEIICGIARGILY 536
+V I+ L + EY L I K R LD ++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 537 LHQ--DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
H+ D ++HRDLK +NV LD N K+ DFG+ARI D VGT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMS 182
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654
PE ++ KSD++S G LL E+ T ++ + +EG
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---------ELAGKIREGKFRR 233
Query: 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVV 694
+ + E+ I + + RP++ ++
Sbjct: 234 IPYR------YSDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-57
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGC 486
+LG+G FG VYK + A K + S + +E++ EI ++A H N+V +L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRII 546
E ++ E+ ++D + + L S+ + + YLH +II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 547 HRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM-----EG 601
HRDLKA N+L + K++DFG++ + + +GT +MAPE M +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 602 LFSTKSDVYSFGVLLLEIILGRR 624
+ K+DV+S G+ L+E+
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-57
Identities = 73/298 (24%), Positives = 109/298 (36%), Gaps = 38/298 (12%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGI-EEFKTEIALIAQLQHRN 479
D+ LGEG +G V V + +AVK + E K EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V G E + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
+ I HRD+K N+LLD N KISDFG+A +F + E N++ GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 600 EGLFST-KSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658
F DV+S G++L ++ G + D ++ T + K
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW-------DQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGL 716
L +H + E + R + + K + K L
Sbjct: 232 ------IDSAPLALLH---KILVENPSARITIPDIK------------KDR-WYNKPL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 41/294 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNG---KEIAVKRLSR-SSGQGIEEFKTEIALIAQL-Q 476
ND + +GEG FG V K ++ + A+KR+ +S +F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYI-------------FDEAKRSLLDWSKR 523
H N++++LG C L EY P+ +L ++ + S L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT 583
+ARG+ YL Q + IHRDL A N+L+ KI+DFG++R ++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 584 NRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643
+MA E +++T SDV+S+GVLL EI+ + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 235
Query: 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
++ +G +E C E L C +E+ +RP+ + ++ L
Sbjct: 236 YEKLPQGYRLEKPLN------CDDE---VYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-56
Identities = 76/284 (26%), Positives = 109/284 (38%), Gaps = 30/284 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSR---SSGQGIEEFKTEIALIAQ 474
D KLG+G FG V +G +AVK L S + +++F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534
L HRNL+ + G + KM + E P SL + LL R +A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG-GDQIEENTNRVVGTYGYM 593
YL R IHRDL A N+LL KI DFG+ R D + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653
APE FS SD + FGV L E+ + L N + + KEG +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGERL 234
Query: 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ C + ++ + C + DRP A+ L
Sbjct: 235 PRPED------CPQD---IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-56
Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 35/304 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQN------GKEIAVKRLSRS-SGQGIEEFKTEIALIAQ 474
+ +LG+G FG VY+GV + +A+K ++ + S + EF E +++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIF-------DEAKRSLLDWSKRFEII 527
++V +LG + Q ++I E + L Y+ + + SK ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 528 CGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVV 587
IA G+ YL+ + + +HRDL A N ++ KI DFGM R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 588 GTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW 647
+M+PE +G+F+T SDV+SFGV+L EI L V
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFV 248
Query: 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPK 707
EG ++ D C L +C Q RP+ ++S + + P +
Sbjct: 249 MEGGLLDKPDN------CPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEMEP-GFR 298
Query: 708 HPAF 711
+F
Sbjct: 299 EVSF 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 65/280 (23%), Positives = 113/280 (40%), Gaps = 37/280 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
DF LG+G FG+VY Q+ +A+K L ++ + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
N++ + G + LI EY P ++ + K S D + I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H R+IHRD+K N+LL +A KI+DFG + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657
+ K D++S GVL E ++G+ ++ T E
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---------------------PFEANTYQETYK 214
Query: 658 KSLGESCCAPEIL--RCIHLGLLCVQEQATDRPNMSAVVS 695
+ P+ + L ++ + RP + V+
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 3e-54
Identities = 75/300 (25%), Positives = 115/300 (38%), Gaps = 41/300 (13%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV------LQNGKEIAVKRLSRSSGQG-IEEFKTEIALIAQ 474
+ LG G FG V + + +AVK L + +E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 475 -LQHRNLVSILGCCIEEQEK-MLIYEYLPNKSLDVYIF-------------DEAKRSLLD 519
H N+V++LG C + M+I E+ +L Y+ ++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 520 WSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579
+A+G+ +L + IHRDL A N+LL KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL 639
+MAPE + +++ +SDV+SFGVLL EI + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-------VKI 242
Query: 640 VGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699
KEGT M A D PE L C + + RP S +V LG+
Sbjct: 243 DEEFCRRLKEGTRMRAPDY------TTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 51/205 (24%), Positives = 101/205 (49%), Gaps = 10/205 (4%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRN 479
++ K+G+G G+VY + + G+E+A+++++ E EI ++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V+ L + E ++ EYL SL + + D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
++IHRD+K+ N+LL + K++DFG +Q + +VGT +MAPE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVT 189
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRR 624
+ K D++S G++ +E+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-52
Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 29/281 (10%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKE----IAVKRLSRSSGQGI-EEFKTEIALIAQLQ 476
+GEG FG V++G+ + + +A+K + + E+F E + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
H ++V ++G E +I E L ++ LD + ++ + Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
L R +HRD+ A NVL+ + K+ DFG++R D ++ +MAPE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 179
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656
F++ SDV+ FGV + EI++ ++ V + G +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGERLPMP 231
Query: 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
C P + + C + RP + + + L
Sbjct: 232 PN------CPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-52
Identities = 74/299 (24%), Positives = 120/299 (40%), Gaps = 43/299 (14%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL--------QNGKEIAVKRLSR-SSGQGIEEFKTEIALI 472
+ LGEG FG V ++AVK L ++ + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 473 AQL-QHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSL-------------L 518
+ +H+N++++LG C ++ +I EY +L Y+ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 519 DWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578
+ARG+ YL + IHRDL A NVL+ KI+DFG+AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 579 IEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638
+ T +MAPE + +++ +SDV+SFGVLL EI + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 242
Query: 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
V ++ L KEG M+ C E + C + RP +V L
Sbjct: 243 -VEELFKLLKEGHRMDKPSN------CTNE---LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 3e-50
Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 11/206 (5%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
+ + +LG G FG V++ G A K + E + EI ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
V++ ++ E ++IYE++ L + DE + + + E + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 541 SRLRIIHRDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
+H DLK N++ + K+ DFG+ Q + GT + APE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
+D++S GVL ++ G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-50
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHR 478
DF LGEG F +V L +E A+K L + + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH 538
V + ++++ Y N L YI D + I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
IIHRDLK N+LL+ M+ +I+DFG A++ + + N VGT Y++PE
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
E SD+++ G ++ +++ G
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 6e-49
Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 11/206 (5%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL 480
+ + +LG G FG V++ V G+ K ++ K EI+++ QL H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 481 VSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD 540
+++ ++ E +LI E+L L I E + + ++ + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 541 SRLRIIHRDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
I+H D+K N++ + KI DFG+A D+I T + APE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
+D+++ GVL ++ G
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 13/217 (5%)
Query: 411 VFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG-IEEFKTE 468
VFD+ +++ + +GEG +G V N +A+K++S Q + E
Sbjct: 3 VFDV------GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE 56
Query: 469 IALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIIC 528
I ++ + +H N++ I + + YL + ++ K L +
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 116
Query: 529 GIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENT-NRVV 587
I RG+ Y+H ++HRDLK SN+LL+ + KI DFG+AR+ D V
Sbjct: 117 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 588 GTYGYMAPEYAMEGLFSTKS-DVYSFGVLLLEIILGR 623
T Y APE + TKS D++S G +L E++ R
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (422), Expect = 3e-46
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTE---IALIAQ 474
NDFS +G GGFG VY GK A+K L + QG E ++L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 475 LQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGI 534
+V + + I + + L ++ + + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
++H +++RDLK +N+LLD + +ISD G+A F + + VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 595 PEYAMEGL-FSTKSDVYSFGVLLLEIILGR 623
PE +G+ + + +D +S G +L +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (416), Expect = 6e-46
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
DF LG G FG V+ NG+ A+K L + + +E E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
++ + G + Q+ +I +Y+ L + + +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
II+RDLK N+LLD + KI+DFG A+ + + T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRR 624
++ D +SFG+L+ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 3e-45
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG---IEEFKTEIALIAQLQ 476
++ + LG GG V+ L+ +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 477 HRNLVSILGCCIEEQEK----MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR 532
H +V++ E ++ EY+ +L + E + + E+I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG-GDQIEENTNRVVGTYG 591
+ + H + IIHRD+K +N+++ A K+ DFG+AR T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 592 YMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
Y++PE A +SDVYS G +L E++ G
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 46/199 (23%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
LG G FG V++ V + K K + + G K EI+++ +HRN++ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+E ++I+E++ + I A L+ + + + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 548 RDLKASNVLLDAAMNP--KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFST 605
D++ N++ + KI +FG AR + +N + Y APE + ST
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 606 KSDVYSFGVLLLEIILGRR 624
+D++S G L+ ++ G
Sbjct: 183 ATDMWSLGTLVYVLLSGIN 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 3e-44
Identities = 44/206 (21%), Positives = 86/206 (41%), Gaps = 8/206 (3%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-FKTEIALIAQLQHR 478
+ + + LG G F V + K +A+K +++ + +G E + EIA++ +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH 538
N+V++ LI + + L I ++ +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
+ + LD ISDFG++++ + + GT GY+APE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
+ +S D +S GV+ ++ G
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-43
Identities = 53/306 (17%), Positives = 102/306 (33%), Gaps = 38/306 (12%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
K+G G FG +Y G + G+E+A+K + + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
E + ++ L SL+ +++ + + I Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 548 RDLKASNVL---LDAAMNPKISDFGMARIFGGDQIEEN-----TNRVVGTYGYMAPEYAM 599
RD+K N L I DFG+A+ + + ++ + GT Y + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 600 EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659
S + D+ S G +L+ LG + +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--------TKRQKYERISEKKMSTPIE 238
Query: 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSPKHPAFIAKGLSNV 719
+ E ++ C + D+P+ S + + ++ F +G S
Sbjct: 239 VLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF---------RNL-FHRQGFSYD 285
Query: 720 DEF-WT 724
F W
Sbjct: 286 YVFDWN 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 5e-43
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGI---------EEFKTEIALI 472
++ LG G V + + KE AVK + + G E E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 473 AQLQ-HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIA 531
++ H N++ + L+++ + L Y+ ++ L + +I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 532 RGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
I LH +L I+HRDLK N+LLD MN K++DFG + E V GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPS 174
Query: 592 YMAPEYAMEGL------FSTKSDVYSFGVLLLEIILGR 623
Y+APE + + + D++S GV++ ++ G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 1e-42
Identities = 40/280 (14%), Positives = 94/280 (33%), Gaps = 29/280 (10%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
++GEG FG +++G L N +++A+K R S + + E L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 488 IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIH 547
+E ++ L SL+ + + + + +H+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 548 RDLKASNVLLDAAMNP-----KISDFGMARIFGGDQIEEN-----TNRVVGTYGYMAPEY 597
RD+K N L+ + + DFGM + + +++ + GT YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657
+ S + D+ + G + + + G + + G ++
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQG--------LKAATNKQKYERIGEKKQSTP 236
Query: 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSML 697
+ E + +H P+ + +
Sbjct: 237 LRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSG---QGIEEFKTEIALIA-QLQ 476
DF LG+G FG V+ + + A+K L + +E E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 477 HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
H L + ++ + EYL L +I K D S+ I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
LH I++RDLK N+LLD + KI+DFGM + + NT GT Y+APE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGRR 624
+ ++ D +SFGVLL E+++G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-41
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 423 DFSSDNKLGEGGFGSVYKGVL-QNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLV 481
++ +G G FG VY+ L +G+ +A+K++ + E+ ++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 482 SILGCCIEEQEKM------LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGIL 535
+ EK L+ +Y+P V + L + + R +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 536 YLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMA 594
Y+H I HRD+K N+LLD K+ DFG A+ E N + + Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAP 191
Query: 595 PEYAMEGLFSTKSDVYSFGVLLLEIILGRR 624
+++ DV+S G +L E++LG+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 5e-41
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 428 NKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE-----FKTEIALIAQLQHRNLV 481
+ LGEG F +VYK + +A+K++ ++ EI L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 482 SILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS 541
+L + L+++++ + +L S + +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 542 RLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME- 600
I+HRDLK +N+LLD K++DFG+A+ FG V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGA 175
Query: 601 GLFSTKSDVYSFGVLLLEIILGR 623
++ D+++ G +L E++L
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 6e-41
Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 28/294 (9%)
Query: 420 ATNDFSSDNKLGEGGFGSVYKG--VLQNGKEIAVKRLSRSSGQG--IEEFKTEIALIAQL 475
A + ++GEG +G V+K + G+ +A+KR+ +G+ E+A++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 476 ---QHRNLVSILGCCIEEQEKMLIYEYLPNKSLD---VYIFDEAKRSLLDWSKRFEIICG 529
+H N+V + C + L + +D D+ + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 530 IARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGT 589
+ RG+ +LH R++HRDLK N+L+ ++ K++DFG+ARI+ VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVT 178
Query: 590 YGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR-----NNTFHLEQGSGSWNLVGHVW 644
Y APE ++ ++T D++S G + E+ + ++ L + L G
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-- 236
Query: 645 DLWKEGTAMEAVDKSLGESCCAPEILR-----CIHLGLLCVQEQATDRPNMSAV 693
+ W A+ + + + L L C+ R + +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 1e-40
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 21/285 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRN 479
+ K+GEG +G VYK G+ A+K RL + EI+++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V + ++ +L++E+L + E L+ + + GI Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAM 599
R++HRDLK N+L++ KI+DFG+AR FG + T Y AP+ M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLM 173
Query: 600 -EGLFSTKSDVYSFGVLLLEIILGR-----RNNTFHLEQ-----GSGSWNLVGHVWDLWK 648
+ST D++S G + E++ G + L + G+ + +V +L K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAV 693
+ ES I L ++ R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 423 DFSSDNKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHRN 479
+F K+GEG +G VYK G+ +A+K RL + EI+L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 480 LVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ 539
+V +L E + L++E+L D + + + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 540 DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE-YA 598
R++HRDLK N+L++ K++DFG+AR FG V T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILL 175
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
+ST D++S G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 411 VFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSS------GQGIE 463
VF N+ + + + +LG G F V K G + A K + + G E
Sbjct: 2 VFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 464 EFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKR 523
+ + E++++ ++QH N++++ + + +LI E + L ++ ++ L +
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEA 115
Query: 524 FEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP----KISDFGMARIFGGDQI 579
E + I G ++ L+I H DLK N++L P KI DFG+A
Sbjct: 116 TEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 171
Query: 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
+ GT ++APE ++D++S GV+ ++ G
Sbjct: 172 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 60/315 (19%), Positives = 124/315 (39%), Gaps = 35/315 (11%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQG--IEEFKTEIALIAQLQHR 478
+ + K+G+G FG V+K + G+++A+K++ + + EI ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 479 NLVSILGCCIEEQEKM--------LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGI 530
N+V+++ C + L++++ + + K +L + + +++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL-- 127
Query: 531 ARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR--VVG 588
L+ R +I+HRD+KA+NVL+ K++DFG+AR F + + V
Sbjct: 128 ----NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 589 TYGYMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGR-----RNNTFHLEQ-GSGSWNLVG 641
T Y PE + E + D++ G ++ E+ L ++
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 642 HVWDLWKEGTAMEAVDKSLGESCCAPEILR-------CIHLGLLCVQEQATDRPNMSAVV 694
VW E ++ G+ + L+ + L + R + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 695 SM--LGSDNAPSSPK 707
+ SD PS K
Sbjct: 304 NHDFFWSDPMPSDLK 318
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 44/214 (20%), Positives = 79/214 (36%), Gaps = 20/214 (9%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEE------FKTEIALIAQ 474
+ + LG GGFGSVY G+ + + +A+K + + E E+ L+ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 475 LQ--HRNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR 532
+ ++ +L +LI E E L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFGMARIFGGDQIEENTNRVVGTYG 591
+ + H ++HRD+K N+L+D K+ DFG + + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRV 174
Query: 592 YMAPEYAM-EGLFSTKSDVYSFGVLLLEIILGRR 624
Y PE+ + V+S G+LL +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 21/204 (10%)
Query: 430 LGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCC 487
LG G G V + + ++ A+K L + + E+ L + Q ++V I+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 488 ----IEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRL 543
+ +++ E L L I D ++ + EI+ I I YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130
Query: 544 RIIHRDLKASNVLLDAAMNP---KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAME 600
I HRD+K N+L + K++DFG A+ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGP 187
Query: 601 GLFSTKSDVYSFGVLLLEIILGRR 624
+ D++S GV++ ++ G
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-38
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 12/207 (5%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
NDF LG+G FG V G+ A+K L + + + TE ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
L ++ + EY L ++ ++ + + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
+++RD+K N++LD + KI+DFG+ + D GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEV 176
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRR 624
+ + D + GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 45/206 (21%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVK--RLSRSSGQGIEEFKTEIALIAQLQHR 478
+ K+GEG +G+V+K + + +A+K RL EI L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 479 NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLH 538
N+V + +++ L++E+ + + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 539 QDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYA 598
++HRDLK N+L++ K+++FG+AR FG + + VV +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174
Query: 599 MEGLFSTKSDVYSFGVLLLEIILGRR 624
L+ST D++S G + E+ R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 8e-36
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILG 485
+G G +G+V V + G ++A+K+L R S + E+ L+ ++H N++ +L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 486 CCIEEQEKMLIYE-YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLR 544
++ + YL + + K L + ++ + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 545 IIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGL-F 603
IIHRDLK N+ ++ KI DFG+AR Q + V T Y APE + + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 604 STKSDVYSFGVLLLEIILGR 623
+ D++S G ++ E+I G+
Sbjct: 197 TQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 2e-35
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 15/207 (7%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQH 477
+ F LG G FG V ++G A+K L + + IE E ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
LV + + ++ EY+ + ++ + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEY 597
H L +I+RDLK N+L+D +++DFG A+ G + GT +APE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEI 209
Query: 598 AMEGLFSTKSDVYSFGVLLLEIILGRR 624
+ ++ D ++ GVL+ E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 3e-33
Identities = 49/229 (21%), Positives = 102/229 (44%), Gaps = 21/229 (9%)
Query: 402 SRRNSEYLPVFDLSNIAAATNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQ 460
+ R EY +D+ KLG G + V++ + + N +++ VK L
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-- 72
Query: 461 GIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEKM--LIYEYLPNKSLDVYIFDEAKRSL 517
++ K EI ++ L+ N++++ + + L++E++ N ++L
Sbjct: 73 -KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTL 126
Query: 518 LDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIFGG 576
D+ RF + I + + Y H + I+HRD+K NV++D ++ D+G+A +
Sbjct: 127 TDYDIRF-YMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 577 DQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRR 624
Q N V + + PE ++ ++ D++S G +L +I +
Sbjct: 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 422 NDFSSDNKLGEGGFGSVYKGVL----QNGKEIAVKRLSRSS----GQGIEEFKTEIALIA 473
+F LG G +G V+ GK A+K L +++ + E +TE ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 474 QLQHR-NLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR 532
++ LV++ E + LI +Y+ L ++ + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
+L L +L II+RD+K N+LLD+ + ++DFG+++ F D+ E GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 593 MAPEYAMEGL--FSTKSDVYSFGVLLLEIILGRR 624
MAP+ G D +S GVL+ E++ G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 422 NDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHR 478
+ + +G G G V + +A+K+LSR + + E+ L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 479 NLVSILGCCI------EEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIAR 532
N++S+L E Q+ L+ E + V + D + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 533 GILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGY 592
GI +LH IIHRDLK SN+++ + KI DFG+AR G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184
Query: 593 MAPEYAMEGLFSTKSDVYSFGVLLLEIILGR 623
APE + + D++S G ++ E++ +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-30
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 421 TNDFSSDNKLGEGGFGSVYKGV-LQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQH 477
+ + + +G G +GSV + G +AVK+LSR S + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 478 RNLVSILGCCIEEQEKMLI-YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILY 536
N++ +L + YL + + + K L +I I RG+ Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 537 LHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPE 596
+H IIHRDLK SN+ ++ KI DFG+AR +E T V +
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 597 YAMEGLFSTKSDVYSFGVLLLEIILGR 623
++ D++S G ++ E++ GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 2e-29
Identities = 43/235 (18%), Positives = 88/235 (37%), Gaps = 20/235 (8%)
Query: 429 KLGEGGFGSVYKGV-LQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCC 487
KLG G F +V+ + N +A+K + E + EI L+ ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 488 IEEQEKMLIYEYLPNKSLDVY-------------IFDEAKRSLLDWSKRFEIICGIARGI 534
K+L + + + + + + +I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 535 LYLHQDSRLRIIHRDLKASNVLLDAA-MNPKISDFGMARIFGGDQIEENTNRVVGTYGYM 593
Y+H+ R IIH D+K NVL++ + +A + +E+ + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 594 APEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648
+PE + + +D++S L+ E+I G F ++G H+ + +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 99.5 bits (247), Expect = 1e-24
Identities = 40/202 (19%), Positives = 70/202 (34%), Gaps = 27/202 (13%)
Query: 428 NKLGEGGFGSVYKGVLQNGKEIAVK--RLSRSSGQ--------GIEEFKTEIALIAQLQH 477
+GEG +V+ + E VK ++ +S + G F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 478 RNLVSILGCCIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYL 537
R L + G + + Y + N L I + + + E++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 538 HQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEENTNR-VVGTYGYMAPE 596
+ I+H DL NVL+ I DF + G + E R V Y +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 597 YAMEGLFSTKSDVYSFGVLLLE 618
Y T+ D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 78.1 bits (192), Expect = 5e-18
Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 18/125 (14%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ +T+ + + G + + N V ++ + T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNLV-----LYDHS----TSVWASNTGILGK 50
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
+ S GN V+ +W ++ + N + L + GN+V+ G +W
Sbjct: 51 KGCK-AVLQSDGNFVVYDAEGR-SLWASHSVRGN-GNYVLVLQEDGNVVIY----GSDIW 103
Query: 125 QSFDH 129
+ +
Sbjct: 104 STGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 73.8 bits (181), Expect = 2e-16
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 43 IWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNT 102
I Y+ + + + L++ + NLVL ++ VW N +
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL--FDRDDRVWSTNTAGKGT-GC 68
Query: 103 IAQLLDTGNLVLARNNTGQTLWQSFDHPSAT 133
A L G + + N +W S + SA
Sbjct: 69 RAVLQPNGRMDV-LTNQNIAVWTSGNSRSAG 98
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 67.1 bits (163), Expect = 3e-14
Identities = 23/126 (18%), Positives = 49/126 (38%), Gaps = 17/126 (13%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
D + S + G + G + + N V ++ N V W + + +
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNLV-----LYDNNRAV----WASGTNGKAS 50
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
VL + + GNLV+ + + +W +N + + N L N+V+ +N+ +W
Sbjct: 51 GC--VLKMQNDGNLVI--YSGSRAIWASNTNRQN-GNYYLILQRDRNVVI-YDNSNNAIW 104
Query: 125 QSFDHP 130
+ +
Sbjct: 105 ATHTNV 110
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.7 bits (160), Expect = 1e-13
Identities = 20/89 (22%), Positives = 31/89 (34%), Gaps = 5/89 (5%)
Query: 43 IWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNT 102
I + + + + +S T+ S NLVL + V VW +N + +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVL--FDSDVRVWASN--TAGATGC 58
Query: 103 IAQLLDTGNLVLARNNTGQTLWQSFDHPS 131
A L G LV+ W S S
Sbjct: 59 RAVLQSDGLLVILTAQ-NTIRWSSGTKGS 86
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 64.3 bits (156), Expect = 3e-13
Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 19/125 (15%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ + S + + G+ + F N V V W N
Sbjct: 2 NILYSGETLSTGEFLNYGS--FVFIMQEDCNLVLYDVDKPI---------WATNTGGL-- 48
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
S L++ + GNLV+ N + A+ + N + L N+V+ G W
Sbjct: 49 SRSCFLSMQTDGNLVV--YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY----GTDRW 102
Query: 125 QSFDH 129
+ H
Sbjct: 103 ATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.6 bits (136), Expect = 2e-10
Identities = 19/122 (15%), Positives = 41/122 (33%), Gaps = 21/122 (17%)
Query: 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPIN 64
+ + + ++ I+ +++ + N V Y+ +W N N
Sbjct: 15 QILHATESLE----ILFGTHVYRFIMQTDCNLV------LYDN---NNPIWATNTGGLGN 61
Query: 65 DTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLW 124
+ G LV+ VW + V+ + + + L N+V+ G LW
Sbjct: 62 GCR--AVLQPDGVLVVITNENV-TVWQSPVAGKAG-HYVLVLQPDRNVVI----YGDALW 113
Query: 125 QS 126
+
Sbjct: 114 AT 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 743 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.82 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.78 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.77 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.63 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.5 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.47 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.18 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.87 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.87 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.81 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.14 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.82 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=410.00 Aligned_cols=253 Identities=27% Similarity=0.348 Sum_probs=202.8
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||+||+|++. +|+.||||++.... .+..+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999985 69999999997543 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999984 3456899999999999999999999998 9999999999999999999999999999775444
Q ss_pred cccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . ................
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~-----~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---C-----QEYSDWKEKKTYLNPW 229 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---S-----HHHHHHHTTCTTSTTG
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---H-----HHHHHHhcCCCCCCcc
Confidence 3334455789999999999988876 67899999999999999999998643221 0 0111111111110000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
..-...+.+|+.+||+.||++|||++||++
T Consensus 230 --------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 --------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111234567888999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=406.99 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=198.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578889999999999999999998999999999754 3445789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998754 3356889999999999999999999998 9999999999999999999999999998765443222
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
.....||+.|+|||++.+..++.++|||||||++|||+++..|+..... . ..+......+.... .
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~----~~~~~~i~~~~~~~--~---- 223 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----N----SEVVEDISTGFRLY--K---- 223 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----H----HHHHHHHHHTCCCC--C----
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----H----HHHHHHHHhcCCCC--C----
Confidence 2336789999999999999999999999999999999996655442211 1 11122222211110 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
....+ ..+.+++.+||+.||++||||++|++.|+.+
T Consensus 224 p~~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 PRLAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11122 3466788899999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=401.77 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=206.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999974 79999999997665566788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999998763 235899999999999999999999998 99999999999999999999999999987754332
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........+...-..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~---- 238 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTPELQN---- 238 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSCCCSS----
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC----
Confidence 23446899999999999999999999999999999999999999864321 11111111111111000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...-...+.+++.+||+.||++|||+.|+++
T Consensus 239 ----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234667888999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-49 Score=408.77 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=211.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457888899999999999999986 58899999996543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++|+|..++... ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999988543 3457899999999999999999999998 99999999999999999999999999987754433
Q ss_pred ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 580 EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.. .....||+.|+|||++.+..++.|+|||||||++|||++|..|+....+ .....+....+...
T Consensus 171 ~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--------~~~~~~~i~~~~~~------ 235 (287)
T d1opja_ 171 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKDYRM------ 235 (287)
T ss_dssp EE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHHTTCCC------
T ss_pred ee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--------HHHHHHHHhcCCCC------
Confidence 22 2335688999999999999999999999999999999998877653322 11122222222111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
+.+......+.+|+..||+.||++||||++|++.|+.+.
T Consensus 236 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111112235677888999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=403.80 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=201.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||+||+|+.+ ..||||+++.. ..+..+.|++|+.++++++|||||++++++.+ ...++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 57899999999999999999865 36999998644 45567889999999999999999999998764 568999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+++|+|.+++... ...+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999988532 346899999999999999999999998 99999999999999999999999999987755444
Q ss_pred ccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 580 EENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+......+.....+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTSCCCCG
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCCCcc
Confidence 344455789999999999864 4589999999999999999999999864321 11122222222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
. .+...+ ...+.+++.+||+.||++||||++|++.|+.+.
T Consensus 232 ~-~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 232 S-KVRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp G-GSCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h-hccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 011111 234667888999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=403.68 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=205.7
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5688889999999999999999988999999996543 445789999999999999999999998765 56799999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|+|.+++.... ...+++..++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999998775432 335899999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
.....||+.|+|||++.++.++.++|||||||++|||++|..|+..... . ..+...+..+.... .
T Consensus 167 -~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~----~~~~~~i~~~~~~~-----~- 231 (272)
T d1qpca_ 167 -REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----N----PEVIQNLERGYRMV-----R- 231 (272)
T ss_dssp -CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----H----HHHHHHHHTTCCCC-----C-
T ss_pred -ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----H----HHHHHHHHhcCCCC-----C-
Confidence 3346789999999999999999999999999999999997776543221 0 11222222221111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
....+ ..+.+|+.+||+.||++||||++|+++|+.
T Consensus 232 p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 232 PDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccCh---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11122 346678889999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=397.60 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=204.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||+||+|+++ +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57899999999999999999986 6899999998643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~~~~~i~~~~~----- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------QETYKRISRVEF----- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHHHHTTCC-----
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---------HHHHHHHHcCCC-----
Confidence 2 3346899999999999999999999999999999999999999864321 111121111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.. ..+ ..+.+++.+||+.||++|||++||++
T Consensus 222 -~~p~-~~s---~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFPD-FVT---EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCT-TSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCc-cCC---HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0111 112 34567888999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=409.10 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=196.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CC---cEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NG---KEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.++||+|+||+||+|+++ ++ ..||||++... .....++|.+|+.+|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999975 23 35899988654 445667899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998753 2346899999999999999999999998 99999999999999999999999999987754
Q ss_pred Cccccc---cccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 577 DQIEEN---TNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 577 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... .....||+.|+|||.+.++.++.++|||||||++|||++ |+.||..... . .+......+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~----~~~~~i~~~~~ 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----Q----DVINAIEQDYR 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H----HHHHHHHTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----H----HHHHHHHcCCC
Confidence 432211 122467899999999999999999999999999999998 8888764321 1 11122222111
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
.+.+......+.+++.+||+.||++||||.||++.|+.+.
T Consensus 252 ---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 252 ---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111222345677888999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=393.13 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=209.7
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||+||+|++++++.||||++++.. ...++|++|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999989999999997643 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|+|..++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999887543 346888999999999999999999998 9999999999999999999999999998765543322
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
.....||+.|+|||.+.+..++.|+|||||||++|||++ |+.||..... ..+...+..+.... .+
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---------~~~~~~i~~~~~~~--~p-- 223 (258)
T d1k2pa_ 158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---------SETAEHIAQGLRLY--RP-- 223 (258)
T ss_dssp -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---------HHHHHHHHTTCCCC--CC--
T ss_pred -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---------HHHHHHHHhCCCCC--Cc--
Confidence 334678999999999999999999999999999999998 7888764321 11222222221111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
...+ ..+.+++.+||+.||++|||+++|++.|..
T Consensus 224 --~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 --HLAS---EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --cccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1112 356678889999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=400.05 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--CCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE--EQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~--~~~~~lV 496 (743)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 6899999998754 34456778999999999999999999999875 4568999
Q ss_pred EEecCCCChhhhhhhcc-cccccCHHHHHHHHHHHHHHHHHhhccC--CCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 497 YEYLPNKSLDVYIFDEA-KRSLLDWSKRFEIICGIARGILYLHQDS--RLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986533 3457999999999999999999999864 23499999999999999999999999999998
Q ss_pred cCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAM 653 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (743)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+...
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---------~~~~~~i~~~~~~ 232 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------KELAGKIREGKFR 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHHHTCCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---------HHHHHHHHcCCCC
Confidence 754322 23347899999999999999999999999999999999999999864321 1122222222222
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 654 EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 654 ~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+ ...+ . ..+.+|+.+||+.||.+|||++||++
T Consensus 233 ~~-----~~~~-s---~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 RI-----PYRY-S---DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC-----CTTS-C---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----Cccc-C---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 1111 2 24667888999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=399.09 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=204.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+.|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888999999999999999975 68999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999887532 346899999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccccccccccccCcceec-----cCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 581 ENTNRVVGTYGYMAPEYAM-----EGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||....+. . .......+....+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-----~----~~~~i~~~~~~~~ 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-----R----VLLKIAKSEPPTL 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----G----HHHHHHHSCCCCC
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----H----HHHHHHcCCCCCC
Confidence 1233478999999999984 456899999999999999999999998643221 1 1111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. +......+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1111234667888999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=399.52 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=200.9
Q ss_pred CCCCcCcccccCCceeEEEEEEcCC-----cEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNG-----KEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
+.|++.++||+|+||.||+|.++.. ..||||++... ......+|.+|+.++++++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997642 36999999754 34455679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
||||+.++++.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887743 3346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ..+......+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--------~~~~~~i~~~~--- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGF--- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC---
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--------HHHHHHHhccC---
Confidence 43222 2233457899999999999999999999999999999999977775533211 11222222221
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..+.+......+.+|+.+||+.||++||||.||+++|+.+..
T Consensus 231 ------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111122223456788889999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=399.41 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=201.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 7999999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998874 3456899999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~----~~~~i~~~~~----- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YL----IFQKIIKLEY----- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHTTCC-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HH----HHHHHHcCCC-----
Confidence 433344457899999999999999999999999999999999999999874321 11 1111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.+.... ...+.+|+.+||+.||++|||++|+++
T Consensus 228 -~~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -DFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111111 234567888999999999999998743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=407.25 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=204.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcC-C-----cEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN-G-----KEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
++|++.++||+|+||+||+|+... + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568889999999999999999753 2 36899998654 334456789999999998 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhhccc--------------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCC
Q 041312 494 MLIYEYLPNKSLDVYIFDEAK--------------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKAS 553 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~ 553 (743)
++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999865321 245899999999999999999999998 999999999
Q ss_pred cEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCccc
Q 041312 554 NVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQ 632 (743)
Q Consensus 554 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~ 632 (743)
|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654443333345678999999999999999999999999999999997 89888643210
Q ss_pred CCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 041312 633 GSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLG 698 (743)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 698 (743)
.........+... +.+......+.+|+.+||+.||++|||++||++.|.
T Consensus 274 --------~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 --------ANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --------HHHHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1122222222111 111111234667888999999999999999999995
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=397.05 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=205.0
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLP 501 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 501 (743)
++|++.++||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578999999999999999999998889999999654 3455789999999999999999999999865 56899999999
Q ss_pred CCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcccc
Q 041312 502 NKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIEE 581 (743)
Q Consensus 502 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~~ 581 (743)
+|+|..++.... ...+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998876532 346899999999999999999999998 9999999999999999999999999998765443322
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcccccC
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSLG 661 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~ 661 (743)
.....||+.|+|||++.++.++.++|||||||++|||++|..|+..... .......+..+.... +
T Consensus 171 -~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--------~~~~~~~i~~~~~~~-----~- 235 (285)
T d1fmka3 171 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYRMP-----C- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCCCC-----C-
T ss_pred -eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcCCCC-----C-
Confidence 2336789999999999999999999999999999999998777654321 111222222221111 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCCCC
Q 041312 662 ESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNAPSSP 706 (743)
Q Consensus 662 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~p 706 (743)
.......+.+++.+||+.||++||+|++|+++|+.......|
T Consensus 236 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 236 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 111123466788899999999999999999999886654444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=407.47 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=177.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.++|++.++||+|+||+||+|+.. +|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999975 6899999999755 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc-CCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD-SRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999853 34689999999999999999999974 7 999999999999999999999999999876322
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCC
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFH 629 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~ 629 (743)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 233478999999999999999999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=393.95 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCCcCc-ccccCCceeEEEEEEc---CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDN-KLGEGGFGSVYKGVLQ---NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 5999999999999864 3557999999755 34556789999999999999999999999865 568999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|.+++.. .+..+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 2346899999999999999999999998 99999999999999999999999999998765
Q ss_pred Cccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 577 DQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 577 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
.... .......||+.|+|||++.++.++.++|||||||++|||++ |+.||..... . .+......+...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~----~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P----EVMAFIEQGKRME 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----H----HHHHHHHTTCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----H----HHHHHHHcCCCCC
Confidence 4322 22334678999999999999999999999999999999998 8999864321 1 1223333332221
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.. .. .+ ..+.+|+.+||+.+|++|||+.+|++.|+.
T Consensus 233 ~p-----~~-~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 233 CP-----PE-CP---PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CC-----TT-CC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-----Cc-CC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 11 12 346678889999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=385.73 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=195.4
Q ss_pred CcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec----CCeeEEEE
Q 041312 425 SSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE----EQEKMLIY 497 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 497 (743)
++.++||+|+||+||+|++. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45578999999999999976 6889999998643 44556789999999999999999999999865 34579999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec-CCCCeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD-AAMNPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~vkl~DFGla~~~~~ 576 (743)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999843 346899999999999999999999874 3599999999999996 578999999999986543
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
.. ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..........+.....+
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--------~~~~~~~i~~~~~~~~~ 234 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--------AAQIYRRVTSGVKPASF 234 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--------HHHHHHHHTTTCCCGGG
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--------HHHHHHHHHcCCCCccc
Confidence 32 334789999999998865 599999999999999999999999863321 11122222222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+. ...+ .+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~-----~~~~---~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 DK-----VAIP---EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG-----CCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-----cCCH---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 1122 3567888999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=392.04 Aligned_cols=247 Identities=30% Similarity=0.429 Sum_probs=196.6
Q ss_pred cccccCCceeEEEEEEc---CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEecCC
Q 041312 428 NKLGEGGFGSVYKGVLQ---NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYLPN 502 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~---~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 502 (743)
++||+|+||+||+|.++ .++.||||+++.. .....++|.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999865 3568999999654 33345789999999999999999999999864 567899999999
Q ss_pred CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc-c
Q 041312 503 KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE-E 581 (743)
Q Consensus 503 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~-~ 581 (743)
|+|.+++.. ...+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999998843 456899999999999999999999998 999999999999999999999999999877544322 2
Q ss_pred ccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhccccc
Q 041312 582 NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKSL 660 (743)
Q Consensus 582 ~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~l 660 (743)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...+..+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---------~~~~~~i~~~~~~~~----- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLEKGERMGC----- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHHTTCCCCC-----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---------HHHHHHHHcCCCCCC-----
Confidence 2334678999999999999999999999999999999998 8999864321 112222322222111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 661 GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 661 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
.. ..+ ..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 232 p~-~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PA-GCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CT-TCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred Cc-ccC---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11 112 346678889999999999999999998864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=396.05 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=199.1
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.|+.+++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999975 68899999997553 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999976653 3456899999999999999999999998 999999999999999999999999999865432
Q ss_pred cccccccccccccccCcceecc---CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 579 IEENTNRVVGTYGYMAPEYAME---GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||..... ......... +....
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~-~~~~~- 233 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-NESPA- 233 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH-SCCCC-
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh-CCCCC-
Confidence 34689999999999864 4689999999999999999999999864321 111111111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.....+ ..+.+|+.+||+.||++|||++|+++
T Consensus 234 ----~~~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ----LQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111122 34667888999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-46 Score=394.89 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=191.3
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
.+.|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999976 68999999997543 3344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec---CCCCeEEeeeccccccC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD---AAMNPKISDFGMARIFG 575 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~vkl~DFGla~~~~ 575 (743)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999843 456999999999999999999999998 99999999999995 57899999999998765
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ...........
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~----~~~~i~~~~~~-- 227 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AK----LFEQILKAEYE-- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH----HHHHHHTTCCC--
T ss_pred CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HH----HHHHHhccCCC--
Confidence 4322 2346899999999999999999999999999999999999999864321 11 11111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDNA 702 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 702 (743)
+..+....-...+.+++.+||+.||++|||++|+++. |.+...
T Consensus 228 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 228 ----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred ----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence 0001111112346678889999999999999999983 554433
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-47 Score=396.88 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=210.0
Q ss_pred cCCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|++.++||+|+||+||+|+.+ +++.||||+++... .+..++|.+|+.++++++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 457999999999999999999964 35789999997653 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcc---------------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCC
Q 041312 494 MLIYEYLPNKSLDVYIFDEA---------------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKA 552 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp 552 (743)
++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999985422 1234889999999999999999999998 99999999
Q ss_pred CcEEecCCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCC-CCCCCcc
Q 041312 553 SNVLLDAAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR-NNTFHLE 631 (743)
Q Consensus 553 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~-p~~~~~~ 631 (743)
+||||+.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|.. |+.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999987655444444445678999999999999999999999999999999999975 4443211
Q ss_pred cCCCccccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 632 QGSGSWNLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
. .+...+..+..... .... ...+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 249 -----~----e~~~~v~~~~~~~~-----p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -----E----EVIYYVRDGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -----H----HHHHHHHTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----H----HHHHHHHcCCCCCC-----Cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 12222333332211 1111 234677888999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-46 Score=397.75 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=207.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999975 7999999999877777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec--CCCCeEEeeeccccccCCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD--AAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~vkl~DFGla~~~~~~ 577 (743)
+++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999888432 346899999999999999999999998 99999999999996 4578999999999887544
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ........... .+
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~----~~~~i~~~~~~--~~ 245 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DE----TLRNVKSCDWN--MD 245 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH----HHHHHHHTCCC--SC
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HH----HHHHHHhCCCC--CC
Confidence 32 3346899999999999999999999999999999999999999864321 11 11111111110 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
... ...-...+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 01112346678889999999999999999984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-46 Score=396.29 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=209.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
.++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999975 7999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec--CCCCeEEeeeccccccCCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD--AAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~vkl~DFGla~~~~~~ 577 (743)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887643 2346899999999999999999999998 99999999999997 6789999999999987654
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ...........
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~----~~~~i~~~~~~---- 246 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LE----TLQNVKRCDWE---- 246 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HH----HHHHHHHCCCC----
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HH----HHHHHHhCCCC----
Confidence 32 3346899999999999999999999999999999999999999864321 11 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCC
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSD 700 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 700 (743)
............+.+|+.+||+.||.+|||+.|+++. |++.
T Consensus 247 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 247 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 0111111112346678889999999999999999874 5443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=392.86 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=198.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecC-Ce
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEE-QE 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~-~~ 492 (743)
++|++.++||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.++.++ +|+||+++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 67999999999999999999964 3468999999754 344566788888888887 689999999998765 46
Q ss_pred eEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA 559 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 559 (743)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+++ ||||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 8999999999999999865332 345889999999999999999999998 999999999999999
Q ss_pred CCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCC-CCCCCcccCCCccc
Q 041312 560 AMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRR-NNTFHLEQGSGSWN 638 (743)
Q Consensus 560 ~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~-p~~~~~~~~~~~~~ 638 (743)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. ||.....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------- 242 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------- 242 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-------
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-------
Confidence 99999999999987765544444555789999999999999999999999999999999999865 4432211
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...+...+..+...... . ..+ ..+.+++.+||+.||++|||++||++.|+++
T Consensus 243 -~~~~~~~~~~~~~~~~~-----~-~~~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 -DEEFCRRLKEGTRMRAP-----D-YTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -SHHHHHHHHHTCCCCCC-----T-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCCCCCCC-----c-cCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222223322222111 1 112 3466788899999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=391.38 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=199.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc----EEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK----EIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKML 495 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~l 495 (743)
++|+++++||+|+||+||+|++. +|+ +||+|++... ..+..++|.+|+.++++++|||||++++++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999975 444 6899988654 445678899999999999999999999999865 5678
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccC
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFG 575 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~ 575 (743)
++|++.+++|.+++.. ....+++..++.++.||++||.|||+++ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887754 3456899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcch
Q 041312 576 GDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME 654 (743)
Q Consensus 576 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (743)
............||+.|+|||++.++.++.++|||||||++|||+| |..|+..... . .+......+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~----~~~~~i~~~~~~- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----S----EISSILEKGERL- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----G----GHHHHHHHTCCC-
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----H----HHHHHHHcCCCC-
Confidence 5554444445678999999999999999999999999999999998 6777653321 1 122222222111
Q ss_pred hcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 655 AVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 655 ~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+.+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 233 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11111223466788899999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=382.09 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=203.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC------hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS------GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.+.|++.++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457999999999999999999985 79999999986432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC----CeEEeeec
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM----NPKISDFG 569 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~vkl~DFG 569 (743)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999853 346899999999999999999999998 99999999999998776 49999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~----~~~~i~~ 230 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----E----TLANVSA 230 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H----HHHHHHT
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----H----HHHHHHh
Confidence 9987754332 23467899999999999999999999999999999999999998743211 1 1111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.... ....... .....+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYE--FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCC--CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC--CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 0000000 11234667888999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=380.69 Aligned_cols=249 Identities=30% Similarity=0.398 Sum_probs=194.9
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC-CeeEEEEEec
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE-QEKMLIYEYL 500 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~~ 500 (743)
++|++.++||+|+||.||+|+++ |+.||||+++.. ...++|++|++++++++||||+++++++.+. ...++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999999985 788999999654 3457899999999999999999999998754 5689999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998643 2345899999999999999999999998 999999999999999999999999999875433
Q ss_pred cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchhcccc
Q 041312 581 ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDKS 659 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~~ 659 (743)
.....+|+.|+|||++.++.++.++|||||||++|||++ |+.|+..... . .+......+...++
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~----~~~~~i~~~~~~~~---- 221 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K----DVVPRVEKGYKMDA---- 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----G----GHHHHHTTTCCCCC----
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----H----HHHHHHHcCCCCCC----
Confidence 233567899999999999999999999999999999998 5666543221 1 12222222221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 660 LGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 660 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+......+.+|+.+||+.||.+||||.+|+++|+.+
T Consensus 222 -----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111123456788899999999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=386.91 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=204.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
.++|++++.||+|+||.||+|+.+ +|+.||||++.+. .....+++.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999975 7999999999754 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999988743 456889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... . ........+..
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~----~~~~~i~~~~~---- 222 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E----RLFELILMEEI---- 222 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCCC----
T ss_pred CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----H----HHHHHHhcCCC----
Confidence 322 23457899999999999999999999999999999999999999874321 1 11122221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
.+.... . ..+.+|+.+||+.||.+||+ ++||++
T Consensus 223 --~~p~~~-s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --RFPRTL-S---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCTTS-C---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCccC-C---HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 011111 2 23567888999999999995 778876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=381.47 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=193.7
Q ss_pred CCCCcCcccccCCceeEEEEEEcC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN----GKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|+.++++++|||||++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578889999999999999998742 456899998654 3445678999999999999999999999986 4678999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|..++.. ....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999988643 3446899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCcchh
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEA 655 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (743)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |..|+..... . .+......+....
T Consensus 161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~----~~~~~i~~~~~~~- 229 (273)
T d1mp8a_ 161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----N----DVIGRIENGERLP- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G----GHHHHHHTTCCCC-
T ss_pred Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----H----HHHHHHHcCCCCC-
Confidence 3322 2334678999999999999999999999999999999998 7888764322 1 1222222222211
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 656 VDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 656 ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
+.... ...+.+|+.+||+.||++|||++||++.|+.+
T Consensus 230 ----~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 230 ----MPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 23466788899999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=388.19 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=210.5
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCee
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~ 493 (743)
++|++.++||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57888899999999999999852 46789999997643 44556799999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcc---------------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 494 MLIYEYLPNKSLDVYIFDEA---------------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986532 2336889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWN 638 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~ 638 (743)
.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++++.|+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~------ 253 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999999876554444455578999999999999999999999999999999999966664432221
Q ss_pred cchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 639 LVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 639 ~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
...+......+... ..+......+.+|+.+||+.||++||||++|+++|++.
T Consensus 254 -~~~~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 -DSKFYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp -SHHHHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11122222222111 11111224567788899999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.44 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=208.1
Q ss_pred CCCCcCcccccCCceeEEEEEEcC--------CcEEEEEEcccCC-hhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCC
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN--------GKEIAVKRLSRSS-GQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQ 491 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~ 491 (743)
++|++.++||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||++++++.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578888999999999999998532 3479999997654 34567889999999998 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhhccc-------------ccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAK-------------RSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD 558 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 558 (743)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999865421 245899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCcc
Q 041312 559 AAMNPKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSW 637 (743)
Q Consensus 559 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~ 637 (743)
.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..|+.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 999999999999998765554444556789999999999999999999999999999999998 5767653221
Q ss_pred ccchhhHhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 638 NLVGHVWDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..+.+.+..+..... +......+.+|+.+||+.||++|||+.||+++|+++.+
T Consensus 244 ---~~~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ---EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 123333333322211 11112346778889999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-44 Score=382.26 Aligned_cols=244 Identities=24% Similarity=0.314 Sum_probs=202.2
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|++.++||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6999999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988874 3445788888899999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~----~~~~i~~~~~----- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MK----TYEKILNAEL----- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HH----HHHHHHHCCC-----
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HH----HHHHHHcCCC-----
Confidence 2347899999999999999999999999999999999999999864321 11 1111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDRP-----NMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 695 (743)
.+... .. ..+.+++.+||+.||.+|| |+++|++
T Consensus 219 -~~p~~-~s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RFPPF-FN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCTT-SC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCC-CC---HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01111 12 3456788899999999996 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=375.81 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=199.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----e
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ----E 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~ 492 (743)
.++|++.+.||+|+||+||+|++. +|+.||||++++.. ....+.+.+|++++++++|||||++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 79999999997543 344567999999999999999999999988654 3
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988743 346899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCcc-ccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 573 IFGGDQI-EENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 573 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ..........+.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhcCC
Confidence 6543322 2233456899999999999999999999999999999999999999864321 111222222221
Q ss_pred cc-hhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 041312 652 AM-EAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRP-NMSAVVSMLGSD 700 (743)
Q Consensus 652 ~~-~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 700 (743)
.. .... .. .+ ..+.+++.+||+.||++|| |+++|++.|.++
T Consensus 232 ~~~~~~~----~~-~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 IPPSARH----EG-LS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCGGGTS----SS-CC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCchhc----cC-CC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11 1111 11 12 3466788899999999999 899999888654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=378.34 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=194.4
Q ss_pred CCCCcCcccccCCceeEEEEEEcC--C--cEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQN--G--KEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.++||+|+||.||+|++.. + ..||||++.+. ..+..++|.+|+.++++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 2 36899998754 34456789999999999999999999999976 4678
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
+||||++++++.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999887754 3446899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cccccccccccccCcceeccCCCCccccchhHHHHHHHHHh-cCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 575 GGDQIE-ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIIL-GRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... .......|+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ........+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGER 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCCCC
Confidence 554332 22334578889999999999999999999999999999998 8988763221 1111222222211
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGS 699 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 699 (743)
... .... + ..+.+++.+||+.||++||||.+|++.|..
T Consensus 234 ~~~-----~~~~-~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 LPR-----PEDC-P---QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCC-----CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----cccc-c---HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 1111 2 346678889999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=383.41 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=211.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ------NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKM 494 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~ 494 (743)
++|++.++||+|+||.||+|++. +++.||||+++.. ..+....|.+|+.++++++|||||++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57888899999999999999864 3578999999754 4455567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcc-------cccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEee
Q 041312 495 LIYEYLPNKSLDVYIFDEA-------KRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISD 567 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~D 567 (743)
+||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 1234688899999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh
Q 041312 568 FGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW 647 (743)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 647 (743)
||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.|+..... . .......
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~-~~~~~~i 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------N-EQVLRFV 248 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------H-HHHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------H-HHHHHHH
Confidence 9999877655444445556789999999999999999999999999999999999654332211 1 1122222
Q ss_pred ccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 648 KEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 648 ~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
..+...... ......+.+++.+||+.+|++||||++|+++|++..+
T Consensus 249 ~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222221111 1112347778889999999999999999999988644
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-44 Score=370.84 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=202.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh---------hcHHHHHHHHHHHHhcC-CccEEeeeeeEec
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG---------QGIEEFKTEIALIAQLQ-HRNLVSILGCCIE 489 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~ 489 (743)
.++|++.++||+|+||+||+|+.. +++.||||++.+... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999975 789999999875421 22356889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
.+..++||||+++|+|.+++.. +..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999853 446899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcceecc------CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAME------GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
+++.+..... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---------~~~ 223 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---------MLM 223 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---------HHH
Confidence 9998765432 234689999999999863 3478899999999999999999999874322 111
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
......+... ........-...+.+++.+||+.||++|||+.||++
T Consensus 224 ~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 LRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1222222111 000011111235667888999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=383.95 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=201.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCc--EEEEEEcccC-ChhcHHHHHHHHHHHHhc-CCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGK--EIAVKRLSRS-SGQGIEEFKTEIALIAQL-QHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~~~~~~lV 496 (743)
++|++.++||+|+||.||+|+++ ++. .||||++... .....+.|.+|+++|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999976 444 4788887644 344567899999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhhhc-------------ccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCe
Q 041312 497 YEYLPNKSLDVYIFDE-------------AKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNP 563 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~v 563 (743)
|||+++|+|.+++... .....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23457899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhh
Q 041312 564 KISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHV 643 (743)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 643 (743)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|..|+..... . ..+
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----~----~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----C----AEL 235 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----H----HHH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----H----HHH
Confidence 999999998654222 22345789999999999999999999999999999999998765332211 1 112
Q ss_pred HhHhccCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 041312 644 WDLWKEGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDNA 702 (743)
Q Consensus 644 ~~~~~~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 702 (743)
...+..+.... .+......+.+|+.+||+.||++||||+||++.|+++..
T Consensus 236 ~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 236 YEKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222221111 111112356678889999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-44 Score=382.23 Aligned_cols=244 Identities=21% Similarity=0.264 Sum_probs=203.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~ 497 (743)
++|+++++||+|+||.||+|+++ +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 7999999998643 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGD 577 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~ 577 (743)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999988843 346899999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhcc
Q 041312 578 QIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVD 657 (743)
Q Consensus 578 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld 657 (743)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~----~~~~~i~~~~~~---- 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----I----QIYEKIVSGKVR---- 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----HHHHHHHHCCCC----
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----H----HHHHHHhcCCCC----
Confidence 2346899999999999999999999999999999999999999864321 1 111111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCC-----CCHHHHHH
Q 041312 658 KSLGESCCAPEILRCIHLGLLCVQEQATDR-----PNMSAVVS 695 (743)
Q Consensus 658 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-----Ps~~evl~ 695 (743)
... ... ..+.+++.+||+.||.+| ||+++|++
T Consensus 257 --~p~-~~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 --FPS-HFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCT-TCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCc-cCC---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111 112 245678889999999999 48999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=379.50 Aligned_cols=274 Identities=21% Similarity=0.287 Sum_probs=199.6
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----eeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ----EKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 497 (743)
++|...++||+|+||.||+|++ +|+.||||+++..... ......|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4567778999999999999986 5889999998643221 222344566667889999999999998654 579999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccC-----CCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDS-----RLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999853 35889999999999999999999741 2349999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccccccCcceeccCC------CCccccchhHHHHHHHHHhcCCCCCCCcccCCCcccc--chh
Q 041312 573 IFGGDQI--EENTNRVVGTYGYMAPEYAMEGL------FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNL--VGH 642 (743)
Q Consensus 573 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~--~~~ 642 (743)
....... ........||+.|+|||++.+.. ++.|+|||||||+||||++|..|+............. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7754332 12234578999999999987643 6778999999999999999998876433221111111 000
Q ss_pred hHhHhccCCcchhcccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 643 VWDLWKEGTAMEAVDKSLGESC-CAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 643 ~~~~~~~~~~~~~ld~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
...........+.+++.+.... ..+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111111111222221111 2344566889999999999999999999999997653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-44 Score=384.50 Aligned_cols=249 Identities=24% Similarity=0.306 Sum_probs=196.5
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC---hhcHHHHH---HHHHHHHhcCCccEEeeeeeEecCCee
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS---GQGIEEFK---TEIALIAQLQHRNLVSILGCCIEEQEK 493 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~---~Ev~~l~~l~h~niv~l~~~~~~~~~~ 493 (743)
.++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+. .|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999976 69999999986431 22233344 446777778899999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999853 456788999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 574 FGGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
+.... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .. ...........
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~-~~~~~~~~~~~- 225 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-HEIDRMTLTMA- 225 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CH-HHHHHHSSSCC-
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HH-HHHHHhcccCC-
Confidence 75442 334689999999999975 56899999999999999999999998753221 00 00111110000
Q ss_pred chhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 653 MEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 653 ~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
..+... .. ..+.+|+.+||+.||++||| ++|+++
T Consensus 226 -----~~~~~~-~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 -----VELPDS-FS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CCCCSS-SC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCCCC-CC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001111 12 24567888999999999999 688875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=376.07 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=200.8
Q ss_pred CcccccCCceeEEEEEEcCC----cEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-CCeeEEEEEec
Q 041312 427 DNKLGEGGFGSVYKGVLQNG----KEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-EQEKMLIYEYL 500 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 500 (743)
.++||+|+||+||+|++.++ ..||||++++. .....++|.+|++++++++|||||++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997532 35899999753 55567889999999999999999999999875 46889999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
++++|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998753 3345678888999999999999999998 999999999999999999999999999877544322
Q ss_pred c--ccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhccc
Q 041312 581 E--NTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAVDK 658 (743)
Q Consensus 581 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ld~ 658 (743)
. ......||+.|+|||.+....++.++||||||+++|||++|+.|+...... ... ......+.... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~----~~~i~~g~~~~--~- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDI----TVYLLQGRRLL--Q- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------C----HHHHHTTCCCC--C-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HHH----HHHHHcCCCCC--C-
Confidence 1 223357899999999999999999999999999999999988887643221 111 11122221111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 041312 659 SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSDN 701 (743)
Q Consensus 659 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 701 (743)
....+ ..+.+++.+||+.||++||+|.||++.|+++.
T Consensus 256 ---p~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 256 ---PEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ---CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122 34667888999999999999999999998774
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=378.04 Aligned_cols=252 Identities=21% Similarity=0.233 Sum_probs=195.8
Q ss_pred cCCCCcCc-ccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhc-CCccEEeeeeeEec----CCee
Q 041312 421 TNDFSSDN-KLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQL-QHRNLVSILGCCIE----EQEK 493 (743)
Q Consensus 421 ~~~y~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l-~h~niv~l~~~~~~----~~~~ 493 (743)
.++|.+.+ .||+|+||+||+|++. +++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888875 5999999999999974 7999999998643 4677899987655 89999999999865 4668
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC---CCCeEEeeecc
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA---AMNPKISDFGM 570 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~vkl~DFGl 570 (743)
++|||||++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998543 2346899999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 571 ARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
|+....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ............+
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIRMG 232 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSC
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHHHHHHhcC
Confidence 987654332 33468999999999999999999999999999999999999998643221 0000000000000
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.. .+.......-...+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 0000000111235778889999999999999999988
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=376.31 Aligned_cols=252 Identities=19% Similarity=0.257 Sum_probs=203.4
Q ss_pred HcCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 420 ATNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 420 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
..++|++.++||+|+||+||+|+.. +++.||||++..... ....+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3568999999999999999999986 688999999976543 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC--CCCeEEeeeccccccCC
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA--AMNPKISDFGMARIFGG 576 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~vkl~DFGla~~~~~ 576 (743)
|+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999988432 335899999999999999999999998 999999999999985 45799999999987654
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ............ +
T Consensus 157 ~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---------~~~~~i~~~~~~--~ 222 (321)
T d1tkia_ 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---------QIIENIMNAEYT--F 222 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---------HHHHHHHHTCCC--C
T ss_pred CCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhCCCC--C
Confidence 332 33467899999999999999999999999999999999999998743221 111111111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+....... ...+.+|+..||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001 124667888999999999999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=372.48 Aligned_cols=256 Identities=22% Similarity=0.286 Sum_probs=193.0
Q ss_pred CcccccCCceeEEEEEEc-CCcEEEEEEcccCChh-----cHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEec
Q 041312 427 DNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQ-----GIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEYL 500 (743)
Q Consensus 427 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 500 (743)
+++||+|+||+||+|++. +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 6999999998654221 2346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCccc
Q 041312 501 PNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQIE 580 (743)
Q Consensus 501 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~~ 580 (743)
.++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 998777665 23456888899999999999999999998 999999999999999999999999999876544322
Q ss_pred cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcch-----
Q 041312 581 ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAME----- 654 (743)
Q Consensus 581 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 654 (743)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.+.........
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTTTSSSTT
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----HHHHHHHHHhcCCCChhhccchh
Confidence 2336899999999998754 689999999999999999999999864322 111111111110000000
Q ss_pred -hccc-cc--CCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 655 -AVDK-SL--GESCCA-----PEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 655 -~ld~-~l--~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.... .. ...... .....+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 00 000011 11235778889999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=374.16 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=200.4
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|+++++||+|+||+||+|++. +|+.||||+++... ....+++.+|++++++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 79999999996542 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
|+.++.+..... .....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997655543322 23456899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcceeccCC-CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc--------
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE-------- 649 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 649 (743)
. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...... ............
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-----DQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTT
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-----HHHHHHHHhcCCCchhhccc
Confidence 2 233468999999999887765 578999999999999999999998743210 000000000000
Q ss_pred ----CCcchhcccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCC
Q 041312 650 ----GTAMEAVDKSLGES---CCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSD 700 (743)
Q Consensus 650 ----~~~~~~ld~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 700 (743)
.............. ........+.+|+.+||+.||.+|||++|+++. |+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000000000000 001112456778889999999999999999984 6543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=376.46 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=200.9
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC---ChhcHHHHHHHHHHHH-hcCCccEEeeeeeEecCCeeEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS---SGQGIEEFKTEIALIA-QLQHRNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ev~~l~-~l~h~niv~l~~~~~~~~~~~lV 496 (743)
++|.+.++||+|+||+||+|+.. +++.||||++++. .....+.+..|+.++. .++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999986 6999999999753 2344566777777665 68999999999999999999999
Q ss_pred EEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCC
Q 041312 497 YEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGG 576 (743)
Q Consensus 497 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~ 576 (743)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999853 345889999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCcchhc
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTAMEAV 656 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 656 (743)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---------~~~~~~i~~~~~---- 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---------EELFHSIRMDNP---- 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHCCC----
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---------HHHHHHHHcCCC----
Confidence 332 23446899999999999999999999999999999999999999874322 112222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 041312 657 DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMS-AVVS 695 (743)
Q Consensus 657 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 695 (743)
.+.. ... ..+.+|+.+||+.||++||++. +|++
T Consensus 221 --~~p~-~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPR-WLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCT-TSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCc-cCC---HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111 112 2356788899999999999996 6754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-43 Score=367.19 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=198.9
Q ss_pred CCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCC--hhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSS--GQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||+||+|++++|+.||||++.... ....+++.+|+.+|++++|||||++++.+...+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999999999999996543 33467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCcc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQI 579 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~~ 579 (743)
+.++.+..+.. ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98887776652 3456999999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC--------
Q 041312 580 EENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG-------- 650 (743)
Q Consensus 580 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 650 (743)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-----DQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCCCCTTTSTTG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhCCCChhhccch
Confidence 22335789999999998764 5789999999999999999999998643210 0101111100000
Q ss_pred ----Ccchhc---ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 ----TAMEAV---DKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 ----~~~~~l---d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...... .+.-...........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000001111235678888999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=364.31 Aligned_cols=240 Identities=23% Similarity=0.393 Sum_probs=193.1
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCCh------hcHHHHHHHHHHHHhcC--CccEEeeeeeEecCC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSG------QGIEEFKTEIALIAQLQ--HRNLVSILGCCIEEQ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ev~~l~~l~--h~niv~l~~~~~~~~ 491 (743)
.++|++.++||+|+||+||+|+.. +|+.||||++.+... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999975 799999999864311 12234678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-CCCeEEeeec
Q 041312 492 EKMLIYEYLPN-KSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-AMNPKISDFG 569 (743)
Q Consensus 492 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~vkl~DFG 569 (743)
..++||||+.+ +++.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 56666653 3456899999999999999999999998 999999999999985 4789999999
Q ss_pred cccccCCCccccccccccccccccCcceeccCCC-CccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 570 MARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLF-STKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~ 218 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIR 218 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHH
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhh
Confidence 998754332 234689999999999987765 6779999999999999999999863211 001
Q ss_pred cCCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 EGTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
+.. .+.... + ..+.+++.+||+.||++|||++|+++
T Consensus 219 -~~~------~~~~~~-s---~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 -GQV------FFRQRV-S---SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCC------CCSSCC-C---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccc------CCCCCC-C---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 011111 2 24567888999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=366.22 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=193.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-C-CcEEEEEEcccC--ChhcHHHHHHHHHHHHhc---CCccEEeeeeeEec----
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-N-GKEIAVKRLSRS--SGQGIEEFKTEIALIAQL---QHRNLVSILGCCIE---- 489 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l---~h~niv~l~~~~~~---- 489 (743)
.++|+++++||+|+||+||+|++. + ++.||||++... .......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 667999998643 222233456777776665 79999999999853
Q ss_pred -CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeee
Q 041312 490 -EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDF 568 (743)
Q Consensus 490 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DF 568 (743)
....+++|||+.++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++..+.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346799999999887754432 34456889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhc
Q 041312 569 GMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWK 648 (743)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 648 (743)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIG 232 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHC
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHhhC
Confidence 9998654322 234578999999999999999999999999999999999999999744211 11111111100
Q ss_pred cCC---------c-chhccccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 649 EGT---------A-MEAVDKSL---GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 649 ~~~---------~-~~~ld~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
... . ........ ...........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0 00000000 00011111234567888999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=365.46 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=192.4
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccEEeeeeeEecC------CeeEE
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNLVSILGCCIEE------QEKML 495 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~------~~~~l 495 (743)
+|+..++||+|+||+||+|++. +|+.||||++...... +.+|+.+|++++|+||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999986 6999999999755322 34799999999999999999998543 35789
Q ss_pred EEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeecccccc
Q 041312 496 IYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIF 574 (743)
Q Consensus 496 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~ 574 (743)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433344567999999999999999999999998 99999999999999775 8999999999876
Q ss_pred CCCccccccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhH---------
Q 041312 575 GGDQIEENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVW--------- 644 (743)
Q Consensus 575 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~--------- 644 (743)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-----~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-----DQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHHHHHHHCCCCHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-----HHHHHHHHHhCCChHH
Confidence 54432 234689999999998875 57899999999999999999999998643211 0000000
Q ss_pred --hHhccC----CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 645 --DLWKEG----TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 645 --~~~~~~----~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
...... .....................+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000000000011111234667888999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=358.65 Aligned_cols=265 Identities=20% Similarity=0.291 Sum_probs=195.9
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec--------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-------- 489 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-------- 489 (743)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|+.+|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999975 7999999998644 33456778999999999999999999999865
Q ss_pred CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeec
Q 041312 490 EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFG 569 (743)
Q Consensus 490 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFG 569 (743)
....++||||+.++.+.... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999888776554 23456888899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhH
Q 041312 570 MARIFGGDQIE--ENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDL 646 (743)
Q Consensus 570 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 646 (743)
+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....+ ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHHh
Confidence 99876543322 122335799999999998765 689999999999999999999999864321 1111111111
Q ss_pred hc-----------cCCcchhcccccCCCCCHHH-------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 647 WK-----------EGTAMEAVDKSLGESCCAPE-------ILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 647 ~~-----------~~~~~~~ld~~l~~~~~~~~-------~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
.. .......+...........+ ...+++|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 10 00000011100111111111 1245678999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=359.25 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=194.2
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC------
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ------ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~------ 491 (743)
.++|+++++||+|+||+||+|++. +|+.||||++++. .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 6999999999754 3445678899999999999999999999998654
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+ +.+|..++ +...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 55666654 3346999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh---
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW--- 647 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 647 (743)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-----DQLKEIMKVTGTP 238 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCCC
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-----HHHHHHHhccCCC
Confidence 876433 2346899999999998764 5789999999999999999999998643210 0000000000
Q ss_pred -----ccCC----------cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCC
Q 041312 648 -----KEGT----------AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSM--LGSDNAP 703 (743)
Q Consensus 648 -----~~~~----------~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~ 703 (743)
.... ..+.....+. .........+.+|+.+||+.||.+|||+.|+++. |+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0000 0000000000 0001112245678889999999999999999985 6666543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-41 Score=349.90 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=201.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCCeeEEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~~~~lV~E 498 (743)
++|+++++||+|+||+||+|++. +++.||||+++.. .....+++++|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 7899999998644 34457889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccccccCCCc
Q 041312 499 YLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIFGGDQ 578 (743)
Q Consensus 499 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~~~~~ 578 (743)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999887763 3456789999999999999999999998 9999999999999999999999999998775433
Q ss_pred cccccccccccccccCcceeccCC-CCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC-------
Q 041312 579 IEENTNRVVGTYGYMAPEYAMEGL-FSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG------- 650 (743)
Q Consensus 579 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 650 (743)
. ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.|+..... .......+.......
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTT
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC----HHHHHHHHHhhcCCCChhhhhh
Confidence 2 223356788999999987765 68999999999999999999999753321 111111111111000
Q ss_pred -------Ccchhccccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 651 -------TAMEAVDKSL-GESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 651 -------~~~~~ld~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
.......... ...........+.+|+.+||+.||.+|||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 00011111234667888999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=358.24 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=195.6
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHhcCCccEEeeeeeEecCC----eeE
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS-SGQGIEEFKTEIALIAQLQHRNLVSILGCCIEEQ----EKM 494 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~~~----~~~ 494 (743)
.++|+++++||+|+||+||+|+.. +|+.||||++.+. .....+++++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999974 7999999999754 3445678999999999999999999999987653 335
Q ss_pred EEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccccc
Q 041312 495 LIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMARIF 574 (743)
Q Consensus 495 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~~ 574 (743)
++++++.+++|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677789999998842 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcceecc-CCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCCc
Q 041312 575 GGDQIE-ENTNRVVGTYGYMAPEYAME-GLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGTA 652 (743)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (743)
...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HHHHHHhhhccCCCh
Confidence 543322 22345689999999999855 56789999999999999999999998643210 000000000000000
Q ss_pred c-----------hhccc-ccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 041312 653 M-----------EAVDK-SLGESCCA-----PEILRCIHLGLLCVQEQATDRPNMSAVVSM 696 (743)
Q Consensus 653 ~-----------~~ld~-~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 696 (743)
. ..... .-...... .-...+.+|+.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000 00000000 011246788899999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=352.32 Aligned_cols=255 Identities=17% Similarity=0.282 Sum_probs=194.7
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEec--CCeeEEEE
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIE--EQEKMLIY 497 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 497 (743)
++|+++++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999975 7899999998654 3467899999999995 9999999999874 35689999
Q ss_pred EecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCC-CeEEeeeccccccCC
Q 041312 498 EYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAM-NPKISDFGMARIFGG 576 (743)
Q Consensus 498 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~vkl~DFGla~~~~~ 576 (743)
||+.+++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997653 35889999999999999999999999 99999999999998665 599999999987654
Q ss_pred CccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHh--------
Q 041312 577 DQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLW-------- 647 (743)
Q Consensus 577 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 647 (743)
... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~----~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH----HHHHHHHHHHHCHHHHHHH
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh----HHHHHHHHHHHCCchhhhh
Confidence 432 3346789999999998875 4799999999999999999999998754321 00000000000
Q ss_pred -c---cCC-----------cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 648 -K---EGT-----------AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 648 -~---~~~-----------~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
. ... ....................+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 00000000111111111234677888999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-40 Score=346.74 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=194.0
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||.||+|++. +|+.||||++...... +++..|++++++++|+|+ +.+..+..+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46999999999999999999975 6899999988654322 457889999999987764 5555666778889999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEec---CCCCeEEeeeccccccCC
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLD---AAMNPKISDFGMARIFGG 576 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~vkl~DFGla~~~~~ 576 (743)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 455554432 3346899999999999999999999998 99999999999986 355799999999998754
Q ss_pred Cccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 577 DQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 577 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--KRQKYERISEKKMSTP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHHHHHHSC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH--HHHHHHHhhcccCCCC
Confidence 3321 12345689999999999999999999999999999999999999987543211 1000000000000000
Q ss_pred cchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 652 AMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 652 ~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
. +.+...+ + ..+.+++..|++.+|++||++++|.+.|+.+
T Consensus 237 ~-----~~~~~~~-p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 I-----EVLCKGY-P---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp H-----HHHTTTS-C---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred h-----hHhccCC-C---HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 0111111 1 3356778899999999999999999988753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.7e-40 Score=342.72 Aligned_cols=260 Identities=16% Similarity=0.199 Sum_probs=201.3
Q ss_pred CCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC-ccEEeeeeeEecCCeeEEEEEe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH-RNLVSILGCCIEEQEKMLIYEY 499 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~ 499 (743)
++|++.++||+|+||+||+|++. +|+.||||++..... ...+++|++.++.++| +|++++++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999975 689999998865432 2457789999999975 8999999999999999999999
Q ss_pred cCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecC-----CCCeEEeeecccccc
Q 041312 500 LPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDA-----AMNPKISDFGMARIF 574 (743)
Q Consensus 500 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~vkl~DFGla~~~ 574 (743)
+ +++|.+++.. ....++...+..++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 8 6888887743 2346889999999999999999999998 999999999999964 578999999999876
Q ss_pred CCCccc-----cccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhcc
Q 041312 575 GGDQIE-----ENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKE 649 (743)
Q Consensus 575 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 649 (743)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQS 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHHHhccCC
Confidence 543211 1233468999999999999999999999999999999999999999743321 011111111111111
Q ss_pred CCcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 041312 650 GTAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPNMSAVVSMLGSD 700 (743)
Q Consensus 650 ~~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 700 (743)
....+ +.... + ..+.+++..|++.+|++||+++.+.+.|+.+
T Consensus 235 ~~~~~-----l~~~~-p---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPLRE-----LCAGF-P---EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCHHH-----HTTTS-C---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CChHH-----hcCCC-C---HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111 11112 2 2456677799999999999999998887653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=350.76 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=198.6
Q ss_pred CCCCcCcccccCCceeEEEEEEc----CCcEEEEEEcccC----ChhcHHHHHHHHHHHHhcCC-ccEEeeeeeEecCCe
Q 041312 422 NDFSSDNKLGEGGFGSVYKGVLQ----NGKEIAVKRLSRS----SGQGIEEFKTEIALIAQLQH-RNLVSILGCCIEEQE 492 (743)
Q Consensus 422 ~~y~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~Ev~~l~~l~h-~niv~l~~~~~~~~~ 492 (743)
++|++.++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 4889999998643 22345678899999999966 899999999999999
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999998853 335678888999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcceeccC--CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccC
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEG--LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEG 650 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (743)
.+....... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||...... .............
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-----~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-----NSQAEISRRILKS 251 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-----CCHHHHHHHHHHC
T ss_pred hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcccC
Confidence 765443332 3346899999999999764 4788999999999999999999998754321 1111111111111
Q ss_pred CcchhcccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 041312 651 TAMEAVDKSLGESCCAPEILRCIHLGLLCVQEQATDRPN-----MSAVVS 695 (743)
Q Consensus 651 ~~~~~ld~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 695 (743)
.. ..+......+.+++.+||+.||.+||| ++|+++
T Consensus 252 ~~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EP----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10 011112345667888999999999995 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=350.45 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=189.4
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec------CC
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE------EQ 491 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~------~~ 491 (743)
.++|+++++||+|+||+||+|++. +|+.||||++... ......++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999976 6999999999754 34456678999999999999999999999964 36
Q ss_pred eeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeeccc
Q 041312 492 EKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMA 571 (743)
Q Consensus 492 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla 571 (743)
..++||||+.++.+..+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 78999999987665443 234789999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccC----------CCcc----
Q 041312 572 RIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQG----------SGSW---- 637 (743)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~----------~~~~---- 637 (743)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8765432 2334678999999999999999999999999999999999999986432100 0000
Q ss_pred ccchhhHhHhccC------CcchhcccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 041312 638 NLVGHVWDLWKEG------TAMEAVDKSLGES---CCAPEILRCIHLGLLCVQEQATDRPNMSAVVS 695 (743)
Q Consensus 638 ~~~~~~~~~~~~~------~~~~~ld~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 695 (743)
............. .........+... ........+.+|+.+||+.||++|||++||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000000 0001111111111 11223456788999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=346.36 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=195.7
Q ss_pred cCCCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHhcCCccEEeeeeeEec-----CCe
Q 041312 421 TNDFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRS--SGQGIEEFKTEIALIAQLQHRNLVSILGCCIE-----EQE 492 (743)
Q Consensus 421 ~~~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ev~~l~~l~h~niv~l~~~~~~-----~~~ 492 (743)
.++|+++++||+|+||+||+|++. +|+.||||++.+. .....+++.+|+.+|++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999975 7999999999754 33455678999999999999999999999863 334
Q ss_pred eEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 493 KMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 493 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.++|||++.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999873 345899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccCcceeccC-CCCccccchhHHHHHHHHHhcCCCCCCCcccCCCccccchhhHhHhccCC
Q 041312 573 IFGGDQIEENTNRVVGTYGYMAPEYAMEG-LFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGSWNLVGHVWDLWKEGT 651 (743)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (743)
..... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||..... ......+........
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-----~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTPG 239 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCC
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCC
Confidence 65322 3346789999999987765 468999999999999999999999864321 111111100000000
Q ss_pred -----------cchhcccccC-CCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhcCCC
Q 041312 652 -----------AMEAVDKSLG-ESCCA-----PEILRCIHLGLLCVQEQATDRPNMSAVVS--MLGSDN 701 (743)
Q Consensus 652 -----------~~~~ld~~l~-~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~ 701 (743)
.......... ..... .....+.+|+.+||+.||.+|||+.|+++ .|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000000000 00000 11234667888999999999999999997 455543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-36 Score=321.63 Aligned_cols=280 Identities=18% Similarity=0.214 Sum_probs=201.2
Q ss_pred CCCcCcccccCCceeEEEEEEc-CCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-----------CccEEeeeeeEec-
Q 041312 423 DFSSDNKLGEGGFGSVYKGVLQ-NGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-----------HRNLVSILGCCIE- 489 (743)
Q Consensus 423 ~y~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-----------h~niv~l~~~~~~- 489 (743)
+|+++++||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999999999999975 79999999996543 33567888999998886 4789999988764
Q ss_pred -CCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCC-----
Q 041312 490 -EQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMN----- 562 (743)
Q Consensus 490 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~----- 562 (743)
....+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 35667788877666554444444556678889999999999999999997 66 999999999999986553
Q ss_pred -eEEeeeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHHHHHHhcCCCCCCCcccCCCc-cccc
Q 041312 563 -PKISDFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLLLEIILGRRNNTFHLEQGSGS-WNLV 640 (743)
Q Consensus 563 -vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil~elltG~~p~~~~~~~~~~~-~~~~ 640 (743)
+|++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.......... ....
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999865322 234679999999999999999999999999999999999999987543211000 0000
Q ss_pred hhhHhHhc--------c----------CCcchhccc----------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 041312 641 GHVWDLWK--------E----------GTAMEAVDK----------SLGESCCAPEILRCIHLGLLCVQEQATDRPNMSA 692 (743)
Q Consensus 641 ~~~~~~~~--------~----------~~~~~~ld~----------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 692 (743)
......+. . ......+.. .............+.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00000000 0 000000000 0012234456677899999999999999999999
Q ss_pred HHHH--hc---CCCCCCCCCCCcc
Q 041312 693 VVSM--LG---SDNAPSSPKHPAF 711 (743)
Q Consensus 693 vl~~--L~---~~~~~~~p~~~~~ 711 (743)
+++. |+ .......|+.|.+
T Consensus 325 ~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HhcCcccCCCCCcccCCCCCcccC
Confidence 9874 43 3344556666655
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.6e-22 Score=195.92 Aligned_cols=169 Identities=20% Similarity=0.193 Sum_probs=121.1
Q ss_pred CcCcccccCCceeEEEEEEcCCcEEEEEEcccCCh------------------hcHHHHHHHHHHHHhcCCccEEeeeee
Q 041312 425 SSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSG------------------QGIEEFKTEIALIAQLQHRNLVSILGC 486 (743)
Q Consensus 425 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ev~~l~~l~h~niv~l~~~ 486 (743)
.+.++||+|+||.||+|+..+|+.||||+++.... ........|...+.++.|.++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999999999999998753210 112345578899999999999887765
Q ss_pred EecCCeeEEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhccCCCceEeccCCCCcEEecCCCCeEEe
Q 041312 487 CIEEQEKMLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQDSRLRIIHRDLKASNVLLDAAMNPKIS 566 (743)
Q Consensus 487 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~vkl~ 566 (743)
. ..+++|||+++..+.. ++......++.|++++|.|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998866543 333445679999999999999998 9999999999999865 59999
Q ss_pred eeccccccCCCccccccccccccccccCcceeccCCCCccccchhHHHHH
Q 041312 567 DFGMARIFGGDQIEENTNRVVGTYGYMAPEYAMEGLFSTKSDVYSFGVLL 616 (743)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDiwSlGvil 616 (743)
|||+|.............+.+ . .-.|. ....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~---~-~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDV---R-NIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHH---H-HHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHH---H-HHHHH-HcCCCCCcccHHHHHHHH
Confidence 999997654222111000000 0 00111 245678899999976443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.82 E-value=3.9e-20 Score=161.58 Aligned_cols=112 Identities=19% Similarity=0.394 Sum_probs=93.2
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
+|||.|||.|.+|+.|+ +|.|+|.|...|+ |.|+.. .++||.||++.|.. .+.|.|+.||+|+|.+.
T Consensus 1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEE--ECCEEEEEcCCCC-----EEEEcC----CcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 59999999999999998 4999999988777 777653 58999999998854 35799999999999974
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcc
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSA 132 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtD 132 (743)
+. .+|++++.... ...+|+|+|+|||||+ +..+.++|||+.+|++
T Consensus 68 -~~-~~w~s~t~~~~-~~~~l~L~ddGNlvly-~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SR-AIWASNTNRQN-GNYYLILQRDRNVVIY-DNSNNAIWATHTNVGN 112 (112)
T ss_dssp -TE-EEEECCCCCSC-CCCEEEECTTSCEEEE-CTTSCEEEECCCCCCC
T ss_pred -CC-eEEEEeeccCC-CceEEEEcCCCCEEEE-CCCCcEEecCCCccCC
Confidence 33 47877765432 4457999999999999 5677899999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.78 E-value=2.8e-19 Score=154.55 Aligned_cols=107 Identities=20% Similarity=0.375 Sum_probs=89.8
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
.|+|.+||.|..|+.|. +|.|.|.|...|+ |.||.. .++||.||++.|.. .+.|.+..+|+|+|.+.
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~--~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGLSR--SCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCS--SCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCCCC--ccEEEEeccceEEEECC
Confidence 48999999999999996 6999999998888 888764 47899999998843 46799999999999976
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCC
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDH 129 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~ 129 (743)
.+. +||++++.... ...+|+|+|+|||||++ ..+||||+|
T Consensus 68 ~g~-~vWsS~t~~~~-~~~~l~L~ddGNlVly~----~~~W~S~t~ 107 (108)
T d1jpca_ 68 SNK-PIWASNTGGQN-GNYVCILQKDRNVVIYG----TDRWATGTH 107 (108)
T ss_dssp TCC-EEEECCCCCSC-SCEEEEECTTSCEEEEE----CCCCCCCCC
T ss_pred Ccc-ceEEccccCCC-CcEEEEEcCCCCEEEeC----CCcccCCCC
Confidence 554 69999976543 34578999999999983 359999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.77 E-value=1.1e-18 Score=150.77 Aligned_cols=108 Identities=17% Similarity=0.281 Sum_probs=88.8
Q ss_pred ccccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeC
Q 041312 4 VDTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGR 83 (743)
Q Consensus 4 ~~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~ 83 (743)
.|+|.|||.|.+|+.|+ +|.|.|+|...++ |.++. ..++||+||++.|... .+.|.|+.||+|+|.+.
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECS
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeC
Confidence 38999999999999997 5889999987666 66664 3589999999999865 45899999999999976
Q ss_pred CCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCC
Q 041312 84 NQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDH 129 (743)
Q Consensus 84 ~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~ 129 (743)
++. +||+++++... ...+|+|+|+|||||++ ..+|||+-|
T Consensus 69 ~g~-~vW~s~t~~~~-~~~~l~L~ddGNlvly~----~~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGR-SLWASHSVRGN-GNYVLVLQEDGNVVIYG----SDIWSTGTY 108 (109)
T ss_dssp SSC-EEEECCCCCCS-SCCEEEECTTSCEEEEC----CEEEECCCC
T ss_pred CCc-EEEEEeeECCC-CCEEEEEeCCCcEEEEC----CCEecCCCc
Confidence 554 59999976533 34579999999999983 369999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=1.9e-16 Score=138.85 Aligned_cols=103 Identities=21% Similarity=0.321 Sum_probs=84.4
Q ss_pred EEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCc
Q 041312 42 GIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQ 121 (743)
Q Consensus 42 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~ 121 (743)
-|||.+++.++.+|++|++.|+....-+|.+..||||+|.+. + .++|++++...+ ....|+|+++|||||+ +.+++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~-~~vW~s~t~~~~-~~~~~~l~~~GnLvl~-d~~~~ 86 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-D-DRVWSTNTAGKG-TGCRAVLQPNGRMDVL-TNQNI 86 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-T-BCCSCCCCCSSC-SSCEEEEETTTEEEEE-ETTTE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-C-cEEEEEccccCC-CcEEEEEeCCeeEEEE-cCCCC
Confidence 599999999999999999999988777899999999999964 3 358999977543 3467999999999998 45789
Q ss_pred eeeeecCCCcccccccccccccccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEE
Q 041312 122 TLWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLY 181 (743)
Q Consensus 122 ~~WqSFd~PtDtllpg~kl~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~ 181 (743)
+|||||. +.++|.|.+.|+++|.. +++
T Consensus 87 ~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnl--vlY 113 (120)
T d1dlpa2 87 AVWTSGN-------------------------------SRSAGRYVFVLQPDRNL--AIY 113 (120)
T ss_dssp EEEECCC-------------------------------CCSSSCCEEEECSSSCE--EEE
T ss_pred EEEEeCC-------------------------------CCCCCcEEEEECCCCcE--EEe
Confidence 9999973 23668899999999984 445
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.50 E-value=6.2e-15 Score=127.62 Aligned_cols=110 Identities=23% Similarity=0.328 Sum_probs=89.3
Q ss_pred EEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCce
Q 041312 43 IWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQT 122 (743)
Q Consensus 43 iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~ 122 (743)
|||.-.+..+..|+.+.+.++.....+|.+..||||||.+. + .++|++++.+. .+..|.|+++|||||+ +..+.+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~-~~vW~s~t~~~--~~~~l~l~~dGNLvl~-d~~~~~ 77 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-D-VRVWASNTAGA--TGCRAVLQSDGLLVIL-TAQNTI 77 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-S-SEEECCCCCSC--SCCBCCBCSSSCBCCB-CTTTCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-C-eeEEEcccCCC--CceEEEEeccCCEEEE-ccCCCE
Confidence 77876777788899999999988778899999999999863 3 46999998653 3456999999999998 567789
Q ss_pred eeeecCCCcccccccccccccccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecc
Q 041312 123 LWQSFDHPSATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGS 192 (743)
Q Consensus 123 ~WqSFd~PtDtllpg~kl~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 192 (743)
||||+- +.++|.|.+.|+++|.. +++ +.++|.+|.
T Consensus 78 vWsS~t-------------------------------~~~~g~y~l~Lq~DGNl--vlY--~~~~Wssgt 112 (115)
T d1dlpa1 78 RWSSGT-------------------------------KGSIGNYVLVLQPDRTV--TIY--GPGLWDSGT 112 (115)
T ss_dssp SCCCCC-------------------------------CCCSSCCEEEECSSSCE--EEE--CSEEEECSC
T ss_pred EEEcCC-------------------------------CCCCCCEEEEECCCCcE--EEe--CCCeecCCC
Confidence 999863 33679999999999984 555 347898874
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.47 E-value=1.3e-13 Score=119.97 Aligned_cols=103 Identities=16% Similarity=0.332 Sum_probs=78.8
Q ss_pred cccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCC
Q 041312 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRN 84 (743)
Q Consensus 5 ~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~ 84 (743)
+||.++|+| .+.+..|.|.|.|-..|+ |.++ . ..++||.||+..|.. .+.|.|..||+|+|.+..
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence 445555554 346789999999988877 6654 2 368999999987753 468999999999999766
Q ss_pred CCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecC
Q 041312 85 QTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFD 128 (743)
Q Consensus 85 ~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd 128 (743)
+. +||++++.... ...+|+|+|+|||||+. .++|||-.
T Consensus 80 g~-~vWsS~t~~~~-~~~~l~Lq~DGNlvlYg----~~~W~S~T 117 (119)
T d1b2pa_ 80 NV-TVWQSPVAGKA-GHYVLVLQPDRNVVIYG----DALWATQT 117 (119)
T ss_dssp CC-EEEECSCCCCS-SCEEEEECTTSCEEEEE----SEEEECCC
T ss_pred Cc-EEEECCCcCCC-CceEEEEcCCCCEEEEC----CCEeccCC
Confidence 55 59999976543 34579999999999982 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.18 E-value=2.1e-11 Score=105.10 Aligned_cols=100 Identities=21% Similarity=0.306 Sum_probs=76.9
Q ss_pred CCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCCCCc
Q 041312 8 TSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRNQTV 87 (743)
Q Consensus 8 ~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~~~~ 87 (743)
+..|.|.++|.| .+|.|.|.|-..|+ |.|+.. .++||.+|...+ ..+.+.|..+|+|||.+..+.
T Consensus 12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~----~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~- 76 (115)
T d1dlpa1 12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNT- 76 (115)
T ss_dssp CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTC-
T ss_pred CCcceecCCCcE--EcCCEEEEECCCCe-----EEEEcC----CeeEEEcccCCC---CceEEEEeccCCEEEEccCCC-
Confidence 445677777777 47889999988877 777642 578999986543 346899999999999976555
Q ss_pred eEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeec
Q 041312 88 PVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSF 127 (743)
Q Consensus 88 ~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSF 127 (743)
+||++.+.... ...+++|+++|||||+ +..+|+|-
T Consensus 77 ~vWsS~t~~~~-g~y~l~Lq~DGNlvlY----~~~~Wssg 111 (115)
T d1dlpa1 77 IRWSSGTKGSI-GNYVLVLQPDRTVTIY----GPGLWDSG 111 (115)
T ss_dssp CSCCCCCCCCS-SCCEEEECSSSCEEEE----CSEEEECS
T ss_pred EEEEcCCCCCC-CCEEEEECCCCcEEEe----CCCeecCC
Confidence 59999876543 4457999999999998 24799984
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.87 E-value=3.6e-09 Score=90.12 Aligned_cols=84 Identities=26% Similarity=0.521 Sum_probs=62.6
Q ss_pred cEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCC
Q 041312 69 VLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGL 148 (743)
Q Consensus 69 ~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~ 148 (743)
+|.+..||||||.+ +..+||++++.+.. ....+.|.++|||||+ +..+.++|+| +
T Consensus 22 ~l~~q~DGNLvly~--~~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~-~~~g~~vWsS-----~---------------- 76 (108)
T d1jpca_ 22 VFIMQEDCNLVLYD--VDKPIWATNTGGLS-RSCFLSMQTDGNLVVY-NPSNKPIWAS-----N---------------- 76 (108)
T ss_dssp EEEECTTSCEEEEE--TTEEEEECCCTTSC-SSCEEEECTTSCEEEE-CTTCCEEEEC-----C----------------
T ss_pred EEEECCCCeEEEEe--CCceeeEeCCCCCC-CccEEEEeccceEEEE-CCCccceEEc-----c----------------
Confidence 68889999999985 34569999987653 3457999999999998 6678999986 1
Q ss_pred ceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEec
Q 041312 149 NRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVG 191 (743)
Q Consensus 149 ~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 191 (743)
+....+.|.+.|+++|. ++++.. +.|.++
T Consensus 77 ----------t~~~~~~~~l~L~ddGN--lVly~~--~~W~S~ 105 (108)
T d1jpca_ 77 ----------TGGQNGNYVCILQKDRN--VVIYGT--DRWATG 105 (108)
T ss_dssp ----------CCCSCSCEEEEECTTSC--EEEEEC--CCCCCC
T ss_pred ----------ccCCCCcEEEEEcCCCC--EEEeCC--CcccCC
Confidence 11145678899999998 445533 466655
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.87 E-value=2.4e-09 Score=92.80 Aligned_cols=97 Identities=20% Similarity=0.329 Sum_probs=67.1
Q ss_pred cccCCCCCcCCCCEEEeCCCeEEEeeeCCCCCCceEEEEEecccCCCeEEEeecCCCCCccCCccEEEeecCcEEEEeCC
Q 041312 5 DTITSNQPIKDGDVIVSSGNIFALGFFSPGNSVRRYVGIWYNQIPVQTVVWVANRDNPINDTSGVLTISSLGNLVLCGRN 84 (743)
Q Consensus 5 ~~~~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~y~giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~G~L~l~~~~ 84 (743)
++|.++|+|.. |.|.|.|=..|+ |.|+. ...+||.+|- +..+..+.+.|..+|||||.+..
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLFD----RDDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEEEB----TTBCCSCCCC--CSSCSSCEEEEETTTEEEEEETT
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEec----CCcEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCC
Confidence 45556666554 456666644444 55553 2467898874 33344568999999999999865
Q ss_pred CCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeee
Q 041312 85 QTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQS 126 (743)
Q Consensus 85 ~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqS 126 (743)
+. ++|++++.... ....++|.++|||||+ +..+|.|
T Consensus 85 ~~-~lW~S~t~~~~-~~~~l~Lq~DGnlvlY----~~~~W~t 120 (120)
T d1dlpa2 85 NI-AVWTSGNSRSA-GRYVFVLQPDRNLAIY----GGALWTT 120 (120)
T ss_dssp TE-EEEECCCCCSS-SCCEEEECSSSCEEEE----CCCCCBC
T ss_pred CC-EEEEeCCCCCC-CcEEEEECCCCcEEEe----CCCcccC
Confidence 54 59999986543 3457999999999998 2368875
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.81 E-value=1.1e-08 Score=87.02 Aligned_cols=86 Identities=27% Similarity=0.540 Sum_probs=65.4
Q ss_pred cEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCC
Q 041312 69 VLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGL 148 (743)
Q Consensus 69 ~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~ 148 (743)
.|.+..||||||.. ...+||++++......+..+.|.++|||||+ +..+.++|+| +|
T Consensus 22 ~l~~q~dgnLvl~~--~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~-~~~g~~vW~s-----~t--------------- 78 (109)
T d1kj1a_ 22 HFIMQEDCNLVLYD--HSTSVWASNTGILGKKGCKAVLQSDGNFVVY-DAEGRSLWAS-----HS--------------- 78 (109)
T ss_dssp EEEECTTSCEEEEE--TTEEEEECCCCCTTCCCCEEEECTTSCEEEE-CSSSCEEEEC-----CC---------------
T ss_pred EEEecCCCeEEEEe--CCEEEEEeCCCCCCceeEEEEEcCCceEEEE-eCCCcEEEEE-----ee---------------
Confidence 67888999999985 3456999998766555677999999999998 5678899987 11
Q ss_pred ceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecc
Q 041312 149 NRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGS 192 (743)
Q Consensus 149 ~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 192 (743)
....|.|.+.|+++|. ++++. .+.|.++.
T Consensus 79 -----------~~~~~~~~l~L~ddGN--lvly~--~~~W~S~t 107 (109)
T d1kj1a_ 79 -----------VRGNGNYVLVLQEDGN--VVIYG--SDIWSTGT 107 (109)
T ss_dssp -----------CCCSSCCEEEECTTSC--EEEEC--CEEEECCC
T ss_pred -----------ECCCCCEEEEEeCCCc--EEEEC--CCEecCCC
Confidence 1134678999999998 45554 35787764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.70 E-value=3e-08 Score=85.50 Aligned_cols=85 Identities=26% Similarity=0.436 Sum_probs=63.8
Q ss_pred cEEEeecCcEEEEeCCCCceEEeeeccCCCCCceEEEEccCCCeeEEecCCCceeeeecCCCcccccccccccccccCCC
Q 041312 69 VLTISSLGNLVLCGRNQTVPVWHANVSDSSESNTIAQLLDTGNLVLARNNTGQTLWQSFDHPSATMLPYMKIGLDKRSGL 148 (743)
Q Consensus 69 ~l~~~~~G~L~l~~~~~~~~~ws~~~~~~~~~~~~~~lld~GNlvl~~~~~~~~~WqSFd~PtDtllpg~kl~~~~~~g~ 148 (743)
.|.+..||||||.+. ..++|++++.+.. .+..+.|.++|||||+ +..+.++|+|. |-
T Consensus 33 ~l~mQ~DGNLVLy~~--~~~vWssnt~~~~-~~~~l~l~~dGnLvL~-d~~g~~vWsS~-----t~-------------- 89 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN--NNPIWATNTGGLG-NGCRAVLQPDGVLVVI-TNENVTVWQSP-----VA-------------- 89 (119)
T ss_dssp EEEECTTSCEEEEET--TEEEEECCCTTSC-SSCEEEECTTSCEEEE-CTTCCEEEECS-----CC--------------
T ss_pred EEEECCCCcEEEEEC--CeEEEEecCCCCC-cceEEEEEeCCCEEEE-CCCCcEEEECC-----Cc--------------
Confidence 578889999999853 3469999986543 3467999999999998 56788999862 10
Q ss_pred ceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecc
Q 041312 149 NRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGS 192 (743)
Q Consensus 149 ~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 192 (743)
-+.|.|.+.|+++|.. +++. .+.|.++.
T Consensus 90 ------------~~~~~~~l~Lq~DGNl--vlYg--~~~W~S~T 117 (119)
T d1b2pa_ 90 ------------GKAGHYVLVLQPDRNV--VIYG--DALWATQT 117 (119)
T ss_dssp ------------CCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred ------------CCCCceEEEEcCCCCE--EEEC--CCEeccCC
Confidence 1446789999999984 4453 46887763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2e-07 Score=92.63 Aligned_cols=150 Identities=16% Similarity=0.094 Sum_probs=102.4
Q ss_pred hhHHHHcCCCCcCcccccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcC-CccEEeeeeeEecCCee
Q 041312 415 SNIAAATNDFSSDNKLGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQ-HRNLVSILGCCIEEQEK 493 (743)
Q Consensus 415 ~~l~~~~~~y~~~~~LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~-h~niv~l~~~~~~~~~~ 493 (743)
.++......|+..+..+.++.+.||+... +++.+++|+...........+..|+..+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35666677888766655555678998764 56678889876554444556778888888774 33467778888888899
Q ss_pred EEEEEecCCCChhhhhhhcccccccCHHHHHHHHHHHHHHHHHhhcc---------------------------------
Q 041312 494 MLIYEYLPNKSLDVYIFDEAKRSLLDWSKRFEIICGIARGILYLHQD--------------------------------- 540 (743)
Q Consensus 494 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------------------------------- 540 (743)
++||+++++..+....... .....++.++++.++.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998875543211 11122344444444444411
Q ss_pred -----------------------CCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 541 -----------------------SRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 541 -----------------------~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 122389999999999999876677999998763
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.23 E-value=2.4e-06 Score=72.68 Aligned_cols=104 Identities=13% Similarity=0.081 Sum_probs=65.7
Q ss_pred cccccccccccccccCCCceeEEeccCCCCCCCCCceEEeeeCCCceEEEEcCCeeEEEecccCCccceeeeee------
Q 041312 131 SATMLPYMKIGLDKRSGLNRFLTSWKSWDNPATGDYTFRMELDGFPQLFLYKGEAKWWRVGSWTGKNFLNATYI------ 204 (743)
Q Consensus 131 tDtllpg~kl~~~~~~g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~w~g~~~~~~~~~------ 204 (743)
||||+|||.|..+.. |++ |.|+|.|+.+|. ++++....++|.++......-....+.
T Consensus 1 tDtL~~gq~L~~g~~------l~~---------g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLv 63 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGS------LAE---------GGYLFIIQNDCN--LVLYDNNRAVWASGTNGKASGCVLKMQNDGNLV 63 (112)
T ss_dssp CCEEETTEEECTTCE------EEE---------TTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSEEEEECTTSCEE
T ss_pred CCEecCCCEecCCCE------EEE---------CCEEEEEcCCCC--EEEEcCCcEEEEccCccCCCCcEEEEeccccEE
Confidence 799999999988766 654 999999999998 667788899998875432211111111
Q ss_pred -ecCCcEEEEEEeeCCCeEEEEEEccCCcEEEEEeecCCCceEEEecCCCCCC
Q 041312 205 -DNEDEVSMAYSVTDPSMLTRIVVNESGNEQRLTWSNQENRWIEYFAPPKEPC 256 (743)
Q Consensus 205 -~~~~~~~~~~~~~~~s~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 256 (743)
.+.................+++|..||++++|.- .....|+...+.|
T Consensus 64 l~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 64 IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVG 111 (112)
T ss_dssp EEETTEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCC
T ss_pred EEecCCeEEEEeeccCCCceEEEEcCCCCEEEECC-----CCcEEecCCCccC
Confidence 1112221111122223346899999999999842 1235566555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.5e-05 Score=78.13 Aligned_cols=131 Identities=18% Similarity=0.175 Sum_probs=86.0
Q ss_pred ccccCCc-eeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCC--ccEEeeeeeEecCCeeEEEEEecCCCCh
Q 041312 429 KLGEGGF-GSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQH--RNLVSILGCCIEEQEKMLIYEYLPNKSL 505 (743)
Q Consensus 429 ~LG~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL 505 (743)
.+..|.. ..||+...+++..+++|....... ..+..|+..++.+.. -.+.+++.+..+.+..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 678999888888899998654432 246677777777643 3356778888888889999999998776
Q ss_pred hhhhhhcccccccCHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 041312 506 DVYIFDEAKRSLLDWSKRFEIICGIARGILYLH----------------------------------------------- 538 (743)
Q Consensus 506 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH----------------------------------------------- 538 (743)
..... .. ..++.++.+.|.-||
T Consensus 94 ~~~~~--------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL--------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC--------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc--------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 43210 00 011122222222222
Q ss_pred ----c----cCCCceEeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 539 ----Q----DSRLRIIHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 539 ----~----~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
. .....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 1123489999999999999876678999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00026 Score=73.86 Aligned_cols=76 Identities=13% Similarity=0.225 Sum_probs=49.3
Q ss_pred cccccCCceeEEEEEEcC-CcEEEEEEcccC-------ChhcHHHHHHHHHHHHhcC-C--ccEEeeeeeEecCCeeEEE
Q 041312 428 NKLGEGGFGSVYKGVLQN-GKEIAVKRLSRS-------SGQGIEEFKTEIALIAQLQ-H--RNLVSILGCCIEEQEKMLI 496 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~Ev~~l~~l~-h--~niv~l~~~~~~~~~~~lV 496 (743)
+.||.|....||+....+ ++.++||.-... .....++...|...|+.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 579999999999998754 678999964321 1123345667888887663 2 345555543 45567899
Q ss_pred EEecCCCCh
Q 041312 497 YEYLPNKSL 505 (743)
Q Consensus 497 ~E~~~~gsL 505 (743)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.00071 Score=68.54 Aligned_cols=135 Identities=13% Similarity=0.144 Sum_probs=78.7
Q ss_pred eeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE--Eeeee-----eEecCCeeEEEEEecCCCChhhh
Q 041312 436 GSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL--VSILG-----CCIEEQEKMLIYEYLPNKSLDVY 508 (743)
Q Consensus 436 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni--v~l~~-----~~~~~~~~~lV~E~~~~gsL~~~ 508 (743)
-.||+++..+|+.+++|+.+.. ....+++..|...+..|...++ +..+. .+......+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999999999999987543 3355778889988888853332 22211 12345567889999987654211
Q ss_pred ----hh----------h------cccccccCHH----------------------HHHHHHHHHHHHHHHh-hccCCCce
Q 041312 509 ----IF----------D------EAKRSLLDWS----------------------KRFEIICGIARGILYL-HQDSRLRI 545 (743)
Q Consensus 509 ----l~----------~------~~~~~~l~~~----------------------~~~~i~~qi~~~L~yL-H~~~~~~i 545 (743)
+. . ...+..++.. .....+.++...+.-+ .......+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 0 0001111111 1112222233222221 22223458
Q ss_pred EeccCCCCcEEecCCCCeEEeeeccccc
Q 041312 546 IHRDLKASNVLLDAAMNPKISDFGMARI 573 (743)
Q Consensus 546 vH~Dikp~NIll~~~~~vkl~DFGla~~ 573 (743)
||+|+.|.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 56899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.45 E-value=0.0035 Score=65.07 Aligned_cols=73 Identities=15% Similarity=0.273 Sum_probs=49.9
Q ss_pred cccccCCceeEEEEEEcC--------CcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE-EeeeeeEecCCeeEEEEE
Q 041312 428 NKLGEGGFGSVYKGVLQN--------GKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL-VSILGCCIEEQEKMLIYE 498 (743)
Q Consensus 428 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 498 (743)
++|+.|-.-.+|+...++ .+.|.+++.. .. .......+|..+++.+.-.++ .++++++.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 688999999999998754 2456666654 22 233455688999888853344 466666643 68999
Q ss_pred ecCCCChh
Q 041312 499 YLPNKSLD 506 (743)
Q Consensus 499 ~~~~gsL~ 506 (743)
|+++..+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99886653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.14 E-value=0.026 Score=56.03 Aligned_cols=157 Identities=14% Similarity=0.036 Sum_probs=83.1
Q ss_pred ChhhHHHHcCCCCcCcc-----cccCCceeEEEEEEcCCcEEEEEEcccCChhcHHHHHHHHHHHHhcCCccE--Eeeee
Q 041312 413 DLSNIAAATNDFSSDNK-----LGEGGFGSVYKGVLQNGKEIAVKRLSRSSGQGIEEFKTEIALIAQLQHRNL--VSILG 485 (743)
Q Consensus 413 ~~~~l~~~~~~y~~~~~-----LG~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ev~~l~~l~h~ni--v~l~~ 485 (743)
+.+++.....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..+++..|+.++..|...++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 44566777777766443 44666678899887765 48999875432 22345567777777753322 11111
Q ss_pred ------eEecCCeeEEEEEecCCCChhhhhhh--------------------------------------cccccccCHH
Q 041312 486 ------CCIEEQEKMLIYEYLPNKSLDVYIFD--------------------------------------EAKRSLLDWS 521 (743)
Q Consensus 486 ------~~~~~~~~~lV~E~~~~gsL~~~l~~--------------------------------------~~~~~~l~~~ 521 (743)
..........++.++.+......... ..........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11223455667777766543211000 0000000111
Q ss_pred HHHHHHHHHHHHHHHhhc-cCCCceEeccCCCCcEEecCCCCeEEeeecccc
Q 041312 522 KRFEIICGIARGILYLHQ-DSRLRIIHRDLKASNVLLDAAMNPKISDFGMAR 572 (743)
Q Consensus 522 ~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~vkl~DFGla~ 572 (743)
.....+..+...+...+. .-..++||+|+.+.||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222222332222 113359999999999999988777899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.82 E-value=0.11 Score=32.01 Aligned_cols=33 Identities=39% Similarity=0.988 Sum_probs=25.4
Q ss_pred CCCCcccCCCCCCccCCCCCCCCCcccccCCCCCCC
Q 041312 254 EPCDFYGHCGSNSNCNPYRVYDEYECTCLPGFEPKS 289 (743)
Q Consensus 254 ~~Cd~~~~CG~~g~C~~~~~~~~~~C~C~~gf~~~~ 289 (743)
|.|.+-..||. |.|+. ...+-.|.|-.||+|..
T Consensus 2 dECsignpCGn-GTCtN--viGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKN--VIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSSS-SCEEE--CSSSEEECCSSSSCCCS
T ss_pred CccccCCccCC-ceeee--cccceEEeecCCcCCCc
Confidence 67888899984 88863 33446799999999965
|